v1	geneId	geneSymbol	DSI	DPI	diseaseId	diseaseName	diseaseType	diseaseClass	diseaseSemanticType	score	EI	YearInitial	YearFinal	NofPmids	NofSnps	source
7	2	A2M	0.529	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.51	1	2004	2004	1	0	CTD_human
76	16	AARS1	0.647	0.462	C2750090	Charcot-Marie-Tooth Disease, Axonal, Type 2n	disease	C16;C10	Disease or Syndrome	0.71	1	2010	2019	5	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
77	16	AARS1	0.647	0.462	C4225361	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29	disease		Disease or Syndrome	0.7	1	2015	2017	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
100	18	ABAT	0.628	0.538	C0277839	Hoffmans Reflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0277850	Reflex, Pendular	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0278211	Reflex, Corneal, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0342708	Gamma aminobutyric acid transaminase deficiency	disease	C16;C18	Disease or Syndrome	0.70	1	1998	2019	   5	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       18	ABAT	0.628	0.538	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0424230	Motor retardation	phenotype	C23;C10;F01	Finding	0.40	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
       18	ABAT	0.628	0.538	C0427201	Floppy Muscles	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0427202	Muscle Tone Atonic	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0522345	Reflex, Acoustic, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.40	1	2016	2016	   1	   0	GENOMICS_ENGLAND
       18	ABAT	0.628	0.538	C0558845	Reflex, Ankle, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0558846	Reflex, Triceps, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0558847	Reflex, Biceps, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0576612	Reflex, Anal, Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0743002	Abnormal Deep Tendon Reflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751330	Unilateral Hypotonia	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751456	Developmental Psychomotor Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751468	Bulbocavernosus Reflex, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751469	Bulbocavernousus Reflex Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751470	Palmo-Mental Reflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751471	Reflex, Anal, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751472	Reflex, Ankle, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751473	Reflex, Ankle, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751474	Reflex, Biceps, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751475	Reflex, Biceps, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751476	Reflex, Gag, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751477	Reflex, Knee, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751478	Reflex, Knee, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751479	Reflex, Moro, Asymmetric	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751480	Reflex, Triceps, Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751481	Reflex, Triceps, Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C2267233	Neonatal Hypotonia	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
       18	ABAT	0.628	0.538	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	0.992	2000	2020	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.52	1	2012	2018	   1	   1	CTD_human;UNIPROT
       19	ABCA1	0.467	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.55	1	2002	2017	   1	   0	CTD_human;GENOMICS_ENGLAND
       19	ABCA1	0.467	0.846	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.33	1	2003	2019	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
       19	ABCA1	0.467	0.846	C0039292	Tangier Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	0.991	1999	2019	  23	  24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       19	ABCA1	0.467	0.846	C0342898	Apolipoprotein A-I deficiency	phenotype	C16;C18	Pathologic Function	0.30	1	2004	2012	   2	   0	ORPHANET
       19	ABCA1	0.467	0.846	C0473527	Hypoalphalipoproteinemias	disease	C16;C18	Disease or Syndrome	0.40	1	2002	2020	   0	   0	CTD_human
       19	ABCA1	0.467	0.846	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.52	1	2005	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
       19	ABCA1	0.467	0.846	C0751544	Tangier Disease Neuropathy	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2007	   3	   0	CTD_human
       19	ABCA1	0.467	0.846	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
       19	ABCA1	0.467	0.846	C1704429	Hypoalphalipoproteinemia, Familial	disease	C16;C18	Disease or Syndrome	0.80	0.972	1999	2017	   9	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       19	ABCA1	0.467	0.846	C2931838	Familial HDL deficiency	disease	C16;C18	Disease or Syndrome	0.40	1	1999	2017	   2	   0	CTD_human
       19	ABCA1	0.467	0.846	C3711531	Hdl Deficiency, Type 2	disease	C16;C18	Disease or Syndrome	0.30	1	1999	2001	   2	   0	CTD_human
       19	ABCA1	0.467	0.846	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
       21	ABCA3	0.592	0.615	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0013990	Pathological accumulation of air in tissues	phenotype	C23	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0020192	Hyaline Membrane Disease	disease	C16;C08	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.42	1	2014	2016	   1	   0	CTD_human
       21	ABCA3	0.592	0.615	C0035220	Respiratory Distress Syndrome, Newborn	disease	C16;C08	Disease or Syndrome	0.40	1	2006	2018	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C0085786	Hamman-Rich syndrome	disease	C23;C01;C08	Disease or Syndrome	0.40	1	2005	2014	   1	   2	ORPHANET
       21	ABCA3	0.592	0.615	C0852283	Respiratory Distress Syndrome	disease		Disease or Syndrome	0.40	1	2006	2018	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2008	2017	   1	   0	ORPHANET
       21	ABCA3	0.592	0.615	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.31	1	2014	2014	   1	   0	GENOMICS_ENGLAND
       21	ABCA3	0.592	0.615	C1970456	Surfactant Metabolism Dysfunction, Pulmonary, 3	disease	C08	Disease or Syndrome	0.70	1	2004	2018	   4	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
       21	ABCA3	0.592	0.615	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0002896	Sideroblastic anemia	disease	C15	Disease or Syndrome	0.43	1	2001	2016	   2	   0	CTD_human
       22	ABCB7	0.678	0.385	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.43	1	2000	2016	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
       22	ABCB7	0.678	0.385	C1845028	ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	disease	C16;C10;C15	Disease or Syndrome	0.74	1	1999	2018	   6	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
       23	ABCF1	0.674	0.538	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2012	2012	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
       23	ABCF1	0.674	0.538	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
       24	ABCA4	0.493	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2001	2019	   0	   1	UNIPROT
       24	ABCA4	0.493	0.769	C0008924	Cleft upper lip	disease	C16;C07	Congenital Abnormality	0.41	0.75	2010	2017	   1	  11	CTD_human
       24	ABCA4	0.493	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2012	2018	   1	   0	CTD_human
       24	ABCA4	0.493	0.769	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
       24	ABCA4	0.493	0.769	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.34	1	2000	2015	   0	   0	GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.70	0.974	1998	2019	   1	  19	CTD_human;GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.70	0.957	1997	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
       24	ABCA4	0.493	0.769	C0271093	Stargardts disease	phenotype		Disease or Syndrome	1	0.995	1997	2020	1	12	CTD_human;GENOMICS_ENGLAND;ORPHANET
102	24	ABCA4	0.493	0.769	C1855465	STARGARDT DISEASE 1 (disorder)	disease		Disease or Syndrome	1	0.978	1997	2020	21	306	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
103	24	ABCA4	0.493	0.769	C1858080	Retinal Dystrophy, Early Onset Severe	disease	C16;C11	Disease or Syndrome	0.6	1	1999	2018	0	2	GENOMICS_ENGLAND
104	24	ABCA4	0.493	0.769	C1858806	CONE-ROD DYSTROPHY 3 (disorder)	disease	C16;C11	Disease or Syndrome	0.9	1	1998	2018	3	53	CTD_human;GENOMICS_ENGLAND;UNIPROT
105	24	ABCA4	0.493	0.769	C1866422	RETINITIS PIGMENTOSA 19	disease	C16;C11	Disease or Syndrome	0.8	1	1999	2017	0	22	CTD_human;GENOMICS_ENGLAND
107	24	ABCA4	0.493	0.769	C3495438	Macular Degeneration, Age-Related, 2	disease	C11	Disease or Syndrome	0.7	1	1997	2009	2	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
119	25	ABL1	0.432	0.923	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.8	0.983	1982	2020	3	21	CGI;CTD_human;ORPHANET
141	25	ABL1	0.432	0.923	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.6	0.96	1998	2019	1	0	CGI;ORPHANET
142	25	ABL1	0.432	0.923	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.6	0.991	1987	2020	2	0	CGI;CTD_human
143	25	ABL1	0.432	0.923	C4539857	CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME	disease		Disease or Syndrome	0.6	1	2017	2017	1	2	GENOMICS_ENGLAND;UNIPROT
187	34	ACADM	0.638	0.462	C0220710	Medium-chain acyl-coenzyme A dehydrogenase deficiency	disease	C16;C18	Disease or Syndrome	1	0.991	1983	2019	24	107	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
194	35	ACADS	0.663	0.538	C0342783	Deficiency of butyryl-CoA dehydrogenase	disease	C16;C18	Disease or Syndrome	1	1	1989	2018	11	41	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
198	36	ACADSB	0.691	0.5	C1864912	2-Methylbutyryl-CoA Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.7	1	2000	2016	8	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
206	37	ACADVL	0.653	0.654	C3887523	Very long chain acyl-CoA dehydrogenase deficiency	disease	C16;C18;C05;C10;C15	Disease or Syndrome	1	0.989	1985	2020	15	116	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
229	38	ACAT1	0.538	0.692	C1536500	Deficiency of acetyl-CoA acetyltransferase	disease	C16;C18	Disease or Syndrome	0.8	1	1979	2019	12	29	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
290	50	ACO2	0.619	0.654	C3281192	INFANTILE CEREBELLAR-RETINAL DEGENERATION	disease		Disease or Syndrome	0.74	1	2012	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
291	50	ACO2	0.619	0.654	C4225384	OPTIC ATROPHY 9	disease		Disease or Syndrome	0.7	1	2012	2014	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
295	51	ACOX1	0.61	0.731	C1849678	Peroxisomal ACYL-COA oxidase deficiency	disease	C16;C18;C10;C19	Disease or Syndrome	0.92	1	1994	2016	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
304	54	ACP5	0.561	0.731	C0432222	Spondyloenchondrodysplasia	disease	C16;C05;C20	Disease or Syndrome	0.57	1	2011	2018	2	0	CTD_human;ORPHANET
306	54	ACP5	0.561	0.731	C1842763	SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION	disease	C16;C05;C20	Disease or Syndrome	0.72	1	1958	2018	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
314	58	ACTA1	0.54	0.769	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.53	1	2001	2013	4	0	CLINGEN;GENOMICS_ENGLAND
323	58	ACTA1	0.54	0.769	C0546264	Congenital Fiber Type Disproportion	disease	C05;C10	Congenital Abnormality	0.74	1	1999	2010	5	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
325	58	ACTA1	0.54	0.769	C1834339	Myopathy, Actin, Congenital, with Excess of Thin Myofilaments	disease	C05;C10	Disease or Syndrome	0.6	1	2009	2011	1	1	GENOMICS_ENGLAND
327	58	ACTA1	0.54	0.769	C2750537	Myopathy, Actin, Congenital, With Cores	disease	C05;C10	Disease or Syndrome	0.6	1	2009	2011	1	2	GENOMICS_ENGLAND
330	58	ACTA1	0.54	0.769	C3711389	Actin-Accumulation Myopathy	disease	C05;C10	Disease or Syndrome	0.93	1	1988	2018	16	48	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
331	58	ACTA1	0.54	0.769	C4225181	MYOPATHY, SCAPULOHUMEROPERONEAL	disease		Disease or Syndrome	0.7	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
346	59	ACTA2	0.508	0.846	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.6	1	2009	2018	2	0	GENOMICS_ENGLAND;ORPHANET
366	59	ACTA2	0.508	0.846	C2673186	Aortic Aneurysm, Familial Thoracic 6	disease	C23;C17;C14	Disease or Syndrome	0.7	1	2007	2017	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
368	59	ACTA2	0.508	0.846	C3151201	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	disease		Disease or Syndrome	0.78	1	2007	2019	3	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
369	59	ACTA2	0.508	0.846	C3279690	MOYAMOYA DISEASE 5	disease		Disease or Syndrome	0.7	1	2007	2016	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
371	59	ACTA2	0.508	0.846	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.6	1	2000	2016	7	0	CLINGEN;GENOMICS_ENGLAND
412	60	ACTB	0.325	0.923	C1846331	Juvenile-onset dystonia	disease	C10	Disease or Syndrome	0.7	1	2002	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
414	60	ACTB	0.325	0.923	C1855722	Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation	disease	C23;C16;C11;C10;F03;F01	Disease or Syndrome	0.72	1	1989	2018	6	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
421	70	ACTC1	0.61	0.538	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.65	1	2006	2019	0	3	CTD_human
422	70	ACTC1	0.61	0.538	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.7	0.962	1999	2019	12	3	CLINGEN;GENOMICS_ENGLAND
435	70	ACTC1	0.61	0.538	C2677506	Cardiomyopathy, Familial Hypertrophic, 11	disease	C16;C14	Disease or Syndrome	0.7	1	1998	2019	7	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
436	70	ACTC1	0.61	0.538	C2748552	Atrial Septal Defect 5	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.7	1	1998	2019	5	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
437	70	ACTC1	0.61	0.538	C3150681	CARDIOMYOPATHY, DILATED, 1R	disease		Disease or Syndrome	0.8	1	1998	2019	4	4	GENOMICS_ENGLAND;UNIPROT
438	70	ACTC1	0.61	0.538	C3150682	LEFT VENTRICULAR NONCOMPACTION 4	disease		Disease or Syndrome	0.6	NA	NA	NA	0	1	GENOMICS_ENGLAND
471	71	ACTG1	0.477	0.846	C1858172	Deafness, Autosomal Dominant 20	disease	C23;C10;C09	Disease or Syndrome	0.7	1	1996	2014	8	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
479	71	ACTG1	0.477	0.846	C3281235	BARAITSER-WINTER SYNDROME 2	disease		Disease or Syndrome	0.7	1	1996	2016	4	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
499	72	ACTG2	0.505	0.808	C0042781	Visceral Myopathy	disease	C06	Disease or Syndrome	0.75	0.917	2012	2020	5	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
500	72	ACTG2	0.505	0.808	C0266833	Visceral Myopathy, Familial	disease	C06	Disease or Syndrome	0.52	1	2012	2015	1	0	CTD_human;ORPHANET
501	72	ACTG2	0.505	0.808	C1608393	Megacystis microcolon intestinal hypoperistalsis syndrome	disease	C16;C06	Disease or Syndrome	0.66	1	2014	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
520	81	ACTN4	0.508	0.808	C4551527	Focal segmental glomerulosclerosis 1	disease	C13;C12	Disease or Syndrome	0.8	1	2000	2015	9	8	GENOMICS_ENGLAND;UNIPROT
526	87	ACTN1	0.695	0.577	C3554663	BLEEDING DISORDER, PLATELET-TYPE, 15	disease		Disease or Syndrome	0.7	1	2013	2015	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
530	88	ACTN2	0.686	0.462	C2677338	Cardiomyopathy, Dilated, 1AA	disease	C14	Disease or Syndrome	0.7	1	2004	2016	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
534	90	ACVR1	0.535	0.731	C0016037	Fibrodysplasia Ossificans Progressiva	disease	C05	Disease or Syndrome	1	1	2006	2020	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
565	93	ACVR2B	0.601	0.615	C0266642	Situs ambiguus	disease	C16;C15;C14	Congenital Abnormality	0.61	1	1999	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
567	93	ACVR2B	0.601	0.615	C3151057	HETEROTAXY, VISCERAL, 4, AUTOSOMAL	disease		Disease or Syndrome	0.9	1	1997	1999	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
568	93	ACVR2B	0.601	0.615	C3178805	Heterotaxy Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.7	1	1997	1999	1	0	CTD_human;GENOMICS_ENGLAND
574	94	ACVRL1	0.493	0.769	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.51	1	2003	2016	1	0	CTD_human
575	94	ACVRL1	0.493	0.769	C0039445	Hereditary hemorrhagic telangiectasia	disease	C16;C15;C14	Disease or Syndrome	0.6	1	1996	2019	1	0	CTD_human
579	94	ACVRL1	0.493	0.769	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.56	1	2010	2017	6	0	GENOMICS_ENGLAND;ORPHANET
585	94	ACVRL1	0.493	0.769	C1838163	OSLER-RENDU-WEBER SYNDROME 2	disease	C16;C15;C14	Disease or Syndrome	0.76	1	1996	2018	23	91	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
602	95	ACY1	0.653	0.577	C1835922	Aminoacylase 1 deficiency	disease	C16;C18	Disease or Syndrome	0.7	1	2005	2011	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
615	100	ADA	0.44	0.885	C0268124	Adenosine deaminase deficiency	disease	C16;C18;C20	Disease or Syndrome	0.6	1	1976	2018	0	0	ORPHANET
617	100	ADA	0.44	0.885	C0392607	Severe combined immunodeficiency due to adenosine deaminase deficiency	disease	C16;C18;C20;C15	Disease or Syndrome	0.8	0.977	1980	2019	0	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
620	100	ADA	0.44	0.885	C1863236	SCID Due to ADA Deficiency, Early-Onset	disease		Disease or Syndrome	0.6	1	1984	2019	12	32	GENOMICS_ENGLAND;UNIPROT
622	100	ADA	0.44	0.885	C2700553	Omenn Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.51	1	2011	2011	0	0	GENOMICS_ENGLAND;ORPHANET
635	102	ADAM10	0.489	0.846	C3810041	ALZHEIMER DISEASE 18	disease		Disease or Syndrome	0.6	1	2009	2013	2	2	CTD_human;UNIPROT
638	103	ADAR	0.501	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.54	1	2015	2019	1	1	CTD_human;UNIPROT
640	103	ADAR	0.501	0.808	C0393591	AICARDI-GOUTIERES SYNDROME	disease	C16;C20;C10	Disease or Syndrome	0.8	1	2012	2020	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
641	103	ADAR	0.501	0.808	C0406775	Symmetrical dyschromatosis of extremities	disease	C23;C17	Congenital Abnormality	0.8	1	2003	2020	5	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
649	103	ADAR	0.501	0.808	C3539013	AICARDI-GOUTIERES SYNDROME 6	disease		Disease or Syndrome	0.6	1	2004	2016	6	13	GENOMICS_ENGLAND;UNIPROT
675	107	ADCY1	0.659	0.462	C1857809	DEAFNESS, AUTOSOMAL RECESSIVE 44	disease	C23;C10;C09	Disease or Syndrome	0.6	1	2014	2014	0	1	CTD_human;GENOMICS_ENGLAND
678	108	ADCY2	0.695	0.308	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.62	1	2014	2019	2	11	CTD_human;PSYGENET
694	111	ADCY5	0.617	0.577	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.7	0.947	2002	2019	2	3	CTD_human
717	111	ADCY5	0.617	0.577	C1847627	Dyskinesia, Familial, with Facial Myokymia	disease	C23;C10	Disease or Syndrome	0.72	1	2001	2017	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
719	112	ADCY6	0.729	0.5	C4225385	LETHAL CONGENITAL CONTRACTURE SYNDROME 8	disease		Disease or Syndrome	0.71	1	2014	2020	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
745	114	ADCY8	0.705	0.577	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.51	1	2009	2013	4	0	CTD_human;PSYGENET
796	118	ADD1	0.612	0.615	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.861	1995	2019	2	0	CTD_human
810	120	ADD3	0.641	0.5	C4310767	CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3	disease		Disease or Syndrome	0.6	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
822	125	ADH1B	0.502	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.7	1	1994	2019	8	8	CTD_human;PSYGENET
833	125	ADH1B	0.502	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.6	1	1994	2019	8	0	CTD_human;PSYGENET
849	126	ADH1C	0.547	0.731	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.7	1	1991	2019	6	0	CTD_human;PSYGENET
851	126	ADH1C	0.547	0.731	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.53	1	1994	2012	5	0	CTD_human;PSYGENET
880	132	ADK	0.584	0.769	C3280381	HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	disease		Disease or Syndrome	0.7	1	2011	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
884	133	ADM	0.436	0.808	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.51	1	2004	2010	2	0	CTD_human
885	133	ADM	0.436	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.51	1	2006	2017	1	0	CTD_human
895	133	ADM	0.436	0.808	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.6	1	2000	2020	1	0	CTD_human
1062	142	PARP1	0.389	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	0.968	1997	2020	1	0	CTD_human;UNIPROT
1177	150	ADRA2A	0.578	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.53	0.75	2001	2011	4	0	PSYGENET
1183	150	ADRA2A	0.578	0.615	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.52	0.75	1999	2012	1	0	CTD_human
1217	153	ADRB1	0.555	0.769	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.58	1	1998	2019	1	0	CTD_human
1222	153	ADRB1	0.555	0.769	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.933	1991	2019	5	0	CTD_human
1223	153	ADRB1	0.555	0.769	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.94	1991	2019	5	0	CTD_human
1225	153	ADRB1	0.555	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	1	1993	2018	2	0	CTD_human
1247	154	ADRB2	0.442	0.923	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.51	1	2002	2008	1	0	CTD_human
1298	155	ADRB3	0.533	0.731	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.52	1	2004	2017	2	0	CTD_human
1299	155	ADRB3	0.533	0.731	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.52	1	2004	2017	2	0	CTD_human
1315	156	GRK2	0.532	0.654	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.98	1994	2020	1	0	CTD_human
1316	156	GRK2	0.532	0.654	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.98	1994	2020	1	0	CTD_human
1317	156	GRK2	0.532	0.654	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2000	2019	1	0	CTD_human
1331	157	GRK3	0.621	0.731	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.56	1	2003	2010	6	0	CTD_human;PSYGENET
1336	158	ADSL	0.631	0.654	C0268126	Adenylosuccinate lyase deficiency (disorder)	disease	C16;C18;F03	Disease or Syndrome	0.79	1	1992	2017	11	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1375	174	AFP	0.429	0.885	C1863081	alpha-Fetoprotein Deficiency	disease	C16;C18	Disease or Syndrome	0.6	1	2004	2004	1	2	CTD_human;ORPHANET
1379	175	AGA	0.57	0.808	C0268225	Aspartylglucosaminuria	phenotype	C16;C18	Disease or Syndrome	1	0.96	1990	2019	7	52	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1386	176	ACAN	0.528	0.846	C1842149	Spondyloepiphyseal Dysplasia, Kimberley Type	disease	C16;C05	Congenital Abnormality	0.61	1	2005	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
1387	176	ACAN	0.528	0.846	C2748544	Spondyloepimetaphyseal Dysplasia, Aggrecan Type	disease	C16;C05	Disease or Syndrome	0.7	1	2009	2017	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1388	176	ACAN	0.528	0.846	C3665488	Familial Osteochondritis Dissecans	disease	C05	Disease or Syndrome	0.61	1	2010	2017	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1390	177	AGER	0.42	0.885	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.6	0.974	1999	2019	2	0	CTD_human
1426	178	AGL	0.644	0.615	C0017922	Glycogen Storage Disease Type III	disease	C16;C18	Disease or Syndrome	1	0.988	1987	2020	8	124	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1431	181	AGRP	0.488	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.7	0.938	1997	2019	0	0	CTD_human
1445	182	JAG1	0.429	0.808	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.8	1	1999	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1446	182	JAG1	0.429	0.808	C0085280	Alagille Syndrome	disease	C16;C06;C14	Congenital Abnormality	0.9	0.952	1997	2019	5	3	CTD_human;GENOMICS_ENGLAND
1460	182	JAG1	0.429	0.808	C1866053	Deafness, Congenital Heart Defects, and Posterior Embryotoxon	disease	C23;C16;C10;C09;C14	Disease or Syndrome	0.6	1	2002	2010	2	2	GENOMICS_ENGLAND;UNIPROT
1461	182	JAG1	0.429	0.808	C1956125	Alagille Syndrome 1	disease	C16;C06;C14	Disease or Syndrome	0.71	1	1997	2016	19	48	CTD_human;GENOMICS_ENGLAND;UNIPROT
1475	183	AGT	0.367	0.923	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.6	1	1998	2019	2	0	CTD_human
1488	183	AGT	0.367	0.923	C0011884	Diabetic Retinopathy	disease	C11;C19;C14	Disease or Syndrome	0.58	1	2000	2018	1	0	CTD_human
1489	183	AGT	0.367	0.923	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.6	1	1998	2019	1	0	CTD_human
1490	183	AGT	0.367	0.923	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.51	1	2002	2015	5	0	CTD_human
1491	183	AGT	0.367	0.923	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.55	1	1999	2019	1	0	CTD_human
1494	183	AGT	0.367	0.923	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.54	0.833	1998	2011	1	0	CTD_human
1497	183	AGT	0.367	0.923	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.989	1992	2020	3	0	CTD_human
1498	183	AGT	0.367	0.923	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.991	1992	2020	3	0	CTD_human
1503	183	AGT	0.367	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.971	1979	2020	77	0	CTD_human
1513	183	AGT	0.367	0.923	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.56	1	2005	2018	1	0	CTD_human
1515	183	AGT	0.367	0.923	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.6	0.955	1991	2020	2	0	CTD_human
1526	183	AGT	0.367	0.923	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.55	1	2007	2019	2	0	CTD_human
1536	183	AGT	0.367	0.923	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.6	0.932	1988	2020	1	0	CTD_human;GENOMICS_ENGLAND
1551	183	AGT	0.367	0.923	C0266313	Allanson Pantzar McLeod syndrome	disease	C16;C13;C12	Disease or Syndrome	0.71	1	2005	2015	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1617	185	AGTR1	0.423	0.846	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.963	1997	2019	3	0	CTD_human
1618	185	AGTR1	0.423	0.846	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.971	1997	2019	3	0	CTD_human
1619	185	AGTR1	0.423	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.944	1993	2020	4	0	CTD_human
1620	185	AGTR1	0.423	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.6	0.95	1997	2018	1	0	CTD_human
1626	185	AGTR1	0.423	0.846	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.6	0.941	1994	2019	1	0	CTD_human;GENOMICS_ENGLAND
1629	185	AGTR1	0.423	0.846	C0266313	Allanson Pantzar McLeod syndrome	disease	C16;C13;C12	Disease or Syndrome	0.7	1	2005	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1639	186	AGTR2	0.496	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	1	2001	2019	1	0	CTD_human
1655	189	AGXT	0.593	0.731	C0268164	Primary hyperoxaluria, type I	disease	C16;C18;C13;C12	Disease or Syndrome	0.8	1	1973	2019	27	166	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1660	190	NR0B1	0.494	0.808	C0342482	X-linked Adrenal Hypoplasia	disease	C19	Disease or Syndrome	1	1	1994	2019	19	58	CTD_human;GENOMICS_ENGLAND;UNIPROT
1664	190	NR0B1	0.494	0.808	C1848296	DOSAGE-SENSITIVE SEX REVERSAL	disease	C16;C13;C12;C19	Disease or Syndrome	0.7	0.972	1997	2019	1	6	CTD_human;GENOMICS_ENGLAND
1682	191	AHCY	0.582	0.692	C3151058	S-adenosylhomocysteine hydrolase deficiency	disease	C16;C18	Disease or Syndrome	0.7	1	1959	2018	13	5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1796	199	AIF1	0.521	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.54	1	2007	2020	1	0	CTD_human
1814	203	AK1	0.711	0.5	C2675459	Adenylate Kinase Deficiency, Hemolytic Anemia Due To	disease	C15	Disease or Syndrome	0.7	1	1989	2017	5	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1820	204	AK2	0.678	0.423	C0272167	Reticular dysgenesis	disease	C16;C18;C20;C15	Disease or Syndrome	0.75	1	2009	2019	2	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1840	274	BIN1	0.55	0.692	C0410204	Myopathy, Centronuclear, Autosomal Recessive	disease	C05;C10	Disease or Syndrome; Congenital Abnormality	0.73	1	2007	2018	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1854	341	APOC1	0.581	0.577	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      341	APOC1	0.581	0.577	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      341	APOC1	0.581	0.577	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      343	AQP8	0.638	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2018	2018	   0	   0	UNIPROT
      344	APOC2	0.606	0.577	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      344	APOC2	0.606	0.577	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0023817	Hyperlipoproteinemia Type I	disease	C16;C18	Disease or Syndrome	0.40	1	1981	2018	   0	   0	CTD_human
      344	APOC2	0.606	0.577	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2001	2001	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C0268199	Familial apolipoprotein C-II deficiency	disease	C16;C18	Disease or Syndrome	0.33	1	1979	2018	   1	   0	ORPHANET
      344	APOC2	0.606	0.577	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      344	APOC2	0.606	0.577	C1720779	Apolipoprotein C-II Deficiency (disorder)	disease	C16;C18	Disease or Syndrome	0.75	1	1993	2017	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      345	APOC3	0.531	0.731	C0002726	Amyloidosis	disease	C18	Disease or Syndrome	0.31	0	2016	2016	   1	   0	GENOMICS_ENGLAND
      345	APOC3	0.531	0.731	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	1	2000	2020	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.40	1	1997	2019	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0011609	Drug Eruptions	group	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.46	1	2001	2019	   0	   0	GENOMICS_ENGLAND
      345	APOC3	0.531	0.731	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0020476	Hyperlipoproteinemias	disease	C18	Disease or Syndrome	0.30	1	1991	1991	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	1999	2009	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0342883	Cholesteryl Ester Transfer Protein Deficiency	disease	C16;C18	Disease or Syndrome	0.32	1	1991	2014	   1	   0	ORPHANET
      345	APOC3	0.531	0.731	C0406537	Morbilliform Drug Reaction	disease	C17;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.40	1	1997	2019	   1	   0	CTD_human
      345	APOC3	0.531	0.731	C3151467	Apolipoprotein C-III Deficiency	disease	C18	Disease or Syndrome	0.61	1	1991	2016	   1	   4	CTD_human;UNIPROT
      346	APOC4	0.743	0.385	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      347	APOD	0.584	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	PSYGENET
      347	APOD	0.584	0.577	C0017638	Glioma	disease	C04	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0023186	Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	0.667	2002	2006	   3	   0	PSYGENET
      347	APOD	0.584	0.577	C0086439	Hypokinesia	phenotype	C23;C10	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0233565	Bradykinesia	phenotype	C23;C10	Sign or Symptom	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0242684	Hypodynamia	phenotype	C23;C10	Organism Function	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.31	1	2008	2018	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751701	Hypokinesia, Antiorthostatic	phenotype	C23;C10	Sign or Symptom	0.30	1	2011	2011	   1	   0	CTD_human
      347	APOD	0.584	0.577	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      347	APOD	0.584	0.577	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.31	0.5	2009	2011	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	0.75	2002	2008	   4	   0	PSYGENET
      348	APOE	0.338	0.962	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.7	0.946	1991	2020	9	5	CTD_human
1863	348	APOE	0.338	0.962	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.7	0.966	1983	2019	1	1	CTD_human
1870	348	APOE	0.338	0.962	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.7	0.957	1985	2019	4	0	CTD_human
1872	348	APOE	0.338	0.962	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.6	0.957	1979	2020	4	0	CTD_human
1873	348	APOE	0.338	0.962	C0020479	Hyperlipoproteinemia Type III	disease	C16;C18	Disease or Syndrome	0.8	0.977	1977	2020	16	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1874	348	APOE	0.338	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.7	0.897	1994	2019	2	1	CTD_human
1886	348	APOE	0.338	0.962	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.6	0.78	1995	2019	1	0	CTD_human
1887	348	APOE	0.338	0.962	C0036489	Sea-Blue Histiocyte Syndrome	disease	C16;C18;C10;C15	Disease or Syndrome	0.7	1	2000	2014	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
1923	348	APOE	0.338	0.962	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.6	0.889	1989	2020	4	3	CTD_human;UNIPROT
1924	348	APOE	0.338	0.962	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1993	2018	   9	   0	CTD_human
      348	APOE	0.338	0.962	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.50	0.935	1993	2020	   9	   1	CTD_human
      348	APOE	0.338	0.962	C0750986	Internal Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0750987	Arterial Diseases, Common Carotid	disease	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751633	Carotid Artery Plaque	disease	C10;C14	Acquired Abnormality	0.32	1	2006	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751634	Carotid Ulcer	phenotype	C10;C14	Acquired Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751635	Common Carotid Artery Stenosis	disease	C10;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751636	External Carotid Artery Stenosis	disease	C10;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0751967	Multiple Sclerosis, Relapsing-Remitting	disease	C20;C10	Disease or Syndrome	0.32	1	2004	2009	   1	   0	CTD_human
      348	APOE	0.338	0.962	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.31	1	2005	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.33	1	2009	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	1997	2018	  29	   0	CTD_human
      348	APOE	0.338	0.962	C1565489	Renal Insufficiency	disease	C13;C12	Disease or Syndrome	0.44	0.8	2006	2019	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.32	1	1985	2007	   1	   0	CTD_human
      348	APOE	0.338	0.962	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2002	2010	   4	   0	CTD_human
      348	APOE	0.338	0.962	C1847200	ALZHEIMER DISEASE 4	disease	C10;F03	Disease or Syndrome	0.30				   0	   0	CTD_human
      348	APOE	0.338	0.962	C1863051	ALZHEIMER DISEASE 2	disease	C10;F03	Disease or Syndrome	0.80	0.96	1985	2017	  11	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      348	APOE	0.338	0.962	C1864205	Macular Degeneration, Age-Related, 1	disease	C11	Disease or Syndrome	0.30				   0	   0	CTD_human
      348	APOE	0.338	0.962	C2673196	LIPOPROTEIN GLOMERULOPATHY	disease	C13;C12	Disease or Syndrome	0.80	0.95	1997	2020	   6	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      348	APOE	0.338	0.962	C2936350	Plaque, Atherosclerotic	phenotype	C23	Body Substance	0.30	1	2007	2018	  11	   0	CTD_human
      348	APOE	0.338	0.962	C2936351	Fibroatheroma	disease	C23	Acquired Abnormality	0.30	1	2007	2018	  11	   0	CTD_human
      348	APOE	0.338	0.962	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      348	APOE	0.338	0.962	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.32	0.333	2012	2018	   1	   0	CTD_human
      350	APOH	0.563	0.769	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2019	   1	   0	PSYGENET
      350	APOH	0.563	0.769	C0085278	Antiphospholipid Syndrome	disease	C20	Disease or Syndrome	0.40	1	1998	2020	   1	   0	GENOMICS_ENGLAND
      350	APOH	0.563	0.769	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      350	APOH	0.563	0.769	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.50	1	2005	2013	   1	   0	CTD_human
      350	APOH	0.563	0.769	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      351	APP	0.422	0.846	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.9	0.981	1987	2020	63	14	CTD_human;UNIPROT
1964	351	APP	0.422	0.846	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.6	0.98	1993	2020	1	0	CTD_human
1967	351	APP	0.422	0.846	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.7	0.964	1993	2020	3	0	CTD_human;GENOMICS_ENGLAND
1973	351	APP	0.422	0.846	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1991	2018	  35	   0	CTD_human
      351	APP	0.422	0.846	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.50	0.984	1991	2020	  35	   1	CTD_human
      351	APP	0.422	0.846	C0750906	Tactile Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0750907	Amnestic State	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751071	Familial Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.32	1	2005	2015	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751156	FRAXA Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751157	FRAXE Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      351	APP	0.422	0.846	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2018	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2018	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2004	2018	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.40	1	1997	2020	  16	   0	CTD_human
      351	APP	0.422	0.846	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2005	2013	   2	   0	CTD_human
      351	APP	0.422	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      351	APP	0.422	0.846	C0948008	Ischemic stroke	disease	C10;C14	Disease or Syndrome	0.31	1	2010	2020	   1	   0	GENOMICS_ENGLAND
      351	APP	0.422	0.846	C1270972	Mild cognitive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2003	2019	   1	   0	CTD_human
      351	APP	0.422	0.846	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      351	APP	0.422	0.846	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2006	2018	   8	   0	CTD_human
      351	APP	0.422	0.846	C2751494	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ARCTIC VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      351	APP	0.422	0.846	C2751536	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED	disease	C16;C18;C10;C14	Disease or Syndrome	0.70	1	1990	2010	   7	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      351	APP	0.422	0.846	C2931672	Cerebral hemorrhage with amyloidosis, hereditary, Dutch type	disease	C16;C18;C10;C14	Disease or Syndrome	0.60	1	1990	2019	   3	   0	CTD_human;ORPHANET
      351	APP	0.422	0.846	C2936349	Plaque, Amyloid	disease	C23	Acquired Abnormality	0.40	0.973	1996	2019	   2	   0	CTD_human
      351	APP	0.422	0.846	C3888307	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, FLEMISH VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      351	APP	0.422	0.846	C3888308	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, ITALIAN VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      351	APP	0.422	0.846	C3888309	CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED, IOWA VARIANT	disease	C16;C18;C10;C14	Disease or Syndrome	0.30	1	1990	2000	   2	   0	CTD_human
      353	APRT	0.423	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1988	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2002	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	1985	2019	   5	   0	PSYGENET
      353	APRT	0.423	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1985	2019	   5	   0	PSYGENET
      353	APRT	0.423	0.846	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.31	1	2012	2019	   1	   0	GENOMICS_ENGLAND
      353	APRT	0.423	0.846	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      353	APRT	0.423	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
      353	APRT	0.423	0.846	C0268120	Adenine phosphoribosyltransferase deficiency	disease	C16;C18;C13;C12	Disease or Syndrome	1.00	1	1986	2016	  11	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      353	APRT	0.423	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2002	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C0451641	Urolithiasis	disease	C13;C12	Disease or Syndrome	0.33	1	1976	2011	   2	   0	CTD_human
      353	APRT	0.423	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1988	2018	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
      353	APRT	0.423	0.846	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	1996	2009	   1	   0	CTD_human
      353	APRT	0.423	0.846	C1561643	Chronic Kidney Diseases	group	C13;C12	Disease or Syndrome	0.39	1	2012	2019	   1	   0	GENOMICS_ENGLAND
      353	APRT	0.423	0.846	C3665382	2,8-Dihydroxyadenine Urolithiasis	disease	C16;C18;C13;C12	Disease or Syndrome	0.80	1	1985	2012	   1	   0	CTD_human;ORPHANET
      353	APRT	0.423	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0005001	Benign prostatic hypertrophy	phenotype	C12	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0027643	Neoplasm Recurrence, Local	phenotype	C23;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	0.988	1991	2019	  11	   0	CTD_human
      354	KLK3	0.443	0.885	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2003	2003	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.50	0.958	1989	2020	  11	   2	CTD_human
      354	KLK3	0.443	0.885	C0520477	Prostatic Adenoma	disease	C12	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C1334615	Malignant Phyllodes Tumor of Prostate	disease	C04;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C1704272	Benign Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.40	0.927	1990	2020	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C1739363	Prostatic Hypertrophy	disease	C12	Disease or Syndrome	0.31	1	2001	2011	   1	   0	CTD_human
      354	KLK3	0.443	0.885	C2937421	Prostatic Hyperplasia	disease	C12	Disease or Syndrome	0.37	1	2001	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0002897	Anemia, Splenic	disease	C15	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.40	0.974	1989	2020	   3	   0	CTD_human
      355	FAS	0.372	0.923	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.33	1	2005	2015	   1	   0	ORPHANET
      355	FAS	0.372	0.923	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.38	1	1997	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.37	1	1997	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.60	0.917	1999	2014	   0	   3	CGI;UNIPROT
      355	FAS	0.372	0.923	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.51	1	1999	2007	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2009	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.32	1	2005	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.41	1	1999	2011	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0018939	Hematological Disease	group	C15	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0020532	Hypersplenism	disease	C15	Disease or Syndrome	0.40	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.38	1	1995	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2006	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.36	1	1998	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.40	1	1995	2016	   0	   0	GENOMICS_ENGLAND
      355	FAS	0.372	0.923	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.54	1	1998	2010	   0	   2	CGI;UNIPROT
      355	FAS	0.372	0.923	C0024535	Malaria, Falciparum	disease	C01	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0026896	Myasthenia Gravis	disease	C04;C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0027697	Nephritis	disease	C13;C12	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0032963	Pregnancy Complications, Cardiovascular	disease	C13;C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2000	2007	   3	   0	CTD_human
      355	FAS	0.372	0.923	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2015	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      355	FAS	0.372	0.923	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2000	2007	   3	   0	CTD_human
      355	FAS	0.372	0.923	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2011	2011	   1	   2	CTD_human
      355	FAS	0.372	0.923	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0039338	Taste Disorders	group	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0042170	Uveomeningoencephalitic Syndrome	disease	C11;C20;C10	Disease or Syndrome	0.31	1	2015	2015	   1	   0	ORPHANET
      355	FAS	0.372	0.923	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.37	1	2003	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.37	1	2002	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.35	1	1995	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234297	Taste Disorder, Primary	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234298	Taste Disorder, Primary, Sweet	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234299	Taste Disorder, Primary, Salt	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234300	Taste Disorder, Primary, Bitter	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234302	Taste Disorder, Anterior Tongue	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234303	Taste Disorder, Secondary	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234304	Taste Disorder, Secondary, Sweet	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234305	Taste Disorder, Secondary, Salt	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234306	Taste Disorder, Secondary, Bitter	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0234319	Taste Disorder, Posterior Tongue	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0240327	Taste, Metallic	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.923	1999	2017	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2000	2000	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.36	1	2011	2018	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0751339	Myasthenia Gravis, Generalized	disease	C04;C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0751340	Myasthenia Gravis, Ocular	disease	C04;C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      355	FAS	0.372	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2000	2007	   3	   0	CTD_human
      355	FAS	0.372	0.923	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	1.00	1	1978	2018	  18	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      355	FAS	0.372	0.923	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.31	1	2007	2016	   1	   0	CTD_human
      355	FAS	0.372	0.923	C1704377	Bright Disease	disease	C13;C12	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      355	FAS	0.372	0.923	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.31	1	2005	2018	   2	   0	CTD_human
      355	FAS	0.372	0.923	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.31	1	1995	1999	   1	   0	CTD_human
      355	FAS	0.372	0.923	C2717884	Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant	disease	C16;C20;C15	Disease or Syndrome	0.30	1	2005	2007	   2	   0	CTD_human
      355	FAS	0.372	0.923	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.32	1	2013	2019	   1	   0	CTD_human
      355	FAS	0.372	0.923	C3496549	Male Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.30				   0	   0	CGI
      356	FASLG	0.43	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.34	1	2008	2015	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.31	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.34	1	2008	2018	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0007273	Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.40	1	2009	2009	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0020474	Hyperlipidemia, Familial Combined	disease	C16;C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.33	1	2004	2007	   0	   0	CTD_human
      356	FASLG	0.43	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.38	1	2001	2019	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
      356	FASLG	0.43	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
      356	FASLG	0.43	0.885	C0039584	Testicular Diseases	group	C12;C19	Disease or Syndrome	0.31	1	2009	2019	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.31	1	2009	2018	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.34	1	2002	2008	   0	   0	CTD_human
      356	FASLG	0.43	0.885	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2000	2000	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2001	2011	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0577631	Carotid Atherosclerosis	disease	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0600178	External Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0750986	Internal Carotid Artery Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0750987	Arterial Diseases, Common Carotid	disease	C10;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.31	1	2006	2007	   2	   0	CTD_human
      356	FASLG	0.43	0.885	C1328840	Autoimmune Lymphoproliferative Syndrome	disease	C16;C20;C15	Disease or Syndrome	0.89	1	1984	2017	   5	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      356	FASLG	0.43	0.885	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      356	FASLG	0.43	0.885	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      356	FASLG	0.43	0.885	C2717884	Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant	disease	C16;C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      357	SHROOM2	0.729	0.385	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      358	AQP1	0.467	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.32	1	2002	2018	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0008340	Choledochal Cyst	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0009439	Choledochal Cyst, Type I	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.31	1	2006	2014	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0013608	Edema, Cardiac	disease	C23;C14	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2010	2019	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0020550	Hyperthyroidism	disease	C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0030193	Pain	phenotype	C23	Sign or Symptom	0.34	1	2010	2019	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0036981	Endotoxic shock	phenotype	C23;C01	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0036983	Septic Shock	phenotype	C23;C01	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0085548	Autosomal Recessive Polycystic Kidney Disease	disease	C16;C13;C12	Disease or Syndrome	0.51	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      358	AQP1	0.467	0.885	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0600327	Toxic Shock Syndrome	disease	C23;C01	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1150929	2-oxo-hept-3-ene-1,7-dioate hydratase activity	phenotype		Molecular Function	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      358	AQP1	0.467	0.885	C1257796	Choledochal Cyst, Type II	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257797	Choledochal Cyst, Type III	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257798	Choledochal Cyst, Type IV	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257799	Choledochal Cyst, Type V	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      358	AQP1	0.467	0.885	C3714618	Primary Hyperthyroidism	disease	C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C0162283	Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.90	1	1988	2020	   5	   4	CTD_human;GENOMICS_ENGLAND
      359	AQP2	0.581	0.769	C0268443	Acquired Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.31	1	1998	2009	   4	   0	CTD_human
      359	AQP2	0.581	0.769	C0677501	Congenital Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.40	1	1996	2019	   4	   0	CTD_human
      359	AQP2	0.581	0.769	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      359	AQP2	0.581	0.769	C1563705	Nephrogenic Diabetes Insipidus, Type I	disease	C13;C12	Disease or Syndrome	0.40	0.968	1994	2020	   4	   0	CTD_human
      359	AQP2	0.581	0.769	C1563706	Nephrogenic Diabetes Insipidus, Type II	disease	C13;C12	Disease or Syndrome	0.70	1	1994	2016	  23	  24	CTD_human;GENOMICS_ENGLAND;UNIPROT
      359	AQP2	0.581	0.769	C3542500	ADH-Resistant Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2009	   4	   0	CTD_human
      360	AQP3	0.546	0.769	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.33	1	2011	2019	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.31	1	2010	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2008	2019	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0040411	Tongue Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0153349	Malignant neoplasm of tongue	disease	C04;C07	Neoplastic Process	0.31	1	2011	2012	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      360	AQP3	0.546	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2009	2017	   2	   0	PSYGENET
      361	AQP4	0.456	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2017	   1	   0	PSYGENET
      361	AQP4	0.456	0.885	C0027873	Neuromyelitis Optica	disease	C11;C20;C10	Disease or Syndrome	0.40	0.963	2005	2020	   2	   0	CTD_human
      361	AQP4	0.456	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	0.5	2005	2018	   2	   0	PSYGENET
      361	AQP4	0.456	0.885	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.50	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.33	1	2010	2017	   1	   0	GENOMICS_ENGLAND
      361	AQP4	0.456	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.33	1	2011	2020	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0338715	Drug-induced depressive state	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2014	   2	   0	PSYGENET
      361	AQP4	0.456	0.885	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      361	AQP4	0.456	0.885	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      362	AQP5	0.552	0.769	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.30	1	2007	2007	   2	   0	CTD_human
      362	AQP5	0.552	0.769	C1833030	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	disease	C16;C17	Disease or Syndrome	0.31	1	2013	2013	   1	   0	ORPHANET
      362	AQP5	0.552	0.769	C1838359	Diffuse palmoplantar keratoderma, Bothnian type	disease	C16;C17	Disease or Syndrome	0.70	1	1996	2016	   5	   5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      362	AQP5	0.552	0.769	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.31	1	2016	2016	   0	   0	GENOMICS_ENGLAND
      364	AQP7	0.67	0.462	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2014	   2	   0	CTD_human
      364	AQP7	0.67	0.462	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.40	1	2006	2019	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0023418	leukemia	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.32	1	2002	2013	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      366	AQP9	0.565	0.808	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      367	AR	0.351	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2011	2014	   2	   0	PSYGENET
      367	AR	0.351	0.846	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.39	1	2000	2016	   1	   0	CTD_human
      367	AR	0.351	0.846	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2005	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	0.947	1990	2020	   2	   2	CTD_human;UNIPROT
      367	AR	0.351	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.60	1	2002	2019	   0	   0	CGI
      367	AR	0.351	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	0.8	1994	2019	   5	   0	PSYGENET
      367	AR	0.351	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.8	1994	2019	   5	   0	PSYGENET
      367	AR	0.351	0.846	C0017412	Genital Diseases, Male	group	C12	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      367	AR	0.351	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	1999	2019	   1	   0	CTD_human
      367	AR	0.351	0.846	C0021361	Female infertility	phenotype	C13	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.40	0.918	1995	2019	   3	   0	CTD_human
      367	AR	0.351	0.846	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      367	AR	0.351	0.846	C0023418	leukemia	disease	C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      367	AR	0.351	0.846	C0027643	Neoplasm Recurrence, Local	phenotype	C23;C04	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      367	AR	0.351	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.60	1	1990	2019	  21	   0	CTD_human
      367	AR	0.351	0.846	C0038279	Sterility, Postpartum	phenotype	C13	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0039585	Androgen-Insensitivity Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	1.00	0.966	1970	2019	  74	  98	CTD_human;GENOMICS_ENGLAND;UNIPROT
      367	AR	0.351	0.846	C0085207	Gestational Diabetes	phenotype	C18;C13;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      367	AR	0.351	0.846	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      367	AR	0.351	0.846	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.40	0.9	1998	2019	   1	   0	CTD_human
      367	AR	0.351	0.846	C0205768	Subependymal Giant Cell Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0236663	Alcohol withdrawal syndrome	disease	C25;F03	Disease or Syndrome	0.34	1	2009	2011	   3	   0	PSYGENET
      367	AR	0.351	0.846	C0238033	Carcinoma of Male Breast	disease	C04;C17	Neoplastic Process	0.40	0.958	1992	2019	   2	   0	CTD_human
      367	AR	0.351	0.846	C0242788	Breast Neoplasms, Male	group	C04;C17	Neoplastic Process	0.30	1	1992	1993	   2	   0	CTD_human
      367	AR	0.351	0.846	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      367	AR	0.351	0.846	C0268301	Reifenstein Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.80	0.989	1984	2019	  41	  31	CTD_human;GENOMICS_ENGLAND;UNIPROT
      367	AR	0.351	0.846	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0282612	Prostatic Intraepithelial Neoplasias	disease	C04	Neoplastic Process	0.40	1	1996	2017	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334580	Protoplasmic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334581	Gemistocytic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334582	Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0338070	Childhood Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0341869	Subfertility, Female	disease	C13	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	1.00	0.982	1992	2020	  21	  16	CTD_human;GENOMICS_ENGLAND;UNIPROT
      367	AR	0.351	0.846	C0393547	Bulbospinal Neuronopathy	disease	C10	Disease or Syndrome	0.36	1	1990	2019	   0	   0	ORPHANET
      367	AR	0.351	0.846	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2017	   1	   0	PSYGENET
      367	AR	0.351	0.846	C0547065	Mixed oligoastrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0556385	Craving for alcohol	phenotype		Finding	0.30	1	2010	2010	   1	   0	PSYGENET
      367	AR	0.351	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.947	1990	2020	   2	   0	CTD_human
      367	AR	0.351	0.846	C0750935	Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0750936	Intracranial Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C0752353	Atrophy, Muscular, Spinobulbar	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	ORPHANET
      367	AR	0.351	0.846	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.32	1	2002	2011	   3	   0	CTD_human
      367	AR	0.351	0.846	C0917730	Female sterility	phenotype	C13	Finding	0.30	1	2013	2013	   1	   0	CTD_human
      367	AR	0.351	0.846	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2002	2010	   3	   0	CTD_human
      367	AR	0.351	0.846	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      367	AR	0.351	0.846	C0936016	Testicular Feminization	disease	C16;C13;C12;C19	Disease or Syndrome	0.60	0.955	1970	2019	   2	   0	CTD_human
      367	AR	0.351	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
      367	AR	0.351	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2001	2019	   2	   0	CTD_human
      367	AR	0.351	0.846	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      367	AR	0.351	0.846	C1839259	Bulbo-Spinal Atrophy, X-Linked	disease	C16;C10	Disease or Syndrome	0.70	0.988	1990	2019	   0	  27	GENOMICS_ENGLAND;ORPHANET
      367	AR	0.351	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1990	2020	   1	   0	CTD_human
      367	AR	0.351	0.846	C2678098	Hypospadias 1, X-Linked	disease	C16;C13;C12	Disease or Syndrome	0.60				   0	   3	CTD_human;GENOMICS_ENGLAND
      367	AR	0.351	0.846	C2713546	Androgen Receptor Deficiency	disease	C16;C13;C12;C19	Disease or Syndrome	0.32	0.75	1984	2018	   2	   0	CTD_human
      367	AR	0.351	0.846	C2931395	Bulbospinal neuronopathy, X-linked recessive	disease	C16;C10	Disease or Syndrome	0.35	0.8	1992	1999	   0	   0	CTD_human
      367	AR	0.351	0.846	C3658266	Prostatic Cancer, Castration-Resistant	disease	C04;C12	Neoplastic Process	0.30	1	2008	2017	   4	   0	CTD_human
      367	AR	0.351	0.846	C3658267	Prostatic Neoplasms, Castration-Resistant	disease	C04;C12	Neoplastic Process	0.30	1	2008	2017	   4	   0	CTD_human
      367	AR	0.351	0.846	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.50	0.963	1998	2019	   1	  11	CTD_human
      367	AR	0.351	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
      368	ABCC6	0.54	0.654	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      368	ABCC6	0.54	0.654	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      368	ABCC6	0.54	0.654	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      368	ABCC6	0.54	0.654	C0033847	Pseudoxanthoma Elasticum	disease	C16;C17;C15;C14	Disease or Syndrome	1.00	0.982	1978	2020	  26	 312	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      368	ABCC6	0.54	0.654	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      368	ABCC6	0.54	0.654	C0264955	Idiopathic arterial calcification of infancy	disease	C18;C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      368	ABCC6	0.54	0.654	C0376359	Gronblad-Strandberg Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2002	2015	   8	   0	CTD_human
      368	ABCC6	0.54	0.654	C1859727	Arterial calcification of infancy	disease	C18	Disease or Syndrome	0.58	1	2011	2020	   2	   0	CTD_human;ORPHANET
      368	ABCC6	0.54	0.654	C1867450	Pseudoxanthoma Elasticum, Incomplete	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	1978	2016	  11	   6	CTD_human;GENOMICS_ENGLAND
      368	ABCC6	0.54	0.654	C3276161	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2	disease		Disease or Syndrome	0.60	1	2000	2012	   2	  16	GENOMICS_ENGLAND;UNIPROT
      369	ARAF	0.619	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.41	1	2014	2016	   0	   2	CGI
      369	ARAF	0.619	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      369	ARAF	0.619	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      369	ARAF	0.619	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      372	ARCN1	0.705	0.462	C4310686	SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY	disease		Disease or Syndrome	0.40	1	2016	2016	   1	   3	GENOMICS_ENGLAND
      374	AREG	0.487	0.769	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.38	1	2005	2019	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1993	2020	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.39	1	2004	2019	   2	   0	CTD_human
      374	AREG	0.487	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.34	1	2001	2019	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.36	1	2005	2019	   3	   0	CTD_human
      374	AREG	0.487	0.769	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.33	1	2005	2019	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2005	2006	   3	   0	CTD_human
      374	AREG	0.487	0.769	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.32	1	2005	2020	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0162568	Erythropoietic Protoporphyria	disease	C16;C06;C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.31	1	2004	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0349426	Ferrochelatase deficiency	disease	C16;C06;C18;C17	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1993	2020	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      374	AREG	0.487	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.35	1	2002	2017	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.34	1	2002	2017	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2001	2018	   1	   0	CTD_human
      374	AREG	0.487	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2005	2006	   3	   0	CTD_human
      374	AREG	0.487	0.769	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      374	AREG	0.487	0.769	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2013	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	2013	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2008	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C1868720	Periventricular Nodular Heterotopia	disease	C16;C10	Disease or Syndrome	0.41	1	2009	2016	   1	   0	ORPHANET
      375	ARF1	0.626	0.615	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      375	ARF1	0.626	0.615	C4748602	PERIVENTRICULAR NODULAR HETEROTOPIA 8	disease		Disease or Syndrome	0.40	1	2016	2016	   1	   3	UNIPROT
      383	ARG1	0.476	0.846	C0002514	Amino Acid Metabolism, Inborn Errors	group	C16;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0003949	Asbestosis	disease	C08;C24	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.40	0.909	2003	2018	   2	   0	CTD_human
      383	ARG1	0.476	0.846	C0018500	Hair Diseases	group	C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0021053	Immune System Diseases	group	C20	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0023281	Leishmaniasis	disease	C01;C17	Disease or Syndrome	0.31	1	2011	2018	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.31	1	2012	2015	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0037116	Silicosis	disease	C08;C24	Disease or Syndrome	0.50	1	2004	2007	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.31	1	2016	2019	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0268548	Hyperargininemia	phenotype	C16;C18;C10	Disease or Syndrome	1.00	1	1944	2020	  12	   3	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      383	ARG1	0.476	0.846	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0750905	Amino Acid Metabolism, Inherited Disorders	disease	C16;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C2930617	Pulmonary Fibrosis - from Asbestos Exposure	disease	C08;C24	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      383	ARG1	0.476	0.846	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.39	1	2003	2017	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2013	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2008	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0035304	Retinal Degeneration	phenotype	C11	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2013	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2008	2013	   1	   0	CTD_human
      384	ARG2	0.569	0.731	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.31	1	2013	2013	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0000771	Abnormalities, Drug-Induced	group	C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.32	1	2014	2016	   0	   0	CGI
      387	RHOA	0.502	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0013575	Ectodermal Dysplasia	disease	C16;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0020981	Angioimmunoblastic Lymphadenopathy	disease	C20;C15	Neoplastic Process	0.40	1	2014	2019	   2	   0	CTD_human
      387	RHOA	0.502	0.808	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.34	1	2014	2019	   0	   0	CGI
      387	RHOA	0.502	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.39	1	2004	2020	   3	   0	CTD_human
      387	RHOA	0.502	0.808	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2004	2014	   3	   0	CTD_human
      387	RHOA	0.502	0.808	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0040435	Tooth Diseases	group	C07	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	2014	2017	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.38	1	2014	2019	   2	   0	CTD_human
      387	RHOA	0.502	0.808	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0162361	Hidrotic Ectodermal Dysplasia	disease	C16;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0162835	Hypopigmentation disorder	disease	C17	Disease or Syndrome	0.31	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0235833	Congenital diaphragmatic hernia	disease	C23;C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      387	RHOA	0.502	0.808	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0265316	Neurocutaneous Syndromes	disease	C16;C17;C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0265699	Congenital hernia of foramen of Morgagni	disease	C23;C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0265700	Congenital hernia of foramen of Bochdalek	disease	C23;C16	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0270612	Leukoencephalopathy	group	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0282160	Aplasia Cutis Congenita	disease	C16;C17	Congenital Abnormality	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C1706004	Anhydrotic Ectodermal Dysplasias	disease	C16;C17	Congenital Abnormality	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2004	2014	   3	   0	CTD_human
      387	RHOA	0.502	0.808	C1744559	Congenital ectodermal dysplasia of face	disease	C16;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	disease	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      387	RHOA	0.502	0.808	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      388	RHOB	0.653	0.423	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.33	0.667	2011	2014	   1	   0	CTD_human
      389	RHOC	0.641	0.308	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	1	2003	2019	   1	   0	CTD_human
      389	RHOC	0.641	0.308	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      390	RND3	0.656	0.385	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2012	2017	   1	   0	CTD_human
      392	ARHGAP1	0.638	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      393	ARHGAP4	0.736	0.5	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      393	ARHGAP4	0.736	0.5	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      395	ARHGAP6	0.769	0.269	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      395	ARHGAP6	0.769	0.269	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2010	2014	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.35	1	2008	2016	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.32	1	2010	2014	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2010	2015	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	disease	C13;C12	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      396	ARHGDIA	0.663	0.577	C3808874	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	disease		Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      396	ARHGDIA	0.663	0.577	C3808953	NEPHROTIC SYNDROME, TYPE 8	disease		Disease or Syndrome	0.60				   0	   3	CTD_human;GENOMICS_ENGLAND
      396	ARHGDIA	0.663	0.577	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      396	ARHGDIA	0.663	0.577	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      397	ARHGDIB	0.633	0.654	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      399	RHOH	0.666	0.462	C0014522	Epidermodysplasia Verruciformis	disease	C01;C17	Neoplastic Process	0.32	1	2012	2013	   1	   0	GENOMICS_ENGLAND
      399	RHOH	0.666	0.462	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
      399	RHOH	0.666	0.462	C4749042	EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4	phenotype		Finding	0.30	1	2012	2012	   1	   0	ORPHANET
      401	PHOX2A	0.7	0.346	C1865915	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2	disease	C23;C16;C11;C10	Disease or Syndrome	0.73	0.8	2001	2012	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      402	ARL2	0.743	0.269	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      403	ARL3	0.603	0.615	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.34	1	2006	2019	   1	   0	ORPHANET
      403	ARL3	0.603	0.615	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.33	1	2014	2018	   1	   0	ORPHANET
      403	ARL3	0.603	0.615	C3553264	JOUBERT SYNDROME 17	disease		Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      403	ARL3	0.603	0.615	C4551568	Joubert syndrome 1	disease	C16;C13;C11;C12	Disease or Syndrome	0.30	1	2018	2018	   1	   0	ORPHANET
      403	ARL3	0.603	0.615	C4748442	JOUBERT SYNDROME 35	disease		Disease or Syndrome	0.40	1	2018	2018	   1	   2	UNIPROT
      403	ARL3	0.603	0.615	C4748536	RETINITIS PIGMENTOSA 83	disease		Disease or Syndrome	0.30	1	2016	2016	   1	   0	UNIPROT
      405	ARNT	0.575	0.692	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2011	2015	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.33	0.75	2002	2015	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0025202	melanoma	disease	C04	Neoplastic Process	0.37	1	2006	2019	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1998	1998	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2006	2012	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      405	ARNT	0.575	0.692	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.31	1	2006	2008	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.37	1	2006	2019	   5	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.36	1	2009	2018	   3	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2009	2018	   3	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0021361	Female infertility	phenotype	C13	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.31	1	2006	2011	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0038279	Sterility, Postpartum	phenotype	C13	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0085159	Seasonal Affective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2015	   1	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0268548	Hyperargininemia	phenotype	C16;C18;C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0341869	Subfertility, Female	disease	C13	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      406	ARNTL	0.51	0.885	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2009	2016	   2	   0	PSYGENET
      406	ARNTL	0.51	0.885	C0917730	Female sterility	phenotype	C13	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      407	ARR3	0.46	0.846	C4538795	MYOPIA 26, X-LINKED, FEMALE-LIMITED	disease		Disease or Syndrome	0.40	1	2016	2016	   1	   3	UNIPROT
      408	ARRB1	0.588	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      408	ARRB1	0.588	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2015	   1	   0	PSYGENET
      408	ARRB1	0.588	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.32	1	2016	2019	   1	   0	CTD_human
      408	ARRB1	0.588	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2015	   1	   0	PSYGENET
      408	ARRB1	0.588	0.846	C3178803	Social Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      409	ARRB2	0.561	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      409	ARRB2	0.561	0.769	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
      410	ARSA	0.448	0.923	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	1984	2002	   4	   0	PSYGENET
      410	ARSA	0.448	0.923	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40				   0	   0	GENOMICS_ENGLAND
      410	ARSA	0.448	0.923	C0023522	Leukodystrophy, Metachromatic	disease	C16;C18;C10	Disease or Syndrome	1.00	0.978	1975	2019	  44	 142	CTD_human;GENOMICS_ENGLAND;UNIPROT
      410	ARSA	0.448	0.923	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1996	1996	   1	   0	PSYGENET
      410	ARSA	0.448	0.923	C0751276	Metachromatic leukodystrophy, juvenile type	disease	C16;C18;C10	Disease or Syndrome	0.43	1	1983	2006	   0	   5	CTD_human
      410	ARSA	0.448	0.923	C0751278	Metachromatic Leukodystrophy, Infant	disease	C16;C18;C10	Disease or Syndrome	0.50	1	1991	2004	   0	   4	CTD_human
      410	ARSA	0.448	0.923	C0751279	Metachromatic Leukodystrophy, Adult-Type (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.45	1	1978	2011	   0	   7	CTD_human
      410	ARSA	0.448	0.923	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	1996	1996	   1	   0	PSYGENET
      410	ARSA	0.448	0.923	C2713319	Arylsulfatase A Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.57	1	1980	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      411	ARSB	0.595	0.692	C0026709	Mucopolysaccharidosis VI	disease	C16;C18;C17	Disease or Syndrome	1.00	1	1979	2019	  15	 121	CTD_human;GENOMICS_ENGLAND;UNIPROT
      411	ARSB	0.595	0.692	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.40				   0	   0	GENOMICS_ENGLAND
      412	STS	0.431	0.846	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.32	1	2005	2019	   1	   0	CTD_human
      412	STS	0.431	0.846	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0019187	Hepatitis, Alcoholic	disease	C06;C25	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      412	STS	0.431	0.846	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.35	1	2014	2019	   1	   0	CTD_human
      412	STS	0.431	0.846	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      412	STS	0.431	0.846	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C0079588	Ichthyosis, X-Linked	disease	C16;C18;C17	Disease or Syndrome	0.80	0.974	1978	2019	   8	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      412	STS	0.431	0.846	C0524610	Chronic Alcoholic Hepatitis	disease	C06;C25	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
      412	STS	0.431	0.846	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.46	1	2008	2017	   1	   0	CTD_human
      412	STS	0.431	0.846	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      412	STS	0.431	0.846	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      412	STS	0.431	0.846	C2717836	Steroid Sulfatase Deficiency Disease	disease	C16;C18;C17	Disease or Syndrome	0.60	0.909	1978	2018	   5	   0	CTD_human;ORPHANET
      412	STS	0.431	0.846	C2720163	Placental Steroid Sulfatase Deficiency	disease	C16;C18;C17	Disease or Syndrome	0.60	0.978	1979	2017	   5	   0	CTD_human;ORPHANET
      412	STS	0.431	0.846	C4274085	Syndromic recessive X-linked ichthyosis	disease	C16;C18;C17	Disease or Syndrome	0.30	1	1988	2008	   4	   0	ORPHANET
      415	ARSL	0.663	0.654	C0008445	Chondrodysplasia Punctata	disease	C05	Congenital Abnormality	0.40	0.875	1995	2017	   1	   0	GENOMICS_ENGLAND
      415	ARSL	0.663	0.654	C1844853	Brachytelephalangic Chondrodysplasia Punctata	disease		Disease or Syndrome	0.63	1	1995	2013	   3	  11	GENOMICS_ENGLAND;UNIPROT
      415	ARSL	0.663	0.654	C3669395	X-Linked Chondrodysplasia Punctata 1	disease	C16;C05	Disease or Syndrome	0.51	1	1995	2008	   1	   0	CTD_human;GENOMICS_ENGLAND
      421	ARVCF	0.54	0.769	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.46	1	2005	2019	   4	   0	PSYGENET
      421	ARVCF	0.54	0.769	C0220704	Shprintzen syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0431406	Asymmetric crying face association	disease	C23;C10;C07	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C0809983	Schizophrenia and related disorders	group	F03	Disease or Syndrome	0.31	1	2010	2010	   1	   0	PSYGENET
      421	ARVCF	0.54	0.769	C2936346	22q11 Deletion Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C3266101	22q11 partial monosomy syndrome	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
      421	ARVCF	0.54	0.769	C3888239	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1	disease		Finding	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      427	ASAH1	0.526	0.808	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.40	1	2017	2018	   2	   1	CTD_human
      427	ASAH1	0.526	0.808	C0020305	Hydrops Fetalis	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
      427	ASAH1	0.526	0.808	C0023794	Lipoidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2006	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      427	ASAH1	0.526	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      427	ASAH1	0.526	0.808	C0221765	Chronic schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      427	ASAH1	0.526	0.808	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C0268255	Farber Lipogranulomatosis	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1989	2019	  15	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      427	ASAH1	0.526	0.808	C0455988	Hydrops Fetalis, Non-Immune	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
      427	ASAH1	0.526	0.808	C1834569	Jankovic Rivera syndrome	disease	C23;C16;C05;C10	Disease or Syndrome	0.75	1	2012	2019	   4	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      427	ASAH1	0.526	0.808	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      427	ASAH1	0.526	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2008	2014	   1	   0	GENOMICS_ENGLAND
      429	ASCL1	0.552	0.692	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.40	1	1997	2020	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      429	ASCL1	0.552	0.692	C1275808	Congenital central hypoventilation	disease	C23;C08;C10	Disease or Syndrome	0.61	1	2003	2003	   0	   0	CTD_human;GENOMICS_ENGLAND
      429	ASCL1	0.552	0.692	C1859049	CCHS WITH HIRSCHSPRUNG DISEASE	disease	C23;C08;C10	Disease or Syndrome; Congenital Abnormality	0.50				   0	   0	CTD_human;ORPHANET
      429	ASCL1	0.552	0.692	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2011	2011	   1	   0	CTD_human
      430	ASCL2	0.691	0.423	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.35	0.833	2004	2019	   1	   0	CTD_human
      430	ASCL2	0.691	0.423	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.31	1	2008	2009	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C0025202	melanoma	disease	C04	Neoplastic Process	0.38	1	2002	2013	   3	   0	CTD_human
      434	ASIP	0.584	0.692	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C1368275	Pigmented Basal Cell Carcinoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      434	ASIP	0.584	0.692	C4721806	Carcinoma, Basal Cell	disease	C04	Neoplastic Process	0.32	1	2008	2009	   1	   0	CTD_human
      435	ASL	0.593	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2015	2015	   0	   0	UNIPROT
      435	ASL	0.593	0.731	C0268547	Argininosuccinic Aciduria	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1976	2019	  12	  83	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      438	ASMT	0.691	0.346	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2008	2014	   1	   0	CTD_human
      438	ASMT	0.691	0.346	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2014	   1	   0	PSYGENET
      438	ASMT	0.691	0.346	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2012	2014	   2	   0	PSYGENET
      438	ASMT	0.691	0.346	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2014	   2	   0	PSYGENET
      438	ASMT	0.691	0.346	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      438	ASMT	0.691	0.346	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0023794	Lipoidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.50	1	1976	2017	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.51	1	1976	2019	   1	   0	CTD_human
      440	ASNS	0.595	0.692	C3809971	ASPARAGINE SYNTHETASE DEFICIENCY	disease		Disease or Syndrome	0.73	1	1968	2019	  16	  12	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      443	ASPA	0.564	0.731	C0206307	Canavan Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	0.967	1990	2020	  17	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
      443	ASPA	0.564	0.731	C0751663	Canavan Disease, Familial Form	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1993	2013	   2	   0	CTD_human
      443	ASPA	0.564	0.731	C0751664	Canavan Disease, Neonatal	disease	C16;C18;C10	Disease or Syndrome	0.50	1	2006	2011	   3	   0	CTD_human;ORPHANET
      443	ASPA	0.564	0.731	C0751665	Canavan Disease, Sporadic Form	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
      443	ASPA	0.564	0.731	C0751666	Canavan Disease, Infantile	disease	C16;C18;C10	Disease or Syndrome	0.50	1	2006	2011	   3	   0	CTD_human;ORPHANET
      443	ASPA	0.564	0.731	C0751667	Canavan Disease, Juvenile	disease	C16;C18;C10	Disease or Syndrome	0.50	1	2006	2011	   3	   0	CTD_human;ORPHANET
      443	ASPA	0.564	0.731	C3542499	Aminoacylase 2 Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2005	2007	   2	   0	CTD_human
      444	ASPH	0.61	0.615	C1832167	Ectopia Lentis, Spontaneous Filtering Blebs, and Craniofacial Dysmorphism	disease	C16;C11;C05	Disease or Syndrome	0.72	1	2014	2018	   1	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      445	ASS1	0.523	0.731	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      445	ASS1	0.523	0.731	C0025945	Microangiopathy, Diabetic	disease	C19;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      445	ASS1	0.523	0.731	C0175683	Citrullinemia	disease	C16;C18;C10	Disease or Syndrome	0.90	1	1982	2020	  10	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND
      445	ASS1	0.523	0.731	C0751750	Argininosuccinic Acid Synthetase Deficiency Disease, Partial	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      445	ASS1	0.523	0.731	C0751751	Argininosuccinic Acid Synthetase Deficiency, Complete	disease	C16;C18;C10	Disease or Syndrome	0.55	1	1982	2017	   9	   0	CLINGEN;CTD_human
      445	ASS1	0.523	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      445	ASS1	0.523	0.731	C4721769	Citrullinemia Type 1	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1982	2019	  22	  85	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      460	ASTN1	0.736	0.308	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      460	ASTN1	0.736	0.308	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      460	ASTN1	0.736	0.308	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      460	ASTN1	0.736	0.308	C2748861	Cortical malformations	phenotype		Finding	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      460	ASTN1	0.736	0.308	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
      462	SERPINC1	0.507	0.769	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	1976	1976	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0012739	Disseminated Intravascular Coagulation	disease	C15	Disease or Syndrome	0.33	1	1984	2019	   3	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.50	1	1994	2001	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.51	1	1983	2007	   4	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0042487	Venous Thrombosis	phenotype	C14	Pathologic Function	0.34	1	1976	2007	   3	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0079102	Cerebral Thrombosis	disease	C10;C14	Disease or Syndrome	0.31	1	1980	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	1983	2000	   4	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0149871	Deep Vein Thrombosis	disease	C14	Disease or Syndrome	0.50	1	1976	2019	   3	   2	CTD_human
      462	SERPINC1	0.507	0.769	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.31	1	1985	2017	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0272375	Antithrombin III Deficiency	disease	C16;C15	Disease or Syndrome	1.00	0.987	1984	2019	  38	  43	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      462	SERPINC1	0.507	0.769	C0752143	Intracranial Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0752144	Brain Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0936261	Brain Thrombus	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0936263	Cerebral Thrombus	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C1861172	Venous Thromboembolism	phenotype	C14	Disease or Syndrome	0.40	1	1979	2019	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	1983	1983	   1	   0	CTD_human
      462	SERPINC1	0.507	0.769	C3658294	Hereditary Antithrombin Deficiency	disease	C16;C15	Disease or Syndrome	0.34	1	1984	2019	   1	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.50	0.966	2009	2019	   5	   7	CTD_human
      463	ZFHX3	0.621	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.33	1	2005	2018	   3	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.48	1	2012	2019	   1	   3	CTD_human
      463	ZFHX3	0.621	0.654	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.31	1	2009	2018	   5	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.47	1	2005	2019	   3	   0	CTD_human
      463	ZFHX3	0.621	0.654	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      463	ZFHX3	0.621	0.654	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2009	2018	   5	   0	CTD_human
      463	ZFHX3	0.621	0.654	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2009	2018	   5	   0	CTD_human
      465	ATD	0.656	0.731	C4551856	Asphyxiating Thoracic Dystrophy 1	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
      466	ATF1	0.588	0.577	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      466	ATF1	0.588	0.577	C0206651	Clear Cell Sarcoma of Soft Tissue	disease	C04	Neoplastic Process	0.40	0.977	1993	2019	   1	   0	ORPHANET
      466	ATF1	0.588	0.577	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.32	1	2007	2016	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2008	2018	   1	   0	PSYGENET
      467	ATF3	0.494	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2018	   1	   0	PSYGENET
      467	ATF3	0.494	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.34	1	2005	2017	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0021400	Influenza	disease	C01;C08	Disease or Syndrome	0.31	1	2007	2013	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
      467	ATF3	0.494	0.885	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2006	2008	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.31	1	2010	2019	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.35	1	2006	2016	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.31	1	2002	2010	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0848558	Hypospadias	disease	C16;C13;C12	Congenital Abnormality	0.37	1	2005	2018	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.32	1	2014	2018	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      467	ATF3	0.494	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2008	   2	   0	PSYGENET
      468	ATF4	0.507	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      468	ATF4	0.507	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      468	ATF4	0.507	0.769	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.33	1	2016	2019	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0021367	Mammary Ductal Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2020	   1	   0	PSYGENET
      468	ATF4	0.507	0.769	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      468	ATF4	0.507	0.769	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.34	1	2016	2020	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.34	1	2004	2016	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0155003	Blindness, Transient	phenotype	C23;C11;C10	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0221473	Blindness, Hysterical	phenotype	C23;C11;C10	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0271215	Blindness, Legal	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0339730	Blindness, Acquired	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0376288	Amaurosis	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0456909	Blindness	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0750958	Blindness, Monocular	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C1837530	AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency	disease	C23;C16;C10;F03;F01	Disease or Syndrome	0.70	1	2004	2004	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      471	ATIC	0.576	0.731	C1879328	Blindness both eyes NOS (disorder)	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      471	ATIC	0.576	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0004135	Ataxia Telangiectasia	disease	C16;C18;C20;C10;C14	Disease or Syndrome	1.00	0.982	1953	2020	  37	 414	CTD_human;GENOMICS_ENGLAND;UNIPROT
      472	ATM	0.374	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.69	1	2008	2017	   1	   1	CGI;CTD_human
      472	ATM	0.374	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.58	1	2008	2017	   1	   0	CGI;CTD_human
      472	ATM	0.374	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.70	0.932	1996	2020	   1	  22	CTD_human;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.959	1995	2020	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40	1	2004	2017	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.31	1	2013	2018	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.42	0.5	2012	2015	   0	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0017638	Glioma	disease	C04	Neoplastic Process	0.60	0.938	2001	2019	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.42	1	2001	2016	   1	   1	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0023418	leukemia	disease	C04	Neoplastic Process	0.90	1	1998	2018	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.70	0.966	1998	2019	   2	   2	CTD_human;ORPHANET;UNIPROT
      472	ATM	0.374	0.885	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.90	0.955	1998	2020	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.60	1	1998	2019	   1	   0	CGI;CTD_human
      472	ATM	0.374	0.885	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.51	0.5	2003	2017	   1	   0	CGI;GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0025202	melanoma	disease	C04	Neoplastic Process	0.50	1	2007	2019	   1	   2	CTD_human
      472	ATM	0.374	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.38	1	1994	2019	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0027651	Neoplasms	group	C04	Neoplastic Process	0.50	0.946	1995	2020	   1	   2	CTD_human
      472	ATM	0.374	0.885	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.33	1	2007	2019	   2	   0	CTD_human
      472	ATM	0.374	0.885	C0033054	Prenatal Exposure Delayed Effects	disease	C13	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2004	2018	   4	   0	CTD_human
      472	ATM	0.374	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2013	   1	   0	PSYGENET
      472	ATM	0.374	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.52	1	2001	2015	   1	   0	CGI;CTD_human
      472	ATM	0.374	0.885	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.33	1	2003	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0086543	Cataract	disease	C11	Acquired Abnormality	0.30	1	2006	2006	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.40	0.9	2009	2019	   0	   1	UNIPROT
      472	ATM	0.374	0.885	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0154017	Benign neoplasm of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0154091	Carcinoma in situ of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      472	ATM	0.374	0.885	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.33	1	2013	2018	   0	   0	UNIPROT
      472	ATM	0.374	0.885	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.80	1	1999	2017	   1	   1	CGI;GENOMICS_ENGLAND;UNIPROT
      472	ATM	0.374	0.885	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.40	1	1998	2019	   5	   0	CLINGEN
      472	ATM	0.374	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	1	2004	2020	   2	   0	CTD_human
      472	ATM	0.374	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.943	2000	2019	   4	   0	CTD_human
      472	ATM	0.374	0.885	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0496930	Neoplasm of uncertain or unknown behavior of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
      472	ATM	0.374	0.885	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      472	ATM	0.374	0.885	C0555202	Malignant lymphoma - lymphocytic, intermediate differentiation	disease		Neoplastic Process	0.30	1	2000	2000	   1	   0	ORPHANET
      472	ATM	0.374	0.885	C0598589	Inherited neuropathies	disease	C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	0.934	1996	2020	   0	   3	CTD_human
      472	ATM	0.374	0.885	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1998	2019	   0	   0	CGI
      472	ATM	0.374	0.885	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.39	1	2008	2017	   0	   0	CGI
      472	ATM	0.374	0.885	C0855095	Small Lymphocytic Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	0.5	1999	2014	   1	   0	ORPHANET
      472	ATM	0.374	0.885	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      472	ATM	0.374	0.885	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.60				   0	   4	CGI;UNIPROT
      472	ATM	0.374	0.885	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.33	1	2005	2018	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.50	0.974	1996	2018	   0	   0	CTD_human
      472	ATM	0.374	0.885	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2006	2006	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      472	ATM	0.374	0.885	C1843542	T-CELL PROLYMPHOCYTIC LEUKEMIA, SOMATIC	disease		Disease or Syndrome	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      472	ATM	0.374	0.885	C1868683	B-CELL MALIGNANCY, LOW-GRADE	disease		Neoplastic Process	0.40	1	1998	2015	   1	   0	ORPHANET
      472	ATM	0.374	0.885	C1876175	Ataxia-Telangiectasia Variant	disease	C16;C18;C20;C10;C14	Disease or Syndrome	0.40	1	2013	2013	   1	   1	ORPHANET
      472	ATM	0.374	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.37	1	1995	2020	   1	   0	CTD_human
      472	ATM	0.374	0.885	C2363142	T-Cell Prolymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.50	1	1997	2018	   0	   2	CGI
      472	ATM	0.374	0.885	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      472	ATM	0.374	0.885	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2012	2017	   6	   0	CLINGEN
      472	ATM	0.374	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      472	ATM	0.374	0.885	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      473	RERE	0.526	0.846	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C1842870	Chromosome 1p36 Deletion Syndrome	disease	C23;C16	Disease or Syndrome	0.31	1	2016	2016	   1	   0	ORPHANET
      473	RERE	0.526	0.846	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C4310772	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART	disease		Disease or Syndrome	0.71	1	2015	2018	   3	  11	CTD_human;GENOMICS_ENGLAND;UNIPROT
      473	RERE	0.526	0.846	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      473	RERE	0.526	0.846	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.40	1	2007	2019	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0205833	Medullomyoblastoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0278510	Childhood Medulloblastoma	disease	C04	Neoplastic Process	0.39	1	2008	2019	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0278876	Adult Medulloblastoma	disease	C04	Neoplastic Process	0.39	1	2008	2019	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C1275668	Melanotic medulloblastoma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      474	ATOH1	0.633	0.5	C1879677	Alcohol Toxicity	disease		Injury or Poisoning	0.30	1	2008	2008	   1	   0	PSYGENET
      475	ATOX1	0.656	0.5	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2013	2013	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      475	ATOX1	0.656	0.5	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0001430	Adenoma	group	C04	Neoplastic Process	0.34	1	2013	2017	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1998	1998	   1	   0	PSYGENET
      476	ATP1A1	0.601	0.808	C0017162	Gastroenteritis, Transmissible, of Swine	disease	C01;C22	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0020428	Hyperaldosteronism	disease	C19	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.56	1	1994	2015	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.31	1	2018	2020	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C0042594	Vestibular Diseases	group	C09	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0151723	Hypomagnesemia	phenotype	C18	Disease or Syndrome	0.42	1	2018	2020	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2013	2013	   2	   0	CTD_human
      476	ATP1A1	0.601	0.808	C0206667	Adrenal Cortical Adenoma	disease	C04;C19	Neoplastic Process	0.31	1	2016	2016	   0	   0	CGI
      476	ATP1A1	0.601	0.808	C1384514	Conn Syndrome	disease	C19	Disease or Syndrome	0.32	1	2013	2019	   1	   0	CTD_human
      476	ATP1A1	0.601	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C4552839	Hypomagnesemia, CTCAE	phenotype		Finding	0.40	1	2018	2018	   1	   0	GENOMICS_ENGLAND
      476	ATP1A1	0.601	0.808	C4747974	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD	disease		Disease or Syndrome	0.70	1	2018	2018	   2	   1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
      477	ATP1A2	0.597	0.615	C0003886	Arthrogryposis	disease	C16;C05	Disease or Syndrome	0.40	1	2020	2020	   1	   2	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      477	ATP1A2	0.597	0.615	C0009421	Comatose	phenotype	C23;C10	Disease or Syndrome	0.40	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40	1	2003	2003	   2	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0020305	Hydrops Fetalis	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.41	1	2020	2020	   1	   2	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.50	1	2001	2005	   2	   0	CTD_human
      477	ATP1A2	0.597	0.615	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2020	2020	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.31	1	2009	2018	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0149931	Migraine Disorders	group	C10	Disease or Syndrome	0.40	0.958	2003	2019	   2	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0220669	Familial benign neonatal epilepsy	disease	C16;C10	Disease or Syndrome	0.32	1	2003	2004	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0238358	Hypokalemic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.31	1	2007	2018	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0270816	epilepsy and migraine	disease		Disease or Syndrome	0.31	1	2003	2008	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C0338488	Alternating hemiplegia of childhood	disease	C23;C10	Disease or Syndrome	0.54	1	2004	2019	   1	   0	CTD_human;ORPHANET
      477	ATP1A2	0.597	0.615	C1865322	MIGRAINE, FAMILIAL HEMIPLEGIC, 2	disease	C10	Disease or Syndrome	0.80	1	2003	2020	   9	  13	CTD_human;GENOMICS_ENGLAND;UNIPROT
      477	ATP1A2	0.597	0.615	C2733158	Cerebral Small Vessel Diseases	group	C10;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	GENOMICS_ENGLAND
      477	ATP1A2	0.597	0.615	C3549447	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	disease		Disease or Syndrome	0.61	1	2003	2020	   4	   1	GENOMICS_ENGLAND;UNIPROT
      478	ATP1A3	0.544	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	0.5	1998	2001	   2	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2011	2011	   1	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.50	1	1999	2016	   1	   2	CTD_human
      478	ATP1A3	0.544	0.615	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      478	ATP1A3	0.544	0.615	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.48	1	2004	2016	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0242423	Ramsay Hunt Paralysis Syndrome	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0338488	Alternating hemiplegia of childhood	disease	C23;C10	Disease or Syndrome	0.90	0.977	2009	2019	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      478	ATP1A3	0.544	0.615	C0393588	Dystonia, Paroxysmal	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0393610	Dystonia, Diurnal	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0751093	Dystonia, Limb	phenotype	C23;C10	Sign or Symptom	0.40	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752097	Autosomal Dominant Juvenile Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752098	Autosomal Dominant Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752100	Autosomal Recessive Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752101	Parkinsonism, Experimental	disease	C10	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752104	Familial Juvenile Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C0752105	Parkinsonism, Juvenile	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C1832466	CAPOS syndrome	disease	C23;C16;C11;C05;C10;C09	Disease or Syndrome	0.80	1	2012	2019	   4	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      478	ATP1A3	0.544	0.615	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C1868681	DYSTONIA 12	disease	C10	Disease or Syndrome	0.80	0.982	2004	2019	   6	  25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      478	ATP1A3	0.544	0.615	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      478	ATP1A3	0.544	0.615	C3549447	ALTERNATING HEMIPLEGIA OF CHILDHOOD 1	disease		Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
      478	ATP1A3	0.544	0.615	C3553788	ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	disease		Disease or Syndrome	0.61	1	2004	2017	   6	  38	GENOMICS_ENGLAND;UNIPROT
      480	ATP1A4	0.805	0.269	C0003165	Anthracosis	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.31	1	2009	2009	   0	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      481	ATP1B1	0.7	0.462	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      482	ATP1B2	0.705	0.308	C0017638	Glioma	disease	C04	Neoplastic Process	0.32	1	2003	2006	   1	   0	CTD_human
      482	ATP1B2	0.705	0.308	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      482	ATP1B2	0.705	0.308	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	2014	2014	   1	   1	CTD_human
      482	ATP1B2	0.705	0.308	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.31	1	2003	2006	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0024473	Magnesium Deficiency	disease	C18	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C0268448	Primary hypomagnesemia (disorder)	disease	C23;C16;C18;C13;C12	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
      486	FXYD2	0.78	0.346	C1835171	Hypomagnesemia 2, renal	disease	C16;C18;C13;C12	Disease or Syndrome	0.70	1	2000	2016	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      487	ATP2A1	0.682	0.423	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C1832918	Brody myopathy	disease	C16;C05;C10	Disease or Syndrome	0.80	1	1995	2014	   3	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      487	ATP2A1	0.682	0.423	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      487	ATP2A1	0.682	0.423	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2001	2004	   2	   0	PSYGENET
      488	ATP2A2	0.529	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2001	2004	   2	   0	PSYGENET
      488	ATP2A2	0.529	0.808	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2017	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.51	1	2005	2016	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.51	0.667	2009	2015	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.50	1	2001	2018	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.60	0.929	1996	2019	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.80	0.929	1996	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
      488	ATP2A2	0.529	0.808	C0022595	Keratosis Follicularis	disease	C16;C17	Disease or Syndrome	1.00	0.974	1999	2018	  12	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      488	ATP2A2	0.529	0.808	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.50	1	2000	2017	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2012	2019	   1	   1	PSYGENET
      488	ATP2A2	0.529	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0206145	Stunned Myocardium	disease	C23;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0206146	Myocardial Stunning	disease	C23;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0264716	Chronic heart failure	disease	C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      488	ATP2A2	0.529	0.808	C0265971	Acrokeratosis Verruciformis of Hopf	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.74	1	2003	2017	   3	   2	CTD_human;ORPHANET;UNIPROT
      488	ATP2A2	0.529	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0376416	Hibernation, Myocardial	disease	C23;C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0473575	Acantholytic Dyskeratotic Epidermal Nevus	disease	C16;C17	Neoplastic Process	0.30	1	2006	2010	   2	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2001	2002	   2	   0	PSYGENET
      488	ATP2A2	0.529	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.52	0.75	2002	2014	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      488	ATP2A2	0.529	0.808	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0001430	Adenoma	group	C04	Neoplastic Process	0.32	1	2005	2014	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.35	1	2016	2019	   0	   1	UNIPROT
      489	ATP2A3	0.617	0.577	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2010	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.32	1	1999	2019	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      489	ATP2A3	0.617	0.577	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.31	1	2012	2019	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.70	0.966	1999	2019	   1	   9	CTD_human
      490	ATP2B1	0.666	0.5	C0086543	Cataract	disease	C11	Acquired Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2004	2004	   1	   0	CTD_human
      490	ATP2B1	0.666	0.5	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.43	1	2012	2019	   1	   3	CTD_human
      491	ATP2B2	0.659	0.731	C1832394	Deafness, Autosomal Recessive 12	disease	C23;C10;C09	Disease or Syndrome	0.50	1	2007	2007	   1	   0	CTD_human;GENOMICS_ENGLAND
      492	ATP2B3	0.631	0.692	C0001430	Adenoma	group	C04	Neoplastic Process	0.31	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0020428	Hyperaldosteronism	disease	C19	Disease or Syndrome	0.31	1	2013	2015	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.31	1	2013	2017	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C0796205	SPINOCEREBELLAR ATAXIA, X-LINKED 1	disease	C16;C10	Disease or Syndrome	0.70	1	2012	2012	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      492	ATP2B3	0.631	0.692	C1384514	Conn Syndrome	disease	C19	Disease or Syndrome	0.31	1	2013	2015	   1	   0	CTD_human
      492	ATP2B3	0.631	0.692	C4707849	X-linked non progressive cerebellar ataxia	disease	C23;C16;C10	Disease or Syndrome	0.30				   0	   0	ORPHANET
      498	ATP5F1A	0.604	0.731	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.54	1	2003	2017	1	0	CTD_human
1979	498	ATP5F1A	0.604	0.731	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      498	ATP5F1A	0.604	0.731	C3808899	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4	disease		Disease or Syndrome	0.70	1	2013	2013	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      498	ATP5F1A	0.604	0.731	C4015062	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	disease		Disease or Syndrome	0.70	1	2013	2013	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      498	ATP5F1A	0.604	0.731	C4757950	Isolated ATP synthase deficiency	disease		Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
      501	ALDH7A1	0.551	0.769	C0005940	Bone Diseases	group	C05	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0009363	Congenital ocular coloboma (disorder)	disease	C16;C11	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      501	ALDH7A1	0.551	0.769	C1849508	EPILEPSY, PYRIDOXINE-DEPENDENT	disease	C10	Disease or Syndrome	0.80	1	2006	2020	   9	  25	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      501	ALDH7A1	0.551	0.769	C4554007	Uveoretinal Coloboma	disease	C16;C11	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.50	1	2015	2015	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.50	1	2015	2015	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C1846707	SPINOCEREBELLAR ATAXIA 17	disease	C16;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      506	ATP5F1B	0.626	0.654	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	2015	2015	   1	   0	CTD_human
      513	ATP5F1D	0.674	0.5	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      513	ATP5F1D	0.674	0.5	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      513	ATP5F1D	0.674	0.5	C4748269	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5	disease		Disease or Syndrome	0.60	1	2018	2018	   1	   2	GENOMICS_ENGLAND;UNIPROT
      513	ATP5F1D	0.674	0.5	C4757950	Isolated ATP synthase deficiency	disease		Disease or Syndrome	0.30	1	2018	2018	   1	   0	ORPHANET
      514	ATP5F1E	0.686	0.5	C3279708	MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3	disease		Disease or Syndrome	0.70	1	2010	2016	   3	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      514	ATP5F1E	0.686	0.5	C4757950	Isolated ATP synthase deficiency	disease		Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
      522	ATP5PF	0.716	0.538	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      523	ATP6V1A	0.579	0.615	C0268355	Cutis Laxa, Autosomal Recessive, Type IIA	disease	C16;C17	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      523	ATP6V1A	0.579	0.615	C4479387	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC	disease		Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      523	ATP6V1A	0.579	0.615	C4479409	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID	disease		Disease or Syndrome	0.70	1	2017	2017	   1	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      523	ATP6V1A	0.579	0.615	C4693934	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3	disease		Disease or Syndrome	0.60	1	2017	2018	   2	   5	GENOMICS_ENGLAND;UNIPROT
      525	ATP6V1B1	0.695	0.346	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C0403554	Renal Tubular Acidosis, Distal, with Progressive Nerve Deafness	disease	C23;C16;C18;C13;C12;C10;C09	Disease or Syndrome	0.70	1	1999	2017	   4	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      525	ATP6V1B1	0.695	0.346	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.30	1	1999	1999	   1	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C1704380	Distal Renal Tubular Acidosis	disease	C16;C18;C13;C12	Disease or Syndrome	0.40	1	2001	2020	   0	   0	GENOMICS_ENGLAND
      525	ATP6V1B1	0.695	0.346	C1864498	RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE	disease	C16;C18;C13;C12	Disease or Syndrome	0.36	1	2002	2017	   1	   0	ORPHANET
      525	ATP6V1B1	0.695	0.346	C4302514	Distal renal tubular acidosis co-occurrent with sensorineural deafness	phenotype	C23;C16;C18;C13;C12;C10;C09	Disease or Syndrome	0.30	1	1999	2017	   2	   0	CLINGEN
      526	ATP6V1B2	0.606	0.577	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.31	1	2016	2019	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0079745	Lymphoma, Large-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0079758	Lymphoma, Mixed-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0079765	Lymphoma, Small Cleaved-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C0796013	Zimmerman Laband syndrome	disease	C16;C05;C07	Disease or Syndrome	0.61	1	2015	2015	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
      526	ATP6V1B2	0.606	0.577	C1956130	Lymphoma, Follicular, Grade 1	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C1956131	Lymphoma, Follicular, Grade 3	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C1956132	Lymphoma, Follicular, Grade 2	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      526	ATP6V1B2	0.606	0.577	C2675730	Deafness, Congenital, and Onychodystrophy, Autosomal Dominant	disease	C23;C16;C10;C07;C09	Disease or Syndrome	0.62	1	2014	2019	   1	   1	CTD_human;ORPHANET
      526	ATP6V1B2	0.606	0.577	C4225321	ZIMMERMANN-LABAND SYNDROME 2	disease		Disease or Syndrome	0.41	1	2015	2019	   1	   2	UNIPROT
      529	ATP6V1E1	0.61	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      529	ATP6V1E1	0.61	0.769	C0268355	Cutis Laxa, Autosomal Recessive, Type IIA	disease	C16;C17	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      529	ATP6V1E1	0.61	0.769	C4479387	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC	disease		Disease or Syndrome	0.70	1	2017	2017	   1	   2	CTD_human;ORPHANET;UNIPROT
      529	ATP6V1E1	0.61	0.769	C4479409	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID	disease		Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
      533	ATP6V0B	0.931	0.115	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      537	ATP6AP1	0.691	0.577	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C0079745	Lymphoma, Large-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C0079758	Lymphoma, Mixed-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C0079765	Lymphoma, Small Cleaved-Cell, Follicular	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C1956130	Lymphoma, Follicular, Grade 1	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C1956131	Lymphoma, Follicular, Grade 3	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C1956132	Lymphoma, Follicular, Grade 2	disease	C04;C20;C15	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
      537	ATP6AP1	0.691	0.577	C4310819	IMMUNODEFICIENCY 47	disease		Disease or Syndrome	0.70	1	2016	2018	   1	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      538	ATP7A	0.494	0.769	C0002871	Anemia	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0003496	Aortic Rupture	disease	C14;C26	Disease or Syndrome	0.30	1	1990	2015	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0010495	Cutis Laxa	disease	C16;C17	Disease or Syndrome	0.40	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      538	ATP7A	0.494	0.769	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019054	Hemolysis (disorder)	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0022716	Menkes Kinky Hair Syndrome	disease	C16;C18;C17;C10	Disease or Syndrome	1.00	1	1953	2019	  46	   0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
      538	ATP7A	0.494	0.769	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
      538	ATP7A	0.494	0.769	C0027854	Neurologic Manifestations	phenotype	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0040822	Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0040827	Saturnine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0149840	Senile Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234370	Persistent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234371	Continuous Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234372	Intermittent Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234373	Fine Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234374	Coarse Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234375	Massive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234376	Action Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234377	Passive Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234378	Static Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234379	Resting Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234381	Darkness Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0234544	Todd Paralysis	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235031	Neurologic Symptoms	group	C23;C10	Sign or Symptom	0.32	1	2011	2017	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235078	Tremor, Perioral	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235081	Tremor, Limb	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235082	Tremor, Muscle	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235083	Nerve Tremors	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235574	Intravascular hemolysis	disease	C23	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0235843	Tremor, Neonatal	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0268353	Cutis laxa, x-linked	disease	C16;C17;C15;C14	Congenital Abnormality	0.80	1	1996	2019	   7	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
      538	ATP7A	0.494	0.769	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0312854	Extravascular Hemolysis	disease	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422837	Neurological observations	group	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0521654	Neurologic Deficits	group	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0522224	Paralysed	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0598589	Inherited neuropathies	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      538	ATP7A	0.494	0.769	C0741160	Aortic Aneurysm, Ruptured	disease	C14;C26	Disease or Syndrome	0.50	1	1990	2015	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0746857	Focal Neurologic Deficits	phenotype	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751377	Neurologic Dysfunction	phenotype	C23;C10	Finding	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751378	Neurologic Signs	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   2	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751564	Pill Rolling Tremor	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C0751565	Tremor, Semirhythmic	phenotype	C23;C10	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C1527384	Involuntary Quiver	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C1845359	Spinal Muscular Atrophy, Distal, X-Linked 3	disease	C16;C10	Disease or Syndrome	0.90	1	2004	2012	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      538	ATP7A	0.494	0.769	C2936380	Neointima	disease	C23	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C2936381	Neointima Formation	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2012	2012	   1	   0	CTD_human
      538	ATP7A	0.494	0.769	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0007097	Carcinoma	group	C04	Neoplastic Process	0.32	1	2002	2008	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.41	1	2007	2017	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.31	1	2003	2007	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	1.00	0.98	1983	2020	 136	 318	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      540	ATP7B	0.529	0.654	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.41	1	2014	2015	   1	   1	CTD_human
      540	ATP7B	0.529	0.654	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.36	1	2010	2018	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.34	1	2001	2017	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
      540	ATP7B	0.529	0.654	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2011	2011	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.44	0.75	2000	2019	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   2	   0	CTD_human
      540	ATP7B	0.529	0.654	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2002	2009	   3	   0	CTD_human
      540	ATP7B	0.529	0.654	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.32	1	2001	2019	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.32	1	2002	2015	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.33	1	2002	2015	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.32	1	2003	2019	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
      540	ATP7B	0.529	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2000	2014	  51	   0	CTD_human
      540	ATP7B	0.529	0.654	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.42	1	2007	2017	   1	   0	CTD_human
      540	ATP7B	0.529	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0004681	Bagassosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.965	1999	2020	   0	   0	CGI
      545	ATR	0.456	0.923	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.31	1	2019	2019	   0	   0	CGI
      545	ATR	0.456	0.923	C0017638	Glioma	disease	C04	Neoplastic Process	0.31	1	2010	2010	   0	   0	CGI
      545	ATR	0.456	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	1999	2005	   0	   0	CGI
      545	ATR	0.456	0.923	C0029925	Ovarian Carcinoma	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0032273	Pneumoconiosis	disease	C08;C24	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0042076	Urologic Neoplasms	group	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
      545	ATR	0.456	0.923	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.32	1	2017	2019	   0	   0	UNIPROT
      545	ATR	0.456	0.923	C0153943	Benign neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0154060	Carcinoma in situ of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.80	1	2003	2018	   1	   0	GENOMICS_ENGLAND;ORPHANET
      545	ATR	0.456	0.923	C0280313	Squamous cell carcinoma of oropharynx	disease	C04;C07;C09	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   0	UNIPROT
      545	ATR	0.456	0.923	C0346191	Carcinoma in situ of endometrium	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2014	2019	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.31	1	2019	2019	   0	   0	CGI
      545	ATR	0.456	0.923	C0496905	Neoplasm of uncertain or unknown behavior of stomach	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
      545	ATR	0.456	0.923	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	1999	1999	   0	   0	CGI
      545	ATR	0.456	0.923	C0751571	Cancer of Urinary Tract	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      545	ATR	0.456	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.32	0.5	2005	2017	   0	   0	CGI
      545	ATR	0.456	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.32	0.5	2005	2017	   0	   0	CGI
      545	ATR	0.456	0.923	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.30				   0	   0	GENOMICS_ENGLAND
      545	ATR	0.456	0.923	C3165106	Infiltrating duct carcinoma of female breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
      545	ATR	0.456	0.923	C3281203	CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL	disease		Neoplastic Process	0.70	1	1990	2012	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      545	ATR	0.456	0.923	C4551474	Seckel syndrome 1	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.61	1	2003	2009	   1	   8	CTD_human;GENOMICS_ENGLAND
      546	ATRX	0.452	0.808	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.41	1	2009	2009	   1	   1	CTD_human
      546	ATRX	0.452	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0017638	Glioma	disease	C04	Neoplastic Process	0.40	1	2012	2020	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.40	1	2012	2019	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0030846	Penile Diseases	group	C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0039978	Thoracic Diseases	group	C08	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.38	1	2011	2018	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2013	2014	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.32	1	2013	2019	   2	   0	CTD_human
      546	ATRX	0.452	0.808	C0585216	Alpha-Thalassemia Myelodysplasia Syndrome	disease	C16;C15	Neoplastic Process	0.71	1	2003	2006	   1	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET
      546	ATRX	0.452	0.808	C0796003	Juberg-Marsidi syndrome	disease	C23;C16;C10;C19;C09	Disease or Syndrome	0.72	1	1995	2020	  17	  10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      546	ATRX	0.452	0.808	C0796159	Mental retardation Smith Fineman Myers type	disease	C23;C10;F03;F01	Disease or Syndrome	0.31	1	2000	2000	   1	   0	ORPHANET
      546	ATRX	0.452	0.808	C1136249	Mental Retardation, X-Linked	disease	C16;C10	Disease or Syndrome	0.40	1	1997	2011	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C1328479	Pancreatic Endocrine Carcinoma	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
      546	ATRX	0.452	0.808	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.38	1	2015	2018	   0	   0	CGI
      546	ATRX	0.452	0.808	C1845055	ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED	disease	C16;C10;C15	Disease or Syndrome	1.00	0.982	1995	2019	  16	  22	CTD_human;GENOMICS_ENGLAND;UNIPROT
      546	ATRX	0.452	0.808	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
      546	ATRX	0.452	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.47	1	2003	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.31	1	2013	2018	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0085996	Child Development Deviations	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0085997	Child Development Disorders, Specific	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
      547	KIF1A	0.559	0.692	C0270914	Hereditary Motor and Sensory-Neuropathy Type II	disease	C16;C10	Disease or Syndrome	0.30	1	2011	2015	   2	   0	GENOMICS_ENGLAND
      547	KIF1A	0.559	0.692	C1835896	SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE (disorder)	disease	C23;C10	Disease or Syndrome	0.93	1	2011	2020	   4	  22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      547	KIF1A	0.559	0.692	C1850055	PEHO syndrome	disease	C11;C10	Disease or Syndrome	0.42	1	2016	2019	   1	   3	ORPHANET
      547	KIF1A	0.559	0.692	C2752089	Neuropathy, Hereditary Sensory And Autonomic, Type IIA	disease	C16;C10	Disease or Syndrome	0.40				   0	   1	CTD_human
      547	KIF1A	0.559	0.692	C3280168	NEUROPATHY, HEREDITARY SENSORY, TYPE IIC	disease		Disease or Syndrome	0.61	1	2011	2017	   3	  19	CTD_human;GENOMICS_ENGLAND
      547	KIF1A	0.559	0.692	C3280283	MENTAL RETARDATION, AUTOSOMAL DOMINANT 9	disease		Disease or Syndrome	0.70	1	2011	2017	   6	  37	CTD_human;GENOMICS_ENGLAND;UNIPROT
      549	AUH	0.686	0.346	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40	1	2010	2010	   1	   0	GENOMICS_ENGLAND
      549	AUH	0.686	0.346	C0342727	3-@METHYLGLUTACONIC ACIDURIA, TYPE I	disease	C16;C18	Disease or Syndrome	0.75	1	1982	2017	  11	   3	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      549	AUH	0.686	0.346	C0342728	3-Methylglutaconic aciduria type 1	disease	C16;C18	Disease or Syndrome	0.61	1	2002	2017	   9	   0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
      551	AVP	0.437	0.846	C0002622	Amnesia	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0002962	Angina Pectoris	phenotype	C23;C14	Sign or Symptom	0.30	1	2000	2002	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.30	1	1982	1982	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	1995	2019	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2017	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0009178	Cocaine withdrawal	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0010398	Cruveilhier-Baumgarten Syndrome	disease	C06	Disease or Syndrome	0.30	1	1984	1984	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0011175	Dehydration	phenotype	C23;C18	Disease or Syndrome	0.60	1	1989	2019	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0011848	Diabetes Insipidus	disease	C13;C12;C19	Disease or Syndrome	0.70	1	1981	2020	   3	   0	CTD_human;ORPHANET
      551	AVP	0.437	0.846	C0013390	Dysmenorrhea	phenotype	C23	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0017181	Gastrointestinal Hemorrhage	phenotype	C23;C06	Pathologic Function	0.30	1	1982	1982	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0018932	Hematochezia	phenotype	C23;C06	Disease or Syndrome	0.30	1	1982	1982	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.31	1	1998	2017	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	1	1984	2020	   5	   0	CTD_human
      551	AVP	0.437	0.846	C0020541	Portal Hypertension	disease	C06	Disease or Syndrome	0.50	1	1984	2009	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020625	Hyponatremia	phenotype	C18	Disease or Syndrome	0.40	0.921	1981	2019	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0020649	Hypotension	phenotype	C14	Finding	0.32	1	1985	2008	   5	   0	CTD_human
      551	AVP	0.437	0.846	C0020683	Hypovolemic Shock	phenotype	C23	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0021141	Inappropriate ADH Syndrome	phenotype	C18;C10;C19	Disease or Syndrome	0.37	0.889	1979	2019	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	1990	1999	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.34	1	1990	2017	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0029944	Drug Overdose	disease	C25	Injury or Poisoning	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0030193	Pain	phenotype	C23	Sign or Symptom	0.35	1	1984	2019	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0032617	Polyuria	phenotype	C23;C13;C12	Sign or Symptom	0.40	1	1999	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0033958	Psychosis, Brief Reactive	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.38	1	1987	2018	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036358	Schizophreniform Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	1987	1987	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0036974	Shock	phenotype	C23	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0037019	Shy-Drager Syndrome	disease	C10;C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1985	1985	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2006	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.31	1	2011	2017	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	1985	1985	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	1985	1985	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.39	1	1987	2017	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0233750	Hysterical amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.32	1	2001	2020	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0233796	Temporary Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0236795	Dissociative Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0262497	Global Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0344315	Depressed mood	phenotype	F01	Mental or Behavioral Dysfunction	0.40	1	2001	2019	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2011	   2	   0	PSYGENET
      551	AVP	0.437	0.846	C0687720	Central Diabetes Insipidus	disease	C13;C12;C19	Disease or Syndrome	1.00	0.988	1978	2020	  28	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      551	AVP	0.437	0.846	C0750906	Tactile Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0750907	Amnestic State	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1995	1995	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	1998	1998	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2001	2001	   1	   0	CTD_human
      551	AVP	0.437	0.846	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	1984	1990	   2	   0	CTD_human
      551	AVP	0.437	0.846	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1136135	Water Stress	disease	C23;C18	Disease or Syndrome	0.30	1	1989	1989	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2018	   1	   0	PSYGENET
      551	AVP	0.437	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
      551	AVP	0.437	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1990	1990	   1	   0	CTD_human
      551	AVP	0.437	0.846	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.31	1	1998	2019	   1	   0	CTD_human
      552	AVPR1A	0.663	0.5	C0001627	Congenital adrenal hyperplasia	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      552	AVPR1A	0.663	0.5	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.39	1	2002	2017	   1	   0	CTD_human
      552	AVPR1A	0.663	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.52	0.5	2007	2017	   2	   0	PSYGENET
      552	AVPR1A	0.663	0.5	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2006	2019	   1	   0	CTD_human
      553	AVPR1B	0.705	0.385	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.5	2012	2013	   2	   0	PSYGENET
      553	AVPR1B	0.705	0.385	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2013	   4	   0	PSYGENET
      554	AVPR2	0.568	0.769	C0001627	Congenital adrenal hyperplasia	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
      554	AVPR2	0.568	0.769	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.32	1	2002	2018	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.32	1	2002	2018	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0028961	Oliguria	phenotype	C23;C13;C12	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0162283	Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.90	1	1992	2019	   6	  30	CTD_human;GENOMICS_ENGLAND
      554	AVPR2	0.568	0.769	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C0268443	Acquired Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.30	1	2002	2010	   5	   0	CTD_human
      554	AVPR2	0.568	0.769	C0677501	Congenital Nephrogenic Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.40	0.973	1994	2018	   5	   0	CTD_human
      554	AVPR2	0.568	0.769	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C1563705	Nephrogenic Diabetes Insipidus, Type I	disease	C13;C12	Disease or Syndrome	0.80	0.978	1989	2020	  30	  23	CTD_human;GENOMICS_ENGLAND;UNIPROT
      554	AVPR2	0.568	0.769	C1563706	Nephrogenic Diabetes Insipidus, Type II	disease	C13;C12	Disease or Syndrome	0.30	1	2002	2010	   5	   0	CTD_human
      554	AVPR2	0.568	0.769	C1845202	Nephrogenic Syndrome of Inappropriate Antidiuresis	disease	C16;C18;C10;C19	Disease or Syndrome	0.77	1	2005	2019	   3	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      554	AVPR2	0.568	0.769	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      554	AVPR2	0.568	0.769	C3542500	ADH-Resistant Diabetes Insipidus	disease	C13;C12	Disease or Syndrome	0.30	1	2002	2010	   5	   0	CTD_human
      558	AXL	0.489	0.615	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.40	1	2011	2019	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2015	2015	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0027809	Neurilemmoma	disease	C04	Neoplastic Process	0.31	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0206728	Plexiform Neurofibroma	disease	C04;C10	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      558	AXL	0.489	0.615	C0342384	Idiopathic hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.31	1	2014	2014	   0	   0	CTD_human
      558	AXL	0.489	0.615	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.36	1	2009	2019	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.31	1	2014	2017	   1	   0	CTD_human
      558	AXL	0.489	0.615	C0751374	Schwannomatosis, Plexiform	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.32	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.33	1	2011	2020	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2006	2007	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0037199	Sinusitis	disease	C01;C08;C09	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.39	1	2006	2019	   1	   0	CTD_human
      563	AZGP1	0.566	0.769	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.31	1	2006	2011	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0020455	Hypergammaglobulinemia	disease	C23;C20;C15	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.48	1	1990	2020	   3	   0	CTD_human
      567	B2M	0.447	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.35	1	1989	2019	   3	   0	CTD_human
      567	B2M	0.447	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2008	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.35	1	1993	2020	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0079774	Peripheral T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2014	2019	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0268389	Amyloidosis, familial visceral	disease	C16;C18	Disease or Syndrome	0.70	1	2012	2012	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
      567	B2M	0.447	0.846	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2018	   1	   0	CTD_human
      567	B2M	0.447	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2007	2015	   1	   0	CTD_human
      567	B2M	0.447	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1989	2017	   3	   0	CTD_human
      567	B2M	0.447	0.846	C1855796	Hypoproteinemia, Hypercatabolic	disease	C16;C18	Disease or Syndrome	0.71	1	2006	2015	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
      567	B2M	0.447	0.846	C1858266	Bare Lymphocyte Syndrome, Type I	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
      567	B2M	0.447	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	1989	2017	   3	   0	CTD_human
      567	B2M	0.447	0.846	C4302669	Autosomal dominant beta2-microglobulinic amyloidosis	disease	C16;C18	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
      570	BAAT	0.578	0.654	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2003	2013	   2	   0	GENOMICS_ENGLAND
      570	BAAT	0.578	0.654	C1843139	Hypercholanemia, Familial	disease	C16;C18	Disease or Syndrome	0.71	1	2003	2013	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      570	BAAT	0.578	0.654	C4747366	Hypercholanemia	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
      572	BAD	0.553	0.769	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0023418	leukemia	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.35	1	2002	2013	   2	   0	CTD_human
      572	BAD	0.553	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2007	2017	   2	   0	CTD_human
      572	BAD	0.553	0.769	C0472381	Posterior Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751019	Carotid Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751020	Transient Ischemic Attack, Vertebrobasilar Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751021	Crescendo Transient Ischemic Attacks	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0751022	Brain Stem Ischemia, Transient	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      572	BAD	0.553	0.769	C1527335	Transient Ischemic Attack, Anterior Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2013	   5	   0	PSYGENET
      573	BAG1	0.538	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      573	BAG1	0.538	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      573	BAG1	0.538	0.769	C0021367	Mammary Ductal Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2002	2013	   1	   0	PSYGENET
      573	BAG1	0.538	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C1134719	Invasive Ductal Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2003	2016	   1	   0	CTD_human
      573	BAG1	0.538	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
      578	BAK1	0.555	0.769	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
      579	NKX3-2	0.736	0.308	C0152423	Congenital small ears	disease	C16;C09	Congenital Abnormality	0.30	1	1997	1997	   1	   0	GENOMICS_ENGLAND
      579	NKX3-2	0.736	0.308	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
      579	NKX3-2	0.736	0.308	C2750066	Spondylo-Megaepiphyseal-Metaphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.72	1	1997	2019	   2	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET
      580	BARD1	0.597	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1.00	0.896	1996	2020	   0	  63	CTD_human;GENOMICS_ENGLAND;UNIPROT
      580	BARD1	0.597	0.538	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.50	1	2009	2019	   2	  13	CTD_human
      580	BARD1	0.597	0.538	C0153567	Uterine Cancer	disease	C04;C13	Neoplastic Process	0.32	1	1998	2006	   0	   1	UNIPROT
      580	BARD1	0.597	0.538	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.35	0.938	2001	2019	  11	   0	CLINGEN
      580	BARD1	0.597	0.538	C0677776	Hereditary Breast and Ovarian Cancer Syndrome	disease	C16;C04;C13;C17;C19	Neoplastic Process	0.40	1	2004	2017	   1	   5	ORPHANET
      580	BARD1	0.597	0.538	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.50	0.86	1996	2020	   0	   0	CTD_human
      580	BARD1	0.597	0.538	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      580	BARD1	0.597	0.538	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.45	1	2004	2008	   0	   1	CTD_human
      580	BARD1	0.597	0.538	C1518693	Clear cell adenocarcinoma of ovary	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      580	BARD1	0.597	0.538	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2001	2016	   4	   0	CLINGEN
      580	BARD1	0.597	0.538	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CTD_human
      581	BAX	0.417	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2013	2013	   1	   0	CTD_human
      581	BAX	0.417	0.885	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.52	1	1997	2018	1	0	CTD_human
2080	595	CCND1	0.344	0.923	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.56	0.875	1997	2017	1	0	CTD_human
2092	595	CCND1	0.344	0.923	C0019562	Von Hippel-Lindau Syndrome	disease	C16;C10;C14	Disease or Syndrome	0.53	1	2002	2005	0	0	CTD_human;GENOMICS_ENGLAND
2106	595	CCND1	0.344	0.923	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.7	0.975	1992	2019	1	2	CTD_human;ORPHANET
2110	595	CCND1	0.344	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.57	1	1999	2015	1	0	CTD_human
2141	595	CCND1	0.344	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.6	0.952	1998	2020	1	0	CTD_human
2183	596	BCL2	0.291	0.885	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0853193	Bipolar I disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2013	   2	   0	PSYGENET
      596	BCL2	0.291	0.885	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2014	2014	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2013	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	0.978	1998	2019	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.31	1	1999	2013	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C1956130	Lymphoma, Follicular, Grade 1	disease	C04;C20;C15	Neoplastic Process	0.32	1	1988	2003	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C1956131	Lymphoma, Follicular, Grade 3	disease	C04;C20;C15	Neoplastic Process	0.32	1	1988	2013	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C1956132	Lymphoma, Follicular, Grade 2	disease	C04;C20;C15	Neoplastic Process	0.31	1	1988	2012	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	1	1999	2020	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C2985290	Fetal Alcohol Spectrum Disorders	group	C16;C13;C25	Disease or Syndrome; Congenital Abnormality	0.31	1	2012	2018	   1	   0	PSYGENET
      596	BCL2	0.291	0.885	C3541456	Spondyloepiphyseal Dysplasia Tarda, X-Linked	disease	C16;C05	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.33	1	1988	2015	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C4551479	Schwartz-Jampel Syndrome, Type 1	disease	C16;C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      596	BCL2	0.291	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2013	   3	   0	CTD_human
      596	BCL2	0.291	0.885	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.40	1	1988	2019	   2	   0	CTD_human
      596	BCL2	0.291	0.885	C4722327	PROSTATE CANCER, HEREDITARY, 1	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2009	2017	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.35	1	2003	2019	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      597	BCL2A1	0.529	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.35	1	2003	2019	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2008	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2003	2008	   2	   0	CTD_human
      597	BCL2A1	0.529	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2008	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0001430	Adenoma	group	C04	Neoplastic Process	0.31	1	1999	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.33	1	1996	2005	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2006	2007	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.31	1	2004	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.33	1	2005	2013	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	2015	2019	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.36	1	1998	2014	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.50	1	2007	2009	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1999	2017	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205646	Adenoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205647	Follicular adenoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205648	Adenoma, Microcystic	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205649	Adenoma, Monomorphic	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205650	Papillary adenoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205651	Adenoma, Trabecular	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	1999	1999	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0242350	Erectile dysfunction	disease	C12;F03	Disease or Syndrome	0.50	1	2002	2002	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.32	1	2005	2019	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.31	1	2008	2010	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.38	1	2000	2019	   2	   0	CTD_human
      598	BCL2L1	0.493	0.885	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
      598	BCL2L1	0.493	0.885	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.31	1	2015	2015	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      602	BCL3	0.541	0.731	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.933	1996	2020	   0	   0	CGI
      604	BCL6	0.444	0.808	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.40	0.961	1995	2020	   1	   0	ORPHANET
      604	BCL6	0.444	0.808	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	1997	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.60	0.956	1993	2015	   1	   0	CGI;CTD_human
      604	BCL6	0.444	0.808	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.33	1	1994	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.34	1	2002	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C0334660	Angioendotheliomatosis	disease	C04;C20;C15	Neoplastic Process	0.31	1	2001	2001	   0	   0	ORPHANET
      604	BCL6	0.444	0.808	C1292754	Mediastinal (Thymic) Large B-Cell Lymphoma	disease	C04;C08;C20;C15	Neoplastic Process	0.31	1	2006	2016	   1	   0	ORPHANET
      604	BCL6	0.444	0.808	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.31	1	1997	2015	   1	   0	CTD_human
      604	BCL6	0.444	0.808	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.40	0.935	1994	2015	   1	   0	CTD_human
      607	BCL9	0.595	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      607	BCL9	0.595	0.615	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
      607	BCL9	0.595	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2011	2015	   2	   1	PSYGENET
      607	BCL9	0.595	0.615	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      607	BCL9	0.595	0.615	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
      607	BCL9	0.595	0.615	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
      607	BCL9	0.595	0.615	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2011	   1	   0	PSYGENET
      611	OPN1SW	0.519	0.769	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      611	OPN1SW	0.519	0.769	C0155017	Color Blindness, Blue	disease	C23;C11;C10	Disease or Syndrome	0.74	0.667	1992	2018	   3	   4	CTD_human;ORPHANET;UNIPROT
      611	OPN1SW	0.519	0.769	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      611	OPN1SW	0.519	0.769	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      611	OPN1SW	0.519	0.769	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2008	   4	   0	PSYGENET
      613	BCR	0.431	0.885	C0005699	Blast Phase	disease	C23;C04;C15	Neoplastic Process	0.40	0.941	1975	2019	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.34	1	1985	2017	   1	   0	ORPHANET
      613	BCR	0.431	0.885	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.948	1987	2019	   0	   0	CTD_human
      613	BCR	0.431	0.885	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
      613	BCR	0.431	0.885	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.70	0.969	1980	2020	   3	   0	CTD_human;ORPHANET
      613	BCR	0.431	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0027022	Myeloproliferative disease	group	C15	Neoplastic Process	0.50	0.976	1979	2019	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2013	2013	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2009	2009	   1	   0	CTD_human
      613	BCR	0.431	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	PSYGENET
      613	BCR	0.431	0.885	C0279680	Transitional cell carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	UNIPROT
      613	BCR	0.431	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	PSYGENET
      613	BCR	0.431	0.885	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.92	1991	2019	   1	   0	ORPHANET
      613	BCR	0.431	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.38	1	1989	2019	   0	   0	ORPHANET
      613	BCR	0.431	0.885	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.50	0.978	1988	2020	   0	   0	CTD_human
      613	BCR	0.431	0.885	C2678480	Chromosome 22q11.2 Deletion Syndrome, Distal	disease	C23;C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
      617	BCS1L	0.534	0.808	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.40	1	1998	2002	   2	   0	GENOMICS_ENGLAND
      617	BCS1L	0.534	0.808	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.70	1	1998	2017	  10	   3	CLINGEN;CTD_human;GENOMICS_ENGLAND
      617	BCS1L	0.534	0.808	C0266006	Pili torti-deafness syndrome	disease	C23;C18;C17;C10;C09	Disease or Syndrome	0.75	1	1998	2017	   9	  10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      617	BCS1L	0.534	0.808	C0751267	Encephalopathy, Subacute Necrotizing, Infantile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      617	BCS1L	0.534	0.808	C0751268	Encephalopathy, Subacute Necrotizing, Juvenile	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
      617	BCS1L	0.534	0.808	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.33	1	2007	2019	   1	   0	GENOMICS_ENGLAND
      617	BCS1L	0.534	0.808	C1838951	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1850597	Leigh Syndrome Due To Mitochondrial Complex II Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1850598	Leigh Syndrome due to Mitochondrial Complex III Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1999	2017	   6	   1	CLINGEN
      617	BCS1L	0.534	0.808	C1850599	Leigh Syndrome due to Mitochondrial Complex IV Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1850600	Leigh Syndrome due to Mitochondrial Complex V Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C1864002	GRACILE SYNDROME (disorder)	disease	C23;C16;C06;C18;C13;C12	Disease or Syndrome	0.77	1	1998	2019	   7	  27	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      617	BCS1L	0.534	0.808	C2931891	Necrotizing encephalopathy, infantile subacute, of Leigh	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2017	   6	   0	CLINGEN
      617	BCS1L	0.534	0.808	C3541471	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	disease		Disease or Syndrome	0.70	1	1998	2017	  11	  13	CTD_human;GENOMICS_ENGLAND;UNIPROT
      622	BDH1	0.729	0.423	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2014	   2	   0	CTD_human
      622	BDH1	0.729	0.423	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      622	BDH1	0.729	0.423	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2002	2011	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	2003	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2005	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0030193	Pain	phenotype	C23	Sign or Symptom	0.50	1	2007	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      623	BDKRB1	0.619	0.731	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
      624	BDKRB2	0.585	0.808	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0015378	Extravasation of Contrast Media	phenotype	C23;C26	Pathologic Function	0.30	1	1998	1998	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0019080	Hemorrhage	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	1999	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020452	Hyperemia	disease	C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.57	1	1996	2016	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1992	2005	   2	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.51	1	1995	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0028796	Dermatitis, Occupational	disease	C17;C24	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0030193	Pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      624	BDKRB2	0.585	0.808	C0042484	Venous Engorgement	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0086457	Industrial Dermatosis	disease	C17;C24	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0178824	Reactive Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0333233	Active Hyperemia	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2010	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
      624	BDKRB2	0.585	0.808	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.31	1	2008	2018	   3	   0	CTD_human
      624	BDKRB2	0.585	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      624	BDKRB2	0.585	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
      627	BDNF	0.345	0.923	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	PSYGENET
      627	BDNF	0.345	0.923	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.4	2004	2020	   5	   0	PSYGENET
      627	BDNF	0.345	0.923	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.6	0.958	1991	2020	1	0	CTD_human
2187	627	BDNF	0.345	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2002	2019	7	0	CTD_human;PSYGENET
2195	627	BDNF	0.345	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	1	2003	2020	5	0	PSYGENET
2197	627	BDNF	0.345	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2003	2020	7	0	CTD_human;PSYGENET
2203	627	BDNF	0.345	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.53	1	2003	2010	1	0	CTD_human
2220	627	BDNF	0.345	0.923	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.56	1	1996	2019	2	0	CTD_human
2224	627	BDNF	0.345	0.923	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2005	2020	7	0	CTD_human;PSYGENET
2267	640	BLK	0.585	0.769	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	0.976	2008	2020	7	9	CTD_human;ORPHANET
2270	640	BLK	0.585	0.769	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.62	1	2009	2013	1	0	GENOMICS_ENGLAND;ORPHANET
2271	640	BLK	0.585	0.769	C3150618	Maturity-onset diabetes of the young, type 11	disease	C18;C19	Disease or Syndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
2273	641	BLM	0.535	0.808	C0005859	Bloom Syndrome	disease	C16;C18;C20	Disease or Syndrome	1	0.994	1994	2020	10	126	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
2278	641	BLM	0.535	0.808	C0023418	leukemia	disease	C04	Neoplastic Process	0.61	1	2005	2017	1	0	CGI;GENOMICS_ENGLAND
2282	641	BLM	0.535	0.808	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.61	1	2002	2017	1	0	CGI;GENOMICS_ENGLAND
2293	644	BLVRA	0.663	0.423	C3279964	Hyperbiliverdinemia	disease	C06	Disease or Syndrome	0.61	1	2009	2011	1	2	CTD_human;ORPHANET
2322	649	BMP1	0.554	0.769	C3553887	OSTEOGENESIS IMPERFECTA, TYPE XIII	disease		Disease or Syndrome	0.71	1	2012	2019	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
2346	650	BMP2	0.432	0.846	C1832702	BRACHYDACTYLY, TYPE A2	disease	C16;C05	Congenital Abnormality	0.75	1	2005	2018	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
2365	652	BMP4	0.422	0.808	C0033375	Prolactinoma	disease	C04;C10;C19	Neoplastic Process	0.54	1	2003	2020	1	0	CTD_human
2379	652	BMP4	0.422	0.808	C1864689	MICROPHTHALMIA, SYNDROMIC 6 (disorder)	disease	C16;C13;C11;C05;C12;C10	Disease or Syndrome	0.7	1	1986	2013	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2381	652	BMP4	0.422	0.808	C2677434	OROFACIAL CLEFT 11	disease	C16;C05;C07	Disease or Syndrome	0.71	1	1986	2009	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
2413	657	BMPR1A	0.522	0.731	C0345893	Juvenile polyposis syndrome	disease	C16;C06;C04	Neoplastic Process	1	0.978	1993	2019	12	49	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2417	657	BMPR1A	0.522	0.731	C1832940	JUVENILE POLYPOSIS OF STOMACH	disease	C16;C06;C04	Disease or Syndrome	0.8	1	2001	2009	5	0	CLINGEN;CTD_human;ORPHANET
2419	657	BMPR1A	0.522	0.731	C1868081	Juvenile Polyposis Coli	disease	C16;C06;C04	Disease or Syndrome	0.8	1	2001	2009	5	0	CLINGEN;CTD_human;ORPHANET
2437	658	BMPR1B	0.573	0.615	C1832702	BRACHYDACTYLY, TYPE A2	disease	C16;C05	Congenital Abnormality	0.76	0.875	2003	2014	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2444	658	BMPR1B	0.573	0.615	C4225183	BRACHYDACTYLY, TYPE A1, D	disease		Disease or Syndrome	0.7	1	2015	2015	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
2445	658	BMPR1B	0.573	0.615	C4225404	ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE	disease		Disease or Syndrome	0.6	1	2005	2015	3	5	GENOMICS_ENGLAND;UNIPROT
2450	659	BMPR2	0.538	0.654	C0034091	Pulmonary Veno-Occlusive Disease (disorder)	disease	C08;C14	Disease or Syndrome	0.72	1	2003	2016	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
2451	659	BMPR2	0.538	0.654	C0152171	Idiopathic pulmonary hypertension	disease	C08;C14	Disease or Syndrome	0.6	1	2000	2019	1	0	GENOMICS_ENGLAND
2453	659	BMPR2	0.538	0.654	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.7	1	1997	2019	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
2463	659	BMPR2	0.538	0.654	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.7	0.978	2000	2020	2	0	CTD_human;GENOMICS_ENGLAND
2467	659	BMPR2	0.538	0.654	C4552070	Pulmonary Hypertension, Primary, 1	disease	C08	Disease or Syndrome	0.7	1	2000	2018	12	308	CTD_human;GENOMICS_ENGLAND;UNIPROT
2479	667	DST	0.552	0.846	C3539003	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI	disease		Disease or Syndrome	0.71	1	2010	2017	2	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
2480	667	DST	0.552	0.846	C3809470	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2	disease		Disease or Syndrome	0.6	1	2010	2015	3	6	GENOMICS_ENGLAND;ORPHANET
2484	668	FOXL2	0.542	0.692	C0220663	BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS (disorder)	disease	C16;C13;C11;C17;C12	Disease or Syndrome	1	1	1995	2020	13	90	CTD_human;GENOMICS_ENGLAND;UNIPROT
2489	668	FOXL2	0.542	0.692	C1837008	PREMATURE OVARIAN FAILURE 3 (disorder)	disease	C13;C19	Disease or Syndrome	0.7	1	2002	2009	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
2496	669	BPGM	0.821	0.154	C1291620	Deficiency of bisphosphoglycerate mutase	disease	C16;C18	Disease or Syndrome	0.7	1	1989	2004	3	3	CTD_human;ORPHANET;UNIPROT
2497	672	BRCA1	0.367	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1	0.956	1992	2020	34	160	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2498	672	BRCA1	0.367	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.6	0.968	1993	2020	1	0	CGI;CTD_human
2505	672	BRCA1	0.367	0.923	C0015625	Fanconi Anemia	disease	C16;C18;C15	Disease or Syndrome	0.6	1	2001	2020	4	0	GENOMICS_ENGLAND;ORPHANET
2513	672	BRCA1	0.367	0.923	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.62	1	2005	2015	1	0	CGI;CTD_human
2525	672	BRCA1	0.367	0.923	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.6	1	1997	2020	1	0	CGI;CTD_human
2531	672	BRCA1	0.367	0.923	C0677776	Hereditary Breast and Ovarian Cancer Syndrome	disease	C16;C04;C13;C17;C19	Neoplastic Process	0.8	0.986	1990	2020	5	873	CTD_human;GENOMICS_ENGLAND;ORPHANET
2532	672	BRCA1	0.367	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.7	0.955	1992	2020	12	5	CGI;CTD_human
2534	672	BRCA1	0.367	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.7	0.965	1992	2020	5	67	CGI;CTD_human
2535	672	BRCA1	0.367	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.8	0.965	1992	2020	9	15	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2541	672	BRCA1	0.367	0.923	C2676676	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1	disease		Finding	0.7	1	1976	2019	16	2258	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
2551	672	BRCA1	0.367	0.923	C4554406	FANCONI ANEMIA, COMPLEMENTATION GROUP S	disease		Disease or Syndrome	0.7	1	2013	2019	7	28	CLINGEN;GENOMICS_ENGLAND;UNIPROT
2565	673	BRAF	0.319	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.7	0.976	2002	2020	8	5	CTD_human;UNIPROT
2567	673	BRAF	0.319	0.846	C0010276	Craniopharyngioma	disease	C04	Neoplastic Process	0.6	1	2014	2019	1	0	CTD_human;ORPHANET
2569	673	BRAF	0.319	0.846	C0017638	Glioma	disease	C04	Neoplastic Process	0.6	1	2005	2020	1	0	CGI;CTD_human
2571	673	BRAF	0.319	0.846	C0019621	Histiocytosis, Langerhans-Cell	disease	C08;C15	Neoplastic Process	0.8	1	2010	2019	1	0	CGI;ORPHANET
2575	673	BRAF	0.319	0.846	C0023443	Hairy Cell Leukemia	disease	C04;C20;C15	Neoplastic Process	0.6	0.938	2011	2020	2	0	CGI;ORPHANET
2578	673	BRAF	0.319	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.55	1	2004	2017	0	0	CGI;CTD_human
2584	673	BRAF	0.319	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	1	0.983	1986	2020	24	31	CGI;CTD_human;UNIPROT
2589	673	BRAF	0.319	0.846	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.77	1	2003	2019	8	18	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
2594	673	BRAF	0.319	0.846	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.7	0.99	2003	2020	6	3	CGI;CTD_human
2599	673	BRAF	0.319	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.7	1	2002	2019	2	14	CGI;CTD_human
2603	673	BRAF	0.319	0.846	C0175704	LEOPARD Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.65	1	2009	2017	6	2	CLINGEN;GENOMICS_ENGLAND
2610	673	BRAF	0.319	0.846	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.9	0.968	2003	2020	8	1	CTD_human;ORPHANET
2611	673	BRAF	0.319	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.6	1	2002	2020	0	0	CGI;CTD_human
2617	673	BRAF	0.319	0.846	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.51	1	2013	2015	1	0	CGI;CTD_human
2621	673	BRAF	0.319	0.846	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.6	0.957	2008	2020	1	0	CGI;CTD_human
2633	673	BRAF	0.319	0.846	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.6	0.99	2003	2019	6	0	CGI;CTD_human
2635	673	BRAF	0.319	0.846	C0587248	Costello syndrome (disorder)	disease	C16;C05	Disease or Syndrome	0.54	1	2006	2016	2	0	CLINGEN;CTD_human
2638	673	BRAF	0.319	0.846	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.7	1	2002	2019	1	12	CGI;UNIPROT
2650	673	BRAF	0.319	0.846	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.6	0.941	2003	2019	0	1	CGI;UNIPROT
2652	673	BRAF	0.319	0.846	C1275081	Cardio-facio-cutaneous syndrome	disease	C23;C16;C17;C14	Congenital Abnormality	1	0.972	2003	2019	14	48	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2653	673	BRAF	0.319	0.846	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.6	1	2011	2019	0	3	CGI;UNIPROT
2660	673	BRAF	0.319	0.846	C3150970	NOONAN SYNDROME 7	disease		Disease or Syndrome	0.7	1	2006	2017	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
2661	673	BRAF	0.319	0.846	C3150971	LEOPARD SYNDROME 3	disease		Disease or Syndrome	0.7	1	2006	2013	4	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
2671	675	BRCA2	0.379	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1	0.951	1994	2020	30	174	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2675	675	BRCA2	0.379	0.846	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.6	1	2014	2014	1	0	CGI;CTD_human
2676	675	BRCA2	0.379	0.846	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.63	1	2003	2018	3	22	CTD_human;GENOMICS_ENGLAND
2678	675	BRCA2	0.379	0.846	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.72	1	2005	2018	4	22	CTD_human;GENOMICS_ENGLAND;ORPHANET
2680	675	BRCA2	0.379	0.846	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.65	0.857	2003	2017	2	0	CGI;CTD_human
2682	675	BRCA2	0.379	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.58	1	2000	2018	1	0	CTD_human
2686	675	BRCA2	0.379	0.846	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.8	0.833	2007	2018	1	1	CGI;CTD_human;UNIPROT
2692	675	BRCA2	0.379	0.846	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.8	0.988	1996	2019	2	4	CGI;CTD_human;UNIPROT
2694	675	BRCA2	0.379	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.9	0.948	1996	2020	5	24	CTD_human;GENOMICS_ENGLAND
2698	675	BRCA2	0.379	0.846	C0677776	Hereditary Breast and Ovarian Cancer Syndrome	disease	C16;C04;C13;C17;C19	Neoplastic Process	0.8	0.993	1990	2020	4	1160	CTD_human;GENOMICS_ENGLAND;ORPHANET
2699	675	BRCA2	0.379	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.7	0.95	1994	2020	3	9	CGI;CTD_human
2705	675	BRCA2	0.379	0.846	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.9	0.947	1994	2020	1	38	CGI;CTD_human
2706	675	BRCA2	0.379	0.846	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.8	0.948	1994	2020	1	10	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2710	675	BRCA2	0.379	0.846	C1838457	FANCONI ANEMIA, COMPLEMENTATION GROUP D1	disease	C16;C18;C15	Disease or Syndrome	0.92	1	2002	2018	14	37	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2712	675	BRCA2	0.379	0.846	C2675520	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2	disease		Finding	0.7	1	1988	2019	13	2632	CLINGEN;CTD_human;GENOMICS_ENGLAND
2749	686	BTD	0.628	0.654	C0220754	Biotinidase Deficiency	disease	C16;C18	Disease or Syndrome	1	0.988	1993	2019	13	187	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
2764	688	KLF5	0.534	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.64	1	2011	2019	1	1	CTD_human;UNIPROT
2785	695	BTK	0.464	0.808	C0221026	X-linked agammaglobulinemia	disease	C16;C20;C15	Disease or Syndrome	1	0.964	1975	2020	27	68	CTD_human;GENOMICS_ENGLAND;UNIPROT
2787	695	BTK	0.464	0.808	C0472813	X-linked agammaglobulinemia with growth hormone deficiency	disease	C16;C05;C20;C10;C19;C15	Disease or Syndrome	0.7	1	1994	2017	4	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
2791	699	BUB1	0.528	0.731	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.7	1	2000	2018	0	4	CTD_human;UNIPROT
2797	701	BUB1B	0.502	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.54	1	2002	2016	0	1	CTD_human;UNIPROT
2811	701	BUB1B	0.502	0.808	C1850343	Mosaic variegated aneuploidy syndrome 1	disease	C16	Disease or Syndrome	1	1	2004	2019	6	15	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2812	701	BUB1B	0.502	0.808	C1864389	PREMATURE CHROMATID SEPARATION TRAIT	disease		Disease or Syndrome	0.64	1	2006	2014	1	8	CTD_human;UNIPROT
2831	708	C1QBP	0.569	0.692	C4540209	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33	disease		Disease or Syndrome	0.6	1	2017	2017	1	6	GENOMICS_ENGLAND;UNIPROT
2834	710	SERPING1	0.507	0.769	C0019243	Angioedemas, Hereditary	disease	C16;C17;C20;C14	Disease or Syndrome	0.6	0.991	1971	2020	7	0	CTD_human;GENOMICS_ENGLAND
2846	710	SERPING1	0.507	0.769	C1852700	Complement Component 4, Partial Deficiency Of	disease	C16;C20	Disease or Syndrome	0.6	1	1995	1995	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
2849	710	SERPING1	0.507	0.769	C2717906	Hereditary Angioedema Type I	disease	C17;C20;C14	Disease or Syndrome	0.73	0.958	1988	2018	19	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2859	712	C1QA	0.623	0.654	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.67	0.7	1996	2012	1	0	CTD_human
2865	712	C1QA	0.623	0.654	C3150902	C1q DEFICIENCY	disease		Disease or Syndrome	0.61	1	2012	2017	1	2	CTD_human;GENOMICS_ENGLAND
2880	713	C1QB	0.711	0.538	C3150902	C1q DEFICIENCY	disease		Disease or Syndrome	0.71	1	1997	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
2883	714	C1QC	0.751	0.423	C3150902	C1q DEFICIENCY	disease		Disease or Syndrome	0.7	1	1996	1996	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
2890	715	C1R	0.638	0.654	C4551499	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.6	1	2016	2017	2	12	GENOMICS_ENGLAND;UNIPROT
2900	716	C1S	0.705	0.462	C3151078	Complement Component C1s Deficiency	disease	C16;C20	Disease or Syndrome	0.6	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND
2901	716	C1S	0.705	0.462	C4310681	EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2	disease		Disease or Syndrome	0.7	1	2016	2017	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
2909	717	C2	0.617	0.692	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.68	1	2006	2018	1	0	CTD_human;GENOMICS_ENGLAND
2913	717	C2	0.617	0.692	C3150275	COMPLEMENT COMPONENT 2 DEFICIENCY	disease		Disease or Syndrome	0.77	0.9	1975	2010	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
2934	718	C3	0.445	0.885	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.7	1	2007	2020	4	2	CTD_human;GENOMICS_ENGLAND
2956	718	C3	0.445	0.885	C1332655	Complement component 3 deficiency	disease		Disease or Syndrome	0.63	1	1972	2013	1	1	GENOMICS_ENGLAND
2962	718	C3	0.445	0.885	C2752037	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5	disease		Finding	0.6	1	2005	2016	4	8	GENOMICS_ENGLAND;UNIPROT
2963	718	C3	0.445	0.885	C2931788	Atypical Hemolytic Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.6	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
2964	718	C3	0.445	0.885	C3151071	COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE	disease	C16;C20	Disease or Syndrome	0.7	1	1972	2016	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2972	720	C4A	0.563	0.769	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	0.957	1987	2018	6	0	ORPHANET
2974	720	C4A	0.563	0.769	C3280642	Complement Component 4a Deficiency	disease	C16;C20	Disease or Syndrome	0.55	1	1990	2016	1	0	CTD_human;GENOMICS_ENGLAND
2979	721	C4B	0.603	0.808	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.6	0.944	1985	2019	7	0	ORPHANET
2982	721	C4B	0.603	0.808	C3280641	Decreased serum complement C4b	disease		Disease or Syndrome	0.63	1	1992	2016	1	0	CTD_human;GENOMICS_ENGLAND
2983	726	CAPN5	0.663	0.615	C0242852	Proliferative vitreoretinopathy	disease	C11	Disease or Syndrome	0.71	1	2012	2019	1	3	CTD_human;ORPHANET;UNIPROT
2990	727	C5	0.55	0.731	C0343047	Complement component 5 deficiency	disease	C16;C20	Disease or Syndrome	0.61	1	1977	2015	1	5	CTD_human;GENOMICS_ENGLAND
3002	729	C6	0.7	0.615	C2676232	Complement Component 6 Deficiency	disease	C16;C20	Disease or Syndrome	0.62	1	1987	2012	1	3	CTD_human;GENOMICS_ENGLAND
3005	730	C7	0.751	0.423	C1864694	Complement Component 7 Deficiency	disease	C16;C20	Disease or Syndrome	0.72	1	1989	2007	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
3020	732	C8B	0.76	0.269	C3151080	COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II	disease		Disease or Syndrome	0.62	1	1990	2009	1	7	CTD_human;GENOMICS_ENGLAND
3051	735	C9	0.619	0.692	C3151189	C9 Deficiency	disease	C16;C20	Disease or Syndrome	0.75	1	1998	2017	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
3052	735	C9	0.619	0.692	C3810042	MACULAR DEGENERATION, AGE-RELATED, 15	disease		Disease or Syndrome	0.6	1	2013	2013	1	1	CTD_human;UNIPROT
3060	745	MYRF	0.584	0.731	C4748946	CARDIAC-UROGENITAL SYNDROME	disease		Disease or Syndrome	0.6	1	2018	2018	3	1	GENOMICS_ENGLAND;UNIPROT
3063	755	CFAP410	0.633	0.615	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.62	1	2016	2019	2	1	CTD_human;ORPHANET
3067	755	CFAP410	0.633	0.615	C1865695	Spondylometaphyseal dysplasia, axial	disease	C16;C05	Disease or Syndrome	0.63	1	2013	2017	5	8	GENOMICS_ENGLAND;UNIPROT
3094	760	CA2	0.506	0.808	C0345407	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3	disease	C16;C18;C13;C05;C12;C10	Disease or Syndrome	0.99	1	1985	2020	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
3113	762	CA4	0.674	0.577	C1833245	Retinitis Pigmentosa 17	disease	C16;C11	Disease or Syndrome	0.74	1	2000	2010	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
3114	763	CA5A	0.686	0.5	C3810404	CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	disease		Disease or Syndrome	0.7	1	1995	2016	4	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3119	767	CA8	0.595	0.654	C2750509	Cerebellar Ataxia, Mental Retardation, And Dysequilibrium Syndrome 3	disease	C23;C10;F03;F01	Disease or Syndrome	0.9	1	2005	2016	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
3134	771	CA12	0.592	0.731	C1840437	Isolated hyperchlorhidrosis	phenotype		Finding	0.7	1	2010	2016	3	5	CTD_human;ORPHANET;UNIPROT
3139	773	CACNA1A	0.489	0.769	C0014553	Absence Epilepsy	disease	C10	Disease or Syndrome	0.76	1	1996	2020	2	0	CTD_human;GENOMICS_ENGLAND
3156	773	CACNA1A	0.489	0.769	C0752124	Spinocerebellar Ataxia Type 6 (disorder)	disease	C16;C10	Disease or Syndrome	1	0.986	1997	2019	12	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
3158	773	CACNA1A	0.489	0.769	C1720416	Episodic ataxia type 2 (disorder)	disease	C23;C11;C10	Disease or Syndrome	1	0.988	1996	2019	21	60	CTD_human;GENOMICS_ENGLAND;UNIPROT
3159	773	CACNA1A	0.489	0.769	C1832884	Hemiplegic migraine, familial type 1	disease	C23;C10	Disease or Syndrome	0.8	0.966	1996	2018	15	21	CTD_human;GENOMICS_ENGLAND;UNIPROT
3162	773	CACNA1A	0.489	0.769	C4310716	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42	disease		Disease or Syndrome	0.7	1	1996	2017	4	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
3179	775	CACNA1C	0.51	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.7	0.8	2008	2020	9	6	CTD_human;PSYGENET
3208	775	CACNA1C	0.51	0.846	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.57	1	1993	2019	7	0	CLINGEN;GENOMICS_ENGLAND
3209	775	CACNA1C	0.51	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.7	1	2010	2019	6	19	CTD_human;PSYGENET
3214	775	CACNA1C	0.51	0.846	C1832916	Timothy syndrome	disease	C23;C16;C05;F03;C14	Disease or Syndrome	1	0.969	2004	2019	8	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3215	775	CACNA1C	0.51	0.846	C2678478	Brugada Syndrome 3	disease	C16;C14	Disease or Syndrome	0.7	1	2007	2018	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
3242	776	CACNA1D	0.582	0.577	C3554018	SINOATRIAL NODE DYSFUNCTION AND DEAFNESS	disease	C23;C14	Disease or Syndrome	0.72	1	2004	2019	5	2	CLINGEN;GENOMICS_ENGLAND;ORPHANET
3244	776	CACNA1D	0.582	0.577	C3809609	PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	disease		Disease or Syndrome	0.71	1	2013	2018	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
3252	777	CACNA1E	0.65	0.577	C4748988	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69	disease		Disease or Syndrome	0.6	1	2018	2018	1	8	GENOMICS_ENGLAND;UNIPROT
3255	778	CACNA1F	0.595	0.5	C0268505	Ocular albinism, type II	disease	C16;C18;C11;C17	Disease or Syndrome	0.76	1	1989	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3256	778	CACNA1F	0.595	0.5	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.7	1	1993	2018	0	12	CTD_human;GENOMICS_ENGLAND
3257	778	CACNA1F	0.595	0.5	C1845407	CONE-ROD DYSTROPHY, X-LINKED, 3	disease	C16;C11	Disease or Syndrome	0.61	1	2009	2015	1	3	CTD_human;GENOMICS_ENGLAND
3258	778	CACNA1F	0.595	0.5	C1848172	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	disease	C16;C11	Disease or Syndrome	1	1	1998	2019	8	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
3269	779	CACNA1S	0.595	0.692	C0238358	Hypokalemic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.7	1	1994	2018	2	5	CTD_human
3273	779	CACNA1S	0.595	0.692	C1866077	MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	phenotype		Finding	0.6	1	1994	2015	2	11	GENOMICS_ENGLAND;UNIPROT
3274	779	CACNA1S	0.595	0.692	C2749982	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1	disease		Finding	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
3276	779	CACNA1S	0.595	0.692	C3714580	Hypokalemic periodic paralysis type 1	disease		Disease or Syndrome	0.8	0.974	1994	2018	6	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
3324	781	CACNA2D1	0.641	0.5	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.62	1	2005	2015	6	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
3339	783	CACNB2	0.659	0.538	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.51	1	2000	2012	7	0	CLINGEN;GENOMICS_ENGLAND
3341	783	CACNB2	0.659	0.538	C2678477	Brugada Syndrome 4	disease	C16;C14	Disease or Syndrome	0.7	1	2005	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
3354	785	CACNB4	0.653	0.231	C0270853	Juvenile Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.51	1	2000	2014	2	0	CTD_human;ORPHANET
3366	785	CACNB4	0.653	0.231	C1866039	EPISODIC ATAXIA, TYPE 5	disease	C23;C10	Disease or Syndrome	0.7	1	2000	2008	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3373	788	SLC25A20	0.563	0.769	C0342791	Carnitine-Acylcarnitine Translocase Deficiency	disease	C16;C18	Disease or Syndrome	0.77	1	1997	2019	12	15	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3392	801	CALM1	0.472	0.808	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
      801	CALM1	0.472	0.808	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.74	1	2009	2019	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
      801	CALM1	0.472	0.808	C2677794	Stress-induced polymorphic ventricular tachycardia	disease	C23;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
      801	CALM1	0.472	0.808	C3554047	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4	disease		Disease or Syndrome	0.60	1	2005	2016	   6	   3	GENOMICS_ENGLAND;UNIPROT
      801	CALM1	0.472	0.808	C4015671	LONG QT SYNDROME 14	disease		Disease or Syndrome	0.70	1	2005	2016	   7	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
      805	CALM2	0.472	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2013	   2	   0	PSYGENET
      805	CALM2	0.472	0.808	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	0.8	2005	2014	   5	   0	PSYGENET
      805	CALM2	0.472	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	0.8	2005	2014	   5	   0	PSYGENET
      805	CALM2	0.472	0.808	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2020	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0031391	Phencyclidine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0035828	Romano-Ward Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.40	1	2013	2014	   2	   1	ORPHANET
      805	CALM2	0.472	0.808	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0236742	Phencyclidine-Related Disorders	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C0588008	Severe depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	PSYGENET
      805	CALM2	0.472	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      805	CALM2	0.472	0.808	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	ORPHANET
      805	CALM2	0.472	0.808	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.34	1	2014	2019	   1	   0	ORPHANET
      805	CALM2	0.472	0.808	C4015695	LONG QT SYNDROME 15	disease		Disease or Syndrome	0.70	1	2013	2016	   6	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
      808	CALM3	0.485	0.846	C1631597	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.34	1	2016	2019	   0	   0	ORPHANET
      810	CALML3	0.621	0.5	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2017	2019	   1	   0	CTD_human
      810	CALML3	0.621	0.5	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0001815	Primary Myelofibrosis	disease	C15	Neoplastic Process	0.80	0.929	2013	2020	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
      811	CALR	0.413	0.923	C0004565	Melanoma, B16	disease	C04	Neoplastic Process; Experimental Model of Disease	0.31	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0009075	Melanoma, Cloudman S91	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.909	2007	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0018598	Melanoma, Harding-Passey	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0025205	Melanoma, Experimental	disease	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0026987	Myelofibrosis	disease	C23;C04;C15	Neoplastic Process	0.60	0.933	2013	2020	   2	   0	GENOMICS_ENGLAND;ORPHANET
      811	CALR	0.413	0.923	C0027022	Myeloproliferative disease	group	C15	Neoplastic Process	0.50	1	2013	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2009	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0033937	Psychoses, Drug	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2011	2012	   2	   0	PSYGENET
      811	CALR	0.413	0.923	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2010	   2	   0	PSYGENET
      811	CALR	0.413	0.923	C0036349	Paranoid Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0036939	Shared Paranoid Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
      811	CALR	0.413	0.923	C0040028	Thrombocythemia, Essential	disease	C15	Disease or Syndrome	0.60	0.969	2013	2020	   2	   0	CTD_human;ORPHANET
      811	CALR	0.413	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.31	1	2005	2017	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.40	1	2009	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2011	2012	   2	   0	PSYGENET
      811	CALR	0.413	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.923	2003	2020	   1	   0	CTD_human
      811	CALR	0.413	0.923	C0376545	Hematologic Neoplasms	group	C04;C15	Neoplastic Process	0.43	1	2014	2018	   0	   0	CGI
      811	CALR	0.413	0.923	C3277671	THROMBOCYTHEMIA 1	disease		Disease or Syndrome	0.40	1	2013	2013	   1	   1	GENOMICS_ENGLAND
      811	CALR	0.413	0.923	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.42	1	2015	2020	   0	   0	CGI
      811	CALR	0.413	0.923	C3489628	Thrombocytosis, Autosomal Dominant	disease	C15	Disease or Syndrome	0.30				   0	   0	CTD_human
      813	CALU	0.7	0.385	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      813	CALU	0.7	0.385	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      813	CALU	0.7	0.385	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
      813	CALU	0.7	0.385	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      813	CALU	0.7	0.385	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
      814	CAMK4	0.621	0.654	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      814	CAMK4	0.621	0.654	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      814	CAMK4	0.621	0.654	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
      814	CAMK4	0.621	0.654	C0345958	Large cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30				   0	   1	UNIPROT
      814	CAMK4	0.621	0.654	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2008	2008	   1	   0	CTD_human;PSYGENET
      815	CAMK2A	0.612	0.538	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2011	2019	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2006	2011	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2011	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0019202	Hepatolenticular Degeneration	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	2007	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2004	2014	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
      815	CAMK2A	0.612	0.538	C1527352	Hepatic Form of Wilson Disease	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
      815	CAMK2A	0.612	0.538	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.43	1	2014	2018	   2	   0	GENOMICS_ENGLAND
      815	CAMK2A	0.612	0.538	C4540481	MENTAL RETARDATION, AUTOSOMAL DOMINANT 53	disease		Mental or Behavioral Dysfunction	0.40	1	2015	2018	   4	   8	UNIPROT
      815	CAMK2A	0.612	0.538	C4748167	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63	disease		Disease or Syndrome	0.30	1	2018	2018	   1	   1	UNIPROT
      816	CAMK2B	0.626	0.538	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0031391	Phencyclidine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0033937	Psychoses, Drug	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0033941	Psychoses, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2000	2010	   2	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0236742	Phencyclidine-Related Disorders	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	CTD_human
      816	CAMK2B	0.626	0.538	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
      816	CAMK2B	0.626	0.538	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2017	2018	   1	   0	GENOMICS_ENGLAND
      816	CAMK2B	0.626	0.538	C4540484	MENTAL RETARDATION, AUTOSOMAL DOMINANT 54	disease		Disease or Syndrome	0.60	1	2017	2018	   2	   7	GENOMICS_ENGLAND;UNIPROT
      817	CAMK2D	0.743	0.308	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.40	1	2018	2018	   2	   2	CTD_human
      817	CAMK2D	0.743	0.308	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
      817	CAMK2D	0.743	0.308	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      817	CAMK2D	0.743	0.308	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      817	CAMK2D	0.743	0.308	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
      818	CAMK2G	0.67	0.462	C4552072	X-linked infantile spasms	disease	C10	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
      821	CANX	0.582	0.769	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
      821	CANX	0.582	0.769	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      821	CANX	0.582	0.769	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
      822	CAPG	0.548	0.731	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.32	1	1999	2019	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.32	1	2012	2019	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0027651	Neoplasms	group	C04	Neoplastic Process	0.38	0.778	1999	2019	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0029134	Optic Neuritis	disease	C11;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0085582	Retrobulbar Neuritis	disease	C11;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C0524679	Neuropapillitis	disease	C11;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
      823	CAPN1	0.539	0.808	C4310800	SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.71	1	2016	2019	   2	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
      824	CAPN2	0.59	0.692	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      824	CAPN2	0.59	0.692	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      824	CAPN2	0.59	0.692	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      825	CAPN3	0.564	0.615	C0686353	Muscular Dystrophies, Limb-Girdle	group	C16;C05;C10	Disease or Syndrome	0.40	0.986	1993	2020	   0	   0	GENOMICS_ENGLAND
      825	CAPN3	0.564	0.615	C1299884	Eosinophilic myositis (disorder)	disease	C16;C05;C10	Disease or Syndrome	0.62	1	2000	2010	   0	   1	CTD_human
      825	CAPN3	0.564	0.615	C1869123	Limb-girdle muscular dystrophy type 2A	disease	C16;C05;C10	Disease or Syndrome	1.00	0.994	1995	2019	  10	 146	CTD_human;GENOMICS_ENGLAND;UNIPROT
      826	CAPNS1	0.674	0.538	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
      826	CAPNS1	0.674	0.538	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
      827	CAPN6	0.839	0.077	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
      829	CAPZA1	0.821	0.115	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
      831	CAST	0.541	0.846	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2007	2007	   1	   0	CTD_human
      831	CAST	0.541	0.846	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
      831	CAST	0.541	0.846	C4225381	PEELING SKIN WITH LEUKONYCHIA, ACRAL PUNCTATE KERATOSES, CHEILITIS, AND KNUCKLE PADS	disease		Disease or Syndrome	0.72	1	2015	2019	   1	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
      832	CAPZB	0.729	0.308	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
      832	CAPZB	0.729	0.308	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
      833	CARS1	0.722	0.538	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
      833	CARS1	0.722	0.538	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      833	CARS1	0.722	0.538	C0263490	Brittle hair	disease		Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      833	CARS1	0.722	0.538	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.31	1	2002	2003	   2	   0	ORPHANET
      833	CARS1	0.722	0.538	C1856963	Fragile nails	phenotype	C23	Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      833	CARS1	0.722	0.538	C4022738	Neurodevelopmental delay	phenotype		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
      834	CASP1	0.413	0.885	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.32	1	2012	2019	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.36	1	1999	2018	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.32	1	2011	2018	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.31	1	2011	2019	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0598608	Hyperhomocysteinemia	disease	C16;C18	Disease or Syndrome	0.31	1	2012	2017	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2002	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.31	1	2000	2011	   1	   0	CTD_human
      834	CASP1	0.413	0.885	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2004	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.31	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
      835	CASP2	0.565	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
      836	CASP3	0.351	0.923	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.6	0.98	1999	2020	1	0	CTD_human
3401	836	CASP3	0.351	0.923	C0011882	Diabetic Neuropathies	group	C10;C19	Disease or Syndrome	0.51	1	2003	2017	1	0	CTD_human
3402	836	CASP3	0.351	0.923	C0011884	Diabetic Retinopathy	disease	C11;C19;C14	Disease or Syndrome	0.51	0.667	2008	2019	1	0	CTD_human
3409	836	CASP3	0.351	0.923	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.6	1	2002	2019	1	0	CTD_human
3418	836	CASP3	0.351	0.923	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.57	1	2006	2019	2	0	CTD_human
3420	836	CASP3	0.351	0.923	C0038525	Subarachnoid Hemorrhage	disease	C23;C10;C14	Disease or Syndrome	0.6	0.96	2014	2019	1	0	CTD_human
3426	836	CASP3	0.351	0.923	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.6	1	2005	2020	1	0	CTD_human
3469	1139	CHRNA7	0.532	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.7	0.75	1998	2019	4	0	PSYGENET
3549	1141	CHRNB2	0.617	0.308	C1854335	Epilepsy, Nocturnal Frontal Lobe, Type 3	disease	C10	Disease or Syndrome	0.9	1	2000	2011	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
3595	1144	CHRND	0.641	0.462	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.52	1	2002	2017	1	0	CTD_human;GENOMICS_ENGLAND
3601	1144	CHRND	0.641	0.462	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	disease	C23;C16;C17	Disease or Syndrome	0.7	1	2006	2008	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3603	1144	CHRND	0.641	0.462	C4225370	MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	disease		Disease or Syndrome	0.6	1	2001	2008	3	1	GENOMICS_ENGLAND;UNIPROT
3604	1144	CHRND	0.641	0.462	C4225371	MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL	disease		Disease or Syndrome	0.6	1	2001	2008	4	5	GENOMICS_ENGLAND;UNIPROT
3605	1144	CHRND	0.641	0.462	C4225372	MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL	disease		Disease or Syndrome	0.8	1	1996	2006	4	2	GENOMICS_ENGLAND;UNIPROT
3606	1145	CHRNE	0.636	0.577	C1837091	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	disease	C16;C10	Disease or Syndrome	0.9	1	1996	2011	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
3610	1145	CHRNE	0.636	0.577	C4225369	MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL	disease		Disease or Syndrome	0.6	1	1996	2012	4	2	GENOMICS_ENGLAND;UNIPROT
3611	1145	CHRNE	0.636	0.577	C4225413	MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL	disease		Disease or Syndrome	0.8	1	1995	2016	6	6	GENOMICS_ENGLAND;UNIPROT
3614	1146	CHRNG	0.573	0.692	C0265261	Multiple pterygium syndrome	disease	C23;C16;C17	Congenital Abnormality	0.78	1	2006	2019	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3619	1146	CHRNG	0.573	0.692	C1854678	MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE	disease	C23;C16;C17	Disease or Syndrome	0.71	1	2006	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3628	1147	CHUK	0.556	0.731	C3150891	COCOON SYNDROME	disease		Disease or Syndrome	0.92	1	1999	2015	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
3677	1161	ERCC8	0.551	0.885	C0009207	Cockayne Syndrome	disease	C16;C18;C05;C10	Disease or Syndrome	0.8	0.978	1996	2020	3	0	CTD_human;GENOMICS_ENGLAND
3680	1161	ERCC8	0.551	0.885	C0751039	Cockayne Syndrome, Type I	disease	C16;C18;C05;C10	Disease or Syndrome	0.8	1	1995	2019	8	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
3681	1161	ERCC8	0.551	0.885	C1833561	UV-Sensitive Syndrome	disease	C17	Disease or Syndrome	0.62	1	2009	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
3682	1161	ERCC8	0.551	0.885	C3553298	UV-SENSITIVE SYNDROME 2	disease		Disease or Syndrome	0.6	1	2009	2009	1	2	GENOMICS_ENGLAND;UNIPROT
3694	1174	AP1S1	0.743	0.308	C1836330	ERYTHROKERATODERMIA VARIABILIS 3 (disorder)	disease	C16;C17	Disease or Syndrome	0.75	1	2005	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
3696	1175	AP2S1	0.705	0.346	C1833372	HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	disease	C18	Disease or Syndrome	0.7	1	2013	2016	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3700	1180	CLCN1	0.641	0.423	C0027127	Myotonia Congenita	disease	C16;C05;C10	Disease or Syndrome	0.9	0.968	1982	2019	2	27	CTD_human;GENOMICS_ENGLAND
3703	1180	CLCN1	0.641	0.423	C0751360	Becker Generalized Myotonia	disease	C16;C05;C10	Disease or Syndrome	0.8	1	1992	2018	23	65	CTD_human;GENOMICS_ENGLAND;UNIPROT
3704	1180	CLCN1	0.641	0.423	C2936781	Generalized Myotonia of Thomsen	disease	C16;C05;C10	Disease or Syndrome	0.8	0.977	1992	2019	15	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
3712	1181	CLCN2	0.626	0.462	C1854107	Hyperaldosteronism, Familial, Type II	disease	C19	Disease or Syndrome	0.61	1	2018	2019	2	5	CTD_human;UNIPROT
3713	1181	CLCN2	0.626	0.462	C2750893	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11	disease		Finding	0.6	1	2009	2013	3	3	GENOMICS_ENGLAND;UNIPROT
3714	1181	CLCN2	0.626	0.462	C3810242	LEUKOENCEPHALOPATHY WITH ATAXIA	disease		Disease or Syndrome	0.7	1	2003	2015	5	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3724	1183	CLCN4	0.587	0.654	C0796221	MENTAL RETARDATION, X-LINKED 15	disease		Disease or Syndrome	0.7	1	2013	2016	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
3734	1184	CLCN5	0.593	0.577	C0403720	X-linked recessive nephrolithiasis with renal failure	disease	C16;C13;C12	Disease or Syndrome	0.62	1	1996	2013	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3778	1200	TPP1	0.551	0.808	C0022340	Late-Infantile Neuronal Ceroid Lipfuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.8	1	1993	2019	2	0	CTD_human;GENOMICS_ENGLAND
3780	1200	TPP1	0.551	0.808	C0027877	Neuronal Ceroid-Lipofuscinoses	disease	C16;C18;C10	Disease or Syndrome	0.7	0.968	1991	2019	2	23	CTD_human
3787	1200	TPP1	0.551	0.808	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1200	TPP1	0.551	0.808	C0751383	Juvenile Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.60	1	1997	2019	   2	   0	CTD_human
     1200	TPP1	0.551	0.808	C1834207	Ceroid Lipofuscinosis, Neuronal, Parry Type	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1999	2001	   2	   0	CTD_human
     1200	TPP1	0.551	0.808	C1836474	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7	disease	C16;C10	Disease or Syndrome	0.71	1	2013	2013	   1	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1200	TPP1	0.551	0.808	C1876161	CEROID LIPOFUSCINOSIS, NEURONAL, 2	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1997	2019	  16	  66	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1200	TPP1	0.551	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     1201	CLN3	0.572	0.692	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1201	CLN3	0.572	0.692	C0022340	Late-Infantile Neuronal Ceroid Lipfuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.54	1	1994	2017	   0	   0	CTD_human
     1201	CLN3	0.572	0.692	C0022797	Adult Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.50	1	1999	2016	   0	   0	CTD_human
     1201	CLN3	0.572	0.692	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C0027877	Neuronal Ceroid-Lipofuscinoses	disease	C16;C18;C10	Disease or Syndrome	0.70	0.957	1993	2019	   0	  12	CTD_human
     1201	CLN3	0.572	0.692	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.41	1	2000	2014	   0	   4	GENOMICS_ENGLAND
     1201	CLN3	0.572	0.692	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C0268281	Infantile neuronal ceroid lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1201	CLN3	0.572	0.692	C0751383	Juvenile Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	1.00	0.994	1990	2019	   7	  72	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1201	CLN3	0.572	0.692	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1201	CLN3	0.572	0.692	C1834207	Ceroid Lipofuscinosis, Neuronal, Parry Type	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1203	CLN5	0.705	0.269	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1203	CLN5	0.705	0.269	C1850442	CEROID LIPOFUSCINOSIS, NEURONAL, 5	disease	C16;C18;C10	Disease or Syndrome	0.97	1	1998	2019	  11	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1207	CLNS1A	1	0.038	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1209	CLPTM1	0.769	0.346	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1209	CLPTM1	0.769	0.346	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1212	CLTB	0.821	0.231	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1212	CLTB	0.821	0.231	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1213	CLTC	0.558	0.769	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2007	2012	   1	   0	CTD_human
     1213	CLTC	0.558	0.769	C0334121	Inflammatory Myofibroblastic Tumor	disease	C23	Neoplastic Process	0.35	1	2001	2007	   1	   0	ORPHANET
     1213	CLTC	0.558	0.769	C4518356	MiT family translocation renal cell carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2003	2010	   2	   0	ORPHANET
     1213	CLTC	0.558	0.769	C4693389	MENTAL RETARDATION, AUTOSOMAL DOMINANT 56	disease		Mental or Behavioral Dysfunction	0.60	1	2016	2017	   2	   1	GENOMICS_ENGLAND;UNIPROT
     1215	CMA1	0.514	0.692	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.33	1	2003	2018	   1	   0	CTD_human
     1215	CMA1	0.514	0.692	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1215	CMA1	0.514	0.692	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.31	1	2003	2005	   1	   0	CTD_human
     1215	CMA1	0.514	0.692	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.54	1	2012	2019	   2	   0	CTD_human;ORPHANET
     1230	CCR1	0.531	0.769	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.36	1	2003	2019	   1	   0	CTD_human
     1230	CCR1	0.531	0.769	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.34	1	1999	2018	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.32	1	1999	2017	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.31	1	2005	2005	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0035228	Respiratory Hypersensitivity	phenotype	C08;C20	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0086196	Eczema, Infantile	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C1319853	Asthma, Aspirin-Induced	disease	C08;C20;C25	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     1232	CCR3	0.527	0.808	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0017638	Glioma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	2002	2020	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.36	1	2005	2020	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1233	CCR4	0.51	0.731	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0019196	Hepatitis C	disease	C06;C01	Disease or Syndrome	0.40	0.839	2002	2019	   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0027697	Nephritis	disease	C13;C12	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2006	2016	   1	   0	PSYGENET
     1234	CCR5	0.398	0.885	C0043124	West Nile Fever	disease	C01;C10	Disease or Syndrome	0.36	0.833	2006	2016	   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0086196	Eczema, Infantile	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751583	Encephalitis, West Nile Fever	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751584	West Nile Fever Meningitis	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751585	West Nile Fever Meningoencephalitis	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C0751586	West Nile Fever Myelitis	disease	C01;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1234	CCR5	0.398	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2016	2016	   1	   0	CTD_human
     1234	CCR5	0.398	0.885	C2675864	DIABETES MELLITUS, INSULIN-DEPENDENT, 22 (disorder)	disease	C18;C20;C19	Disease or Syndrome	0.30				   0	   0	CTD_human
     1235	CCR6	0.485	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.50	1	2001	2019	   3	   6	CTD_human
     1235	CCR6	0.485	0.808	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.35	1	2005	2019	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0042900	Vitiligo	disease	C17	Disease or Syndrome	0.31	1	2010	2019	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1235	CCR6	0.485	0.808	C0206138	CREST Syndrome	disease	C06;C18;C17;C14	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1235	CCR6	0.485	0.808	C0748540	Scleroderma, Limited	disease	C17	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1235	CCR6	0.485	0.808	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C1258104	Diffuse Scleroderma	disease	C17	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1235	CCR6	0.485	0.808	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1235	CCR6	0.485	0.808	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     1236	CCR7	0.443	0.769	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1236	CCR7	0.443	0.769	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1237	CCR8	0.597	0.692	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1240	CMKLR1	0.612	0.692	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2012	2018	   1	   0	PSYGENET
     1240	CMKLR1	0.612	0.692	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2018	   1	   0	PSYGENET
     1240	CMKLR1	0.612	0.692	C0018206	granulosa cell tumor	disease	C04;C13;C19	Neoplastic Process	0.31	1	2018	2018	   1	   0	CTD_human
     1240	CMKLR1	0.612	0.692	C1567257	Granulosa Cell Cancer	disease	C04;C13;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0002792	anaphylaxis	phenotype	C20	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2000	2005	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1241	LTB4R	0.576	0.692	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.31	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.52	1	2003	2005	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.80	0.963	2000	2020	   5	   0	CTD_human;GENOMICS_ENGLAND
     1244	ABCC2	0.483	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2012	2015	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2008	2012	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0013182	Drug Allergy	group	C20;C25	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2010	2014	   3	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0017178	Gastrointestinal Diseases	group	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0020433	Hyperbilirubinemia	disease	C23	Disease or Syndrome	0.59	1	1996	2019	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0022350	Jaundice, Chronic Idiopathic	disease	C16;C18	Disease or Syndrome	1.00	1	1996	2020	  11	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1244	ABCC2	0.483	0.808	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.50	1	2004	2005	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.33	1	2006	2020	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.50	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2010	2014	   3	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.31	1	2006	2013	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0162311	Androgenetic Alopecia	disease	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0263477	Female pattern alopecia (disorder)	phenotype	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0268318	Cholestasis of pregnancy	disease	C06;C13	Disease or Syndrome	0.35	1	2008	2018	   2	   0	GENOMICS_ENGLAND
     1244	ABCC2	0.483	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.50	1	2003	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2011	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.32	1	2009	2020	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0559031	Functional Gastrointestinal Disorders	disease	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.36	0.875	2008	2020	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.32	1	2014	2019	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C1565321	Cholera Infantum	disease	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.31	1	2006	2020	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4083212	Alopecia, Male Pattern	disease	C23;C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1244	ABCC2	0.483	0.808	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1258	CNGB1	0.628	0.538	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1258	CNGB1	0.628	0.538	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.68	1	2001	2019	   1	  12	CTD_human;GENOMICS_ENGLAND
     1258	CNGB1	0.628	0.538	C3151066	RETINITIS PIGMENTOSA 45	disease		Disease or Syndrome	0.70	1	2001	2001	   1	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1259	CNGA1	0.695	0.269	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1259	CNGA1	0.695	0.269	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.64	1	1995	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
     1259	CNGA1	0.695	0.269	C3151059	RETINITIS PIGMENTOSA 49	disease		Disease or Syndrome	0.70	1	1995	2014	   2	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1260	CNGA2	0.931	0.154	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   2	UNIPROT
     1260	CNGA2	0.931	0.154	C0393778	Congenital anosmia	disease	C23;C10	Congenital Abnormality	0.32	1	2015	2017	   1	   0	ORPHANET
     1261	CNGA3	0.65	0.154	C0009398	Color vision defect	phenotype	C23;C11;C10	Disease or Syndrome	0.43	1	2004	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.31	1	2014	2017	   1	   0	GENOMICS_ENGLAND
     1261	CNGA3	0.65	0.154	C0152200	Achromatopsia	disease	C23;C11;C10	Disease or Syndrome	0.80	0.982	2000	2019	   1	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1261	CNGA3	0.65	0.154	C0155015	Color Blindness, Red	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0155016	Color Blindness, Red-Green	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0155017	Color Blindness, Blue	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0155018	Color Blindness, Acquired	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0239777	Color Blindness, Green	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0242225	Color blindness	disease	C23;C11;C10	Disease or Syndrome	0.31	1	2008	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0751042	Color Blindness, Inherited	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C0751043	Monochromatopsia	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1261	CNGA3	0.65	0.154	C1857618	Achromatopsia 2	disease	C23;C11;C10	Disease or Syndrome	0.94	1	1998	2019	   9	  43	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1261	CNGA3	0.65	0.154	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.32	1	2015	2019	   1	   0	ORPHANET
     1265	CNN2	0.666	0.538	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1265	CNN2	0.666	0.538	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1266	CNN3	0.705	0.462	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1267	CNP	0.604	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1267	CNP	0.604	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.4	2006	2018	   5	   0	PSYGENET
     1267	CNP	0.604	0.692	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
     1267	CNP	0.604	0.692	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2015	   1	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.37	1	2002	2014	   5	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.40	1	2004	2019	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2010	2013	   2	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0006868	Cannabis Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	0.5	2009	2016	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.37	1	2006	2016	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0007370	Catalepsy	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2017	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	1	2005	2019	   5	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2005	2019	   5	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.32	1	1999	2017	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0018614	Hashish Abuse	disease	C25;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020179	Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.36	1	2009	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.32	1	2007	2018	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020649	Hypotension	phenotype	C14	Finding	0.50	1	1999	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0020672	Hypothermia, natural	phenotype	C23	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2001	2011	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	1	1997	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.37	1	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0026838	Muscle Spasticity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.50	1	2001	2014	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.60	0.982	2005	2020	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0030193	Pain	phenotype	C23	Sign or Symptom	0.60	1	2009	2020	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0035412	Rhabdomyosarcoma	disease	C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.60	0.951	2000	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.37	0.75	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.51	1	2009	2018	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.35	1	1999	2013	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.34	1	1999	2019	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2008	2015	   4	   0	PSYGENET
     1268	CNR1	0.446	0.808	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.31	1	2017	2017	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0233612	Waxy flexibility	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0236735	Cannabis-Related Disorder	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2009	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.32	1	2001	2017	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0266487	Etat Marbre	disease	C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0277820	Clasp-Knife Spasticity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2008	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393574	Huntington Disease, Late Onset	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0443306	Spastic	disease	C23;C05;C10	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0596170	Binge eating disorder	phenotype	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.53	1	2006	2013	   4	   0	CTD_human;PSYGENET
     1268	CNR1	0.446	0.808	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	1999	2020	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751207	Akinetic-Rigid Variant of Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751208	Juvenile Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2008	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2008	2018	   4	   0	PSYGENET
     1268	CNR1	0.446	0.808	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2008	   2	   0	CTD_human
     1268	CNR1	0.446	0.808	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.38	1	1997	2019	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.31	0.5	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	1999	2011	   3	   0	CTD_human
     1268	CNR1	0.446	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.31	1	2003	2019	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     1268	CNR1	0.446	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.36	1	2005	2019	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2019	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2006	2017	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.35	1	2006	2019	   5	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.55	1	2006	2019	   5	   0	CTD_human;PSYGENET
     1269	CNR2	0.509	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.31	1	2006	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0021053	Immune System Diseases	group	C20	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.32	1	2003	2004	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2005	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2014	2018	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.51	1	2007	2009	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0030569	Secondary Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	0.75	2010	2017	   4	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.33	1	2005	2017	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.33	1	2006	2017	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2008	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751414	Parkinson Disease, Secondary Vascular	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C0751415	Atherosclerotic Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1269	CNR2	0.509	0.846	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.32	1	2007	2019	   2	   0	CTD_human
     1269	CNR2	0.509	0.846	C3160814	Cannabis use	disease		Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     1269	CNR2	0.509	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2004	2019	   4	   0	PSYGENET
     1270	CNTF	0.561	0.615	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2004	2019	   4	   0	PSYGENET
     1270	CNTF	0.561	0.615	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.39	0.25	1996	2008	   4	   0	PSYGENET
     1270	CNTF	0.561	0.615	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.31	1	2002	2002	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.31	0	2002	2002	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1270	CNTF	0.561	0.615	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.32	1	1995	2002	   1	   0	CTD_human
     1272	CNTN1	0.599	0.577	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1272	CNTN1	0.599	0.577	C2675527	Myopathy, Congenital, Compton-North	disease	C16;C10	Disease or Syndrome	0.90	1	2008	2011	   1	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1277	COL1A1	0.43	0.808	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0002949	Aneurysm, Dissecting	disease	C14	Disease or Syndrome	0.40	1	1996	1996	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0003504	Aortic Valve Insufficiency	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0008311	Cholangitis	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0013720	Ehlers-Danlos Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	1991	2020	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0020497	Cortical Congenital Hyperostosis	disease	C16;C05	Disease or Syndrome	0.77	1	1993	2019	   3	   8	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1277	COL1A1	0.43	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.40	1	2001	2001	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.32	1	1993	2019	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.32	1	2009	2018	   4	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2005	2016	   3	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0023931	Lobstein Disease	disease	C16;C17;C05	Disease or Syndrome	1.00	0.976	1988	2019	  15	 191	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0027719	Nephrosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.31	1	1992	2016	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0029118	Opportunistic Infections	group	C01	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0029172	Oral Submucous Fibrosis	disease	C07	Disease or Syndrome	0.31	1	2002	2006	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0029434	Osteogenesis Imperfecta	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.90	0.984	1985	2020	   1	  36	CTD_human;GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.70	1	1996	2017	   0	   0	CTD_human;GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0220679	Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2000	2000	   1	   0	ORPHANET
     1277	COL1A1	0.43	0.808	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.40	0.929	2011	2019	   4	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0268345	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE	disease	C16;C18;C17;C15;C14	Disease or Syndrome	0.31	1	1991	1997	   2	   0	ORPHANET
     1277	COL1A1	0.43	0.808	C0268358	Osteogenesis imperfecta, dominant perinatal lethal	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.89	1	1986	2019	  38	  61	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0268362	Osteogenesis imperfecta type III (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.99	1	1989	2018	  17	  31	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0268363	Osteogenesis imperfecta type IV (disorder)	disease		Disease or Syndrome; Congenital Abnormality	0.97	1	1989	2018	  12	  33	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1277	COL1A1	0.43	0.808	C0340643	Dissection of aorta	disease	C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0392784	Dermatofibrosarcoma Protuberans	disease	C04	Neoplastic Process	0.40	0.964	1997	2019	   0	   0	ORPHANET
     1277	COL1A1	0.43	0.808	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1277	COL1A1	0.43	0.808	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C1619692	Nephrogenic Fibrosing Dermopathy	disease	C23;C17	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.31	1	2010	2018	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.31	1	1991	2017	   1	   0	GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C4277533	Dissection, Blood Vessel	phenotype	C14	Pathologic Function	0.30	1	1996	1996	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C4551623	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	1991	2016	   4	  11	CTD_human;GENOMICS_ENGLAND
     1277	COL1A1	0.43	0.808	C4552122	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1	disease		Disease or Syndrome	0.50	1	1991	2007	   4	   1	GENOMICS_ENGLAND;UNIPROT
     1277	COL1A1	0.43	0.808	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1277	COL1A1	0.43	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.40				   0	   1	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0013720	Ehlers-Danlos Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	1987	2020	   0	   0	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	2005	2016	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	1993	2014	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0023931	Lobstein Disease	disease	C16;C17;C05	Disease or Syndrome	0.89	1	1982	2019	   6	  64	ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0029172	Oral Submucous Fibrosis	disease	C07	Disease or Syndrome	0.32	1	1995	2006	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.31	1	2006	2009	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0029434	Osteogenesis Imperfecta	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.70	0.977	1980	2020	   0	  15	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.67	1	1985	2018	   0	   0	CTD_human;GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.40	1	1987	2014	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.34	1	1987	2019	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C0268345	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE	disease	C16;C18;C17;C15;C14	Disease or Syndrome	0.39	1	1987	2000	   2	   0	ORPHANET
     1278	COL1A2	0.486	0.846	C0268358	Osteogenesis imperfecta, dominant perinatal lethal	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.66	1	1985	2011	  16	  29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0268362	Osteogenesis imperfecta type III (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.95	1	1991	2018	  16	  34	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0268363	Osteogenesis imperfecta type IV (disorder)	disease		Disease or Syndrome; Congenital Abnormality	0.80	1	1985	2015	  11	  26	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1278	COL1A2	0.486	0.846	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30				   0	   0	CTD_human
     1278	COL1A2	0.486	0.846	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C1857034	Ehlers-Danlos syndrome, cardiac valvular form	disease	C16;C17;C15;C14	Disease or Syndrome	0.60	1	2004	2011	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1278	COL1A2	0.486	0.846	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C4303789	Ehlers-Danlos syndrome cardiac valvular type	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	2006	2006	   1	   3	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C4551623	EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	2006	2006	   1	   4	GENOMICS_ENGLAND
     1278	COL1A2	0.486	0.846	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1278	COL1A2	0.486	0.846	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0003864	Arthritis	disease	C05	Disease or Syndrome	0.31	1	2007	2016	   3	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0003865	Arthritis, Adjuvant-Induced	disease	C05	Experimental Model of Disease	0.30	1	2005	2018	   9	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.35	0.857	1993	2018	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0005974	Bone Resorption	phenotype	C05	Organ or Tissue Function	0.30	1	2017	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0007302	Cartilage Diseases	group	C17;C05	Disease or Syndrome	0.32	1	1995	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0008479	Chondrosarcoma	disease	C04	Neoplastic Process	0.33	1	2013	2015	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.64	1	1991	2011	   2	   0	CTD_human;GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0013366	Dyschondroplasias	group	C16;C05	Congenital Abnormality	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0013604	Edema	phenotype	C23	Pathologic Function	0.40	1	2014	2018	   4	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0015814	Femur Head Necrosis	disease	C23;C05	Disease or Syndrome	0.50	1	2010	2010	   0	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.42	1	2004	2008	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0020507	Hyperplasia	phenotype	C23	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2013	2017	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0023234	Legg-Calve-Perthes Disease	disease	C05	Disease or Syndrome	0.74	1	2007	2014	   3	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0025237	Melnick-Needles Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.41	1	1993	1993	   1	   1	CTD_human
     1280	COL2A1	0.444	0.846	C0027092	Myopia	disease	C11	Disease or Syndrome	0.42	1	2007	2012	   1	   1	CTD_human
     1280	COL2A1	0.444	0.846	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.50	0.941	1993	2020	   2	   1	CTD_human
     1280	COL2A1	0.444	0.846	C0029422	Osteochondrodysplasias	group	C16;C05	Disease or Syndrome	0.44	1	1993	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0035305	Retinal Detachment	disease	C11	Disease or Syndrome	0.48	1	1993	2018	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0036391	Schwartz-Jampel Syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0038015	Spondyloepiphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.50	1	1989	2019	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0039103	Synovitis	disease	C05	Disease or Syndrome	0.31	1	2005	2014	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0041834	Erythema	phenotype	C23;C17	Disease or Syndrome	0.30	1	2014	2017	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0085700	Chondromalacia	disease	C17;C05	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0086543	Cataract	disease	C11	Acquired Abnormality	0.41	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	1997	2005	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2014	2018	   4	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0162323	Polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2007	2016	   3	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0220685	Achondrogenesis type 2	disease	C16;C05	Congenital Abnormality	1.00	1	1988	2012	  13	  12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0265279	Kniest dysplasia	disease	C16;C17;C05;C08;C19;C07	Disease or Syndrome	0.80	1	1989	2017	   9	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0339546	Retinal Pigment Epithelial Detachment	disease	C11	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1997	2004	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0410480	Avascular Necrosis of Femur Head	phenotype	C23;C05	Disease or Syndrome	0.65	1	2005	2018	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1280	COL2A1	0.444	0.846	C0410574	Synovial Hypertrophy	disease	C05	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0432214	Namaqualand hip dysplasia	disease	C16;C05	Disease or Syndrome	0.70	1	1990	2012	   5	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0432221	Spondylometaphyseal dysplasia, corner fracture type	disease	C23;C16;C05;C26	Disease or Syndrome	0.30	1	2007	2007	   1	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C0432272	Van Buchem disease	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0524595	Aseptic Necrosis of Femur Head	phenotype	C23;C05	Pathologic Function	0.30				   0	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0542428	Hypochondrogenesis	disease	C16;C05	Congenital Abnormality	0.66	1	1988	2003	   1	   3	ORPHANET
     1280	COL2A1	0.444	0.846	C0700635	Strudwick syndrome	disease	C16;C05	Disease or Syndrome	0.73	1	1989	2017	   5	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C0796173	Spondyloperipheral dysplasia short ulna	disease	C16;C05	Disease or Syndrome	0.75	1	1989	2013	   4	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1280	COL2A1	0.444	0.846	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.40				   0	   0	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C0971858	Arthritis, Collagen-Induced	disease	C05	Experimental Model of Disease	0.30	1	2005	2018	   9	   0	CTD_human
     1280	COL2A1	0.444	0.846	C0993582	Arthritis, Experimental	disease	C05	Experimental Model of Disease	0.30	1	2005	2018	   9	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1262477	Weight decreased	phenotype	C23	Finding	0.30	1	2015	2018	   2	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1691779	Sensory hearing loss	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1835437	Platyspondylic Lethal Skeletal Dysplasia, Torrance Type	disease	C16;C05	Disease or Syndrome	0.73	1	1989	2016	   6	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C1836080	Stickler Syndrome, Type I, Nonsyndromic Ocular	disease	C16;C11	Disease or Syndrome	0.71	1	1989	2018	   8	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1280	COL2A1	0.444	0.846	C1836081	RHEGMATOGENOUS RETINAL DETACHMENT, AUTOSOMAL DOMINANT	disease	C16;C11	Disease or Syndrome	0.41	1	2003	2005	   1	   2	ORPHANET
     1280	COL2A1	0.444	0.846	C1836683	Czech dysplasia, metatarsal type	disease	C16;C05	Congenital Abnormality	0.73	1	1993	2016	   6	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.44	1	2003	2011	   1	   1	CTD_human
     1280	COL2A1	0.444	0.846	C1840452	Hyaloideoretinal degeneration of Wagner	disease	C11	Disease or Syndrome	0.36	1	1993	2003	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1851536	Epiphyseal Dysplasia, Multiple, with Myopia and Conductive Deafness	disease	C23;C16;C11;C05;C10;C09	Disease or Syndrome	0.70	1	1998	2012	   3	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C1852989	Vitreoretinopathy with Phalangeal Epiphyseal Dysplasia	disease	C16;C11;C05	Disease or Syndrome	0.40	1	2008	2012	   2	   1	GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C1855310	Megaepiphyseal dwarfism	disease	C16;C05;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C1861481	Stickler syndrome, type 3	disease	C17;C05	Disease or Syndrome	0.30	1	2005	2011	   2	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C1866688	Spondylometaphyseal dysplasia, Algerian type	disease	C16;C05	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C2020284	Stickler syndrome, type 1	disease	C23;C11;C17;C05;C10;C09	Disease or Syndrome	0.80	0.968	1987	2019	   6	  23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C2745959	Spondyloepiphyseal dysplasia, congenita	disease	C16;C05	Congenital Abnormality	1.00	0.981	1989	2020	  12	  14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C3541456	Spondyloepiphyseal Dysplasia Tarda, X-Linked	disease	C16;C05	Congenital Abnormality	0.31	1	1993	1994	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C4225273	SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	disease		Disease or Syndrome	0.71	1	1991	2016	   5	   5	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1280	COL2A1	0.444	0.846	C4302548	Dysspondyloenchondromatosis	disease	C05	Disease or Syndrome	0.32	1	2011	2015	   2	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C4479260	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2	disease		Disease or Syndrome	0.30	1	2005	2005	   1	   0	ORPHANET
     1280	COL2A1	0.444	0.846	C4520892	Otospondylomegaepiphyseal dysplasia	disease	C16;C05;C19	Disease or Syndrome	0.61	1	2005	2012	   2	   1	CTD_human;GENOMICS_ENGLAND
     1280	COL2A1	0.444	0.846	C4551479	Schwartz-Jampel Syndrome, Type 1	disease	C16;C05	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     1280	COL2A1	0.444	0.846	C4551562	AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 1	disease	C23;C05	Disease or Syndrome	0.70	1	1989	2012	   4	   6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1281	COL3A1	0.477	0.808	C0003504	Aortic Valve Insufficiency	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2016	2016	   0	   2	UNIPROT
     1281	COL3A1	0.477	0.808	C0013720	Ehlers-Danlos Syndrome	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	1986	2020	   0	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.41	1	2001	2017	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.31	1	2010	2017	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.31	1	1989	2008	   5	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023891	Liver Cirrhosis, Alcoholic	disease	C23;C06;C25	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2002	2014	   2	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.31	1	2001	2008	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0027719	Nephrosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2013	2018	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.31	1	1995	2014	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C0041956	Ureteral obstruction	phenotype	C13;C12	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0162871	Aortic Aneurysm, Abdominal	disease	C14	Disease or Syndrome	0.31	1	1990	2015	   2	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C0238288	Muscular Dystrophy, Facioscapulohumeral	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0238590	Acrogeria	disease	C23;C16;C18;C17	Disease or Syndrome	0.32	1	1996	2004	   1	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	1989	2006	   5	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0268338	Ehlers-Danlos Syndrome, Type IV	disease	C16;C17;C15;C14	Disease or Syndrome	1.00	1	1980	2019	  43	 390	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1281	COL3A1	0.477	0.808	C0338586	Vertebral Artery Dissection	disease	C10;C14;C26	Disease or Syndrome	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C0406584	Acrogeria, gottron type	disease	C16;C18	Disease or Syndrome	0.30	1	2000	2000	   1	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C0553692	Brain hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C0553980	Endomyocardial Fibrosis	phenotype	C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C0948008	Ischemic stroke	disease	C10;C14	Disease or Syndrome	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C1257963	Endogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1257964	Exogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1257965	Compensatory Hyperinsulinemia	disease	C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.31	1	2008	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1853365	AORTIC ANEURYSM, FAMILIAL ABDOMINAL 1	disease	C14	Disease or Syndrome	0.30	1	1990	1999	   2	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C1862932	ANEURYSM, INTRACRANIAL BERRY, 1 (disorder)	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
     1281	COL3A1	0.477	0.808	C2697932	Loeys-Dietz Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.41	1	1990	2016	   2	   1	GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     1281	COL3A1	0.477	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.60	1	1988	2015	  10	   4	CLINGEN;GENOMICS_ENGLAND
     1281	COL3A1	0.477	0.808	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0002878	Anemia, Hemolytic	disease	C15	Disease or Syndrome	0.42	1	2013	2016	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0002879	Anemia, Hemolytic, Acquired	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0002889	Anemia, Microangiopathic	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0009691	Congenital cataract	disease	C23;C16;C13;C11;C10	Congenital Abnormality	0.32	1	2014	2019	   0	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.31	1	2009	2016	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2009	2016	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2009	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0018965	Hematuria	phenotype	C23;C13;C12	Disease or Syndrome	0.42	1	2007	2010	   3	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.37	1	2007	2020	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.31	1	1992	2019	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2007	2007	   1	   1	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.50	1	2006	2020	   1	   1	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0086432	Hyalinosis, Segmental Glomerular	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2009	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0149931	Migraine Disorders	group	C10	Disease or Syndrome	0.40	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0221021	Microangiopathic hemolytic anemia	disease	C15	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.52	1	2011	2015	   1	   0	ORPHANET
     1282	COL4A1	0.484	0.731	C0265341	Rieger syndrome	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0266484	Schizencephaly	disease	C16;C10	Congenital Abnormality	0.75	1	2013	2019	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1282	COL4A1	0.484	0.731	C0266548	Axenfeld anomaly (disorder)	disease	C16;C11	Congenital Abnormality	0.51	1	2007	2010	   3	   0	CTD_human;GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0270612	Leukoencephalopathy	group	C10	Disease or Syndrome	0.48	0.889	2007	2019	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0302892	Congenital porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.60	1	1977	2020	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2017	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2016	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.42	1	2007	2017	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C1280768	Axenfeld syndrome	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C1843512	BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE	disease		Disease or Syndrome	0.82	1	2005	2013	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1282	COL4A1	0.484	0.731	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     1282	COL4A1	0.484	0.731	C1860475	Retinal vascular tortuosity	phenotype		Finding	0.40	1	2007	2010	   3	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C1867327	RETINAL ARTERIES, TORTUOSITY OF	phenotype		Finding	0.70	1	2014	2014	   1	   1	CTD_human;ORPHANET;UNIPROT
     1282	COL4A1	0.484	0.731	C1867983	PORENCEPHALY, FAMILIAL	disease	C16;C05;C10	Disease or Syndrome	0.83	1	1977	2016	   2	   1	CTD_human;ORPHANET
     1282	COL4A1	0.484	0.731	C2673195	Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps	disease	C23;C05;C10;C14	Disease or Syndrome	0.77	0.909	2007	2019	   6	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1282	COL4A1	0.484	0.731	C2675650	Brain Small Vessel Disease With Axenfeld-Rieger Anomaly	disease		Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C2678503	AXENFELD-RIEGER SYNDROME, TYPE 3	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C2733158	Cerebral Small Vessel Diseases	group	C10;C14	Disease or Syndrome	0.40	1	2007	2020	   1	   0	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C2930808	Familial vascular leukoencephalopathy	disease	C23;C16;C10;C14	Disease or Syndrome	0.50	1	2005	2013	   1	   0	ORPHANET
     1282	COL4A1	0.484	0.731	C2931870	Familial schizencephaly	disease	C16;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     1282	COL4A1	0.484	0.731	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.40				   0	   0	CTD_human
     1282	COL4A1	0.484	0.731	C3281105	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	disease		Finding	0.60	1	2007	2012	   2	   2	GENOMICS_ENGLAND;UNIPROT
     1282	COL4A1	0.484	0.731	C3495488	Axenfeld-Rieger syndrome	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C3698507	Post-traumatic Porencephaly	phenotype	C16;C05;C10	Acquired Abnormality	0.50	1	1977	2013	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C3714873	Axenfeld-Rieger Syndrome, Type 1	disease	C16;C11	Disease or Syndrome	0.30	1	2007	2010	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C4013035	BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES	disease		Disease or Syndrome	0.40	1	2006	2018	   1	   2	GENOMICS_ENGLAND
     1282	COL4A1	0.484	0.731	C4082173	Porencephaly	disease	C16;C05;C10	Disease or Syndrome	0.40	1	1977	2020	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C4082301	Developmental Porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	1977	2013	   2	   0	CTD_human
     1282	COL4A1	0.484	0.731	C4551998	Porencephaly, Type 1, Autosomal Dominant	disease	C16;C05;C10	Disease or Syndrome	0.90	1	1977	2018	  18	  15	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1282	COL4A1	0.484	0.731	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1284	COL4A2	0.563	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1284	COL4A2	0.563	0.654	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
     1284	COL4A2	0.563	0.654	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1284	COL4A2	0.563	0.654	C0302892	Congenital porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.36	0.833	2012	2016	   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C1867983	PORENCEPHALY, FAMILIAL	disease	C16;C05;C10	Disease or Syndrome	0.51	1	2012	2012	   0	   0	CTD_human;ORPHANET
     1284	COL4A2	0.563	0.654	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30				   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C3280970	PORENCEPHALY 2	disease		Disease or Syndrome	0.60	1	2012	2018	   4	   4	GENOMICS_ENGLAND;UNIPROT
     1284	COL4A2	0.563	0.654	C3281105	HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO	disease		Finding	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     1284	COL4A2	0.563	0.654	C3698507	Post-traumatic Porencephaly	phenotype	C16;C05;C10	Acquired Abnormality	0.30				   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C4082173	Porencephaly	disease	C16;C05;C10	Disease or Syndrome	0.56	0.857	2012	2016	   1	   0	CTD_human;GENOMICS_ENGLAND
     1284	COL4A2	0.563	0.654	C4082301	Developmental Porencephaly	disease	C16;C05;C10	Congenital Abnormality	0.30				   0	   0	CTD_human
     1284	COL4A2	0.563	0.654	C4551998	Porencephaly, Type 1, Autosomal Dominant	disease	C16;C05;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1285	COL4A3	0.552	0.692	C0027706	Hereditary nephritis	disease	C16;C13;C17;C12	Disease or Syndrome	0.39	1	1989	2018	   1	   0	CTD_human
     1285	COL4A3	0.552	0.692	C0241908	Hematuria, Benign Familial	disease	C23;C13;C12	Disease or Syndrome	0.80	1	1996	2019	   3	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1285	COL4A3	0.552	0.692	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.32	1	2007	2017	   0	   0	GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C0403440	Thin basement membrane disease	disease	C23;C13;C12	Disease or Syndrome	0.60	1	2001	2018	   0	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C0848548	hypertensive nephropathy	disease	C13;C12;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567741	Alport Syndrome	disease	C16;C13;C17;C12	Disease or Syndrome	0.70	0.982	1986	2020	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567742	Alport Syndrome, X-Linked	disease	C16;C13;C17;C12	Disease or Syndrome	0.60	1	1994	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567743	Alport Syndrome, Autosomal Dominant	disease	C16;C13;C17;C12	Disease or Syndrome	0.53	1	1997	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1567744	Alport Syndrome, Autosomal Recessive	disease	C16;C13;C17;C12	Disease or Syndrome	0.80	1	1994	2017	   2	   0	CTD_human;GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	disease	C13;C12	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     1285	COL4A3	0.552	0.692	C2931253	Alport syndrome, dominant type	disease	C16;C13;C17;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     1285	COL4A3	0.552	0.692	C2931254	Alport syndrome, recessive type	disease	C16;C13;C17;C12	Disease or Syndrome	0.50	1	1996	2014	   0	   0	CTD_human
     1285	COL4A3	0.552	0.692	C2931861	Hemorrhagic hereditary nephritis	disease	C16;C13;C17;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1285	COL4A3	0.552	0.692	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1285	COL4A3	0.552	0.692	C4746547	ALPORT SYNDROME 3, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.60	1	1997	2019	   5	   0	GENOMICS_ENGLAND;UNIPROT
     1285	COL4A3	0.552	0.692	C4746745	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.80	1	1994	2017	   5	   3	GENOMICS_ENGLAND;UNIPROT
     1286	COL4A4	0.644	0.5	C0241908	Hematuria, Benign Familial	disease	C23;C13;C12	Disease or Syndrome	0.80	1	1982	2018	   4	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1286	COL4A4	0.644	0.5	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.31	1	2011	2011	   0	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C0403440	Thin basement membrane disease	disease	C23;C13;C12	Disease or Syndrome	0.60	1	2001	2019	   0	   0	CTD_human;GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C0848548	hypertensive nephropathy	disease	C13;C12;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C1567741	Alport Syndrome	disease	C16;C13;C17;C12	Disease or Syndrome	0.40	1	1995	2020	   1	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C1567742	Alport Syndrome, X-Linked	disease	C16;C13;C17;C12	Disease or Syndrome	0.40	1	2001	2019	   1	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C1567743	Alport Syndrome, Autosomal Dominant	disease	C16;C13;C17;C12	Disease or Syndrome	0.53	1	1997	2018	   5	   0	GENOMICS_ENGLAND;ORPHANET
     1286	COL4A4	0.644	0.5	C1567744	Alport Syndrome, Autosomal Recessive	disease	C16;C13;C17;C12	Disease or Syndrome	0.60	1	1997	2019	   1	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C2931253	Alport syndrome, dominant type	disease	C16;C13;C17;C12	Disease or Syndrome	0.30	1	1997	2009	   4	   0	ORPHANET
     1286	COL4A4	0.644	0.5	C2931254	Alport syndrome, recessive type	disease	C16;C13;C17;C12	Disease or Syndrome	0.50	1	2011	2014	   0	   0	CTD_human
     1286	COL4A4	0.644	0.5	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1286	COL4A4	0.644	0.5	C4746745	ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.80	1	1994	2017	   4	  62	GENOMICS_ENGLAND;UNIPROT
     1287	COL4A5	0.553	0.654	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.31	1	2017	2019	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0018965	Hematuria	phenotype	C23;C13;C12	Disease or Syndrome	0.48	1	2001	2019	   1	   3	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.40	1	2017	2017	   1	   4	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0086533	Leiomyoma, Epithelioid	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1287	COL4A5	0.553	0.654	C0241908	Hematuria, Benign Familial	disease	C23;C13;C12	Disease or Syndrome	0.34	1	2003	2014	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C0268731	Renal glomerular disease	group	C23;C13;C12	Disease or Syndrome	0.44	1	2011	2018	   0	   1	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.41	1	1995	1997	   1	   1	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567741	Alport Syndrome	disease	C16;C13;C17;C12	Disease or Syndrome	0.70	0.977	1990	2020	  12	 307	CLINGEN;GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567742	Alport Syndrome, X-Linked	disease	C16;C13;C17;C12	Disease or Syndrome	0.60	0.96	1992	2020	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567743	Alport Syndrome, Autosomal Dominant	disease	C16;C13;C17;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1567744	Alport Syndrome, Autosomal Recessive	disease	C16;C13;C17;C12	Disease or Syndrome	0.31	1	2003	2005	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C1839884	Leiomyomatosis, esophageal and vulval, with nephropathy	disease	C16;C04;C13;C17;C12	Disease or Syndrome	0.32	1	1992	2013	   1	   0	ORPHANET
     1287	COL4A5	0.553	0.654	C4049702	Focal Segmental Glomerulosclerosis, Not Otherwise Specified	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C4521256	Glomerulopathy Assessment	phenotype		Diagnostic Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1287	COL4A5	0.553	0.654	C4746986	ALPORT SYNDROME 1, X-LINKED	disease		Disease or Syndrome	0.90	1	1991	2017	  24	 450	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1288	COL4A6	0.686	0.423	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1288	COL4A6	0.686	0.423	C0086533	Leiomyoma, Epithelioid	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C1839884	Leiomyomatosis, esophageal and vulval, with nephropathy	disease	C16;C04;C13;C17;C12	Disease or Syndrome	0.51	1	1998	2013	   2	   0	GENOMICS_ENGLAND;ORPHANET
     1288	COL4A6	0.686	0.423	C3806737	DEAFNESS, X-LINKED 6	disease		Disease or Syndrome	0.70	1	1998	2015	   3	   1	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1288	COL4A6	0.686	0.423	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1288	COL4A6	0.686	0.423	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C0220679	Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2005	2012	   2	   0	ORPHANET
     1289	COL5A1	0.536	0.769	C0268335	Ehlers-Danlos syndrome type 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.73	1	1996	2010	   3	   0	CTD_human;GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C0268336	Ehlers-Danlos syndrome type 2	disease	C16;C17;C15;C14	Disease or Syndrome	0.53	1	1995	1998	   2	   0	CTD_human;GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.30	1	1997	1997	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C4225429	Ehlers-Danlos syndrome classic type	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1289	COL5A1	0.536	0.769	C4552122	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1	disease		Disease or Syndrome	0.60	1	1993	2018	   7	  38	GENOMICS_ENGLAND;UNIPROT
     1289	COL5A1	0.536	0.769	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1289	COL5A1	0.536	0.769	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.40				   0	   1	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0220679	Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	2005	2012	   2	   0	ORPHANET
     1290	COL5A2	0.568	0.731	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C0268335	Ehlers-Danlos syndrome type 1	disease	C16;C17;C15;C14	Disease or Syndrome	0.50	1	1998	2015	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C0268336	Ehlers-Danlos syndrome type 2	disease	C16;C17;C15;C14	Disease or Syndrome	0.31	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C1458140	Bleeding tendency	phenotype	C15	Pathologic Function	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C1846545	Autoimmune Lymphoproliferative Syndrome Type 2B	disease	C16;C20;C15	Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C3151201	MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	disease		Disease or Syndrome	0.30	1	2017	2018	   2	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C4225429	Ehlers-Danlos syndrome classic type	disease	C16;C17;C15;C14	Disease or Syndrome	0.30	1	1998	1998	   1	   0	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C4538407	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2	disease		Disease or Syndrome	0.60	1	1993	2016	   4	  11	GENOMICS_ENGLAND;UNIPROT
     1290	COL5A2	0.568	0.731	C4552122	EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1	disease		Disease or Syndrome	0.40	1	1998	2018	   3	   3	GENOMICS_ENGLAND
     1290	COL5A2	0.568	0.731	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1290	COL5A2	0.568	0.731	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.40				   0	   2	GENOMICS_ENGLAND
     1291	COL6A1	0.587	0.731	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0026850	Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.48	1	2002	2019	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C0410179	Ullrich congenital muscular dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	0.80	0.96	2003	2018	   6	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1291	COL6A1	0.587	0.731	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	1.00	1	1993	2019	   7	  33	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1291	COL6A1	0.587	0.731	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1291	COL6A1	0.587	0.731	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	1995	2014	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1292	COL6A2	0.599	0.692	C0410179	Ullrich congenital muscular dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	0.80	1	2001	2017	   5	  12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1292	COL6A2	0.599	0.692	C1611706	Myosclerosis	disease	C16	Disease or Syndrome	0.31	1	2008	2008	   1	   0	ORPHANET
     1292	COL6A2	0.599	0.692	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	0.79	1	1993	2016	   5	  36	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1292	COL6A2	0.599	0.692	C1850671	Myosclerosis, Autosomal Recessive	disease	C05;C10	Disease or Syndrome	0.61	1	2001	2014	   1	   3	CTD_human;GENOMICS_ENGLAND
     1293	COL6A3	0.563	0.769	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.34	1	2016	2018	   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0393588	Dystonia, Paroxysmal	phenotype	C23;C10	Sign or Symptom	0.30				   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0393610	Dystonia, Diurnal	phenotype	C23;C10	Sign or Symptom	0.30				   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C0410179	Ullrich congenital muscular dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	1.00	1	2002	2018	   4	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1293	COL6A3	0.563	0.769	C0751093	Dystonia, Limb	phenotype	C23;C10	Sign or Symptom	0.40				   0	   0	CTD_human
     1293	COL6A3	0.563	0.769	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	0.80	1	1993	2018	   5	  37	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1293	COL6A3	0.563	0.769	C2930471	Bilateral Wilms Tumor	disease	C16;C04;C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     1293	COL6A3	0.563	0.769	C4225336	DYSTONIA 27	disease		Disease or Syndrome	0.72	1	2002	2018	   2	   7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1293	COL6A3	0.563	0.769	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.50	1	2008	2008	   1	   1	CTD_human;UNIPROT
     1294	COL7A1	0.545	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0079136	Cockayne-Touraine Disease	disease	C16;C17	Disease or Syndrome	0.40	0.957	1991	2017	   0	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0079294	Epidermolysis Bullosa Dystrophica	disease	C16;C17	Disease or Syndrome	0.90	1	1992	2019	   2	   9	CTD_human;GENOMICS_ENGLAND
     1294	COL7A1	0.545	0.808	C0079474	Hallopeau-Siemens Disease	disease	C16;C17	Disease or Syndrome	1.00	0.983	1993	2020	  16	  51	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2018	2018	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C0268371	Epidermolysis Bullosa With Congenital Localized Absence Of Skin And Deformity Of Nails	disease	C16;C17	Congenital Abnormality	0.60	1	2002	2013	   2	  10	CTD_human;GENOMICS_ENGLAND
     1294	COL7A1	0.545	0.808	C0432321	Epidermolysis bullosa, pretibial	disease	C16;C17	Congenital Abnormality	0.75	1	1995	2018	   3	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C0432322	Dominant dystrophic epidermolysis bullosa, albopapular type (disorder)	disease	C16;C17	Congenital Abnormality	0.78	1	1989	2017	  18	  24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C1275114	Epidermolysis Bullosa Pruriginosa	disease	C16;C17	Disease or Syndrome	0.80	0.933	1999	2018	   2	  10	CTD_human;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1294	COL7A1	0.545	0.808	C1843477	Epidermolysis Bullosa Simplex Superficialis	disease	C16;C17	Disease or Syndrome	0.30	1	2002	2002	   1	   0	ORPHANET
     1294	COL7A1	0.545	0.808	C1843761	TOENAIL DYSTROPHY, ISOLATED	disease	C23;C17	Disease or Syndrome	0.60	1	2002	2002	   1	  13	CTD_human;UNIPROT
     1294	COL7A1	0.545	0.808	C1851573	Transient bullous dermolysis of the newborn	disease	C16;C17	Disease or Syndrome	0.73	1	1997	2013	   3	  13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1294	COL7A1	0.545	0.808	C2673611	Epidermolysis Bullosa Dystrophica, Autosomal Recessive, Localisata Variant	disease	C16;C17	Disease or Syndrome	0.60	1	1999	2009	   0	   1	ORPHANET
     1294	COL7A1	0.545	0.808	C2673612	Epidermolysis Bullosa Dystrophica Inversa, Autosomal Recessive	disease	C16;C17	Disease or Syndrome	0.60	1	1999	2009	   0	   4	ORPHANET
     1294	COL7A1	0.545	0.808	C4511056	Centripetalis recessive dystrophic epidermolysis bullosa	disease	C16;C17	Disease or Syndrome	0.30				   0	   0	ORPHANET
     1294	COL7A1	0.545	0.808	C4518087	Acral dystrophic epidermolysis bullosa	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     1294	COL7A1	0.545	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     1295	COL8A1	0.678	0.538	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     1295	COL8A1	0.678	0.538	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     1296	COL8A2	0.67	0.423	C0016781	Fuchs Endothelial Dystrophy	disease	C16;C11	Disease or Syndrome	0.60	0.938	2004	2018	   1	   0	ORPHANET
     1296	COL8A2	0.67	0.423	C0339284	Polymorphous corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.34	1	2001	2019	   1	   0	ORPHANET
     1296	COL8A2	0.67	0.423	C1850959	Corneal dystrophy, Fuchs endothelial, 1	disease	C16;C11	Disease or Syndrome	0.72	1	2001	2019	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
3788	1296	COL8A2	0.67	0.423	C1852795	CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2	disease	C16;C11	Disease or Syndrome	0.7	1	2001	2001	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
3794	1297	COL9A1	0.566	0.731	C0026760	Multiple Epiphyseal Dysplasia	disease	C16;C05	Congenital Abnormality	0.7	1	2001	2019	3	0	CTD_human;GENOMICS_ENGLAND
3805	1297	COL9A1	0.566	0.731	C3279941	STICKLER SYNDROME, TYPE IV	disease		Disease or Syndrome	0.6	1	2001	2006	2	2	CTD_human;GENOMICS_ENGLAND
3815	1298	COL9A2	0.572	0.769	C0158252	Intervertebral disc disorder	group	C23;C05	Disease or Syndrome	0.55	1	1999	2016	3	1	GENOMICS_ENGLAND;UNIPROT
3820	1298	COL9A2	0.572	0.769	C3280342	STICKLER SYNDROME, TYPE V	disease		Disease or Syndrome	0.6	1	2002	2011	3	1	CTD_human;GENOMICS_ENGLAND
3827	1299	COL9A3	0.569	0.769	C0158252	Intervertebral disc disorder	group	C23;C05	Disease or Syndrome	0.55	0.8	2004	2018	0	0	CTD_human;GENOMICS_ENGLAND
3831	1299	COL9A3	0.569	0.769	C1832998	EPIPHYSEAL DYSPLASIA, MULTIPLE, 3	disease	C16;C05	Disease or Syndrome	0.7	1	1999	2014	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
3834	1300	COL10A1	0.619	0.5	C0265289	Metaphyseal chondrodysplasia Schmid type	disease	C16;C05	Disease or Syndrome	0.95	1	1994	2019	10	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3850	1301	COL11A1	0.495	0.846	C0158252	Intervertebral disc disorder	group	C23;C05	Disease or Syndrome	0.51	1	1996	2014	1	0	CTD_human;GENOMICS_ENGLAND
3852	1301	COL11A1	0.495	0.846	C0265235	Marshall syndrome	disease	C23;C16;C11;C05;C10;C09	Disease or Syndrome	0.73	1	1996	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
3853	1301	COL11A1	0.495	0.846	C0265282	Fibrochondrogenesis	disease	C23;C16;C05;C19	Congenital Abnormality	0.63	1	2010	2013	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
3858	1301	COL11A1	0.495	0.846	C1858084	STICKLER SYNDROME, TYPE II (disorder)	disease	C11;C17	Disease or Syndrome	0.98	1	1971	2020	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3859	1301	COL11A1	0.495	0.846	C2020284	Stickler syndrome, type 1	disease	C23;C11;C17;C05;C10;C09	Disease or Syndrome	0.6	1	1971	2017	0	0	GENOMICS_ENGLAND
3861	1301	COL11A1	0.495	0.846	C3278138	FIBROCHONDROGENESIS 1	disease		Disease or Syndrome	0.6	1	1996	2010	2	4	GENOMICS_ENGLAND;UNIPROT
3872	1302	COL11A2	0.435	0.846	C0265282	Fibrochondrogenesis	disease	C23;C16;C05;C19	Congenital Abnormality	0.51	1	2012	2012	1	0	CTD_human;ORPHANET
3877	1302	COL11A2	0.435	0.846	C1848488	Pierre Robin syndrome with fetal chondrodysplasia	disease	C16;C05;C07	Disease or Syndrome	0.82	1	1964	2015	17	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
3879	1302	COL11A2	0.435	0.846	C1861481	Stickler syndrome, type 3	disease	C17;C05	Disease or Syndrome	0.6	1	2004	2004	1	4	GENOMICS_ENGLAND;ORPHANET
3880	1302	COL11A2	0.435	0.846	C1864746	Deafness, Autosomal Recessive 53	disease	C23;C10;C09	Disease or Syndrome	0.71	1	1964	2015	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
3881	1302	COL11A2	0.435	0.846	C1866095	Deafness, Autosomal Dominant 13	disease	C23;C10;C09	Disease or Syndrome	0.93	1	1964	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
3884	1302	COL11A2	0.435	0.846	C4520892	Otospondylomegaepiphyseal dysplasia	disease	C16;C05;C19	Disease or Syndrome	1	1	1964	2015	18	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3888	1303	COL12A1	0.615	0.692	C1834674	BETHLEM MYOPATHY 1	disease	C16;C05;C10	Disease or Syndrome	0.61	1	2014	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
3890	1303	COL12A1	0.615	0.692	C4225313	BETHLEM MYOPATHY 2	disease		Disease or Syndrome	0.6	1	2014	2017	3	7	GENOMICS_ENGLAND;UNIPROT
3899	1305	COL13A1	0.608	0.654	C4225235	MYASTHENIC SYNDROME, CONGENITAL, 19	disease		Disease or Syndrome	0.6	1	2015	2017	1	3	GENOMICS_ENGLAND
3906	1308	COL17A1	0.545	0.769	C0268374	Adult junctional epidermolysis bullosa (disorder)	disease	C16;C17	Disease or Syndrome	0.7	1	1996	2014	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
3907	1308	COL17A1	0.545	0.769	C1852551	Epithelial Recurrent Erosion Dystrophy	disease	C16;C11	Disease or Syndrome	0.75	1	2003	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3917	1311	COMP	0.503	0.808	C0410538	Pseudoachondroplasia	disease	C16;C05	Congenital Abnormality	1	0.974	1995	2019	14	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
3919	1311	COMP	0.503	0.808	C1838280	Epiphyseal dysplasia, multiple, 1	disease	C16;C05	Disease or Syndrome	0.74	1	1995	2016	11	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
3927	1312	COMT	0.4	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.7	1	1997	2019	6	0	CTD_human;PSYGENET
3928	1312	COMT	0.4	0.923	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.51	0.5	2002	2006	3	0	CTD_human;PSYGENET
3934	1312	COMT	0.4	0.923	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.6	0.929	1996	2008	1	0	CTD_human;ORPHANET
3942	1312	COMT	0.4	0.923	C0030193	Pain	phenotype	C23	Sign or Symptom	0.6	0.958	2003	2020	1	0	CTD_human
3954	1312	COMT	0.4	0.923	C0220704	Shprintzen syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.6	0.9	1996	2012	1	0	CTD_human;ORPHANET
3973	1312	COMT	0.4	0.923	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.52	1	2008	2010	3	0	CTD_human;PSYGENET
4009	1314	COPA	0.7	0.385	C4225334	AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE	disease		Disease or Syndrome	0.71	1	2015	2017	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4013	1316	KLF6	0.501	0.846	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.66	1	2005	2019	0	0	CGI;CTD_human
4015	1316	KLF6	0.501	0.846	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.61	1	2005	2005	0	1	CGI;CTD_human
4047	1337	COX6A1	0.78	0.154	C4015029	CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D	disease		Disease or Syndrome	0.9	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
4048	1340	COX6B1	0.7	0.577	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.7	1	2008	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4050	1349	COX7B	0.595	0.654	C0796070	MICROPHTHALMIA, SYNDROMIC 7	disease	C16;C11;C17	Disease or Syndrome; Congenital Abnormality	0.52	1	2012	2015	1	0	CTD_human;ORPHANET
4051	1349	COX7B	0.595	0.654	C3550921	LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2	disease		Disease or Syndrome	0.6	1	1998	2016	3	3	CTD_human;GENOMICS_ENGLAND
4054	1351	COX8A	0.4	0.846	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.75	1	1997	2016	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
4055	1352	COX10	0.623	0.654	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.61	1	1990	2015	9	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
4056	1352	COX10	0.623	0.654	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.94	1	1999	2016	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4066	1355	COX15	0.638	0.538	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.74	1	2002	2016	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
4078	1355	COX15	0.638	0.538	C3554534	CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2	disease		Disease or Syndrome	0.6	1	2003	2016	4	0	GENOMICS_ENGLAND;UNIPROT
4089	1356	CP	0.466	0.846	C0012715	Iron Metabolism Disorders	group	C18	Disease or Syndrome	0.53	1	1998	2006	1	0	CTD_human
4140	1356	CP	0.466	0.846	C0878682	Ceruloplasmin deficiency	disease	C18;C10	Disease or Syndrome	0.9	1	1987	2019	6	51	CTD_human;GENOMICS_ENGLAND
4154	1357	CPA1	0.65	0.577	C0149521	Pancreatitis, Chronic	disease	C06	Disease or Syndrome	0.63	1	2013	2017	2	0	CTD_human;GENOMICS_ENGLAND
4155	1357	CPA1	0.65	0.577	C0238339	Hereditary pancreatitis	disease	C06	Disease or Syndrome	0.51	1	2013	2019	3	0	GENOMICS_ENGLAND;ORPHANET
4167	1363	CPE	0.584	0.692	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.73	0.923	1991	2013	2	0	CTD_human;GENOMICS_ENGLAND
4193	1371	CPOX	0.488	0.846	C0162531	Hereditary Coproporphyria	disease	C16;C06;C18;C17	Disease or Syndrome	1	0.938	1983	2019	12	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
4203	1373	CPS1	0.59	0.615	C0751753	Carbamoyl-Phosphate Synthase I Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	0.87	1	1986	2019	13	0	CLINGEN;CTD_human;ORPHANET
4208	1373	CPS1	0.59	0.615	C3714958	PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO	phenotype		Finding	0.6	NA	NA	NA	0	3	CTD_human;GENOMICS_ENGLAND
4209	1373	CPS1	0.59	0.615	C4082171	Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.71	1	1993	2018	19	112	CTD_human;GENOMICS_ENGLAND;UNIPROT
4217	1374	CPT1A	0.555	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.56	1	2005	2019	1	0	CTD_human
4224	1374	CPT1A	0.555	0.808	C1829703	Carnitine palmitoyl transferase 1A deficiency	disease	C16;C18	Disease or Syndrome	0.9	1	1981	2016	13	55	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
4246	1376	CPT2	0.542	0.769	C1833508	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET	disease	C16;C18;C05;C10	Disease or Syndrome	0.7	1	1992	2015	14	36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4247	1376	CPT2	0.542	0.769	C1833511	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	disease	C16;C06;C18	Disease or Syndrome	0.71	1	1992	2016	5	54	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4248	1376	CPT2	0.542	0.769	C1833518	CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL	disease	C16;C18	Disease or Syndrome	0.7	1	1998	2016	3	24	CTD_human;GENOMICS_ENGLAND;ORPHANET
4254	1380	CR2	0.556	0.654	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.6	1	2009	2019	1	0	CTD_human;ORPHANET
4257	1380	CR2	0.556	0.654	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.69	1	2006	2020	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
4277	1384	CRAT	0.656	0.577	C4693587	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8	disease		Disease or Syndrome	0.6	1	2018	2018	1	1	GENOMICS_ENGLAND;UNIPROT
4296	1385	CREB1	0.463	0.885	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2001	2009	4	0	CTD_human;PSYGENET
4310	1387	CREBBP	0.428	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.6	1	1996	2019	0	0	CGI
4314	1387	CREBBP	0.428	0.808	C0035934	Rubinstein-Taybi Syndrome	disease	C16;C05;C10	Disease or Syndrome	0.9	0.988	1997	2019	6	86	CLINGEN;CTD_human
4333	1387	CREBBP	0.428	0.808	C4551859	RUBINSTEIN-TAYBI SYNDROME 1	disease	C16;C05;C10	Disease or Syndrome	0.7	1	1997	2016	12	37	CLINGEN;GENOMICS_ENGLAND;UNIPROT
4378	1393	CRHBP	0.659	0.5	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.52	1	1996	2010	2	0	PSYGENET
4392	1394	CRHR1	0.517	0.769	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	1	2004	2019	5	0	PSYGENET
4416	1394	CRHR1	0.517	0.769	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2006	2019	5	0	CTD_human;PSYGENET
4424	1395	CRHR2	0.584	0.731	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.54	1	1999	2019	1	0	CTD_human
4428	1395	CRHR2	0.584	0.731	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.52	1	2003	2019	4	0	PSYGENET
4441	1399	CRKL	0.553	0.769	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.52	1	2001	2019	1	0	CTD_human
4449	1401	CRP	0.299	0.962	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.6	0.955	1989	2020	1	0	CTD_human
4461	1401	CRP	0.299	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.944	2003	2020	4	0	CTD_human
4463	1401	CRP	0.299	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.6	1	2001	2011	3	0	CTD_human
4475	1401	CRP	0.299	0.962	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.6	0.98	2001	2020	1	0	CTD_human
4490	1401	CRP	0.299	0.962	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.6	0.938	2000	2019	1	0	CTD_human
4531	1406	CRX	0.565	0.692	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.8	1	1997	2018	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
4532	1406	CRX	0.565	0.692	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.8	0.955	1998	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
4533	1406	CRX	0.565	0.692	C3151192	LEBER CONGENITAL AMAUROSIS 7	disease		Disease or Syndrome	0.9	1	1998	2014	5	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
4534	1406	CRX	0.565	0.692	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.8	1	1997	2019	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4556	1409	CRYAA	0.653	0.385	C0009691	Congenital cataract	disease	C23;C16;C13;C11;C10	Congenital Abnormality	0.7	1	1996	2018	0	4	GENOMICS_ENGLAND
4560	1409	CRYAA	0.653	0.385	C0392557	Nuclear cataract	disease	C11	Disease or Syndrome	0.52	1	2007	2014	3	0	GENOMICS_ENGLAND;ORPHANET
4565	1409	CRYAA	0.653	0.385	C1858679	CATARACT, AUTOSOMAL DOMINANT	disease	C11	Disease or Syndrome	0.9	1	1996	2013	8	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
4597	1410	CRYAB	0.515	0.731	C1837317	Alpha-B Crystallinopathy	disease	C11;C05;C10;C14	Disease or Syndrome	0.9	1	1998	2012	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4600	1410	CRYAB	0.515	0.731	C3151236	MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED	disease		Disease or Syndrome	0.7	1	2011	2011	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
4601	1410	CRYAB	0.515	0.731	C3554649	CARDIOMYOPATHY, DILATED, 1II	disease		Disease or Syndrome	0.7	1	2006	2017	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
4602	1410	CRYAB	0.515	0.731	C3808377	CATARACT 16, MULTIPLE TYPES	disease		Disease or Syndrome	0.8	1	2001	2013	2	4	CTD_human;GENOMICS_ENGLAND
4606	1411	CRYBA1	0.716	0.269	C1833229	Cataract, Congenital Zonular, with Sutural Opacities	disease	C11	Disease or Syndrome	0.8	1	1998	2015	2	4	CTD_human;GENOMICS_ENGLAND
4613	1413	CRYBA4	0.716	0.269	C3808012	CATARACT 23, MULTIPLE TYPES	disease		Disease or Syndrome	0.7	1	2006	2010	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
4624	1414	CRYBB1	0.686	0.231	C3888124	CATARACT 17, MULTIPLE TYPES	disease		Disease or Syndrome	0.6	1	2002	2017	4	3	GENOMICS_ENGLAND;UNIPROT
4628	1415	CRYBB2	0.623	0.462	C0344523	Cataract, congenital, cerulean type 1	disease	C11	Congenital Abnormality	0.63	1	1997	2019	2	0	CTD_human;ORPHANET
4631	1415	CRYBB2	0.623	0.462	C1832175	Cataract, Congenital, Cerulean Type, 2	disease	C11	Disease or Syndrome	0.8	1	1980	2017	2	5	CTD_human;GENOMICS_ENGLAND
4633	1415	CRYBB2	0.623	0.462	C1852438	CATARACT, COPPOCK-LIKE	disease	C11	Disease or Syndrome	0.61	1	2000	2000	1	0	GENOMICS_ENGLAND;ORPHANET
4641	1417	CRYBB3	0.769	0.269	C1857853	Cataract, Congenital Nuclear, Autosomal Recessive 2	disease	C16;C11	Disease or Syndrome	0.7	1	2005	2013	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
4644	1419	CRYGB	0.78	0.269	C3808800	CATARACT 39, MULTIPLE TYPES	disease		Disease or Syndrome	0.8	1	1984	2012	1	2	CTD_human;GENOMICS_ENGLAND
4651	1420	CRYGC	0.612	0.577	C1852438	CATARACT, COPPOCK-LIKE	disease	C11	Disease or Syndrome	0.82	1	1999	2017	2	1	CTD_human;ORPHANET
4654	1420	CRYGC	0.612	0.577	C4721890	CATARACT 2, MULTIPLE TYPES	disease		Disease or Syndrome	0.8	1	1999	2014	8	6	GENOMICS_ENGLAND;UNIPROT
4656	1421	CRYGD	0.51	0.808	C0086543	Cataract	disease	C11	Acquired Abnormality	0.7	0.96	1999	2019	2	0	CTD_human;GENOMICS_ENGLAND
4667	1421	CRYGD	0.51	0.808	C3540850	CATARACT 4, MULTIPLE TYPES	disease		Disease or Syndrome	0.9	1	1999	2011	11	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
4672	1427	CRYGS	0.743	0.192	C3805410	CATARACT 20, MULTIPLE TYPES	disease		Disease or Syndrome	0.9	1	1983	2005	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
4674	1428	CRYM	0.769	0.346	C4084708	DEAFNESS, AUTOSOMAL DOMINANT 40	disease		Disease or Syndrome	0.7	1	1997	2016	7	2	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
4722	1436	CSF1R	0.448	0.808	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.6	1	1992	2020	1	0	CGI;CTD_human
4739	1436	CSF1R	0.448	0.808	C3711381	Hereditary Diffuse Leukoencephalopathy with Spheroids	disease	C10	Disease or Syndrome	0.8	1	1989	2020	3	44	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4777	1437	CSF2	0.33	0.962	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.51	1	1998	2007	1	0	CTD_human
4845	1438	CSF2RA	0.67	0.615	C0034050	Pulmonary Alveolar Proteinosis	disease	C08	Disease or Syndrome	0.7	1	2008	2019	3	0	CTD_human;GENOMICS_ENGLAND
4847	1438	CSF2RA	0.67	0.615	C2677877	Surfactant Metabolism Dysfunction, Pulmonary, 4	disease	C16;C08	Disease or Syndrome	0.7	1	2008	2014	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
4848	1438	CSF2RA	0.67	0.615	C2931035	Pulmonary alveolar proteinosis, congenital	disease	C08	Disease or Syndrome	0.51	1	2008	2013	2	0	GENOMICS_ENGLAND;ORPHANET
4850	1439	CSF2RB	0.705	0.423	C0034050	Pulmonary Alveolar Proteinosis	disease	C08	Disease or Syndrome	0.64	1	1995	2019	2	0	GENOMICS_ENGLAND
4855	1439	CSF2RB	0.705	0.423	C3280574	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5	disease		Disease or Syndrome	0.6	1	2004	2011	2	1	CTD_human;GENOMICS_ENGLAND
5027	1441	CSF3R	0.55	0.692	C0023481	Chronic Neutrophilic Leukemia	disease	C15	Neoplastic Process	0.6	0.935	2013	2020	1	0	CGI;ORPHANET
5032	1441	CSF3R	0.55	0.692	C0543669	Neutrophilia, Hereditary	disease	C15	Disease or Syndrome	0.83	1	1998	2014	1	1	ORPHANET;UNIPROT
5033	1441	CSF3R	0.55	0.692	C1292772	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	disease	C04;C15	Neoplastic Process	0.59	1	2013	2020	1	0	CGI;ORPHANET
5035	1441	CSF3R	0.55	0.692	C4310764	NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2009	2015	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5065	1453	CSNK1D	0.65	0.615	C1858496	Advanced Sleep-Phase Syndrome, Familial	disease	C10;F03;C24	Disease or Syndrome	0.51	1	2005	2005	1	0	CTD_human;ORPHANET
5066	1453	CSNK1D	0.65	0.615	C3808874	ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2	disease		Disease or Syndrome	0.6	1	2005	2015	3	2	GENOMICS_ENGLAND;UNIPROT
5075	1457	CSNK2A1	0.597	0.731	C4310739	OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME	disease		Disease or Syndrome	0.72	1	2016	2020	1	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
5089	1462	VCAN	0.497	0.808	C1840452	Hyaloideoretinal degeneration of Wagner	disease	C11	Disease or Syndrome	0.7	0.938	1999	2018	0	0	CTD_human;GENOMICS_ENGLAND
5091	1463	NCAN	0.67	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.68	1	2011	2019	6	2	CTD_human;PSYGENET
5132	1471	CST3	0.436	0.808	C1527338	Hereditary Cerebral Amyloid Angiopathy, Icelandic Type	disease	C16;C18;C10;C14	Disease or Syndrome	0.77	1	1987	2013	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5141	1471	CST3	0.436	0.808	C2677774	Age-Related Macular Degeneration type 11	disease	C11	Disease or Syndrome	0.6	1	1989	2009	3	1	CTD_human;UNIPROT
5185	1476	CSTB	0.53	0.692	C0751785	Unverricht-Lundborg Syndrome	disease	C16;C10	Disease or Syndrome	1	0.984	1994	2019	7	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5204	1482	NKX2-5	0.533	0.692	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.96	0.909	1999	2018	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5207	1482	NKX2-5	0.533	0.692	C0152101	Hypoplastic Left Heart Syndrome	disease	C16;C14	Disease or Syndrome	0.81	1	2003	2017	3	0	CTD_human;ORPHANET
5220	1482	NKX2-5	0.533	0.692	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	disease	C16;C14	Disease or Syndrome	0.6	1	2003	2012	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
5223	1482	NKX2-5	0.533	0.692	C2673630	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5 (disorder)	disease	C16;C05;C19	Disease or Syndrome	0.6	1	2006	2006	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
5226	1482	NKX2-5	0.533	0.692	C3276096	ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS	disease		Disease or Syndrome	0.8	1	1998	2017	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
5230	1482	NKX2-5	0.533	0.692	C3502353	Atrial Septal Defect with Atrioventricular Conduction Defects	disease	C23;C16;C14	Disease or Syndrome	0.7	1	2008	2017	2	0	GENOMICS_ENGLAND;ORPHANET
5237	1487	CTBP1	0.559	0.692	C4693578	HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME	disease		Disease or Syndrome	0.6	1	2016	2019	3	0	GENOMICS_ENGLAND;UNIPROT
5268	1490	CCN2	0.399	0.846	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.7	0.963	2001	2019	4	0	CTD_human
5296	1491	CTH	0.578	0.615	C0220993	Cystathioninuria	phenotype	C16;C18	Disease or Syndrome	0.94	1	1986	2019	8	3	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5297	1491	CTH	0.578	0.615	C0268616	Gamma-cystathionase deficiency	disease	C16;C18	Disease or Syndrome	0.94	1	1986	2019	6	0	CLINGEN;CTD_human;ORPHANET
5310	1493	CTLA4	0.369	0.923	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	0.829	1998	2020	1	0	CTD_human;ORPHANET
5331	1493	CTLA4	0.369	0.923	C4015214	CTLA4 Haploinsufficiency	disease	C20	Disease or Syndrome	0.75	1	2014	2019	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5345	1495	CTNNA1	0.584	0.538	C1837029	Macular Dystrophy, Butterfly-Shaped Pigmentary, 2	disease	C11	Disease or Syndrome	0.8	1	2016	2016	1	4	CTD_human;UNIPROT
5364	1497	CTNS	0.628	0.538	C0268626	Juvenile nephropathic cystinosis (disorder)	disease	C16;C18;C13;C12	Disease or Syndrome; Congenital Abnormality	0.71	1	1998	2017	6	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
5366	1497	CTNS	0.628	0.538	C2931013	Cystinosis, benign, nonnephropathic	disease	C16;C18	Disease or Syndrome	0.7	1	1998	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
5367	1497	CTNS	0.628	0.538	C2931187	Nephropathic cystinosis	disease	C16;C18	Disease or Syndrome	1	0.98	1998	2019	14	54	CTD_human;GENOMICS_ENGLAND;UNIPROT
5383	1499	CTNNB1	0.303	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.7	0.983	1997	2020	5	3	CTD_human;UNIPROT
5384	1499	CTNNB1	0.303	0.885	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.7	0.985	1997	2019	4	6	CTD_human
5385	1499	CTNNB1	0.303	0.885	C0010276	Craniopharyngioma	disease	C04	Neoplastic Process	0.7	1	2004	2019	1	3	CTD_human;ORPHANET
5397	1499	CTNNB1	0.303	0.885	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.8	0.979	1998	2020	2	9	CGI;CTD_human;UNIPROT
5407	1499	CTNNB1	0.303	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.6	1	2002	2020	2	0	CTD_human
5411	1499	CTNNB1	0.303	0.885	C0079218	Fibromatosis, Aggressive	disease	C04	Neoplastic Process	0.7	0.974	1996	2019	0	0	CGI;ORPHANET
5431	1499	CTNNB1	0.303	0.885	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.7	0.981	1999	2019	1	3	CGI;CTD_human
5435	1499	CTNNB1	0.303	0.885	C0206711	Pilomatrixoma	disease	C04	Neoplastic Process	0.8	1	1999	2019	3	8	CTD_human;ORPHANET;UNIPROT
5459	1499	CTNNB1	0.303	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.6	0.979	1998	2020	2	0	CTD_human
5474	1499	CTNNB1	0.303	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.9	1	1999	2019	1	4	CGI;CTD_human
5475	1499	CTNNB1	0.303	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.9	1	1998	2019	2	2	CGI;CTD_human;UNIPROT
5487	1499	CTNNB1	0.303	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.8	0.982	1998	2020	5	16	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
5490	1499	CTNNB1	0.303	0.885	C3554449	MENTAL RETARDATION, AUTOSOMAL DOMINANT 19	disease		Disease or Syndrome	0.7	1	1989	2017	6	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5497	1499	CTNNB1	0.303	0.885	C4539767	EXUDATIVE VITREORETINOPATHY 7	disease		Disease or Syndrome	0.6	1	2017	2017	2	3	GENOMICS_ENGLAND;UNIPROT
5513	1503	CTPS1	0.736	0.269	C4014617	IMMUNODEFICIENCY 24	disease		Disease or Syndrome	0.7	1	1998	2016	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
5531	1508	CTSB	0.457	0.846	C0406756	Keratolytic winter erythema	disease	C23;C16;C17	Disease or Syndrome; Congenital Abnormality	0.52	1	2012	2017	1	0	CTD_human;ORPHANET
5554	1509	CTSD	0.478	0.846	C1864669	NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.93	1	1995	2018	4	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5580	1513	CTSK	0.497	0.808	C0238402	Pycnodysostosis	disease	C16;C18;C05	Disease or Syndrome	0.8	0.979	1996	2019	11	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5651	1528	CYB5A	0.601	0.654	C4285231	METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA	disease		Disease or Syndrome	0.6	1	1994	2012	3	3	GENOMICS_ENGLAND;UNIPROT
5660	1535	CYBA	0.52	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.964	2002	2017	3	0	CTD_human
5661	1535	CYBA	0.52	0.769	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.55	1	2005	2016	1	0	CTD_human
5670	1535	CYBA	0.52	0.769	C1856255	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Negative	disease	C16;C20;C15	Disease or Syndrome	0.7	1	1990	2016	11	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
5675	1536	CYBB	0.452	0.885	C0018203	Chronic granulomatous disease	group	C16;C20;C15	Disease or Syndrome	0.9	0.986	1987	2020	2	2	CTD_human;GENOMICS_ENGLAND
5678	1536	CYBB	0.452	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.812	2003	2020	4	0	CTD_human
5680	1536	CYBB	0.452	0.885	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.51	1	2005	2017	1	0	CTD_human
5694	1536	CYBB	0.452	0.885	C1844376	Granulomatous Disease, Chronic, X-Linked	disease	C16;C20;C15	Disease or Syndrome	0.8	0.991	1976	2020	25	71	CTD_human;GENOMICS_ENGLAND;UNIPROT
5698	1536	CYBB	0.452	0.885	C1970859	Atypical Mycobacteriosis, Familial, X-Linked 2	disease	C16;C01	Disease or Syndrome	0.7	1	2007	2011	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5701	1537	CYC1	0.656	0.462	C3809553	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6	disease		Disease or Syndrome	0.6	1	2013	2013	1	2	GENOMICS_ENGLAND;UNIPROT
5709	1540	CYLD	0.498	0.846	C1275122	Familial multiple trichoepitheliomata	disease	C16;C04;C17	Neoplastic Process	0.8	1	2003	2019	5	2	CTD_human;ORPHANET;UNIPROT
5712	1540	CYLD	0.498	0.846	C1857941	Brooke-Spiegler syndrome	disease	C16;C04;C17	Disease or Syndrome	0.8	0.938	2000	2019	13	7	CLINGEN;CTD_human;UNIPROT
5855	1545	CYP1B1	0.457	0.769	C1856439	GLAUCOMA 3, PRIMARY CONGENITAL, A	disease	C11	Disease or Syndrome; Congenital Abnormality	0.7	1	1997	2016	22	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
6021	1571	CYP2E1	0.459	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.6	1	1995	2018	6	0	CTD_human;PSYGENET
6025	1571	CYP2E1	0.459	0.885	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.55	1	2003	2018	1	0	CTD_human
6026	1571	CYP2E1	0.459	0.885	C0015696	Fatty Liver, Alcoholic	disease	C06;C25	Disease or Syndrome	0.52	1	2009	2018	1	0	CTD_human
6043	1571	CYP2E1	0.459	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.58	1	1998	2019	1	0	CTD_human
6053	1571	CYP2E1	0.459	0.885	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.74	1	1992	2013	6	0	CTD_human;PSYGENET
6111	1581	CYP7A1	0.576	0.615	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.65	1	1998	2018	2	0	CTD_human
6112	1581	CYP7A1	0.576	0.615	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.7	1	1993	2020	1	0	CTD_human
6148	1583	CYP11A1	0.547	0.731	C3151055	ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL OR COMPLETE	disease		Disease or Syndrome	0.72	1	2001	2017	7	8	GENOMICS_ENGLAND;ORPHANET;UNIPROT
6160	1584	CYP11B1	0.563	0.615	C0268292	Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.8	1	1991	2019	13	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6161	1584	CYP11B1	0.563	0.615	C1260386	Glucocorticoid-remediable aldosteronism	disease	C19	Disease or Syndrome	0.8	1	1992	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
6167	1585	CYP11B2	0.553	0.615	C0268293	Corticosterone Methyl Oxidase Type I Deficiency	disease	C19	Disease or Syndrome	0.71	1	1997	2014	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
6172	1585	CYP11B2	0.553	0.615	C3463917	Corticosterone Methyl Oxidase Type II Deficiency	disease		Disease or Syndrome	0.61	1	1992	2014	6	0	GENOMICS_ENGLAND;UNIPROT
6174	1586	CYP17A1	0.462	0.769	C0001627	Congenital adrenal hyperplasia	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.7	1	1989	2019	1	0	CTD_human;GENOMICS_ENGLAND
6201	1586	CYP17A1	0.462	0.769	C0268285	Adrenal hyperplasia, congenital, type 5	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.8	0.978	1988	2018	19	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6230	1588	CYP19A1	0.41	0.885	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.6	0.956	1996	2020	2	0	CTD_human
6241	1588	CYP19A1	0.41	0.885	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.6	0.915	1993	2020	4	0	CTD_human
6270	1588	CYP19A1	0.41	0.885	C1960539	Aromatase deficiency	disease	C16;C18;C13;C17;C12;C19	Disease or Syndrome	0.8	1	1993	2019	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6271	1588	CYP19A1	0.41	0.885	C1970109	AROMATASE EXCESS SYNDROME	disease	C16;C18;C13;C17;C12;C19	Disease or Syndrome	0.8	1	1998	2019	3	0	GENOMICS_ENGLAND;ORPHANET
6278	1589	CYP21A2	0.525	0.769	C2936858	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency	disease	C16;C18;C13;C12;C19	Congenital Abnormality	0.8	0.976	1980	2020	54	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
6293	1591	CYP24A1	0.518	0.692	C0475732	Hypercalcemia, Infantile	phenotype	C18	Finding	0.6	NA	NA	NA	0	0	CTD_human;GENOMICS_ENGLAND
6300	1591	CYP24A1	0.518	0.692	C4310232	Hypercalcemia, Infantile, 1	disease	C18	Disease or Syndrome	0.7	1	2011	2018	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6330	1593	CYP27A1	0.538	0.731	C0238052	Xanthomatosis, Cerebrotendinous	disease	C16;C18	Disease or Syndrome	0.8	0.985	1975	2019	18	69	CTD_human;GENOMICS_ENGLAND;UNIPROT
6336	1594	CYP27B1	0.502	0.769	C0035579	Rickets	disease	C18;C05	Disease or Syndrome	0.7	1	1998	2018	1	0	CTD_human
6339	1594	CYP27B1	0.502	0.769	C0268689	Vitamin D-dependent rickets, type 1	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.8	1	1997	2020	6	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6342	1600	DAB1	0.626	0.615	C3889636	SPINOCEREBELLAR ATAXIA 37	disease	C16;C10	Disease or Syndrome	0.53	1	2017	2019	2	0	GENOMICS_ENGLAND;ORPHANET
6345	1604	CD55	0.51	0.808	C0033680	Protein-Losing Enteropathies	group	C06	Disease or Syndrome	0.54	1	2017	2019	1	0	CTD_human;GENOMICS_ENGLAND
6356	1605	DAG1	0.498	0.808	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.7	0.955	1998	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
6364	1605	DAG1	0.498	0.808	C3151184	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9	disease		Disease or Syndrome	0.91	1	2003	2019	6	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6365	1605	DAG1	0.498	0.808	C4225291	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9	disease		Disease or Syndrome	0.6	1	2012	2015	4	4	GENOMICS_ENGLAND;UNIPROT
6376	1609	DGKQ	0.736	0.423	C1527336	Sjogrens Syndrome	disease	C11;C17;C05;C20;C07	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1610	DAO	0.636	0.615	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.67	1	2010	2018	   2	   0	GENOMICS_ENGLAND;ORPHANET
     1610	DAO	0.636	0.615	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     1610	DAO	0.636	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	0.8	2004	2012	   5	   0	PSYGENET
     1610	DAO	0.636	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     1610	DAO	0.636	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.92	2002	2019	   1	   0	CTD_human
     1610	DAO	0.636	0.615	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.31	1	2007	2007	   1	   0	PSYGENET
     1610	DAO	0.636	0.615	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     1610	DAO	0.636	0.615	C0853193	Bipolar I disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	PSYGENET
     1610	DAO	0.636	0.615	C1839839	MAJOR AFFECTIVE DISORDER 2	disease	C16;F03	Mental or Behavioral Dysfunction	0.33	1	2004	2008	   1	   0	PSYGENET
     1611	DAP	0.53	0.808	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.40	1	2011	2016	   1	   3	CTD_human
     1612	DAPK1	0.472	0.808	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.34	0.8	2004	2018	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.39	0.9	2001	2018	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.34	1	2003	2015	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.34	1	2006	2011	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0009759	Conjunctival Diseases	group	C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.31	1	2005	2006	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.35	1	2002	2014	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.33	1	2004	2012	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.917	2006	2019	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0035242	Respiratory Tract Diseases	group	C08	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.31	1	2006	2006	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0085183	Neoplasms, Second Primary	phenotype	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0086696	Neoplasms, Therapy-Associated	phenotype	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0153633	Malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.36	1	2004	2015	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.36	1	2003	2019	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0496899	Benign neoplasm of brain, unspecified	disease	C04;C10	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0750974	Brain Tumor, Primary	disease	C04;C10	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0750977	Recurrent Brain Neoplasm	disease	C04;C10	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0750979	Primary malignant neoplasm of brain	disease	C04;C10	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C0877578	Treatment related secondary malignancy	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C1527390	Neoplasms, Intracranial	group	C04;C10	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.35	1	2010	2015	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     1612	DAPK1	0.472	0.808	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     1613	DAPK3	0.612	0.654	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1613	DAPK3	0.612	0.654	C1335167	Ovarian Mucinous Adenocarcinoma	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     1615	DARS1	0.711	0.5	C1271100	Lower limb spasticity	phenotype	C23;C05;C10	Finding	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     1615	DARS1	0.711	0.5	C3809008	HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG SPASTICITY	disease		Disease or Syndrome	0.73	1	2013	2018	   3	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     1616	DAXX	0.544	0.692	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.33	1	2015	2018	   0	   0	CGI
     1616	DAXX	0.544	0.692	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.31	1	2011	2014	   1	   0	CTD_human
     1616	DAXX	0.544	0.692	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     1616	DAXX	0.544	0.692	C0206754	Neuroendocrine Tumors	group	C04	Neoplastic Process	0.38	1	2011	2019	   1	   0	CTD_human
     1616	DAXX	0.544	0.692	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.31	1	2011	2015	   1	   0	CTD_human
     1616	DAXX	0.544	0.692	C1328479	Pancreatic Endocrine Carcinoma	disease	C06;C04;C19	Neoplastic Process	0.30				   0	   0	CGI
     1617	DAZ1	0.705	0.385	C1507149	Partial chromosome Y deletion	phenotype	C23;C16;C13;C12;C19	Cell or Molecular Dysfunction	0.30	1	2002	2010	   2	   0	ORPHANET
     1617	DAZ1	0.705	0.385	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	disease	C16;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     1617	DAZ1	0.705	0.385	C2931163	Male sterility due to Y-chromosome deletions	phenotype	C23;C16;C13;C12;C19	Disease or Syndrome	0.30	1	2002	2010	   2	   0	ORPHANET
     1618	DAZL	0.78	0.154	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     1620	BRINP1	0.615	0.615	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.33	1	2014	2018	   0	   0	UNIPROT
     1621	DBH	0.511	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	1	1981	2014	   5	   0	PSYGENET
     1621	DBH	0.511	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1994	2013	   5	   0	PSYGENET
     1621	DBH	0.511	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.53	1	1993	2013	   5	   0	PSYGENET
     1621	DBH	0.511	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	1993	2013	   5	   0	PSYGENET
     1621	DBH	0.511	0.846	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.37	1	1989	2015	   1	   0	CTD_human
     1621	DBH	0.511	0.846	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.34	1	1978	2015	   1	   0	CTD_human
     1621	DBH	0.511	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2002	2015	   3	   0	PSYGENET
     1621	DBH	0.511	0.846	C0342687	dopamine beta hydroxylase deficiency	disease	C10	Disease or Syndrome	0.71	1	1995	2011	   0	   0	CTD_human;GENOMICS_ENGLAND
     1621	DBH	0.511	0.846	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.34	1	1982	2009	   4	   0	PSYGENET
     1621	DBH	0.511	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.39	1	2009	2019	   5	   0	PSYGENET
     1621	DBH	0.511	0.846	C1257877	Pheochromocytoma, Extra-Adrenal	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1621	DBH	0.511	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2002	2015	   3	   0	PSYGENET
     1621	DBH	0.511	0.846	C1306067	Drug-induced paranoid state	disease		Mental or Behavioral Dysfunction	0.30	1	2000	2014	   3	   0	PSYGENET
     1621	DBH	0.511	0.846	C1456784	Paranoia	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2000	2014	   3	   0	CTD_human
     1621	DBH	0.511	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     1621	DBH	0.511	0.846	C4746777	ORTHOSTATIC HYPOTENSION 1	disease		Disease or Syndrome	0.60	1	2002	2017	   4	   7	GENOMICS_ENGLAND;UNIPROT
     1622	DBI	0.65	0.654	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1622	DBI	0.65	0.654	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1622	DBI	0.65	0.654	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     1622	DBI	0.65	0.654	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1622	DBI	0.65	0.654	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1622	DBI	0.65	0.654	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1622	DBI	0.65	0.654	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1622	DBI	0.65	0.654	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     1627	DBN1	0.633	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     1627	DBN1	0.633	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     1627	DBN1	0.633	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2013	   3	   0	PSYGENET
     1628	DBP	0.556	0.731	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     1629	DBT	0.638	0.462	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     1629	DBT	0.638	0.462	C0024776	Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1991	2020	  13	  25	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     1629	DBT	0.638	0.462	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1629	DBT	0.638	0.462	C0268568	Classic Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1629	DBT	0.638	0.462	C0268569	Intermittent Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1629	DBT	0.638	0.462	C0751285	Maple Syrup Urine Disease, Thiamine Responsive	disease	C16;C18;C10	Disease or Syndrome	0.31	1	1991	1991	   0	   0	CTD_human
     1629	DBT	0.638	0.462	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1629	DBT	0.638	0.462	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1629	DBT	0.638	0.462	C1621920	Intermediate Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     1629	DBT	0.638	0.462	C1855371	MAPLE SYRUP URINE DISEASE, TYPE II	disease	C16;C18;C10	Disease or Syndrome	0.40	1	2016	2016	   1	   3	GENOMICS_ENGLAND
     1629	DBT	0.638	0.462	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1629	DBT	0.638	0.462	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     1629	DBT	0.638	0.462	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1629	DBT	0.638	0.462	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.70	0.946	1990	2019	   1	   0	CTD_human;UNIPROT
     1630	DCC	0.471	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.38	1	1992	2007	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.51	1	1992	1992	   0	   0	CGI;CTD_human
     1630	DCC	0.471	0.808	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2012	2019	   1	   2	PSYGENET
     1630	DCC	0.471	0.808	C0152018	Esophageal carcinoma	disease	C06;C04	Neoplastic Process	0.50				   0	   1	CGI;UNIPROT
     1630	DCC	0.471	0.808	C0153942	Benign neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1630	DCC	0.471	0.808	C0154059	Carcinoma in situ of esophagus	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     1630	DCC	0.471	0.808	C0162809	Kallmann Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.30	1	2018	2018	   1	   0	ORPHANET
     1630	DCC	0.471	0.808	C0175754	Agenesis of corpus callosum	disease	C23;C16;C10	Congenital Abnormality	0.43	1	2017	2020	   1	   9	CTD_human
     1630	DCC	0.471	0.808	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.50				   0	   0	CGI;CTD_human
     1630	DCC	0.471	0.808	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.31	1	2003	2003	   0	   0	CGI
     1630	DCC	0.471	0.808	C1834870	MIRROR MOVEMENTS 1	phenotype		Finding	0.70	1	2010	2017	   2	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     1630	DCC	0.471	0.808	C1846496	Gaze Palsy, Familial Horizontal, with Progressive Scoliosis	disease	C05	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
     1630	DCC	0.471	0.808	C3179058	Corpus Callosum Malformation	disease	C23;C16;C10	Congenital Abnormality	0.30	1	2017	2017	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2017	2017	   1	   0	CTD_human
     1630	DCC	0.471	0.808	C4479640	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 2	disease		Disease or Syndrome	0.50	1	2017	2017	   1	   1	GENOMICS_ENGLAND;UNIPROT
     1630	DCC	0.471	0.808	C4551964	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1	disease	C23;C18;C11;C05;C10	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C0014170	Endometrial Neoplasms	group	C04;C13	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.50	1	2005	2005	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C0027707	Nephritis, Interstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C0041349	Nephritis, Tubulointerstitial	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C0238288	Muscular Dystrophy, Facioscapulohumeral	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.32	1	2000	2011	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.31	1	2001	2005	   1	   0	CTD_human
     1634	DCN	0.457	0.808	C1864738	Corneal Dystrophy, Congenital Stromal	disease	C16;C11	Disease or Syndrome	0.95	1	2005	2015	   2	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET
     1634	DCN	0.457	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2002	2018	   1	   0	CTD_human
     1636	ACE	0.328	0.923	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     1636	ACE	0.328	0.923	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.51	1	2006	2013	   1	   0	CTD_human
     1636	ACE	0.328	0.923	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2005	2013	   3	   0	PSYGENET
     1636	ACE	0.328	0.923	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2012	2012	   1	   0	CTD_human
     1636	ACE	0.328	0.923	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.9	0.915	1998	2020	5	1	CTD_human;GENOMICS_ENGLAND
6381	1636	ACE	0.328	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.57	0.5	2000	2019	4	0	PSYGENET
6392	1636	ACE	0.328	0.923	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.6	0.914	1994	2019	4	0	CTD_human
6398	1636	ACE	0.328	0.923	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.981	1992	2020	1	0	CTD_human
6399	1636	ACE	0.328	0.923	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.984	1992	2020	1	0	CTD_human
6400	1636	ACE	0.328	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.921	1986	2020	3	0	CTD_human
6406	1636	ACE	0.328	0.923	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.6	0.878	1995	2020	2	0	CTD_human
6408	1636	ACE	0.328	0.923	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.56	0.889	1997	2019	1	0	CTD_human
6412	1636	ACE	0.328	0.923	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.6	0.921	1992	2020	2	0	CTD_human
6425	1636	ACE	0.328	0.923	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.6	0.844	1994	2020	1	0	CTD_human
6429	1636	ACE	0.328	0.923	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.6	0.867	1993	2019	1	0	CTD_human
6439	1636	ACE	0.328	0.923	C0266313	Allanson Pantzar McLeod syndrome	disease	C16;C13;C12	Disease or Syndrome	0.76	1	2005	2019	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
6464	1723	DHODH	0.576	0.769	C0265257	Genee-Wiedemann syndrome	disease	C16;C11;C05;C07	Disease or Syndrome	0.75	1	2010	2016	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6474	1727	CYB5R3	0.638	0.654	C0025637	Methemoglobinemia	disease	C15	Disease or Syndrome	0.7	1	1979	2008	2	0	CTD_human;GENOMICS_ENGLAND
6475	1727	CYB5R3	0.638	0.654	C0268193	NADH cytochrome B5 reductase deficiency	disease	C15	Disease or Syndrome	0.71	1	1991	2018	12	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
6483	1728	NQO1	0.434	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.6	0.947	1996	2017	1	0	CTD_human
6484	1728	NQO1	0.434	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.6	0.95	1996	2017	1	0	CTD_human
6485	1728	NQO1	0.434	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	0.833	2002	2019	1	0	CTD_human
6536	1729	DIAPH1	0.623	0.654	C1852282	DEAFNESS, AUTOSOMAL DOMINANT 1 (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.61	1	1997	2017	10	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6538	1729	DIAPH1	0.623	0.654	C4225261	SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	disease		Disease or Syndrome	0.7	1	1989	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
6561	1736	DKC1	0.547	0.769	C0265965	Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.9	0.969	1998	2019	6	35	CTD_human;GENOMICS_ENGLAND
6562	1736	DKC1	0.547	0.769	C1148551	X-Linked Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.8	1	1998	2019	16	31	CTD_human;GENOMICS_ENGLAND;UNIPROT
6563	1736	DKC1	0.547	0.769	C1846142	HOYERAAL-HREIDARSSON SYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	Disease or Syndrome	0.55	1	1999	2016	1	0	GENOMICS_ENGLAND;ORPHANET
6572	1737	DLAT	0.576	0.731	C1855565	Pyruvate Dehydrogenase E2 Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.7	1	2005	2016	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
6578	1738	DLD	0.517	0.769	C0268193	NADH cytochrome B5 reductase deficiency	disease	C15	Disease or Syndrome	0.8	1	1981	2018	18	33	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6597	1741	DLG3	0.544	0.615	C2931498	Mental Retardation, X-Linked 1	disease	C16;C10	Disease or Syndrome	0.55	1	1998	2016	1	0	ORPHANET
6598	1741	DLG3	0.544	0.615	C3275443	MENTAL RETARDATION, X-LINKED 90 (disorder)	disease		Disease or Syndrome	0.8	1	2016	2016	0	5	CTD_human;GENOMICS_ENGLAND
6606	1742	DLG4	0.595	0.654	C0175702	Williams Syndrome	disease	C16;C10;C14	Disease or Syndrome	0.51	1	2010	2010	1	0	CTD_human
6610	1742	DLG4	0.595	0.654	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.55	1	2010	2019	1	0	CTD_human
6623	1747	DLX3	0.601	0.692	C0265333	Tricho-dento-osseous syndrome (disorder)	disease	C16;C17;C05;C07	Disease or Syndrome	0.8	1	1998	2019	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
6625	1747	DLX3	0.601	0.692	C1863012	Amelogenesis Imperfecta, Type IV	disease	C16;C07	Disease or Syndrome	0.71	1	2005	2016	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
6628	1748	DLX4	0.585	0.654	C4225209	OROFACIAL CLEFT 15	disease		Congenital Abnormality	0.6	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND
6630	1749	DLX5	0.604	0.692	C0265554	Ectrodactyly	disease	C16;C05	Congenital Abnormality	0.53	1	2002	2014	1	0	ORPHANET
6632	1749	DLX5	0.604	0.692	C1857344	Split-Hand-Foot Malformation With Sensorineural Hearing Loss	disease	C23;C16;C05;C10;C09	Disease or Syndrome; Congenital Abnormality	0.7	1	2012	2016	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6633	1750	DLX6	0.659	0.615	C0265554	Ectrodactyly	disease	C16;C05	Congenital Abnormality	0.52	1	2002	2017	1	0	ORPHANET
6636	1750	DLX6	0.659	0.615	C2931019	Split hand foot deformity 1	disease	C16;C05	Congenital Abnormality	0.55	1	2002	2017	1	0	GENOMICS_ENGLAND
6642	1756	DMD	0.423	0.923	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.7	0.929	1993	2015	1	1	CTD_human
6644	1756	DMD	0.423	0.923	C0013264	Muscular Dystrophy, Duchenne	disease	C16;C05;C10	Disease or Syndrome	1	0.98	1981	2020	18	151	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6655	1756	DMD	0.423	0.923	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.51	1	2010	2019	1	0	CTD_human
6671	1756	DMD	0.423	0.923	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.7	0.962	1993	2020	3	1	CTD_human;GENOMICS_ENGLAND
6672	1756	DMD	0.423	0.923	C0917713	Becker Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.8	0.971	1984	2020	13	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6679	1756	DMD	0.423	0.923	C3668940	Dmd-Associated Dilated Cardiomyopathy	disease	C14	Disease or Syndrome	0.8	1	1992	2018	4	164	CTD_human;GENOMICS_ENGLAND;UNIPROT
6684	1757	SARDH	0.523	0.846	C0268563	Sarcosinemia	phenotype	C16;C18	Disease or Syndrome	0.73	1	1986	2016	4	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6688	1758	DMP1	0.556	0.615	C0342643	Autosomal recessive hypophosphatemic vitamin D refractory rickets	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.8	1	2006	2020	0	0	CTD_human;ORPHANET
6696	1758	DMP1	0.556	0.615	C4551495	Hypophosphatemic Rickets, Autosomal Recessive, 1	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.8	1	2006	2011	1	4	CTD_human;GENOMICS_ENGLAND
6707	1759	DNM1	0.595	0.692	C4225357	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31	disease		Disease or Syndrome	0.7	1	2014	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
6709	1760	DMPK	0.603	0.692	C0027125	Myotonia	phenotype	C23;C10	Finding	0.6	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND
6710	1760	DMPK	0.603	0.692	C0027126	Myotonic Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.6	0.981	1992	2020	1	0	CTD_human
6716	1760	DMPK	0.603	0.692	C3250443	MYOTONIC DYSTROPHY 1	disease	C16;C05;C10	Disease or Syndrome	0.7	0.981	1992	2019	4	1	GENOMICS_ENGLAND;ORPHANET
6730	1763	DNA2	0.626	0.731	C3554599	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT, 6	disease		Disease or Syndrome	0.7	1	2013	2013	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6736	1767	DNAH5	0.59	0.692	C1837618	CILIARY DYSKINESIA, PRIMARY, 3	disease	C16;C08;C09;C14	Disease or Syndrome	0.9	1	2000	2016	5	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
6763	1770	DNAH9	0.716	0.5	C4551720	Primary Ciliary Dyskinesia	disease	C16;C08;C09	Disease or Syndrome	0.54	1	2001	2018	2	0	GENOMICS_ENGLAND;ORPHANET
6766	1773	DNASE1	0.505	0.846	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.9	0.955	2000	2020	1	0	CTD_human;ORPHANET
6798	1778	DYNC1H1	0.547	0.769	C1834690	Spinal Muscular Atrophy, Childhood, Proximal, Autosomal Dominant	disease	C16;C10	Disease or Syndrome	0.72	1	2012	2018	8	9	GENOMICS_ENGLAND;ORPHANET;UNIPROT
6803	1778	DYNC1H1	0.547	0.769	C3280220	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O	disease		Disease or Syndrome	0.9	1	2011	2018	5	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6804	1778	DYNC1H1	0.547	0.769	C3281202	MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	disease		Mental or Behavioral Dysfunction	0.7	1	2010	2018	7	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
6815	1785	DNM2	0.542	0.769	C0175709	Centronuclear myopathy	disease	C05;C10	Disease or Syndrome	0.9	0.982	2005	2019	2	9	CTD_human;GENOMICS_ENGLAND
6820	1785	DNM2	0.542	0.769	C1834558	Myopathy, Centronuclear, Autosomal Dominant	disease	C05;C10	Disease or Syndrome	0.7	0.958	2005	2019	7	0	CLINGEN;CTD_human;ORPHANET
6821	1785	DNM2	0.542	0.769	C1847902	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B (disorder)	disease	C16;C10	Disease or Syndrome	0.71	1	2005	2017	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6825	1785	DNM2	0.542	0.769	C3809272	LETHAL CONGENITAL CONTRACTURE SYNDROME 5	disease		Disease or Syndrome	0.71	1	2005	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6826	1785	DNM2	0.542	0.769	C4551952	Myopathy, Centronuclear, 1	disease	C05;C10	Disease or Syndrome	0.71	1	2005	2016	13	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
6835	1786	DNMT1	0.406	0.885	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.52	1	2009	2019	1	0	CTD_human
6876	1786	DNMT1	0.406	0.885	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.51	1	1998	2019	2	0	CTD_human;GENOMICS_ENGLAND
6881	1786	DNMT1	0.406	0.885	C3279885	Hereditary Sensory and Autonomic Neuropathy Type Ie	disease	C16;C10	Disease or Syndrome	0.72	1	1998	2018	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6882	1786	DNMT1	0.406	0.885	C3807295	CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.77	1	1998	2016	11	3	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6891	1788	DNMT3A	0.445	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.8	0.955	2009	2019	0	4	CGI;CTD_human;GENOMICS_ENGLAND
6920	1788	DNMT3A	0.445	0.846	C4014545	Tatton Brown Rahman syndrome	disease	C23;C10;F03;F01	Disease or Syndrome	0.78	1	2014	2020	4	28	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6946	1789	DNMT3B	0.453	0.846	C4551557	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 1	disease	C16;C20	Disease or Syndrome	0.92	1	1999	2016	11	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
6961	1794	DOCK2	0.674	0.462	C4225328	IMMUNODEFICIENCY 40	disease		Disease or Syndrome	0.7	1	2015	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6963	1795	DOCK3	0.619	0.692	C4749014	NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA	disease		Disease or Syndrome	0.6	1	2017	2019	3	4	GENOMICS_ENGLAND;UNIPROT
6980	1798	DPAGT1	0.621	0.538	C2931004	Congenital disorder of glycosylation type 1J	disease	C16;C18	Disease or Syndrome	0.73	1	2003	2019	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
6981	1798	DPAGT1	0.621	0.538	C3553645	MYASTHENIC SYNDROME, CONGENITAL, 13	disease		Disease or Syndrome	0.6	1	2012	2019	6	9	GENOMICS_ENGLAND;UNIPROT
6986	1801	DPH1	0.653	0.538	C4310801	DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	disease		Disease or Syndrome	0.7	1	2015	2015	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6999	1804	DPP6	0.603	0.692	C4225375	MENTAL RETARDATION, AUTOSOMAL DOMINANT 33	disease		Mental or Behavioral Dysfunction	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7007	1806	DPYD	0.493	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.6	0.952	1999	2016	5	0	CTD_human
7040	1806	DPYD	0.493	0.846	C1959620	Dihydropyrimidine Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.8	0.941	1988	2019	7	55	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7047	1807	DPYS	0.621	0.577	C0342803	Dihydropyrimidinase deficiency	disease	C16;C18	Disease or Syndrome	0.71	1	1998	2017	2	6	CTD_human;ORPHANET;UNIPROT
7053	1811	SLC26A3	0.554	0.692	C0267662	Congenital chloride diarrhea	disease	C23;C16;C18	Disease or Syndrome	1	0.964	1996	2019	11	55	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7056	1812	DRD1	0.529	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	1992	2015	6	0	CTD_human;PSYGENET
7060	1812	DRD1	0.529	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.53	1	2007	2018	3	0	PSYGENET
7067	1812	DRD1	0.529	0.808	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.57	1	1996	2020	1	0	CTD_human
7113	1813	DRD2	0.436	0.846	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.54	1	2000	2014	14	0	CTD_human;PSYGENET
7116	1813	DRD2	0.436	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	1	2001	2016	5	0	PSYGENET
7124	1813	DRD2	0.436	0.846	C0019337	Heroin Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.6	1	2002	2019	1	0	CTD_human
7125	1813	DRD2	0.436	0.846	C0020514	Hyperprolactinemia	disease	C10;C19	Disease or Syndrome	0.6	0.923	2004	2020	2	0	CTD_human
7139	1813	DRD2	0.436	0.846	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.6	0.931	1995	2020	1	0	CTD_human
7153	1813	DRD2	0.436	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.57	1	1994	2015	5	0	PSYGENET
7199	1813	DRD2	0.436	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.8	1	1993	2019	15	0	CTD_human;PSYGENET
7228	1813	DRD2	0.436	0.846	C1834570	Myoclonic dystonia	disease	C10	Disease or Syndrome	0.57	1	1999	2009	0	0	GENOMICS_ENGLAND;ORPHANET
7282	1814	DRD3	0.529	0.692	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.52	0.667	1999	2010	7	0	CTD_human;PSYGENET
7339	1816	DRD5	0.603	0.423	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.53	1	1998	2014	6	0	CTD_human;PSYGENET
7375	1822	ATN1	0.409	0.885	C0751781	Dentatorubral-Pallidoluysian Atrophy	disease	C10	Disease or Syndrome	0.7	1	1995	2020	0	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7384	1824	DSC2	0.61	0.538	C1864850	Arrhythmogenic Right Ventricular Dysplasia, Familial, 11	disease	C16;C14	Disease or Syndrome	0.7	1	2006	2018	7	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
7392	1825	DSC3	0.57	0.808	C2751292	Hypotrichosis And Recurrent Skin Vesicles	disease	C23;C17	Disease or Syndrome; Congenital Abnormality	0.71	1	2009	2009	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
7423	1828	DSG1	0.606	0.538	C2931122	Keratosis palmoplantaris striata 1	disease	C16;C17	Disease or Syndrome	0.6	1	2017	2017	1	8	CTD_human;GENOMICS_ENGLAND
7424	1828	DSG1	0.606	0.538	C3809719	Severe dermatitis, multiple allergies, metabolic wasting syndrome	disease	C16;C17	Disease or Syndrome	0.8	1	2013	2020	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
7431	1829	DSG2	0.601	0.692	C1857777	Arrhythmogenic Right Ventricular Dysplasia, Familial, 10	disease	C16;C14	Disease or Syndrome	0.7	1	2006	2018	6	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
7432	1829	DSG2	0.601	0.692	C2752072	Cardiomyopathy, Dilated, 1BB	disease	C14	Disease or Syndrome	0.6	1	2017	2018	2	2	CTD_human;GENOMICS_ENGLAND
7450	1832	DSP	0.514	0.808	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.66	1	2013	2019	1	1	CTD_human;ORPHANET
7451	1832	DSP	0.514	0.808	C1843292	Skin Fragility-Woolly Hair Syndrome	disease	C16;C17	Disease or Syndrome	0.72	1	2002	2019	6	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7452	1832	DSP	0.514	0.808	C1843896	Arrhythmogenic Right Ventricular Dysplasia, Familial, 8	disease	C16;C14	Disease or Syndrome	0.9	1	1999	2019	8	69	CTD_human;GENOMICS_ENGLAND;UNIPROT
7453	1832	DSP	0.514	0.808	C1852127	KERATOSIS PALMOPLANTARIS STRIATA II	disease	C16;C17	Disease or Syndrome	0.6	1	2011	2019	5	4	CTD_human;GENOMICS_ENGLAND
7454	1832	DSP	0.514	0.808	C1854063	Cardiomyopathy dilated with Woolly hair and keratoderma	disease	C16;C17;C14	Disease or Syndrome	0.96	0.971	1999	2019	7	54	CTD_human;GENOMICS_ENGLAND;ORPHANET
7456	1832	DSP	0.514	0.808	C1864826	Epidermolysis bullosa, lethal acantholytic	disease	C16;C17	Disease or Syndrome	0.74	1	2005	2019	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
7458	1832	DSP	0.514	0.808	C4014393	CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR, KERATODERMA, AND TOOTH AGENESIS	disease		Disease or Syndrome	0.7	1	2006	2019	6	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
7465	1834	DSPP	0.556	0.769	C0011436	Dentinogenesis Imperfecta	disease	C16;C07	Congenital Abnormality	0.7	1	1992	2019	8	0	CLINGEN;CTD_human
7514	1889	ECE1	0.541	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.63	1	2000	2014	1	0	CTD_human
7524	1889	ECE1	0.541	0.769	C3151237	Hirschsprung Disease, Cardiac Defects, and Autonomic Dysfunction	disease	C16;C06;C10;C14	Disease or Syndrome	0.6	1	1999	1999	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7544	1890	TYMP	0.495	0.769	C0872218	MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOPATHY SYNDROME	disease		Disease or Syndrome	0.6	1	2001	2019	2	0	GENOMICS_ENGLAND;ORPHANET
7548	1890	TYMP	0.495	0.769	C4551995	Mitochondrial DNA Depletion Syndrome 1	disease		Disease or Syndrome	0.7	1	1999	2015	5	43	CTD_human;GENOMICS_ENGLAND;UNIPROT
7561	1892	ECHS1	0.601	0.654	C4225391	MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY	disease		Disease or Syndrome	0.7	1	1993	2017	9	24	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
7567	1893	ECM1	0.576	0.731	C0023795	Lipoid Proteinosis of Urbach and Wiethe	disease	C16;C08	Disease or Syndrome	0.8	1	2002	2018	5	12	CTD_human;ORPHANET;UNIPROT
7580	1896	EDA	0.553	0.808	C0162359	Christ-Siemens-Touraine syndrome	disease	C16;C17	Disease or Syndrome	0.8	0.99	1992	2019	27	78	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7582	1896	EDA	0.553	0.808	C1970757	Tooth Agenesis, Selective, X-Linked, 1	disease	C16;C07	Disease or Syndrome	0.7	1	2006	2016	7	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
7627	1906	EDN1	0.38	0.846	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	1	1999	2019	1	0	CTD_human
7631	1906	EDN1	0.38	0.846	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.51	1	1995	2012	1	0	CTD_human
7632	1906	EDN1	0.38	0.846	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.971	1994	2020	7	0	CTD_human
7633	1906	EDN1	0.38	0.846	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.976	1994	2020	7	0	CTD_human
7638	1906	EDN1	0.38	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.983	1993	2020	14	0	CTD_human
7639	1906	EDN1	0.38	0.846	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.53	1	1994	2010	5	0	CTD_human
7655	1906	EDN1	0.38	0.846	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.6	1	1997	2019	1	0	CTD_human
7658	1906	EDN1	0.38	0.846	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.51	1	1992	2017	1	0	CTD_human
7667	1906	EDN1	0.38	0.846	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.55	1	1997	2016	2	0	CTD_human
7670	1906	EDN1	0.38	0.846	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.56	1	1999	2019	3	0	CTD_human
7678	1906	EDN1	0.38	0.846	C0242350	Erectile dysfunction	disease	C12;F03	Disease or Syndrome	0.52	1	1996	2017	1	0	CTD_human
7718	1906	EDN1	0.38	0.846	C1865295	Auriculo-condylar syndrome	disease	C09	Disease or Syndrome	0.62	1	2013	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7727	1906	EDN1	0.38	0.846	C4551996	Auriculocondylar syndrome 1	disease	C09	Disease or Syndrome	0.61	1	2013	2018	1	0	CTD_human;GENOMICS_ENGLAND
7731	1908	EDN3	0.608	0.577	C0019569	Hirschsprung Disease	disease	C16;C06	Disease or Syndrome	0.7	1	1964	2011	4	0	CTD_human
7735	1908	EDN3	0.608	0.577	C0085758	Aganglionosis, Colonic	disease	C16;C06	Congenital Abnormality	0.52	1	1996	2009	5	0	CTD_human;GENOMICS_ENGLAND
7738	1908	EDN3	0.608	0.577	C1275808	Congenital central hypoventilation	disease	C23;C08;C10	Disease or Syndrome	0.6	1	1996	1998	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7739	1908	EDN3	0.608	0.577	C1848519	WAARDENBURG SYNDROME, TYPE 4A	disease	C16;C06	Disease or Syndrome	0.56	1	1996	2011	4	0	CTD_human;ORPHANET
7741	1908	EDN3	0.608	0.577	C2750457	Waardenburg Syndrome, Type 4b	disease	C16;C06	Disease or Syndrome	0.9	1	1994	2017	11	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
7742	1908	EDN3	0.608	0.577	C3150975	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4	disease		Finding	0.6	1	1998	2009	2	3	GENOMICS_ENGLAND;UNIPROT
7743	1908	EDN3	0.608	0.577	C3266898	Waardenburg Syndrome	disease	C16	Disease or Syndrome	0.54	1	1996	2020	2	0	GENOMICS_ENGLAND;ORPHANET
7748	1909	EDNRA	0.426	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	1	2006	2018	1	0	CTD_human
7753	1909	EDNRA	0.426	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	1	1996	2019	1	0	CTD_human
7756	1909	EDNRA	0.426	0.885	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.51	1	2007	2019	1	0	CTD_human
7764	1909	EDNRA	0.426	0.885	C0520679	Sleep Apnea, Obstructive	disease	C08;C10	Disease or Syndrome	0.53	1	2009	2018	1	0	CTD_human
7772	1909	EDNRA	0.426	0.885	C4225349	MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA	disease		Disease or Syndrome	0.91	1	2010	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7774	1910	EDNRB	0.47	0.846	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.51	1	2006	2009	1	0	CTD_human
7778	1910	EDNRB	0.47	0.846	C0019569	Hirschsprung Disease	disease	C16;C06	Disease or Syndrome	0.7	1	1966	2019	1	0	CTD_human
7784	1910	EDNRB	0.47	0.846	C0085758	Aganglionosis, Colonic	disease	C16;C06	Congenital Abnormality	0.65	1	1996	2015	2	2	CTD_human;GENOMICS_ENGLAND
7794	1910	EDNRB	0.47	0.846	C1838099	ABCD syndrome	disease	C16	Disease or Syndrome	0.61	1	1995	2015	3	1	CTD_human;GENOMICS_ENGLAND
7795	1910	EDNRB	0.47	0.846	C1838564	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2	disease		Finding	0.6	1	1994	2017	7	6	GENOMICS_ENGLAND;UNIPROT
7796	1910	EDNRB	0.47	0.846	C1848519	WAARDENBURG SYNDROME, TYPE 4A	disease	C16;C06	Disease or Syndrome	1	1	1994	2018	11	7	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7800	1910	EDNRB	0.47	0.846	C3266898	Waardenburg Syndrome	disease	C16	Disease or Syndrome	0.53	0.667	1999	2017	1	0	GENOMICS_ENGLAND;ORPHANET
7813	1911	PHC1	0.644	0.692	C3809431	MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2013	2015	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7833	1917	EEF1A2	0.554	0.808	C4225337	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33	disease		Disease or Syndrome	0.7	1	1988	2018	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
7834	1917	EEF1A2	0.554	0.808	C4225343	MENTAL RETARDATION, AUTOSOMAL DOMINANT 38	disease		Disease or Syndrome	0.6	1	2015	2015	1	4	CTD_human;UNIPROT
7867	1938	EEF2	0.599	0.731	C1836395	SPINOCEREBELLAR ATAXIA 26	disease	C16;C10	Disease or Syndrome	0.7	1	2012	2012	1	1	CTD_human;ORPHANET;UNIPROT
7880	1947	EFNB1	0.561	0.769	C0220767	Craniofrontonasal dysplasia	disease	C16;C05	Disease or Syndrome	1	0.958	2004	2019	3	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7938	1950	EGF	0.357	0.923	C2673648	Hypomagnesemia 4, Renal	disease	C16;C18;C13;C12	Disease or Syndrome	0.6	1	2007	2007	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7954	1954	MEGF8	0.584	0.538	C1275078	Acrocephalopolysyndactyly type 2	disease	C16;C05	Disease or Syndrome	0.82	1	2012	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7955	1954	MEGF8	0.584	0.538	C3554247	CARPENTER SYNDROME 2	disease		Disease or Syndrome	0.6	1	2012	2012	1	4	GENOMICS_ENGLAND;UNIPROT
7971	1956	EGFR	0.295	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.7	0.976	1989	2020	16	20	CGI;CTD_human
7981	1956	EGFR	0.295	0.885	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.6	1	1988	2019	3	0	CGI;CTD_human
7983	1956	EGFR	0.295	0.885	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.7	0.975	1988	2020	3	10	CGI;CTD_human
7985	1956	EGFR	0.295	0.885	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.63	0.889	2003	2017	3	3	CGI;CTD_human
7989	1956	EGFR	0.295	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.6	0.984	1994	2019	7	0	CGI;CTD_human
8012	1956	EGFR	0.295	0.885	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.7	0.978	1990	2020	2	6	CGI;CTD_human
8034	1956	EGFR	0.295	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.6	0.983	1988	2020	7	0	CGI;CTD_human
8037	1956	EGFR	0.295	0.885	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.6	0.965	1989	2019	3	0	CGI;CTD_human
8038	1956	EGFR	0.295	0.885	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.7	1	1994	2020	1	1	CGI;CTD_human
8048	1956	EGFR	0.295	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.6	1	1988	2020	3	0	CGI;CTD_human
8077	1956	EGFR	0.295	0.885	C4015130	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2	disease		Disease or Syndrome	0.7	1	2014	2015	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
8115	1959	EGR2	0.547	0.769	C0011195	Dejerine-Sottas Disease (disorder)	disease	C16;C10	Disease or Syndrome	0.94	1	1999	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8123	1959	EGR2	0.547	0.769	C1843247	Charcot-Marie-Tooth disease, Type 1D (disorder)	disease	C16;C10	Disease or Syndrome	0.71	1	1998	2012	7	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
8125	1959	EGR2	0.547	0.769	C4721436	NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE	disease	C16;C10	Disease or Syndrome	0.8	1	1998	2012	2	1	GENOMICS_ENGLAND;UNIPROT
8149	1962	EHHADH	0.67	0.5	C0341703	Adult Fanconi syndrome	disease	C16;C13;C12	Disease or Syndrome	0.52	1	2014	2015	1	0	CTD_human;ORPHANET
8156	1962	EHHADH	0.67	0.5	C3810100	FANCONI RENOTUBULAR SYNDROME 3	disease		Disease or Syndrome	0.6	1	2014	2014	1	1	GENOMICS_ENGLAND;UNIPROT
8168	1967	EIF2B1	0.663	0.538	C1847967	OVARIOLEUKODYSTROPHY	disease	C13;C10;C19	Disease or Syndrome	0.55	1	2004	2008	1	0	CTD_human;ORPHANET
8169	1967	EIF2B1	0.663	0.538	C1858991	Childhood Ataxia with Central Nervous System Hypomyelinization	disease	C10	Disease or Syndrome	0.8	0.906	2001	2020	6	8	GENOMICS_ENGLAND;ORPHANET;UNIPROT
8176	1968	EIF2S3	0.604	0.731	C1846278	MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM, MICROCEPHALY, AND OBESITY (disorder)	disease	C23;C16;C18;C05;C10;C19	Disease or Syndrome	0.75	1	1998	2020	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8193	1969	EPHA2	0.501	0.731	C1861825	CATARACT, POSTERIOR POLAR, 1	disease	C11	Disease or Syndrome	0.9	1	2006	2013	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
8228	1981	EIF4G1	0.553	0.808	C3280271	PARKINSON DISEASE 18	disease		Disease or Syndrome	0.7	1	2011	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
8249	1991	ELANE	0.447	0.846	C0221023	Cyclic neutropenia	disease	C15	Disease or Syndrome	0.8	1	1999	2019	6	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8251	1991	ELANE	0.447	0.846	C1859966	Neutropenia, Severe Congenital, Autosomal Dominant 1	disease	C15	Disease or Syndrome	0.7	1	1999	2016	14	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8275	2006	ELN	0.415	0.885	C0003499	Supravalvular aortic stenosis	disease	C14	Disease or Syndrome	0.8	1	1993	2019	7	33	CTD_human;GENOMICS_ENGLAND;ORPHANET
8276	2006	ELN	0.415	0.885	C0010495	Cutis Laxa	disease	C16;C17	Disease or Syndrome	0.7	1	1980	2020	2	0	CTD_human;GENOMICS_ENGLAND
8277	2006	ELN	0.415	0.885	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.51	1	1999	2002	1	0	CTD_human
8289	2006	ELN	0.415	0.885	C0268350	Cutis Laxa, Autosomal Dominant	disease	C16;C17	Disease or Syndrome	0.67	1	1997	2018	2	1	CTD_human;ORPHANET
8301	2009	EML1	0.705	0.462	C4284594	BAND HETEROTOPIA	disease		Disease or Syndrome	0.6	1	2014	2017	2	4	GENOMICS_ENGLAND;UNIPROT
8304	2010	EMD	0.542	0.731	C0751337	X-Linked Emery-Dreifuss Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.8	1	1994	2019	6	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8322	2013	EMP2	0.65	0.692	C4014507	NEPHROTIC SYNDROME, TYPE 10	disease		Disease or Syndrome	0.7	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
8348	2020	EN2	0.674	0.462	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.59	1	2004	2019	1	0	CTD_human
8352	2022	ENG	0.446	0.846	C0039445	Hereditary hemorrhagic telangiectasia	disease	C16;C15;C14	Disease or Syndrome	1	0.991	1994	2019	13	81	CLINGEN;CTD_human;GENOMICS_ENGLAND
8353	2022	ENG	0.446	0.846	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.52	1	2004	2017	5	0	GENOMICS_ENGLAND;ORPHANET
8354	2022	ENG	0.446	0.846	C0345893	Juvenile polyposis syndrome	disease	C16;C06;C04	Neoplastic Process	0.63	1	2005	2016	5	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
8363	2022	ENG	0.446	0.846	C4551861	Telangiectasia, Hereditary Hemorrhagic, Type 1	disease	C16;C15;C14	Disease or Syndrome	0.76	1	1994	2018	18	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
8402	2027	ENO3	0.769	0.308	C2752027	Glycogen Storage Disease XIII	disease	C16;C18	Disease or Syndrome	0.7	1	2001	2014	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8408	2030	SLC29A1	0.587	0.731	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.52	1	2004	2018	2	0	PSYGENET
8422	2033	EP300	0.459	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.7	1	2004	2020	1	1	CGI;CTD_human;UNIPROT
8425	2033	EP300	0.459	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.64	1	1996	2017	0	3	CTD_human;UNIPROT
8434	2033	EP300	0.459	0.846	C0035934	Rubinstein-Taybi Syndrome	disease	C16;C05;C10	Disease or Syndrome	0.6	0.969	2005	2019	0	0	CTD_human;GENOMICS_ENGLAND
8442	2033	EP300	0.459	0.846	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.51	1	2004	2004	0	0	CGI;UNIPROT
8447	2033	EP300	0.459	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.6	1	2004	2020	1	0	CGI;CTD_human
8460	2034	EPAS1	0.454	0.731	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.7	0.974	2001	2019	1	18	CTD_human
8470	2034	EPAS1	0.454	0.731	C2673187	Erythrocytosis, Familial, 4	disease	C15	Disease or Syndrome	0.7	1	2008	2012	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
8473	2035	EPB41	0.691	0.5	C0013902	Elliptocytosis, Hereditary	disease	C16;C15	Disease or Syndrome	0.83	1	1988	2016	3	1	GENOMICS_ENGLAND;ORPHANET
8476	2035	EPB41	0.691	0.5	C2678497	Elliptocytosis 1	disease	C16;C15	Disease or Syndrome	0.6	1	1988	1992	2	1	CTD_human;GENOMICS_ENGLAND
8477	2036	EPB41L1	0.839	0.192	C3280285	MENTAL RETARDATION, AUTOSOMAL DOMINANT 11	disease		Disease or Syndrome	0.6	1	2011	2015	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
8484	2038	EPB42	0.729	0.269	C2675192	Spherocytosis, Type 5	disease	C16;C15	Disease or Syndrome	0.7	1	1992	1999	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
8535	2050	EPHB4	0.524	0.692	C4310629	LYMPHATIC MALFORMATION 7	disease		Disease or Syndrome	0.7	1	2016	2018	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
8537	2050	EPHB4	0.524	0.692	C4748670	CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION 2	disease		Disease or Syndrome	0.61	1	2017	2019	5	14	GENOMICS_ENGLAND;UNIPROT
8593	2052	EPHX1	0.5	0.846	C1843139	Hypercholanemia, Familial	disease	C16;C18	Disease or Syndrome	0.6	1	2003	2015	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
8615	2053	EPHX2	0.568	0.654	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.61	1	2004	2004	0	1	CTD_human;GENOMICS_ENGLAND
8625	2055	CLN8	0.682	0.423	C1838570	CEROID LIPOFUSCINOSIS, NEURONAL, 8	disease	C16;C18;C10	Disease or Syndrome	0.94	1	1986	2019	9	43	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8626	2055	CLN8	0.682	0.423	C1864923	Northern epilepsy syndrome	disease	C16;C18;C10	Disease or Syndrome	0.76	1	1999	2017	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8671	2099	ESR1	0.324	0.962	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.6	0.95	1995	2019	0	0	CGI
8672	2099	ESR1	0.324	0.962	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.6	0.947	1990	2019	0	0	CGI
8684	2099	ESR1	0.324	0.962	C3809250	ESTROGEN RESISTANCE	disease		Disease or Syndrome	0.79	1	1994	2018	3	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
8696	2100	ESR2	0.4	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	0.97	1996	2020	3	0	CTD_human
8774	2103	ESRRB	0.565	0.846	C1837857	DEAFNESS, AUTOSOMAL RECESSIVE 35	disease	C23;C10;C09	Disease or Syndrome	0.7	1	1997	2008	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
8778	2108	ETFA	0.508	0.731	C0268596	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.79	1	1991	2019	11	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
8788	2109	ETFB	0.711	0.538	C0268596	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.65	1	1993	2019	10	2	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
8798	2110	ETFDH	0.678	0.462	C0268596	Multiple Acyl Coenzyme A Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.8	1	1985	2019	18	26	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
8807	2113	ETS1	0.444	0.731	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	0.957	2000	2019	3	1	CTD_human;ORPHANET
8843	2120	ETV6	0.477	0.731	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.8	0.981	1995	2019	1	2	CGI;CTD_human;GENOMICS_ENGLAND
8850	2120	ETV6	0.477	0.731	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.69	1	2015	2019	3	5	CTD_human;GENOMICS_ENGLAND
8866	2120	ETV6	0.477	0.731	C4015537	THROMBOCYTOPENIA 5	disease		Disease or Syndrome	0.7	1	2015	2017	4	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
8870	2121	EVC	0.587	0.577	C0013903	Ellis-Van Creveld Syndrome	disease	C16;C17;C05	Disease or Syndrome	0.96	1	2000	2018	9	21	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8873	2121	EVC	0.587	0.577	C0457013	Weyers acrofacial dysostosis	disease	C16;C05;C07	Disease or Syndrome	0.72	1	2000	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8895	2122	MECOM	0.513	0.731	C1854273	Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia	disease	C16;C05;C15	Disease or Syndrome	0.51	1	2015	2015	1	0	GENOMICS_ENGLAND;ORPHANET
8899	2122	MECOM	0.513	0.731	C4225221	RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	disease		Disease or Syndrome	0.6	1	2015	2018	3	3	GENOMICS_ENGLAND;UNIPROT
8912	2147	F2	0.415	0.885	C0012739	Disseminated Intravascular Coagulation	disease	C15	Disease or Syndrome	0.6	0.941	1991	2019	1	0	CTD_human
8916	2147	F2	0.415	0.885	C0020640	Inherited Factor II deficiency	disease	C16;C15	Disease or Syndrome	0.8	0.964	1983	2019	14	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8921	2147	F2	0.415	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.54	1	2007	2015	1	0	CTD_human
8927	2147	F2	0.415	0.885	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.58	1	1992	2013	4	0	CTD_human
8928	2147	F2	0.415	0.885	C0042487	Venous Thrombosis	phenotype	C14	Pathologic Function	0.57	1	1999	2013	3	0	CTD_human
8938	2147	F2	0.415	0.885	C0398623	Thrombophilia	disease	C15	Disease or Syndrome	0.6	0.956	1992	2019	1	0	CTD_human
8945	2213	FCGR2B	0.522	0.846	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.9	0.98	1995	2019	3	0	CTD_human;ORPHANET
8946	2213	FCGR2B	0.522	0.846	C0024530	Malaria	disease	C01	Disease or Syndrome	0.53	1	2007	2014	0	0	CTD_human
8954	2214	FCGR3A	0.432	0.962	C3810342	IMMUNODEFICIENCY 20	disease		Disease or Syndrome	0.6	1	1996	2012	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8972	2218	FKTN	0.511	0.692	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.66	1	1998	2016	2	9	CTD_human;ORPHANET
8974	2218	FKTN	0.511	0.692	C0410174	Fukuyama Type Congenital Muscular Dystrophy	disease	C16;C11;C10	Disease or Syndrome	1	1	1992	2019	13	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
8975	2218	FKTN	0.511	0.692	C0457133	Muscle eye brain disease	disease	C16;C11;C10	Disease or Syndrome	0.52	1	2003	2011	1	0	CTD_human;ORPHANET
8979	2218	FKTN	0.511	0.692	C1969024	CARDIOMYOPATHY, DILATED, 1X	disease	C14	Disease or Syndrome	0.7	1	2006	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
8980	2218	FKTN	0.511	0.692	C1969040	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2M	disease	C16;C05;C10	Disease or Syndrome	0.7	1	2001	2016	5	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
8981	2218	FKTN	0.511	0.692	C2751052	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	disease		Disease or Syndrome	0.9	1	2001	2016	7	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
9009	2224	FDPS	0.599	0.769	C4225262	POROKERATOSIS 9, MULTIPLE TYPES	disease		Disease or Syndrome	0.7	1	2015	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9010	2232	FDXR	0.566	0.808	C4521678	AUDITORY NEUROPATHY AND OPTIC ATROPHY	disease		Disease or Syndrome	0.7	1	2017	2017	1	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9013	2235	FECH	0.585	0.577	C0162568	Erythropoietic Protoporphyria	disease	C16;C06;C18;C17	Disease or Syndrome	0.8	0.992	1977	2020	6	0	CTD_human;GENOMICS_ENGLAND
9016	2235	FECH	0.585	0.577	C4692546	PROTOPORPHYRIA, ERYTHROPOIETIC, 1	disease		Disease or Syndrome	0.6	1	1991	2017	16	25	GENOMICS_ENGLAND;UNIPROT
9023	2239	GPC4	0.547	0.769	C0796154	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	disease	C23;C16;C05;C10;C19;F03;F01;C14	Disease or Syndrome	0.57	0.875	1998	2020	1	0	CTD_human;ORPHANET
9043	2243	FGA	0.573	0.769	C0268389	Amyloidosis, familial visceral	disease	C16;C18	Disease or Syndrome	0.7	1	1993	2015	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
9044	2243	FGA	0.573	0.769	C0272350	Dysfibrinogenemia, Congenital	disease	C16;C15	Disease or Syndrome	0.62	1	1993	2018	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9053	2243	FGA	0.573	0.769	C2584774	Congenital hypofibrinogenemia	disease	C16;C15	Disease or Syndrome	0.79	0.933	1992	2020	8	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9058	2243	FGA	0.573	0.769	C4316812	Fibrinogen Deficiency	disease	C16;C15	Disease or Syndrome	0.62	1	1992	2010	4	0	CTD_human;GENOMICS_ENGLAND
9064	2244	FGB	0.584	0.692	C0272350	Dysfibrinogenemia, Congenital	disease	C16;C15	Disease or Syndrome	0.61	1	1992	2015	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9066	2244	FGB	0.584	0.692	C2584774	Congenital hypofibrinogenemia	disease	C16;C15	Disease or Syndrome	0.76	1	2000	2017	7	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9067	2244	FGB	0.584	0.692	C4316812	Fibrinogen Deficiency	disease	C16;C15	Disease or Syndrome	0.63	1	2013	2019	0	0	CTD_human;GENOMICS_ENGLAND
9072	2245	FGD1	0.573	0.731	C0175701	Aarskog syndrome	disease	C16;C05;C19;C14	Disease or Syndrome	0.8	0.935	1994	2017	11	11	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9099	2247	FGF2	0.383	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.51	1	2002	2010	1	0	CTD_human
9170	2248	FGF3	0.505	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	0.96	1988	2015	1	0	CGI;CTD_human
9177	2248	FGF3	0.505	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.6	0.968	1989	2015	1	0	CGI;CTD_human
9186	2248	FGF3	0.505	0.808	C1853144	Deafness, Congenital, with Inner Ear Agenesis, Microtia, and Microdontia	disease	C23;C16;C10;C07;C09	Disease or Syndrome	0.73	1	1987	2018	10	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
9190	2249	FGF4	0.588	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.56	1	1989	2011	1	0	CGI;CTD_human
9192	2249	FGF4	0.588	0.577	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.6	1	1989	2011	1	0	CGI;CTD_human
9231	2253	FGF8	0.507	0.769	C0162809	Kallmann Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.56	1	2008	2019	2	0	CTD_human;ORPHANET
9244	2253	FGF8	0.507	0.769	C3552574	HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.6	1	2008	2014	5	9	GENOMICS_ENGLAND;UNIPROT
9260	2254	FGF9	0.528	0.846	C2751826	Multiple Synostoses Syndrome 3	disease	C16;C05	Disease or Syndrome	0.92	1	2009	2017	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
9267	2255	FGF10	0.53	0.692	C0158667	Aplasia of Lacrimal and Salivary Glands	disease	C11;C07	Congenital Abnormality	0.75	1	2006	2017	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
9268	2255	FGF10	0.53	0.692	C0265269	Lacrimoauriculodentodigital syndrome	disease	C23;C16;C11;C05;C10;C07;C09	Disease or Syndrome	0.93	1	1999	2016	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9278	2257	FGF12	0.619	0.615	C4310685	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	disease		Disease or Syndrome	0.7	1	2016	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
9286	2259	FGF14	0.619	0.692	C1836383	SPINOCEREBELLAR ATAXIA 27	disease	C16;C10	Disease or Syndrome	0.95	1	2002	2019	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9289	2260	FGFR1	0.362	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	0.976	1999	2020	2	0	CGI;CTD_human
9295	2260	FGFR1	0.362	0.885	C0010278	Craniosynostosis	disease	C16;C05	Disease or Syndrome	0.7	0.941	1995	2018	1	0	CTD_human;GENOMICS_ENGLAND
9298	2260	FGFR1	0.362	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.62	1	2003	2018	5	0	CTD_human;PSYGENET
9308	2260	FGFR1	0.362	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.51	0.667	2006	2017	4	0	CTD_human;PSYGENET
9314	2260	FGFR1	0.362	0.885	C0162809	Kallmann Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.6	0.979	2003	2019	2	0	CTD_human;ORPHANET
9317	2260	FGFR1	0.362	0.885	C0220658	Pfeiffer Syndrome	disease	C16;C05	Disease or Syndrome	0.9	1	1994	2020	5	5	GENOMICS_ENGLAND;UNIPROT
9322	2260	FGFR1	0.362	0.885	C0265535	Trigonocephaly	disease	C16;C05	Congenital Abnormality	0.64	0.75	2000	2019	1	0	CTD_human;ORPHANET
9338	2260	FGFR1	0.362	0.885	C0406612	Encephalocraniocutaneous lipomatosis	disease	C16;C18;C11;C17;C10	Congenital Abnormality	0.74	1	2009	2020	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9340	2260	FGFR1	0.362	0.885	C0432122	Interfrontal craniofaciosynostosis	disease	C16;C05	Congenital Abnormality	0.61	1	2000	2006	2	2	GENOMICS_ENGLAND;UNIPROT
9341	2260	FGFR1	0.362	0.885	C0432283	Osteoglophonic dwarfism	disease	C16;C05	Congenital Abnormality	0.73	1	2003	2020	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9345	2260	FGFR1	0.362	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.6	0.977	1994	2020	2	0	CGI;CTD_human
9349	2260	FGFR1	0.362	0.885	C0795998	JACKSON-WEISS SYNDROME	disease	C16;C05	Disease or Syndrome	0.71	1	2000	2017	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
9357	2260	FGFR1	0.362	0.885	C1563720	Kallmann Syndrome 2 (disorder)	disease	C16;C13;C12;C19	Disease or Syndrome	0.72	0.971	1994	2017	18	42	CTD_human;GENOMICS_ENGLAND;UNIPROT
9361	2260	FGFR1	0.362	0.885	C1845146	Holoprosencephaly, Ectrodactyly, and Bilateral Cleft Lip-Palate	disease	C23;C16;C05;C10;F03;C07;F01	Congenital Abnormality	0.75	0.889	2003	2019	6	16	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9374	2261	FGFR3	0.391	0.846	C0001080	Achondroplasia	disease	C16;C05	Congenital Abnormality	1	0.974	1994	2020	13	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9375	2261	FGFR3	0.391	0.846	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.8	0.979	1999	2019	6	8	CGI;CTD_human;UNIPROT
9376	2261	FGFR3	0.391	0.846	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.6	0.981	2001	2019	4	0	CGI;CTD_human
9379	2261	FGFR3	0.391	0.846	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.51	1	2005	2005	0	0	CGI;CTD_human
9382	2261	FGFR3	0.391	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.66	1	2000	2018	0	8	CTD_human;UNIPROT
9387	2261	FGFR3	0.391	0.846	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.7	0.971	1997	2019	1	2	CGI;CTD_human
9389	2261	FGFR3	0.391	0.846	C0039743	Thanatophoric Dysplasia	disease	C16;C05	Congenital Abnormality	0.6	1	1995	2019	1	0	CTD_human
9391	2261	FGFR3	0.391	0.846	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.65	1	2013	2018	0	1	CGI;UNIPROT
9399	2261	FGFR3	0.391	0.846	C0265269	Lacrimoauriculodentodigital syndrome	disease	C23;C16;C11;C05;C10;C07;C09	Disease or Syndrome	0.72	1	1995	2017	2	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9402	2261	FGFR3	0.391	0.846	C0334082	NEVUS, EPIDERMAL (disorder)	disease	C04	Disease or Syndrome	0.69	1	2006	2017	1	7	CTD_human;UNIPROT
9405	2261	FGFR3	0.391	0.846	C0410529	Hypochondroplasia (disorder)	disease	C16;C05;C19	Congenital Abnormality	0.8	0.972	1995	2020	10	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9411	2261	FGFR3	0.391	0.846	C1300257	Thanatophoric dysplasia, type 2	disease	C16;C05	Disease or Syndrome	0.8	0.941	1995	2018	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
9416	2261	FGFR3	0.391	0.846	C1864436	Muenke Syndrome	disease	C16;C05	Disease or Syndrome	1	1	1994	2019	9	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9417	2261	FGFR3	0.391	0.846	C1864852	CATSHL syndrome	disease	C23;C16;C05;C10;C09	Disease or Syndrome	0.71	1	1995	2016	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9418	2261	FGFR3	0.391	0.846	C1868678	THANATOPHORIC DYSPLASIA, TYPE I (disorder)	disease	C16;C05	Disease or Syndrome	0.8	1	1994	2019	9	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
9419	2261	FGFR3	0.391	0.846	C2674173	Achondroplasia, Severe, With Developmental Delay And Acanthosis Nigricans	disease	C16;C05	Congenital Abnormality	0.8	1	1996	2018	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9420	2261	FGFR3	0.391	0.846	C2677099	CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.78	1	1994	2018	7	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
9422	2261	FGFR3	0.391	0.846	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.54	1	1999	2019	1	1	CTD_human;UNIPROT
9426	2263	FGFR2	0.38	0.808	C0001193	Apert syndrome	disease	C16;C05	Congenital Abnormality	0.8	0.976	1994	2019	19	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9429	2263	FGFR2	0.38	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.7	0.942	1991	2020	3	11	CTD_human;UNIPROT
9434	2263	FGFR2	0.38	0.808	C0010273	Craniofacial Dysostosis	disease	C16;C05	Disease or Syndrome	0.7	1	1994	2019	1	0	CTD_human
9435	2263	FGFR2	0.38	0.808	C0010278	Craniosynostosis	disease	C16;C05	Disease or Syndrome	0.7	0.956	1995	2019	4	7	CTD_human;GENOMICS_ENGLAND
9445	2263	FGFR2	0.38	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.7	0.957	1996	2019	2	0	CGI;CTD_human
9454	2263	FGFR2	0.38	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.62	1	2007	2012	2	9	CGI;CTD_human
9457	2263	FGFR2	0.38	0.808	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.63	0.75	2013	2016	0	3	CGI;UNIPROT
9463	2263	FGFR2	0.38	0.808	C0175699	Saethre-Chotzen Syndrome	disease	C16;C05	Disease or Syndrome	0.74	1	1997	2016	8	9	CTD_human;GENOMICS_ENGLAND;ORPHANET
9466	2263	FGFR2	0.38	0.808	C0220658	Pfeiffer Syndrome	disease	C16;C05	Disease or Syndrome	1	0.983	1994	2019	21	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
9470	2263	FGFR2	0.38	0.808	C0265269	Lacrimoauriculodentodigital syndrome	disease	C23;C16;C11;C05;C10;C07;C09	Disease or Syndrome	0.73	1	1996	2019	5	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9481	2263	FGFR2	0.38	0.808	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.7	0.964	2007	2019	1	2	CGI;CTD_human
9486	2263	FGFR2	0.38	0.808	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.957	1996	2019	1	0	CGI;GENOMICS_ENGLAND
9487	2263	FGFR2	0.38	0.808	C0795998	JACKSON-WEISS SYNDROME	disease	C16;C05	Disease or Syndrome	0.76	1	1994	2017	10	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9495	2263	FGFR2	0.38	0.808	C1510455	Acrocephalosyndactylia	disease	C16;C05	Congenital Abnormality	0.88	1	1997	2013	6	1	CTD_human;ORPHANET
9499	2263	FGFR2	0.38	0.808	C1852406	Cutis Gyrata Syndrome of Beare And Stevenson	disease	C16;C17;C05	Disease or Syndrome	0.97	1	1994	2017	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9503	2263	FGFR2	0.38	0.808	C1865070	SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION	disease	C23;C16;C05;C10;F03;C07;F01	Disease or Syndrome	0.7	1	1996	2016	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9508	2263	FGFR2	0.38	0.808	C2931196	Craniofacial dysostosis type 1	disease	C16;C05	Disease or Syndrome	0.8	1	1994	2019	23	36	CTD_human;GENOMICS_ENGLAND;UNIPROT
9510	2263	FGFR2	0.38	0.808	C2936791	Antley-Bixler Syndrome, Autosomal Dominant	disease	C16;C18;C05	Disease or Syndrome	0.74	1	1996	2017	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9512	2263	FGFR2	0.38	0.808	C3281247	BENT BONE DYSPLASIA SYNDROME	disease		Disease or Syndrome	0.73	1	2006	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9523	2264	FGFR4	0.49	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.6	0.929	2004	2016	5	1	CTD_human;UNIPROT
9524	2266	FGG	0.633	0.615	C0001733	Afibrinogenemia	disease	C16;C15	Disease or Syndrome	0.53	1	2000	2004	0	0	CTD_human
9528	2266	FGG	0.633	0.615	C0272350	Dysfibrinogenemia, Congenital	disease	C16;C15	Disease or Syndrome	0.61	1	1986	2018	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9531	2266	FGG	0.633	0.615	C2584774	Congenital hypofibrinogenemia	disease	C16;C15	Disease or Syndrome	0.74	1	2000	2018	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9532	2266	FGG	0.633	0.615	C4316812	Fibrinogen Deficiency	disease	C16;C15	Disease or Syndrome	0.7	1	2005	2018	0	0	CTD_human;GENOMICS_ENGLAND
9537	2271	FH	0.489	0.846	C0342770	Fumarase deficiency	disease	C23;C16;C18;C10;F01	Disease or Syndrome	0.74	1	1990	2019	3	90	CTD_human;GENOMICS_ENGLAND;UNIPROT
9539	2271	FH	0.489	0.846	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.6	0.971	2002	2020	0	0	CGI;GENOMICS_ENGLAND
9541	2271	FH	0.489	0.846	C1708350	Hereditary Leiomyomatosis and Renal Cell Cancer	disease	C16;C04;C13;C17	Neoplastic Process	0.8	0.972	1994	2020	10	53	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9552	2272	FHIT	0.444	0.846	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.51	1	2002	2009	1	0	CTD_human
9571	2272	FHIT	0.444	0.846	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.53	1	1998	2017	1	0	CTD_human
9587	2273	FHL1	0.532	0.731	C2678055	MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY (disorder)	disease	C16;C05;C10	Disease or Syndrome	0.78	1	2008	2018	5	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9588	2273	FHL1	0.532	0.731	C2678061	SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT	disease	C16;C05;C10	Disease or Syndrome	0.71	1	2008	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9590	2273	FHL1	0.532	0.731	C4225159	REDUCING BODY MYOPATHY, X-LINKED 1B, WITH LATE CHILDHOOD OR ADULT ONSET	disease		Disease or Syndrome	0.6	1	1995	2018	6	3	GENOMICS_ENGLAND;UNIPROT
9591	2273	FHL1	0.532	0.731	C4225423	REDUCING BODY MYOPATHY, X-LINKED 1A, SEVERE, WITH INFANTILE OR EARLY CHILDHOOD ONSET	disease		Disease or Syndrome	0.6	1	2008	2018	4	5	GENOMICS_ENGLAND;UNIPROT
9630	2289	FKBP5	0.524	0.769	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	0.8	2009	2020	5	0	CTD_human;PSYGENET
9668	2290	FOXG1	0.522	0.692	C3150705	FOXG1 syndrome	disease	C16;C10;F03	Disease or Syndrome	0.79	1	2008	2019	6	46	CTD_human;GENOMICS_ENGLAND;UNIPROT
9680	2294	FOXF1	0.54	0.692	C0031190	Persistent Fetal Circulation Syndrome	disease	C16;C08	Disease or Syndrome	0.7	1	2009	2019	5	4	GENOMICS_ENGLAND;UNIPROT
9686	2294	FOXF1	0.54	0.692	C2677362	Alveolar capillary dysplasia	disease	C16;C08	Congenital Abnormality	0.57	1	2009	2019	2	0	CTD_human;ORPHANET
9692	2296	FOXC1	0.483	0.846	C0010964	Dandy-Walker Syndrome	disease	C16;C10	Disease or Syndrome	0.52	1	2009	2013	2	0	CTD_human;GENOMICS_ENGLAND
9703	2296	FOXC1	0.483	0.846	C0344559	Irido-corneo-trabecular dysgenesis (disorder)	disease	C16;C11	Congenital Abnormality	0.62	1	1998	2008	4	0	GENOMICS_ENGLAND;ORPHANET
9712	2296	FOXC1	0.483	0.846	C1839928	IRIS HYPOPLASIA WITH GLAUCOMA	disease	C11	Disease or Syndrome	0.51	1	1998	2013	8	5	GENOMICS_ENGLAND;UNIPROT
9714	2296	FOXC1	0.483	0.846	C2678503	AXENFELD-RIEGER SYNDROME, TYPE 3	disease	C16;C11	Disease or Syndrome	0.7	1	1998	2017	23	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
9722	2313	FLI1	0.468	0.692	C0553580	Ewings sarcoma	disease	C04	Neoplastic Process	0.6	0.988	1993	2019	3	0	CTD_human;ORPHANET
9728	2313	FLI1	0.468	0.692	C4479515	BLEEDING DISORDER, PLATELET-TYPE, 21	disease		Disease or Syndrome	0.7	1	2013	2017	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
9742	2316	FLNA	0.419	0.846	C0025237	Melnick-Needles Syndrome	disease	C16;C05	Disease or Syndrome	0.68	1	2003	2018	7	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9750	2316	FLNA	0.419	0.846	C0262436	Cardiac valvular dysplasia, X-linked	disease	C16;C04;C14	Congenital Abnormality	0.61	1	2006	2007	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9751	2316	FLNA	0.419	0.846	C0265251	Oto-Palato-digital syndrome type 1	disease	C16;C05	Disease or Syndrome	0.62	1	2003	2017	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9752	2316	FLNA	0.419	0.846	C0265293	Frontometaphyseal dysplasia	disease	C16;C05	Congenital Abnormality	0.7	1	2003	2018	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
9762	2316	FLNA	0.419	0.846	C1844696	OTOPALATODIGITAL SYNDROME, TYPE II	disease	C16;C05	Disease or Syndrome	0.7	0.923	2003	2017	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9766	2316	FLNA	0.419	0.846	C1845902	FG SYNDROME 2	disease	C23;C16;C06;C10	Disease or Syndrome	0.6	1	2004	2007	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9767	2316	FLNA	0.419	0.846	C1846129	Terminal Osseous Dysplasia and Pigmentary Defects	disease	C23;C16;C17;C05	Disease or Syndrome	0.61	1	2003	2017	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
9768	2316	FLNA	0.419	0.846	C1848213	Periventricular Heterotopia, X-Linked	disease	C16;C10	Disease or Syndrome	0.81	1	1998	2013	9	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9770	2316	FLNA	0.419	0.846	C1868720	Periventricular Nodular Heterotopia	disease	C16;C10	Disease or Syndrome	0.7	0.978	1998	2019	2	0	CTD_human
9771	2316	FLNA	0.419	0.846	C2746068	Congenital idiopathic intestinal pseudoobstruction	disease	C16;C06	Disease or Syndrome	0.51	1	2004	2009	2	0	CTD_human;GENOMICS_ENGLAND
9774	2316	FLNA	0.419	0.846	C4281559	FRONTOMETAPHYSEAL DYSPLASIA 1	disease	C16;C05	Congenital Abnormality	0.59	1	2003	2018	4	0	GENOMICS_ENGLAND;UNIPROT
9780	2317	FLNB	0.458	0.923	C0175778	Larsen syndrome	disease	C16;C05	Disease or Syndrome	0.8	1	2004	2017	2	12	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9781	2317	FLNB	0.458	0.923	C0265283	Atelosteogenesis, type 1	disease	C16;C05	Congenital Abnormality	0.76	1	2004	2017	1	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
9782	2317	FLNB	0.458	0.923	C0432201	Boomerang dysplasia	disease	C23;C16;C05;C19	Disease or Syndrome	0.75	1	2004	2018	2	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9784	2317	FLNB	0.458	0.923	C1848934	SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	disease	C16;C05	Disease or Syndrome	0.87	1	2004	2018	1	9	CTD_human;GENOMICS_ENGLAND
9785	2317	FLNB	0.458	0.923	C2931648	Larsen syndrome, dominant type	disease	C16;C05;C07;C26	Disease or Syndrome	0.51	1	2004	2007	1	0	CTD_human;ORPHANET
9786	2317	FLNB	0.458	0.923	C3668942	Atelosteogenesis Type 3	disease	C16;C05	Congenital Abnormality	0.71	1	2004	2006	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9790	2318	FLNC	0.568	0.615	C1836050	Filaminopathy, autosomal dominant	disease	C16;C05;C10	Disease or Syndrome	0.91	1	1998	2018	16	38	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
9791	2318	FLNC	0.568	0.615	C3279722	MYOPATHY, DISTAL, 4	disease		Disease or Syndrome	0.7	1	2005	2016	3	38	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9792	2318	FLNC	0.568	0.615	C4310749	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 26	disease		Disease or Syndrome	0.7	1	2011	2016	3	43	CTD_human;GENOMICS_ENGLAND;UNIPROT
9793	2321	FLT1	0.419	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	1	1999	2019	2	0	CTD_human
9799	2321	FLT1	0.419	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.51	1	2002	2007	1	0	CTD_human
9805	2321	FLT1	0.419	0.846	C0032914	Pre-Eclampsia	phenotype	C13	Pathologic Function	0.6	1	2004	2017	2	0	CTD_human;ORPHANET
9835	2322	FLT3	0.462	0.654	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	1	0.985	1992	2020	13	28	CGI;CTD_human;UNIPROT
9839	2322	FLT3	0.462	0.654	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.52	1	2002	2017	14	0	CTD_human;ORPHANET
9846	2322	FLT3	0.462	0.654	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.52	1	2006	2017	14	0	CTD_human;ORPHANET
9848	2322	FLT3	0.462	0.654	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.8	1	2004	2020	0	4	CGI;CTD_human;UNIPROT
9857	2324	FLT4	0.457	0.808	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.54	1	2013	2019	1	0	CTD_human;GENOMICS_ENGLAND
9863	2324	FLT4	0.457	0.808	C1704423	Milroy Disease	disease	C15	Disease or Syndrome	0.8	1	1998	2019	11	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
9864	2324	FLT4	0.457	0.808	C1865871	HEMANGIOMA, CAPILLARY INFANTILE	disease	C16;C04	Disease or Syndrome	0.6	1	2002	2002	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
9876	2328	FMO3	0.638	0.5	C0342739	Trimethylaminuria	disease	C16;C18	Disease or Syndrome	0.8	0.972	1997	2020	9	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
9888	2332	FMR1	0.473	0.769	C0016667	Fragile X Syndrome	disease	C16;C10	Disease or Syndrome	1	0.985	1991	2020	37	6	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
9907	2332	FMR1	0.473	0.769	C1839780	FRAGILE X TREMOR/ATAXIA SYNDROME	disease	C23;C16;C10	Disease or Syndrome	0.9	0.995	2003	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
9912	2332	FMR1	0.473	0.769	C4552079	Premature Ovarian Failure 1	disease	C13;C19	Disease or Syndrome	0.6	1	2003	2019	1	0	CTD_human;GENOMICS_ENGLAND
9915	2334	AFF2	0.636	0.538	C0751157	FRAXE Syndrome	disease	C16;C10	Disease or Syndrome	0.74	1	1993	2013	11	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
9919	2335	FN1	0.365	0.962	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	1	1997	2020	1	1	CTD_human;UNIPROT
9925	2335	FN1	0.365	0.962	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.6	0.958	1996	2019	1	0	CTD_human
9941	2335	FN1	0.365	0.962	C0432221	Spondylometaphyseal dysplasia, corner fracture type	disease	C23;C16;C05;C26	Disease or Syndrome	0.7	1	2017	2019	2	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9949	2335	FN1	0.365	0.962	C1866075	GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2 (disorder)	disease	C13;C12;C20	Disease or Syndrome	0.7	1	2008	2008	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9951	2335	FN1	0.365	0.962	C3888104	Glomerulopathy with fibronectin deposits	disease	C13;C12;C20	Disease or Syndrome	0.57	1	1998	2019	1	0	CTD_human;ORPHANET
9995	2348	FOLR1	0.522	0.885	C2751584	Neurodegeneration Due To Cerebral Folate Transport Deficiency	phenotype	C10	Disease or Syndrome	0.79	0.952	1991	2019	16	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
10020	2353	FOS	0.411	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.51	1	2012	2018	1	0	CTD_human
10021	2353	FOS	0.411	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.51	1	2002	2013	2	0	CTD_human
10173	2395	FXN	0.51	0.654	C0016719	Friedreich Ataxia	disease	C16;C18;C10	Disease or Syndrome	0.9	0.997	1976	2020	18	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
10175	2395	FXN	0.51	0.654	C1856689	FRIEDREICH ATAXIA 1	disease	C16;C18;C10	Disease or Syndrome	0.8	0.983	1997	2020	10	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
10191	2475	MTOR	0.343	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.54	1	2009	2019	1	0	CTD_human
10195	2475	MTOR	0.343	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.53	1	2011	2019	1	0	CTD_human
10198	2475	MTOR	0.343	0.885	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.52	1	2004	2018	1	0	CTD_human
10211	2475	MTOR	0.343	0.885	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.6	0.984	2005	2020	1	0	CGI;CTD_human
10234	2475	MTOR	0.343	0.885	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.6	0.967	2005	2019	1	0	CTD_human;UNIPROT
10235	2475	MTOR	0.343	0.885	C1846385	FOCAL CORTICAL DYSPLASIA OF TAYLOR	disease	C16;C10	Disease or Syndrome	0.74	1	2015	2018	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
10243	2475	MTOR	0.343	0.885	C4225259	SMITH-KINGSMORE SYNDROME	disease		Disease or Syndrome	0.72	1	2015	2019	5	7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
10271	2488	FSHB	0.631	0.577	C1856716	Follicle-stimulating hormone deficiency, isolated	disease	C12	Disease or Syndrome	0.71	1	1993	2017	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10274	2492	FSHR	0.539	0.654	C0085083	Ovarian Hyperstimulation Syndrome	disease	C13;C19	Disease or Syndrome	0.8	0.96	2003	2019	9	5	CTD_human;ORPHANET;UNIPROT
10277	2492	FSHR	0.539	0.654	C0949595	Gonadal Dysgenesis, 46,XX	disease	C16;C13;C12;C19	Congenital Abnormality	0.75	1	1995	2016	7	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10319	2495	FTH1	0.559	0.731	C1851316	Iron Overload, Autosomal Dominant	disease	C18	Disease or Syndrome	0.7	1	2001	2001	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
10337	2512	FTL	0.559	0.692	C1833213	Hyperferritinemia, hereditary, with congenital cataracts	disease	C18;C11	Disease or Syndrome	0.8	1	1990	2019	3	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10338	2512	FTL	0.559	0.692	C1853578	Neuroferritinopathy	disease	C18;C10	Disease or Syndrome	0.8	0.967	1990	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10339	2512	FTL	0.559	0.692	C3810090	L-FERRITIN DEFICIENCY	disease		Disease or Syndrome	0.7	1	2009	2013	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
10357	2516	NR5A1	0.479	0.731	C0949595	Gonadal Dysgenesis, 46,XX	disease	C16;C13;C12;C19	Congenital Abnormality	0.51	1	2009	2012	1	0	CTD_human;ORPHANET
10361	2516	NR5A1	0.479	0.731	C2751825	PREMATURE OVARIAN FAILURE 7 (disorder)	disease	C13;C19	Disease or Syndrome	0.7	1	2000	2016	5	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
10364	2516	NR5A1	0.479	0.731	C3151406	SPERMATOGENIC FAILURE 8	disease		Disease or Syndrome	0.7	1	2010	2015	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
10365	2516	NR5A1	0.479	0.731	C3489793	46,XY Sex Reversal 3	disease	C16;C13;C12;C19	Congenital Abnormality	0.7	1	1999	2017	10	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
10370	2517	FUCA1	0.623	0.577	C0016788	Fucosidase Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	1	1	1988	2019	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10396	2521	FUS	0.47	0.846	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.7	0.981	2009	2020	2	0	CTD_human;ORPHANET
10398	2521	FUS	0.47	0.846	C0206634	Liposarcoma, Myxoid	disease	C04	Neoplastic Process	0.6	1	1993	2019	2	0	CTD_human;ORPHANET
10405	2521	FUS	0.47	0.846	C3539195	TREMOR, HEREDITARY ESSENTIAL, 4	disease		Disease or Syndrome	0.6	1	2009	2014	1	4	CTD_human;UNIPROT
10423	2530	FUT8	0.603	0.692	C4693905	CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION	disease		Disease or Syndrome	0.61	1	2005	2019	3	4	GENOMICS_ENGLAND;UNIPROT
10433	2531	KDSR	0.674	0.538	C4479620	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 4	disease		Disease or Syndrome	0.6	1	2017	2017	1	4	GENOMICS_ENGLAND;UNIPROT
10437	2533	FYB1	0.711	0.538	C2678311	Thrombocytopenia 3	disease	C15	Disease or Syndrome	0.6	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND
10458	2535	FZD2	0.558	0.654	C2750355	Omodysplasia 2	disease	C23;C16;C05	Disease or Syndrome	0.71	1	2015	2018	4	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
10470	2538	G6PC	0.56	0.692	C0017920	Glycogen Storage Disease Type I	disease	C16;C18	Disease or Syndrome	0.9	1	1983	2020	26	30	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10472	2538	G6PC	0.56	0.692	C2919796	Glycogen storage disease type Ia	disease	C16;C18	Disease or Syndrome	0.7	1	1993	2020	0	44	CTD_human;ORPHANET
10473	2539	G6PD	0.424	0.846	C0002878	Anemia, Hemolytic	disease	C15	Disease or Syndrome	0.6	1	1973	2019	4	0	CTD_human;GENOMICS_ENGLAND
10480	2539	G6PD	0.424	0.846	C0015702	Favism	disease	C16;C25;C15	Disease or Syndrome	0.6	1	1971	2018	2	0	CTD_human
10494	2539	G6PD	0.424	0.846	C2720289	ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	disease	C16;C18;C15	Disease or Syndrome	0.7	1	1969	2019	21	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
10499	2542	SLC37A4	0.617	0.654	C0017920	Glycogen Storage Disease Type I	disease	C16;C18	Disease or Syndrome	0.57	1	1998	2018	1	0	GENOMICS_ENGLAND
10501	2542	SLC37A4	0.617	0.654	C0268146	Glucose-6-phosphate transport defect	disease	C16;C18	Disease or Syndrome	0.8	1	1997	2020	22	51	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10502	2542	SLC37A4	0.617	0.654	C0342749	GLYCOGEN STORAGE DISEASE Ic	disease	C16;C18	Disease or Syndrome	0.71	1	1998	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
10515	2548	GAA	0.631	0.577	C0017921	Glycogen storage disease type II	disease	C16;C18;C10	Disease or Syndrome	1	0.994	1965	2019	57	196	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
10519	2548	GAA	0.631	0.577	C0342751	Generalized glycogen storage disease of infants	disease	C16;C18;C10	Disease or Syndrome	0.6	0.982	1976	2019	5	0	CTD_human;GENOMICS_ENGLAND
10521	2548	GAA	0.631	0.577	C0751173	Glycogen Storage Disease Type II, Infantile	disease	C16;C18;C10	Disease or Syndrome	0.61	1	2001	2011	5	4	CTD_human;ORPHANET
10527	2548	GAA	0.631	0.577	C3888925	Pompes disease adult onset	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     2548	GAA	0.631	0.577	C4551472	Hypertrophic obstructive cardiomyopathy	disease	C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2549	GAB1	0.584	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.34	1	2003	2019	   0	   0	UNIPROT
     2549	GAB1	0.584	0.654	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.32	1	2011	2014	   1	   0	CTD_human
     2549	GAB1	0.584	0.654	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2549	GAB1	0.584	0.654	C1854275	DEAFNESS, AUTOSOMAL RECESSIVE 26	disease	C23;C10;C09	Disease or Syndrome	0.60	1	2018	2018	   1	   1	CTD_human;UNIPROT
     2550	GABBR1	0.587	0.769	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2018	   1	   0	CTD_human
     2550	GABBR1	0.587	0.769	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.56	0.5	1999	2018	   5	   0	CTD_human;PSYGENET
     2550	GABBR1	0.587	0.769	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2009	   2	   0	CTD_human
     2550	GABBR1	0.587	0.769	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2550	GABBR1	0.587	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.46	1	2002	2017	   2	   1	PSYGENET
     2550	GABBR1	0.587	0.769	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2550	GABBR1	0.587	0.769	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2550	GABBR1	0.587	0.769	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2550	GABBR1	0.587	0.769	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     2550	GABBR1	0.587	0.769	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2551	GABPA	0.379	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2013	2019	   1	   0	PSYGENET
     2551	GABPA	0.379	0.885	C0015923	Fetal Alcohol Syndrome	disease	C16;C13;C25	Disease or Syndrome	0.30	1	2008	2008	   1	   0	PSYGENET
     2551	GABPA	0.379	0.885	C2985290	Fetal Alcohol Spectrum Disorders	group	C16;C13;C25	Disease or Syndrome; Congenital Abnormality	0.30	1	2008	2008	   1	   0	PSYGENET
     2553	GABPB1	0.743	0.346	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     2554	GABRA1	0.563	0.577	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2006	2006	   1	   0	PSYGENET
     2554	GABRA1	0.563	0.577	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	0.667	2003	2019	   3	   0	PSYGENET
     2554	GABRA1	0.563	0.577	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.40	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2004	   1	   0	PSYGENET
     2554	GABRA1	0.563	0.577	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0019147	Hepatic Coma	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0019151	Hepatic Encephalopathy	disease	C06;C18;C10	Disease or Syndrome	0.51	1	2005	2014	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	0.5	2005	2017	   4	   0	PSYGENET
     2554	GABRA1	0.563	0.577	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	PSYGENET
     2554	GABRA1	0.563	0.577	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0270736	Essential Tremor	disease	C10	Disease or Syndrome	0.32	1	2005	2011	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0270853	Juvenile Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.67	1	2002	2019	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2554	GABRA1	0.563	0.577	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0393615	Familial Tremor	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.34	0.75	1998	2004	   4	   0	PSYGENET
     2554	GABRA1	0.563	0.577	C0543888	Epileptic encephalopathy	disease	C10	Disease or Syndrome	0.41	1	2013	2019	   1	   1	GENOMICS_ENGLAND
     2554	GABRA1	0.563	0.577	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0751122	Infantile Severe Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.33	1	2010	2016	   1	   0	ORPHANET
     2554	GABRA1	0.563	0.577	C0751197	Fulminant Hepatic Failure with Cerebral Edema	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C0751198	Hepatic Stupor	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	disease		Disease or Syndrome	0.30	1	2006	2006	   1	   0	ORPHANET
     2554	GABRA1	0.563	0.577	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C3810400	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19	disease	C10	Disease or Syndrome	0.60	1	2014	2017	   2	   9	CTD_human;UNIPROT
     2554	GABRA1	0.563	0.577	C4013473	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13	disease		Finding	0.60	1	2002	2019	   5	   6	GENOMICS_ENGLAND;UNIPROT
     2554	GABRA1	0.563	0.577	C4551857	Juvenile Myoclonic Epilepsy of Janz	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2554	GABRA1	0.563	0.577	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2554	GABRA1	0.563	0.577	C4552768	Myoclonic Epilepsy, Adolescent	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2554	GABRA1	0.563	0.577	C4553087	Myoclonic Epilepsy, Juvenile, 1	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2554	GABRA1	0.563	0.577	C4553298	Impulsive Petit Mal Epilepsy	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.40	0.857	2009	2019	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.70	0.8	2004	2017	   6	   0	CTD_human;PSYGENET
     2555	GABRA2	0.641	0.346	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2006	2018	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2006	2009	   1	   0	PSYGENET
     2555	GABRA2	0.641	0.346	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   2	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0019337	Heroin Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2012	2014	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   2	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.31	1	1978	2018	   1	   0	GENOMICS_ENGLAND
     2555	GABRA2	0.641	0.346	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.31	1	1978	2018	   1	   0	GENOMICS_ENGLAND
     2555	GABRA2	0.641	0.346	C0600241	heroin abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.55	1	2010	2019	   3	   0	CTD_human;PSYGENET
     2555	GABRA2	0.641	0.346	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2555	GABRA2	0.641	0.346	C3160814	Cannabis use	disease		Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
     2555	GABRA2	0.641	0.346	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1978	1978	   1	   0	GENOMICS_ENGLAND
     2555	GABRA2	0.641	0.346	C4505390	Heroin Smoking	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2556	GABRA3	0.636	0.577	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2556	GABRA3	0.636	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1989	2004	   5	   0	PSYGENET
     2556	GABRA3	0.636	0.577	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     2556	GABRA3	0.636	0.577	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     2556	GABRA3	0.636	0.577	C0268446	Thyrotoxic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	ORPHANET
     2557	GABRA4	0.751	0.308	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2557	GABRA4	0.751	0.308	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2005	2015	   2	   0	CTD_human
     2557	GABRA4	0.751	0.308	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     2557	GABRA4	0.751	0.308	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     2557	GABRA4	0.751	0.308	C0240991	Ataxia, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2557	GABRA4	0.751	0.308	C0270496	Schizoaffective disorder, bipolar type	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     2557	GABRA4	0.751	0.308	C0278161	Ataxia, Motor	phenotype	C23;C10	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     2557	GABRA4	0.751	0.308	C0427190	Ataxia, Truncal	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2557	GABRA4	0.751	0.308	C0520966	Abnormal coordination	phenotype	C23;C10	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     2557	GABRA4	0.751	0.308	C0750937	Ataxia, Appendicular	phenotype	C23;C10	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     2557	GABRA4	0.751	0.308	C0750940	Tremor, Rubral	disease	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	PSYGENET
     2558	GABRA5	0.621	0.385	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2001	2007	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1998	2010	   5	   0	PSYGENET
     2558	GABRA5	0.621	0.385	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2001	2001	   1	   0	PSYGENET
     2558	GABRA5	0.621	0.385	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0150080	Social Communication Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.31	1	2018	2019	   1	   0	GENOMICS_ENGLAND
     2558	GABRA5	0.621	0.385	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	1998	1998	   1	   0	PSYGENET
     2558	GABRA5	0.621	0.385	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.31	1	2018	2019	   1	   0	GENOMICS_ENGLAND
     2558	GABRA5	0.621	0.385	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.31	1	2010	2017	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C3711376	Isodicentric Chromosome 15 Syndrome	disease	C16	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   1	   0	CTD_human
     2558	GABRA5	0.621	0.385	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	0.667	1999	2019	   3	   0	PSYGENET
     2559	GABRA6	0.678	0.423	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     2559	GABRA6	0.678	0.423	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2006	2017	   1	   0	PSYGENET
     2559	GABRA6	0.678	0.423	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2017	   1	   0	PSYGENET
     2559	GABRA6	0.678	0.423	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2013	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	PSYGENET
     2559	GABRA6	0.678	0.423	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2559	GABRA6	0.678	0.423	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2560	GABRB1	0.686	0.5	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	1999	2006	   5	   0	PSYGENET
     2560	GABRB1	0.686	0.5	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2005	2013	   2	   0	CTD_human
     2560	GABRB1	0.686	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   2	   0	PSYGENET
     2560	GABRB1	0.686	0.5	C0019147	Hepatic Coma	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2560	GABRB1	0.686	0.5	C0019151	Hepatic Encephalopathy	disease	C06;C18;C10	Disease or Syndrome	0.50	1	2005	2005	   1	   0	CTD_human
     2560	GABRB1	0.686	0.5	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2560	GABRB1	0.686	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2010	2014	   2	   0	PSYGENET
     2560	GABRB1	0.686	0.5	C0270496	Schizoaffective disorder, bipolar type	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2560	GABRB1	0.686	0.5	C0751197	Fulminant Hepatic Failure with Cerebral Edema	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2560	GABRB1	0.686	0.5	C0751198	Hepatic Stupor	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2560	GABRB1	0.686	0.5	C4310691	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	disease		Disease or Syndrome	0.70	1	2013	2016	   3	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2561	GABRB2	0.619	0.5	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	0.667	2005	2010	   3	   0	PSYGENET
     2561	GABRB2	0.619	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
     2561	GABRB2	0.619	0.5	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.34	1	2011	2018	   1	   0	CTD_human
     2561	GABRB2	0.619	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.955	2004	2019	   1	   0	CTD_human
     2561	GABRB2	0.619	0.5	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2561	GABRB2	0.619	0.5	C0236018	Aura	phenotype	C10	Finding	0.30	1	2018	2018	   1	   0	CTD_human
     2561	GABRB2	0.619	0.5	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     2561	GABRB2	0.619	0.5	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2561	GABRB2	0.619	0.5	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2014	2018	   1	   0	CTD_human
     2561	GABRB2	0.619	0.5	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2014	2017	   1	   0	GENOMICS_ENGLAND
     2561	GABRB2	0.619	0.5	C4693362	EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2	disease		Disease or Syndrome	0.50	1	2014	2017	   3	   0	GENOMICS_ENGLAND;UNIPROT
     2562	GABRB3	0.546	0.615	C0001890	Akinetic Petit Mal	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	1998	2013	   4	   0	PSYGENET
     2562	GABRB3	0.546	0.615	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.867	1998	2018	   2	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2001	2010	   2	   0	PSYGENET
     2562	GABRB3	0.546	0.615	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	2001	2012	   5	   0	PSYGENET
     2562	GABRB3	0.546	0.615	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2001	2012	   5	   0	PSYGENET
     2562	GABRB3	0.546	0.615	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.39	1	1998	2019	   2	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0014553	Absence Epilepsy	disease	C10	Disease or Syndrome	0.50	0.917	1999	2019	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0021603	Sleep Initiation and Maintenance Disorders	disease	C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0033139	Primary Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.37	1	2005	2019	   2	   0	PSYGENET
     2562	GABRB3	0.546	0.615	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2005	2018	   2	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0162635	Angelman Syndrome	disease	C16;C10	Disease or Syndrome	0.40	1	1991	2019	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0236018	Aura	phenotype	C10	Finding	0.30	1	2005	2018	   2	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0238111	Lennox-Gastaut syndrome	disease	C16;C10	Disease or Syndrome	0.34	1	2013	2019	   2	   0	ORPHANET
     2562	GABRB3	0.546	0.615	C0270541	Rebound Insomnia	phenotype	C10;F03	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0349255	Nonorganic Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2005	2005	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0393759	Transient Insomnia	phenotype	C10;F03	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0541798	Early Awakening	phenotype	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2005	2018	   2	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0751124	Epilepsy, Absence, Atypical	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0751249	Chronic Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0751250	Psychophysiological Insomnia	disease	C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0751251	Secondary Insomnia	phenotype	C10;F03	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0751252	Sleep Initiation Dysfunction	disease	C10;F03	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C0917801	Sleeplessness	phenotype	C10;F03	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.54	1	2005	2018	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	1999	2018	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	disease		Disease or Syndrome	0.40	1	2008	2017	   1	   3	ORPHANET
     2562	GABRB3	0.546	0.615	C2677087	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5	phenotype		Finding	0.60	1	2008	2017	   3	   6	GENOMICS_ENGLAND;UNIPROT
     2562	GABRB3	0.546	0.615	C3711376	Isodicentric Chromosome 15 Syndrome	disease	C16	Disease or Syndrome	0.31	1	2013	2013	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C4281785	Childhood Absence Epilepsy	disease	C10	Disease or Syndrome	0.40	0.9	1999	2019	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C4310712	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	disease		Disease or Syndrome	0.60	1	2013	2017	   6	   8	CTD_human;UNIPROT
     2562	GABRB3	0.546	0.615	C4317339	Juvenile Absence Epilepsy	disease	C10	Disease or Syndrome	0.31	1	2008	2019	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C4552765	Epilepsy, Minor	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2562	GABRB3	0.546	0.615	C4553705	Absence Seizure Disorder	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2563	GABRD	0.558	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2563	GABRD	0.558	0.692	C0270850	Idiopathic generalized epilepsy	disease	C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2563	GABRD	0.558	0.692	C0270853	Juvenile Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.32	1	2010	2018	   1	   0	ORPHANET
     2563	GABRD	0.558	0.692	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2563	GABRD	0.558	0.692	C1842870	Chromosome 1p36 Deletion Syndrome	disease	C23;C16	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
     2563	GABRD	0.558	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     2563	GABRD	0.558	0.692	C2751603	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10	disease		Finding	0.50	1	2004	2018	   2	   2	GENOMICS_ENGLAND;UNIPROT
     2563	GABRD	0.558	0.692	C3502809	Generalized Epilepsy with Febrile Seizures Plus	disease	C23;C10	Disease or Syndrome	0.33	1	2004	2010	   0	   0	ORPHANET
     2565	GABRG1	0.78	0.192	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2008	2014	   4	   0	PSYGENET
     2565	GABRG1	0.78	0.192	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     2566	GABRG2	0.548	0.654	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2014	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.53	1	2005	2018	   3	   0	CTD_human;PSYGENET
     2566	GABRG2	0.548	0.654	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0009952	Febrile Convulsions	disease	C23;C10	Disease or Syndrome	0.50	0.85	2002	2019	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.40	0.844	2001	2019	   8	   0	CLINGEN
     2566	GABRG2	0.548	0.654	C0019147	Hepatic Coma	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0019151	Hepatic Encephalopathy	disease	C06;C18;C10	Disease or Syndrome	0.51	1	2005	2014	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	0.5	2005	2014	   4	   0	PSYGENET
     2566	GABRG2	0.548	0.654	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0149886	Seizure, Febrile, Simple	disease	C23;C10	Disease or Syndrome	0.31	1	2012	2014	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0376532	Epilepsy, Rolandic	disease	C10	Disease or Syndrome	0.31	1	2015	2015	   1	   0	ORPHANET
     2566	GABRG2	0.548	0.654	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0751057	Seizure, Febrile, Complex	disease	C23;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0751122	Infantile Severe Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.40	0.941	2002	2017	   3	   0	ORPHANET
     2566	GABRG2	0.548	0.654	C0751197	Fulminant Hepatic Failure with Cerebral Edema	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C0751198	Hepatic Stupor	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2566	GABRG2	0.548	0.654	C1838604	EPILEPSY, CHILDHOOD ABSENCE, 1	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     2566	GABRG2	0.548	0.654	C1843244	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2	disease		Disease or Syndrome	0.60	1	2001	2018	   5	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2566	GABRG2	0.548	0.654	C1858674	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3	disease	C23;C10	Disease or Syndrome	0.50	1	2001	2018	   5	   0	GENOMICS_ENGLAND;UNIPROT
     2566	GABRG2	0.548	0.654	C2363129	Benign Rolandic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     2566	GABRG2	0.548	0.654	C3502809	Generalized Epilepsy with Febrile Seizures Plus	disease	C23;C10	Disease or Syndrome	0.38	1	2002	2014	   0	   0	ORPHANET
     2567	GABRG3	0.711	0.423	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2004	2015	   1	   0	PSYGENET
     2567	GABRG3	0.711	0.423	C3711376	Isodicentric Chromosome 15 Syndrome	disease	C16	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2568	GABRP	0.736	0.462	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2005	2019	   0	   1	UNIPROT
     2569	GABRR1	0.839	0.115	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2569	GABRR1	0.839	0.115	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   2	   0	PSYGENET
     2569	GABRR1	0.839	0.115	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2570	GABRR2	0.805	0.115	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2570	GABRR2	0.805	0.115	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     2570	GABRR2	0.805	0.115	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2570	GABRR2	0.805	0.115	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2570	GABRR2	0.805	0.115	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     2570	GABRR2	0.805	0.115	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     2570	GABRR2	0.805	0.115	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.35	1	1988	2018	   5	   0	PSYGENET
     2571	GAD1	0.486	0.885	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2004	2018	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2000	2017	   6	   0	CTD_human;PSYGENET
     2571	GAD1	0.486	0.885	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	1	2008	2020	   4	   0	PSYGENET
     2571	GAD1	0.486	0.885	C0011574	Involutional Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2008	2020	   4	   0	PSYGENET
     2571	GAD1	0.486	0.885	C0013386	Dyskinesia, Drug-Induced	disease	C23;C10;C25	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0020514	Hyperprolactinemia	disease	C10;C19	Disease or Syndrome	0.30	1	1982	1982	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.956	2000	2019	   4	   0	CTD_human
     2571	GAD1	0.486	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2014	   5	   0	PSYGENET
     2571	GAD1	0.486	0.885	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2011	   1	   0	PSYGENET
     2571	GAD1	0.486	0.885	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C0751088	Dyskinesia, Medication-Induced	phenotype	C23;C10;C25	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.53	1	2005	2014	   6	   0	CTD_human;PSYGENET
     2571	GAD1	0.486	0.885	C1571983	Involutional paraphrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C1571984	Psychosis, Involutional	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2571	GAD1	0.486	0.885	C2751938	Cerebral Palsy, Spastic Quadriplegic, 1	disease	C10	Disease or Syndrome	0.70	1	2004	2004	   1	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2572	GAD2	0.529	0.731	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0011574	Involutional Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0011884	Diabetic Retinopathy	disease	C11;C19;C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.38	0.9	2004	2017	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.34	1	1996	2018	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2009	2016	   1	   0	PSYGENET
     2572	GAD2	0.529	0.731	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2005	2018	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C1571983	Involutional paraphrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C1571984	Psychosis, Involutional	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2572	GAD2	0.529	0.731	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1996	1996	   2	   0	CTD_human
     2572	GAD2	0.529	0.731	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2580	GAK	0.805	0.231	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.50	1	2009	2020	   1	   3	CTD_human
     2581	GALC	0.604	0.615	C0023521	Globoid cell leukodystrophy	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1970	2020	  14	 106	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2581	GALC	0.604	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2581	GALC	0.604	0.615	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2010	2010	   1	   2	GENOMICS_ENGLAND
     2581	GALC	0.604	0.615	C0268252	Late-Onset Globoid Cell Leukodystrophy	disease	C16;C18;C10	Disease or Syndrome	0.56	1	1981	2019	   1	   0	CTD_human;ORPHANET
     2581	GALC	0.604	0.615	C0751273	Infantile Globoid Cell Leukodystrophy	disease	C16;C18;C10	Disease or Syndrome	0.59	0.9	1995	2019	   1	   0	CTD_human;ORPHANET
     2582	GALE	0.722	0.385	C0016952	Galactosemias	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1998	2019	   1	   0	CTD_human
     2582	GALE	0.722	0.385	C0268151	Classical galactosemia	disease	C16;C18;C10	Disease or Syndrome	0.40	1	1995	2019	   1	   0	CTD_human
     2582	GALE	0.722	0.385	C0268155	Deficiency of galactokinase	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2582	GALE	0.722	0.385	C0751161	UDPglucose 4-epimerase deficiency disease	disease	C16;C18;C10	Disease or Syndrome	0.72	1	1995	2015	   9	  16	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2582	GALE	0.722	0.385	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     2583	B4GALNT1	0.644	0.615	C1441613	Immune diffusion	phenotype		Laboratory Procedure	0.30				   0	   0	GENOMICS_ENGLAND
     2583	B4GALNT1	0.644	0.615	C1836632	SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE (disorder)	disease	C16;C10	Disease or Syndrome	0.70	1	2013	2014	   2	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2584	GALK1	0.682	0.346	C0016952	Galactosemias	disease	C16;C18;C10	Disease or Syndrome	0.40	0.933	1988	2019	   1	   0	CTD_human
     2584	GALK1	0.682	0.346	C0086543	Cataract	disease	C11	Acquired Abnormality	0.50	0.909	1986	2018	   1	   0	CTD_human
     2584	GALK1	0.682	0.346	C0268151	Classical galactosemia	disease	C16;C18;C10	Disease or Syndrome	0.40	0.923	1988	2019	   1	   0	CTD_human
     2584	GALK1	0.682	0.346	C0268155	Deficiency of galactokinase	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1986	2018	   8	  22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2584	GALK1	0.682	0.346	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     2584	GALK1	0.682	0.346	C0751161	UDPglucose 4-epimerase deficiency disease	disease	C16;C18;C10	Disease or Syndrome	0.32	1	1995	2017	   1	   0	CTD_human
     2584	GALK1	0.682	0.346	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	1995	1995	   1	   0	CTD_human
     2587	GALR1	0.656	0.5	C0011574	Involutional Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     2587	GALR1	0.656	0.5	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     2587	GALR1	0.656	0.5	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     2587	GALR1	0.656	0.5	C1571983	Involutional paraphrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     2587	GALR1	0.656	0.5	C1571984	Psychosis, Involutional	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
     2588	GALNS	0.56	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     2588	GALNS	0.56	0.808	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	1994	1994	   1	   0	CTD_human
     2588	GALNS	0.56	0.808	C0026707	Mucopolysaccharidosis IV	disease	C16;C18;C17	Disease or Syndrome	0.90	1	1980	2016	   2	   7	CTD_human;GENOMICS_ENGLAND
     2588	GALNS	0.56	0.808	C0086651	Mucopolysaccharidosis, MPS-IV-A	disease	C16;C18;C17	Disease or Syndrome	0.80	1	1988	2019	  14	  82	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2588	GALNS	0.56	0.808	C0086652	Mucopolysaccharidosis type IVB	disease	C16;C18;C17	Disease or Syndrome	0.30				   0	   0	CTD_human
     2588	GALNS	0.56	0.808	C3179194	GALNS Deficiency	disease	C16;C18;C17	Disease or Syndrome	0.33	1	1999	2019	   0	   0	CTD_human
     2591	GALNT3	0.603	0.769	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.43	1	2004	2008	   1	   0	CTD_human
     2591	GALNT3	0.603	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2591	GALNT3	0.603	0.769	C0085681	Hyperphosphatemia (disorder)	disease	C18	Disease or Syndrome	0.48	1	2007	2017	   1	   0	CTD_human
     2591	GALNT3	0.603	0.769	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.38	1	2005	2015	   1	   0	CTD_human
     2591	GALNT3	0.603	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2005	2007	   1	   0	CTD_human
     2591	GALNT3	0.603	0.769	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     2591	GALNT3	0.603	0.769	C1876187	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	disease	C16;C18;C05	Disease or Syndrome	0.80	1	2004	2019	   2	   0	CTD_human;ORPHANET
     2591	GALNT3	0.603	0.769	C4692564	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1	disease		Disease or Syndrome	0.80	1	2004	2016	   3	  14	GENOMICS_ENGLAND;ORPHANET
     2592	GALT	0.612	0.654	C0016952	Galactosemias	disease	C16;C18;C10	Disease or Syndrome	0.80	0.963	1970	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     2592	GALT	0.612	0.654	C0086543	Cataract	disease	C11	Acquired Abnormality	0.42	1	2008	2016	   1	   0	GENOMICS_ENGLAND
     2592	GALT	0.612	0.654	C0268151	Classical galactosemia	disease	C16;C18;C10	Disease or Syndrome	0.80	0.993	1970	2020	  29	 223	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2592	GALT	0.612	0.654	C0268155	Deficiency of galactokinase	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2592	GALT	0.612	0.654	C0751161	UDPglucose 4-epimerase deficiency disease	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2001	2013	   1	   0	CTD_human
     2592	GALT	0.612	0.654	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     2593	GAMT	0.691	0.269	C0002514	Amino Acid Metabolism, Inborn Errors	group	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.40	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     2593	GAMT	0.691	0.269	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.60	1	2005	2014	   2	   0	CTD_human;GENOMICS_ENGLAND
     2593	GAMT	0.691	0.269	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.40	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.40	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.40	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0574080	Guanidinoacetate methyltransferase deficiency	disease	C23;C10	Disease or Syndrome	0.94	1	1940	2017	  21	  18	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     2593	GAMT	0.691	0.269	C0750905	Amino Acid Metabolism, Inherited Disorders	disease	C16;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.60	1	1996	2005	   2	   0	CTD_human;GENOMICS_ENGLAND
     2593	GAMT	0.691	0.269	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     2593	GAMT	0.691	0.269	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2006	   1	   0	PSYGENET
     2596	GAP43	0.564	0.731	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	PSYGENET
     2596	GAP43	0.564	0.731	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	1998	2020	   1	   0	PSYGENET
     2596	GAP43	0.564	0.731	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1998	2020	   1	   0	PSYGENET
     2596	GAP43	0.564	0.731	C0013415	Dysthymic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2000	2000	   1	   0	PSYGENET
     2596	GAP43	0.564	0.731	C0017181	Gastrointestinal Hemorrhage	phenotype	C23;C06	Pathologic Function	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     2596	GAP43	0.564	0.731	C0019569	Hirschsprung Disease	disease	C16;C06	Disease or Syndrome	0.31	1	2012	2018	   1	   0	GENOMICS_ENGLAND
     2596	GAP43	0.564	0.731	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     2596	GAP43	0.564	0.731	C0020179	Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     2596	GAP43	0.564	0.731	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	1	1998	2012	   4	   0	PSYGENET
     2596	GAP43	0.564	0.731	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.31	1	1999	2017	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     2596	GAP43	0.564	0.731	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2596	GAP43	0.564	0.731	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2597	GAPDH	0.447	0.808	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.33	1	2003	2015	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2006	2019	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2015	2015	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.31	1	2008	2017	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.32	1	2004	2019	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2005	2005	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2597	GAPDH	0.447	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1988	2019	   2	   0	CTD_human
     2617	GARS1	0.623	0.5	C1832274	Charcot-Marie-Tooth disease, Type 2D	disease	C16;C10	Disease or Syndrome	0.90	1	2003	2019	   9	   9	CTD_human;UNIPROT
     2617	GARS1	0.623	0.5	C1833308	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V	disease	C10	Disease or Syndrome	0.80	1	2000	2018	   5	   8	CTD_human;ORPHANET;UNIPROT
     2618	GART	0.631	0.615	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2618	GART	0.631	0.615	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     2619	GAS1	0.587	0.654	C0078982	Arhinencephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     2619	GAS1	0.587	0.654	C0079541	Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.43	1	2007	2012	   1	   0	CTD_human
     2619	GAS1	0.587	0.654	C0431362	Lobar Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.50	1	2007	2007	   1	   0	CTD_human;ORPHANET
     2619	GAS1	0.587	0.654	C0431363	Alobar Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.50	1	2007	2007	   1	   0	CTD_human;ORPHANET
     2619	GAS1	0.587	0.654	C0751617	Semilobar Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.50	1	2007	2007	   1	   0	CTD_human;ORPHANET
     2620	GAS2	0.792	0.269	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     2620	GAS2	0.792	0.269	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     2620	GAS2	0.792	0.269	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.34	1	2003	2018	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.31	1	2009	2019	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0040038	Thromboembolism	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.31	1	2001	2006	   4	   0	CTD_human
     2621	GAS6	0.5	0.769	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2001	2006	   4	   0	CTD_human
     2621	GAS6	0.5	0.769	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2621	GAS6	0.5	0.769	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
     2622	GAS8	0.636	0.654	C0022521	Kartagener Syndrome	disease	C16;C08;C09;C14	Disease or Syndrome	0.31	1	2015	2015	   1	   0	ORPHANET
     2622	GAS8	0.636	0.654	C4225230	CILIARY DYSKINESIA, PRIMARY, 33	disease		Disease or Syndrome	0.90	1	2015	2016	   3	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2622	GAS8	0.636	0.654	C4317124	Polynesian Bronchiectasis	disease	C16;C08;C09;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     2622	GAS8	0.636	0.654	C4551720	Primary Ciliary Dyskinesia	disease	C16;C08;C09	Disease or Syndrome	0.53	1	2015	2019	   2	   0	GENOMICS_ENGLAND;ORPHANET
     2622	GAS8	0.636	0.654	C4551906	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	disease	C16;C08;C09;C14	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     2623	GATA1	0.483	0.808	C0002871	Anemia	disease	C15	Disease or Syndrome	0.50	1	2000	2019	   1	   0	GENOMICS_ENGLAND
     2623	GATA1	0.483	0.808	C0013080	Down Syndrome	disease	C16;C10	Disease or Syndrome	0.40	0.981	2002	2020	   0	   0	CTD_human
     2623	GATA1	0.483	0.808	C0023437	Acute Basophilic Leukemia	disease	C04	Neoplastic Process	0.32	1	2011	2019	   1	   0	ORPHANET
     2623	GATA1	0.483	0.808	C0023462	Acute Megakaryocytic Leukemias	disease	C04	Neoplastic Process	0.50	0.955	2002	2018	   0	   1	CGI
     2623	GATA1	0.483	0.808	C0027947	Neutropenia	disease	C15	Disease or Syndrome	0.40	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     2623	GATA1	0.483	0.808	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.90	0.947	1995	2020	   3	   2	CTD_human;GENOMICS_ENGLAND
     2623	GATA1	0.483	0.808	C0162530	Porphyria, Erythropoietic	disease	C16;C18;C17	Disease or Syndrome	0.55	1	2001	2019	   1	   0	GENOMICS_ENGLAND;ORPHANET
     2623	GATA1	0.483	0.808	C0432416	Down Syndrome, Partial Trisomy 21	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2623	GATA1	0.483	0.808	C0432417	Trisomy 21, Meiotic Nondisjunction	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2623	GATA1	0.483	0.808	C0751081	Trisomy 21, Mitotic Nondisjunction	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2623	GATA1	0.483	0.808	C1260899	Anemia, Diamond-Blackfan	disease	C16;C15	Disease or Syndrome	0.70	1	1996	2019	   6	   4	GENOMICS_ENGLAND;ORPHANET
     2623	GATA1	0.483	0.808	C1834582	MYELOPROLIFERATIVE SYNDROME, TRANSIENT	disease	C16;C10;C15	Neoplastic Process	0.40	0.97	2003	2020	   1	   0	ORPHANET
     2623	GATA1	0.483	0.808	C1839161	Thrombocytopenia, Platelet Dysfunction, Hemolysis, and Imbalanced Globin Synthesis	disease	C23;C16;C15	Disease or Syndrome	0.70	1	1977	2014	   2	  12	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2623	GATA1	0.483	0.808	C1845837	Dyserythropoietic Anemia with Thrombocytopenia	disease	C16;C15	Disease or Syndrome	0.43	1	1996	2014	   0	   2	ORPHANET
     2623	GATA1	0.483	0.808	C1860788	Transient Myeloproliferative Disorder of Down Syndrome	disease	C16;C10;C15	Disease or Syndrome	0.31	1	2003	2013	   1	   0	CTD_human
     2623	GATA1	0.483	0.808	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.50	1	1998	2017	   1	   0	CTD_human
     2623	GATA1	0.483	0.808	C2718078	Deficiency of Uroporphyrinogen III Synthase	disease	C16;C18;C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	ORPHANET
     2623	GATA1	0.483	0.808	C2931850	Aase Smith syndrome 2	disease	C16;C15	Disease or Syndrome	0.30	1	2012	2014	   2	   0	ORPHANET
     2623	GATA1	0.483	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.40	1	1999	2020	   1	   0	CTD_human
     2623	GATA1	0.483	0.808	C3550789	THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA	disease		Disease or Syndrome	0.70	1	2000	2018	   8	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2623	GATA1	0.483	0.808	C3550856	ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES	disease		Disease or Syndrome	0.70	1	2000	2018	   6	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2623	GATA1	0.483	0.808	C4228778	Abnormality of radial ray	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
     2624	GATA2	0.496	0.654	C0007302	Cartilage Diseases	group	C17;C05	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2624	GATA2	0.496	0.654	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.80	0.974	1994	2020	   4	   2	CGI;CTD_human;GENOMICS_ENGLAND
     2624	GATA2	0.496	0.654	C0024236	Lymphedema	disease	C15	Pathologic Function	0.40	1	2011	2011	   1	   0	CTD_human
     2624	GATA2	0.496	0.654	C0026985	Myelodysplasia	disease		Congenital Abnormality	0.47	1	2011	2019	   1	   0	ORPHANET
     2624	GATA2	0.496	0.654	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.31	1	2011	2015	   2	   0	CTD_human
     2624	GATA2	0.496	0.654	C0085700	Chondromalacia	disease	C17;C05	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2624	GATA2	0.496	0.654	C0243050	Cardiovascular Abnormalities	group	C16;C14	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     2624	GATA2	0.496	0.654	C0340970	Congenital neutropenia	disease	C16;C15	Congenital Abnormality	0.33	1	2015	2018	   1	   0	GENOMICS_ENGLAND
     2624	GATA2	0.496	0.654	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	0.32	1	2015	2019	   1	   0	CTD_human
     2624	GATA2	0.496	0.654	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     2624	GATA2	0.496	0.654	C1704423	Milroy Disease	disease	C15	Disease or Syndrome	0.34	1	2011	2017	   1	   0	CTD_human
     2624	GATA2	0.496	0.654	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
     2624	GATA2	0.496	0.654	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2011	2017	   3	   0	CTD_human
     2624	GATA2	0.496	0.654	C3279664	Emberger Syndrome	disease	C16	Disease or Syndrome	0.77	1	2010	2018	   4	  15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2624	GATA2	0.496	0.654	C3280030	GATA2 Deficiency	disease	C16	Disease or Syndrome	0.80	1	1994	2019	  13	  18	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2624	GATA2	0.496	0.654	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.80	0.976	2002	2019	   5	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2624	GATA2	0.496	0.654	C4707228	Inherited acute myeloid leukemia	disease	C04	Neoplastic Process	0.30	1	2011	2015	   2	   0	ORPHANET
     2625	GATA3	0.415	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.43	1	2005	2019	   1	   2	CTD_human
     2625	GATA3	0.415	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	0.95	1999	2020	   0	   0	CGI;UNIPROT
     2625	GATA3	0.415	0.846	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.30	1	2013	2013	   3	   0	ORPHANET
     2625	GATA3	0.415	0.846	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	1	2005	2019	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0014457	Eosinophilia	disease	C15	Disease or Syndrome	0.33	0.75	2008	2018	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0014458	Eosinophilia, Tropical	disease	C15	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.46	1	2005	2019	   1	   1	CTD_human
     2625	GATA3	0.415	0.846	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0023485	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	1	2013	2018	   1	   1	CTD_human
     2625	GATA3	0.415	0.846	C0023493	Adult T-Cell Lymphoma/Leukemia	disease	C04;C20;C15	Neoplastic Process	0.31	1	2000	2015	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0025568	Metaplasia	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.36	1	2010	2019	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0152266	Mixed Cellularity Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0152267	Hodgkin lymphoma, lymphocyte depletion	disease	C04;C20;C15	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0220597	Adult Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.36	1	2005	2019	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     2625	GATA3	0.415	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.94	1999	2020	   0	   0	CGI
     2625	GATA3	0.415	0.846	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2016	2016	   0	   0	CGI
     2625	GATA3	0.415	0.846	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C1266194	Lymphocyte Rich Classical Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2013	2013	   3	   0	ORPHANET
     2625	GATA3	0.415	0.846	C1334968	Nodular Lymphocyte Predominant Hodgkin Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2010	2019	   1	   0	CTD_human
     2625	GATA3	0.415	0.846	C1840333	Barakat syndrome	disease	C23;C13;C12;C10;C19;C09	Disease or Syndrome	1.00	0.957	1995	2019	  16	   8	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2625	GATA3	0.415	0.846	C2930967	Gastro-enteropancreatic neuroendocrine tumor	disease	C06;C04;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2011	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.35	0.8	2011	2016	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.34	1	2010	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2003	2009	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2003	2009	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2005	2008	   2	   0	CTD_human
     2626	GATA4	0.458	0.846	C0018818	Ventricular Septal Defects	group	C16;C14	Congenital Abnormality	0.50	0.95	2006	2018	   0	   0	CTD_human
     2626	GATA4	0.458	0.846	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.50	1	2007	2008	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.55	1	2010	2019	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.80	0.952	2006	2018	   3	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2626	GATA4	0.458	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0158981	Neonatal diabetes mellitus	disease	C16;C18;C19	Disease or Syndrome	0.31	1	2010	2014	   1	   0	GENOMICS_ENGLAND
     2626	GATA4	0.458	0.846	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0235833	Congenital diaphragmatic hernia	disease	C23;C16	Congenital Abnormality	0.46	1	2008	2013	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0265699	Congenital hernia of foramen of Morgagni	disease	C23;C16	Congenital Abnormality	0.30	1	2013	2013	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0265700	Congenital hernia of foramen of Bochdalek	disease	C23;C16	Congenital Abnormality	0.30	1	2013	2013	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0344724	Ostium secundum atrial septal defect	disease	C16;C14	Congenital Abnormality	0.41	1	2003	2011	   3	   1	ORPHANET
     2626	GATA4	0.458	0.846	C0344735	Partial atrioventricular canal	disease	C16;C14	Congenital Abnormality	0.40	1	2003	2009	   3	   0	ORPHANET
     2626	GATA4	0.458	0.846	C0600519	Ventricular Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2018	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C0600520	Left Ventricle Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2018	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2005	2008	   2	   0	CTD_human
     2626	GATA4	0.458	0.846	C1389016	ATRIOVENTRICULAR CANAL DEFECT	disease	C16;C14	Anatomical Abnormality	0.45	1	2007	2017	   0	   0	CTD_human
     2626	GATA4	0.458	0.846	C1389018	Atrioventricular Septal Defect	disease	C16;C14	Congenital Abnormality	0.32	1	2016	2016	   0	   0	CTD_human
     2626	GATA4	0.458	0.846	C1842778	Atrial septal defect 2	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.90	1	2003	2016	   7	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2626	GATA4	0.458	0.846	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.30	1	2011	2012	   3	   0	ORPHANET
     2626	GATA4	0.458	0.846	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C2931638	Chromosome 8, monosomy 8p23 1	disease	C23	Disease or Syndrome	0.30	1	1999	2009	   2	   0	ORPHANET
     2626	GATA4	0.458	0.846	C3280777	VENTRICULAR SEPTAL DEFECT 1	disease		Disease or Syndrome; Congenital Abnormality	0.60	1	2009	2012	   4	   7	GENOMICS_ENGLAND;UNIPROT
     2626	GATA4	0.458	0.846	C3280781	ATRIOVENTRICULAR SEPTAL DEFECT 4	disease		Disease or Syndrome; Congenital Abnormality	0.60	1	2003	2007	   1	   3	GENOMICS_ENGLAND;UNIPROT
     2626	GATA4	0.458	0.846	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     2626	GATA4	0.458	0.846	C3809858	TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE	disease		Disease or Syndrome	0.70	1	2011	2011	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2626	GATA4	0.458	0.846	C4510744	46,XY partial gonadal dysgenesis	disease		Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     2627	GATA6	0.478	0.808	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.51	1	2008	2019	   1	   0	CTD_human
     2627	GATA6	0.478	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2627	GATA6	0.478	0.808	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.73	1	2010	2014	   2	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2627	GATA6	0.478	0.808	C0158981	Neonatal diabetes mellitus	disease	C16;C18;C19	Disease or Syndrome	0.36	1	2012	2019	   1	   0	GENOMICS_ENGLAND
     2627	GATA6	0.478	0.808	C0235833	Congenital diaphragmatic hernia	disease	C23;C16	Congenital Abnormality	0.43	1	2014	2019	   1	   3	ORPHANET
     2627	GATA6	0.478	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.34	1	2004	2020	   1	   0	CTD_human
     2627	GATA6	0.478	0.808	C0344724	Ostium secundum atrial septal defect	disease	C16;C14	Congenital Abnormality	0.40	1	2010	2010	   1	   0	ORPHANET
     2627	GATA6	0.478	0.808	C0344735	Partial atrioventricular canal	disease	C16;C14	Congenital Abnormality	0.30	1	2010	2010	   1	   0	ORPHANET
     2627	GATA6	0.478	0.808	C1389016	ATRIOVENTRICULAR CANAL DEFECT	disease	C16;C14	Anatomical Abnormality	0.41	1	2017	2017	   0	   0	CTD_human
     2627	GATA6	0.478	0.808	C1389018	Atrioventricular Septal Defect	disease	C16;C14	Congenital Abnormality	0.40				   0	   0	CTD_human
     2627	GATA6	0.478	0.808	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.30	1	2012	2012	   3	   0	ORPHANET
     2627	GATA6	0.478	0.808	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	disease	C16;C14	Disease or Syndrome	0.60	1	2009	2016	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2627	GATA6	0.478	0.808	C2931296	Yorifuji Okuno syndrome	disease	C23;C18;C13;C12;C10;C19;F03;F01;C14	Disease or Syndrome	0.30	1	2011	2012	   2	   0	ORPHANET
     2627	GATA6	0.478	0.808	C3280939	ATRIOVENTRICULAR SEPTAL DEFECT 5	disease		Disease or Syndrome; Congenital Abnormality	0.50	1	2010	2010	   2	   1	GENOMICS_ENGLAND;UNIPROT
     2627	GATA6	0.478	0.808	C3280943	ATRIAL SEPTAL DEFECT 9	disease		Disease or Syndrome; Congenital Abnormality	0.60	1	2010	2010	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2627	GATA6	0.478	0.808	C3888085	PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS	disease		Disease or Syndrome	0.31	1	2011	2017	   3	   0	GENOMICS_ENGLAND
     2627	GATA6	0.478	0.808	C3888631	Monogenic diabetes	disease	C18;C19	Disease or Syndrome	0.31	1	2013	2013	   0	   0	GENOMICS_ENGLAND
     2627	GATA6	0.478	0.808	C4012454	HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES	disease		Disease or Syndrome	0.70	1	2010	2017	   3	  10	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2628	GATM	0.666	0.615	C0007097	Carcinoma	group	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.31	1	2006	2006	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.31	1	2006	2006	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0027540	Necrosis	phenotype	C23	Organ or Tissue Function	0.30	1	2012	2012	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     2628	GATM	0.666	0.615	C2675179	Arginine:Glycine Amidinotransferase Deficiency	disease	C23;C16;C18;C10;F03;F01	Disease or Syndrome	0.76	1	1940	2018	  17	  18	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     2629	GBA	0.5	0.808	C0017205	Gaucher Disease	disease	C16;C18;C10	Disease or Syndrome	0.90	0.985	1973	2020	  10	  40	CTD_human;GENOMICS_ENGLAND
     2629	GBA	0.5	0.808	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.50	0.989	2004	2020	   2	   1	CTD_human
     2629	GBA	0.5	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	1997	1997	   1	   0	GENOMICS_ENGLAND
     2629	GBA	0.5	0.808	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.50	1	2004	2020	   1	   2	CTD_human
     2629	GBA	0.5	0.808	C0242423	Ramsay Hunt Paralysis Syndrome	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0268250	Gaucher Disease, Type 2 (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.93	1	1984	2019	  21	  34	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2629	GBA	0.5	0.808	C0268251	Gaucher Disease, Type 3 (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.77	1	1984	2019	  15	  26	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2629	GBA	0.5	0.808	C0752097	Autosomal Dominant Juvenile Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0752098	Autosomal Dominant Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0752100	Autosomal Recessive Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0752101	Parkinsonism, Experimental	disease	C10	Experimental Model of Disease	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0752104	Familial Juvenile Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0752105	Parkinsonism, Juvenile	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C0752347	Lewy Body Disease	disease	C10;F03	Disease or Syndrome	0.50	1	2008	2020	   1	   7	CTD_human
     2629	GBA	0.5	0.808	C1842704	GAUCHER DISEASE, PERINATAL LETHAL	disease	C16;C18;C10	Disease or Syndrome	0.70	1	1984	2016	   8	  16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2629	GBA	0.5	0.808	C1856476	Gaucher Disease, Type Iiic	disease	C16;C18;C10	Disease or Syndrome	0.70	1	1984	2016	   6	  19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2629	GBA	0.5	0.808	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2629	GBA	0.5	0.808	C1961835	Gaucher Disease, Type 1	disease	C16;C18;C10	Disease or Syndrome	1.00	0.984	1983	2020	  62	 113	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2629	GBA	0.5	0.808	C2931585	Gaucher-like disease	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2000	2000	   1	   0	ORPHANET
     2629	GBA	0.5	0.808	C3160718	PARKINSON DISEASE, LATE-ONSET	disease		Disease or Syndrome	0.69	1	2012	2020	   3	  11	CTD_human;GENOMICS_ENGLAND
     2632	GBE1	0.612	0.654	C0017919	Glycogen Storage Disease	group	C16;C18	Disease or Syndrome	0.36	1	1999	2016	   1	   0	GENOMICS_ENGLAND
     2632	GBE1	0.612	0.654	C0017922	Glycogen Storage Disease Type III	disease	C16;C18	Disease or Syndrome	0.31	1	2000	2000	   0	   0	ORPHANET
     2632	GBE1	0.612	0.654	C0017923	Glycogen Storage Disease Type IV	disease	C16;C18	Disease or Syndrome	1.00	1	1996	2017	   7	  20	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2632	GBE1	0.612	0.654	C1276035	Pena-Shokeir syndrome type I	disease	C16;C05	Disease or Syndrome	0.31	1	2004	2011	   1	   0	GENOMICS_ENGLAND
     2632	GBE1	0.612	0.654	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     2632	GBE1	0.612	0.654	C1849722	Polyglucosan Body Disease, Adult Form	disease	C16;C18;C10	Disease or Syndrome	0.80	1	1998	2018	   5	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2632	GBE1	0.612	0.654	C1856303	GSD IV, Neuromuscular Form, Fatal Perinatal	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	ORPHANET
     2632	GBE1	0.612	0.654	C1856304	GSD IV, Neuromuscular Form, Congenital	disease	C16;C18;C10	Disease or Syndrome	0.40				   0	   6	ORPHANET
     2632	GBE1	0.612	0.654	C1856305	GSD IV, Neuromuscular Form, Childhood	disease	C16;C18;C10	Disease or Syndrome	0.40				   0	   1	ORPHANET
     2632	GBE1	0.612	0.654	C1856309	Fetal hydrops (in perinatal or congenital neuromuscular forms)	phenotype		Finding	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     2633	GBP1	0.626	0.731	C0021400	Influenza	disease	C01;C08	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2634	GBP2	0.751	0.385	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2634	GBP2	0.751	0.385	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2637	GBX2	0.751	0.385	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2637	GBX2	0.751	0.385	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2637	GBX2	0.751	0.385	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.35	0.8	1985	2019	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0005944	Metabolic Bone Disorder	group	C18;C05	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0018213	Graves Disease	disease	C11;C20;C19	Disease or Syndrome	0.32	1	2002	2014	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0019147	Hepatic Coma	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0019151	Hepatic Encephalopathy	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.32	1	2014	2019	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.37	0.75	1988	2018	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0029453	Osteopenia	disease	C18;C05	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	1982	2015	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0036981	Endotoxic shock	phenotype	C23;C01	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0036983	Septic Shock	phenotype	C23;C01	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.33	1	1996	2019	   2	   0	CTD_human
     2638	GC	0.489	0.885	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.31	1	2014	2017	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2007	2018	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0600327	Toxic Shock Syndrome	disease	C23;C01	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0751197	Fulminant Hepatic Failure with Cerebral Edema	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0751198	Hepatic Stupor	disease	C06;C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2638	GC	0.489	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2638	GC	0.489	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2638	GC	0.489	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     2638	GC	0.489	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
     2638	GC	0.489	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2638	GC	0.489	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2638	GC	0.489	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2639	GCDH	0.691	0.385	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.43	1	1995	2015	   2	   1	GENOMICS_ENGLAND
     2639	GCDH	0.691	0.385	C0268595	Glutaric aciduria, type 1	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1988	2020	  20	 104	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2641	GCG	0.431	0.885	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.38	1	2017	2019	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.32	0.667	2008	2017	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0007370	Catalepsy	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0009319	Colitis	disease	C06	Disease or Syndrome	0.36	1	2012	2019	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0009421	Comatose	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0009806	Constipation	phenotype	C23	Sign or Symptom	0.31	1	2002	2020	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.40	0.99	1986	2020	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.31	1	1988	2017	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.40	0.919	1995	2020	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.40	0.919	1995	2020	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.40	0.966	1975	2020	   2	   0	CTD_human
     2641	GCG	0.431	0.885	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.40	0.878	1979	2019	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.34	1	1977	2019	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.39	1	2001	2020	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1988	1993	   2	   0	CTD_human
     2641	GCG	0.431	0.885	C0020672	Hypothermia, natural	phenotype	C23	Finding	0.30	1	1999	1999	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.40	0.992	1996	2020	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0037763	Spasm	phenotype	C23;C10	Sign or Symptom	0.30	1	1980	1980	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0038354	Stomach Diseases	group	C06	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0039231	Tachycardia	phenotype	C23;C14	Finding	0.30	1	1995	1995	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0039239	Sinus Tachycardia	disease	C23;C14	Disease or Syndrome	0.30	1	1980	1980	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0042373	Vascular Diseases	group	C14	Disease or Syndrome	0.31	1	1999	2020	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0080203	Tachyarrhythmia	phenotype	C23;C14	Finding	0.30	1	1995	1995	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0151911	Generalized Spasms	phenotype	C23;C10	Finding	0.30	1	1980	1980	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0233612	Waxy flexibility	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0235229	Ciliary Body Spasm	phenotype	C23;C10	Finding	0.30	1	1980	1980	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0237326	Dyschezia	phenotype	C23	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	1984	1998	   5	   0	CTD_human
     2641	GCG	0.431	0.885	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	1999	1999	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C0860634	Psychogenic coma	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	1999	1999	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1257861	Colonic Inertia	phenotype	C23	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1257963	Endogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	1986	1986	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1257964	Exogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	1986	1986	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1257965	Compensatory Hyperinsulinemia	disease	C18	Disease or Syndrome	0.30	1	1986	1986	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	1977	1977	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	1986	2008	   2	   0	CTD_human
     2641	GCG	0.431	0.885	C1879526	Aberrant Crypt Foci	phenotype	C04	Finding	0.30	1	2012	2012	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	1995	1995	   1	   0	CTD_human
     2641	GCG	0.431	0.885	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     2642	GCGR	0.656	0.308	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.50	0.891	1995	2020	   0	   0	CTD_human
     2642	GCGR	0.656	0.308	C1857451	Acth-Independent Macronodular Adrenal Hyperplasia	disease	C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0013386	Dyskinesia, Drug-Induced	disease	C23;C10;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0013421	Dystonia	phenotype	C23;C10	Sign or Symptom	0.70	0.982	1991	2019	   2	   2	CTD_human;GENOMICS_ENGLAND
     2643	GCH1	0.511	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.42	1	2003	2018	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0026837	Muscle Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.40	1	2007	2007	   1	   1	CTD_human
     2643	GCH1	0.511	0.846	C0026858	Musculoskeletal Pain	phenotype	C23;C05	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0030193	Pain	phenotype	C23	Sign or Symptom	0.40	0.885	2007	2019	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2014	2019	   1	   0	PSYGENET
     2643	GCH1	0.511	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2014	2018	   1	   0	PSYGENET
     2643	GCH1	0.511	0.846	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.40	1	2008	2008	   1	   0	GENOMICS_ENGLAND
     2643	GCH1	0.511	0.846	C0037772	Spastic Paraplegia	disease	C23;C10	Disease or Syndrome	0.31	1	2001	2011	   1	   0	GENOMICS_ENGLAND
     2643	GCH1	0.511	0.846	C0086439	Hypokinesia	phenotype	C23;C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0151564	Cogwheel Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0231519	Gegenhalten	phenotype	C23;C05;C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0233565	Bradykinesia	phenotype	C23;C10	Sign or Symptom	0.40	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0233608	Catatonic Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0239325	Extensor Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0242684	Hypodynamia	phenotype	C23;C10	Organism Function	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0268467	Hyperphenylalaninemia, BH4-Deficient, B	disease	C16;C18;C10	Disease or Syndrome	0.75	1	1994	2019	   8	  13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2643	GCH1	0.511	0.846	C0277821	Extrapyramidal Rigidity	phenotype	C23;C05;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2014	2019	   1	   0	PSYGENET
     2643	GCH1	0.511	0.846	C0393588	Dystonia, Paroxysmal	phenotype	C23;C10	Sign or Symptom	0.30	1	2004	2004	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0393610	Dystonia, Diurnal	phenotype	C23;C10	Sign or Symptom	0.32	1	2000	2004	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0751088	Dyskinesia, Medication-Induced	phenotype	C23;C10;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0751093	Dystonia, Limb	phenotype	C23;C10	Sign or Symptom	0.43	1	2004	2017	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C0751701	Hypokinesia, Antiorthostatic	phenotype	C23;C10	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C1320474	Nuchal Rigidity	phenotype	C23;C05;C10	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     2643	GCH1	0.511	0.846	C1851920	Dopa-Responsive Dystonia	disease	C10	Disease or Syndrome	0.80	0.939	1989	2019	  19	  26	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2643	GCH1	0.511	0.846	C1855483	Progressive spastic paraplegia	phenotype	C23;C10	Finding	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     2644	GCHFR	0.579	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	1990	2005	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.90	0.953	1992	2020	   4	   7	CTD_human;GENOMICS_ENGLAND
     2645	GCK	0.523	0.808	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.50	1	1992	2020	   1	  14	CTD_human
     2645	GCK	0.523	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C0158981	Neonatal diabetes mellitus	disease	C16;C18;C19	Disease or Syndrome	0.40	1	2003	2018	   0	   0	GENOMICS_ENGLAND
     2645	GCK	0.523	0.808	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.70	0.978	1992	2020	   2	   6	GENOMICS_ENGLAND;ORPHANET
     2645	GCK	0.523	0.808	C0342277	Diabetes mellitus autosomal dominant type II (disorder)	disease	C18;C19	Disease or Syndrome	1.00	1	1992	2019	  21	 137	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2645	GCK	0.523	0.808	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	disease	C18;C19	Disease or Syndrome	0.80	1	2001	2019	   4	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2645	GCK	0.523	0.808	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C1865290	Hyperinsulinemic hypoglycemia, familial, 3	disease	C18	Disease or Syndrome	0.70	1	1998	2017	   9	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2645	GCK	0.523	0.808	C2609269	Fasting hyperglycaemia	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
     2645	GCK	0.523	0.808	C2931832	Hyperinsulinemic hypoglycemia, familial, 1	disease	C16;C06;C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C2931833	Hyperinsulinemic hypoglycemia, familial, 2	disease	C16;C06;C18	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C3888018	Congenital Hyperinsulinism	disease	C16;C06;C18	Disease or Syndrome	0.50	0.958	1997	2019	   1	   0	CTD_human
     2645	GCK	0.523	0.808	C3888631	Monogenic diabetes	disease	C18;C19	Disease or Syndrome	0.50	0.977	2002	2019	   0	   8	GENOMICS_ENGLAND
     2646	GCKR	0.604	0.615	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.50	0.957	2005	2020	   1	   3	CTD_human
     2646	GCKR	0.604	0.615	C0020557	Hypertriglyceridemia	phenotype	C18	Disease or Syndrome	0.49	0.909	2010	2019	   1	   3	CTD_human
     2647	BLOC1S1	1	0.038	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2015	2015	   1	   0	PSYGENET
     2650	GCNT1	0.716	0.346	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2650	GCNT1	0.716	0.346	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2005	2005	   1	   0	CTD_human
     2650	GCNT1	0.716	0.346	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2005	2014	   1	   0	CTD_human
     2651	GCNT2	0.65	0.538	C0266539	Congenital total cataract	disease	C16;C11	Congenital Abnormality	0.30	1	2012	2015	   2	   0	ORPHANET
     2651	GCNT2	0.65	0.538	C3805373	CATARACT 13 WITH ADULT i PHENOTYPE	disease		Disease or Syndrome	0.70	1	2001	2001	   1	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2652	OPN1MW	0.572	0.769	C0339537	Cone monochromatism	disease	C23;C11;C10	Disease or Syndrome	0.77	1	1995	2019	   3	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2652	OPN1MW	0.572	0.769	C2931753	Achromatopsia incomplete, X-linked	disease	C23;C16;C11;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	ORPHANET
     2652	OPN1MW	0.572	0.769	C3159311	BORNHOLM EYE DISEASE	disease	C16;C11	Disease or Syndrome	0.30	1	2013	2013	   1	   0	ORPHANET
     2652	OPN1MW	0.572	0.769	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
     2652	OPN1MW	0.572	0.769	C3887938	Deuteranomaly	disease	C23;C11;C10	Disease or Syndrome	0.62	1	1992	2016	   2	   3	CTD_human;UNIPROT
     2653	GCSH	0.76	0.385	C0268560	Hyperglycinemia, Transient Neonatal	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2002	2006	   1	   0	GENOMICS_ENGLAND
     2653	GCSH	0.76	0.385	C0268561	Hyperglycinemia, Nonketotic, Type I	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2653	GCSH	0.76	0.385	C0268562	Hyperglycinemia, Nonketotic, Type II	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2653	GCSH	0.76	0.385	C0751747	Hyperglycinemia, Nonketotic, Type III	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2653	GCSH	0.76	0.385	C0751748	Nonketotic Hyperglycinemia	disease	C16;C18;C10	Disease or Syndrome	0.69	1	1990	2016	   1	   1	CTD_human;GENOMICS_ENGLAND
     2657	GDF1	0.529	0.692	C0013069	Double Outlet Right Ventricle	disease	C16;C14	Congenital Abnormality	0.40	1	2007	2007	   1	   0	CTD_human
     2657	GDF1	0.529	0.692	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.43	1	1997	2017	   1	   0	CTD_human
     2657	GDF1	0.529	0.692	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.71	1	2007	2017	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2657	GDF1	0.529	0.692	C0040761	Transposition of Great Vessels	disease	C16;C14	Congenital Abnormality	0.41	1	2007	2007	   1	   0	CTD_human
     2657	GDF1	0.529	0.692	C0175707	Asplenia Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.60	1	2010	2010	   1	   0	CTD_human;ORPHANET
     2657	GDF1	0.529	0.692	C0265357	Polysplenia Syndrome	disease	C16;C15;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
     2657	GDF1	0.529	0.692	C0266642	Situs ambiguus	disease	C16;C15;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
     2657	GDF1	0.529	0.692	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	disease	C16;C14	Disease or Syndrome	0.50	1	2006	2017	   3	   0	GENOMICS_ENGLAND;UNIPROT
     2657	GDF1	0.529	0.692	C1956410	Double Outlet Right Ventricle, Noncommitted VSD	disease	C16;C14	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     2657	GDF1	0.529	0.692	C1956411	Double Outlet Right Ventricle, Subaortic VSD	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     2657	GDF1	0.529	0.692	C1956412	Double Outlet Right Ventricle, Subpulmonary VSD	disease	C16;C14	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     2657	GDF1	0.529	0.692	C1956413	Taussig-Bing Anomaly	disease	C16;C14	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     2657	GDF1	0.529	0.692	C3151221	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6	disease	C16;C14	Congenital Abnormality	0.70	1	2007	2017	   2	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2657	GDF1	0.529	0.692	C3178805	Heterotaxy Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.40	1	2010	2017	   0	   0	CTD_human
     2657	GDF1	0.529	0.692	C3178806	Right Atrial Isomerism	disease	C16;C15;C14	Congenital Abnormality	0.62	1	2010	2018	   1	   0	CTD_human;GENOMICS_ENGLAND
     2657	GDF1	0.529	0.692	C3178807	Left Atrial Isomerism	disease	C16;C15;C14	Congenital Abnormality	0.30				   0	   0	CTD_human
     2657	GDF1	0.529	0.692	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     2658	GDF2	0.529	0.731	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.30	1	2016	2016	   1	   0	CTD_human
     2658	GDF2	0.529	0.731	C0039445	Hereditary hemorrhagic telangiectasia	disease	C16;C15;C14	Disease or Syndrome	0.54	1	2012	2018	   2	   0	CTD_human;ORPHANET
     2658	GDF2	0.529	0.731	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     2658	GDF2	0.529	0.731	C1150929	2-oxo-hept-3-ene-1,7-dioate hydratase activity	phenotype		Molecular Function	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     2658	GDF2	0.529	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	0.75	2013	2017	   2	   0	CTD_human
     2658	GDF2	0.529	0.731	C3809710	TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5	disease		Disease or Syndrome	0.70	1	2013	2015	   2	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2658	GDF2	0.529	0.731	C4551861	Telangiectasia, Hereditary Hemorrhagic, Type 1	disease	C16;C15;C14	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     2660	MSTN	0.528	0.731	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.54	1	2006	2019	   1	   0	CTD_human
     2660	MSTN	0.528	0.731	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.57	1	2006	2019	   1	   0	CTD_human
     2660	MSTN	0.528	0.731	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2660	MSTN	0.528	0.731	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2660	MSTN	0.528	0.731	C0236033	Muscle hypertrophy	phenotype	C23;C05;C10	Organ or Tissue Function	0.40				   0	   0	CTD_human
     2660	MSTN	0.528	0.731	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2660	MSTN	0.528	0.731	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     2660	MSTN	0.528	0.731	C2931112	Myostatin-related muscle hypertrophy	disease	C23;C05;C10	Congenital Abnormality	0.60	1	1997	2009	   2	   0	CTD_human
     2661	GDF9	0.644	0.385	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.40	1	2000	2019	   1	   0	CTD_human
     2661	GDF9	0.644	0.385	C0085215	Ovarian Failure, Premature	disease	C13;C19	Disease or Syndrome	0.40	0.938	2000	2019	   1	   0	GENOMICS_ENGLAND
     2661	GDF9	0.644	0.385	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2661	GDF9	0.644	0.385	C4693941	PREMATURE OVARIAN FAILURE 14	disease		Disease or Syndrome	0.30	1	2006	2018	   7	   5	UNIPROT
     2662	GDF10	0.628	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2662	GDF10	0.628	0.654	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
     2662	GDF10	0.628	0.654	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2662	GDF10	0.628	0.654	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2662	GDF10	0.628	0.654	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2662	GDF10	0.628	0.654	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C1136249	Mental Retardation, X-Linked	disease	C16;C10	Disease or Syndrome	0.32	1	1996	2002	   2	   0	CTD_human
     2664	GDI1	0.572	0.654	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C2931498	Mental Retardation, X-Linked 1	disease	C16;C10	Disease or Syndrome	0.50	1	2009	2011	   1	   0	ORPHANET
     2664	GDI1	0.572	0.654	C3501611	Mental Retardation, X-Linked Nonsyndromic	disease	C16;C10	Disease or Syndrome	0.30	1	1997	2012	   6	   0	CLINGEN
     2664	GDI1	0.572	0.654	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C3887939	MENTAL RETARDATION, X-LINKED 41	disease		Disease or Syndrome	0.90	1	1998	2009	   2	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2664	GDI1	0.572	0.654	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2664	GDI1	0.572	0.654	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2665	GDI2	0.76	0.308	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.5	2008	2017	   2	   0	PSYGENET
     2668	GDNF	0.434	0.885	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2005	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0013386	Dyskinesia, Drug-Induced	disease	C23;C10;C25	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0014474	Ependymoma	disease	C04	Neoplastic Process	0.31	1	2004	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.37	1	1999	2018	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0017638	Glioma	disease	C04	Neoplastic Process	0.40	1	1999	2019	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0019569	Hirschsprung Disease	disease	C16;C06	Disease or Syndrome	0.70	1	1996	2013	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0020179	Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.34	1	2005	2016	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.32	1	2010	2018	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     2668	GDNF	0.434	0.885	C0027854	Neurologic Manifestations	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0028945	oligodendroglioma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.40	0.983	1993	2020	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0030569	Secondary Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.65	0.8	1997	2013	   1	   0	CTD_human;UNIPROT
     2668	GDNF	0.434	0.885	C0035304	Retinal Degeneration	phenotype	C11	Pathologic Function	0.31	1	2007	2007	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.5	2001	2019	   4	   0	PSYGENET
     2668	GDNF	0.434	0.885	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2008	2019	   4	   0	PSYGENET
     2668	GDNF	0.434	0.885	C0085758	Aganglionosis, Colonic	disease	C16;C06	Congenital Abnormality	0.30	1	1996	1996	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0205769	Myxopapillary ependymoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0235031	Neurologic Symptoms	group	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2005	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.53	1	1997	2018	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0242423	Ramsay Hunt Paralysis Syndrome	disease	C10	Disease or Syndrome	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0279070	Adult Oligodendroglioma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0280475	Childhood Oligodendroglioma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0280788	Anaplastic Ependymoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0280793	Mixed Oligodendroglioma-Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0334578	Papillary ependymoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0334590	Anaplastic Oligodendroglioma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0344461	Oligodendroblastoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0393574	Huntington Disease, Late Onset	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0422837	Neurological observations	group	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0521654	Neurologic Deficits	group	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.38	1	1998	2019	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.33	1	2009	2017	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2005	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0683357	Excessive drinking	phenotype		Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     2668	GDNF	0.434	0.885	C0746857	Focal Neurologic Deficits	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751088	Dyskinesia, Medication-Induced	phenotype	C23;C10;C25	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751207	Akinetic-Rigid Variant of Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751208	Juvenile Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.31	1	2010	2014	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751377	Neurologic Dysfunction	phenotype	C23;C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751378	Neurologic Signs	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751395	Mixed Oligodendroglioma-Ependymoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751396	Well Differentiated Oligodendroglioma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751414	Parkinson Disease, Secondary Vascular	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751415	Atherosclerotic Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	1994	2003	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C0752097	Autosomal Dominant Juvenile Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0752098	Autosomal Dominant Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0752100	Autosomal Recessive Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0752101	Parkinsonism, Experimental	disease	C10	Experimental Model of Disease	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0752104	Familial Juvenile Parkinsonism	disease	C10	Disease or Syndrome	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C0752105	Parkinsonism, Juvenile	disease	C10	Disease or Syndrome	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C1257840	Aganglionosis, Rectosigmoid Colon	disease	C16;C06	Congenital Abnormality	0.30	1	1996	1996	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C1257877	Pheochromocytoma, Extra-Adrenal	disease	C04	Neoplastic Process	0.30	1	1997	1997	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.37	1	2008	2019	   4	   0	PSYGENET
     2668	GDNF	0.434	0.885	C1275808	Congenital central hypoventilation	disease	C23;C08;C10	Disease or Syndrome	0.60	1	1998	1998	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2668	GDNF	0.434	0.885	C1384403	Cellular Ependymoma	disease	C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.37	1	1999	2018	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C1708353	Hereditary Paraganglioma-Pheochromocytoma Syndrome	disease	C16;C04	Disease or Syndrome	0.30	1	1997	1997	   1	   0	CLINGEN
     2668	GDNF	0.434	0.885	C1859049	CCHS WITH HIRSCHSPRUNG DISEASE	disease	C23;C08;C10	Disease or Syndrome; Congenital Abnormality	0.30	1	1998	1998	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	disease	C10	Disease or Syndrome	0.30	1	1997	2002	   2	   0	CTD_human
     2668	GDNF	0.434	0.885	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.31	1	2010	2018	   1	   0	CTD_human
     2668	GDNF	0.434	0.885	C3150974	HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3	disease		Finding	0.60	1	1996	2002	   5	   0	GENOMICS_ENGLAND;UNIPROT
     2668	GDNF	0.434	0.885	C3661523	Congenital Intestinal Aganglionosis	disease	C16;C06	Disease or Syndrome	0.30	1	1996	1996	   2	   0	CTD_human
     2670	GFAP	0.421	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	PSYGENET
     2670	GFAP	0.421	0.885	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.40	1	2001	2019	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2005	2010	   2	   0	PSYGENET
     2670	GFAP	0.421	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.36	1	2002	2019	   3	   0	PSYGENET
     2670	GFAP	0.421	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2002	2019	   3	   0	PSYGENET
     2670	GFAP	0.421	0.885	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0017639	Gliosis	phenotype	C23	Pathologic Function	0.31	1	2002	2005	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.50	1	2005	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.40	1	1997	2019	   3	   0	CTD_human
     2670	GFAP	0.421	0.885	C0027873	Neuromyelitis Optica	disease	C11;C20;C10	Disease or Syndrome	0.38	1	2008	2019	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.39	1	2005	2017	   2	   0	PSYGENET
     2670	GFAP	0.421	0.885	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.46	1	2006	2019	   1	   1	GENOMICS_ENGLAND
     2670	GFAP	0.421	0.885	C0037917	Spina Bifida Cystica	disease	C16;C10	Congenital Abnormality	0.30	1	1993	1993	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0040997	Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2017	   2	   0	PSYGENET
     2670	GFAP	0.421	0.885	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0236018	Aura	phenotype	C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0270726	Alexander Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	0.972	1976	2020	  30	  90	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2670	GFAP	0.421	0.885	C0393554	Amyotrophic Lateral Sclerosis With Dementia	disease	C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0393786	Trigeminal Neuralgia, Idiopathic	disease	C10;C07	Disease or Syndrome	0.31	1	2016	2019	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0393787	Secondary Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2016	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0543859	Amyotrophic Lateral Sclerosis, Guam Form	disease	C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0752347	Lewy Body Disease	disease	C10;F03	Disease or Syndrome	0.32	1	2009	2018	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C0917813	Spina Bifida, Open	disease	C16;C10	Congenital Abnormality	0.30	1	1993	1993	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2018	   2	   0	PSYGENET
     2670	GFAP	0.421	0.885	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C2931673	Ceroid lipofuscinosis, neuronal 1, infantile	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.37	1	2016	2019	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C3887640	Astrocytosis	phenotype	C23	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2670	GFAP	0.421	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.32	1	1999	2019	   1	   0	CTD_human
     2671	GFER	0.56	0.846	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.35	1	2009	2019	   1	   0	CTD_human
     2671	GFER	0.56	0.846	C0162557	Liver Failure, Acute	disease	C06	Disease or Syndrome	0.32	1	2005	2017	   1	   0	CTD_human
     2671	GFER	0.56	0.846	C0392622	Toxic effect of carbon tetrachloride	disease	C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
     2671	GFER	0.56	0.846	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2671	GFER	0.56	0.846	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	2009	2009	   1	   0	CTD_human
     2671	GFER	0.56	0.846	C2751320	Myopathy, Mitochondrial Progressive, With Congenital Cataract, Hearing Loss, And Developmental Delay	disease	C23;C18;C11;C05;C10;F03;C09	Disease or Syndrome	0.71	1	2009	2017	   4	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2671	GFER	0.56	0.846	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     2672	GFI1	0.546	0.769	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.50	1	2007	2020	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0087012	Ataxia, Spinocerebellar	disease	C16;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0340970	Congenital neutropenia	disease	C16;C15	Congenital Abnormality	0.37	1	2003	2018	   0	   0	GENOMICS_ENGLAND
     2672	GFI1	0.546	0.769	C0752120	Spinocerebellar Ataxia Type 1	disease	C16;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0752121	Spinocerebellar Ataxia Type 2	disease	C16;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0752122	Spinocerebellar Ataxia Type 4	disease	C16;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0752123	Spinocerebellar Ataxia Type 5	disease	C16;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0752124	Spinocerebellar Ataxia Type 6 (disorder)	disease	C16;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C0752125	Spinocerebellar Ataxia Type 7	disease	C16;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C1842930	Neutropenia, Nonimmune Chronic Idiopathic, Adult	disease	C16;C15	Disease or Syndrome	0.60	1	2003	2003	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2672	GFI1	0.546	0.769	C1859966	Neutropenia, Severe Congenital, Autosomal Dominant 1	disease	C15	Disease or Syndrome	0.30	1	2003	2003	   1	   0	ORPHANET
     2672	GFI1	0.546	0.769	C1879321	Acute Myeloid Leukemia (AML-M2)	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2672	GFI1	0.546	0.769	C2751288	Neutropenia, Severe Congenital, Autosomal Dominant 2	disease	C15	Disease or Syndrome	0.70	1	2003	2003	   2	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2672	GFI1	0.546	0.769	C2930967	Gastro-enteropancreatic neuroendocrine tumor	disease	C06;C04;C19	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     2673	GFPT1	0.612	0.654	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.42	1	2018	2019	   1	   0	CTD_human
     2673	GFPT1	0.612	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2673	GFPT1	0.612	0.654	C0333768	Tubular aggregates	phenotype		Cell or Molecular Dysfunction	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     2673	GFPT1	0.612	0.654	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.70	1	2011	2019	   2	   1	CTD_human;GENOMICS_ENGLAND
     2673	GFPT1	0.612	0.654	C0751883	Congenital Myasthenic Syndromes, Postsynaptic	disease	C16;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2673	GFPT1	0.612	0.654	C0751884	Congenital Myasthenic Syndromes, Presynaptic	disease	C16;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2673	GFPT1	0.612	0.654	C0751885	Myasthenic Syndromes, Congenital, Slow Channel	disease	C16;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2673	GFPT1	0.612	0.654	C1837091	MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2673	GFPT1	0.612	0.654	C3552335	MYASTHENIC SYNDROME, CONGENITAL, 12	disease		Disease or Syndrome	0.80	1	2011	2017	   3	  16	GENOMICS_ENGLAND;UNIPROT
     2674	GFRA1	0.619	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0027796	Neuralgia	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2674	GFRA1	0.619	0.615	C0038870	Neuralgia, Supraorbital	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0042656	Neuralgia, Vidian	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0234247	Neuralgia, Atypical	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0234249	Neuralgia, Stump	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0423711	Neuralgia, Perineal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0423712	Neuralgia, Iliohypogastric Nerve	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0751371	Neuralgia, Ilioinguinal	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0751372	Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2674	GFRA1	0.619	0.615	C0751373	Paroxysmal Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2676	GFRA3	0.736	0.346	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2677	GGCX	0.678	0.538	C0005779	Blood Coagulation Disorders	group	C15	Disease or Syndrome	0.32	1	2000	2016	   1	   0	CTD_human
     2677	GGCX	0.678	0.538	C0451641	Urolithiasis	disease	C13;C12	Disease or Syndrome	0.50	1	1998	1998	   1	   0	CTD_human
     2677	GGCX	0.678	0.538	C1835813	Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency	disease	C16;C17;C15;C14	Disease or Syndrome	0.70	1	2007	2009	   2	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2677	GGCX	0.678	0.538	C1848534	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1	disease	C16;C15	Disease or Syndrome	0.74	1	1998	2019	   6	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2678	GGT1	0.496	0.885	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	1980	2003	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0007097	Carcinoma	group	C04	Neoplastic Process	0.31	1	1998	2002	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.38	1	2000	2020	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0031051	Pericementitis	disease	C07	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0031099	Periodontitis	disease	C07	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C0268524	gamma-Glutamyltransferase deficiency	disease	C16;C18	Disease or Syndrome	0.60	1	2014	2018	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2678	GGT1	0.496	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2007	2019	   1	   0	CTD_human
     2678	GGT1	0.496	0.885	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     2683	B4GALT1	0.674	0.538	C2931009	Congenital disorder of glycosylation type 2D	disease	C16;C18	Disease or Syndrome	0.60	1	2002	2016	   3	   1	CTD_human;GENOMICS_ENGLAND
     2688	GH1	0.373	0.923	C0001206	Acromegaly	disease	C05;C10;C19	Disease or Syndrome	0.40	0.982	1978	2020	   7	   0	CTD_human
     2688	GH1	0.373	0.923	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	1991	2010	   5	   0	PSYGENET
     2688	GH1	0.373	0.923	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.40	0.923	2003	2019	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	0.667	1996	2019	   3	   0	PSYGENET
     2688	GH1	0.373	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.667	1996	2019	   3	   0	PSYGENET
     2688	GH1	0.373	0.923	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.50	1	1984	2007	   2	   0	CTD_human
     2688	GH1	0.373	0.923	C0026846	Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.31	1	1996	2008	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.40	1	1982	2019	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0032000	Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.40	1	1998	2019	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0032019	Pituitary Neoplasms	group	C04;C10;C19	Neoplastic Process	0.40	1	1986	2019	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0032461	Polycythemia	disease	C15	Disease or Syndrome	0.31	1	2004	2017	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0041408	Turner Syndrome	disease	C16;C13;C12;C19;C14	Disease or Syndrome	0.40	0.938	1979	2019	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0242526	Gonadal Dysgenesis, 45,X	disease	C16;C13;C12;C19;C14	Disease or Syndrome	0.31	1	1979	2004	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0242528	Azotemia	disease	C23;C13;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0270948	Neurogenic Muscular Atrophy	phenotype	C23;C10	Pathologic Function	0.30	1	1996	1996	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0271561	Somatotropin deficiency	disease	C16;C05;C10;C19	Disease or Syndrome	0.50	0.958	1984	2020	   0	   0	GENOMICS_ENGLAND
     2688	GH1	0.373	0.923	C0271567	Isolated Growth Hormone Deficiency, Type II	disease	C05;C10;C19	Disease or Syndrome	0.75	1	1996	2019	   4	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2688	GH1	0.373	0.923	C0342573	PITUITARY DWARFISM I	disease	C05;C10;C19	Congenital Abnormality	0.72	1	1993	2012	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2688	GH1	0.373	0.923	C0346300	Pituitary carcinoma	disease	C04;C10;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C0346302	Growth Hormone-Secreting Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.40	0.952	1991	2019	   2	   0	CTD_human
     2688	GH1	0.373	0.923	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C1527168	Bonnevie-Ullrich Syndrome	disease	C16;C13;C12;C19;C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C1527405	Erythrocytosis	phenotype	C15	Finding	0.30	1	2004	2004	   1	   0	CTD_human
     2688	GH1	0.373	0.923	C1849779	Kowarski syndrome	disease	C05;C10;C19	Disease or Syndrome	0.71	1	1996	2007	   4	   0	CTD_human;ORPHANET;UNIPROT
     2688	GH1	0.373	0.923	C2748571	Isolated Growth Hormone Deficiency, Type IB	disease	C16;C05;C10;C19	Disease or Syndrome	0.60	1	2003	2012	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2688	GH1	0.373	0.923	C3489630	Somatotrophinoma, Familial	disease	C04;C10;C19	Neoplastic Process	0.30	1	1991	1992	   2	   0	CTD_human
     2688	GH1	0.373	0.923	C3714796	Isolated somatotropin deficiency	disease		Disease or Syndrome	0.50	0.952	1982	2020	   0	   0	GENOMICS_ENGLAND
     2688	GH1	0.373	0.923	C4748435	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V	disease		Disease or Syndrome	0.30	1	2009	2012	   2	   0	ORPHANET
     2689	GH2	0.769	0.5	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2690	GHR	0.49	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2690	GHR	0.49	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2003	2014	   2	   0	CTD_human
     2690	GHR	0.49	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2004	2007	   1	   0	CTD_human
     2690	GHR	0.49	0.846	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2690	GHR	0.49	0.846	C0271568	Laron Syndrome	disease	C16;C05;C19	Disease or Syndrome	1.00	0.98	1987	2020	  12	  21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2690	GHR	0.49	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.34	0.5	2002	2013	   1	   0	CTD_human
     2690	GHR	0.49	0.846	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.51	1	2003	2003	   0	   0	CTD_human;GENOMICS_ENGLAND
     2690	GHR	0.49	0.846	C1858656	Short Stature, Idiopathic, Autosomal	disease	C05;C10;C19	Disease or Syndrome	0.72	0.667	1995	2000	   1	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2690	GHR	0.49	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	1994	2017	   1	   0	CTD_human
     2690	GHR	0.49	0.846	C3888131	INCREASED RESPONSIVENESS TO GROWTH HORMONE	phenotype		Finding	0.50				   0	   0	GENOMICS_ENGLAND;ORPHANET
     2691	GHRH	0.503	0.769	C0034063	Pulmonary Edema	phenotype	C08	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     2692	GHRHR	0.568	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2016	2016	   0	   0	UNIPROT
     2692	GHRHR	0.568	0.692	C0271561	Somatotropin deficiency	disease	C16;C05;C10;C19	Disease or Syndrome	0.38	1	1997	2016	   0	   0	GENOMICS_ENGLAND
     2692	GHRHR	0.568	0.692	C2748571	Isolated Growth Hormone Deficiency, Type IB	disease	C16;C05;C10;C19	Disease or Syndrome	0.35	1	1998	2018	   2	   0	ORPHANET
     2692	GHRHR	0.568	0.692	C3714796	Isolated somatotropin deficiency	disease		Disease or Syndrome	0.40	1	1995	2019	   0	   0	GENOMICS_ENGLAND
     2692	GHRHR	0.568	0.692	C4722273	ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IV	disease		Disease or Syndrome	0.61	1	1996	2003	   5	   9	GENOMICS_ENGLAND;UNIPROT
     2693	GHSR	0.528	0.769	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2013	2019	   1	   0	CTD_human
     2693	GHSR	0.528	0.769	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2019	   1	   0	CTD_human
     2693	GHSR	0.528	0.769	C0012243	Digestive System Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2693	GHSR	0.528	0.769	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     2693	GHSR	0.528	0.769	C0751075	Cancer of Digestive System	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2693	GHSR	0.528	0.769	C1858656	Short Stature, Idiopathic, Autosomal	disease	C05;C10;C19	Disease or Syndrome	0.70	1	2006	2009	   2	   3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2694	CBLIF	0.507	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2015	2015	   1	   0	PSYGENET
     2694	CBLIF	0.507	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2694	CBLIF	0.507	0.808	C0340957	Congenital deficiency of intrinsic factor	disease	C16;C18;C15	Congenital Abnormality	0.41	1	2004	2017	   1	   2	ORPHANET
     2694	CBLIF	0.507	0.808	C1394891	Intrinsic Factor Deficiency	disease	C18;C15	Disease or Syndrome	0.72	1	2004	2015	   2	   3	CTD_human;ORPHANET;UNIPROT
     2695	GIP	0.57	0.654	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.33	1	2017	2018	   3	   0	CTD_human
     2696	GIPR	0.67	0.538	C0005910	Body Weight	phenotype	C23	Organism Attribute	0.30	1	2012	2012	   1	   0	CTD_human
     2696	GIPR	0.67	0.538	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.31	1	2006	2017	   1	   0	CTD_human
     2697	GJA1	0.393	0.885	C0001430	Adenoma	group	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     2697	GJA1	0.393	0.885	C0003811	Cardiac Arrhythmia	phenotype	C23;C14	Disease or Syndrome	0.70	0.969	2006	2019	   2	   0	CTD_human
     2697	GJA1	0.393	0.885	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	CTD_human
     2697	GJA1	0.393	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	2000	2019	   1	   0	CTD_human
     2697	GJA1	0.393	0.885	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
     2697	GJA1	0.393	0.885	C0010051	Coronary Aneurysm	disease	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2697	GJA1	0.393	0.885	C0018522	Hallermanns Syndrome	disease	C16;C05	Disease or Syndrome	0.52	1	2004	2012	2	1	GENOMICS_ENGLAND;UNIPROT
10529	2697	GJA1	0.393	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.61	1	2006	2017	1	0	CTD_human
10536	2697	GJA1	0.393	0.885	C0152101	Hypoplastic Left Heart Syndrome	disease	C16;C14	Disease or Syndrome	0.7	1	2001	2009	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
10551	2697	GJA1	0.393	0.885	C0812437	Oculo-dento-digital syndrome	disease	C16;C11;C05;C07	Congenital Abnormality	1	1	1975	2019	8	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10557	2697	GJA1	0.393	0.885	C1861366	SYNDACTYLY, TYPE III	disease	C16;C05	Disease or Syndrome	0.72	1	2003	2013	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10559	2697	GJA1	0.393	0.885	C2749477	Oculodentodigital Dysplasia, Autosomal Recessive	disease	C16;C11;C05;C07	Disease or Syndrome	0.6	1	2007	2016	2	6	CTD_human;GENOMICS_ENGLAND
10560	2697	GJA1	0.393	0.885	C2931244	Craniometaphyseal dysplasia, autosomal recessive type	disease	C16;C05	Disease or Syndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
10562	2697	GJA1	0.393	0.885	C3151468	PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1	disease		Disease or Syndrome	0.62	1	2006	2019	3	1	GENOMICS_ENGLAND;UNIPROT
10565	2697	GJA1	0.393	0.885	C4479619	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 3	disease		Disease or Syndrome	0.6	1	2006	2015	2	2	GENOMICS_ENGLAND;UNIPROT
10568	2697	GJA1	0.393	0.885	C4551854	HYPOPLASTIC LEFT HEART SYNDROME 1	disease	C16;C14	Disease or Syndrome	0.6	1	2001	2011	2	2	GENOMICS_ENGLAND;UNIPROT
10575	2700	GJA3	0.647	0.346	C1866078	Cataract, Zonular Pulverulent 3	disease	C11	Disease or Syndrome	0.9	1	1999	2018	22	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
10580	2702	GJA5	0.575	0.577	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2002	2018	1	0	CTD_human
10581	2702	GJA5	0.575	0.577	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.62	1	2003	2013	1	0	ORPHANET
10587	2702	GJA5	0.575	0.577	C3279693	ATRIAL FIBRILLATION, FAMILIAL, 11	disease		Disease or Syndrome	0.6	1	2010	2010	1	5	CTD_human;UNIPROT
10600	2703	GJA8	0.587	0.577	C1861828	Cataract, Zonular Pulverulent 1	disease	C11	Disease or Syndrome	0.93	1	1998	2016	11	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
10601	2703	GJA8	0.587	0.577	C1861829	Cataract microcornea syndrome	disease	C11	Disease or Syndrome	0.61	1	2006	2010	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
10606	2705	GJB1	0.514	0.731	C0011195	Dejerine-Sottas Disease (disorder)	disease	C16;C10	Disease or Syndrome	0.63	1	1996	2005	1	1	UNIPROT
10626	2705	GJB1	0.514	0.731	C0393808	Charcot-Marie-Tooth disease, X-linked, 1	disease	C16;C10	Disease or Syndrome	1	1	1993	2019	61	82	CTD_human;GENOMICS_ENGLAND;UNIPROT
10636	2706	GJB2	0.441	0.846	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.7	0.973	1994	2020	1	4	CTD_human
10649	2706	GJB2	0.441	0.846	C0265336	Senter syndrome	disease	C23;C16;C11;C17;C10;C09	Disease or Syndrome	1	1	1991	2019	5	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10650	2706	GJB2	0.441	0.846	C0265964	Mutilating keratoderma	disease	C23;C16;C17;C05;C10;C09	Congenital Abnormality	0.8	1	1997	2019	9	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10651	2706	GJB2	0.441	0.846	C0266004	Knuckle pads, leuconychia and sensorineural deafness	disease	C23;C16;C17;C10;C09	Congenital Abnormality	0.72	1	1997	2019	5	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10658	2706	GJB2	0.441	0.846	C1835672	Palmoplantar Keratoderma with Deafness	disease	C23;C16;C17;C10;C09	Disease or Syndrome	0.73	1	1997	2019	10	26	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10661	2706	GJB2	0.441	0.846	C1865234	ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS	disease	C23;C16;C17;C10;C09	Disease or Syndrome	0.71	1	1997	2019	4	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
10662	2706	GJB2	0.441	0.846	C2673759	DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.9	1	1997	2019	9	95	CTD_human;GENOMICS_ENGLAND;UNIPROT
10663	2706	GJB2	0.441	0.846	C2673760	DEAFNESS, DIGENIC, GJB2/GJB6 (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.6	NA	NA	NA	0	1	CTD_human
10664	2706	GJB2	0.441	0.846	C2673761	DEAFNESS, DIGENIC, GJB2/GJB3 (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.6	NA	NA	NA	0	1	CTD_human
10665	2706	GJB2	0.441	0.846	C2675750	DEAFNESS, AUTOSOMAL DOMINANT 3A (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.7	1	1997	2019	8	49	CTD_human;GENOMICS_ENGLAND;UNIPROT
10667	2706	GJB2	0.441	0.846	C3665333	Keratitis-Ichthyosis-Deafness Syndrome	disease	C11	Disease or Syndrome	0.6	1	1990	2019	0	0	ORPHANET
10677	2707	GJB3	0.621	0.462	C0265961	Erythrokeratodermia variabilis	disease	C16;C17	Disease or Syndrome	0.9	0.967	1998	2019	17	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
10685	2707	GJB3	0.621	0.462	C2673759	DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.6	1	1998	1998	1	0	CTD_human;GENOMICS_ENGLAND
10688	2707	GJB3	0.621	0.462	C2675236	Deafness, Autosomal Dominant 2B	disease	C23;C10;C09	Disease or Syndrome	0.7	1	1998	1998	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
10694	2707	GJB3	0.621	0.462	C4551486	ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA 1	disease	C16;C17	Disease or Syndrome	0.6	1	1998	2000	4	0	GENOMICS_ENGLAND;UNIPROT
10695	2707	GJB3	0.621	0.462	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.54	1	1999	2009	2	0	CTD_human;GENOMICS_ENGLAND
10700	2710	GK	0.656	0.577	C0268418	Deficiency of glycerol kinase	disease		Disease or Syndrome	0.8	1	1988	2009	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
10702	2717	GLA	0.537	0.769	C0002986	Fabry Disease	disease	C16;C18;C10;C14	Disease or Syndrome	1	0.992	1967	2020	57	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
10717	2719	GPC3	0.466	0.808	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.8	0.938	1997	2019	2	7	CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET
10719	2719	GPC3	0.466	0.808	C0796154	SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	disease	C23;C16;C05;C10;C19;F03;F01;C14	Disease or Syndrome	1	0.956	1995	2019	6	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10720	2719	GPC3	0.466	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.984	1997	2020	2	0	CTD_human
10728	2720	GLB1	0.448	0.808	C0026707	Mucopolysaccharidosis IV	disease	C16;C18;C17	Disease or Syndrome	0.52	1	1977	2019	4	0	CTD_human;GENOMICS_ENGLAND
10734	2720	GLB1	0.448	0.808	C0085131	Gangliosidosis GM1	disease	C16;C18;C10	Disease or Syndrome	0.7	0.99	1975	2019	0	19	CTD_human
10737	2720	GLB1	0.448	0.808	C0086652	Mucopolysaccharidosis type IVB	disease	C16;C18;C17	Disease or Syndrome	0.8	1	1977	2018	12	68	CTD_human;GENOMICS_ENGLAND;UNIPROT
10739	2720	GLB1	0.448	0.808	C0268271	Gangliosidosis, Generalized GM1, Type 1 (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.76	0.982	1979	2017	21	76	CTD_human;GENOMICS_ENGLAND;UNIPROT
10740	2720	GLB1	0.448	0.808	C0268272	Gangliosidosis, Generalized GM1, Type 2	disease	C16;C18;C10	Disease or Syndrome	0.73	1	1991	2018	14	59	CTD_human;GENOMICS_ENGLAND;UNIPROT
10741	2720	GLB1	0.448	0.808	C0268273	Gangliosidosis, Generalized GM1, Type 3	disease	C16;C18;C10	Disease or Syndrome	0.72	1	1984	2017	13	52	CTD_human;GENOMICS_ENGLAND;UNIPROT
10770	2729	GCLC	0.509	0.885	C1856603	Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to	disease	C15	Disease or Syndrome	0.7	1	1996	2016	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10789	2731	GLDC	0.628	0.577	C0751748	Nonketotic Hyperglycinemia	disease	C16;C18;C10	Disease or Syndrome	1	0.982	1990	2020	18	136	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
10791	2733	GLE1	0.628	0.577	C1854664	LETHAL CONGENITAL CONTRACTURE SYNDROME 1	disease	C16;C05	Disease or Syndrome	0.74	0.857	2006	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10792	2733	GLE1	0.628	0.577	C2678471	Lethal Arthrogryposis With Anterior Horn Cell Disease	disease	C16;C05;C10	Disease or Syndrome	0.72	1	2006	2018	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10800	2735	GLI1	0.431	0.846	C1395852	Polydactyly preaxial type 1	disease	C16;C05	Congenital Abnormality	0.7	1	2019	2019	1	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
10811	2736	GLI2	0.446	0.846	C0079541	Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.7	1	2003	2019	1	0	CTD_human;GENOMICS_ENGLAND
10814	2736	GLI2	0.446	0.846	C0431362	Lobar Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.51	1	2006	2016	1	0	CTD_human;ORPHANET
10818	2736	GLI2	0.446	0.846	C1835819	PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES (disorder)	disease	C16;C05;C10;C19	Disease or Syndrome	0.7	1	2003	2015	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
10822	2736	GLI2	0.446	0.846	C4014479	CULLER-JONES SYNDROME	disease		Disease or Syndrome	0.71	1	2003	2019	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10833	2737	GLI3	0.436	0.846	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.7	1	1999	2019	2	0	CTD_human;GENOMICS_ENGLAND
10837	2737	GLI3	0.436	0.846	C0265220	Pallister-Hall syndrome	disease	C16;C04;C05;C10	Disease or Syndrome	0.9	1	1997	2019	6	39	CTD_human;GENOMICS_ENGLAND
10838	2737	GLI3	0.436	0.846	C0265306	Greig cephalopolysyndactyly syndrome	disease	C16;C05	Congenital Abnormality	1	0.917	1991	2019	13	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10842	2737	GLI3	0.436	0.846	C0342418	Hypothalamic hamartomas	disease	C04;C10	Congenital Abnormality	0.63	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
10848	2737	GLI3	0.436	0.846	C1868111	Polydactyly, preaxial 4	disease	C16;C05	Disease or Syndrome	0.7	1	2015	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
10852	2737	GLI3	0.436	0.846	C3495676	Anorectal Malformations	group	C16;C06	Anatomical Abnormality	0.51	1	2008	2019	1	0	GENOMICS_ENGLAND
10853	2737	GLI3	0.436	0.846	C3887487	Postaxial polydactyly type A	disease	C16;C05	Disease or Syndrome	0.62	1	1999	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
10854	2737	GLI3	0.436	0.846	C4282400	Polydactyly, Postaxial, Type A1	disease	C16;C05	Disease or Syndrome	0.71	1	1997	2019	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
10860	2739	GLO1	0.537	0.769	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2005	2019	2	0	CTD_human;PSYGENET
10873	2740	GLP1R	0.471	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.56	1	2002	2020	1	0	CTD_human
10876	2741	GLRA1	0.628	0.5	C0234166	Hyperexplexia	phenotype	C10	Sign or Symptom	0.7	0.979	1992	2019	2	13	GENOMICS_ENGLAND
10903	2775	GNAO1	0.523	0.808	C0393706	Early infantile epileptic encephalopathy with suppression bursts	disease	C10	Disease or Syndrome	0.51	1	1997	2019	13	0	CLINGEN;ORPHANET
10909	2775	GNAO1	0.523	0.808	C3809606	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17	disease		Disease or Syndrome	0.91	1	2013	2019	5	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
10910	2775	GNAO1	0.523	0.808	C4479569	NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS	disease		Disease or Syndrome	0.61	1	2013	2018	6	10	GENOMICS_ENGLAND;UNIPROT
10916	2776	GNAQ	0.516	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.7	0.967	1989	2019	1	1	CGI;CTD_human
10917	2776	GNAQ	0.516	0.808	C0038505	Sturge-Weber Syndrome	disease	C04;C10;C14	Disease or Syndrome	0.8	1	2013	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10920	2776	GNAQ	0.516	0.808	C0220633	Uveal melanoma	disease	C04;C11	Neoplastic Process	0.8	0.984	2008	2019	5	2	CGI;CTD_human;ORPHANET
10921	2776	GNAQ	0.516	0.808	C0235752	Port-Wine Stain	disease	C16;C17	Congenital Abnormality	0.66	1	2013	2020	1	1	CTD_human;ORPHANET
10923	2776	GNAQ	0.516	0.808	C0340803	Capillary malformation (disorder)	disease	C16;C14	Congenital Abnormality	0.66	0.833	2016	2020	0	1	CTD_human;GENOMICS_ENGLAND
10941	2778	GNAS	0.42	0.885	C0016065	Polyostotic fibrous dysplasia	disease	C05	Congenital Abnormality	0.65	1	1991	2017	5	0	CTD_human;ORPHANET
10954	2778	GNAS	0.42	0.885	C0033806	Pseudohypoparathyroidism	disease	C16;C18;C05	Disease or Syndrome	0.7	0.963	1991	2019	3	0	CTD_human
10955	2778	GNAS	0.42	0.885	C0033835	Pseudopseudohypoparathyroidism	disease	C16;C18;C05	Disease or Syndrome	1	1	1998	2018	1	11	CTD_human;GENOMICS_ENGLAND;ORPHANET
10958	2778	GNAS	0.42	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.51	1	2006	2006	1	0	PSYGENET
10970	2778	GNAS	0.42	0.885	C0242292	McCune-Albright Syndrome	disease	C05	Disease or Syndrome	0.8	0.966	1991	2019	7	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10973	2778	GNAS	0.42	0.885	C0334041	Osteoma cutis	disease	C23;C16;C18;C17;C05	Disease or Syndrome	0.8	0.955	2000	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10986	2778	GNAS	0.42	0.885	C1857451	Acth-Independent Macronodular Adrenal Hyperplasia	disease	C19	Disease or Syndrome	0.7	1	1997	2003	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10987	2778	GNAS	0.42	0.885	C1864100	PSEUDOHYPOPARATHYROIDISM, TYPE IB	disease	C16;C18;C05	Disease or Syndrome	0.8	0.96	1997	2017	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
10989	2778	GNAS	0.42	0.885	C2931404	Albrights hereditary osteodystrophy	disease	C16;C18;C05	Disease or Syndrome	0.80	0.939	1990	2019	   4	   0	CTD_human;GENOMICS_ENGLAND
     2778	GNAS	0.42	0.885	C2932715	Pseudohypoparathyroidism Type 1B	disease	C16;C18;C05	Disease or Syndrome	0.70	1	2002	2019	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2778	GNAS	0.42	0.885	C2932716	Pseudohypoparathyroidism Type 1C	disease	C16;C18;C05	Disease or Syndrome	0.73	1	2002	2017	   2	   5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2778	GNAS	0.42	0.885	C3489630	Somatotrophinoma, Familial	disease	C04;C10;C19	Neoplastic Process	0.30	1	2001	2001	   1	   0	CTD_human
     2778	GNAS	0.42	0.885	C3494506	Pseudohypoparathyroidism, Type Ia	disease	C16;C18;C05	Disease or Syndrome	0.80	0.957	1991	2019	  17	  13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2778	GNAS	0.42	0.885	C3697137	Fibrous dysplasia of bone with intramuscular myxoma	disease	C05	Disease or Syndrome	0.31	1	2012	2019	   1	   0	ORPHANET
     2778	GNAS	0.42	0.885	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.41	1	2001	2004	   1	   0	CTD_human
     2778	GNAS	0.42	0.885	C3805278	Extrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     2779	GNAT1	0.666	0.308	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     2779	GNAT1	0.666	0.308	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.73	1	1996	2016	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2779	GNAT1	0.666	0.308	C1848172	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2779	GNAT1	0.666	0.308	C1850362	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2779	GNAT1	0.666	0.308	C1864870	Night Blindness, Congenital Stationary, Autosomal Dominant 3	disease	C16;C11	Disease or Syndrome	0.70	1	1996	2007	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2779	GNAT1	0.666	0.308	C1864877	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2779	GNAT1	0.666	0.308	C3495587	Night Blindness, Congenital Stationary, Type 1A	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2779	GNAT1	0.666	0.308	C3501847	Night blindness, congenital stationary, type 1	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2779	GNAT1	0.666	0.308	C3711543	X-Linked Csnb	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2779	GNAT1	0.666	0.308	C4041558	Cone-rod synaptic disorder, congenital nonprogressive	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2779	GNAT1	0.666	0.308	C4225345	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1G	disease		Disease or Syndrome	0.60	1	2012	2012	   1	   1	GENOMICS_ENGLAND;UNIPROT
     2780	GNAT2	0.674	0.231	C0009398	Color vision defect	phenotype	C23;C11;C10	Disease or Syndrome	0.41	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     2780	GNAT2	0.674	0.231	C0152200	Achromatopsia	disease	C23;C11;C10	Disease or Syndrome	0.79	1	2002	2019	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2780	GNAT2	0.674	0.231	C0155015	Color Blindness, Red	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0155016	Color Blindness, Red-Green	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0155017	Color Blindness, Blue	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0155018	Color Blindness, Acquired	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0239777	Color Blindness, Green	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0242225	Color blindness	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0271092	Progressive cone dystrophy (without rod involvement)	disease	C11	Disease or Syndrome	0.30	1	2003	2003	   1	   0	ORPHANET
     2780	GNAT2	0.674	0.231	C0751042	Color Blindness, Inherited	disease	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C0751043	Monochromatopsia	phenotype	C23;C11;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2780	GNAT2	0.674	0.231	C1841721	ACHROMATOPSIA 4	disease	C23;C16;C11;C10	Disease or Syndrome	0.81	1	2002	2013	   0	  13	CTD_human;GENOMICS_ENGLAND
     2781	GNAZ	0.722	0.346	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.31	0.5	2006	2017	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
     2782	GNB1	0.617	0.731	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CTD_human
     2782	GNB1	0.617	0.731	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.41	1	2015	2016	   1	   8	GENOMICS_ENGLAND
     2782	GNB1	0.617	0.731	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.31	1	2017	2019	   1	   0	GENOMICS_ENGLAND
     2782	GNB1	0.617	0.731	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.42	1	2016	2019	   1	   9	GENOMICS_ENGLAND
     2782	GNB1	0.617	0.731	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	CTD_human
     2782	GNB1	0.617	0.731	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40				   0	   1	CTD_human
     2782	GNB1	0.617	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     2782	GNB1	0.617	0.731	C4310774	MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	disease		Disease or Syndrome	0.70	1	2015	2018	   5	  12	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2784	GNB3	0.518	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     2784	GNB3	0.518	0.808	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.35	1	2000	2014	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.34	1	2004	2018	   5	   0	PSYGENET
     2784	GNB3	0.518	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2002	2018	   5	   0	PSYGENET
     2784	GNB3	0.518	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.40	0.923	1999	2018	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.40	0.938	1998	2018	   2	   0	CTD_human
     2784	GNB3	0.518	0.808	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.40	0.939	1999	2018	   2	   0	CTD_human
     2784	GNB3	0.518	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2007	   1	   0	PSYGENET
     2784	GNB3	0.518	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.37	0.6	2007	2017	   5	   0	PSYGENET
     2784	GNB3	0.518	0.808	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.40	0.909	1998	2017	   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.51	0.5	2015	2016	   1	   0	CTD_human;ORPHANET
     2784	GNB3	0.518	0.808	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2001	2003	   2	   0	PSYGENET
     2784	GNB3	0.518	0.808	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.38	0.6	2004	2017	   5	   0	PSYGENET
     2784	GNB3	0.518	0.808	C1848172	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C1850362	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C1864877	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.38	1	2000	2017	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C3495587	Night Blindness, Congenital Stationary, Type 1A	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C3501847	Night blindness, congenital stationary, type 1	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C3711543	X-Linked Csnb	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C4041558	Cone-rod synaptic disorder, congenital nonprogressive	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2784	GNB3	0.518	0.808	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C4310758	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H	disease		Disease or Syndrome	0.40	1	2016	2016	   1	   2	UNIPROT
     2784	GNB3	0.518	0.808	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2784	GNB3	0.518	0.808	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2787	GNG5	0.89	0.231	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2787	GNG5	0.89	0.231	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2788	GNG7	0.76	0.269	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     2788	GNG7	0.76	0.269	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
     2791	GNG11	0.76	0.231	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2791	GNG11	0.76	0.231	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     2791	GNG11	0.76	0.231	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2791	GNG11	0.76	0.231	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2791	GNG11	0.76	0.231	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2791	GNG11	0.76	0.231	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2793	GNGT2	0.805	0.154	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0001624	Adrenal Gland Neoplasms	group	C04;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0018681	Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0020514	Hyperprolactinemia	disease	C10;C19	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	1983	1983	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0020619	Hypogonadism	disease	C19	Disease or Syndrome	0.34	1	2008	2019	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0020672	Hypothermia, natural	phenotype	C23	Finding	0.30	1	1983	1983	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0028838	Ocular Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0034013	Precocious Puberty	disease	C19	Disease or Syndrome	0.31	1	1993	2008	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0039231	Tachycardia	phenotype	C23;C14	Finding	0.30	1	1983	1983	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0042963	Vomiting	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0080203	Tachyarrhythmia	phenotype	C23;C14	Finding	0.30	1	1983	1983	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0271527	Cryptogenic sexual precocity	phenotype	C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.65	1	1977	2019	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0342384	Idiopathic hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.38	0.875	1989	2016	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0342543	Central Precocious Puberty	disease	C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0423618	Throbbing Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0423623	Bilateral Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	1983	1983	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0474366	Generalized Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0750887	Adrenal Cancer	disease	C04;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0751186	Orthostatic Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0751187	Periorbital Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0751189	Retro-Ocular Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0751190	Sharp Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0751192	Vertex Headache	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0877781	Hemicrania	phenotype	C23	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C0948896	Primary hypogonadism	disease	C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C1504412	Testotoxicosis	disease	C19	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2796	GNRH1	0.524	0.731	C1856897	Eunuchoidism, familial hypogonadotropic	disease	C19	Disease or Syndrome	0.90	1	1977	2013	   3	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2796	GNRH1	0.524	0.731	C3489396	Hypogonadism, Isolated Hypogonadotropic	disease	C19	Disease or Syndrome	0.31	1	2010	2010	   1	   0	CTD_human
     2798	GNRHR	0.54	0.654	C0001624	Adrenal Gland Neoplasms	group	C04;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2798	GNRHR	0.54	0.654	C0020619	Hypogonadism	disease	C19	Disease or Syndrome	0.39	1	1999	2017	   1	   0	CTD_human
     2798	GNRHR	0.54	0.654	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.70	0.971	1999	2018	   1	   0	CTD_human
     2798	GNRHR	0.54	0.654	C0342384	Idiopathic hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	1.00	0.981	1997	2018	  12	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2798	GNRHR	0.54	0.654	C0750887	Adrenal Cancer	disease	C04;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     2798	GNRHR	0.54	0.654	C0948896	Primary hypogonadism	disease	C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2798	GNRHR	0.54	0.654	C3489396	Hypogonadism, Isolated Hypogonadotropic	disease	C19	Disease or Syndrome	0.56	1	2001	2016	   1	   0	CTD_human
     2799	GNS	0.705	0.538	C0026706	Mucopolysaccharidosis III	disease	C16;C18;C17	Disease or Syndrome	0.72	1	1988	2017	   2	   0	CTD_human;GENOMICS_ENGLAND
     2799	GNS	0.705	0.538	C0086647	Mucopolysaccharidosis Type IIIA	disease	C16;C18;C17	Disease or Syndrome	0.34	1	1988	2019	   1	   0	CTD_human
     2799	GNS	0.705	0.538	C0086648	MPS III B	disease	C16;C18;C17	Disease or Syndrome	0.30	1	1988	1988	   1	   0	CTD_human
     2799	GNS	0.705	0.538	C0086649	MPS III C	disease	C16;C18;C17	Disease or Syndrome	0.31	1	1988	2016	   1	   0	CTD_human
     2799	GNS	0.705	0.538	C0086650	MPS III D	disease	C16;C18;C17	Disease or Syndrome	0.77	1	1988	2016	   6	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2803	GOLGA4	0.656	0.692	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2803	GOLGA4	0.656	0.692	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2803	GOLGA4	0.656	0.692	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2803	GOLGA4	0.656	0.692	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2803	GOLGA4	0.656	0.692	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2803	GOLGA4	0.656	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2803	GOLGA4	0.656	0.692	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2803	GOLGA4	0.656	0.692	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2804	GOLGB1	0.695	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     2805	GOT1	0.601	0.692	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
     2805	GOT1	0.601	0.692	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
     2805	GOT1	0.601	0.692	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2805	GOT1	0.601	0.692	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2805	GOT1	0.601	0.692	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2805	GOT1	0.601	0.692	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2805	GOT1	0.601	0.692	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2806	GOT2	0.529	0.731	C0015544	Failure to Thrive	disease	C23	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C0220994	Hyperammonemia	phenotype	C23	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C0232466	Feeding difficulties	phenotype		Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C1836440	Increased serum lactate	phenotype	C18	Finding	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2806	GOT2	0.529	0.731	C4022810	Abnormality of nervous system morphology	disease	C16;C10	Anatomical Abnormality	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2810	SFN	0.561	0.769	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.35	1	2004	2008	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2005	2010	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.31	1	2010	2010	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.31	1	2004	2007	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.38	1	2010	2019	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.32	1	2010	2011	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2005	2010	   1	   0	CTD_human
     2810	SFN	0.561	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2000	2019	   1	   0	CTD_human
     2811	GP1BA	0.565	0.692	C0005129	Bernard-Soulier Syndrome	disease	C16;C15	Disease or Syndrome	1.00	1	1990	2020	   9	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2811	GP1BA	0.565	0.692	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2811	GP1BA	0.565	0.692	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.31	1	2007	2007	   1	   0	CTD_human
     2811	GP1BA	0.565	0.692	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     2811	GP1BA	0.565	0.692	C1280798	Von Willebrand disease, platelet type	disease	C16;C15	Disease or Syndrome	0.80	1	1991	2019	   5	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2811	GP1BA	0.565	0.692	C1319466	Barber Say syndrome	disease	C23;C16;C11;C17;C05;C07	Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     2811	GP1BA	0.565	0.692	C1847711	NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO	phenotype		Finding	0.30				   0	   0	CTD_human
     2811	GP1BA	0.565	0.692	C1857941	Brooke-Spiegler syndrome	disease	C16;C04;C17	Disease or Syndrome	0.31	1	2011	2018	   1	   0	GENOMICS_ENGLAND
     2811	GP1BA	0.565	0.692	C2713537	Deficiency of Platelet Glycoprotein 1b	disease	C16;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
     2811	GP1BA	0.565	0.692	C3277076	BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.60	1	2001	2001	   1	   0	CTD_human;UNIPROT
     2811	GP1BA	0.565	0.692	C3853779	Neonatal Alloimmune Thrombocytopenia	disease	C16;C15	Disease or Syndrome	0.40				   0	   0	ORPHANET
     2811	GP1BA	0.565	0.692	C3854603	FNAITP	disease		Disease or Syndrome	0.31	1	2013	2013	   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C0005129	Bernard-Soulier Syndrome	disease	C16;C15	Disease or Syndrome	1.00	1	1988	2019	  15	   1	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2812	GP1BB	0.524	0.769	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.31	1	2007	2007	   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.40	1	2004	2019	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C0220704	Shprintzen syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2004	2004	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C0431406	Asymmetric crying face association	disease	C23;C10;C07	Disease or Syndrome	0.30				   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.30				   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C1319466	Barber Say syndrome	disease	C23;C16;C11;C17;C05;C07	Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     2812	GP1BB	0.524	0.769	C1857941	Brooke-Spiegler syndrome	disease	C16;C04;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     2812	GP1BB	0.524	0.769	C2713537	Deficiency of Platelet Glycoprotein 1b	disease	C16;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
     2812	GP1BB	0.524	0.769	C2936346	22q11 Deletion Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.31	1	2019	2019	   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C3266101	22q11 partial monosomy syndrome	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C3853779	Neonatal Alloimmune Thrombocytopenia	disease	C16;C15	Disease or Syndrome	0.40				   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C3854603	FNAITP	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C4304021	Autosomal dominant macrothrombocytopenia	disease	C16	Disease or Syndrome	0.31	1	2017	2017	   1	   0	ORPHANET
     2812	GP1BB	0.524	0.769	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2812	GP1BB	0.524	0.769	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2813	GP2	0.67	0.5	C0005910	Body Weight	phenotype	C23	Organism Attribute	0.30	1	2012	2012	   1	   0	CTD_human
     2813	GP2	0.67	0.5	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.40	1	2019	2019	   1	   1	CTD_human
     2815	GP9	0.695	0.5	C0005129	Bernard-Soulier Syndrome	disease	C16;C15	Disease or Syndrome	0.80	0.981	1983	2019	  20	   6	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2815	GP9	0.695	0.5	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.46	1	1998	2020	   1	   1	CTD_human
     2815	GP9	0.695	0.5	C1319466	Barber Say syndrome	disease	C23;C16;C11;C17;C05;C07	Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     2815	GP9	0.695	0.5	C1856448	Bernard-Soulier Syndrome, Type C	disease	C16;C15	Disease or Syndrome	0.41	1	2019	2019	   0	   6	GENOMICS_ENGLAND
     2815	GP9	0.695	0.5	C1857941	Brooke-Spiegler syndrome	disease	C16;C04;C17	Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     2815	GP9	0.695	0.5	C2713537	Deficiency of Platelet Glycoprotein 1b	disease	C16;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
     2817	GPC1	0.587	0.731	C0005411	Biliary Atresia	disease	C16;C06	Congenital Abnormality	0.32	1	2013	2016	   1	   0	ORPHANET
     2817	GPC1	0.587	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2001	2018	   0	   0	UNIPROT
     2819	GPD1	0.67	0.5	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     2819	GPD1	0.67	0.5	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.31	1	1994	1994	   0	   0	GENOMICS_ENGLAND
     2819	GPD1	0.67	0.5	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2819	GPD1	0.67	0.5	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2819	GPD1	0.67	0.5	C3280953	HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE	disease		Disease or Syndrome	0.72	1	2012	2018	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2819	GPD1	0.67	0.5	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2819	GPD1	0.67	0.5	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2819	GPD1	0.67	0.5	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.45	0.833	1996	2005	   1	   1	CTD_human
     2820	GPD2	0.678	0.538	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0268583	Methylmalonic acidemia	phenotype	C16;C18	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2820	GPD2	0.678	0.538	C1855119	Methylmalonic aciduria	disease	C16;C18	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C0002878	Anemia, Hemolytic	disease	C15	Disease or Syndrome	0.39	1	1978	2019	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C0002879	Anemia, Hemolytic, Acquired	disease	C15	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C0002889	Anemia, Microangiopathic	disease	C15	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.38	1	2000	2017	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C0221021	Microangiopathic hemolytic anemia	disease	C15	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	2000	2017	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2003	2008	   1	   0	CTD_human
     2821	GPI	0.491	0.769	C3150730	HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY	disease		Disease or Syndrome	0.70	1	1977	2018	  10	  24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2821	GPI	0.491	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2008	2008	   1	   0	CTD_human
     2823	GPM6A	0.729	0.423	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.42	1	2008	2019	   1	   4	PSYGENET
     2823	GPM6A	0.729	0.423	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     2826	CCR10	0.626	0.654	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2826	CCR10	0.626	0.654	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2826	CCR10	0.626	0.654	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2826	CCR10	0.626	0.654	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2826	CCR10	0.626	0.654	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2826	CCR10	0.626	0.654	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2826	CCR10	0.626	0.654	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2831	NPBWR1	0.89	0.115	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
     2832	NPBWR2	0.931	0.192	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     2833	CXCR3	0.436	0.808	C0002171	Alopecia Areata	disease	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.39	1	2002	2019	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.32	1	2000	2019	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2003	2004	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0032226	Pleural Diseases	group	C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.31	1	2008	2011	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.31	1	2000	2002	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0086196	Eczema, Infantile	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C1704377	Bright Disease	disease	C13;C12	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2833	CXCR3	0.436	0.808	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.31	1	2008	2011	   1	   0	CTD_human
     2837	UTS2R	0.566	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.32	1	2014	2016	   0	   1	UNIPROT
     2840	GPR17	0.686	0.615	C0393953	Anterior Cerebral Circulation Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2840	GPR17	0.686	0.615	C0751952	Anterior Circulation Brain Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2840	GPR17	0.686	0.615	C0751953	Brain Infarction, Posterior Circulation	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2840	GPR17	0.686	0.615	C0751954	Venous Infarction, Brain	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2840	GPR17	0.686	0.615	C0751955	Brain Infarction	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2846	LPAR4	0.769	0.346	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.31	1	2016	2016	   1	   0	ORPHANET
     2847	MCHR1	0.65	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2009	   2	   0	PSYGENET
     2847	MCHR1	0.65	0.5	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	2005	2019	   5	   0	PSYGENET
     2847	MCHR1	0.65	0.5	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2005	2019	   5	   0	PSYGENET
     2847	MCHR1	0.65	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2006	2020	   3	   0	PSYGENET
     2847	MCHR1	0.65	0.5	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2006	2009	   2	   0	PSYGENET
     2850	GPR27	1	0.077	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.982	1997	2020	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.982	1997	2020	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	2000	2019	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C4721508	Hamman-Rich Disease	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C4721509	Usual Interstitial Pneumonia	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2852	GPER1	0.505	0.731	C4721952	Familial Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2857	GPR34	0.743	0.346	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2857	GPR34	0.743	0.346	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2859	GPR35	0.587	0.654	C0566602	Primary sclerosing cholangitis	disease	C06	Disease or Syndrome	0.31	1	2013	2013	   1	   0	ORPHANET
     2861	GPR37	0.716	0.385	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     2868	GRK4	0.716	0.5	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     2868	GRK4	0.716	0.5	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2868	GRK4	0.716	0.5	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2868	GRK4	0.716	0.5	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2868	GRK4	0.716	0.5	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2868	GRK4	0.716	0.5	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2869	GRK5	0.588	0.769	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.32	1	2015	2019	   1	   0	CTD_human
     2869	GRK5	0.588	0.769	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2869	GRK5	0.588	0.769	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2870	GRK6	0.67	0.654	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	1999	1999	   1	   0	CTD_human
     2870	GRK6	0.67	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	0.5	2006	2014	   2	   0	PSYGENET
     2870	GRK6	0.67	0.654	C0278701	Gastric Adenocarcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
     2870	GRK6	0.67	0.654	C3165106	Infiltrating duct carcinoma of female breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     2873	GPS1	0.769	0.346	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
     2875	GPT	0.403	0.923	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.40	0.943	2000	2020	   1	   0	CTD_human
     2875	GPT	0.403	0.923	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	1977	2009	   2	   0	CTD_human
     2875	GPT	0.403	0.923	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2006	2012	   1	   0	CTD_human
     2875	GPT	0.403	0.923	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.40	0.985	1993	2020	   1	   0	CTD_human
     2875	GPT	0.403	0.923	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	1993	1993	   1	   0	CTD_human
     2875	GPT	0.403	0.923	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     2875	GPT	0.403	0.923	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.40	1	1977	2020	   2	   0	CTD_human
     2875	GPT	0.403	0.923	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	1977	2009	   2	   0	CTD_human
     2875	GPT	0.403	0.923	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.40	0.955	2000	2020	   1	   0	CTD_human
     2875	GPT	0.403	0.923	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	1977	2009	   2	   0	CTD_human
     2875	GPT	0.403	0.923	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.50	1	1977	2016	   2	   0	CTD_human
     2875	GPT	0.403	0.923	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	1977	2009	   2	   0	CTD_human
     2876	GPX1	0.458	0.923	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.40	0.909	2004	2017	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.40	0.909	2004	2017	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.833	1995	2019	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.33	1	2002	2017	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.31	1	2009	2009	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0007222	Cardiovascular Diseases	group	C14	Disease or Syndrome	0.36	1	2003	2019	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2013	2017	   1	   0	PSYGENET
     2876	GPX1	0.458	0.923	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2013	2017	   1	   0	PSYGENET
     2876	GPX1	0.458	0.923	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2004	2015	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.37	1	2005	2018	   2	   0	CTD_human
     2876	GPX1	0.458	0.923	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.31	1	2009	2017	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0020456	Hyperglycemia	disease	C18	Disease or Syndrome	0.31	1	2004	2010	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.32	1	2004	2019	   2	   0	CTD_human
     2876	GPX1	0.458	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.52	1	2010	2017	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0020550	Hyperthyroidism	disease	C19	Disease or Syndrome	0.51	1	2010	2019	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.35	1	1994	2008	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.32	1	2004	2020	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.31	1	2008	2010	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.31	1	2005	2009	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2013	2013	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0236018	Aura	phenotype	C10	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.38	0.889	1994	2015	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.33	1	2004	2017	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0398747	Gluthathione peroxidase deficiency	disease		Disease or Syndrome	0.30	1	1975	1975	   1	   0	GENOMICS_ENGLAND
     2876	GPX1	0.458	0.923	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.889	1995	2019	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C1257963	Endogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2004	2008	   2	   0	CTD_human
     2876	GPX1	0.458	0.923	C1257964	Exogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2004	2008	   2	   0	CTD_human
     2876	GPX1	0.458	0.923	C1257965	Compensatory Hyperinsulinemia	disease	C18	Disease or Syndrome	0.30	1	2004	2008	   2	   0	CTD_human
     2876	GPX1	0.458	0.923	C1449563	Cardiomyopathy, Familial Idiopathic	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2002	2008	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	2004	2004	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C3501647	Glutathione Peroxidase Deficiency, Hemolytic Anemia possibly due to	disease	C15	Disease or Syndrome	0.30				   0	   0	CTD_human
     2876	GPX1	0.458	0.923	C3714618	Primary Hyperthyroidism	disease	C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2876	GPX1	0.458	0.923	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.34	1	1999	2019	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.35	0.8	2013	2019	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.34	1	1999	2019	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2877	GPX2	0.619	0.5	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.34	1	2005	2018	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.917	2010	2019	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   2	   0	CTD_human
     2878	GPX3	0.522	0.769	C0015624	Fanconi Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2009	2011	   2	   0	CTD_human
     2878	GPX3	0.522	0.769	C0027651	Neoplasms	group	C04	Neoplastic Process	0.40	1	2001	2019	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.52	1	2001	2018	   2	   0	CTD_human
     2878	GPX3	0.522	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.33	1	2009	2019	   2	   0	CTD_human
     2878	GPX3	0.522	0.769	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   2	   0	CTD_human
     2878	GPX3	0.522	0.769	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0341703	Adult Fanconi syndrome	disease	C16;C13;C12	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.36	1	2007	2018	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C1857395	De Toni-Debre-Fanconi Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     2878	GPX3	0.522	0.769	C3495427	Fanconi-Bickel Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.35	1	2001	2019	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0006635	Cadmium poisoning	disease	C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2007	2018	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0012684	Blastocyst Disintegration	phenotype	C23;C13	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0013937	Embryo Resorption	phenotype	C23;C13	Organism Function	0.30	1	2003	2003	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.31	1	2003	2009	   2	   0	CTD_human
     2879	GPX4	0.516	0.808	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0431663	Bilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0431664	Unilateral Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.35	1	2001	2019	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0752350	Embryo Death	phenotype	C23;C13	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0752351	Embryo Loss	phenotype	C23;C13	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2009	2009	   2	   0	CTD_human
     2879	GPX4	0.516	0.808	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2009	2009	   2	   0	CTD_human
     2879	GPX4	0.516	0.808	C1136082	Embryo Disintegration	phenotype	C23;C13	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	2001	2007	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C1563730	Abdominal Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C1563731	Inguinal Cryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C1855229	Spondylometaphyseal dysplasia, Sedaghatian type	disease	C16;C05	Disease or Syndrome	0.72	1	2014	2018	   1	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2879	GPX4	0.516	0.808	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     2879	GPX4	0.516	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2885	GRB2	0.546	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2008	2019	   2	   0	PSYGENET
     2886	GRB7	0.603	0.462	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1994	2019	   2	   0	CTD_human
     2886	GRB7	0.603	0.462	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1994	2019	   2	   0	CTD_human
     2886	GRB7	0.603	0.462	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2009	   2	   0	CTD_human
     2886	GRB7	0.603	0.462	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     2886	GRB7	0.603	0.462	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.32	1	1994	2009	   2	   0	CTD_human
     2886	GRB7	0.603	0.462	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2009	   2	   0	CTD_human
     2887	GRB10	0.628	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     2888	GRB14	0.743	0.346	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.43	1	2011	2019	   1	   1	CTD_human
     2888	GRB14	0.743	0.346	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2001	2017	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2007	2012	   4	   0	PSYGENET
     2890	GRIA1	0.57	0.577	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2008	   5	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.38	0.6	2012	2020	   5	   0	PSYGENET
     2890	GRIA1	0.57	0.577	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.38	0.6	2012	2020	   5	   0	PSYGENET
     2890	GRIA1	0.57	0.577	C0016722	Frigidity	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0020594	Hypoactive Sexual Desire Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0023186	Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0026552	Morphine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2001	2019	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0029261	Orgasmic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0033953	Psychosexual Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.50	1	2012	2012	   1	   0	PSYGENET
     2890	GRIA1	0.57	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.50	1	1995	2019	   2	   2	PSYGENET
     2890	GRIA1	0.57	0.577	C0036902	Sexual Arousal Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2003	   2	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2001	2003	   2	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2001	2003	   2	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2008	   5	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0600272	Morphine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2008	   5	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   2	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0751262	Adult Learning Disorders	group	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0751263	Learning Disturbance	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C0751265	Learning Disabilities	disease	C23;C10;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2017	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C1330966	Developmental Academic Disorder	phenotype	C23;C10;F03	Finding	0.30	1	2007	2007	   1	   0	CTD_human
     2890	GRIA1	0.57	0.577	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     2890	GRIA1	0.57	0.577	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   2	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.667	2007	2020	   3	   0	PSYGENET
     2891	GRIA2	0.573	0.692	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	0.5	1995	2020	   2	   0	PSYGENET
     2891	GRIA2	0.573	0.692	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.36	1	2001	2019	   1	   0	GENOMICS_ENGLAND
     2891	GRIA2	0.573	0.692	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.72	1	2009	2019	   2	   0	CTD_human;GENOMICS_ENGLAND
     2891	GRIA2	0.573	0.692	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2012	2013	   2	   0	PSYGENET
     2891	GRIA2	0.573	0.692	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2891	GRIA2	0.573	0.692	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2891	GRIA2	0.573	0.692	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2012	2013	   2	   0	PSYGENET
     2891	GRIA2	0.573	0.692	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.32	0.5	2013	2019	   1	   0	GENOMICS_ENGLAND
     2891	GRIA2	0.573	0.692	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2891	GRIA2	0.573	0.692	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     2892	GRIA3	0.566	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	1999	2010	   5	   0	PSYGENET
     2892	GRIA3	0.566	0.692	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2010	2017	   2	   0	PSYGENET
     2892	GRIA3	0.566	0.692	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2010	2017	   3	   0	PSYGENET
     2892	GRIA3	0.566	0.692	C0016722	Frigidity	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2892	GRIA3	0.566	0.692	C0020594	Hypoactive Sexual Desire Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2892	GRIA3	0.566	0.692	C0029261	Orgasmic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2892	GRIA3	0.566	0.692	C0033953	Psychosexual Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2892	GRIA3	0.566	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2008	2013	   2	   0	PSYGENET
     2892	GRIA3	0.566	0.692	C0036902	Sexual Arousal Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2892	GRIA3	0.566	0.692	C0796250	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME	disease	C23;C16;C10	Disease or Syndrome	0.30	1	1999	2014	   6	   0	CLINGEN
     2892	GRIA3	0.566	0.692	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2892	GRIA3	0.566	0.692	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2892	GRIA3	0.566	0.692	C2678051	MENTAL RETARDATION, X-LINKED 94 (disorder)	disease	C16;C10	Disease or Syndrome	0.70	1	2007	2007	   1	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2892	GRIA3	0.566	0.692	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0027092	Myopia	disease	C11	Disease or Syndrome	0.40	1	2013	2016	   1	   1	CTD_human
     2893	GRIA4	0.631	0.615	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	0.25	2003	2012	   4	   0	PSYGENET
     2893	GRIA4	0.631	0.615	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2893	GRIA4	0.631	0.615	C4693391	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES	disease		Disease or Syndrome	0.50	1	2008	2017	   2	   4	GENOMICS_ENGLAND;UNIPROT
     2894	GRID1	0.743	0.385	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     2894	GRID1	0.743	0.385	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2894	GRID1	0.743	0.385	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     2894	GRID1	0.743	0.385	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2012	2013	   3	   0	PSYGENET
     2894	GRID1	0.743	0.385	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2013	   3	   0	PSYGENET
     2894	GRID1	0.743	0.385	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2005	2018	   5	   0	PSYGENET
     2895	GRID2	0.67	0.5	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     2895	GRID2	0.67	0.5	C0087012	Ataxia, Spinocerebellar	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2895	GRID2	0.67	0.5	C0752120	Spinocerebellar Ataxia Type 1	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2895	GRID2	0.67	0.5	C0752121	Spinocerebellar Ataxia Type 2	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2895	GRID2	0.67	0.5	C0752122	Spinocerebellar Ataxia Type 4	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2895	GRID2	0.67	0.5	C0752123	Spinocerebellar Ataxia Type 5	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2895	GRID2	0.67	0.5	C0752124	Spinocerebellar Ataxia Type 6 (disorder)	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2895	GRID2	0.67	0.5	C0752125	Spinocerebellar Ataxia Type 7	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2895	GRID2	0.67	0.5	C4015505	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	disease		Disease or Syndrome	0.90	1	2010	2016	   5	   2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2896	GRN	0.435	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2012	2017	   2	   0	PSYGENET
     2896	GRN	0.435	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2010	2012	   3	   0	PSYGENET
     2896	GRN	0.435	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2010	2012	   3	   0	PSYGENET
     2896	GRN	0.435	0.846	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     2896	GRN	0.435	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2896	GRN	0.435	0.846	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2896	GRN	0.435	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2010	2012	   2	   0	PSYGENET
     2896	GRN	0.435	0.846	C0338451	Frontotemporal dementia	disease	C18;C10;F03	Disease or Syndrome	0.90	0.976	2006	2020	   3	  15	CTD_human;GENOMICS_ENGLAND
     2896	GRN	0.435	0.846	C0338462	Semantic Dementia	disease	C18;C10;F03	Mental or Behavioral Dysfunction	0.53	1	2010	2018	   3	   0	CTD_human;ORPHANET
     2896	GRN	0.435	0.846	C0338630	Senile Paranoid Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2008	   2	   0	CTD_human
     2896	GRN	0.435	0.846	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.50	1	2006	2019	   2	   0	CTD_human
     2896	GRN	0.435	0.846	C0751071	Familial Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2007	2008	   2	   0	CTD_human
     2896	GRN	0.435	0.846	C0751072	Frontotemporal Lobar Degeneration	disease	C18;C10;F03	Mental or Behavioral Dysfunction	0.40	0.989	2006	2020	   1	   0	CTD_human
     2896	GRN	0.435	0.846	C0751706	Primary Progressive Nonfluent Aphasia	disease	C23;C18;C10;F03	Mental or Behavioral Dysfunction	0.40	0.917	2006	2018	   1	   0	ORPHANET
     2896	GRN	0.435	0.846	C1843792	FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	disease		Disease or Syndrome	0.98	1	2006	2018	   3	  22	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2896	GRN	0.435	0.846	C1850792	Congenital myasthenic syndrome ib	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     2896	GRN	0.435	0.846	C3539123	CEROID LIPOFUSCINOSIS, NEURONAL, 11	disease		Disease or Syndrome	0.70	1	2006	2017	   1	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2896	GRN	0.435	0.846	C4011788	Behavioral variant of frontotemporal dementia	disease	C18;C10;F03	Disease or Syndrome	0.39	1	2007	2019	   2	   0	ORPHANET
     2897	GRIK1	0.641	0.462	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     2897	GRIK1	0.641	0.462	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2009	2015	   1	   0	PSYGENET
     2897	GRIK1	0.641	0.462	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2007	2009	   1	   0	PSYGENET
     2897	GRIK1	0.641	0.462	C0022333	Jacksonian Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	0.5	1994	2012	   2	   0	PSYGENET
     2897	GRIK1	0.641	0.462	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.31	1	2001	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0149958	Complex partial seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0234533	Generalized seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0234535	Clonic Seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0270824	Visual seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0270844	Tonic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0270846	Epileptic drop attack	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0422850	Seizures, Somatosensory	phenotype	C23;C10	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0422852	Seizures, Auditory	phenotype	C23;C10	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0422853	Olfactory seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0422854	Gustatory seizure	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0422855	Vertiginous seizure	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0494475	Tonic - clonic seizures	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0573196	Overdose of cocaine	disease		Injury or Poisoning	0.30	1	2003	2003	   1	   0	PSYGENET
     2897	GRIK1	0.641	0.462	C0687132	heavy drinking	disease		Mental or Behavioral Dysfunction	0.32	1	2014	2014	   2	   0	PSYGENET
     2897	GRIK1	0.641	0.462	C0751056	Non-epileptic convulsion	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0751110	Single Seizure	disease	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0751123	Atonic Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0751494	Convulsive Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0751495	Seizures, Focal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C0751496	Seizures, Sensory	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C3495874	Nonepileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C3496069	cocaine use	disease		Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	PSYGENET
     2897	GRIK1	0.641	0.462	C4048158	Convulsions	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C4316903	Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C4317109	Epileptic Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C4317123	Myoclonic Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     2897	GRIK1	0.641	0.462	C4505436	Generalized Absence Seizures	phenotype	C23;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.38	1	2002	2010	   2	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.51	1	2007	2009	   3	   0	CTD_human;PSYGENET
     2898	GRIK2	0.561	0.769	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.51	1	2019	2019	   1	   0	CTD_human;UNIPROT
     2898	GRIK2	0.561	0.769	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0016722	Frigidity	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0020594	Hypoactive Sexual Desire Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0024232	Lymphatic Metastasis	disease	C23;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0029261	Orgasmic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0033953	Psychosexual Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	0.667	1996	2017	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0036902	Sexual Arousal Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2017	   1	   0	PSYGENET
     2898	GRIK2	0.561	0.769	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C1970198	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6	disease	C23;C10;F03;F01	Disease or Syndrome	0.60	1	2007	2007	   1	   1	CTD_human;GENOMICS_ENGLAND
     2898	GRIK2	0.561	0.769	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2898	GRIK2	0.561	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     2899	GRIK3	0.674	0.538	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	0.5	2006	2013	   2	   0	PSYGENET
     2899	GRIK3	0.674	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2019	2019	   0	   0	UNIPROT
     2899	GRIK3	0.674	0.538	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
     2899	GRIK3	0.674	0.538	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2899	GRIK3	0.674	0.538	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2010	2010	   1	   0	PSYGENET
     2899	GRIK3	0.674	0.538	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	PSYGENET
     2899	GRIK3	0.674	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.37	0.6	2002	2010	   5	   0	PSYGENET
     2899	GRIK3	0.674	0.538	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     2900	GRIK4	0.678	0.423	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2006	2019	   5	   0	PSYGENET
     2900	GRIK4	0.678	0.423	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     2900	GRIK4	0.678	0.423	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2008	   1	   0	PSYGENET
     2900	GRIK4	0.678	0.423	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.35	0.5	2006	2018	   4	   0	PSYGENET
     2900	GRIK4	0.678	0.423	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2012	2017	   1	   0	PSYGENET
     2900	GRIK4	0.678	0.423	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2008	   1	   0	PSYGENET
     2900	GRIK4	0.678	0.423	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2012	2019	   1	   0	PSYGENET
     2901	GRIK5	0.792	0.231	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     2901	GRIK5	0.792	0.231	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2006	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2003	2013	   3	   0	PSYGENET
     2902	GRIN1	0.561	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	0.5	2003	2012	   2	   0	PSYGENET
     2902	GRIN1	0.561	0.692	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2010	   2	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.31	1	2016	2017	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0030193	Pain	phenotype	C23	Sign or Symptom	0.31	1	2008	2017	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0033958	Psychosis, Brief Reactive	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2001	2013	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0036358	Schizophreniform Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0040997	Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2010	   2	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0393786	Trigeminal Neuralgia, Idiopathic	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0393787	Secondary Trigeminal Neuralgia	disease	C10;C07	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0427086	Involuntary Movements	phenotype	C23;C10	Sign or Symptom	0.41	1	2015	2017	   1	   0	GENOMICS_ENGLAND
     2902	GRIN1	0.561	0.692	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0543888	Epileptic encephalopathy	disease	C10	Disease or Syndrome	0.44	1	2013	2019	   3	   0	GENOMICS_ENGLAND
     2902	GRIN1	0.561	0.692	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2010	   2	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2016	2016	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2008	2008	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.34	1	2016	2019	   1	   0	CTD_human
     2902	GRIN1	0.561	0.692	C3280282	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.70	1	2011	2017	   9	  16	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2902	GRIN1	0.561	0.692	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.43	1	2015	2017	   1	   0	GENOMICS_ENGLAND
     2902	GRIN1	0.561	0.692	C4693325	NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.60	1	2013	2017	   3	   2	GENOMICS_ENGLAND;UNIPROT
     2903	GRIN2A	0.522	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.34	1	2008	2015	   4	   0	PSYGENET
     2903	GRIN2A	0.522	0.808	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2005	2005	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.58	0.8	2005	2019	   6	   0	CTD_human;PSYGENET
     2903	GRIN2A	0.522	0.808	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0009090	Cluttering	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	2006	2019	   4	   0	PSYGENET
     2903	GRIN2A	0.522	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2006	2019	   4	   0	PSYGENET
     2903	GRIN2A	0.522	0.808	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.40	0.96	1999	2019	   2	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0023012	Language Delay	phenotype	C23;C10	Finding	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0023014	Language Development Disorders	group	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.33	1	2011	2017	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0026552	Morphine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.6	2003	2020	   5	   0	PSYGENET
     2903	GRIN2A	0.522	0.808	C0037822	Speech Disorders	group	C23;C10	Disease or Syndrome	0.31	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2010	2013	   2	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0233726	Aprosodia	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0236018	Aura	phenotype	C10	Finding	0.30	1	2010	2013	   2	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0241210	Speech Delay	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0282512	Landau-Kleffner Syndrome	disease	C10	Mental or Behavioral Dysfunction	0.64	1	2013	2018	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2903	GRIN2A	0.522	0.808	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2019	2019	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0376532	Epilepsy, Rolandic	disease	C10	Disease or Syndrome	0.53	1	2012	2018	   1	   0	CTD_human;ORPHANET
     2903	GRIN2A	0.522	0.808	C0454655	Semantic-Pragmatic Disorder	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2003	2017	   3	   0	PSYGENET
     2903	GRIN2A	0.522	0.808	C0600272	Morphine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2010	2013	   2	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0751257	Auditory Processing Disorder, Central	disease	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0751512	Dysglossia	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0751513	Rhinolalia	phenotype	C23;C10	Sign or Symptom	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C0751514	Verbal Fluency Disorders	phenotype	C23;C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C2363129	Benign Rolandic Epilepsy	disease	C10	Disease or Syndrome	0.52	1	2013	2018	   1	   0	CTD_human;ORPHANET
     2903	GRIN2A	0.522	0.808	C3495145	Dyslalia	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	CTD_human
     2903	GRIN2A	0.522	0.808	C3806402	EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION	disease		Disease or Syndrome	0.60	1	2010	2017	  12	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2903	GRIN2A	0.522	0.808	C4749281	Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation	phenotype	C23;C10;F03;F01	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
     2904	GRIN2B	0.51	0.692	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.38	0.8	2003	2017	   5	   0	PSYGENET
     2904	GRIN2B	0.51	0.692	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.43	1	2013	2018	   1	   2	GENOMICS_ENGLAND
     2904	GRIN2B	0.51	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.39	0.8	2005	2020	   5	   0	PSYGENET
     2904	GRIN2B	0.51	0.692	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	0.8	2009	2019	   5	   0	PSYGENET
     2904	GRIN2B	0.51	0.692	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	0.8	2009	2019	   5	   0	PSYGENET
     2904	GRIN2B	0.51	0.692	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.65	0.875	2004	2018	   2	   1	CTD_human
     2904	GRIN2B	0.51	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.56	1	2009	2020	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.70	0.972	2000	2020	   1	   1	CTD_human
     2904	GRIN2B	0.51	0.692	C0037769	West Syndrome	disease	C10	Disease or Syndrome	0.42	1	2014	2017	   1	   0	ORPHANET
     2904	GRIN2B	0.51	0.692	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2006	2018	   2	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0236018	Aura	phenotype	C10	Finding	0.30	1	2006	2018	   2	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2009	2009	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0543888	Epileptic encephalopathy	disease	C10	Disease or Syndrome	0.41	1	2013	2016	   1	   0	GENOMICS_ENGLAND
     2904	GRIN2B	0.51	0.692	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2006	2018	   2	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2009	2009	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.38	1	2011	2019	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.34	1	2012	2018	   2	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.36	1	2009	2019	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C3151411	MENTAL RETARDATION, AUTOSOMAL DOMINANT 6	disease		Mental or Behavioral Dysfunction	0.70	1	2010	2017	   8	  21	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2904	GRIN2B	0.51	0.692	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.47	1	2010	2018	   1	   0	CTD_human
     2904	GRIN2B	0.51	0.692	C4015316	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27	disease		Disease or Syndrome	0.70	1	2014	2017	   3	  12	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2905	GRIN2C	0.792	0.269	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	0.75	2003	2014	   4	   0	PSYGENET
     2906	GRIN2D	0.65	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   1	UNIPROT
     2906	GRIN2D	0.65	0.538	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2906	GRIN2D	0.65	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2005	2019	   1	   0	CTD_human
     2906	GRIN2D	0.65	0.538	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.40	1	2018	2018	   1	   0	GENOMICS_ENGLAND
     2906	GRIN2D	0.65	0.538	C4310687	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46	disease		Disease or Syndrome	0.70	1	2016	2018	   2	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2908	NR3C1	0.393	0.885	C0001969	Alcoholic Intoxication	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2011	2012	   2	   0	PSYGENET
     2908	NR3C1	0.393	0.885	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2004	2017	   6	   0	CTD_human;PSYGENET
     2908	NR3C1	0.393	0.885	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2009	   2	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.60	0.8	1999	2020	   5	   0	PSYGENET
     2908	NR3C1	0.393	0.885	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.60	0.8	1999	2020	   6	   0	CTD_human;PSYGENET
     2908	NR3C1	0.393	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2018	2018	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.32	1	2012	2018	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0017614	Glaucoma, Suspect	disease	C11	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.70	0.824	1993	2018	   2	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0020621	Hypokalemia	phenotype	C18	Finding	0.40	1	2002	2002	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2013	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0028840	Ocular Hypertension	disease	C11	Disease or Syndrome	0.34	0.75	2007	2019	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2015	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0033958	Psychosis, Brief Reactive	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.33	1	2004	2015	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.929	2000	2019	   2	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0036358	Schizophreniform Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2004	2020	   6	   0	CTD_human;PSYGENET
     2908	NR3C1	0.393	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2003	2009	   2	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0238394	Female Pseudohermaphroditism	disease	C16;C13;C12;C19	Congenital Abnormality	0.41	1	2002	2006	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2004	2011	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	1	1997	2020	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.60	0.8	2002	2018	   6	   0	CTD_human;PSYGENET
     2908	NR3C1	0.393	0.885	C0600260	Lung Diseases, Obstructive	group	C08	Disease or Syndrome	0.31	1	1998	2007	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2003	2017	   2	   0	CTD_human
     2908	NR3C1	0.393	0.885	C1257958	Glucose Metabolism Disorders	group	C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2006	2020	   5	   0	PSYGENET
     2908	NR3C1	0.393	0.885	C1841972	Glucocorticoid Receptor Deficiency	disease	C16;C18	Disease or Syndrome	0.80	0.953	1991	2020	  16	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2908	NR3C1	0.393	0.885	C1841973	Pseudohermaphroditism, Female, With Hypokalemia, Due To Glucocorticoid Resistance	disease	C16;C18	Disease or Syndrome	0.40				   0	   1	CTD_human
     2908	NR3C1	0.393	0.885	C1841982	BODY COMPOSITION, BENEFICIAL	phenotype	C16;C18	Finding	0.30				   0	   0	CTD_human
     2908	NR3C1	0.393	0.885	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C2936403	46, XX Disorders of Sex Development	group	C16;C13;C12;C19	Congenital Abnormality	0.30	1	2002	2002	   1	   0	CTD_human
     2908	NR3C1	0.393	0.885	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     2909	ARHGAP35	0.751	0.269	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.31	1	2016	2018	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2014	2020	   1	   0	PSYGENET
     2911	GRM1	0.528	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
     2911	GRM1	0.528	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2001	2014	   5	   0	PSYGENET
     2911	GRM1	0.528	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2001	2014	   5	   0	PSYGENET
     2911	GRM1	0.528	0.808	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.34	1	2010	2019	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.52	1	2000	2005	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0016045	fibroma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0016048	Fibromatosis	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2005	2019	   2	   0	PSYGENET
     2911	GRM1	0.528	0.808	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
     2911	GRM1	0.528	0.808	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     2911	GRM1	0.528	0.808	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0087012	Ataxia, Spinocerebellar	disease	C16;C10	Disease or Syndrome	0.32	1	2015	2017	   0	   0	CTD_human
     2911	GRM1	0.528	0.808	C0205766	Myxofibroma	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0206639	Neoplasms, Bone Tissue	group	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0221290	Chondromyxoid fibroma	disease	C04	Neoplastic Process	0.32	1	2014	2019	   1	   0	ORPHANET
     2911	GRM1	0.528	0.808	C0236018	Aura	phenotype	C10	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
     2911	GRM1	0.528	0.808	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
     2911	GRM1	0.528	0.808	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
     2911	GRM1	0.528	0.808	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
     2911	GRM1	0.528	0.808	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
     2911	GRM1	0.528	0.808	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
     2911	GRM1	0.528	0.808	C0752120	Spinocerebellar Ataxia Type 1	disease	C16;C10	Disease or Syndrome	0.31	1	2017	2017	   0	   0	CTD_human
     2911	GRM1	0.528	0.808	C0752121	Spinocerebellar Ataxia Type 2	disease	C16;C10	Disease or Syndrome	0.32	1	2015	2017	   0	   0	CTD_human
     2911	GRM1	0.528	0.808	C0752122	Spinocerebellar Ataxia Type 4	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2911	GRM1	0.528	0.808	C0752123	Spinocerebellar Ataxia Type 5	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2911	GRM1	0.528	0.808	C0752124	Spinocerebellar Ataxia Type 6 (disorder)	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2911	GRM1	0.528	0.808	C0752125	Spinocerebellar Ataxia Type 7	disease	C16;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     2911	GRM1	0.528	0.808	C0852975	Congenital cerebellar ataxia	disease		Disease or Syndrome	0.31	1	2012	2012	   0	   0	GENOMICS_ENGLAND
     2911	GRM1	0.528	0.808	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2911	GRM1	0.528	0.808	C3553816	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	disease		Disease or Syndrome	0.90	1	2006	2015	   2	   1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     2911	GRM1	0.528	0.808	C4521563	SPINOCEREBELLAR ATAXIA 44	disease		Disease or Syndrome	0.61	1	2017	2019	   1	   3	GENOMICS_ENGLAND;UNIPROT
     2912	GRM2	0.582	0.577	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
     2912	GRM2	0.582	0.577	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.31	1	2001	2008	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0033937	Psychoses, Drug	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0033941	Psychoses, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.893	1995	2019	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2912	GRM2	0.582	0.577	C0858355	Addicted to cocaine	phenotype		Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
     2913	GRM3	0.606	0.538	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
     2913	GRM3	0.606	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	0.8	2002	2017	   5	   0	PSYGENET
     2913	GRM3	0.606	0.538	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2913	GRM3	0.606	0.538	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2913	GRM3	0.606	0.538	C0025202	melanoma	disease	C04	Neoplastic Process	0.32	1	2011	2018	   2	   0	CTD_human
     2913	GRM3	0.606	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.50	0.885	2002	2019	   1	   0	CTD_human
     2913	GRM3	0.606	0.538	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2913	GRM3	0.606	0.538	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     2913	GRM3	0.606	0.538	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2009	2013	   2	   0	PSYGENET
     2913	GRM3	0.606	0.538	C0858355	Addicted to cocaine	phenotype		Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
     2914	GRM4	0.636	0.5	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2005	2007	   2	   0	PSYGENET
     2914	GRM4	0.636	0.5	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2914	GRM4	0.636	0.5	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2914	GRM4	0.636	0.5	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2914	GRM4	0.636	0.5	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	0.45	1	2013	2020	   1	   1	CTD_human
     2914	GRM4	0.636	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	0.333	2001	2013	   3	   0	PSYGENET
     2914	GRM4	0.636	0.5	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2914	GRM4	0.636	0.5	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2013	2018	   1	   0	PSYGENET
     2915	GRM5	0.525	0.846	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2019	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0011882	Diabetic Neuropathies	group	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2010	2019	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2020	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0014556	Epilepsy, Temporal Lobe	disease	C10	Disease or Syndrome	0.33	1	2000	2019	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0014558	Uncinate Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0027796	Neuralgia	phenotype	C23;C10	Sign or Symptom	0.40	1	2010	2019	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.60	1	2001	2020	   3	   0	PSYGENET
     2915	GRM5	0.525	0.846	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.31	1	2007	2019	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0038870	Neuralgia, Supraorbital	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2011	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2010	2019	   3	   0	PSYGENET
     2915	GRM5	0.525	0.846	C0042656	Neuralgia, Vidian	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0234247	Neuralgia, Atypical	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0234249	Neuralgia, Stump	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0270823	Petit mal status	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2008	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C0271673	Symmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0271674	Asymmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0271678	Diabetic Mononeuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0271680	Diabetic Polyneuropathies	group	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0271685	Diabetic Amyotrophy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0271686	Diabetic Autonomic Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0311335	Grand Mal Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2008	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C0393672	Epilepsy, Benign Psychomotor, Childhood	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0393682	Epilepsy, Lateral Temporal	disease	C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0393734	Complex Partial Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2008	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C0393835	Diabetic Asymmetric Polyneuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0423711	Neuralgia, Perineal	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0423712	Neuralgia, Iliohypogastric Nerve	phenotype	C23;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2010	2018	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2019	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0751074	Diabetic Neuralgia	disease	C10;C19	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0751371	Neuralgia, Ilioinguinal	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0751372	Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0751373	Paroxysmal Nerve Pain	phenotype	C23;C10	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C0751522	Status Epilepticus, Subclinical	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2008	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C0751523	Non-Convulsive Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.30	1	2007	2008	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C0751524	Simple Partial Status Epilepticus	phenotype	C23;C10	Disease or Syndrome	0.30	1	2007	2008	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.45	1	2010	2015	   2	   1	CTD_human
     2915	GRM5	0.525	0.846	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.49	1	2010	2019	   3	   4	PSYGENET
     2915	GRM5	0.525	0.846	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2011	   2	   0	CTD_human
     2915	GRM5	0.525	0.846	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2915	GRM5	0.525	0.846	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2916	GRM6	0.7	0.308	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     2916	GRM6	0.7	0.308	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     2916	GRM6	0.7	0.308	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.80	1	2005	2019	   1	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET
     2916	GRM6	0.7	0.308	C1848172	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2916	GRM6	0.7	0.308	C1850362	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	disease	C16;C11	Disease or Syndrome	0.91	1	2005	2017	   3	   8	CTD_human;GENOMICS_ENGLAND;UNIPROT
     2916	GRM6	0.7	0.308	C1864877	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2916	GRM6	0.7	0.308	C3495587	Night Blindness, Congenital Stationary, Type 1A	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2916	GRM6	0.7	0.308	C3501847	Night blindness, congenital stationary, type 1	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2916	GRM6	0.7	0.308	C3711543	X-Linked Csnb	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2916	GRM6	0.7	0.308	C4041558	Cone-rod synaptic disorder, congenital nonprogressive	disease	C16;C11	Disease or Syndrome	0.30				   0	   0	CTD_human
     2917	GRM7	0.628	0.538	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
     2917	GRM7	0.628	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.667	2007	2014	   3	   0	PSYGENET
     2917	GRM7	0.628	0.538	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	2010	2018	   5	   0	PSYGENET
     2917	GRM7	0.628	0.538	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	1	2010	2018	   5	   0	PSYGENET
     2917	GRM7	0.628	0.538	C0013146	Drug abuse	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0013170	Drug habituation	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0013222	Drug Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0029231	Organic Mental Disorders, Substance-Induced	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2000	2019	   4	   0	PSYGENET
     2917	GRM7	0.628	0.538	C0038580	Substance Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0038586	Substance Use Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2016	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2011	2019	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.34	0.8	2010	2018	   5	   0	PSYGENET
     2917	GRM7	0.628	0.538	C0236969	Substance-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C0740858	Substance abuse problem	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2011	2019	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.49	0.8	2010	2019	   5	   1	PSYGENET
     2917	GRM7	0.628	0.538	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C1510472	Drug Dependence	group	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2016	   1	   0	CTD_human
     2917	GRM7	0.628	0.538	C4316881	Prescription Drug Abuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2009	2017	   1	   0	PSYGENET
     2918	GRM8	0.636	0.577	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	0	2007	2007	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2008	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C0017639	Gliosis	phenotype	C23	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	0.333	2001	2018	   3	   0	PSYGENET
     2918	GRM8	0.636	0.577	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C1263846	Attention deficit hyperactivity disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2015	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C1321905	Minimal Brain Dysfunction	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     2918	GRM8	0.636	0.577	C3887640	Astrocytosis	phenotype	C23	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.34	1	2013	2019	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.58	1	1996	2019	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	2000	2006	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0035228	Respiratory Hypersensitivity	phenotype	C08;C20	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0036982	Shock, Hemorrhagic	phenotype	C23	Pathologic Function	0.50	1	2011	2011	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0085129	Bronchial Hyperreactivity	disease	C08	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0241910	Autoimmune Chronic Hepatitis	disease	C06;C20	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2009	2017	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.35	1	1996	2018	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2919	CXCL1	0.449	0.923	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.32	1	2004	2017	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0005974	Bone Resorption	phenotype	C05	Organ or Tissue Function	0.30	1	2011	2011	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2011	2011	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.31	1	2013	2016	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.33	1	2004	2014	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	2000	2010	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0036982	Shock, Hemorrhagic	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.50	1	2009	2016	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.31	1	2011	2011	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2005	2008	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2920	CXCL2	0.513	0.885	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.31	1	2005	2014	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.31	1	2005	2014	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2005	2014	   1	   0	CTD_human
     2921	CXCL3	0.65	0.692	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0002622	Amnesia	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1989	1989	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1989	1989	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1989	1989	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1989	1989	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0233750	Hysterical amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0233796	Temporary Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0236795	Dissociative Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0262497	Global Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0750906	Tactile Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0750907	Amnestic State	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2922	GRP	0.524	0.769	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.37	0.875	2007	2019	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C0027651	Neoplasms	group	C04	Neoplastic Process	0.34	0.8	2007	2015	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2007	2016	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C1846707	SPINOCEREBELLAR ATAXIA 17	disease	C16;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     2923	PDIA3	0.566	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2006	2019	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
     2925	GRPR	0.595	0.538	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	PSYGENET
     2925	GRPR	0.595	0.538	C0025261	Memory Disorders	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.36	0.857	2002	2019	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0233794	Memory impairment	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.973	2000	2020	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0751292	Age-Related Memory Disorders	group	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0751293	Memory Disorder, Semantic	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0751294	Memory Disorder, Spatial	phenotype	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     2925	GRPR	0.595	0.538	C0751295	Memory Loss	phenotype	C23;C10;F01	Sign or Symptom	0.30	1	2007	2007	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0024713	Manic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2014	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2931	GSK3A	0.644	0.538	C0338831	Manic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     2932	GSK3B	0.43	0.846	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
     2932	GSK3B	0.43	0.846	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.7	0.982	2000	2020	2	1	CTD_human
10991	2932	GSK3B	0.43	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	0.8	2004	2019	6	0	CTD_human;PSYGENET
10996	2932	GSK3B	0.43	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.58	1	2007	2019	3	0	PSYGENET
10998	2932	GSK3B	0.43	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.57	1	2007	2019	5	0	CTD_human;PSYGENET
11002	2932	GSK3B	0.43	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.51	1	2012	2018	1	0	CTD_human
11008	2932	GSK3B	0.43	0.846	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.56	1	2006	2018	1	0	CTD_human
11011	2932	GSK3B	0.43	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.6	0.88	2003	2020	2	0	CTD_human
11032	2972	BRF1	0.7	0.462	C4015495	CEREBELLOFACIODENTAL SYNDROME	disease		Disease or Syndrome	0.71	1	2015	2017	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11045	2978	GUCA1A	0.647	0.5	C1865869	CONE DYSTROPHY 3 (disorder)	disease	C16;C11	Disease or Syndrome	0.72	1	1998	2011	8	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
11048	2979	GUCA1B	0.682	0.423	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.52	1	2004	2011	2	0	CTD_human;GENOMICS_ENGLAND
11049	2979	GUCA1B	0.682	0.423	C3151190	RETINITIS PIGMENTOSA 48	disease		Disease or Syndrome	0.61	1	2005	2011	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11064	2982	GUCY1A1	0.686	0.577	C3810403	MOYAMOYA DISEASE 6 WITH OR WITHOUT ACHALASIA	disease		Disease or Syndrome	0.7	1	2014	2016	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
11071	2984	GUCY2C	0.599	0.577	C2939175	Meconium ileus	disease	C06	Disease or Syndrome	0.73	0.75	2012	2019	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11072	2984	GUCY2C	0.599	0.577	C3553270	DIARRHEA 6	disease		Disease or Syndrome	0.7	1	2012	2016	2	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
11080	2990	GUSB	0.53	0.846	C0085132	Mucopolysaccharidosis VII	disease	C16;C18;C17	Disease or Syndrome	1	1	1973	2019	17	34	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11082	2992	GYG1	0.722	0.308	C0017919	Glycogen Storage Disease	group	C16;C18	Disease or Syndrome	0.55	1	2010	2017	1	0	CTD_human;GENOMICS_ENGLAND
11085	2992	GYG1	0.722	0.308	C3150754	GLYCOGEN STORAGE DISEASE XV	disease		Disease or Syndrome	0.71	1	2010	2020	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11086	2992	GYG1	0.722	0.308	C4015452	POLYGLUCOSAN BODY MYOPATHY 2	disease		Disease or Syndrome	0.71	1	2010	2018	3	7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
11100	2997	GYS1	0.722	0.385	C1969054	Glycogen Storage Disease 0, Muscle	disease	C16;C18	Disease or Syndrome	0.7	1	2007	2015	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
11102	2998	GYS2	0.686	0.462	C1855861	Glycogen Storage Disease 0, Liver	disease	C16;C06;C18	Disease or Syndrome	0.72	1	1998	2018	2	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11105	3000	GUCY2D	0.57	0.769	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.68	0.875	2005	2016	1	0	CTD_human;GENOMICS_ENGLAND
11109	3000	GUCY2D	0.57	0.769	C1536451	Central areolar choroidal sclerosis	disease	C11	Disease or Syndrome	0.61	1	2012	2012	1	1	CTD_human;ORPHANET
11110	3000	GUCY2D	0.57	0.769	C1866293	Retinal cone dystrophy 2	disease	C16;C11	Disease or Syndrome	0.98	1	1996	2020	14	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
11111	3000	GUCY2D	0.57	0.769	C2931258	Amaurosis congenita of Leber, type 1	disease	C11	Disease or Syndrome	1	0.984	1995	2020	9	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
11114	3000	GUCY2D	0.57	0.769	C4551884	Choroidal Dystrophy, Central Areolar 1	disease	C11	Disease or Syndrome	0.6	1	2012	2012	1	1	CTD_human;UNIPROT
11175	3026	HABP2	0.593	0.615	C4225292	THYROID CANCER, NONMEDULLARY, 5	disease		Neoplastic Process	0.6	1	2003	2017	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11179	3028	HSD17B10	0.656	0.538	C3266731	2-methyl-3-hydroxybutyric aciduria	phenotype	C23;C16;C10	Disease or Syndrome	0.75	1	1999	2019	17	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
11191	3030	HADHA	0.569	0.769	C1969443	Trifunctional Protein Deficiency With Myopathy And Neuropathy	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.8	1	1994	2019	3	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11193	3030	HADHA	0.569	0.769	C3711645	Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.8	1	1994	2019	9	48	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
11206	3032	HADHB	0.619	0.692	C1969443	Trifunctional Protein Deficiency With Myopathy And Neuropathy	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.78	1	1996	2019	7	16	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11211	3033	HADH	0.65	0.538	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.51	1	2005	2017	1	0	CTD_human
11214	3033	HADH	0.65	0.538	C1291230	3-Hydroxyacyl-CoA Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.7	1	2001	2016	7	3	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11215	3033	HADH	0.65	0.538	C1864948	Hyperinsulinemic Hypoglycemia, Familial, 4	disease	C18	Disease or Syndrome	0.7	1	2001	2016	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
11217	3034	HAL	0.641	0.538	C0220992	Histidinemia	phenotype	C16;C18	Disease or Syndrome	0.73	1	1991	2005	1	4	CTD_human;ORPHANET;UNIPROT
11228	3035	HARS1	0.569	0.808	C3281066	USHER SYNDROME, TYPE IIIB	disease		Disease or Syndrome	0.71	1	1995	2017	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
11229	3035	HARS1	0.569	0.808	C4225265	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	disease		Disease or Syndrome	0.7	1	2013	2018	3	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11232	3039	HBA1	0.508	0.808	C0002312	alpha-Thalassemia	disease	C16;C15	Disease or Syndrome	0.8	0.985	1979	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
11257	3040	HBA2	0.512	0.808	C0700299	Heinz Body Anemias	disease	C16;C15	Disease or Syndrome	0.6	1	1991	1991	1	1	CTD_human;GENOMICS_ENGLAND
11261	3040	HBA2	0.512	0.808	C3161174	Hemoglobin H Disease	disease	C16;C15	Disease or Syndrome	0.6	0.971	1979	2018	2	0	GENOMICS_ENGLAND;ORPHANET
11266	3043	HBB	0.494	0.808	C0002875	Cooleys anemia	disease	C16;C15	Disease or Syndrome	0.70	1	1979	2019	   7	   7	CTD_human;ORPHANET
     3043	HBB	0.494	0.808	C0002895	Anemia, Sickle Cell	disease	C16;C15	Disease or Syndrome	0.80	0.994	1957	2020	   8	  36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3043	HBB	0.494	0.808	C0005283	beta Thalassemia	disease	C16;C15	Disease or Syndrome	0.80	0.994	1961	2019	  13	  87	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3043	HBB	0.494	0.808	C0010520	Cyanosis	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3043	HBB	0.494	0.808	C0013502	Echinococcosis	disease	C01	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3043	HBB	0.494	0.808	C0019021	Hemoglobin C Disease	disease	C16;C15	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
     3043	HBB	0.494	0.808	C0019025	Hemoglobin F Disease	disease	C16;C15	Disease or Syndrome	0.60	0.962	1979	2017	   7	   0	CTD_human;ORPHANET
     3043	HBB	0.494	0.808	C0019045	Hemoglobinopathies	group	C16;C15	Disease or Syndrome	0.50	1	1969	2019	   1	  35	CTD_human
     3043	HBB	0.494	0.808	C0024530	Malaria	disease	C01	Disease or Syndrome	0.50	0.846	1999	2018	   0	   2	CTD_human
     3043	HBB	0.494	0.808	C0024535	Malaria, Falciparum	disease	C01	Disease or Syndrome	0.33	0.75	1999	2010	   1	   0	CTD_human
     3043	HBB	0.494	0.808	C0025637	Methemoglobinemia	disease	C15	Disease or Syndrome	0.31	1	2005	2017	   1	   0	CTD_human
     3043	HBB	0.494	0.808	C0032461	Polycythemia	disease	C15	Disease or Syndrome	0.30	1	1975	1982	   2	   0	CTD_human
     3043	HBB	0.494	0.808	C0032463	Polycythemia Vera	disease	C04;C15	Neoplastic Process	0.30	1	1969	1969	   1	   0	CTD_human
     3043	HBB	0.494	0.808	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2018	2018	   1	   0	CTD_human
     3043	HBB	0.494	0.808	C0085578	Thalassemia Minor	disease	C16;C15	Disease or Syndrome	0.30	1	1979	2014	   6	   0	CTD_human
     3043	HBB	0.494	0.808	C0238159	Hemoglobin E disease	disease	C16;C15	Disease or Syndrome	0.40	1	2011	2016	   1	   1	ORPHANET
     3043	HBB	0.494	0.808	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     3043	HBB	0.494	0.808	C0271979	Thalassemia Intermedia	disease	C16;C15	Disease or Syndrome	0.40	1	1979	2017	   6	   0	CTD_human
     3043	HBB	0.494	0.808	C0271985	Delta-Beta Thalassemia	disease	C16;C15	Disease or Syndrome	0.40	0.941	1983	2008	   1	   0	ORPHANET
     3043	HBB	0.494	0.808	C0272080	Hemoglobin D disease	disease	C16;C15	Disease or Syndrome	0.30	1	2001	2014	   2	   0	ORPHANET
     3043	HBB	0.494	0.808	C0472767	Beta thalassemia intermedia	disease	C16;C15	Disease or Syndrome	0.50	1	1985	2019	   1	   7	ORPHANET
     3043	HBB	0.494	0.808	C0472777	Hemoglobin E/beta thalassemia disease	disease	C16;C15	Disease or Syndrome	0.40	1	2011	2011	   1	   1	ORPHANET
     3043	HBB	0.494	0.808	C0700299	Heinz Body Anemias	disease	C16;C15	Disease or Syndrome	0.60	1	2010	2010	   1	  17	CTD_human;GENOMICS_ENGLAND
     3043	HBB	0.494	0.808	C1527405	Erythrocytosis	phenotype	C15	Finding	0.40	1	1975	1982	   2	   1	CTD_human
     3043	HBB	0.494	0.808	C1841621	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	phenotype		Finding	0.40	1	2010	2010	   1	  12	GENOMICS_ENGLAND
     3043	HBB	0.494	0.808	C1858990	Beta Thalassemia, Dominant Inclusion Body Type	disease	C16;C15	Disease or Syndrome	0.70	1	2010	2011	   2	  14	CTD_human;GENOMICS_ENGLAND;ORPHANET
     3043	HBB	0.494	0.808	C3665425	Hemoglobin M Disease	disease	C15	Disease or Syndrome	0.30	1	1993	1993	   1	   0	ORPHANET
     3043	HBB	0.494	0.808	C3889261	Other License Status	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
     3043	HBB	0.494	0.808	C4551637	Erythrocytosis familial, 1	disease	C15	Disease or Syndrome	0.32	1	2005	2014	   1	   0	GENOMICS_ENGLAND
     3043	HBB	0.494	0.808	C4553297	Cystic Echinocccosis	disease	C01	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3045	HBD	0.659	0.231	C0022548	Keloid	disease	C23;C17	Acquired Abnormality	0.30	1	2010	2010	   1	   0	CTD_human
     3045	HBD	0.659	0.231	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     3045	HBD	0.659	0.231	C0271985	Delta-Beta Thalassemia	disease	C16;C15	Disease or Syndrome	0.35	1	1982	1992	   1	   0	ORPHANET
     3047	HBG1	0.615	0.538	C0019025	Hemoglobin F Disease	disease	C16;C15	Disease or Syndrome	0.40	0.978	1982	2019	   2	   0	ORPHANET
     3047	HBG1	0.615	0.538	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3047	HBG1	0.615	0.538	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     3047	HBG1	0.615	0.538	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     3047	HBG1	0.615	0.538	C0271985	Delta-Beta Thalassemia	disease	C16;C15	Disease or Syndrome	0.35	0.833	1982	2008	   1	   0	ORPHANET
     3047	HBG1	0.615	0.538	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     3047	HBG1	0.615	0.538	C1841621	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	phenotype		Finding	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     3048	HBG2	0.565	0.692	C0019025	Hemoglobin F Disease	disease	C16;C15	Disease or Syndrome	0.40	1	1982	2019	   3	   0	ORPHANET
     3048	HBG2	0.565	0.692	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	1977	1977	   2	   0	CTD_human
     3048	HBG2	0.565	0.692	C0028961	Oliguria	phenotype	C23;C13;C12	Disease or Syndrome	0.30	1	1977	1977	   1	   0	CTD_human
     3048	HBG2	0.565	0.692	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     3048	HBG2	0.565	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     3048	HBG2	0.565	0.692	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1977	1977	   2	   0	CTD_human
     3048	HBG2	0.565	0.692	C1841621	FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1	phenotype		Finding	0.40	1	2015	2015	   1	   3	GENOMICS_ENGLAND
     3048	HBG2	0.565	0.692	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1977	1977	   2	   0	CTD_human
     3048	HBG2	0.565	0.692	C3151421	CYANOSIS, TRANSIENT NEONATAL	disease		Disease or Syndrome	0.71	1	1989	2015	   7	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3050	HBZ	0.686	0.346	C3278365	HEMOGLOBIN H HYDROPS FETALIS SYNDROME	disease		Disease or Syndrome	0.30	1	1997	1997	   1	   0	GENOMICS_ENGLAND
     3052	HCCS	0.559	0.731	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     3052	HCCS	0.559	0.731	C0796070	MICROPHTHALMIA, SYNDROMIC 7	disease	C16;C11;C17	Disease or Syndrome; Congenital Abnormality	0.80	1	1998	2016	   2	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3053	SERPIND1	0.619	0.654	C0007274	Carotid Artery Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     3053	SERPIND1	0.619	0.654	C0025472	Mesenteric Vascular Occlusion	disease	C06;C14	Disease or Syndrome	0.30	1	1991	1991	   1	   0	CTD_human
     3053	SERPIND1	0.619	0.654	C0398623	Thrombophilia	disease	C15	Disease or Syndrome	0.32	1	1987	1999	   1	   0	CTD_human
     3053	SERPIND1	0.619	0.654	C0398626	Heparin cofactor II deficiency (disorder)	disease	C14	Disease or Syndrome	0.70	1	1989	2004	   4	   0	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3053	SERPIND1	0.619	0.654	C0750988	Common Carotid Artery Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     3053	SERPIND1	0.619	0.654	C0750989	External Carotid Artery Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     3053	SERPIND1	0.619	0.654	C0750990	Internal Carotid Artery Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     3053	SERPIND1	0.619	0.654	C1861172	Venous Thromboembolism	phenotype	C14	Disease or Syndrome	0.30	1	1991	1991	   1	   0	CTD_human
     3054	HCFC1	0.601	0.692	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
     3054	HCFC1	0.601	0.692	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.31	1	2009	2009	   1	   0	CTD_human
     3054	HCFC1	0.601	0.692	C0796208	MENTAL RETARDATION, X-LINKED 3	disease	C16;C10	Disease or Syndrome	0.70	1	2012	2013	   2	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3054	HCFC1	0.601	0.692	C2931498	Mental Retardation, X-Linked 1	disease	C16;C10	Disease or Syndrome	0.31	1	1992	2012	   1	   0	ORPHANET
     3055	HCK	0.663	0.5	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     3055	HCK	0.663	0.5	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     3055	HCK	0.663	0.5	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3055	HCK	0.663	0.5	C1335167	Ovarian Mucinous Adenocarcinoma	disease	C04	Neoplastic Process	0.30				   0	   0	UNIPROT
     3055	HCK	0.663	0.5	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     3059	HCLS1	0.539	0.846	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	1992	2003	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0006870	Cannabis Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     3060	HCRT	0.5	0.808	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2005	2018	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.40	1	2009	2020	   5	   0	PSYGENET
     3060	HCRT	0.5	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2009	2020	   5	   0	PSYGENET
     3060	HCRT	0.5	0.808	C0024809	Marijuana Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     3060	HCRT	0.5	0.808	C0027404	Narcolepsy	disease	C10;F03	Disease or Syndrome	0.70	0.959	1999	2019	   2	   0	ORPHANET
     3060	HCRT	0.5	0.808	C0030193	Pain	phenotype	C23	Sign or Symptom	0.40	1	2005	2019	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2017	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0234230	Pain, Burning	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0234238	Ache	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0234254	Radiating pain	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0338715	Drug-induced depressive state	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2009	2009	   1	   0	PSYGENET
     3060	HCRT	0.5	0.808	C0458257	Pain, Splitting	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0458259	Pain, Crushing	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.37	1	2010	2019	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.32	1	2005	2019	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0751362	Narcolepsy-Cataplexy Syndrome	disease	C10;F03	Disease or Syndrome	0.40	1	2000	2019	   2	   0	ORPHANET
     3060	HCRT	0.5	0.808	C0751407	Pain, Migratory	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0751408	Suffering, Physical	phenotype	C23	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     3060	HCRT	0.5	0.808	C1834372	Narcolepsy 1	disease	C10;F03	Disease or Syndrome	0.70	1	2000	2000	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3061	HCRTR1	0.623	0.654	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2010	   3	   0	CTD_human
     3061	HCRTR1	0.623	0.654	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2011	2012	   2	   0	PSYGENET
     3061	HCRTR1	0.623	0.654	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2011	2012	   2	   0	PSYGENET
     3061	HCRTR1	0.623	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2005	2007	   2	   0	PSYGENET
     3061	HCRTR1	0.623	0.654	C0038587	Substance Withdrawal Syndrome	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2010	2017	   1	   0	CTD_human
     3061	HCRTR1	0.623	0.654	C0086189	Drug Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     3061	HCRTR1	0.623	0.654	C0087169	Withdrawal Symptoms	phenotype	C25;F03	Sign or Symptom	0.30	1	2010	2010	   1	   0	CTD_human
     3061	HCRTR1	0.623	0.654	C0236736	Cocaine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2010	   3	   0	CTD_human
     3061	HCRTR1	0.623	0.654	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2019	   1	   0	PSYGENET
     3061	HCRTR1	0.623	0.654	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2005	2020	   3	   0	CTD_human
     3062	HCRTR2	0.7	0.577	C0027404	Narcolepsy	disease	C10;F03	Disease or Syndrome	0.60	0.941	1999	2018	   1	   0	CTD_human
     3062	HCRTR2	0.7	0.577	C0751362	Narcolepsy-Cataplexy Syndrome	disease	C10;F03	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     3064	HTT	0.548	0.654	C0006635	Cadmium poisoning	disease	C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     3064	HTT	0.548	0.654	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.32	1	2004	2017	   4	   0	PSYGENET
     3064	HTT	0.548	0.654	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.42	1	2004	2017	   4	   0	PSYGENET
     3064	HTT	0.548	0.654	C0020179	Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	1.00	0.987	1993	2020	  12	  17	CTD_human;GENOMICS_ENGLAND;ORPHANET
     3064	HTT	0.548	0.654	C0026650	Movement Disorders	group	C10	Disease or Syndrome	0.44	1	2004	2016	   1	   0	CTD_human
     3064	HTT	0.548	0.654	C0266487	Etat Marbre	disease	C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3064	HTT	0.548	0.654	C0393574	Huntington Disease, Late Onset	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2004	2017	  11	   0	CTD_human
     3064	HTT	0.548	0.654	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   2	   0	PSYGENET
     3064	HTT	0.548	0.654	C0677050	Manganese Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2010	2010	   1	   0	CTD_human
     3064	HTT	0.548	0.654	C0751207	Akinetic-Rigid Variant of Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2004	2017	  11	   0	CTD_human
     3064	HTT	0.548	0.654	C0751208	Juvenile Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.53	1	2004	2019	  12	   0	CTD_human;ORPHANET
     3064	HTT	0.548	0.654	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     3064	HTT	0.548	0.654	C4479476	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	disease		Mental or Behavioral Dysfunction	0.30				   0	   0	GENOMICS_ENGLAND
     3064	HTT	0.548	0.654	C4479491	LOPES-MACIEL-RODAN SYNDROME	disease		Disease or Syndrome	0.60	1	2016	2016	   2	   4	GENOMICS_ENGLAND;UNIPROT
     3065	HDAC1	0.46	0.846	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.32	1	2003	2011	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.31	1	2012	2012	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2008	2017	   2	   0	PSYGENET
     3065	HDAC1	0.46	0.846	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.31	1	2012	2013	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
     3065	HDAC1	0.46	0.846	C1969342	PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	disease	C08	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C1969343	Pulmonary Hypertension, Primary, Fenfluramine-Associated	disease	C08	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C2713368	Hematopoetic Myelodysplasia	phenotype	C15	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.31	1	2017	2017	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C3714844	Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	disease	C08	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3065	HDAC1	0.46	0.846	C4552070	Pulmonary Hypertension, Primary, 1	disease	C08	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
     3066	HDAC2	0.476	0.846	C0007112	Adenocarcinoma of prostate	disease	C04;C12	Neoplastic Process	0.30				   0	   0	CGI
     3066	HDAC2	0.476	0.846	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.32	1	2011	2011	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.33	1	2010	2019	   1	   0	PSYGENET
     3066	HDAC2	0.476	0.846	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.51	1	2011	2012	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0023466	Leukemia, Monocytic, Chronic	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0023470	Myeloid Leukemia	disease	C04	Neoplastic Process	0.31	1	2011	2011	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.60	1	2004	2019	   2	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     3066	HDAC2	0.476	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.36	1	2012	2019	   1	   0	PSYGENET
     3066	HDAC2	0.476	0.846	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.31	1	2016	2016	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     3066	HDAC2	0.476	0.846	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2010	2013	   2	   0	PSYGENET
     3066	HDAC2	0.476	0.846	C0920269	Microsatellite Instability	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3066	HDAC2	0.476	0.846	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2004	2008	   2	   0	CTD_human
     3066	HDAC2	0.476	0.846	C1721098	Replication Error Phenotype	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2015	2015	   1	   0	CTD_human
     3067	HDC	0.584	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2017	2017	   0	   1	UNIPROT
     3067	HDC	0.584	0.692	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
     3067	HDC	0.584	0.692	C0040517	Gilles de la Tourette syndrome	disease	C16;C10;F03	Disease or Syndrome	0.68	0.9	2001	2020	   0	   1	CTD_human
     3068	HDGF	0.575	0.654	C0019693	HIV Infections	group	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3068	HDGF	0.575	0.654	C4505456	HIV Coinfection	disease	C01;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3069	HDLBP	0.636	0.731	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2009	2009	   1	   0	CTD_human
     3069	HDLBP	0.636	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.33	1	2011	2019	   0	   0	UNIPROT
     3069	HDLBP	0.636	0.731	C2931817	Chromosome 2q37 deletion syndrome	disease	C23	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3070	HELLS	0.603	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3070	HELLS	0.603	0.731	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3070	HELLS	0.603	0.731	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.31	1	2015	2016	   1	   0	CTD_human
     3070	HELLS	0.603	0.731	C0398788	Immunodeficiency syndrome, variable	disease	C16;C20	Disease or Syndrome	0.31	1	2006	2015	   1	   0	GENOMICS_ENGLAND
     3070	HELLS	0.603	0.731	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3070	HELLS	0.603	0.731	C4310798	IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4	disease		Disease or Syndrome	0.70	1	2006	2015	   2	   6	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3071	NCKAP1L	0.839	0.269	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3073	HEXA	0.633	0.615	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     3073	HEXA	0.633	0.615	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     3073	HEXA	0.633	0.615	C0039373	Tay-Sachs Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	1	1982	2019	  31	 118	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3073	HEXA	0.633	0.615	C0282220	Amaurotic Familial Idiocy	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     3073	HEXA	0.633	0.615	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     3073	HEXA	0.633	0.615	C1848914	Hexosaminidase A Deficiency, Adult Type	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	ORPHANET
     3073	HEXA	0.633	0.615	C1848916	Tay-Sachs Disease, Variant B1	disease	C16;C18;C10	Disease or Syndrome	0.41	1	2017	2017	   0	   4	ORPHANET
     3073	HEXA	0.633	0.615	C1848922	Hexosaminidase alpha-Subunit Deficiency (Variant B)	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     3073	HEXA	0.633	0.615	C2749283	Gm2-Gangliosidosis, Variant B1	disease	C16;C18;C10	Disease or Syndrome	0.40				   0	   1	ORPHANET
     3073	HEXA	0.633	0.615	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2011	2011	   1	   0	CTD_human
     3074	HEXB	0.644	0.654	C0014550	Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     3074	HEXB	0.644	0.654	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3074	HEXB	0.644	0.654	C0036161	Sandhoff Disease	disease	C16;C18;C10	Disease or Syndrome	1.00	0.987	1989	2020	  12	  45	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3074	HEXB	0.644	0.654	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.30	1	1995	1995	   1	   0	GENOMICS_ENGLAND
     3074	HEXB	0.644	0.654	C0751489	Adult Sandhoff Disease	disease	C16;C18;C10	Disease or Syndrome	0.52	1	1998	2010	   1	   0	CTD_human;ORPHANET
     3074	HEXB	0.644	0.654	C0751490	Infantile Sandhoff Disease	disease	C16;C18;C10	Disease or Syndrome	0.63	1	1992	2010	   1	   1	CTD_human;ORPHANET
     3074	HEXB	0.644	0.654	C0751491	Juvenile Sandhoff Disease	disease	C16;C18;C10	Disease or Syndrome	0.53	1	1992	2010	   1	   0	CTD_human;ORPHANET
     3074	HEXB	0.644	0.654	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3074	HEXB	0.644	0.654	C1849320	Sandhoff Disease, Adult Type	disease	C16;C18;C10	Disease or Syndrome	0.40	1	2010	2010	   1	   2	ORPHANET
     3074	HEXB	0.644	0.654	C1849321	Sandhoff Disease, Juvenile Type	disease	C16;C18;C10	Disease or Syndrome	0.40	1	2010	2010	   1	   1	ORPHANET
     3074	HEXB	0.644	0.654	C1849322	Sandhoff Disease, Infantile Type	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
     3074	HEXB	0.644	0.654	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
     3074	HEXB	0.644	0.654	C2713499	Total Hexosaminidase Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     3075	CFH	0.441	0.885	C0003257	Antibody Deficiency Syndrome	disease	C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C0017662	Glomerulonephritis, Membranoproliferative	disease	C13;C12;C20	Disease or Syndrome	0.60	1	1994	2015	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2015	2015	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C0021051	Immunologic Deficiency Syndromes	group	C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C0025303	Meningococcal Infections	group	C01	Disease or Syndrome	0.40	1	2006	2019	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C0162739	HELLP Syndrome	disease	C13	Disease or Syndrome	0.32	1	2008	2012	   2	   0	ORPHANET
     3075	CFH	0.441	0.885	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.50	0.961	2005	2019	   6	  69	CTD_human
     3075	CFH	0.441	0.885	C0268742	Membranoproliferative Glomerulonephritis, Type I	disease	C13;C12;C20	Disease or Syndrome	0.52	1	2004	2017	   2	   0	CTD_human;ORPHANET
     3075	CFH	0.441	0.885	C0268743	Membranoproliferative Glomerulonephritis, Type II	disease	C13;C12;C20	Disease or Syndrome	0.70	1	1994	2016	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     3075	CFH	0.441	0.885	C0272242	Complement deficiency disease	group	C20;C15	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     3075	CFH	0.441	0.885	C0398777	Complement Factor H Deficiency	disease	C16;C13;C12;C20	Disease or Syndrome	0.80	0.947	1990	2016	   9	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3075	CFH	0.441	0.885	C0730295	BASAL LAMINAR DRUSEN (disorder)	disease	C16;C11	Disease or Syndrome	0.65	1	2007	2016	   0	   4	CTD_human;GENOMICS_ENGLAND
     3075	CFH	0.441	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C1720821	Membranoproliferative Glomerulonephritis, Type III	disease	C13;C12;C20	Disease or Syndrome	0.50	1	2004	2011	   2	   0	CTD_human;ORPHANET
     3075	CFH	0.441	0.885	C1832174	DOYNE HONEYCOMB RETINAL DYSTROPHY	disease	C11;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	ORPHANET
     3075	CFH	0.441	0.885	C1852020	Malattia Leventinese	disease	C11;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	ORPHANET
     3075	CFH	0.441	0.885	C1852021	Drusen, Radial, Autosomal Dominant	disease	C16;C11	Disease or Syndrome	0.30	1	2008	2008	   1	   0	ORPHANET
     3075	CFH	0.441	0.885	C1853147	MACULAR DEGENERATION, AGE-RELATED, 4 (disorder)	disease	C11	Disease or Syndrome	0.90	1	2003	2015	   1	   5	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3075	CFH	0.441	0.885	C2749604	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1	disease		Finding	0.60	1	1998	2016	  11	  23	GENOMICS_ENGLAND;UNIPROT
     3075	CFH	0.441	0.885	C2931788	Atypical Hemolytic Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.70	0.983	1999	2019	   2	   2	CTD_human
     3075	CFH	0.441	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C4087273	C3 glomerulopathy	disease		Disease or Syndrome	0.40	1	2012	2018	   1	   0	GENOMICS_ENGLAND
     3075	CFH	0.441	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3075	CFH	0.441	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3077	HFE	0.436	0.846	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.7	0.963	2001	2018	2	1	CTD_human;GENOMICS_ENGLAND
11269	3077	HFE	0.436	0.846	C0018995	Hemochromatosis	disease	C16;C18	Disease or Syndrome	0.6	0.979	1987	2019	15	0	CTD_human;GENOMICS_ENGLAND
11276	3077	HFE	0.436	0.846	C0162566	Porphyria Cutanea Tarda	disease	C16;C06;C18;C17	Disease or Syndrome	0.6	0.967	1996	2019	0	0	CTD_human;GENOMICS_ENGLAND
11279	3077	HFE	0.436	0.846	C0392514	Hereditary hemochromatosis	disease	C16;C18	Disease or Syndrome	0.7	0.975	1991	2020	14	5	CTD_human
11303	3162	HMOX1	0.381	0.923	C0009319	Colitis	disease	C06	Disease or Syndrome	0.57	1	2005	2019	2	0	CTD_human
11308	3162	HMOX1	0.381	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	0.95	2002	2019	3	0	CTD_human
11315	3162	HMOX1	0.381	0.923	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.55	1	2005	2019	1	0	CTD_human
11316	3162	HMOX1	0.381	0.923	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.56	1	2005	2019	1	0	CTD_human
11323	3162	HMOX1	0.381	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.947	1997	2019	3	0	CTD_human
11335	3162	HMOX1	0.381	0.923	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.7	0.9	2005	2020	0	0	CTD_human
11350	3162	HMOX1	0.381	0.923	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.51	1	2002	2015	6	0	CTD_human
11353	3162	HMOX1	0.381	0.923	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.51	1	2011	2018	1	0	CTD_human
11360	3162	HMOX1	0.381	0.923	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.52	1	2004	2005	1	0	CTD_human
11411	3417	IDH1	0.424	0.808	C0014084	Enchondromatosis	disease	C05	Disease or Syndrome	0.79	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11412	3417	IDH1	0.424	0.808	C0017638	Glioma	disease	C04	Neoplastic Process	0.7	0.984	2008	2020	5	2	CGI;CTD_human;UNIPROT
11416	3417	IDH1	0.424	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.7	0.969	2009	2020	2	2	CGI;CTD_human
11418	3417	IDH1	0.424	0.808	C0024454	Maffucci Syndrome	disease	C05	Disease or Syndrome	0.7	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11426	3417	IDH1	0.424	0.808	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.6	1	2012	2020	1	0	CGI;CTD_human
11450	3417	IDH1	0.424	0.808	C3553958	METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA	disease		Disease or Syndrome	0.61	1	2011	2011	2	1	GENOMICS_ENGLAND;ORPHANET
11457	3418	IDH2	0.434	0.808	C0014084	Enchondromatosis	disease	C05	Disease or Syndrome	0.77	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11464	3418	IDH2	0.434	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.7	0.961	2010	2019	2	5	CGI;CTD_human
11466	3418	IDH2	0.434	0.808	C0024454	Maffucci Syndrome	disease	C05	Disease or Syndrome	0.65	1	2011	2016	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11469	3418	IDH2	0.434	0.808	C0028945	oligodendroglioma	disease	C04	Neoplastic Process	0.6	1	2009	2019	8	0	CTD_human;ORPHANET
11480	3418	IDH2	0.434	0.808	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.56	1	2012	2018	1	0	CGI;CTD_human
11489	3418	IDH2	0.434	0.808	C0280793	Mixed Oligodendroglioma-Astrocytoma	disease	C04	Neoplastic Process	0.51	1	2009	2015	7	0	CTD_human;ORPHANET
11494	3418	IDH2	0.434	0.808	C0334590	Anaplastic Oligodendroglioma	disease	C04	Neoplastic Process	0.58	0.933	2009	2019	8	0	CTD_human;ORPHANET
11525	3418	IDH2	0.434	0.808	C3150909	D-2-HYDROXYGLUTARIC ACIDURIA 2	disease		Disease or Syndrome	0.61	1	2010	2018	3	2	GENOMICS_ENGLAND;UNIPROT
11537	3419	IDH3A	0.705	0.385	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.51	1	2017	2018	2	0	GENOMICS_ENGLAND;ORPHANET
11542	3420	IDH3B	0.7	0.462	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.51	1	2008	2008	1	0	CTD_human;GENOMICS_ENGLAND
11546	3420	IDH3B	0.7	0.462	C2675496	Retinitis Pigmentosa 46	disease	C16;C11	Disease or Syndrome	0.7	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11548	3423	IDS	0.559	0.769	C0026705	Mucopolysaccharidosis II	disease	C16;C18;C17;C10	Disease or Syndrome	1	0.994	1991	2019	41	68	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
11551	3425	IDUA	0.499	0.846	C0023786	Mucopolysaccharidosis I	disease	C16;C18;C17	Disease or Syndrome	0.9	1	1992	2020	6	21	CTD_human;GENOMICS_ENGLAND
11552	3425	IDUA	0.499	0.846	C0026708	Mucopolysaccharidosis V	disease	C16;C18;C17	Disease or Syndrome	0.76	1	1992	2020	17	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11553	3425	IDUA	0.499	0.846	C0086431	Hurler-Scheie Syndrome	disease	C16;C18;C17	Disease or Syndrome	0.77	1	1992	2020	15	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11554	3425	IDUA	0.499	0.846	C0086795	Pfaundler-Hurler Syndrome	disease	C16;C18;C17	Disease or Syndrome	0.8	0.992	1973	2020	23	72	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11562	3426	CFI	0.569	0.731	C2752039	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3	disease		Finding	0.6	1	2004	2016	7	13	GENOMICS_ENGLAND;UNIPROT
11564	3426	CFI	0.569	0.731	C3463916	Complement Factor I (C3 inactivator) deficiency	disease	C16;C20	Disease or Syndrome	0.72	1	1996	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11565	3426	CFI	0.569	0.731	C3809523	MACULAR DEGENERATION, AGE-RELATED, 13	disease		Disease or Syndrome	0.6	1	2013	2013	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11578	3431	SP110	0.656	0.5	C1856128	Hepatic venoocclusive disease with immunodeficiency	disease	C06;C20;C14	Disease or Syndrome	0.72	0.75	2006	2017	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
11793	3455	IFNAR2	0.585	0.731	C4225252	IMMUNODEFICIENCY 45	disease		Disease or Syndrome	0.7	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
11800	3456	IFNB1	0.421	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.56	1	2008	2019	1	0	CTD_human;UNIPROT
11846	3458	IFNG	0.288	0.962	C0002874	Aplastic Anemia	disease	C15	Disease or Syndrome	0.9	1	1992	2020	1	0	CTD_human;GENOMICS_ENGLAND
11869	3458	IFNG	0.288	0.962	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.6	1	1994	2019	1	0	CTD_human
11901	3458	IFNG	0.288	0.962	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.6	1	1998	2019	1	0	CTD_human
11910	3479	IGF1	0.318	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	0.955	1986	2020	2	0	CTD_human
11913	3479	IGF1	0.318	0.885	C0008370	Cholestasis	disease	C06	Disease or Syndrome	0.51	1	2003	2008	1	0	CTD_human
11931	3479	IGF1	0.318	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.931	1993	2020	2	0	CTD_human
11944	3479	IGF1	0.318	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.6	1	2002	2019	3	0	CTD_human
11951	3479	IGF1	0.318	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.55	1	2003	2011	1	0	CTD_human
11969	3479	IGF1	0.318	0.885	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	1997	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	1997	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	1997	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	1997	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0853897	Diabetic Cardiomyopathies	disease	C19;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2013	2014	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C0949272	IIeocolitis	disease	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.37	1	2006	2018	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2008	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2013	2014	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C1292778	Chronic myeloproliferative disorder	disease	C04;C15	Neoplastic Process	0.30	1	1996	1996	   1	   0	GENOMICS_ENGLAND
     3479	IGF1	0.318	0.885	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	1999	1999	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	1990	2019	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C1504412	Testotoxicosis	disease	C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C1720887	Female Urogenital Diseases	group	C13	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C1837475	Insulin-Like Growth Factor I Deficiency	disease	C23;C10;C09	Disease or Syndrome	0.80	1	1993	2020	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     3479	IGF1	0.318	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.962	1989	2019	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C2350037	Clinically Isolated Syndrome, CNS Demyelinating	disease	C10	Disease or Syndrome	0.30	1	1997	1997	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1995	1995	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	1997	1997	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2013	2014	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2013	2014	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2013	2014	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3479	IGF1	0.318	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2007	2008	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.32	1	1996	2019	   2	   0	CTD_human
     3479	IGF1	0.318	0.885	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.56	1	2005	2020	1	0	CTD_human
11976	3480	IGF1R	0.399	0.885	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.7	1	1991	2019	1	0	CTD_human
11979	3480	IGF1R	0.399	0.885	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.51	1	2009	2019	1	0	CTD_human
11997	3480	IGF1R	0.399	0.885	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C0752347	Lewy Body Disease	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C1145670	Respiratory Failure	disease	C08	Disease or Syndrome	0.31	1	2010	2015	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.40	1	1992	2019	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C1849157	Resistance to Insulin-Like Growth Factor I	disease	C23;C16	Disease or Syndrome	0.70	0.977	2001	2019	   5	   4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3480	IGF1R	0.399	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1996	2020	   2	   0	CTD_human
     3480	IGF1R	0.399	0.885	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
     3480	IGF1R	0.399	0.885	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
     3480	IGF1R	0.399	0.885	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     3480	IGF1R	0.399	0.885	C4721453	Peripheral Nervous System Diseases	group	C10	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     3481	IGF2	0.39	0.885	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.31	1	2008	2008	   1	   0	CTD_human
     3481	IGF2	0.39	0.885	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3481	IGF2	0.39	0.885	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.57	1	2002	2019	1	0	CTD_human
12001	3481	IGF2	0.39	0.885	C0004903	Beckwith-Wiedemann Syndrome	disease	C16	Disease or Syndrome	0.6	0.959	1986	2019	4	0	CTD_human;GENOMICS_ENGLAND
12009	3481	IGF2	0.39	0.885	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.9	1	1992	2019	3	0	CTD_human;GENOMICS_ENGLAND
12014	3481	IGF2	0.39	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.54	1	1990	2016	1	0	CTD_human
12024	3481	IGF2	0.39	0.885	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.7	1	2006	2020	2	0	CTD_human;GENOMICS_ENGLAND
12025	3481	IGF2	0.39	0.885	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.7	1	1993	2013	1	0	CTD_human
12033	3481	IGF2	0.39	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.54	1	1988	2007	1	0	CTD_human
12053	3482	IGF2R	0.518	0.731	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     3482	IGF2R	0.518	0.731	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     3482	IGF2R	0.518	0.731	C0752347	Lewy Body Disease	disease	C10;F03	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     3482	IGF2R	0.518	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.70	1	1995	2019	   1	   2	CGI;CTD_human
     3483	IGFALS	0.511	0.846	C0013336	Dwarfism	disease	C16;C05;C19	Congenital Abnormality	0.35	1	2004	2020	   1	   0	GENOMICS_ENGLAND
     3483	IGFALS	0.511	0.846	C0018273	Growth Disorders	group	C23	Pathologic Function	0.30	1	2004	2007	   2	   0	CTD_human
     3483	IGFALS	0.511	0.846	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.40	1	2007	2007	   1	   0	CTD_human
     3483	IGFALS	0.511	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3483	IGFALS	0.511	0.846	C0034012	Delayed Puberty	phenotype	C19	Pathologic Function	0.60	1	2004	2007	   2	   0	CTD_human;GENOMICS_ENGLAND
     3483	IGFALS	0.511	0.846	C0349588	Short stature	phenotype		Finding	0.30	1	2004	2004	   1	   0	GENOMICS_ENGLAND
     3483	IGFALS	0.511	0.846	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2007	2007	   1	   0	CTD_human
     3483	IGFALS	0.511	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     3483	IGFALS	0.511	0.846	C2919142	Short Stature, CTCAE	phenotype		Finding	0.30	1	2004	2004	   1	   0	GENOMICS_ENGLAND
     3483	IGFALS	0.511	0.846	C3900122	Acid-Labile Subunit Deficiency	disease		Laboratory or Test Result	0.70	1	2004	2016	   8	   0	CTD_human;ORPHANET;UNIPROT
     3484	IGFBP1	0.502	0.808	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.36	1	2003	2012	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.33	0.75	1994	2018	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2014	   2	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.33	1	1999	1999	   1	   0	GENOMICS_ENGLAND
     3484	IGFBP1	0.502	0.808	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.32	0.667	2010	2012	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1995	1995	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3484	IGFBP1	0.502	0.808	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.31	1	2008	2011	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	0.667	2005	2018	   3	   0	PSYGENET
     3485	IGFBP2	0.478	0.769	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.31	1	2006	2018	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2014	   2	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.34	1	2010	2019	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     3485	IGFBP2	0.478	0.769	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.34	0.75	2007	2019	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.32	1	2011	2012	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.33	1	2006	2011	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0007138	Carcinoma, Transitional Cell	disease	C04	Neoplastic Process	0.31	1	2007	2011	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.60	0.815	2004	2019	   1	   1	CTD_human;UNIPROT
     3486	IGFBP3	0.439	0.808	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2005	2011	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.37	1	2004	2017	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	2002	2014	   3	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.32	1	2002	2008	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.32	1	2000	2005	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.34	1	1999	2017	   1	   0	GENOMICS_ENGLAND
     3486	IGFBP3	0.439	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.943	1996	2018	   3	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     3486	IGFBP3	0.439	0.808	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.32	1	2015	2017	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.32	1	2015	2017	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.941	1996	2018	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.938	1993	2018	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.33	1	2003	2010	   1	   0	CTD_human
     3488	IGFBP5	0.544	0.692	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2005	2005	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     3489	IGFBP6	0.601	0.692	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1998	2017	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.34	1	2006	2018	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2003	2003	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.37	1	1999	2012	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.38	1	1998	2017	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2002	2018	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     3490	IGFBP7	0.476	0.769	C3280205	RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS	disease		Disease or Syndrome	0.51	1	2002	2020	   2	   0	GENOMICS_ENGLAND;ORPHANET
     3490	IGFBP7	0.476	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     3491	CCN1	0.473	0.731	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	0.929	2006	2019	   1	   0	CTD_human
     3491	CCN1	0.473	0.731	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2007	2017	   1	   0	CTD_human
     3491	CCN1	0.473	0.731	C0036421	Systemic Scleroderma	disease	C17	Disease or Syndrome	0.33	1	1998	2019	   1	   0	CTD_human
     3491	CCN1	0.473	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.33	1	2007	2018	   1	   0	CTD_human
     3491	CCN1	0.473	0.731	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.38	1	2004	2018	   1	   0	CTD_human
     3492	IGH	0.473	0.654	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.40	1	1991	2020	   1	   0	ORPHANET
     3492	IGH	0.473	0.654	C0024301	Lymphoma, Follicular	disease	C04;C20;C15	Neoplastic Process	0.40	0.935	1990	2020	   1	   0	ORPHANET
     3492	IGH	0.473	0.654	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.40	0.97	1996	2019	   1	   0	ORPHANET
     3492	IGH	0.473	0.654	C0555202	Malignant lymphoma - lymphocytic, intermediate differentiation	disease		Neoplastic Process	0.30	1	2001	2002	   2	   0	ORPHANET
     3492	IGH	0.473	0.654	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	1991	2019	   1	   0	ORPHANET
     3500	IGHG1	0.7	0.5	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	ORPHANET
     3500	IGHG1	0.7	0.5	C0027121	Myositis	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3500	IGHG1	0.7	0.5	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3500	IGHG1	0.7	0.5	C0158353	Infectious Myositis	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3500	IGHG1	0.7	0.5	C0544796	Myositis, Proliferative	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3500	IGHG1	0.7	0.5	C0751356	Idiopathic Inflammatory Myopathies	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3500	IGHG1	0.7	0.5	C0751357	Myositis, Focal	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3500	IGHG1	0.7	0.5	C0855095	Small Lymphocytic Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	ORPHANET
     3500	IGHG1	0.7	0.5	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3500	IGHG1	0.7	0.5	C1868683	B-CELL MALIGNANCY, LOW-GRADE	disease		Neoplastic Process	0.30				   0	   0	ORPHANET
     3501	IGHG2	0.76	0.192	C0027121	Myositis	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3501	IGHG2	0.76	0.192	C0158353	Infectious Myositis	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3501	IGHG2	0.76	0.192	C0162539	IgG Deficiency disorder	disease	C20;C15	Disease or Syndrome	0.30	1	1998	1998	   1	   0	ORPHANET
     3501	IGHG2	0.76	0.192	C0544796	Myositis, Proliferative	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3501	IGHG2	0.76	0.192	C0751356	Idiopathic Inflammatory Myopathies	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3501	IGHG2	0.76	0.192	C0751357	Myositis, Focal	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3501	IGHG2	0.76	0.192	C3279824	Kappa-Chain Deficiency	disease	C20	Disease or Syndrome	0.30	1	1998	1998	   1	   0	ORPHANET
     3507	IGHM	0.644	0.654	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.60	1	2002	2002	   1	   0	CTD_human;GENOMICS_ENGLAND
     3507	IGHM	0.644	0.654	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.31	1	2002	2002	   0	   0	CTD_human
     3507	IGHM	0.644	0.654	C1832241	Agammaglobulinemia, non-Bruton type	disease	C20;C15	Disease or Syndrome	0.30	1	1996	1996	   1	   0	ORPHANET
     3507	IGHM	0.644	0.654	C3152144	AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.40	1	2002	2002	   1	   1	GENOMICS_ENGLAND
     3507	IGHM	0.644	0.654	C4016215	AGAMMAGLOBULINEMIA 1	phenotype		Finding	0.30	1	2002	2002	   1	   0	GENOMICS_ENGLAND
     3508	IGHMBP2	0.636	0.615	C1858517	SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1	disease	C16;C08;C10	Disease or Syndrome	1.00	0.957	1975	2020	   8	  48	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3508	IGHMBP2	0.636	0.615	C4015349	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S	disease		Disease or Syndrome	0.70	1	1975	2017	   2	  32	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3514	IGKC	0.7	0.423	C0013374	Dysgammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.30	1	1985	1985	   1	   0	CTD_human
     3514	IGKC	0.7	0.423	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	   1	   0	CTD_human
     3514	IGKC	0.7	0.423	C0027121	Myositis	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3514	IGKC	0.7	0.423	C0158353	Infectious Myositis	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3514	IGKC	0.7	0.423	C0162539	IgG Deficiency disorder	disease	C20;C15	Disease or Syndrome	0.30				   0	   0	ORPHANET
     3514	IGKC	0.7	0.423	C0231221	Asymptomatic	phenotype		Finding	0.30	1	1969	1969	   1	   0	GENOMICS_ENGLAND
     3514	IGKC	0.7	0.423	C0544796	Myositis, Proliferative	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3514	IGKC	0.7	0.423	C0751356	Idiopathic Inflammatory Myopathies	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3514	IGKC	0.7	0.423	C0751357	Myositis, Focal	disease	C05;C10	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3514	IGKC	0.7	0.423	C3279824	Kappa-Chain Deficiency	disease	C20	Disease or Syndrome	0.60	1	1969	1985	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3516	RBPJ	0.518	0.808	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.32	1	2010	2016	   2	   0	CTD_human
     3516	RBPJ	0.518	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3516	RBPJ	0.518	0.808	C0026769	Multiple Sclerosis	disease	C20;C10	Disease or Syndrome	0.31	1	2011	2015	   1	   0	CTD_human
     3516	RBPJ	0.518	0.808	C0265268	Adams Oliver syndrome	disease	C16;C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
     3516	RBPJ	0.518	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     3516	RBPJ	0.518	0.808	C0751324	Multiple Sclerosis, Acute Fulminating	disease	C20;C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3516	RBPJ	0.518	0.808	C2931779	Congenital defect of skull and scalp	disease	C16;C17;C05	Congenital Abnormality	0.30				   0	   0	CTD_human
     3516	RBPJ	0.518	0.808	C3553748	ADAMS-OLIVER SYNDROME 3	disease		Disease or Syndrome	0.60	1	2012	2018	   3	   5	GENOMICS_ENGLAND;UNIPROT
     3516	RBPJ	0.518	0.808	C4551482	Adams-Oliver syndrome 1	disease	C16;C17;C05	Disease or Syndrome	0.51	1	2012	2018	   2	   0	CTD_human;GENOMICS_ENGLAND
     3543	IGLL1	0.678	0.538	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.60	1	2016	2016	   1	   0	CTD_human;GENOMICS_ENGLAND
     3543	IGLL1	0.678	0.538	C0086438	Hypogammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
     3543	IGLL1	0.678	0.538	C1832241	Agammaglobulinemia, non-Bruton type	disease	C20;C15	Disease or Syndrome	0.30	1	1998	1998	   1	   0	ORPHANET
     3543	IGLL1	0.678	0.538	C3150750	AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.60	1	1998	2016	   2	   2	GENOMICS_ENGLAND;UNIPROT
     3547	IGSF1	0.608	0.5	C0010308	Congenital Hypothyroidism	disease	C16;C05;C19	Disease or Syndrome	0.50	1	2012	2012	   1	   0	CTD_human
     3547	IGSF1	0.608	0.5	C0039584	Testicular Diseases	group	C12;C19	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3547	IGSF1	0.608	0.5	C0271586	Prolactin Deficiency, Isolated	phenotype	C16;C13;C17	Finding	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     3547	IGSF1	0.608	0.5	C0271801	Central hypothyroidism	disease	C19	Disease or Syndrome	0.40	1	2012	2020	   1	   0	GENOMICS_ENGLAND
     3547	IGSF1	0.608	0.5	C0342200	Endemic Cretinism	disease	C16;C05;C19	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     3547	IGSF1	0.608	0.5	C1263023	Macroorchidism	disease		Finding	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     3547	IGSF1	0.608	0.5	C1578691	Myxedema, Congenital	disease	C16;C05;C19	Disease or Syndrome; Congenital Abnormality	0.30	1	2012	2012	   1	   0	CTD_human
     3547	IGSF1	0.608	0.5	C3550963	HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT	disease	C23	Disease or Syndrome	0.90	1	2012	2015	   3	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3547	IGSF1	0.608	0.5	C3714796	Isolated somatotropin deficiency	disease		Disease or Syndrome	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     3549	IHH	0.573	0.538	C0010093	Corpus Luteum Cyst	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3549	IHH	0.573	0.538	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3549	IHH	0.573	0.538	C0029927	Ovarian Cysts	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3549	IHH	0.573	0.538	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     3549	IHH	0.573	0.538	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     3549	IHH	0.573	0.538	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.40				   0	   0	GENOMICS_ENGLAND
     3549	IHH	0.573	0.538	C1843096	Acrocapitofemoral Dysplasia	disease	C23;C16;C05	Disease or Syndrome	0.71	1	2003	2015	   3	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3549	IHH	0.573	0.538	C1861380	Syndactyly, Type I	disease	C16;C05	Disease or Syndrome	0.30	1	2011	2011	   1	   0	GENOMICS_ENGLAND
     3549	IHH	0.573	0.538	C1862151	BRACHYDACTYLY, TYPE A1 (disorder)	disease	C16;C05	Disease or Syndrome	0.96	0.9	2001	2019	   6	   8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3549	IHH	0.573	0.538	C1863307	Acropectorovertebral Dysplasia, F-Form	disease	C16;C05	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     3549	IHH	0.573	0.538	C3179349	Gastrointestinal Stromal Sarcoma	disease	C06;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.38	1	2011	2019	   0	   0	UNIPROT
     3551	IKBKB	0.506	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.50	1	2009	2016	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.30				   0	   0	CGI
     3551	IKBKB	0.506	0.846	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.54	1	2010	2019	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.32	1	2017	2019	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.31	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     3551	IKBKB	0.506	0.846	C0857007	Hyperbilirubinemia, Neonatal	disease	C23;C16	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2019	2019	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C1565885	Direct Hyperbilirubinemia, Neonatal	phenotype	C23;C16	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C1565886	Indirect Hyperbilirubinemia, Neonatal	disease	C23;C16	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.33	1	2017	2019	   1	   0	CTD_human
     3551	IKBKB	0.506	0.846	C4747743	IMMUNODEFICIENCY 15B	disease		Disease or Syndrome	0.60	1	2013	2014	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     3551	IKBKB	0.506	0.846	C4748694	IMMUNODEFICIENCY 15A	disease		Disease or Syndrome	0.40	1	2018	2018	   1	   1	UNIPROT
     3552	IL1A	0.333	0.962	C0002622	Amnesia	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0002631	Infection of amniotic cavity	disease	C16;C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0003165	Anthracosis	disease	C08	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0008495	Chorioamnionitis	phenotype	C16;C13	Disease or Syndrome	0.32	1	2011	2018	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.39	0.8	1999	2019	   5	   0	PSYGENET
     3552	IL1A	0.333	0.962	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.39	0.8	1999	2019	   5	   0	PSYGENET
     3552	IL1A	0.333	0.962	C0011633	Dermatomyositis	disease	C17;C05;C10	Disease or Syndrome	0.32	1	2007	2008	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0011991	Diarrhea	phenotype	C23	Sign or Symptom	0.31	1	1997	2018	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0015967	Fever	phenotype	C23	Sign or Symptom	0.40	0.955	1986	2019	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0019061	Hemolytic-Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.32	1	2003	2018	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2004	2004	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2011	2011	   2	   0	CTD_human
     3552	IL1A	0.333	0.962	C0022541	Kearns-Sayre syndrome	disease	C23;C18;C11;C05;C10;C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.38	0.9	2006	2019	   2	   0	CTD_human
     3552	IL1A	0.333	0.962	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0042900	Vitiligo	disease	C17	Disease or Syndrome	0.31	1	2009	2017	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0085655	Polymyositis	disease	C05;C10	Disease or Syndrome	0.31	1	1994	2007	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.32	1	2000	2017	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0162668	Megaconial Myopathies	disease	C18;C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0162669	Pleoconial Myopathies	disease	C18;C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0162670	Mitochondrial Myopathies	group	C18;C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0162671	MELAS Syndrome	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0162672	MERRF Syndrome	disease	C16;C18;C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0162674	Chronic progressive external ophthalmoplegia	disease	C23;C18;C11;C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.31	0.5	2013	2017	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0206637	Mesenchymal Chondrosarcoma	disease	C04	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0221056	Adult type dermatomyositis	disease	C17;C05;C10	Disease or Syndrome	0.31	1	2007	2008	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0233750	Hysterical amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0233796	Temporary Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2016	2016	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0236795	Dissociative Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0262497	Global Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0263666	Dermatomyositis, Childhood Type	disease	C17;C05;C10	Disease or Syndrome	0.31	1	2008	2008	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0263984	Polymyositis Ossificans	disease	C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0274861	Arsenic Poisoning, Inorganic	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0274862	Nervous System, Organic Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0311375	Arsenic Poisoning	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0343755	HIV Wasting Syndrome	disease	C18;C01;C20	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.31	1	2014	2015	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.33	1	2011	2019	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2003	2003	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0554591	Polymyositis, Idiopathic	disease	C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0750906	Tactile Amnesia	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0750907	Amnestic State	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0751211	Hyperalgesia, Primary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0751212	Hyperalgesia, Secondary	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0751213	Tactile Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0751214	Hyperalgesia, Thermal	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0751851	Arsenic Encephalopathy	disease	C10;C25	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0751852	Arsenic Induced Polyneuropathy	disease	C10;C25	Injury or Poisoning	0.30	1	2006	2006	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.32	1	1993	2017	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.32	1	1994	2007	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0917796	Optic Atrophy, Hereditary, Leber	disease	C16;C18;C11;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C0949496	Luft Disease	disease	C18;C05;C10	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.36	1	1996	2019	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C1275592	Funisitis (disorder)	disease	C16;C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C2936719	Mechanical Allodynia	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     3552	IL1A	0.333	0.962	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	1993	1993	   1	   0	CTD_human
     3553	IL1B	0.276	0.962	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3553	IL1B	0.276	0.962	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     3553	IL1B	0.276	0.962	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.35	1	1995	2018	   1	   0	CTD_human
     3553	IL1B	0.276	0.962	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	0.75	2005	2018	   4	   0	PSYGENET
     3553	IL1B	0.276	0.962	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2002	2002	   1	   0	CTD_human
     3553	IL1B	0.276	0.962	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.6	0.966	1989	2020	1	0	CTD_human
12054	3553	IL1B	0.276	0.962	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.53	1	2012	2017	1	0	CTD_human
12067	3553	IL1B	0.276	0.962	C0009319	Colitis	disease	C06	Disease or Syndrome	0.6	1	2000	2020	2	0	CTD_human
12068	3553	IL1B	0.276	0.962	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.6	0.959	1992	2020	4	0	CTD_human
12071	3553	IL1B	0.276	0.962	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	0.8	1999	2020	5	0	PSYGENET
12077	3553	IL1B	0.276	0.962	C0015967	Fever	phenotype	C23	Sign or Symptom	0.6	0.98	1986	2019	5	0	CTD_human
12081	3553	IL1B	0.276	0.962	C0017658	Glomerulonephritis	disease	C13;C12	Disease or Syndrome	0.55	1	1993	2017	2	0	CTD_human
12089	3553	IL1B	0.276	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.6	1	1995	2019	6	0	CTD_human
12092	3553	IL1B	0.276	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.964	1994	2019	3	0	CTD_human
12095	3553	IL1B	0.276	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.57	1	1999	2017	9	0	CTD_human
12113	3553	IL1B	0.276	0.962	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.6	1	2001	2020	3	0	CTD_human
12123	3553	IL1B	0.276	0.962	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.6	0.975	1995	2020	1	0	CTD_human
12127	3553	IL1B	0.276	0.962	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.6	1	2005	2019	2	0	CTD_human
12239	3586	IL10	0.281	0.923	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.6	0.975	2000	2019	1	0	CTD_human
12247	3593	IL12B	0.48	0.885	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.6	1	2004	2018	1	0	CTD_human;GENOMICS_ENGLAND
12267	3593	IL12B	0.48	0.885	C4013948	IMMUNODEFICIENCY 29	disease		Disease or Syndrome	0.7	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
12272	3594	IL12RB1	0.555	0.731	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.52	1	2013	2017	0	0	ORPHANET
12274	3594	IL12RB1	0.555	0.731	C4013949	IMMUNODEFICIENCY 30	disease		Disease or Syndrome	0.75	1	1998	2019	2	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12276	3596	IL13	0.386	0.846	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.7	0.982	1995	2020	1	0	CTD_human
12280	3596	IL13	0.386	0.846	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.7	0.99	1996	2020	2	0	CTD_human
12292	3596	IL13	0.386	0.846	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.56	1	1998	2019	1	0	CTD_human
12338	3605	IL17A	0.324	0.923	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.51	1	2005	2005	1	0	CTD_human
12339	3605	IL17A	0.324	0.923	C0009319	Colitis	disease	C06	Disease or Syndrome	0.6	0.979	2007	2020	1	0	CTD_human
12355	3605	IL17A	0.324	0.923	C0549463	X-Linked Lymphoproliferative Disorder	disease	C20;C15	Neoplastic Process	0.51	1	2010	2012	1	0	CTD_human;GENOMICS_ENGLAND
12372	3606	IL18	0.365	0.923	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.51	1	2002	2020	1	0	CTD_human
12388	3606	IL18	0.365	0.923	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.51	1	2001	2019	1	0	CTD_human
12403	3606	IL18	0.365	0.923	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.6	1	2006	2018	1	0	CTD_human
12477	3614	IMPDH1	0.623	0.462	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.7	1	2002	2020	2	1	CTD_human;GENOMICS_ENGLAND
12478	3614	IMPDH1	0.623	0.462	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.63	1	2006	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12479	3614	IMPDH1	0.623	0.462	C1840284	LEBER CONGENITAL AMAUROSIS 11	disease	C11	Disease or Syndrome	0.7	1	2006	2006	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
12480	3614	IMPDH1	0.623	0.462	C1867299	Retinitis Pigmentosa 10	disease	C16;C11	Disease or Syndrome	0.72	1	2002	2008	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
12487	3617	IMPG1	0.722	0.154	C4015342	MACULAR DYSTROPHY, VITELLIFORM, 4	disease		Disease or Syndrome	0.6	1	2013	2013	1	4	GENOMICS_ENGLAND;UNIPROT
12519	3621	ING1	0.573	0.692	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.71	1	2000	2000	1	3	CGI;CTD_human;UNIPROT
12540	3627	CXCL10	0.378	0.885	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.51	1	2005	2018	1	0	CTD_human
12598	3630	INS	0.445	0.923	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	disease	C18;C19	Disease or Syndrome	1	0.955	1998	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12599	3630	INS	0.445	0.923	C1852092	DIABETES MELLITUS, INSULIN-DEPENDENT, 2	disease	C18;C20;C19	Disease or Syndrome	0.7	1	2007	2008	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
12606	3630	INS	0.445	0.923	C3150617	Maturity-onset diabetes of the young, type 10	disease	C18;C19	Disease or Syndrome	0.7	1	2007	2015	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
12636	3636	INPPL1	0.59	0.769	C0432219	Opsismodysplasia	disease	C16;C05	Disease or Syndrome	0.76	1	2013	2017	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12646	3640	INSL3	0.604	0.538	C0010417	Cryptorchidism	disease	C16;C12;C19	Congenital Abnormality	0.9	0.857	1999	2019	5	5	CTD_human;UNIPROT
12667	3643	INSR	0.432	0.846	C1864952	Hyperinsulinemic Hypoglycemia, Familial, 5	disease	C18	Disease or Syndrome	0.7	1	1994	2004	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12677	3651	PDX1	0.53	0.654	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.7	0.956	1998	2019	2	5	CTD_human
12681	3651	PDX1	0.53	0.654	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.9	0.97	1998	2019	2	1	GENOMICS_ENGLAND;ORPHANET
12683	3651	PDX1	0.53	0.654	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	disease	C18;C19	Disease or Syndrome	0.61	1	2003	2017	1	4	CTD_human;ORPHANET
12684	3651	PDX1	0.53	0.654	C1833382	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE IV (disorder)	disease	C18;C19	Disease or Syndrome	0.83	1	1998	2018	1	6	CTD_human;GENOMICS_ENGLAND
12712	3655	ITGA6	0.539	0.769	C1856934	Epidermolysis bullosa with pyloric atresia	disease	C16;C17	Disease or Syndrome	0.68	1	1997	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12717	3659	IRF1	0.468	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.66	1	1998	2019	0	0	CGI;CTD_human
12718	3659	IRF1	0.468	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.6	NA	NA	NA	0	1	CGI;CTD_human
12726	3659	IRF1	0.468	0.769	C0699791	Stomach Carcinoma	disease	C06;C04	Neoplastic Process	0.65	1	1998	2019	2	2	CGI;GENOMICS_ENGLAND;UNIPROT
12733	3661	IRF3	0.517	0.808	C4225294	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7	phenotype		Finding	0.6	1	2015	2015	2	1	GENOMICS_ENGLAND;UNIPROT
12741	3663	IRF5	0.489	0.731	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.57	1	2007	2019	1	0	CTD_human;GENOMICS_ENGLAND
12742	3663	IRF5	0.489	0.731	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	0.949	2005	2020	6	4	CTD_human;ORPHANET
12749	3664	IRF6	0.486	0.769	C0008924	Cleft upper lip	disease	C16;C07	Congenital Abnormality	0.9	0.923	2003	2019	4	5	CTD_human;ORPHANET
12750	3664	IRF6	0.486	0.769	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.7	0.952	1999	2019	1	1	CTD_human;GENOMICS_ENGLAND
12754	3664	IRF6	0.486	0.769	C0175697	Van der Woude syndrome	disease	C23;C16;C04;C05;C07	Disease or Syndrome	0.9	0.966	1999	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12756	3664	IRF6	0.486	0.769	C0265259	Popliteal pterygium syndrome	disease	C16;C13;C11;C05;C12;C07	Disease or Syndrome	1	0.969	2002	2018	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
12763	3664	IRF6	0.486	0.769	C1837213	OROFACIAL CLEFT 6, SUSCEPTIBILITY TO	disease		Finding	0.7	1	2002	2017	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
12766	3664	IRF6	0.486	0.769	C4551864	VAN DER WOUDE SYNDROME 1	disease	C23;C16;C04;C05;C07	Disease or Syndrome	0.61	1	2002	2017	9	27	GENOMICS_ENGLAND;UNIPROT
12771	3665	IRF7	0.547	0.846	C4225358	IMMUNODEFICIENCY 39	disease		Disease or Syndrome	0.7	1	1997	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
12778	3667	IRS1	0.488	0.769	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.9	0.939	1993	2019	9	2	CTD_human;UNIPROT
12782	3667	IRS1	0.488	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.6	0.969	1995	2019	1	0	CTD_human
12824	3674	ITGA2B	0.493	0.692	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.57	0.667	1997	2017	1	0	CTD_human
12825	3674	ITGA2B	0.493	0.692	C0040015	Thrombasthenia	disease	C16;C15	Disease or Syndrome	0.8	0.977	1982	2020	27	27	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12832	3674	ITGA2B	0.493	0.692	C1861195	Glanzmann Thrombasthenia, Autosomal Dominant	disease	C16;C15	Disease or Syndrome	0.9	1	1998	2013	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
12843	3675	ITGA3	0.573	0.731	C3553636	INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL	disease		Disease or Syndrome	0.72	1	2012	2018	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12860	3679	ITGA7	0.588	0.654	C0546264	Congenital Fiber Type Disproportion	disease	C05;C10	Congenital Abnormality	0.51	1	1997	2013	1	0	ORPHANET
12863	3679	ITGA7	0.588	0.654	C2750786	Muscular Dystrophy, Congenital, Due To Integrin Alpha-7 Deficiency	disease	C16;C05;C10	Disease or Syndrome	0.9	1	1997	2015	2	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
12878	3684	ITGAM	0.443	0.808	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	1	2008	2019	5	10	CTD_human;ORPHANET
12935	3689	ITGB2	0.444	0.923	C0398738	Leukocyte adhesion deficiency type 1	disease	C16;C20	Disease or Syndrome	1	1	1990	2019	12	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12954	3690	ITGB3	0.485	0.846	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.59	1	1998	2019	1	0	CTD_human
12955	3690	ITGB3	0.485	0.846	C0040015	Thrombasthenia	disease	C16;C15	Disease or Syndrome	1	1	1982	2020	29	22	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12966	3690	ITGB3	0.485	0.846	C1861195	Glanzmann Thrombasthenia, Autosomal Dominant	disease	C16;C15	Disease or Syndrome	0.9	1	1999	2018	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
12969	3690	ITGB3	0.485	0.846	C3853779	Neonatal Alloimmune Thrombocytopenia	disease	C16;C15	Disease or Syndrome	0.77	1	1990	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12972	3690	ITGB3	0.485	0.846	C4304021	Autosomal dominant macrothrombocytopenia	disease	C16	Disease or Syndrome	0.51	1	1999	2018	2	0	ORPHANET
12986	3691	ITGB4	0.525	0.731	C0079301	Junctional Epidermolysis Bullosa	disease	C16;C17	Disease or Syndrome	0.57	1	1995	2018	1	0	CTD_human
12992	3691	ITGB4	0.525	0.731	C0268374	Adult junctional epidermolysis bullosa (disorder)	disease	C16;C17	Disease or Syndrome	0.9	1	1996	2002	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
12993	3691	ITGB4	0.525	0.731	C0282160	Aplasia Cutis Congenita	disease	C16;C17	Congenital Abnormality	0.61	1	2008	2019	2	0	CTD_human;ORPHANET
12995	3691	ITGB4	0.525	0.731	C1856934	Epidermolysis bullosa with pyloric atresia	disease	C16;C17	Disease or Syndrome	1	1	1995	2017	11	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13030	3694	ITGB6	0.597	0.692	C4015557	AMELOGENESIS IMPERFECTA, TYPE IH	disease		Disease or Syndrome	0.7	1	2014	2016	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
13037	3697	ITIH1	0.691	0.462	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2009	2019	3	3	CTD_human;PSYGENET
13050	3766	KCNJ10	0.599	0.654	C2748572	SeSAME syndrome	disease	C23;C10;F03;C09;F01	Disease or Syndrome	1	1	1997	2019	6	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13051	3766	KCNJ10	0.599	0.654	C3538946	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	disease	C23;C10;C09	Disease or Syndrome	0.6	1	1997	2009	1	2	CTD_human;GENOMICS_ENGLAND
13055	3767	KCNJ11	0.529	0.615	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.9	0.943	1996	2019	2	4	CTD_human;GENOMICS_ENGLAND
13068	3767	KCNJ11	0.529	0.615	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.66	1	2009	2019	1	0	GENOMICS_ENGLAND;ORPHANET
13084	3767	KCNJ11	0.529	0.615	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	disease	C18;C19	Disease or Syndrome	1	0.984	2001	2018	19	33	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13085	3767	KCNJ11	0.529	0.615	C1853564	Developmental Delay, Epilepsy, and Neonatal Diabetes	disease	C23;C16;C18;C10;C19;F01	Disease or Syndrome	0.57	1	2006	2018	6	0	ORPHANET
13086	3767	KCNJ11	0.529	0.615	C1864623	DIABETES MELLITUS, TRANSIENT NEONATAL, 3 (disorder)	disease	C18;C19	Disease or Syndrome	0.7	1	2001	2016	2	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
13088	3767	KCNJ11	0.529	0.615	C2931833	Hyperinsulinemic hypoglycemia, familial, 2	disease	C16;C06;C18	Disease or Syndrome	0.7	1	1995	2016	12	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
13091	3767	KCNJ11	0.529	0.615	C3888018	Congenital Hyperinsulinism	disease	C16;C06;C18	Disease or Syndrome	0.7	1	2001	2019	2	0	CTD_human;GENOMICS_ENGLAND
13094	3767	KCNJ11	0.529	0.615	C4225365	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 13	disease		Disease or Syndrome	0.61	1	2011	2017	1	5	CTD_human;UNIPROT
13103	3769	KCNJ13	0.659	0.308	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.65	1	2011	2019	2	0	GENOMICS_ENGLAND;ORPHANET
13104	3769	KCNJ13	0.659	0.308	C1860405	Snowflake vitreoretinal degeneration	disease	C11	Disease or Syndrome	0.78	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13105	3769	KCNJ13	0.659	0.308	C3280062	LEBER CONGENITAL AMAUROSIS 16	disease		Disease or Syndrome	0.72	1	2011	2019	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
13116	3776	KCNK2	0.626	0.654	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2007	2019	6	0	CTD_human;PSYGENET
13126	3777	KCNK3	0.584	0.654	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.64	1	2013	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13133	3777	KCNK3	0.584	0.654	C3203102	Idiopathic pulmonary arterial hypertension	disease	C08	Disease or Syndrome	0.7	0.952	2012	2020	1	0	CTD_human;GENOMICS_ENGLAND
13135	3777	KCNK3	0.584	0.654	C3809198	PULMONARY HYPERTENSION, PRIMARY, 4	disease		Disease or Syndrome	0.6	1	2013	2017	2	7	GENOMICS_ENGLAND;UNIPROT
13162	3778	KCNMA1	0.518	0.846	C1836173	Generalized Epilepsy and Paroxysmal Dyskinesia	disease	C23;C10	Disease or Syndrome	0.73	1	2005	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13164	3779	KCNMB1	0.716	0.423	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2003	2010	1	0	CTD_human
13179	3782	KCNN3	0.621	0.615	C0796013	Zimmerman Laband syndrome	disease	C16;C05;C07	Disease or Syndrome	0.51	1	2019	2019	1	0	GENOMICS_ENGLAND;ORPHANET
13182	3783	KCNN4	0.653	0.577	C0272051	Xerocytosis	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.65	0.833	2015	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13183	3783	KCNN4	0.653	0.577	C4225242	DEHYDRATED HEREDITARY STOMATOCYTOSIS 2	disease		Disease or Syndrome	0.6	1	2015	2015	3	3	GENOMICS_ENGLAND;UNIPROT
13186	3784	KCNQ1	0.485	0.769	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.52	1	2014	2016	1	0	CLINGEN;GENOMICS_ENGLAND
13190	3784	KCNQ1	0.485	0.769	C0022387	Jervell-Lange Nielsen Syndrome	disease	C16;C14	Disease or Syndrome	1	1	1997	2019	10	6	CLINGEN;CTD_human;ORPHANET
13191	3784	KCNQ1	0.485	0.769	C0023976	Long QT Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.7	0.98	1993	2020	7	96	CTD_human;GENOMICS_ENGLAND
13201	3784	KCNQ1	0.485	0.769	C1837014	Atrial Fibrillation, Familial, 3	disease	C23;C14	Disease or Syndrome	0.7	1	1996	2018	3	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
13203	3784	KCNQ1	0.485	0.769	C1865019	SHORT QT SYNDROME 2 (disorder)	disease	C23;C16;C14	Disease or Syndrome	0.72	1	1996	2018	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
13206	3784	KCNQ1	0.485	0.769	C4551509	Jervell And Lange-Nielsen Syndrome 1	disease	C16;C14	Disease or Syndrome	0.7	1	1996	2018	9	21	CTD_human;GENOMICS_ENGLAND;UNIPROT
13207	3784	KCNQ1	0.485	0.769	C4551647	Long QT Syndrome 1	disease	C23;C16;C14	Disease or Syndrome	1	0.99	1996	2019	44	220	CTD_human;GENOMICS_ENGLAND;UNIPROT
13222	3785	KCNQ2	0.537	0.654	C0220669	Familial benign neonatal epilepsy	disease	C16;C10	Disease or Syndrome	0.6	0.946	1994	2020	4	0	CTD_human;ORPHANET
13229	3785	KCNQ2	0.537	0.654	C0270851	Benign neonatal epilepsy	disease	C16;C10	Disease or Syndrome	0.59	1	2000	2019	2	0	CTD_human
13248	3785	KCNQ2	0.537	0.654	C3149074	SEIZURES, BENIGN FAMILIAL NEONATAL, 1	disease		Disease or Syndrome	0.7	1	1998	2016	9	104	CTD_human;GENOMICS_ENGLAND;UNIPROT
13249	3785	KCNQ2	0.537	0.654	C3150986	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	disease		Disease or Syndrome	0.7	1	1998	2018	9	91	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13261	3786	KCNQ3	0.604	0.462	C1852581	EPILEPSY, BENIGN NEONATAL, 2	disease	C16;C10	Disease or Syndrome	0.8	0.941	1998	2018	5	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
13268	3791	KDR	0.378	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.964	2002	2019	1	0	CTD_human;UNIPROT
13276	3791	KDR	0.378	0.885	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.59	1	2007	2019	1	0	CGI;CTD_human
13311	3791	KDR	0.378	0.885	C1865871	HEMANGIOMA, CAPILLARY INFANTILE	disease	C16;C04	Disease or Syndrome	0.7	1	2002	2008	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13317	3795	KHK	0.7	0.346	C0268160	Deficiency of fructokinase	disease	C16;C18	Disease or Syndrome	0.74	1	1994	2018	4	2	CTD_human;ORPHANET;UNIPROT
13323	3796	KIF2A	0.59	0.731	C3809414	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3	disease		Disease or Syndrome	0.7	1	2013	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
13335	3798	KIF5A	0.593	0.731	C1858712	Spastic paraplegia 10, autosomal dominant	disease	C16;C10	Disease or Syndrome	0.76	1	2002	2018	12	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13337	3798	KIF5A	0.593	0.731	C4310658	MYOCLONUS, INTRACTABLE, NEONATAL	disease		Disease or Syndrome	0.6	1	2017	2018	2	2	CTD_human;GENOMICS_ENGLAND
13338	3798	KIF5A	0.593	0.731	C4693609	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25	phenotype		Finding	0.6	1	2018	2018	3	8	GENOMICS_ENGLAND;UNIPROT
13346	3800	KIF5C	0.686	0.346	C3809013	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2	disease		Disease or Syndrome	0.7	1	2012	2017	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13356	3814	KISS1	0.507	0.808	C3541462	HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.9	1	2007	2012	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
13361	3815	KIT	0.366	0.808	C0023461	Leukemia, Mast-Cell	disease	C04	Neoplastic Process	0.6	1	1993	2019	0	1	CGI;UNIPROT
13362	3815	KIT	0.366	0.808	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.8	0.955	1989	2019	0	3	CGI;CTD_human;GENOMICS_ENGLAND
13366	3815	KIT	0.366	0.808	C0024899	Mastocytosis	disease	C04;C17;C20	Disease or Syndrome	1	0.989	1992	2020	2	0	CGI;CTD_human;GENOMICS_ENGLAND
13373	3815	KIT	0.366	0.808	C0080024	Piebaldism	disease	C16;C18;C17	Congenital Abnormality	1	1	1991	2018	11	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13377	3815	KIT	0.366	0.808	C0221013	Mastocytosis, Systemic	disease	C04;C20	Neoplastic Process	0.7	0.984	1998	2020	1	1	CGI;CTD_human
13378	3815	KIT	0.366	0.808	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	1	0.951	1995	2020	19	40	CGI;CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13387	3815	KIT	0.366	0.808	C1136033	Cutaneous Mastocytosis	disease	C04;C17	Neoplastic Process	0.68	1	1992	2019	6	6	GENOMICS_ENGLAND;UNIPROT
13392	3815	KIT	0.366	0.808	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.63	1	2008	2016	0	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13395	3815	KIT	0.366	0.808	C3179349	Gastrointestinal Stromal Sarcoma	disease	C06;C04	Neoplastic Process	0.67	1	1998	2016	17	0	CLINGEN;CTD_human;ORPHANET
13405	3816	KLK1	0.533	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	1	1995	2018	1	0	CTD_human
13420	3818	KLKB1	0.604	0.692	C0272339	Prekallikrein deficiency	disease	C15	Disease or Syndrome	0.74	0.9	1974	2019	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13437	3827	KNG1	0.481	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.56	0.958	1988	2019	17	0	CTD_human
13458	3827	KNG1	0.481	0.885	C0272340	High molecular weight kininogen deficiency	disease	C15	Disease or Syndrome	0.77	0.889	1976	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
13488	3832	KIF11	0.56	0.769	C1835265	Lymphedema, microcephaly and chorioretinopathy syndrome	disease	C23;C16;C11;C05;C10;C15	Disease or Syndrome	0.74	1	2012	2016	2	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13493	3835	KIF22	0.552	0.654	C1863732	Spondyloepimetaphyseal dysplasia with multiple dislocations	disease	C16;C05;C26	Disease or Syndrome	0.73	1	2011	2015	3	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
13510	3845	KRAS	0.32	0.923	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.7	1	2000	2019	1	2	CTD_human;UNIPROT
13512	3845	KRAS	0.32	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.7	0.947	2005	2020	0	1	CGI;CTD_human
13513	3845	KRAS	0.32	0.923	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.6	0.972	1987	2020	2	0	CGI;CTD_human
13517	3845	KRAS	0.32	0.923	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.7	0.979	1989	2020	7	10	CGI;CTD_human
13525	3845	KRAS	0.32	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.963	1990	2020	3	4	CTD_human;UNIPROT
13527	3845	KRAS	0.32	0.923	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.6	0.917	2005	2019	1	0	CTD_human
13529	3845	KRAS	0.32	0.923	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.64	1	1997	2016	4	1	CGI;CTD_human
13532	3845	KRAS	0.32	0.923	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.7	0.939	1987	2020	0	7	CGI;CTD_human
13535	3845	KRAS	0.32	0.923	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.66	1	1993	2017	2	0	CTD_human
13537	3845	KRAS	0.32	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.6	0.974	1991	2019	33	0	CGI;CTD_human
13547	3845	KRAS	0.32	0.923	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	1	0.985	1993	2019	13	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
13549	3845	KRAS	0.32	0.923	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.7	0.974	1997	2019	6	0	CGI;CTD_human
13554	3845	KRAS	0.32	0.923	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.68	1	1988	2016	1	8	CGI;CTD_human
13563	3845	KRAS	0.32	0.923	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.7	0.967	1990	2020	5	2	CGI;CTD_human
13589	3845	KRAS	0.32	0.923	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.7	0.983	1985	2020	0	2	CGI
13592	3845	KRAS	0.32	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.7	0.974	1990	2020	33	1	CGI;CTD_human;UNIPROT
13593	3845	KRAS	0.32	0.923	C0265329	Organoid Nevus Phakomatosis	disease	C16;C04;C10	Disease or Syndrome	0.75	1	2012	2019	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
13605	3845	KRAS	0.32	0.923	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.62	1	2007	2013	1	1	CGI;CTD_human
13607	3845	KRAS	0.32	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.52	1	1993	2020	2	0	CTD_human
13608	3845	KRAS	0.32	0.923	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.6	0.957	1994	2019	2	0	CTD_human
13609	3845	KRAS	0.32	0.923	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.6	0.985	1985	2020	6	0	CGI;CTD_human
13611	3845	KRAS	0.32	0.923	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	1	1	1994	2019	4	4	CTD_human;ORPHANET;UNIPROT
13613	3845	KRAS	0.32	0.923	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.6	1	2005	2018	1	0	CTD_human
13620	3845	KRAS	0.32	0.923	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.59	1	1988	2016	1	0	CGI;CTD_human
13621	3845	KRAS	0.32	0.923	C0587248	Costello syndrome (disorder)	disease	C16;C05	Disease or Syndrome	0.6	1	2006	2018	4	0	CLINGEN;CTD_human
13623	3845	KRAS	0.32	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.7	0.95	1987	2020	0	0	CGI;CTD_human
13624	3845	KRAS	0.32	0.923	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.7	0.98	1985	2020	0	4	CGI;UNIPROT
13634	3845	KRAS	0.32	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.7	0.903	1991	2019	1	3	CGI;CTD_human
13636	3845	KRAS	0.32	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.7	0.909	1986	2019	1	0	CGI;CTD_human
13638	3845	KRAS	0.32	0.923	C1275081	Cardio-facio-cutaneous syndrome	disease	C23;C16;C17;C14	Congenital Abnormality	0.8	1	1993	2019	12	8	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
13648	3845	KRAS	0.32	0.923	C1860991	NOONAN SYNDROME 3	disease	C16;C17;C05;C14	Disease or Syndrome	0.9	1	2006	2014	9	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
13650	3845	KRAS	0.32	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.7	0.92	1985	2020	2	2	CTD_human
13651	3845	KRAS	0.32	0.923	C2674723	RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER	disease	C16;C04;C20;C15	Disease or Syndrome	0.63	1	2006	2019	2	6	GENOMICS_ENGLAND;ORPHANET
13662	3845	KRAS	0.32	0.923	C3809005	CARDIOFACIOCUTANEOUS SYNDROME 2	disease		Disease or Syndrome	0.6	1	2006	2014	10	9	GENOMICS_ENGLAND;UNIPROT
13667	3845	KRAS	0.32	0.923	C4552097	Nevus Sebaceus of Jadassohn	disease	C16;C04;C10	Disease or Syndrome	0.62	1	2012	2017	1	2	CTD_human;GENOMICS_ENGLAND
13674	3848	KRT1	0.575	0.654	C0079153	Hyperkeratosis, Epidermolytic	disease	C16;C17	Congenital Abnormality	1	0.951	1992	2019	15	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13677	3848	KRT1	0.575	0.654	C1721006	Keratoderma, Palmoplantar, Epidermolytic	disease	C16;C17	Disease or Syndrome	0.67	1	2001	2018	1	0	CTD_human;ORPHANET
13678	3848	KRT1	0.575	0.654	C1833030	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC	disease	C16;C17	Disease or Syndrome	0.72	1	1994	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13681	3848	KRT1	0.575	0.654	C1840296	Ichthyosis hystrix, Curth Macklin type	disease	C16;C17	Disease or Syndrome	0.61	1	1994	2006	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13682	3848	KRT1	0.575	0.654	C1843463	Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis	disease	C16;C17	Disease or Syndrome	0.71	1	1994	2018	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13691	3849	KRT2	0.76	0.154	C0432306	Ichthyosis Bullosa of Siemens	disease	C16;C17	Congenital Abnormality	0.8	1	1994	2005	15	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13694	3850	KRT3	0.751	0.385	C0339277	Corneal Dystrophy, Juvenile Epithelial of Meesmann	disease	C16;C11	Congenital Abnormality	0.67	1	1997	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13698	3851	KRT4	0.736	0.423	C1721005	Leukokeratosis, Hereditary Mucosal	disease	C16;C17	Disease or Syndrome	0.78	1	1998	2019	3	0	CTD_human;ORPHANET
13708	3852	KRT5	0.512	0.731	C0079295	Epidermolysis Bullosa Herpetiformis Dowling-Meara	disease	C16;C17	Disease or Syndrome	0.95	1	1992	2019	10	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
13709	3852	KRT5	0.512	0.731	C0079298	Epidermolysis Bullosa Simplex	disease	C16;C17	Disease or Syndrome	0.9	0.985	1991	2019	0	4	CTD_human;GENOMICS_ENGLAND
13710	3852	KRT5	0.512	0.731	C0079299	Epidermolysis Bullosa Simplex Kobner	disease	C16;C17	Congenital Abnormality	0.73	1	1993	2019	7	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
13711	3852	KRT5	0.512	0.731	C0080333	Weber-Cockayne Syndrome	disease	C16;C17	Disease or Syndrome	0.76	1	1993	2019	15	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
13718	3852	KRT5	0.512	0.731	C0432316	Epidermolysis bullosa simplex with mottled pigmentation	disease	C16;C17	Congenital Abnormality	0.78	1	1996	2014	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13725	3852	KRT5	0.512	0.731	C1836284	Epidermolysis Bullosa Simplex with Migratory Circinate Erythema	disease	C23;C16;C17	Disease or Syndrome	0.62	1	2003	2006	1	2	CTD_human;ORPHANET
13726	3852	KRT5	0.512	0.731	C3714534	dowling-degos disease	disease	C16;C17	Disease or Syndrome	0.7	1	2006	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13728	3852	KRT5	0.512	0.731	C4552092	Dowling-Degos disease 1	disease	C16;C17	Disease or Syndrome	0.6	1	2006	2006	1	3	CTD_human;GENOMICS_ENGLAND
13732	3853	KRT6A	0.61	0.692	C1706595	Pachyonychia Congenita, Jadassohn Lewandowsky Type	disease	C16;C17	Disease or Syndrome	0.53	1	1999	2013	1	0	CTD_human;GENOMICS_ENGLAND
13741	3854	KRT6B	0.663	0.577	C3714949	PACHYONYCHIA CONGENITA 4	disease		Disease or Syndrome	0.6	1	1998	2011	4	1	GENOMICS_ENGLAND;UNIPROT
13796	3857	KRT9	0.678	0.346	C1721006	Keratoderma, Palmoplantar, Epidermolytic	disease	C16;C17	Disease or Syndrome	0.8	1	1992	2019	26	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13804	3858	KRT10	0.579	0.692	C0079153	Hyperkeratosis, Epidermolytic	disease	C16;C17	Congenital Abnormality	0.8	0.98	1992	2020	10	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13813	3858	KRT10	0.579	0.692	C1843463	Ichthyosis, Cyclic, with Epidermolytic Hyperkeratosis	disease	C16;C17	Disease or Syndrome	0.73	1	1997	1999	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13814	3858	KRT10	0.579	0.692	C3665704	Congenital reticular ichthyosiform erythroderma	disease	C16;C17	Disease or Syndrome	0.79	1	1994	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
13816	3859	KRT12	0.751	0.192	C0339277	Corneal Dystrophy, Juvenile Epithelial of Meesmann	disease	C16;C11	Congenital Abnormality	0.7	1	1996	2019	16	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13818	3860	KRT13	0.631	0.692	C1721005	Leukokeratosis, Hereditary Mucosal	disease	C16;C17	Disease or Syndrome	0.54	1	1995	2018	4	0	CTD_human;ORPHANET
13827	3861	KRT14	0.53	0.731	C0079295	Epidermolysis Bullosa Herpetiformis Dowling-Meara	disease	C16;C17	Disease or Syndrome	0.98	1	1991	2019	18	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
13828	3861	KRT14	0.53	0.731	C0079298	Epidermolysis Bullosa Simplex	disease	C16;C17	Disease or Syndrome	0.7	1	1991	2019	0	4	CTD_human
13829	3861	KRT14	0.53	0.731	C0079299	Epidermolysis Bullosa Simplex Kobner	disease	C16;C17	Congenital Abnormality	0.75	1	1991	2019	10	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
13830	3861	KRT14	0.53	0.731	C0080333	Weber-Cockayne Syndrome	disease	C16;C17	Disease or Syndrome	0.7	1	1993	2006	14	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
13833	3861	KRT14	0.53	0.731	C0343111	Naegeli syndrome	disease	C16;C17	Disease or Syndrome	0.72	1	1995	2008	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
13834	3861	KRT14	0.53	0.731	C0406778	Dermatopathia pigmentosa reticularis	disease	C23;C04;C17	Congenital Abnormality	0.62	1	1995	2009	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13841	3861	KRT14	0.53	0.731	C3715082	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1	disease		Disease or Syndrome	0.7	1	1993	2005	3	6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
13850	3868	KRT16	0.565	0.769	C0265334	Pachyonychia Congenita	disease	C16;C17	Disease or Syndrome	0.6	1	2001	2020	0	0	CTD_human
13852	3868	KRT16	0.565	0.769	C1706595	Pachyonychia Congenita, Jadassohn Lewandowsky Type	disease	C16;C17	Disease or Syndrome	0.95	1	1995	2013	12	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
13856	3868	KRT16	0.565	0.769	C4552049	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 1	disease	C16;C04;C17	Disease or Syndrome	0.7	1	1995	2011	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
13859	3872	KRT17	0.531	0.654	C0259771	Steatocystoma multiplex	disease	C16;C17	Neoplastic Process	0.75	1	1997	2019	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13861	3872	KRT17	0.531	0.654	C0265334	Pachyonychia Congenita	disease	C16;C17	Disease or Syndrome	0.7	1	1995	2020	0	1	CTD_human;GENOMICS_ENGLAND
13865	3872	KRT17	0.531	0.654	C1721007	Pachyonychia Congenita, Type 2 (disorder)	disease	C16;C17	Disease or Syndrome	0.78	1	1994	2013	21	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
13905	3887	KRT81	0.659	0.462	C0546966	Monilethrix	disease	C16;C17	Congenital Abnormality	0.72	1	1997	2015	3	4	CTD_human;ORPHANET;UNIPROT
13907	3889	KRT83	0.716	0.269	C0546966	Monilethrix	disease	C16;C17	Congenital Abnormality	0.72	1	2005	2015	2	2	CTD_human;ORPHANET;UNIPROT
13908	3891	KRT85	0.751	0.115	C1865951	Ectodermal Dysplasia, Pure Hair-Nail Type	disease	C16;C17	Disease or Syndrome	0.7	1	2006	2010	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13909	3892	KRT86	0.736	0.308	C0546966	Monilethrix	disease	C16;C17	Congenital Abnormality	0.65	1	1997	2015	7	0	CTD_human;ORPHANET;UNIPROT
13937	3897	L1CAM	0.475	0.769	C0265216	X-linked hydrocephalus syndrome	disease	C16;C10	Disease or Syndrome	1	0.984	1986	2020	27	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
13957	3897	L1CAM	0.475	0.769	C0795953	MASA SYNDROME (disorder)	disease	C23;C16;C10;F03;F01	Disease or Syndrome	1	1	1986	2019	24	12	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
13963	3897	L1CAM	0.475	0.769	C1839909	CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	disease	C23;C16;C10	Disease or Syndrome	0.7	1	1986	2006	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13985	3908	LAMA2	0.553	0.692	C1263858	Muscular dystrophy congenital, merosin negative	disease	C16;C05;C10	Disease or Syndrome	1	1	1955	2018	6	109	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13990	3909	LAMA3	0.576	0.731	C0079301	Junctional Epidermolysis Bullosa	disease	C16;C17	Disease or Syndrome	0.8	1	1992	2018	3	0	CTD_human;GENOMICS_ENGLAND
13991	3909	LAMA3	0.576	0.731	C0079683	Herlitz Disease	disease	C16;C17	Disease or Syndrome	0.61	1	1992	2016	4	76	CTD_human;GENOMICS_ENGLAND
13992	3909	LAMA3	0.576	0.731	C0268374	Adult junctional epidermolysis bullosa (disorder)	disease	C16;C17	Disease or Syndrome	0.8	1	1995	2016	3	3	CTD_human;GENOMICS_ENGLAND
13994	3909	LAMA3	0.576	0.731	C1328355	Laryngoonychocutaneous syndrome	disease	C11;C08;C09	Disease or Syndrome	0.71	1	1995	2016	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
14000	3910	LAMA4	0.682	0.577	C3808935	CARDIOMYOPATHY, DILATED, 1JJ	disease		Disease or Syndrome	0.6	1	2007	2007	1	1	CTD_human;UNIPROT
14013	3912	LAMB1	0.615	0.654	C3554657	LISSENCEPHALY 5	disease		Disease or Syndrome	0.7	1	2007	2015	3	5	CLINGEN;GENOMICS_ENGLAND;ORPHANET
14021	3913	LAMB2	0.601	0.654	C1836876	Pierson syndrome	disease	C23;C16;C13;C11;C12;C10	Disease or Syndrome	1	1	1995	2018	6	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14022	3913	LAMB2	0.601	0.654	C3280113	NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES	disease		Disease or Syndrome	0.7	1	2010	2018	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
14027	3914	LAMB3	0.558	0.692	C0079301	Junctional Epidermolysis Bullosa	disease	C16;C17	Disease or Syndrome	0.8	1	1994	2019	1	0	CTD_human;GENOMICS_ENGLAND
14028	3914	LAMB3	0.558	0.692	C0079683	Herlitz Disease	disease	C16;C17	Disease or Syndrome	0.92	1	1994	2018	2	66	CTD_human;GENOMICS_ENGLAND;UNIPROT
14029	3914	LAMB3	0.558	0.692	C0268374	Adult junctional epidermolysis bullosa (disorder)	disease	C16;C17	Disease or Syndrome	0.9	1	1997	2016	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
14030	3914	LAMB3	0.558	0.692	C0399367	Amelogenesis imperfecta local hypoplastic form	disease	C16;C07	Congenital Abnormality	0.52	1	2014	2015	1	0	CTD_human;ORPHANET
14043	3918	LAMC2	0.389	0.923	C0079301	Junctional Epidermolysis Bullosa	disease	C16;C17	Disease or Syndrome	0.8	1	1992	2018	2	0	CTD_human;GENOMICS_ENGLAND
14044	3918	LAMC2	0.389	0.923	C0079683	Herlitz Disease	disease	C16;C17	Disease or Syndrome	0.81	1	1992	2017	3	54	CTD_human;GENOMICS_ENGLAND
14047	3918	LAMC2	0.389	0.923	C0268374	Adult junctional epidermolysis bullosa (disorder)	disease	C16;C17	Disease or Syndrome	0.8	1	1994	2017	4	3	CTD_human;GENOMICS_ENGLAND
14049	3918	LAMC2	0.389	0.923	C2673609	Epidermolysis bullosa inversa dystrophica	disease	C16;C17	Disease or Syndrome	0.51	1	1994	2010	0	0	ORPHANET
14059	3920	LAMP2	0.552	0.731	C0878677	Glycogen Storage Disease Type IIb	disease	C16;C18;C10;C14	Disease or Syndrome	1	1	1995	2020	15	37	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14062	3921	RPSA	0.485	0.769	C0685889	Splenic Hypoplasia	disease	C16;C20	Congenital Abnormality	0.74	1	2013	2019	1	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14092	3929	LBP	0.525	0.808	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.6	1	2010	2019	1	0	CTD_human
14104	3930	LBR	0.473	0.808	C0030779	Pelger-Huet Anomaly	disease	C16;C15	Disease or Syndrome	1	0.944	2002	2019	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
14107	3930	LBR	0.473	0.808	C0748397	Reynolds syndrome	disease	C23;C06;C17	Disease or Syndrome	0.71	1	2010	2013	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14109	3930	LBR	0.473	0.808	C2931048	HEM dysplasia	disease	C16;C05	Disease or Syndrome	0.8	0.933	1993	2019	6	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14111	3930	LBR	0.473	0.808	C4747922	PELGER-HUET ANOMALY WITH MILD SKELETAL ANOMALIES	disease		Disease or Syndrome	0.7	1	2003	2015	5	4	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14113	3931	LCAT	0.588	0.654	C0023195	Lecithin Acyltransferase Deficiency	disease	C16;C18	Disease or Syndrome	1	0.974	1967	2019	18	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14114	3931	LCAT	0.588	0.654	C0342895	Fish-Eye Disease	disease	C16;C18	Disease or Syndrome	0.8	1	1987	2019	10	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14117	3932	LCK	0.564	0.769	C4014233	IMMUNODEFICIENCY 22	disease		Disease or Syndrome	0.7	1	2001	2012	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14118	3934	LCN2	0.405	0.885	C0002875	Cooleys anemia	disease	C16;C15	Disease or Syndrome	0.32	1	2006	2019	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0005283	beta Thalassemia	disease	C16;C15	Disease or Syndrome	0.32	1	2006	2008	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	1	2005	2019	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0007570	Celiac Disease	disease	C06;C18	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.31	0.5	2002	2015	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0013221	Drug toxicity	group	C25	Injury or Poisoning	0.30	1	2017	2017	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0019025	Hemoglobin F Disease	disease	C16;C15	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0019188	Hepatitis, Animal	disease	C06;C01;C22	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2010	2011	   2	   0	CTD_human
     3934	LCN2	0.405	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.31	1	2005	2010	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.40	1	2006	2019	   4	   0	CTD_human
     3934	LCN2	0.405	0.885	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.40	0.982	2003	2020	   5	   0	CTD_human
     3934	LCN2	0.405	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2014	   2	   0	CTD_human
     3934	LCN2	0.405	0.885	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.971	2005	2019	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0027651	Neoplasms	group	C04	Neoplastic Process	0.40	0.98	2005	2019	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2018	   1	   0	PSYGENET
     3934	LCN2	0.405	0.885	C0041755	Adverse reaction to drug	group	C25	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0085578	Thalassemia Minor	disease	C16;C15	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0086692	Benign Neoplasm	group	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0271979	Thalassemia Intermedia	disease	C16;C15	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0403447	Chronic Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2010	2011	   2	   0	CTD_human
     3934	LCN2	0.405	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2011	   2	   0	CTD_human
     3934	LCN2	0.405	0.885	C1561643	Chronic Kidney Diseases	group	C13;C12	Disease or Syndrome	0.40	0.935	2010	2019	   1	   0	CTD_human
     3934	LCN2	0.405	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	2011	2017	   5	   0	CTD_human
     3934	LCN2	0.405	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	2011	2017	   5	   0	CTD_human
     3934	LCN2	0.405	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2011	   2	   0	CTD_human
     3934	LCN2	0.405	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2011	   2	   0	CTD_human
     3934	LCN2	0.405	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2010	2011	   2	   0	CTD_human
     3936	LCP1	0.663	0.654	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3936	LCP1	0.663	0.654	C0028043	Nicotine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     3936	LCP1	0.663	0.654	C0040332	Tobacco Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     3936	LCP1	0.663	0.654	C0376384	Nicotine Use Disorder	phenotype	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     3937	LCP2	0.716	0.308	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3938	LCT	0.581	0.808	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     3938	LCT	0.581	0.808	C0268179	Lactase Deficiency, Congenital	phenotype	C16;C18	Pathologic Function	0.70	1	2006	2016	   2	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     3939	LDHA	0.507	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
     3939	LDHA	0.507	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.31	1	2013	2019	   1	   0	PSYGENET
     3939	LDHA	0.507	0.808	C0017919	Glycogen Storage Disease	group	C16;C18	Disease or Syndrome	0.30	1	1984	2016	   2	   0	GENOMICS_ENGLAND
     3939	LDHA	0.507	0.808	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.30	1	1988	1988	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C0027080	Myoglobinuria	phenotype	C05	Finding	0.40	1	2011	2011	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.31	1	2014	2018	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
     3939	LDHA	0.507	0.808	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.32	1	2016	2019	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.38	0.889	2013	2020	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2013	2013	   1	   0	PSYGENET
     3939	LDHA	0.507	0.808	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     3939	LDHA	0.507	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2013	2013	   1	   0	PSYGENET
     3939	LDHA	0.507	0.808	C2931743	Lactate dehydrogenase deficiency type A	disease	C16;C18	Disease or Syndrome	0.60	1	1984	2016	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     3945	LDHB	0.604	0.615	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.34	1	2012	2018	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0007124	Noninfiltrating Intraductal Carcinoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0025521	Inborn Errors of Metabolism	group	C16;C18	Disease or Syndrome; Congenital Abnormality	0.30	1	1990	1990	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.32	1	2006	2018	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.34	1	2012	2018	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C0948089	Acute Coronary Syndrome	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C1332347	Atypical Ductal Breast Hyperplasia	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3945	LDHB	0.604	0.615	C3279904	Lactate Dehydrogenase B Deficiency	disease	C16;C18	Disease or Syndrome	0.70	1	1990	2001	   8	   5	CTD_human;ORPHANET;UNIPROT
     3945	LDHB	0.604	0.615	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     3948	LDHC	0.711	0.5	C0021364	Male infertility	phenotype	C12	Disease or Syndrome	0.30	1	2011	2013	   2	   0	CTD_human
     3948	LDHC	0.711	0.5	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     3948	LDHC	0.711	0.5	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2011	2013	   2	   0	CTD_human
     3948	LDHC	0.711	0.5	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2011	2013	   2	   0	CTD_human
     3949	LDLR	0.449	0.885	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.70	0.984	1980	2020	   5	   1	CTD_human
     3949	LDLR	0.449	0.885	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.40	0.986	1988	2020	   2	   0	CTD_human
     3949	LDLR	0.449	0.885	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.50	0.967	1986	2020	   1	   2	CTD_human
     3949	LDLR	0.449	0.885	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.64	1	1997	2019	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.90	0.977	1982	2020	   6	   9	CTD_human;GENOMICS_ENGLAND
     3949	LDLR	0.449	0.885	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.90	0.982	1964	2020	   9	1252	CTD_human;GENOMICS_ENGLAND
     3949	LDLR	0.449	0.885	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.50	1	1990	2020	   2	   0	CTD_human
     3949	LDLR	0.449	0.885	C0020507	Hyperplasia	phenotype	C23	Pathologic Function	0.30	1	1997	1997	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.40	1	1992	2018	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C0034362	Q Fever	disease	C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2006	2006	   1	   0	PSYGENET
     3949	LDLR	0.449	0.885	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.40	0.917	1996	2019	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.37	1	2009	2016	   3	   0	CTD_human
     3949	LDLR	0.449	0.885	C0519066	Acute Q fever	disease	C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2010	2010	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C0745103	Hyperlipoproteinemia Type IIa	disease	C16;C18	Disease or Syndrome	0.80	0.977	1975	2020	  61	 548	CTD_human;GENOMICS_ENGLAND;UNIPROT
     3949	LDLR	0.449	0.885	C1443892	Chronic Q Fever	disease	C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2002	2017	   5	   0	CTD_human
     3949	LDLR	0.449	0.885	C1704417	Hyperlipoproteinemia Type IIb	disease	C16;C18	Disease or Syndrome	0.40	1	1990	2017	   7	   0	CTD_human
     3949	LDLR	0.449	0.885	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2002	2015	   2	   0	CTD_human
     3949	LDLR	0.449	0.885	C1862939	AMYOTROPHIC LATERAL SCLEROSIS 1	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C1862941	Amyotrophic Lateral Sclerosis, Sporadic	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.50	0.989	1986	2020	   2	   2	CTD_human
     3949	LDLR	0.449	0.885	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.43	1	2011	2019	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C2973787	Coxiella burnetii Infection	disease	C01	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     3949	LDLR	0.449	0.885	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.32	1	2010	2020	   3	   0	CTD_human
     3949	LDLR	0.449	0.885	C4551993	Amyotrophic Lateral Sclerosis, Familial	disease	C18;C10	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     3950	LECT2	0.653	0.5	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     3950	LECT2	0.653	0.5	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.31	1	2018	2018	   1	   0	CTD_human
     3950	LECT2	0.653	0.5	C0027659	Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2018	2018	   1	   0	CTD_human
     3950	LECT2	0.653	0.5	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.31	1	2018	2018	   1	   0	CTD_human
     3950	LECT2	0.653	0.5	C0243038	Carcinoma, Lewis Lung	disease	C04	Neoplastic Process; Experimental Model of Disease	0.31	1	2018	2018	   1	   0	CTD_human
     3952	LEP	0.349	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.33	1	2015	2019	   1	   0	PSYGENET
     3952	LEP	0.349	0.846	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
     3952	LEP	0.349	0.846	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.6	0.944	2004	2019	1	0	CTD_human
14129	3952	LEP	0.349	0.846	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	0.952	1996	2020	1	0	CTD_human
14130	3952	LEP	0.349	0.846	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.6	1	2003	2020	6	0	CTD_human
14133	3952	LEP	0.349	0.846	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.54	1	2012	2017	1	0	CTD_human
14135	3952	LEP	0.349	0.846	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.7	0.976	1997	2020	1	0	CTD_human
14138	3952	LEP	0.349	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.972	1998	2020	4	0	CTD_human
14139	3952	LEP	0.349	0.846	C0020619	Hypogonadism	disease	C19	Disease or Syndrome	0.65	1	1998	2017	2	0	CTD_human
14146	3952	LEP	0.349	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.7	0.952	1973	2020	14	0	CTD_human
14170	3952	LEP	0.349	0.846	C0271650	Impaired glucose tolerance	phenotype	C18	Disease or Syndrome	0.6	0.944	1996	2020	2	0	CTD_human
14183	3952	LEP	0.349	0.846	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.6	0.992	1976	2019	2	0	CTD_human
14206	4129	MAOB	0.533	0.808	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.6	0.991	1993	2020	1	0	CTD_human
14217	4129	MAOB	0.533	0.808	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1994	2011	   2	   0	CTD_human
     4129	MAOB	0.533	0.808	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	1994	2011	   2	   0	CTD_human
     4129	MAOB	0.533	0.808	C0751197	Fulminant Hepatic Failure with Cerebral Edema	disease	C06;C18;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     4129	MAOB	0.533	0.808	C0751198	Hepatic Stupor	disease	C06;C18;C10	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     4129	MAOB	0.533	0.808	C0751207	Akinetic-Rigid Variant of Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     4129	MAOB	0.533	0.808	C0751208	Juvenile Huntington Disease	disease	C16;C10;F03	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     4129	MAOB	0.533	0.808	C1257877	Pheochromocytoma, Extra-Adrenal	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     4129	MAOB	0.533	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	1	2007	2019	   2	   0	PSYGENET
     4129	MAOB	0.533	0.808	C2936349	Plaque, Amyloid	disease	C23	Acquired Abnormality	0.30	1	1994	1994	   1	   0	CTD_human
     4131	MAP1B	0.628	0.5	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   2	UNIPROT
     4131	MAP1B	0.628	0.5	C1868720	Periventricular Nodular Heterotopia	disease	C16;C10	Disease or Syndrome	0.42	1	2018	2019	   1	   4	ORPHANET
     4131	MAP1B	0.628	0.5	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.33	1	2015	2019	   1	   0	GENOMICS_ENGLAND
     4133	MAP2	0.537	0.692	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	PSYGENET
     4133	MAP2	0.537	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
     4133	MAP2	0.537	0.692	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	PSYGENET
     4133	MAP2	0.537	0.692	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	2004	2017	   1	   0	PSYGENET
     4133	MAP2	0.537	0.692	C0752347	Lewy Body Disease	disease	C10;F03	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2004	2004	   1	   0	PSYGENET
     4133	MAP2	0.537	0.692	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     4133	MAP2	0.537	0.692	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4134	MAP4	0.682	0.5	C0043094	Weight Gain	phenotype	C23	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     4135	MAP6	0.578	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.57	1	2002	2018	   4	   0	PSYGENET
     4135	MAP6	0.578	0.769	C0085633	Mood swings	disease	C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2012	2012	   1	   0	PSYGENET
     4135	MAP6	0.578	0.769	C0751217	Hyperkinesia, Generalized	phenotype	C23;C10	Sign or Symptom	0.30	1	2005	2005	   1	   0	CTD_human
     4135	MAP6	0.578	0.769	C2678117	Schizophrenia-like symptoms (uncommon)	phenotype		Finding	0.30	1	2010	2010	   1	   0	PSYGENET
     4135	MAP6	0.578	0.769	C3887506	Hyperkinesia	phenotype	C23;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     4137	MAPT	0.446	0.923	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.7	0.99	1988	2020	7	1	CTD_human
14230	4137	MAPT	0.446	0.923	C0038868	Progressive supranuclear palsy	disease	C23;C11;C10	Disease or Syndrome	0.7	0.953	1995	2019	4	2	CTD_human;ORPHANET
14235	4137	MAPT	0.446	0.923	C0236642	Pick Disease of the Brain	disease	C10;F03	Disease or Syndrome	0.8	0.975	1998	2020	6	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
14236	4137	MAPT	0.446	0.923	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.7	1	1998	2019	2	0	CTD_human
14240	4137	MAPT	0.446	0.923	C0338451	Frontotemporal dementia	disease	C18;C10;F03	Disease or Syndrome	0.8	0.978	1997	2020	27	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
14241	4137	MAPT	0.446	0.923	C0338462	Semantic Dementia	disease	C18;C10;F03	Mental or Behavioral Dysfunction	0.56	1	1998	2017	7	0	CTD_human;ORPHANET
14291	4353	MPO	0.377	0.923	C0398595	Myeloperoxidase Deficiency	disease	C16;C18	Disease or Syndrome	0.8	0.824	1979	2019	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14302	4524	MTHFR	0.337	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2006	2015	6	0	CTD_human;PSYGENET
14322	4524	MTHFR	0.337	0.885	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	1997	2019	6	0	CTD_human;PSYGENET
14376	4524	MTHFR	0.337	0.885	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.6	1	1997	2020	6	0	CTD_human;PSYGENET
14425	4609	MYC	0.344	0.923	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.59	1	1996	2019	2	0	CTD_human
14441	4609	MYC	0.344	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.6	1	1985	2020	4	0	CTD_human
14467	4613	MYCN	0.454	0.808	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.7	0.971	1984	2020	14	0	CGI;CTD_human;ORPHANET
14473	4613	MYCN	0.454	0.808	C0796068	Oculodigitoesophagoduodenal syndrome	disease	C23;C16;C06;C05;C08;C10;F03;F01	Disease or Syndrome	0.65	1	1997	2012	4	1	CTD_human;ORPHANET
14480	4613	MYCN	0.454	0.808	C4551774	FEINGOLD SYNDROME 1	disease	C23;C16;C06;C05;C08;C10;F03;F01	Disease or Syndrome	0.71	0.75	2005	2018	3	11	GENOMICS_ENGLAND;ORPHANET;UNIPROT
14490	4615	MYD88	0.414	0.923	C0024419	Waldenstrom Macroglobulinemia	disease	C04;C20;C15;C14	Neoplastic Process	0.7	0.965	2012	2019	3	0	CGI;CTD_human;ORPHANET
14496	4615	MYD88	0.414	0.923	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.6	0.953	2012	2020	1	0	CGI;CTD_human
14509	4615	MYD88	0.414	0.923	C2677092	MYD88 Deficiency	disease	C16;C20	Disease or Syndrome	0.76	0.909	2008	2019	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14534	4846	NOS3	0.378	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	0.9	1999	2019	2	0	CTD_human
14535	4846	NOS3	0.378	0.885	C0011875	Diabetic Angiopathies	disease	C19;C14	Disease or Syndrome	0.52	1	2002	2017	1	0	CTD_human
14536	4846	NOS3	0.378	0.885	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.6	0.941	2000	2019	1	0	CTD_human
14538	4846	NOS3	0.378	0.885	C0015934	Fetal Growth Retardation	phenotype	C23;C16;C13	Disease or Syndrome	0.69	0.917	2009	2019	1	0	CTD_human
14541	4846	NOS3	0.378	0.885	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.51	1	2001	2018	4	0	CTD_human
14542	4846	NOS3	0.378	0.885	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.9	2004	2018	2	0	CTD_human
14543	4846	NOS3	0.378	0.885	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.926	2003	2019	2	0	CTD_human
14548	4846	NOS3	0.378	0.885	C0020473	Hyperlipidemia	disease	C18	Disease or Syndrome	0.53	1	2001	2018	1	0	CTD_human
14549	4846	NOS3	0.378	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.7	0.942	1996	2019	5	1	CTD_human
14550	4846	NOS3	0.378	0.885	C0020541	Portal Hypertension	disease	C06	Disease or Syndrome	0.51	1	2000	2017	1	0	CTD_human
14564	4846	NOS3	0.378	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.6	0.915	1998	2019	2	0	CTD_human
14568	4846	NOS3	0.378	0.885	C0032914	Pre-Eclampsia	phenotype	C13	Pathologic Function	0.68	1	2001	2017	0	0	CTD_human
14570	4846	NOS3	0.378	0.885	C0034063	Pulmonary Edema	phenotype	C08	Pathologic Function	0.51	1	2002	2006	1	0	CTD_human
14581	4846	NOS3	0.378	0.885	C0085580	Essential Hypertension	disease	C14	Disease or Syndrome	0.6	0.917	1995	2018	0	0	CTD_human
14595	4846	NOS3	0.378	0.885	C0242350	Erectile dysfunction	disease	C12;F03	Disease or Syndrome	0.6	1	1999	2019	2	0	CTD_human
14605	4846	NOS3	0.378	0.885	C0524620	Metabolic Syndrome X	disease	C18	Disease or Syndrome	0.6	1	2003	2019	3	0	CTD_human
14610	4846	NOS3	0.378	0.885	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	1999	2006	   2	   0	CTD_human
     4846	NOS3	0.378	0.885	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	1999	2006	   2	   0	CTD_human
     4846	NOS3	0.378	0.885	C0751010	Cerebral Infarction, Left Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     4846	NOS3	0.378	0.885	C0751011	Cerebral Infarction, Right Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     4846	NOS3	0.378	0.885	C0751012	Anterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     4846	NOS3	0.378	0.885	C0751014	Subcortical Infarction	disease	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     4846	NOS3	0.378	0.885	C0848676	Subfertility, Male	phenotype	C12	Sign or Symptom	0.30	1	2014	2014	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C0852036	Pregnancy associated hypertension	phenotype	C13;C14	Disease or Syndrome	0.40	0.846	1997	2017	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C0887799	Posterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     4846	NOS3	0.378	0.885	C0917731	Male sterility	phenotype	C12	Finding	0.30	1	2014	2014	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2001	2009	   4	   0	CTD_human
     4846	NOS3	0.378	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
     4846	NOS3	0.378	0.885	C1257963	Endogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1257964	Exogenous Hyperinsulinism	disease	C18	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1257965	Compensatory Hyperinsulinemia	disease	C18	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1306571	Hepatic Insufficiency	phenotype	C06	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1383860	Cardiac Hypertrophy	phenotype	C23;C14	Pathologic Function	0.30	1	2001	2006	   4	   0	CTD_human
     4846	NOS3	0.378	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.36	1	2004	2009	   2	   0	CTD_human
     4846	NOS3	0.378	0.885	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2002	2010	   2	   0	CTD_human
     4846	NOS3	0.378	0.885	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.31	1	2010	2011	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.30	1	2011	2011	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1855520	Hyperglycemia, Postprandial	phenotype	C18	Finding	0.30	1	2001	2001	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.50	0.918	1996	2020	   4	   1	CTD_human
     4846	NOS3	0.378	0.885	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2010	   2	   0	CTD_human
     4846	NOS3	0.378	0.885	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2009	2010	   2	   0	CTD_human
     4846	NOS3	0.378	0.885	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.50	1	1998	2017	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     4846	NOS3	0.378	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2004	2009	   2	   0	CTD_human
     4849	CNOT3	0.686	0.615	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   2	   0	CTD_human
     4849	CNOT3	0.686	0.615	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2018	2018	   2	   0	CTD_human
     4849	CNOT3	0.686	0.615	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.64	0.75	2013	2019	   1	   0	CGI;CTD_human;ORPHANET
     4851	NOTCH1	0.369	0.885	C0000768	Congenital Abnormality	group	C16	Congenital Abnormality	0.40	1	2005	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0004114	Astrocytoma	disease	C04	Neoplastic Process	0.32	1	2010	2013	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.37	1	2014	2019	   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.36	1	2014	2019	   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.60	1	2004	2020	   2	   0	CGI;CTD_human
     4851	NOTCH1	0.369	0.885	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0006826	Malignant Neoplasms	group	C04	Neoplastic Process	0.40	0.943	1999	2019	   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.36	1	2009	2017	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.33	1	2008	2018	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.60	0.935	2007	2019	   1	   0	CGI;CTD_human
     4851	NOTCH1	0.369	0.885	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0007873	Uterine Cervical Neoplasm	disease	C04;C13	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0009375	Colonic Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0009782	Connective Tissue Diseases	group	C17	Disease or Syndrome	0.40	1	2006	2006	   1	   1	GENOMICS_ENGLAND
     4851	NOTCH1	0.369	0.885	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.44	1	2013	2018	   1	   2	CTD_human
     4851	NOTCH1	0.369	0.885	C0017636	Glioblastoma	disease	C04	Neoplastic Process	0.40	0.929	2010	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0018824	Heart valve disease	group	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2019	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0023449	Acute lymphocytic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	2005	2019	   1	   0	GENOMICS_ENGLAND
     4851	NOTCH1	0.369	0.885	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.36	1	2009	2017	   1	   0	GENOMICS_ENGLAND
     4851	NOTCH1	0.369	0.885	C0023492	Leukemia, T-Cell	disease	C04;C20;C15	Neoplastic Process	0.40	1	2006	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0024299	Lymphoma	group	C04;C20;C15	Neoplastic Process	0.40	1	1998	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0027765	nervous system disorder	group	C10	Disease or Syndrome	0.31	1	1998	2013	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0036439	Scoliosis, unspecified	disease	C05	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2012	2017	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2015	2015	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0149630	Bicuspid aortic valve	disease	C14	Congenital Abnormality	0.70	0.955	2005	2019	   2	   0	CTD_human;ORPHANET
     4851	NOTCH1	0.369	0.885	C0149782	Squamous cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.31	1	2019	2019	   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0154017	Benign neoplasm of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0154091	Carcinoma in situ of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0205768	Subependymal Giant Cell Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0265268	Adams Oliver syndrome	disease	C16;C17	Disease or Syndrome	0.34	1	2014	2019	   1	   0	ORPHANET
     4851	NOTCH1	0.369	0.885	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.39	0.8	2011	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0280783	Juvenile Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0280785	Diffuse Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0334579	Anaplastic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0334580	Protoplasmic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0334581	Gemistocytic astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0334582	Fibrillary Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0334583	Pilocytic Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0334588	Giant Cell Glioblastoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0334634	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	disease	C04;C20;C15	Neoplastic Process	0.33	1	2012	2019	   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0338070	Childhood Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0344917	Left ventricular outflow tract obstruction	disease		Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     4851	NOTCH1	0.369	0.885	C0345050	Congenital aneurysm of ascending aorta	disease	C14	Congenital Abnormality	0.30	1	2006	2006	   1	   0	GENOMICS_ENGLAND
     4851	NOTCH1	0.369	0.885	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0428791	Aortic valve calcification	disease	C18;C14	Disease or Syndrome	0.65	1	2005	2020	   1	   0	CTD_human;ORPHANET
     4851	NOTCH1	0.369	0.885	C0496930	Neoplasm of uncertain or unknown behavior of bladder	disease	C04;C13;C12	Neoplastic Process	0.30				   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2011	2011	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0547065	Mixed oligoastrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.60	1	2004	2020	   2	   0	CGI;CTD_human
     4851	NOTCH1	0.369	0.885	C0699885	Carcinoma of bladder	disease	C04;C13;C12	Neoplastic Process	0.37	1	2013	2019	   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0750935	Cerebral Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0750936	Intracranial Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0751606	Adult Acute Lymphocytic Leukemia	disease		Neoplastic Process	0.35	1	2009	2017	   1	   0	GENOMICS_ENGLAND
     4851	NOTCH1	0.369	0.885	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C0887833	Carcinoma, Pancreatic Ductal	disease	C06;C04;C19	Neoplastic Process	0.30	1	2009	2009	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C1168401	Squamous cell carcinoma of the head and neck	disease	C04	Neoplastic Process	0.40	1	2011	2019	   0	   0	CGI
     4851	NOTCH1	0.369	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C1260873	Aortic valve disorder	disease	C14	Disease or Syndrome	0.36	1	2005	2016	   1	   0	ORPHANET
     4851	NOTCH1	0.369	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.38	1	2004	2018	   2	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.40	0.952	2007	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C1704230	Grade I Astrocytoma	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.60	0.978	1998	2020	   5	   0	CGI;CTD_human
     4851	NOTCH1	0.369	0.885	C2931779	Congenital defect of skull and scalp	disease	C16;C17;C05	Congenital Abnormality	0.31	1	2014	2014	   0	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C3887892	Aortic Valve Disease 1	disease	C16;C14	Disease or Syndrome	0.70	1	2005	2016	   4	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET
     4851	NOTCH1	0.369	0.885	C4014970	ADAMS-OLIVER SYNDROME 5	disease		Disease or Syndrome	0.60	1	2014	2018	   1	  27	GENOMICS_ENGLAND;UNIPROT
     4851	NOTCH1	0.369	0.885	C4048328	cervical cancer	disease	C04;C13	Neoplastic Process	0.37	1	2007	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C4551482	Adams-Oliver syndrome 1	disease	C16;C17;C05	Disease or Syndrome	0.56	1	2014	2019	   1	   0	CTD_human;GENOMICS_ENGLAND
     4851	NOTCH1	0.369	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     4851	NOTCH1	0.369	0.885	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.60	1	2005	2016	   4	   1	CLINGEN;GENOMICS_ENGLAND
     4852	NPY	0.447	0.846	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2007	2017	   1	   0	CTD_human
     4852	NPY	0.447	0.846	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.60	1	2001	2017	   6	   0	CTD_human;PSYGENET
     4852	NPY	0.447	0.846	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.6	0.833	2000	2018	1	0	CTD_human
14611	4852	NPY	0.447	0.846	C0003123	Anorexia	disease	C23	Disease or Syndrome	0.57	1	2001	2019	3	0	CTD_human
14619	4852	NPY	0.447	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	1	2002	2019	5	0	PSYGENET
14621	4852	NPY	0.447	0.846	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	1998	2019	7	0	CTD_human;PSYGENET
14642	4852	NPY	0.447	0.846	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.56	1	1998	2017	7	0	CTD_human;PSYGENET
14644	4852	NPY	0.447	0.846	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.72	1	2003	2017	3	0	CTD_human;PSYGENET
14679	4852	NPY	0.447	0.846	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2008	2009	2	0	CTD_human;PSYGENET
14688	4901	NRL	0.647	0.462	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.67	0.75	1999	2017	2	1	CTD_human;GENOMICS_ENGLAND
14689	4901	NRL	0.647	0.462	C1834329	RETINITIS PIGMENTOSA 27	disease	C16;C11	Disease or Syndrome	0.7	1	1999	2012	8	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
14708	4907	NT5E	0.436	0.885	C1859372	Calcification of Joints and Arteries	disease	C18;C05;C14	Disease or Syndrome	0.73	1	2011	2016	2	3	CTD_human;ORPHANET;UNIPROT
14752	4909	NTF4	0.644	0.692	C2751294	GLAUCOMA 1, OPEN ANGLE, O	disease	C11	Disease or Syndrome	0.7	1	2009	2010	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
14758	4913	NTHL1	0.623	0.615	C4225157	FAMILIAL ADENOMATOUS POLYPOSIS 3	disease		Disease or Syndrome	0.7	1	2015	2017	4	2	CLINGEN;GENOMICS_ENGLAND;ORPHANET
14765	4914	NTRK1	0.422	0.808	C0020074	HSAN Type IV	disease	C16;C10	Disease or Syndrome	0.8	1	1996	2020	17	32	CTD_human;GENOMICS_ENGLAND;UNIPROT
14766	4914	NTRK1	0.422	0.808	C0020075	Hereditary Sensory Autonomic Neuropathy, Type 5	disease	C16;C10	Disease or Syndrome	0.52	1	2001	2002	1	0	CTD_human;ORPHANET
14789	4914	NTRK1	0.422	0.808	C0699739	Sensory Neuropathy, Hereditary	disease	C16;C10	Disease or Syndrome	0.51	1	2006	2006	0	0	CTD_human
14796	4914	NTRK1	0.422	0.808	C1833921	Familial medullary thyroid carcinoma	disease	C16;C04;C19	Neoplastic Process	0.75	1	1995	2005	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
14801	4915	NTRK2	0.479	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2008	2016	3	0	CTD_human;PSYGENET
14805	4915	NTRK2	0.479	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	1	2009	2020	5	0	PSYGENET
14853	4915	NTRK2	0.479	0.808	C3151303	Obesity, Hyperphagia, and Developmental Delay	disease	C23;C18;F03	Disease or Syndrome	0.7	1	2004	2017	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
14855	4915	NTRK2	0.479	0.808	C4693367	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58	disease		Disease or Syndrome	0.6	1	2004	2017	3	1	GENOMICS_ENGLAND;UNIPROT
14884	4919	ROR1	0.552	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	1	2012	2020	1	1	CTD_human;UNIPROT
14899	4920	ROR2	0.498	0.731	C1849334	Robinow syndrome, autosomal recessive	disease	C16;C05;C07	Disease or Syndrome	1	1	2000	2020	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
14900	4920	ROR2	0.498	0.731	C1862112	BRACHYDACTYLY, TYPE B1	disease	C16;C05	Congenital Abnormality	0.7	0.941	2000	2019	2	6	CTD_human;GENOMICS_ENGLAND
14909	4921	DDR2	0.541	0.769	C1849011	SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	disease	C16;C05;C19	Disease or Syndrome	0.73	1	1993	2018	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14946	4926	NUMA1	0.644	0.577	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.62	1	1997	2017	1	0	CTD_human;ORPHANET
14970	4929	NR4A2	0.529	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.6	0.8	1999	2020	5	0	PSYGENET
14989	4935	GPR143	0.659	0.385	C0342684	Ocular albinism, type I	disease	C16;C18;C11;C17	Disease or Syndrome	0.8	0.974	1995	2020	14	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14991	4935	GPR143	0.659	0.385	C3151752	NYSTAGMUS 6, CONGENITAL, X-LINKED	disease		Disease or Syndrome	0.7	1	2007	2011	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
15004	4942	OAT	0.593	0.731	C0018425	Gyrate Atrophy	disease	C16;C11	Disease or Syndrome	1	0.962	1981	2019	18	34	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15009	4942	OAT	0.593	0.731	C0599035	Hyperornithinemia	phenotype	C16;C11	Disease or Syndrome	0.67	1	1981	2017	1	61	CTD_human;ORPHANET
15013	4948	OCA2	0.539	0.808	C0078918	Albinism, Oculocutaneous	disease	C16;C18;C11;C17	Congenital Abnormality	0.6	0.974	1994	2019	1	0	GENOMICS_ENGLAND
15014	4948	OCA2	0.539	0.808	C0268495	Oculocutaneous albinism type 2	disease	C16;C18;C11;C17	Disease or Syndrome	0.8	1	1994	2017	12	49	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15017	4952	OCRL	0.553	0.731	C0028860	Oculocerebrorenal Syndrome	disease	C16;C18;C13;C12;C10	Disease or Syndrome	0.8	1	1993	2020	15	42	CTD_human;GENOMICS_ENGLAND;UNIPROT
15018	4952	OCRL	0.553	0.731	C1845167	Dent Disease 2	disease	C16;C13;C12	Disease or Syndrome	0.7	1	1999	2016	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
15040	4967	OGDH	0.653	0.538	C2752074	ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	disease	C16;C18	Disease or Syndrome	0.6	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15047	4968	OGG1	0.453	0.808	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.62	1	2003	2011	0	0	CTD_human
15075	4968	OGG1	0.453	0.808	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.64	1	2003	2011	0	1	CGI;CTD_human
15092	4973	OLR1	0.544	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.54	1	1998	2019	1	0	CTD_human
15110	4976	OPA1	0.51	0.846	C0221061	Behr syndrome	disease	C23;C11;C10;F03;C09;F01	Disease or Syndrome	0.74	1	2011	2019	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
15111	4976	OPA1	0.51	0.846	C0338508	Optic Atrophy 1	disease	C16;C18;C11;C10	Disease or Syndrome	0.8	0.989	1997	2019	24	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
15117	4976	OPA1	0.51	0.846	C3276549	OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	disease		Disease or Syndrome	0.7	1	1999	2019	11	21	GENOMICS_ENGLAND;UNIPROT
15123	4978	OPCML	0.606	0.654	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.63	1	2003	2014	0	1	CGI;CTD_human
15124	4978	OPCML	0.606	0.654	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.61	1	2003	2014	1	1	CGI;CTD_human;UNIPROT
15137	4982	TNFRSF11B	0.422	0.808	C0268414	Hyperphosphatasemia with bone disease	disease	C05	Disease or Syndrome	0.8	1	2002	2020	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
15154	4983	OPHN1	0.633	0.538	C1845366	Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	disease	C16;C10	Disease or Syndrome	0.7	1	1998	2018	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
15206	4986	OPRK1	0.555	0.615	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.55	1	1996	2019	7	0	CTD_human;PSYGENET
15235	4988	OPRM1	0.457	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.6	0.8	1998	2019	6	0	CTD_human;PSYGENET
15268	4988	OPRM1	0.457	0.808	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2003	2014	3	0	CTD_human;PSYGENET
15308	4988	OPRM1	0.457	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.55	1	2000	2019	6	0	CTD_human;PSYGENET
15345	4990	SIX6	0.588	0.654	C4225424	OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY	disease		Disease or Syndrome	0.6	1	2004	2015	3	0	GENOMICS_ENGLAND;ORPHANET
15353	4998	ORC1	0.595	0.654	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	disease	C23;C16;C05;C07;C09	Disease or Syndrome	0.65	1	2011	2017	2	1	CTD_human;ORPHANET
15357	4998	ORC1	0.595	0.654	C4552001	MEIER-GORLIN SYNDROME 1	disease	C23;C16;C05;C07;C09	Disease or Syndrome	0.6	1	1996	2015	5	7	GENOMICS_ENGLAND;UNIPROT
15361	5000	ORC4	0.612	0.654	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	disease	C23;C16;C05;C07;C09	Disease or Syndrome	0.52	1	2011	2017	3	0	CTD_human;ORPHANET
15362	5000	ORC4	0.612	0.654	C3151097	MEIER-GORLIN SYNDROME 2	disease		Disease or Syndrome	0.6	1	1998	2015	5	4	GENOMICS_ENGLAND;UNIPROT
15371	5002	SLC22A18	0.595	0.692	C0684249	Carcinoma of lung	disease	C04;C08	Neoplastic Process	0.6	1	1998	1998	1	1	CGI;UNIPROT
15399	5009	OTC	0.565	0.846	C0268542	Ornithine carbamoyltransferase deficiency	disease	C16;C18;C10	Disease or Syndrome	1	1	1976	2018	42	133	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
15421	5015	OTX2	0.514	0.808	C1864690	Microphthalmia, Syndromic 5	disease	C16;C11	Disease or Syndrome	0.7	1	1997	2014	10	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15425	5015	OTX2	0.514	0.808	C3151440	PITUITARY HORMONE DEFICIENCY, COMBINED, 6	disease		Disease or Syndrome	0.6	1	2008	2015	4	2	GENOMICS_ENGLAND;UNIPROT
15438	5019	OXCT1	0.686	0.423	C0342792	Succinyl-CoA:3-oxoacid CoA transferase deficiency	disease	C18	Disease or Syndrome	0.7	1	1998	2019	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15587	5027	P2RX7	0.45	0.808	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.59	0.7	2000	2016	2	0	CTD_human;ORPHANET
15597	5032	P2RY11	0.705	0.538	C0027404	Narcolepsy	disease	C10;F03	Disease or Syndrome	0.58	1	2011	2019	2	0	CTD_human;ORPHANET
15598	5032	P2RY11	0.705	0.538	C0751362	Narcolepsy-Cataplexy Syndrome	disease	C10;F03	Disease or Syndrome	0.51	1	2011	2017	2	0	CTD_human;ORPHANET
15611	5034	P4HB	0.488	0.808	C1862178	Cole Carpenter syndrome	disease	C16;C11;C17;C05;C10	Disease or Syndrome	0.63	1	2015	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15615	5034	P4HB	0.488	0.808	C4317154	COLE-CARPENTER SYNDROME 1	disease	C16;C11;C17;C05;C10	Disease or Syndrome	0.61	1	2015	2017	2	1	GENOMICS_ENGLAND;UNIPROT
15661	5048	PAFAH1B1	0.504	0.769	C0265219	Miller Dieker syndrome	disease	C16;C10	Disease or Syndrome	0.6	0.968	1994	2019	1	0	ORPHANET
15662	5048	PAFAH1B1	0.504	0.769	C0266463	Lissencephaly	disease	C16;C10	Congenital Abnormality	0.7	1	1984	2019	0	0	CTD_human
15663	5048	PAFAH1B1	0.504	0.769	C0266483	Pachygyria	disease	C16;C10	Congenital Abnormality	0.65	1	1998	2018	0	0	CTD_human
15664	5048	PAFAH1B1	0.504	0.769	C0431375	Classical Lissencephaly	disease	C16;C10	Disease or Syndrome	0.8	1	1993	2018	9	97	GENOMICS_ENGLAND;ORPHANET;UNIPROT
15666	5048	PAFAH1B1	0.504	0.769	C1848201	Subcortical Band Heterotopia	disease	C16;C10	Disease or Syndrome	0.7	1	2000	2017	1	3	GENOMICS_ENGLAND;ORPHANET
15688	5053	PAH	0.516	0.769	C0031485	Phenylketonurias	group	C16;C18;C10	Disease or Syndrome	0.8	0.985	1977	2020	1	0	CTD_human;GENOMICS_ENGLAND
15691	5053	PAH	0.516	0.769	C0085547	Phenylketonuria, Maternal	disease	C16;C18;C13;C10	Disease or Syndrome	0.59	0.929	1987	2018	1	0	ORPHANET
15693	5053	PAH	0.516	0.769	C0751434	Classical phenylketonuria	disease	C16;C18;C10	Disease or Syndrome	0.8	0.996	1975	2019	47	381	CTD_human;GENOMICS_ENGLAND;UNIPROT
15708	5054	SERPINE1	0.359	0.885	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.6	0.889	1996	2019	1	0	CTD_human
15714	5054	SERPINE1	0.359	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.889	1998	2019	2	0	CTD_human
15715	5054	SERPINE1	0.359	0.885	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.51	1	2003	2016	1	0	CTD_human
15744	5054	SERPINE1	0.359	0.885	C2750067	Plasminogen Activator Inhibitor-1 Deficiency	disease	C15	Disease or Syndrome	0.7	1	1992	2011	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
15772	5058	PAK1	0.494	0.808	C4748428	INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY	disease		Disease or Syndrome	0.6	1	2018	2019	2	2	GENOMICS_ENGLAND;UNIPROT
15780	5063	PAK3	0.569	0.731	C0796237	Mental Retardation, X-Linked 30	disease	C16;C10	Disease or Syndrome	0.7	1	1998	2003	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
15840	5071	PRKN	0.431	0.846	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.6	0.974	1998	2020	13	0	CTD_human
15863	5071	PRKN	0.431	0.846	C0752105	Parkinsonism, Juvenile	disease	C10	Disease or Syndrome	0.59	1	1998	2018	10	0	CTD_human;GENOMICS_ENGLAND
15865	5071	PRKN	0.431	0.846	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.55	1	2011	2019	0	0	CTD_human;GENOMICS_ENGLAND
15869	5071	PRKN	0.431	0.846	C1868675	PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	disease	C10	Disease or Syndrome	1	0.994	1998	2019	37	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
15872	5073	PARN	0.575	0.769	C0265965	Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.67	1	2015	2019	2	2	GENOMICS_ENGLAND;ORPHANET
15873	5073	PARN	0.575	0.769	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.55	0.833	2015	2019	1	0	CTD_human;ORPHANET
15875	5073	PARN	0.575	0.769	C4225347	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4	disease		Disease or Syndrome	0.7	1	2015	2015	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
15876	5073	PARN	0.575	0.769	C4225356	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	disease		Disease or Syndrome	0.7	1	2015	2019	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
15894	5075	PAX1	0.593	0.654	C1833691	Otofaciocervical Syndrome	disease	C16	Disease or Syndrome	0.53	1	2013	2018	1	0	CTD_human;ORPHANET
15902	5076	PAX2	0.495	0.731	C0431692	Bilateral renal hypoplasia	disease		Congenital Abnormality	0.51	1	1995	2018	4	0	ORPHANET
15904	5076	PAX2	0.495	0.731	C1852759	Papillorenal syndrome	disease	C16;C13;C11;C12	Disease or Syndrome	1	1	1995	2019	9	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15907	5076	PAX2	0.495	0.731	C4014925	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7	disease		Disease or Syndrome	0.6	1	1999	2015	3	6	GENOMICS_ENGLAND;UNIPROT
15916	5077	PAX3	0.481	0.769	C0079661	Kleins Syndrome	disease	C16	Disease or Syndrome	0.75	1	1993	2018	  16	   5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5077	PAX3	0.481	0.769	C0080178	Spina Bifida	disease	C16;C10	Congenital Abnormality	0.48	0.909	1984	2017	   4	   0	CTD_human
     5077	PAX3	0.481	0.769	C0080218	Tethered Cord Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	1988	2003	   3	   0	CTD_human
     5077	PAX3	0.481	0.769	C0086395	Hearing Loss, Extreme	phenotype	C23;C10;C09	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C0152234	Iniencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	1988	2003	   3	   0	CTD_human
     5077	PAX3	0.481	0.769	C0152426	Craniorachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	1988	2003	   3	   0	CTD_human
     5077	PAX3	0.481	0.769	C0205944	Sarcoma, Epithelioid	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C0205945	Sarcoma, Spindle Cell	disease	C04	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C0206655	Alveolar rhabdomyosarcoma	disease	C04	Neoplastic Process	1.00	0.983	1993	2019	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5077	PAX3	0.481	0.769	C0265541	Cranioschisis	disease	C16;C10	Congenital Abnormality	0.30	1	1995	1995	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C0266453	Exencephaly	disease	C16;C10	Congenital Abnormality	0.31	1	1988	2017	   3	   0	CTD_human
     5077	PAX3	0.481	0.769	C0266508	Rachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	1984	2007	   4	   0	CTD_human
     5077	PAX3	0.481	0.769	C0344479	Spinal Cord Myelodysplasia	disease	C16;C10	Congenital Abnormality	0.30	1	1988	2003	   3	   0	CTD_human
     5077	PAX3	0.481	0.769	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2003	2003	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C0497552	Congenital neurologic anomalies	group	C16;C10	Congenital Abnormality	0.30	1	1995	1995	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C0581883	Complete Hearing Loss	phenotype	C23;C10;C09	Finding	0.30	1	2003	2003	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C0599973	Waardenburg Anophthalmia Syndrome	disease	C16	Disease or Syndrome	0.30	1	1993	2003	   3	   0	ORPHANET
     5077	PAX3	0.481	0.769	C0702169	Acrania	disease	C16;C10	Congenital Abnormality	0.30	1	1988	2003	   3	   0	CTD_human
     5077	PAX3	0.481	0.769	C0751068	Deafness, Acquired	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C1261473	Sarcoma	group	C04	Neoplastic Process	0.38	1	1995	2018	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C1710096	Sinonasal undifferentiated carcinoma	disease	C04;C08;C09	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C1847800	Waardenburg Syndrome Type 1	disease	C16	Disease or Syndrome	1.00	0.987	1983	2019	  33	  43	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     5077	PAX3	0.481	0.769	C1852510	Craniofacial deafness hand syndrome	disease	C23;C16;C05;C10;C09	Disease or Syndrome	0.71	1	1983	2018	   5	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5077	PAX3	0.481	0.769	C3266898	Waardenburg Syndrome	disease	C16	Disease or Syndrome	0.80	1	1992	2018	  12	   2	CLINGEN;CTD_human;GENOMICS_ENGLAND
     5077	PAX3	0.481	0.769	C3665473	Bilateral Deafness	phenotype	C23;C10;C09	Finding	0.30	1	2003	2003	   1	   0	CTD_human
     5077	PAX3	0.481	0.769	C4082305	Deaf Mutism	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     5078	PAX4	0.644	0.423	C0011854	Diabetes Mellitus, Insulin-Dependent	disease	C18;C20;C19	Disease or Syndrome	0.37	0.571	2004	2018	   0	   0	CTD_human
     5078	PAX4	0.644	0.423	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	1.00	0.857	1999	2019	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5078	PAX4	0.644	0.423	C0025202	melanoma	disease	C04	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
     5078	PAX4	0.644	0.423	C0205734	Diabetes, Autoimmune	disease	C18;C20;C19	Disease or Syndrome	0.30				   0	   0	CTD_human
     5078	PAX4	0.644	0.423	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.66	0.857	1999	2019	   4	   0	GENOMICS_ENGLAND;ORPHANET
     5078	PAX4	0.644	0.423	C0342302	Brittle diabetes	disease	C18;C20;C19	Disease or Syndrome	0.30				   0	   0	CTD_human
     5078	PAX4	0.644	0.423	C2677132	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9 (disorder)	disease	C18;C19	Disease or Syndrome	0.71	1	2007	2016	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5078	PAX4	0.644	0.423	C3837958	Diabetes Mellitus, Ketosis-Prone	disease	C18;C20;C19	Disease or Syndrome	0.61	0	2004	2004	   1	   1	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5078	PAX4	0.644	0.423	C3888631	Monogenic diabetes	disease	C18;C19	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5078	PAX4	0.644	0.423	C4554117	Diabetes Mellitus, Sudden-Onset	disease	C18;C20;C19	Disease or Syndrome	0.30				   0	   0	CTD_human
     5079	PAX5	0.487	0.654	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.35	1	2003	2019	   4	   0	ORPHANET
     5079	PAX5	0.487	0.654	C0023452	Childhood Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	0.923	2001	2019	   1	   0	CTD_human
     5079	PAX5	0.487	0.654	C0023453	L2 Acute Lymphoblastic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5079	PAX5	0.487	0.654	C0023485	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.33	1	2012	2019	   2	   0	CTD_human
     5079	PAX5	0.487	0.654	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.32	1	1998	2016	   0	   0	CGI
     5079	PAX5	0.487	0.654	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.40	1	2006	2019	   4	   0	ORPHANET
     5079	PAX5	0.487	0.654	C1535926	Neurodevelopmental Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	CTD_human
     5079	PAX5	0.487	0.654	C1961102	Precursor Cell Lymphoblastic Leukemia Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.70	0.96	2001	2019	   2	   1	CGI;CTD_human;UNIPROT
     5080	PAX6	0.45	0.769	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0003076	Aniridia	disease	C16;C11	Congenital Abnormality	1.00	0.984	1978	2020	  25	  18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5080	PAX6	0.45	0.769	C0003119	Anophthalmos	disease	C16;C11	Congenital Abnormality	0.32	1	1995	2015	   1	   0	GENOMICS_ENGLAND
     5080	PAX6	0.45	0.769	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.53	1	2008	2014	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0009363	Congenital ocular coloboma (disorder)	disease	C16;C11	Congenital Abnormality	0.75	0.875	1988	2020	   3	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5080	PAX6	0.45	0.769	C0011847	Diabetes	disease	C19	Disease or Syndrome	0.35	1	2002	2019	   0	   0	GENOMICS_ENGLAND
     5080	PAX6	0.45	0.769	C0011849	Diabetes Mellitus	group	C18;C19	Disease or Syndrome	0.38	1	2002	2019	   0	   0	GENOMICS_ENGLAND
     5080	PAX6	0.45	0.769	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.31	1	2005	2014	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.38	1	1999	2017	   0	   0	GENOMICS_ENGLAND
     5080	PAX6	0.45	0.769	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.33	1	2006	2019	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0029132	Disorder of the optic nerve	group	C11;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	1	1999	2020	   1	   0	PSYGENET
     5080	PAX6	0.45	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0040427	Tooth Abnormalities	group	C16;C07	Anatomical Abnormality	0.30	1	1995	1997	   2	   0	CTD_human
     5080	PAX6	0.45	0.769	C0086543	Cataract	disease	C11	Acquired Abnormality	0.46	1	2000	2018	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0152112	Foster-Kennedy Syndrome	disease	C11;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0155299	Coloboma of optic disc	disease	C16;C11	Disease or Syndrome	0.71	1	1988	2019	   5	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5080	PAX6	0.45	0.769	C0206115	WAGR Syndrome	disease	C16;C04;C13;C11;C12;C10;C19	Disease or Syndrome	0.80	0.933	1988	2017	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5080	PAX6	0.45	0.769	C0265541	Cranioschisis	disease	C16;C10	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0266551	Congenital coloboma of iris	disease	C16;C11	Congenital Abnormality	0.31	1	2003	2012	   2	   0	ORPHANET
     5080	PAX6	0.45	0.769	C0338502	Hypoplasia of the optic nerve	disease	C16;C11;C10	Disease or Syndrome	0.40	1	2003	2003	   1	   0	ORPHANET
     5080	PAX6	0.45	0.769	C0344516	Coloboma of lens	disease	C16;C11	Congenital Abnormality	0.30	1	2003	2006	   2	   0	ORPHANET
     5080	PAX6	0.45	0.769	C0344559	Irido-corneo-trabecular dysgenesis (disorder)	disease	C16;C11	Congenital Abnormality	1.00	0.938	1983	2011	   3	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5080	PAX6	0.45	0.769	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2010	2018	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1995	1997	   3	   0	CTD_human
     5080	PAX6	0.45	0.769	C0431401	Gillespie syndrome	disease	C23;C16;C11;C10;F03;F01	Disease or Syndrome	0.53	0.857	1988	2016	   4	   0	GENOMICS_ENGLAND;ORPHANET
     5080	PAX6	0.45	0.769	C0497552	Congenital neurologic anomalies	group	C16;C10	Congenital Abnormality	0.30	1	2009	2009	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0521573	Coloboma of eyelid	phenotype	C16;C11	Disease or Syndrome	0.30	1	2003	2006	   2	   0	ORPHANET
     5080	PAX6	0.45	0.769	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0524730	Odontome	disease	C16;C07	Congenital Abnormality	0.30	1	1995	1997	   2	   0	CTD_human
     5080	PAX6	0.45	0.769	C0549307	Morning glory syndrome	disease	C23;C16;C13;C11;C10	Disease or Syndrome	0.31	1	2003	2008	   1	   0	ORPHANET
     5080	PAX6	0.45	0.769	C0751402	Optic Disk Disorders	group	C11;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	2018	2018	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5080	PAX6	0.45	0.769	C1833797	Optic Nerve Hypoplasia, Bilateral	disease	C11;C10	Disease or Syndrome	0.70	1	1988	2006	   4	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5080	PAX6	0.45	0.769	C1835698	Keratitis, hereditary	disease	C11	Disease or Syndrome	0.70	1	1988	2006	   4	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5080	PAX6	0.45	0.769	C1840452	Hyaloideoretinal degeneration of Wagner	disease	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5080	PAX6	0.45	0.769	C1852767	Hereditary macular coloboma	disease	C16;C11	Congenital Abnormality	0.30	1	2003	2006	   2	   0	ORPHANET
     5080	PAX6	0.45	0.769	C2673946	Foveal hypoplasia (finding)	phenotype		Finding	0.40				   0	   0	GENOMICS_ENGLAND
     5080	PAX6	0.45	0.769	C2931644	ODonnell Pappas syndrome	disease	C16;C11;C10	Disease or Syndrome	0.6	1	1999	1999	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15920	5080	PAX6	0.45	0.769	C3805604	FOVEAL HYPOPLASIA 1	disease		Disease or Syndrome	0.6	1	1988	2006	5	3	GENOMICS_ENGLAND;UNIPROT
15921	5080	PAX6	0.45	0.769	C4310809	ANTERIOR SEGMENT DYSGENESIS 5	disease		Disease or Syndrome	0.6	1	1988	2018	6	24	GENOMICS_ENGLAND;UNIPROT
15928	5081	PAX7	0.597	0.538	C0206655	Alveolar rhabdomyosarcoma	disease	C04	Neoplastic Process	0.8	0.976	1995	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15932	5083	PAX9	0.636	0.538	C1970291	Tooth Agenesis, Selective, 3	disease	C16;C07	Disease or Syndrome	0.7	1	2003	2017	1	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
15952	5092	PCBD1	0.623	0.769	C1849700	Hyperphenylalaninemia with primapterinuria	disease	C16;C18;C10	Disease or Syndrome	0.71	1	1993	2017	5	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15953	5095	PCCA	0.682	0.538	C0268579	Propionic acidemia	disease	C16;C18	Disease or Syndrome	0.8	1	1993	2019	8	56	CTD_human;GENOMICS_ENGLAND;UNIPROT
15956	5096	PCCB	0.695	0.577	C0268579	Propionic acidemia	disease	C16;C18	Disease or Syndrome	0.8	1	1990	2019	11	62	CTD_human;GENOMICS_ENGLAND;UNIPROT
15979	5105	PCK1	0.608	0.538	C0268194	Phosphoenolpyruvate carboxykinase deficiency	disease	C16;C06;C18	Disease or Syndrome	0.61	1	2014	2017	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16012	5111	PCNA	0.382	0.846	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.51	1	2002	2013	1	0	CTD_human
16020	5111	PCNA	0.382	0.846	C4014676	ATAXIA-TELANGIECTASIA-LIKE DISORDER 2	disease		Disease or Syndrome	0.6	1	2014	2014	1	1	ORPHANET;UNIPROT
16026	5116	PCNT	0.564	0.808	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.55	1	2008	2011	1	0	GENOMICS_ENGLAND;ORPHANET
16028	5116	PCNT	0.564	0.808	C0432246	Microcephalic Osteodysplastic Primordial Dwarfism, Type II	disease	C23;C16;C13;C05;C10;C19	Congenital Abnormality	0.8	1	2004	2019	4	32	CTD_human;GENOMICS_ENGLAND;ORPHANET
16044	5119	CHMP1A	0.695	0.5	C3554209	Congenital pontocerebellar hypoplasia type 8	disease	C10	Disease or Syndrome	0.7	1	2012	2012	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
16048	5122	PCSK1	0.548	0.615	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.7	0.857	1997	2018	1	0	CTD_human
16049	5122	PCSK1	0.548	0.615	C1833053	Proprotein Convertase 1 3 Deficiency	disease	C23;C18;C19	Disease or Syndrome	0.71	1	1997	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16083	5130	PCYT1A	0.485	0.885	C1837073	Spondylometaphyseal Dysplasia with Cone-Rod Dystrophy	disease	C16;C11;C05	Disease or Syndrome	0.71	1	2014	2014	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16087	5133	PDCD1	0.402	0.846	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.8	0.949	1998	2020	1	0	CTD_human;ORPHANET
16114	5139	PDE3A	0.67	0.577	C1862170	Brachydactyly with hypertension	disease	C16;C05;C14	Disease or Syndrome	0.77	1	1998	2020	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16127	5142	PDE4B	0.566	0.731	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.53	1	2007	2010	4	0	CTD_human;PSYGENET
16153	5144	PDE4D	0.519	0.846	C0220659	Acrodysostosis	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.7	0.867	2012	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
16159	5144	PDE4D	0.519	0.846	C3553250	ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.71	1	2012	2017	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
16162	5145	PDE6A	0.691	0.269	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.9	1	1995	2019	2	7	CTD_human;GENOMICS_ENGLAND
16163	5145	PDE6A	0.691	0.269	C3151139	RETINITIS PIGMENTOSA 43	disease		Disease or Syndrome	0.7	1	1995	1999	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
16165	5146	PDE6C	0.7	0.269	C0152200	Achromatopsia	disease	C23;C11;C10	Disease or Syndrome	0.87	1	2009	2019	1	13	GENOMICS_ENGLAND;ORPHANET
16170	5146	PDE6C	0.7	0.269	C2751308	CONE DYSTROPHY 4 (disorder)	disease	C16;C11	Disease or Syndrome	0.7	1	2009	2017	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
16175	5148	PDE6G	0.695	0.308	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.72	1	1997	2010	0	0	CTD_human;GENOMICS_ENGLAND
16179	5149	PDE6H	0.7	0.269	C0152200	Achromatopsia	disease	C23;C11;C10	Disease or Syndrome	0.72	1	2012	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
16188	5149	PDE6H	0.7	0.269	C1864900	Retinal Cone Dystrophy 3A	disease	C16;C11	Disease or Syndrome	0.6	1	2012	2015	2	1	CTD_human;GENOMICS_ENGLAND
16241	5156	PDGFRA	0.415	0.808	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.8	0.954	2003	2020	10	13	CGI;CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16251	5156	PDGFRA	0.415	0.808	C1540912	Hypereosinophilic syndrome	disease	C15	Disease or Syndrome	0.6	0.958	2003	2019	2	0	CGI;CTD_human
16258	5156	PDGFRA	0.415	0.808	C3179349	Gastrointestinal Stromal Sarcoma	disease	C06;C04	Neoplastic Process	0.61	1	2003	2018	9	0	CLINGEN;CTD_human;ORPHANET
16266	5158	PDE6B	0.626	0.346	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.9	1	1992	2019	1	18	CTD_human;GENOMICS_ENGLAND
16267	5158	PDE6B	0.626	0.346	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.72	1	1994	2007	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
16271	5158	PDE6B	0.626	0.346	C1876182	NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2	disease	C16;C11	Disease or Syndrome	0.9	1	1924	2007	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
16272	5158	PDE6B	0.626	0.346	C3151107	RETINITIS PIGMENTOSA 40 (disorder)	disease		Disease or Syndrome	0.9	1	1993	2016	7	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
16288	5159	PDGFRB	0.416	0.846	C0393590	Fahrs syndrome (disorder)	disease	C18;C10;C14	Disease or Syndrome	0.71	1	2013	2015	   3	   0	GENOMICS_ENGLAND;ORPHANET
     5159	PDGFRB	0.416	0.846	C0432284	Infantile myofibromatosis	disease	C04	Disease or Syndrome	1.00	1	2013	2019	   2	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5159	PDGFRB	0.416	0.846	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     5159	PDGFRB	0.416	0.846	C0750951	Lenticulostriate Disorders	disease	C10	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     5159	PDGFRB	0.416	0.846	C1333046	Myeloproliferative Neoplasm, Unclassifiable	disease		Neoplastic Process	0.30	1	2007	2007	   1	   0	ORPHANET
     5159	PDGFRB	0.416	0.846	C1851585	MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	disease	C15	Disease or Syndrome	0.40				   0	   0	CTD_human
     5159	PDGFRB	0.416	0.846	C1866182	Penttinen-Aula syndrome	disease	C16;C18;C05	Disease or Syndrome	0.71	1	2015	2019	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5159	PDGFRB	0.416	0.846	C3165106	Infiltrating duct carcinoma of female breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     5159	PDGFRB	0.416	0.846	C3472621	Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	disease		Neoplastic Process	0.30	1	2013	2013	   1	   0	ORPHANET
     5159	PDGFRB	0.416	0.846	C3554321	BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4	disease		Disease or Syndrome	0.70	1	2013	2015	   6	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5159	PDGFRB	0.416	0.846	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
     5159	PDGFRB	0.416	0.846	C4225270	Kosaki overgrowth syndrome	disease		Disease or Syndrome	0.73	1	2015	2019	   3	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5159	PDGFRB	0.416	0.846	C4551572	MYOFIBROMATOSIS, INFANTILE, 1	disease	C04	Disease or Syndrome	0.80	1	2013	2017	   3	   5	GENOMICS_ENGLAND;UNIPROT
     5159	PDGFRB	0.416	0.846	C4551624	Idiopathic basal ganglia calcification 1	disease	C18;C10	Disease or Syndrome	0.30				   0	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0001125	Acidosis, Lactic	phenotype	C18	Disease or Syndrome	0.43	1	1989	2017	   1	   1	CTD_human
     5160	PDHA1	0.581	0.538	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.31	1	1993	2017	   8	   0	CLINGEN
     5160	PDHA1	0.581	0.538	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.32	1	2011	2019	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2007	2018	   2	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0034345	Pyruvate Dehydrogenase Complex Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	0.90	1	1990	2015	   4	   2	CTD_human;ORPHANET
     5160	PDHA1	0.581	0.538	C0034350	Pyruvate Metabolism, Inborn Errors	disease	C16;C18	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0235874	Disease Exacerbation	phenotype	C23	Finding	0.30	1	2011	2011	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.33	1	2007	2018	   2	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0751595	Juvenile Pyruvate Dehydrogenase Complex Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0751596	Pyruvate Dehydrogenase Complex Deficiency Disease, Neonatal	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C0751597	Ataxia with Lactic Acidosis, Type I	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1990	1990	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     5160	PDHA1	0.581	0.538	C1838951	LEIGH SYNDROME DUE TO MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1993	2017	   8	   0	CLINGEN
     5160	PDHA1	0.581	0.538	C1839413	Pyruvate Dehydrogenase E1 Alpha Deficiency	disease	C18	Disease or Syndrome	0.70	1	1991	2017	  24	  42	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5160	PDHA1	0.581	0.538	C1850597	Leigh Syndrome Due To Mitochondrial Complex II Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1993	2017	   8	   0	CLINGEN
     5160	PDHA1	0.581	0.538	C1850598	Leigh Syndrome due to Mitochondrial Complex III Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1993	2017	   8	   0	CLINGEN
     5160	PDHA1	0.581	0.538	C1850599	Leigh Syndrome due to Mitochondrial Complex IV Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1993	2017	   8	   0	CLINGEN
     5160	PDHA1	0.581	0.538	C1850600	Leigh Syndrome due to Mitochondrial Complex V Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1993	2017	   8	   0	CLINGEN
     5160	PDHA1	0.581	0.538	C2931891	Necrotizing encephalopathy, infantile subacute, of Leigh	disease	C16;C18;C10	Disease or Syndrome	0.30	1	1993	2017	   8	   0	CLINGEN
     5162	PDHB	0.711	0.385	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C0034345	Pyruvate Dehydrogenase Complex Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2004	2008	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C0751595	Juvenile Pyruvate Dehydrogenase Complex Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C0751596	Pyruvate Dehydrogenase Complex Deficiency Disease, Neonatal	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C0751597	Ataxia with Lactic Acidosis, Type I	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C1266042	Chromophobe Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C1266043	Sarcomatoid Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C1266044	Collecting Duct Carcinoma of the Kidney	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C1306837	Papillary Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5162	PDHB	0.711	0.385	C3279841	Pyruvate Dehydrogenase E1-Beta Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.70	1	2004	2016	   5	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5164	PDK2	0.751	0.269	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     5164	PDK2	0.751	0.269	C0036529	Myocardial Diseases, Secondary	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     5164	PDK2	0.751	0.269	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     5164	PDK2	0.751	0.269	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.30				   0	   1	UNIPROT
     5165	PDK3	0.678	0.5	C3806702	CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6	disease		Disease or Syndrome	0.73	1	2013	2016	   1	   1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5166	PDK4	0.578	0.577	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2011	2011	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2004	2004	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2015	2019	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.31	1	2018	2018	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     5166	PDK4	0.578	0.577	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     5167	ENPP1	0.498	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.70	0.814	2000	2019	   0	   0	CTD_human;GENOMICS_ENGLAND
     5167	ENPP1	0.498	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.31	1	2011	2018	   1	   0	CTD_human
     5167	ENPP1	0.498	0.808	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.70	0.786	2001	2019	   0	   0	CTD_human;GENOMICS_ENGLAND
     5167	ENPP1	0.498	0.808	C0033847	Pseudoxanthoma Elasticum	disease	C16;C17;C15;C14	Disease or Syndrome	0.40	1	2012	2019	   1	   0	ORPHANET
     5167	ENPP1	0.498	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.31	1	2011	2018	   1	   0	CTD_human
     5167	ENPP1	0.498	0.808	C0342643	Autosomal recessive hypophosphatemic vitamin D refractory rickets	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.37	1	2010	2020	   0	   0	ORPHANET
     5167	ENPP1	0.498	0.808	C1859727	Arterial calcification of infancy	disease	C18	Disease or Syndrome	0.70	1	2003	2018	   0	   1	CTD_human
     5167	ENPP1	0.498	0.808	C1865343	OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE	disease	C23;C05	Disease or Syndrome	0.70	1	1981	1999	   1	   1	GENOMICS_ENGLAND;UNIPROT
     5167	ENPP1	0.498	0.808	C2750078	Hypophosphatemic Rickets, Autosomal Recessive, 2	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.70	1	2005	2015	   4	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5167	ENPP1	0.498	0.808	C3809781	Cole disease	disease		Disease or Syndrome	0.72	1	2009	2018	   4	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5167	ENPP1	0.498	0.808	C4551985	ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1	disease	C18	Disease or Syndrome	0.60	1	2003	2016	   7	  28	GENOMICS_ENGLAND;UNIPROT
     5168	ENPP2	0.582	0.769	C0005612	Birth Weight	phenotype	C23	Organism Attribute	0.40	1	2013	2019	   1	   1	CTD_human
     5168	ENPP2	0.582	0.769	C0019158	Hepatitis	group	C06	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     5168	ENPP2	0.582	0.769	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2006	2012	   1	   0	CTD_human
     5168	ENPP2	0.582	0.769	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.34	1	1999	2018	   1	   0	CTD_human
     5168	ENPP2	0.582	0.769	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.32	1	2004	2015	   1	   0	CTD_human
     5168	ENPP2	0.582	0.769	C0151468	Thyroid Gland Follicular Adenoma	disease	C04;C19	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     5168	ENPP2	0.582	0.769	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.32	1	2004	2015	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.55	1	2005	2019	   1	   0	CGI;CTD_human
     5170	PDPK1	0.588	0.808	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.31	1	2011	2018	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C0496956	Neoplasm of uncertain or unknown behavior of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     5170	PDPK1	0.588	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.55	1	2005	2019	   1	   0	CGI;CTD_human
     5170	PDPK1	0.588	0.808	C0858252	Breast adenocarcinoma	disease	C04;C17	Neoplastic Process	0.30				   0	   0	CGI
     5170	PDPK1	0.588	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2005	2014	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     5170	PDPK1	0.588	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     5172	SLC26A4	0.507	0.885	C0018021	Goiter	phenotype	C19	Disease or Syndrome	0.70	0.972	1996	2017	   4	   0	CTD_human;GENOMICS_ENGLAND
     5172	SLC26A4	0.507	0.885	C0018784	Sensorineural Hearing Loss (disorder)	disease	C23;C10;C09	Disease or Syndrome	0.70	1	1996	2019	   4	   0	CTD_human;GENOMICS_ENGLAND
     5172	SLC26A4	0.507	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     5172	SLC26A4	0.507	0.885	C0151516	Thyroid Hypoplasia	disease	C16;C19	Disease or Syndrome	0.41	1	2014	2014	   1	   0	ORPHANET
     5172	SLC26A4	0.507	0.885	C0271829	Pendreds syndrome	disease	C23;C10;C19;C09	Disease or Syndrome	1	1	1996	2019	28	125	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
16292	5172	SLC26A4	0.507	0.885	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.7	1	1999	2018	3	36	CTD_human;GENOMICS_ENGLAND
16295	5172	SLC26A4	0.507	0.885	C3538946	DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	disease	C23;C10;C09	Disease or Syndrome	0.73	1	1998	2019	13	73	CTD_human;GENOMICS_ENGLAND;UNIPROT
16297	5173	PDYN	0.535	0.577	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.6	0.8	1997	2018	7	0	CTD_human;PSYGENET
16362	5173	PDYN	0.535	0.577	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.54	1	2002	2014	7	0	CTD_human;PSYGENET
16389	5173	PDYN	0.535	0.577	C1853250	SPINOCEREBELLAR ATAXIA 23	disease	C16;C10	Disease or Syndrome	0.74	1	2010	2013	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16419	5176	SERPINF1	0.46	0.846	C0029434	Osteogenesis Imperfecta	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.6	1	2011	2018	1	0	GENOMICS_ENGLAND
16427	5176	SERPINF1	0.46	0.846	C3279564	Osteogenesis Imperfecta, Type VI	disease	C16;C17;C05	Disease or Syndrome	0.9	1	2011	2019	1	6	CTD_human;GENOMICS_ENGLAND
16466	5184	PEPD	0.621	0.769	C0268532	Deficiency of prolidase	disease	C16	Disease or Syndrome	0.76	1	1990	2017	9	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16485	5189	PEX1	0.538	0.769	C0043459	Zellweger Syndrome	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.8	1	1997	2020	5	0	CTD_human;GENOMICS_ENGLAND
16488	5189	PEX1	0.538	0.769	C0282527	Infantile Refsum Disease (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.72	1	1997	2017	9	57	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16490	5189	PEX1	0.538	0.769	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.7	1	1997	2016	4	8	CTD_human;GENOMICS_ENGLAND
16491	5189	PEX1	0.538	0.769	C1856186	Deafness enamel hypoplasia nail defects	disease	C23;C16;C10;C07;C09	Disease or Syndrome	0.53	1	2015	2018	1	0	CTD_human;ORPHANET
16496	5189	PEX1	0.538	0.769	C4551980	HEIMLER SYNDROME 1	disease	C23;C16;C10;C07;C09	Disease or Syndrome	0.6	1	1997	2017	3	12	GENOMICS_ENGLAND;UNIPROT
16497	5189	PEX1	0.538	0.769	C4721541	PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.6	1	1997	2017	9	96	GENOMICS_ENGLAND;UNIPROT
16500	5190	PEX6	0.547	0.731	C0043459	Zellweger Syndrome	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.56	1	1996	2017	2	0	CTD_human;GENOMICS_ENGLAND
16505	5190	PEX6	0.547	0.731	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.68	1	1996	2019	3	13	CTD_human;GENOMICS_ENGLAND
16507	5190	PEX6	0.547	0.731	C1856186	Deafness enamel hypoplasia nail defects	disease	C23;C16;C10;C07;C09	Disease or Syndrome	0.51	1	2015	2018	1	0	CTD_human;ORPHANET
16508	5190	PEX6	0.547	0.731	C3553936	PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	disease	C16;C18	Disease or Syndrome	0.7	1	1996	2016	10	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
16509	5190	PEX6	0.547	0.731	C3553937	PEROXISOME BIOGENESIS DISORDER 4B	disease	C16;C18	Disease or Syndrome	0.6	1	1996	2016	5	35	CTD_human;GENOMICS_ENGLAND
16512	5190	PEX6	0.547	0.731	C4225267	HEIMLER SYNDROME 2	disease		Disease or Syndrome	0.6	1	2002	2016	4	12	GENOMICS_ENGLAND;UNIPROT
16515	5191	PEX7	0.603	0.615	C0034960	Refsum Disease	disease	C16;C18;C10	Disease or Syndrome	0.66	1	1997	2012	2	2	CTD_human;GENOMICS_ENGLAND
16516	5191	PEX7	0.603	0.615	C0282529	Chondrodysplasia Punctata, Rhizomelic	disease	C16;C18;C05	Disease or Syndrome	0.6	0.95	1997	2017	1	0	CTD_human
16520	5191	PEX7	0.603	0.615	C1859133	RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1	disease	C16;C18;C05	Disease or Syndrome	0.98	0.964	1995	2017	8	42	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16521	5191	PEX7	0.603	0.615	C2749346	Refsum Disease, Adult, 2	disease	C16;C18;C10	Disease or Syndrome	0.7	1	1997	2016	3	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
16522	5192	PEX10	0.584	0.654	C0043459	Zellweger Syndrome	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.52	1	1998	2017	5	0	CTD_human;GENOMICS_ENGLAND
16523	5192	PEX10	0.584	0.654	C0282525	Adrenoleukodystrophy, Neonatal	disease	C16;C18	Disease or Syndrome	0.52	1	1998	2017	0	0	GENOMICS_ENGLAND;ORPHANET
16526	5192	PEX10	0.584	0.654	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.67	1	1998	2019	4	2	CTD_human;GENOMICS_ENGLAND
16528	5192	PEX10	0.584	0.654	C3553947	PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER)	disease	C16;C18	Disease or Syndrome	0.6	1	1995	2017	3	23	CTD_human;GENOMICS_ENGLAND
16529	5192	PEX10	0.584	0.654	C3553948	PEROXISOME BIOGENESIS DISORDER 6B	disease	C16;C18	Disease or Syndrome	0.7	1	1995	2016	4	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
16532	5193	PEX12	0.601	0.615	C0043459	Zellweger Syndrome	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.53	1	1997	2015	2	0	CTD_human;GENOMICS_ENGLAND
16536	5193	PEX12	0.601	0.615	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.65	1	1997	2018	2	7	CTD_human;GENOMICS_ENGLAND
16537	5193	PEX12	0.601	0.615	C3550693	PEROXISOME BIOGENESIS DISORDER 3B	disease	C16;C18	Disease or Syndrome	0.6	1	1997	2017	4	34	GENOMICS_ENGLAND;UNIPROT
16538	5193	PEX12	0.601	0.615	C3553929	PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER)	disease	C16;C18	Disease or Syndrome	0.7	1	1997	2017	6	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
16543	5194	PEX13	0.597	0.654	C0282525	Adrenoleukodystrophy, Neonatal	disease	C16;C18	Disease or Syndrome	0.51	1	2005	2005	0	0	GENOMICS_ENGLAND;ORPHANET
16547	5194	PEX13	0.597	0.654	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.54	1	1998	2017	4	0	CTD_human;GENOMICS_ENGLAND
16549	5194	PEX13	0.597	0.654	C3554000	PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	disease		Disease or Syndrome	0.6	1	2009	2016	5	4	CTD_human;GENOMICS_ENGLAND
16550	5194	PEX13	0.597	0.654	C3554001	PEROXISOME BIOGENESIS DISORDER 11B	disease		Disease or Syndrome	0.7	1	1999	2015	6	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
16554	5195	PEX14	0.592	0.692	C0043459	Zellweger Syndrome	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.52	1	2004	2008	2	0	CTD_human;GENOMICS_ENGLAND
16558	5195	PEX14	0.592	0.692	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.52	1	2004	2016	4	0	CTD_human;GENOMICS_ENGLAND
16559	5195	PEX14	0.592	0.692	C3554004	PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	disease		Disease or Syndrome	0.6	1	2004	2016	5	1	CTD_human;GENOMICS_ENGLAND
16576	5199	CFP	0.573	0.692	C0398762	Properdin deficiency disease	disease		Disease or Syndrome	0.51	1	1980	2006	2	0	GENOMICS_ENGLAND;ORPHANET
16582	5199	CFP	0.573	0.692	C1839454	PROPERDIN DEFICIENCY, X-LINKED	disease	C16;C20	Disease or Syndrome	0.7	1	1995	2019	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16587	5205	ATP8B1	0.61	0.5	C0268318	Cholestasis of pregnancy	disease	C06;C13	Disease or Syndrome	0.58	1	2003	2017	1	0	CTD_human;ORPHANET
16589	5205	ATP8B1	0.61	0.5	C3549845	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1	disease		Disease or Syndrome	0.6	1	2005	2016	4	4	GENOMICS_ENGLAND;UNIPROT
16590	5205	ATP8B1	0.61	0.5	C4551898	Cholestasis, progressive familial intrahepatic 1	disease	C06	Disease or Syndrome	0.8	0.978	1996	2018	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
16591	5205	ATP8B1	0.61	0.5	C4551899	Cholestasis, benign recurrent intrahepatic 1	disease	C06	Disease or Syndrome	0.7	1	1998	2016	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16612	5213	PFKM	0.666	0.5	C0017926	Glycogen Storage Disease Type VII	disease	C16;C18;C05;C10	Disease or Syndrome	0.94	1	1990	2016	11	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16620	5216	PFN1	0.565	0.769	C3553719	AMYOTROPHIC LATERAL SCLEROSIS 18	disease		Disease or Syndrome	0.7	1	2012	2012	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
16648	5224	PGAM2	0.792	0.308	C0268149	Glycogen storage disease type X	disease	C13;C05;C12;C10	Disease or Syndrome	0.73	1	1993	2017	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16665	5230	PGK1	0.542	0.769	C1970848	Phosphoglycerate Kinase 1 Deficiency	disease	C16;C18	Disease or Syndrome	0.77	1	1980	2019	11	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16675	5236	PGM1	0.628	0.577	C2752015	Glycogen Storage Disease XIV	disease	C16;C18	Disease or Syndrome	0.7	1	2009	2016	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16682	5238	PGM3	0.61	0.769	C4014371	IMMUNODEFICIENCY 23	disease		Disease or Syndrome	0.7	1	2014	2015	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16692	5241	PGR	0.426	0.885	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.6	0.966	1995	2020	2	0	CTD_human
16750	5243	ABCB1	0.344	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.96	1990	2020	2	0	CTD_human;UNIPROT
16755	5243	ABCB1	0.344	0.885	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.6	0.908	1995	2019	2	0	CTD_human
16805	5243	ABCB1	0.344	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.54	0.833	2011	2019	1	0	CTD_human
16815	5243	ABCB1	0.344	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.96	1991	2019	1	0	CTD_human
16839	5244	ABCB4	0.529	0.615	C0268318	Cholestasis of pregnancy	disease	C06;C13	Disease or Syndrome	0.6	1	2000	2020	1	0	CTD_human;ORPHANET
16841	5244	ABCB4	0.529	0.615	C0566602	Primary sclerosing cholangitis	disease	C06	Disease or Syndrome	0.56	0.9	2004	2019	2	0	CTD_human
16844	5244	ABCB4	0.529	0.615	C1865643	Cholestasis, progressive familial intrahepatic 3	disease	C06	Disease or Syndrome	0.77	1	1998	2019	12	27	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16845	5244	ABCB4	0.529	0.615	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.59	1	1993	2017	1	0	CTD_human
16846	5244	ABCB4	0.529	0.615	C2609268	Low phospholipid-associated cholelithiasis	disease	C06	Disease or Syndrome	0.8	0.947	2001	2020	8	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16850	5244	ABCB4	0.529	0.615	C3554241	CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	disease		Disease or Syndrome	0.6	1	2000	2016	4	13	GENOMICS_ENGLAND;UNIPROT
16852	5244	ABCB4	0.529	0.615	C4551898	Cholestasis, progressive familial intrahepatic 1	disease	C06	Disease or Syndrome	0.7	1	1996	2020	1	4	CTD_human;GENOMICS_ENGLAND
16855	5245	PHB	0.511	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	0.944	1994	2018	0	2	CTD_human;UNIPROT
16885	5250	SLC25A3	0.566	0.692	C1835845	Mitochondrial Phosphate Carrier Deficiency	disease	C18	Disease or Syndrome	0.7	1	2007	2016	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16888	5251	PHEX	0.548	0.808	C0733682	Hypophosphatemic Rickets, X-Linked Dominant	disease	C16;C18;C13;C05;C12	Disease or Syndrome	1	0.976	1987	2020	14	79	CTD_human;GENOMICS_ENGLAND;UNIPROT
16891	5251	PHEX	0.548	0.808	C3536984	Vitamin D-Resistant Rickets, X-Linked	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.6	0.987	1988	2020	4	0	CTD_human;GENOMICS_ENGLAND
16892	5251	PHEX	0.548	0.808	C3540852	Rickets, X-Linked Hypophosphatemic	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.6	1	1988	2020	3	0	CTD_human
16894	5255	PHKA1	0.839	0.115	C1845151	Glycogen Storage Disease, Type IXD	disease	C16;C18	Disease or Syndrome	0.9	1	1970	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16895	5256	PHKA2	0.678	0.462	C0017919	Glycogen Storage Disease	group	C16;C18	Disease or Syndrome	0.6	1	1992	2017	2	0	CTD_human;GENOMICS_ENGLAND
16897	5256	PHKA2	0.678	0.462	C3694531	GLYCOGEN STORAGE DISEASE IXa1	disease		Disease or Syndrome	0.7	1	1994	2017	8	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
16900	5257	PHKB	0.769	0.269	C0543514	Glycogen Storage Disease IXB	disease	C16;C18	Disease or Syndrome	0.7	1	1997	2016	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16903	5261	PHKG2	0.674	0.538	C0017919	Glycogen Storage Disease	group	C16;C18	Disease or Syndrome	0.57	1	1996	2018	1	0	GENOMICS_ENGLAND
16904	5261	PHKG2	0.674	0.538	C2751643	Glycogen Storage Disease IXC	disease	C16;C18	Disease or Syndrome	0.71	1	1996	2018	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16906	5264	PHYH	0.659	0.577	C0034960	Refsum Disease	disease	C16;C18;C10	Disease or Syndrome	1	1	1984	2017	7	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
16913	5265	SERPINA1	0.41	0.923	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.51	1	2006	2015	2	0	CTD_human;PSYGENET
16925	5265	SERPINA1	0.41	0.923	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.6	0.983	1982	2019	1	0	CTD_human;GENOMICS_ENGLAND
16945	5265	SERPINA1	0.41	0.923	C0221757	alpha 1-Antitrypsin Deficiency	disease	C23;C16;C06;C08	Disease or Syndrome	0.7	0.978	1978	2020	6	45	CTD_human;GENOMICS_ENGLAND
16987	5269	SERPINB6	0.547	0.769	C3150704	DEAFNESS, AUTOSOMAL RECESSIVE 91	disease		Disease or Syndrome	0.6	1	1995	1995	1	1	CTD_human;GENOMICS_ENGLAND
16992	5271	SERPINB8	0.792	0.154	C1838440	ICHTHYOSIS EXFOLIATIVA	disease	C16;C17	Disease or Syndrome	0.51	1	2002	2016	2	0	CLINGEN;ORPHANET
17007	5274	SERPINI1	0.631	0.462	C1858680	Familial encephalopathy with neuroserpin inclusion bodies	disease	C16;C10	Disease or Syndrome	0.95	1	1999	2018	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17009	5277	PIGA	0.575	0.654	C0024790	Paroxysmal nocturnal hemoglobinuria	disease	C15	Disease or Syndrome	0.7	0.969	1993	2019	3	0	CTD_human;ORPHANET
17012	5277	PIGA	0.575	0.654	C3275508	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2	disease		Disease or Syndrome	0.71	1	2012	2018	9	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17013	5277	PIGA	0.575	0.654	C3806670	PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1	disease		Disease or Syndrome	0.6	1	1993	2002	5	10	GENOMICS_ENGLAND;UNIPROT
17015	5279	PIGC	0.691	0.346	C4540521	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16	disease		Disease or Syndrome	0.6	1	2017	2017	1	0	GENOMICS_ENGLAND;UNIPROT
17018	5283	PIGH	0.76	0.231	C4747891	GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17	disease		Disease or Syndrome	0.6	1	2018	2018	3	2	GENOMICS_ENGLAND;UNIPROT
17023	5290	PIK3CA	0.292	0.923	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1	0.985	2001	2020	9	8	CGI;CTD_human;UNIPROT
17028	5290	PIK3CA	0.292	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.7	0.985	2002	2020	2	11	CTD_human;UNIPROT
17037	5290	PIK3CA	0.292	0.923	C0022603	Seborrheic keratosis	disease	C17	Neoplastic Process	0.67	1	2007	2018	1	5	CTD_human;UNIPROT
17039	5290	PIK3CA	0.292	0.923	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.6	1	2003	2019	0	0	CGI;CTD_human
17040	5290	PIK3CA	0.292	0.923	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.7	0.992	2005	2020	1	0	CGI;CTD_human
17048	5290	PIK3CA	0.292	0.923	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.62	1	2005	2016	1	4	CGI;CTD_human
17067	5290	PIK3CA	0.292	0.923	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.6	0.967	2002	2019	0	0	CGI;CTD_human
17069	5290	PIK3CA	0.292	0.923	C0265552	Congenital macrodactylia	disease	C16;C05	Congenital Abnormality	0.67	1	2009	2020	2	3	GENOMICS_ENGLAND;UNIPROT
17086	5290	PIK3CA	0.292	0.923	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.7	0.987	2001	2020	8	0	CGI;CTD_human
17090	5290	PIK3CA	0.292	0.923	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.7	0.984	1999	2019	0	12	CGI;CTD_human
17092	5290	PIK3CA	0.292	0.923	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.7	0.986	1999	2019	1	2	CGI;CTD_human;UNIPROT
17107	5290	PIK3CA	0.292	0.923	C1865285	Megalencephaly cutis marmorata telangiectatica congenita	disease	C16;C17;C05;C10;C14	Disease or Syndrome	0.77	1	2009	2020	5	16	GENOMICS_ENGLAND;ORPHANET;UNIPROT
17109	5290	PIK3CA	0.292	0.923	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.8	0.966	2002	2020	1	11	CGI;CTD_human;UNIPROT
17110	5290	PIK3CA	0.292	0.923	C2751313	CLAPO Syndrome	disease	C16;C15;C14	Disease or Syndrome; Congenital Abnormality	0.6	1	2009	2018	2	5	GENOMICS_ENGLAND;UNIPROT
17111	5290	PIK3CA	0.292	0.923	C2752042	Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi	disease	C16;C04;C05;C14	Disease or Syndrome	0.95	1	2009	2017	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17115	5290	PIK3CA	0.292	0.923	C3554518	COWDEN SYNDROME 5	disease		Disease or Syndrome	0.7	1	2005	2013	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
17152	5293	PIK3CD	0.319	0.885	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.6	1	2005	2019	1	0	CGI;CTD_human
17158	5293	PIK3CD	0.319	0.885	C3714976	ACTIVATED PI3K-DELTA SYNDROME	disease	C16;C20	Disease or Syndrome	0.8	1	2006	2020	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17184	5295	PIK3R1	0.477	0.885	C0021655	Insulin Resistance	phenotype	C18	Pathologic Function	0.6	1	1999	2003	1	0	CTD_human
17194	5295	PIK3R1	0.477	0.885	C0343640	African Burkitts lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     5295	PIK3R1	0.477	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.35	1	2010	2019	   2	   0	CTD_human
     5295	PIK3R1	0.477	0.885	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     5295	PIK3R1	0.477	0.885	C0496920	Neoplasm of uncertain or unknown behavior of ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     5295	PIK3R1	0.477	0.885	C0878684	SHORT syndrome	disease	C23;C18;C13;C12	Disease or Syndrome	0.80	0.955	2000	2019	   7	  12	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5295	PIK3R1	0.477	0.885	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	CGI
     5295	PIK3R1	0.477	0.885	C0920563	Insulin Sensitivity	phenotype	C18	Pathologic Function	0.30	1	2003	2003	   1	   0	CTD_human
     5295	PIK3R1	0.477	0.885	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.31	1	2019	2019	   0	   0	CGI
     5295	PIK3R1	0.477	0.885	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2003	2003	   1	   0	CTD_human
     5295	PIK3R1	0.477	0.885	C1319315	Adenocarcinoma of large intestine	disease	C06;C04	Neoplastic Process	0.30				   0	   0	CGI
     5295	PIK3R1	0.477	0.885	C1621958	Glioblastoma Multiforme	disease	C04	Neoplastic Process	0.35	0.8	2004	2012	   0	   0	CGI
     5295	PIK3R1	0.477	0.885	C1832241	Agammaglobulinemia, non-Bruton type	disease	C20;C15	Disease or Syndrome	0.30	1	2012	2012	   1	   0	ORPHANET
     5295	PIK3R1	0.477	0.885	C3554689	AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.60	1	2012	2017	   2	   5	CTD_human;GENOMICS_ENGLAND
     5295	PIK3R1	0.477	0.885	C3714976	ACTIVATED PI3K-DELTA SYNDROME	disease	C16;C20	Disease or Syndrome	0.33	1	2014	2017	   1	   0	ORPHANET
     5295	PIK3R1	0.477	0.885	C4014934	IMMUNODEFICIENCY 36	disease		Disease or Syndrome	0.60	1	2012	2018	   2	   7	CTD_human;GENOMICS_ENGLAND
     5295	PIK3R1	0.477	0.885	C4721444	Burkitt Leukemia	disease	C04;C01;C20;C15	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     5296	PIK3R2	0.551	0.808	C0007103	Malignant neoplasm of endometrium	disease	C04;C13	Neoplastic Process	0.32	1	2011	2011	   0	   0	CGI
     5296	PIK3R2	0.551	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     5296	PIK3R2	0.551	0.808	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     5296	PIK3R2	0.551	0.808	C0346191	Carcinoma in situ of endometrium	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
     5296	PIK3R2	0.551	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.34	1	2016	2019	   1	   0	CTD_human
     5296	PIK3R2	0.551	0.808	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.32	1	2011	2011	   0	   0	CGI
     5296	PIK3R2	0.551	0.808	C1153706	Endometrial adenocarcinoma	disease	C04;C13	Neoplastic Process	0.30				   0	   0	CGI
     5296	PIK3R2	0.551	0.808	C1863924	Megalanecephaly Polymicrogyria-Polydactyly Hydrocephalus Syndrome	disease	C16;C05;C10	Disease or Syndrome	0.50	1	2012	2015	   2	   0	CTD_human;ORPHANET
     5296	PIK3R2	0.551	0.808	C4012727	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 1	disease	C16;C05;C10	Disease or Syndrome	0.60	1	2006	2017	   5	   5	GENOMICS_ENGLAND;UNIPROT
     5297	PI4KA	0.695	0.577	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.33	0.75	2008	2014	   4	   0	PSYGENET
     5297	PI4KA	0.695	0.577	C1845668	Perisylvian syndrome	disease	C23;C16;C10;F03;F01	Congenital Abnormality	0.30	1	2015	2015	   1	   0	ORPHANET
     5297	PI4KA	0.695	0.577	C4225295	POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS	disease		Disease or Syndrome	0.60	1	2015	2015	   1	   2	GENOMICS_ENGLAND;UNIPROT
     5300	PIN1	0.488	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.944	2001	2019	   2	   0	CTD_human
     5300	PIN1	0.488	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.943	2001	2019	   2	   0	CTD_human
     5300	PIN1	0.488	0.769	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   2	   0	CTD_human
     5300	PIN1	0.488	0.769	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.34	1	2002	2012	   2	   0	CTD_human
     5300	PIN1	0.488	0.769	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2009	   2	   0	CTD_human
     5304	PIP	0.556	0.808	C0037199	Sinusitis	disease	C01;C08;C09	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5305	PIP4K2A	0.647	0.423	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.33	0.667	2005	2007	   3	   0	PSYGENET
     5305	PIP4K2A	0.647	0.423	C0006413	Burkitt Lymphoma	disease	C04;C01;C20;C15	Neoplastic Process	0.30	1	2013	2013	   1	   0	ORPHANET
     5305	PIP4K2A	0.647	0.423	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     5305	PIP4K2A	0.647	0.423	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.75	2005	2014	   4	   0	PSYGENET
     5305	PIP4K2A	0.647	0.423	C1292769	Precursor B-cell lymphoblastic leukemia	disease	C04;C20;C15	Neoplastic Process	0.30	1	2013	2013	   1	   0	ORPHANET
     5307	PITX1	0.561	0.654	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	CTD_human
     5307	PITX1	0.561	0.654	C0009081	Congenital clubfoot	disease	C16;C05	Congenital Abnormality	0.97	0.889	2008	2019	   4	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5307	PITX1	0.561	0.654	C0152427	Polydactyly	disease	C16;C05	Congenital Abnormality	0.33	1	2012	2019	   1	   0	GENOMICS_ENGLAND
     5307	PITX1	0.561	0.654	C1336708	Testicular Germ Cell Tumor	disease	C04;C12;C19	Neoplastic Process	0.41	1	2013	2013	   1	   1	CTD_human
     5307	PITX1	0.561	0.654	C1851100	LAURIN-SANDROW SYNDROME	disease	C16;C05	Disease or Syndrome	0.31	1	2012	2012	   1	   0	ORPHANET
     5307	PITX1	0.561	0.654	C1861313	Synostosis, Carpal, with Dysplastic Elbow Joints and Brachydactyly	disease	C16;C05	Disease or Syndrome	0.62	1	2012	2014	   2	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5307	PITX1	0.561	0.654	C1861316	Radially deviated wrists	phenotype		Finding	0.40				   0	   0	GENOMICS_ENGLAND
     5307	PITX1	0.561	0.654	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2011	2017	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.50	0.956	2010	2019	   1	   1	CTD_human
     5308	PITX2	0.489	0.808	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5308	PITX2	0.489	0.808	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.37	1	2012	2019	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C0040427	Tooth Abnormalities	group	C16;C07	Anatomical Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C0086543	Cataract	disease	C11	Acquired Abnormality	0.31	1	1998	1998	   0	   0	GENOMICS_ENGLAND
     5308	PITX2	0.489	0.808	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.31	1	2014	2018	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C0265341	Rieger syndrome	disease	C16;C11	Disease or Syndrome	0.50	1	1998	2018	   2	   1	ORPHANET
     5308	PITX2	0.489	0.808	C0266548	Axenfeld anomaly (disorder)	disease	C16;C11	Congenital Abnormality	0.33	1	2000	2014	   2	   0	ORPHANET
     5308	PITX2	0.489	0.808	C0344559	Irido-corneo-trabecular dysgenesis (disorder)	disease	C16;C11	Congenital Abnormality	0.61	1	1999	1999	   1	   0	GENOMICS_ENGLAND;ORPHANET
     5308	PITX2	0.489	0.808	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1999	2003	   2	   0	CTD_human
     5308	PITX2	0.489	0.808	C0524730	Odontome	disease	C16;C07	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.40				   0	   0	GENOMICS_ENGLAND
     5308	PITX2	0.489	0.808	C1842031	IRIDOGONIODYSGENESIS, TYPE 2	disease	C16;C11;C07	Disease or Syndrome	0.73	1	1996	2011	   6	   4	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5308	PITX2	0.489	0.808	C1843687	ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder)	disease	C23;C14	Disease or Syndrome	0.40	1	2014	2014	   1	   1	ORPHANET
     5308	PITX2	0.489	0.808	C1867155	RING DERMOID OF CORNEA	disease	C04;C11	Disease or Syndrome	0.70	1	2001	2012	   3	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5308	PITX2	0.489	0.808	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     5308	PITX2	0.489	0.808	C3495488	Axenfeld-Rieger syndrome	disease	C16;C11	Disease or Syndrome	0.60	1	1998	2019	   1	   0	GENOMICS_ENGLAND;ORPHANET
     5308	PITX2	0.489	0.808	C3714873	Axenfeld-Rieger Syndrome, Type 1	disease	C16;C11	Disease or Syndrome	0.91	1	1996	2006	  10	  15	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5308	PITX2	0.489	0.808	C4310809	ANTERIOR SEGMENT DYSGENESIS 5	disease		Disease or Syndrome	0.30	1	2001	2001	   1	   0	GENOMICS_ENGLAND
     5309	PITX3	0.585	0.692	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.31	1	2004	2004	   1	   0	PSYGENET
     5309	PITX3	0.585	0.692	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     5309	PITX3	0.585	0.692	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30	1	2010	2010	   1	   0	GENOMICS_ENGLAND
     5309	PITX3	0.585	0.692	C0026010	Microphthalmos	disease	C16;C11	Congenital Abnormality	0.44	1	2006	2012	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0027643	Neoplasm Recurrence, Local	phenotype	C23;C04	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0027854	Neurologic Manifestations	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2010	2017	   1	   0	PSYGENET
     5309	PITX3	0.585	0.692	C0086543	Cataract	disease	C11	Acquired Abnormality	0.50	1	1998	2019	   2	   0	CTD_human
     5309	PITX3	0.585	0.692	C0178417	Anhedonia	disease	C23;C10;F01	Mental or Behavioral Dysfunction	0.30	1	2014	2014	   1	   0	PSYGENET
     5309	PITX3	0.585	0.692	C0235031	Neurologic Symptoms	group	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2016	2016	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0422837	Neurological observations	group	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0521654	Neurologic Deficits	group	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0524524	Pseudoaphakia	disease	C11	Disease or Syndrome	0.30	1	1998	2006	   2	   0	CTD_human
     5309	PITX3	0.585	0.692	C0746857	Focal Neurologic Deficits	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0751377	Neurologic Dysfunction	phenotype	C23;C10	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0751378	Neurologic Signs	phenotype	C23;C10	Sign or Symptom	0.30	1	2006	2006	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C0858617	Posterior subcapsular cataract	disease	C11	Disease or Syndrome	0.31	1	2006	2019	   2	   0	ORPHANET
     5309	PITX3	0.585	0.692	C1510497	Lens Opacities	phenotype	C11	Finding	0.30	1	1998	2006	   2	   0	CTD_human
     5309	PITX3	0.585	0.692	C1858679	CATARACT, AUTOSOMAL DOMINANT	disease	C11	Disease or Syndrome	0.30	1	2004	2004	   1	   0	GENOMICS_ENGLAND
     5309	PITX3	0.585	0.692	C1862839	Anterior segment mesenchymal dysgenesis	disease	C16;C11	Disease or Syndrome	0.75	1	1998	2012	   2	   0	CTD_human;GENOMICS_ENGLAND
     5309	PITX3	0.585	0.692	C1864567	CATARACT, POSTERIOR POLAR, 4 (disorder)	disease	C11	Disease or Syndrome	0.70	1	1998	2014	   3	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5309	PITX3	0.585	0.692	C1970386	Cataract, Posterior Polar, 4, With Microphthalmia And Neurodevelopmental Abnormalities	disease	C11	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     5309	PITX3	0.585	0.692	C4551992	ANTERIOR SEGMENT DYSGENESIS 1	disease	C16;C11	Disease or Syndrome	0.60	1	2004	2014	   2	   1	GENOMICS_ENGLAND
     5310	PKD1	0.493	0.769	C0009782	Connective Tissue Diseases	group	C17	Disease or Syndrome	0.31	1	2000	2011	   1	   0	GENOMICS_ENGLAND
     5310	PKD1	0.493	0.769	C0010709	Cyst	disease	C23;C04	Disease or Syndrome	0.40	1	1990	2019	   1	   0	CTD_human
     5310	PKD1	0.493	0.769	C0022680	Polycystic Kidney Diseases	group	C16;C13;C12	Disease or Syndrome	0.90	0.976	1990	2019	  14	  23	CLINGEN;CTD_human
     5310	PKD1	0.493	0.769	C0085413	Polycystic Kidney, Autosomal Dominant	disease	C16;C13;C12	Disease or Syndrome	0.90	0.979	1988	2020	  16	   1	CLINGEN;CTD_human
     5310	PKD1	0.493	0.769	C0887850	Polycystic Kidney, Type 1 Autosomal Dominant Disease	disease	C16;C13;C12	Congenital Abnormality	0.30	1	1994	2017	   6	   0	CTD_human
     5310	PKD1	0.493	0.769	C1567435	Polycystic Kidney - body part	disease	C16;C13;C12	Anatomical Abnormality	0.35	1	1998	2017	   3	   0	CTD_human
     5310	PKD1	0.493	0.769	C1838327	Polycystic kidneys, severe infantile with tuberous sclerosis	disease	C16;C04;C13;C12;C10	Disease or Syndrome	0.30	1	2004	2011	   2	   0	ORPHANET
     5310	PKD1	0.493	0.769	C2751306	Polycystic kidney disease, type 2	disease	C16;C13;C12	Disease or Syndrome	0.37	1	1994	2018	   6	   0	CTD_human
     5310	PKD1	0.493	0.769	C3149841	POLYCYSTIC KIDNEY DISEASE 1	disease	C16;C13;C12	Disease or Syndrome	1.00	0.986	1992	2018	  43	 133	CLINGEN;GENOMICS_ENGLAND;UNIPROT
     5310	PKD1	0.493	0.769	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5311	PKD2	0.552	0.731	C0009782	Connective Tissue Diseases	group	C17	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5311	PKD2	0.552	0.731	C0022680	Polycystic Kidney Diseases	group	C16;C13;C12	Disease or Syndrome	0.70	0.963	1996	2019	  12	   4	CLINGEN
     5311	PKD2	0.552	0.731	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     5311	PKD2	0.552	0.731	C0035309	Retinal Diseases	group	C11	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     5311	PKD2	0.552	0.731	C0042373	Vascular Diseases	group	C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     5311	PKD2	0.552	0.731	C0085413	Polycystic Kidney, Autosomal Dominant	disease	C16;C13;C12	Disease or Syndrome	1.00	0.984	1994	2020	  20	  13	CLINGEN;CTD_human;GENOMICS_ENGLAND
     5311	PKD2	0.552	0.731	C0270715	Degenerative Diseases, Central Nervous System	group	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     5311	PKD2	0.552	0.731	C0524851	Neurodegenerative Disorders	group	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     5311	PKD2	0.552	0.731	C0751733	Degenerative Diseases, Spinal Cord	group	C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     5311	PKD2	0.552	0.731	C0887850	Polycystic Kidney, Type 1 Autosomal Dominant Disease	disease	C16;C13;C12	Congenital Abnormality	0.30	1	2002	2019	   6	   0	CTD_human
     5311	PKD2	0.552	0.731	C2751306	Polycystic kidney disease, type 2	disease	C16;C13;C12	Disease or Syndrome	0.97	1	1995	2019	  23	  32	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5311	PKD2	0.552	0.731	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     5311	PKD2	0.552	0.731	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5313	PKLR	0.603	0.615	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
     5313	PKLR	0.603	0.615	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2006	2010	   1	   0	CTD_human
     5313	PKLR	0.603	0.615	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     5313	PKLR	0.603	0.615	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2010	2010	   1	   0	CTD_human
     5313	PKLR	0.603	0.615	C0340968	Deficiency of pyruvate kinase	disease	C16;C18;C15	Disease or Syndrome	1.00	1	1991	2019	  20	  61	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5313	PKLR	0.603	0.615	C0520572	Enzymopathy	group	C18	Disease or Syndrome	0.30	1	1991	1996	   2	   0	GENOMICS_ENGLAND
     5313	PKLR	0.603	0.615	C1863224	Adenosine Triphosphate, Elevated, Of Erythrocytes	disease	C15	Disease or Syndrome	0.60	1	1997	1997	   1	   3	CTD_human;UNIPROT
     5313	PKLR	0.603	0.615	C4551637	Erythrocytosis familial, 1	disease	C15	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     5314	PKHD1	0.576	0.654	C0008340	Choledochal Cyst	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     5314	PKHD1	0.576	0.654	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.31	1	2011	2011	   0	   2	UNIPROT
     5314	PKHD1	0.576	0.654	C0009439	Choledochal Cyst, Type I	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     5314	PKHD1	0.576	0.654	C0085548	Autosomal Recessive Polycystic Kidney Disease	disease	C16;C13;C12	Disease or Syndrome	1.00	1	1975	2019	  14	 293	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5314	PKHD1	0.576	0.654	C0162510	Caroli Disease	disease	C16;C06	Disease or Syndrome; Congenital Abnormality	0.34	1	2004	2017	   2	   0	ORPHANET
     5314	PKHD1	0.576	0.654	C1257796	Choledochal Cyst, Type II	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     5314	PKHD1	0.576	0.654	C1257797	Choledochal Cyst, Type III	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     5314	PKHD1	0.576	0.654	C1257798	Choledochal Cyst, Type IV	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     5314	PKHD1	0.576	0.654	C1257799	Choledochal Cyst, Type V	disease	C16;C06;C04	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     5314	PKHD1	0.576	0.654	C1833541	Caroli disease isolated	disease	C16;C06	Disease or Syndrome	0.30	1	2014	2015	   2	   0	ORPHANET
     5314	PKHD1	0.576	0.654	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.32	1	2015	2019	   0	   0	GENOMICS_ENGLAND
     5315	PKM	0.482	0.808	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.33	1	2005	2016	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2005	2005	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2004	2005	   2	   0	CTD_human
     5315	PKM	0.482	0.808	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     5315	PKM	0.482	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	1	1998	2020	   1	   0	CTD_human
     5316	PKNOX1	0.674	0.538	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   1	UNIPROT
     5317	PKP1	0.659	0.462	C1858302	Ectodermal dysplasia/ skin fragility syndrome	disease	C16;C17	Disease or Syndrome	0.78	1	1997	2013	   3	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5317	PKP1	0.659	0.462	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     5318	PKP2	0.606	0.538	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.40	1	2017	2018	   2	   2	CTD_human
     5318	PKP2	0.606	0.538	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.31	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     5318	PKP2	0.606	0.538	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   2	   0	CTD_human
     5318	PKP2	0.606	0.538	C0264893	Nodal rhythm disorder	phenotype	C23;C14	Disease or Syndrome	0.30	1	1996	2015	   8	   0	CLINGEN
     5318	PKP2	0.606	0.538	C0348626	Other specified cardiac arrhythmias	phenotype	C23;C14	Disease or Syndrome	0.30	1	1996	2015	   8	   0	CLINGEN
     5318	PKP2	0.606	0.538	C0349788	Arrhythmogenic Right Ventricular Dysplasia	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.50	0.974	1985	2019	   3	  49	GENOMICS_ENGLAND
     5318	PKP2	0.606	0.538	C0428908	Sinus Node Dysfunction (disorder)	disease	C23;C14	Disease or Syndrome	0.30	1	1996	2015	   8	   0	CLINGEN
     5318	PKP2	0.606	0.538	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.50	1	2006	2019	   0	   8	GENOMICS_ENGLAND
     5318	PKP2	0.606	0.538	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.65	1	1996	2016	  10	   0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
     5318	PKP2	0.606	0.538	C1399226	Ectopic rhythm	phenotype	C23;C14	Disease or Syndrome	0.30	1	1996	2015	   8	   0	CLINGEN
     5318	PKP2	0.606	0.538	C1836906	Arrhythmogenic Right Ventricular Dysplasia, Familial, 9	disease	C16;C14	Disease or Syndrome	0.70	1	1996	2017	  16	  66	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
     5318	PKP2	0.606	0.538	C1960469	Left ventricular noncompaction	disease	C14	Disease or Syndrome	0.30	1	2017	2017	   1	   0	ORPHANET
     5318	PKP2	0.606	0.538	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
     5318	PKP2	0.606	0.538	C2748542	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	disease	C16;C14	Disease or Syndrome	0.30	1	1996	2015	   8	   0	CLINGEN
     5318	PKP2	0.606	0.538	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   2	   0	CTD_human
     5318	PKP2	0.606	0.538	C4551804	Brugada Syndrome 1	disease	C16;C14	Disease or Syndrome	0.30	1	1996	2015	   8	   0	CLINGEN
     5319	PLA2G1B	0.468	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.35	0.6	1995	2006	   5	   0	PSYGENET
     5319	PLA2G1B	0.468	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	1	1997	2019	   3	   0	PSYGENET
     5319	PLA2G1B	0.468	0.846	C0338715	Drug-induced depressive state	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	PSYGENET
     5319	PLA2G1B	0.468	0.846	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.32	1	1996	2003	   2	   0	PSYGENET
     5320	PLA2G2A	0.488	0.808	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.40	1	1999	2018	   1	   0	CTD_human
     5320	PLA2G2A	0.488	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2003	2011	   2	   0	PSYGENET
     5320	PLA2G2A	0.488	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2013	   1	   0	PSYGENET
     5320	PLA2G2A	0.488	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.31	1	2015	2016	   1	   0	CTD_human
     5320	PLA2G2A	0.488	0.808	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.30	1	2003	2003	   1	   0	CTD_human
     5320	PLA2G2A	0.488	0.808	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5320	PLA2G2A	0.488	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.32	1	2015	2016	   1	   0	CTD_human
     5320	PLA2G2A	0.488	0.808	C0349218	Recurrent depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2012	2012	   1	   0	PSYGENET
     5320	PLA2G2A	0.488	0.808	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.31	1	1999	2005	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2004	2017	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.32	0.5	2003	2011	   2	   0	PSYGENET
     5321	PLA2G4A	0.496	0.846	C0005818	Blood Platelet Disorders	group	C15	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.55	1	2010	2019	   1	   1	CTD_human;UNIPROT
     5321	PLA2G4A	0.496	0.846	C0010474	Curling Ulcer	disease	C06	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0011603	Dermatitis	disease	C17	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0013295	Duodenal Ulcer	disease	C06	Disease or Syndrome	0.41	1	2008	2014	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2007	2014	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0025521	Inborn Errors of Metabolism	group	C16;C18	Disease or Syndrome; Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0036337	Schizoaffective Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	PSYGENET
     5321	PLA2G4A	0.496	0.846	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	0.8	1996	2019	   5	   0	PSYGENET
     5321	PLA2G4A	0.496	0.846	C0264423	Asthma, Occupational	disease	C08;C20;C24	Disease or Syndrome	0.30	1	2017	2017	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0393554	Amyotrophic Lateral Sclerosis With Dementia	disease	C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0543859	Amyotrophic Lateral Sclerosis, Guam Form	disease	C18;C10	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.35	1	2010	2019	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     5321	PLA2G4A	0.496	0.846	C4016672	PHOSPHOLIPASE A2, GROUP IV A, DEFICIENCY OF	disease		Finding	0.30	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     5321	PLA2G4A	0.496	0.846	C4302263	Cryptogenic multifocal ulcerous stenosing enteritis	disease		Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
     5321	PLA2G4A	0.496	0.846	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     5322	PLA2G5	0.751	0.385	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5322	PLA2G5	0.751	0.385	C1856718	Fleck Retina, Familial Benign	disease	C16;C11	Disease or Syndrome	0.70	1	2011	2011	   1	   5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5324	PLAG1	0.493	0.808	C0175693	Russell-Silver syndrome	disease	C16;C05	Disease or Syndrome	0.40	1	2018	2018	   1	   2	GENOMICS_ENGLAND
     5324	PLAG1	0.493	0.808	C0334475	Lipoblastomatosis	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5324	PLAG1	0.493	0.808	C0473935	Radiolabeled somatostatin analog study	phenotype		Diagnostic Procedure	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
     5324	PLAG1	0.493	0.808	C0796160	MENTAL RETARDATION, X-LINKED, SNYDER-ROBINSON TYPE	disease	C16;C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
     5324	PLAG1	0.493	0.808	C1260965	Lipoblastoma	disease	C04	Neoplastic Process	0.40	1	2000	2020	   1	   0	CTD_human
     5324	PLAG1	0.493	0.808	C1519176	Salivary Gland Pleomorphic Adenoma	disease	C04;C07	Neoplastic Process	0.60	0.941	1996	2019	   2	   0	CTD_human;ORPHANET
     5325	PLAGL1	0.566	0.769	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.31	1	2006	2014	   1	   0	CTD_human
     5325	PLAGL1	0.566	0.769	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5325	PLAGL1	0.566	0.769	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5325	PLAGL1	0.566	0.769	C1832386	Diabetes Mellitus, Transient Neonatal, 1	disease	C16;C18;C19	Disease or Syndrome	0.36	1	2000	2012	   2	   0	ORPHANET
     5325	PLAGL1	0.566	0.769	C4749378	Paternal uniparental disomy of chromosome 6	disease		Disease or Syndrome	0.30				   0	   0	ORPHANET
     5327	PLAT	0.445	0.885	C0001125	Acidosis, Lactic	phenotype	C18	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0001883	Airway Obstruction	group	C08	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0002994	Angioedema	phenotype	C17;C20;C14	Pathologic Function	0.30	1	2005	2010	   3	   0	CTD_human
     5327	PLAT	0.445	0.885	C0003129	Anoxemia	phenotype	C23	Sign or Symptom	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0003130	Anoxia	phenotype	C23	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0003537	Aphasia	disease	C23;C10	Mental or Behavioral Dysfunction	0.31	1	2003	2018	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0003546	Aphasia, Acquired	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0003838	Arterial Occlusive Diseases	group	C14	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.36	1	1995	2010	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0004604	Back Pain	phenotype	C23	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0004610	Bacteremia	disease	C23;C01	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0007177	Cardiac Tamponade	disease	C14	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0007781	Intracranial Embolism and Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1993	1995	   2	   0	CTD_human
     5327	PLAT	0.445	0.885	C0007785	Cerebral Infarction	disease	C23;C10;C14	Disease or Syndrome	0.39	1	1991	2019	   6	   0	CTD_human
     5327	PLAT	0.445	0.885	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.31	1	1995	2018	  24	   0	CTD_human
     5327	PLAT	0.445	0.885	C0008301	Choking	phenotype	C08	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0010072	Coronary Thrombosis	disease	C14	Disease or Syndrome	0.32	1	1988	2004	   3	   0	CTD_human
     5327	PLAT	0.445	0.885	C0013922	Embolism	phenotype	C14	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.31	1	2009	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0018946	Hematoma, Subdural	phenotype	C23;C10;C14;C26	Pathologic Function	0.30	1	1991	1991	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0018989	Hemiparesis	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0019064	Hemopericardium	phenotype	C14	Pathologic Function	0.30	1	1998	1998	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0019080	Hemorrhage	phenotype	C23	Pathologic Function	0.30	1	1989	2012	   8	   0	CTD_human
     5327	PLAT	0.445	0.885	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.38	1	2001	2019	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1992	1992	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0023212	Left-Sided Heart Failure	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2010	2014	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0024031	Low Back Pain	phenotype	C23	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0025309	Meningoencephalitis	disease	C01;C10	Disease or Syndrome	0.30	1	1992	1992	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.40	0.978	1986	2019	  33	   0	CTD_human
     5327	PLAT	0.445	0.885	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0030552	Paresis	phenotype	C23;C10	Disease or Syndrome	0.31	1	2003	2018	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0031039	Pericardial effusion	disease	C14	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0034065	Pulmonary Embolism	disease	C08;C14	Pathologic Function	0.30	1	1987	2009	   9	   0	CTD_human
     5327	PLAT	0.445	0.885	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	1998	2004	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0035229	Respiratory Insufficiency	phenotype	C08	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.32	1	2011	2018	   1	   0	PSYGENET
     5327	PLAT	0.445	0.885	C0036980	Shock, Cardiogenic	phenotype	C23;C14	Pathologic Function	0.30	1	1992	1992	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0037926	Compression of spinal cord	disease	C10;C26	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.40	0.973	1989	2020	  58	   0	CTD_human
     5327	PLAT	0.445	0.885	C0040038	Thromboembolism	phenotype	C14	Pathologic Function	0.30	1	1993	1993	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0040053	Thrombosis	phenotype	C14	Pathologic Function	0.32	1	1990	2012	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0042487	Venous Thrombosis	phenotype	C14	Pathologic Function	0.30	1	2000	2009	   3	   0	CTD_human
     5327	PLAT	0.445	0.885	C0079102	Cerebral Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0085307	Embolism and Thrombosis	disease	C14	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0087086	Thrombus	phenotype	C14	Pathologic Function	0.30	1	1990	2012	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0149504	Encephalopathy, Toxic	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0149649	Cholesterol Embolism	disease	C14	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0149871	Deep Vein Thrombosis	disease	C14	Disease or Syndrome	0.33	1	2000	2019	   3	   0	CTD_human
     5327	PLAT	0.445	0.885	C0151699	Intracranial Hemorrhage	group	C23;C10;C14	Pathologic Function	0.30	1	1988	2010	  14	   0	CTD_human
     5327	PLAT	0.445	0.885	C0154659	Toxic Encephalitis	disease	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0162820	Dermatitis, Allergic Contact	disease	C17;C20	Disease or Syndrome	0.31	1	2007	2013	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0234462	Aphasia, Ageusic	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0234469	Aphasia, Global	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0234472	Aphasia, Functional	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0234474	Aphasia, Graphomotor	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0234476	Aphasia, Intellectual	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0234482	Aphasia, Semantic	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0234484	Aphasia, Syntactical	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0235032	Neurotoxicity Syndromes	group	C10;C25	Injury or Poisoning	0.30	1	2009	2009	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0235063	Respiratory Depression	phenotype	C08	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0235527	Heart Failure, Right-Sided	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0236733	Amphetamine-Related Disorders	group	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0236804	Amphetamine Addiction	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0236807	Amphetamine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0238281	Middle Cerebral Artery Syndrome	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0242184	Hypoxia	phenotype	C23	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0242426	Chylopericardium	disease	C14	Disease or Syndrome	0.30	1	1998	1998	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0242698	Ventricular Dysfunction, Left	phenotype	C14	Pathologic Function	0.30	1	1996	1996	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0265110	Cerebral Vasospasm	disease	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0270795	Monoparesis	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0338457	Aphasia, Progressive	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0393953	Anterior Cerebral Circulation Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0423682	Low Back Pain, Mechanical	disease	C23	Disease or Syndrome	0.30	1	1995	1995	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0423689	Low Back Pain, Posterior Compartment	phenotype	C23	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0438921	Back Pain without Radiation	phenotype	C23	Finding	0.30	1	2002	2002	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0454576	Aphasia, Mixed	disease	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0524702	Pulmonary Thromboembolisms	disease	C08;C14	Disease or Syndrome	0.31	1	1987	2018	   9	   0	CTD_human
     5327	PLAT	0.445	0.885	C0553692	Brain hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	1988	2010	  14	   0	CTD_human
     5327	PLAT	0.445	0.885	C0577660	Low Back Pain, Postural	phenotype	C23	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0740363	Back Pain with Radiation	phenotype	C23	Sign or Symptom	0.30	1	2002	2002	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0740376	Middle Cerebral Artery Thrombosis	disease	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0740391	Middle Cerebral Artery Occlusion	disease	C23;C10;C14	Acquired Abnormality	0.34	1	2002	2019	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0740392	Infarction, Middle Cerebral Artery	disease	C23;C10;C14	Disease or Syndrome	0.50	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0742803	Conus Medullaris Syndrome	disease	C10;C26	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0750917	Aphasia, Auditory Discriminatory	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0750918	Aphasia, Commisural	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0750919	Aphasia, Post-Ictal	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0750920	Aphasia, Post-Traumatic	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0750921	Dejerine-Lichtheim Phenomenon	phenotype	C23;C10	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0750949	Vertebrogenic Pain Syndrome	phenotype	C23	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751010	Cerebral Infarction, Left Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	1991	2008	   6	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751011	Cerebral Infarction, Right Hemisphere	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	1991	2008	   6	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751012	Anterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	1991	2008	   6	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751014	Subcortical Infarction	disease	C23;C10;C14	Disease or Syndrome	0.30	1	1991	2008	   6	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751409	Upper Extremity Paresis	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751410	Lower Extremity Paresis	phenotype	C23;C10	Sign or Symptom	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751648	Recurrent Low Back Pain	phenotype	C23	Sign or Symptom	0.30	1	1995	1995	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751845	Middle Cerebral Artery Embolus	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751846	Left Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751847	Embolic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751848	Thrombotic Infarction, Middle Cerebral Artery	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751849	Right Middle Cerebral Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2002	2010	   4	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751893	Posterior Fossa Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.30	1	1988	2010	  14	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751895	Vasospasm, Intracranial	disease	C10;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751952	Anterior Circulation Brain Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751953	Brain Infarction, Posterior Circulation	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751954	Venous Infarction, Brain	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751955	Brain Infarction	disease	C23;C10;C14	Disease or Syndrome	0.31	1	2005	2020	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.36	1	1989	2019	  58	   0	CTD_human
     5327	PLAT	0.445	0.885	C0752143	Intracranial Thrombosis	disease	C10;C14	Disease or Syndrome	0.33	1	1996	2020	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0752144	Brain Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0877172	Hematoma, Epidural, Spinal	phenotype	C23	Pathologic Function	0.30	1	2000	2002	   2	   0	CTD_human
     5327	PLAT	0.445	0.885	C0877855	Cerebral Embolism and Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1993	1995	   2	   0	CTD_human
     5327	PLAT	0.445	0.885	C0887799	Posterior Choroidal Artery Infarction	phenotype	C23;C10;C14	Disease or Syndrome	0.30	1	1991	2008	   6	   0	CTD_human
     5327	PLAT	0.445	0.885	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	1995	2011	  24	   0	CTD_human
     5327	PLAT	0.445	0.885	C0936247	Brain Embolism and Thrombosis	disease	C10;C14	Disease or Syndrome	0.30	1	1993	1995	   2	   0	CTD_human
     5327	PLAT	0.445	0.885	C0936261	Brain Thrombus	disease	C10;C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0936263	Cerebral Thrombus	disease	C10;C14	Disease or Syndrome	0.30	1	1996	1996	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C0973461	Dysphasia	disease	C23;C10	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C1145670	Respiratory Failure	disease	C08	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C1704212	Embolus	phenotype	C14	Finding	0.30	1	2005	2005	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C1861172	Venous Thromboembolism	phenotype	C14	Disease or Syndrome	0.32	1	2005	2017	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C1959583	Myocardial Failure	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C1961112	Heart Decompensation	phenotype	C14	Pathologic Function	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C2676721	Thrombophilia, Familial, Due To Decreased Release Of Tissue Plasminogen Activator	disease	C15	Disease or Syndrome	0.50				   0	   0	CTD_human;GENOMICS_ENGLAND
     5327	PLAT	0.445	0.885	C2937358	Cerebral Hemorrhage	phenotype	C23;C10;C14	Pathologic Function	0.50	1	1991	2011	  20	   0	CTD_human
     5327	PLAT	0.445	0.885	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5327	PLAT	0.445	0.885	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5328	PLAU	0.425	0.923	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.39	1	1991	2018	   1	   0	CTD_human
     5328	PLAU	0.425	0.923	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.68	1	2002	2013	0	0	CTD_human
17220	5328	PLAU	0.425	0.923	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.51	1	1985	2011	6	0	CTD_human
17274	5336	PLCG2	0.588	0.808	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.7	0.929	2007	2020	1	2	CGI;CTD_human
17290	5376	PMP22	0.471	0.885	C0393814	Hereditary liability to pressure palsies	disease	C16;C05;C10	Disease or Syndrome	1	0.979	1993	2019	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17321	5376	PMP22	0.471	0.885	C3495591	Charcot-Marie-Tooth Disease, Demyelinating, Type 1e	disease	C23;C16;C10;C09	Disease or Syndrome	0.92	1	1999	2013	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
17324	5376	PMP22	0.471	0.885	C4551910	Acute Inflammatory Demyelinating Polyneuropathy	disease	C20;C10	Disease or Syndrome	0.52	1	2002	2017	1	0	CTD_human;ORPHANET
17340	5393	EXOSC9	0.705	0.423	C4748058	PONTOCEREBELLAR HYPOPLASIA, TYPE 1D	disease		Disease or Syndrome	0.61	1	2018	2020	1	2	GENOMICS_ENGLAND;UNIPROT
17343	5395	PMS2	0.484	0.808	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.64	1	1986	2018	12	143	CLINGEN;CTD_human
17352	5395	PMS2	0.484	0.808	C0265325	Turcot syndrome (disorder)	disease	C16;C06;C04;C10	Disease or Syndrome	0.8	0.978	1995	2020	21	32	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17357	5395	PMS2	0.484	0.808	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.7	1	1999	2020	0	1	CGI;GENOMICS_ENGLAND
17366	5395	PMS2	0.484	0.808	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.63	1	2014	2019	0	1	CGI;GENOMICS_ENGLAND
17368	5395	PMS2	0.484	0.808	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.8	0.979	1994	2020	12	73	CLINGEN;CTD_human;ORPHANET
17369	5395	PMS2	0.484	0.808	C1838333	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4	disease	C16;C06;C04;C18	Disease or Syndrome	0.7	1	1995	2017	11	49	CTD_human;GENOMICS_ENGLAND;UNIPROT
17370	5395	PMS2	0.484	0.808	C4321324	Constitutional Mismatch Repair Deficiency Syndrome	disease	C16;C04	Disease or Syndrome	0.56	1	1998	2017	11	0	CLINGEN;GENOMICS_ENGLAND
17371	5395	PMS2	0.484	0.808	C4552100	Lynch Syndrome	disease	C16;C06;C04;C18	Disease or Syndrome	0.7	0.973	1994	2020	13	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
17378	5396	PRRX1	0.543	0.769	C0265242	Otocephaly	disease	C16;C05	Congenital Abnormality	0.62	1	2011	2013	1	2	ORPHANET;UNIPROT
17389	5406	PNLIP	0.743	0.308	C3280527	PANCREATIC LIPASE DEFICIENCY	disease		Disease or Syndrome	0.7	1	2014	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
17408	5422	POLA1	0.653	0.731	C1845050	PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS	disease	C23;C16;C18;C17	Disease or Syndrome	0.7	1	2009	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
17416	5424	POLD1	0.507	0.769	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.944	1995	2020	1	0	CTD_human;GENOMICS_ENGLAND
17426	5424	POLD1	0.507	0.769	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.69	1	2013	2016	1	0	CTD_human;GENOMICS_ENGLAND
17430	5424	POLD1	0.507	0.769	C2675481	COLORECTAL CANCER, SUSCEPTIBILITY TO, 10	disease		Finding	0.6	1	2006	2016	3	2	GENOMICS_ENGLAND;UNIPROT
17433	5424	POLD1	0.507	0.769	C3715192	ANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME	disease		Disease or Syndrome	0.74	1	2013	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
17437	5426	POLE	0.526	0.731	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.6	1	2013	2020	2	0	CTD_human;GENOMICS_ENGLAND
17450	5426	POLE	0.526	0.731	C3554460	COLORECTAL CANCER, SUSCEPTIBILITY TO, 12	disease		Finding	0.6	1	2003	2017	5	5	GENOMICS_ENGLAND;UNIPROT
17451	5426	POLE	0.526	0.731	C3554576	FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE	disease		Disease or Syndrome	0.71	1	2012	2012	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
17463	5443	POMC	0.356	0.846	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.9	0.959	1996	2020	2	0	CTD_human;GENOMICS_ENGLAND
17501	5444	PON1	0.409	0.885	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.7	0.929	2007	2019	3	0	CTD_human;ORPHANET
17629	5447	POR	0.502	0.769	C1860042	Antley-Bixler Syndrome with Disordered Steroidogenesis	disease	C16;C18;C05	Disease or Syndrome	0.74	1	2004	2018	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17632	5447	POR	0.502	0.769	C3150099	ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS	disease		Disease or Syndrome	0.7	1	2002	2006	5	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
17636	5449	POU1F1	0.548	0.654	C2751608	Pituitary Hormone Deficiency, Combined, 1	disease	C23;C16;C19	Disease or Syndrome	0.7	1	1992	2016	14	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17643	5454	POU3F2	0.7	0.423	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2011	2019	2	0	CTD_human;PSYGENET
17656	5456	POU3F4	0.633	0.654	C1844678	Progressive hearing loss stapes fixation	disease	C23;C16;C10;C09	Disease or Syndrome	0.75	1	1995	2014	4	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
17667	5459	POU4F3	0.7	0.538	C1865366	Deafness, Autosomal Dominant 15	disease	C23;C10;C09	Disease or Syndrome	0.71	1	1998	2017	8	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
17693	5465	PPARA	0.432	0.885	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.6	1	2005	2020	1	0	CTD_human
17694	5465	PPARA	0.432	0.885	C0015696	Fatty Liver, Alcoholic	disease	C06;C25	Disease or Syndrome	0.53	1	2006	2018	1	0	CTD_human
17700	5465	PPARA	0.432	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.57	1	2002	2018	2	0	CTD_human
17708	5465	PPARA	0.432	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.58	1	2003	2019	2	0	CTD_human
17726	5465	PPARA	0.432	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.55	1	1999	2019	2	0	CTD_human
17774	5468	PPARG	0.358	0.885	C0271694	Familial partial lipodystrophy	disease	C18;C17	Disease or Syndrome	0.6	0.938	2002	2019	1	0	CTD_human
17791	5621	PRNP	0.445	0.923	C0017495	Gerstmann-Straussler-Scheinker Disease	disease	C16;C01;C10	Disease or Syndrome	1	0.993	1989	2019	14	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
17793	5621	PRNP	0.445	0.923	C0022336	Creutzfeldt-Jakob disease	disease	C01;C10;F03	Disease or Syndrome	1	0.98	1988	2020	13	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17801	5621	PRNP	0.445	0.923	C0036457	Scrapie	disease	C01;C10;C22	Disease or Syndrome	0.55	1	1993	2018	4	0	CTD_human
17804	5621	PRNP	0.445	0.923	C0206042	Fatal Familial Insomnia	disease	C01;C10	Disease or Syndrome	1	0.989	1992	2019	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
17806	5621	PRNP	0.445	0.923	C0376329	New Variant Creutzfeldt-Jakob Disease	disease	C01;C10;F03	Disease or Syndrome	0.6	0.981	1998	2019	3	0	CTD_human;ORPHANET
17814	5649	RELN	0.515	0.731	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.57	1	2000	2020	8	0	CTD_human;PSYGENET
17820	5649	RELN	0.515	0.731	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.53	1	2004	2018	4	0	CTD_human;PSYGENET
17827	5649	RELN	0.515	0.731	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.7	0.909	1998	2020	4	1	CTD_human
17836	5649	RELN	0.515	0.731	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2010	2010	   1	   0	CTD_human
     5649	RELN	0.515	0.731	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
     5649	RELN	0.515	0.731	C0796089	LISSENCEPHALY SYNDROME, NORMAN-ROBERTS TYPE	disease	C16;C10	Disease or Syndrome	0.70	1	1993	2000	   2	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5649	RELN	0.515	0.731	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.50	1	2000	2013	   3	   0	CTD_human;PSYGENET
     5649	RELN	0.515	0.731	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.40	0.929	2002	2019	   2	   0	CTD_human
     5649	RELN	0.515	0.731	C1571983	Involutional paraphrenia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2000	2000	   1	   0	CTD_human
     5649	RELN	0.515	0.731	C1571984	Psychosis, Involutional	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2000	2000	   1	   0	CTD_human
     5649	RELN	0.515	0.731	C1838062	Autosomal Dominant Lateral Temporal Lobe Epilepsy	disease	C23;C10;F03	Disease or Syndrome	0.31	1	2015	2017	   1	   0	ORPHANET
     5649	RELN	0.515	0.731	C4225327	EPILEPSY, FAMILIAL TEMPORAL LOBE, 7	disease		Disease or Syndrome	0.70	1	2015	2015	   1	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5649	RELN	0.515	0.731	C4551957	Epilepsy, Familial Temporal Lobe 1	disease	C23;C10;F03	Disease or Syndrome	0.31	1	2017	2017	   0	   0	CTD_human
     5651	TMPRSS15	0.751	0.385	C0268416	Enterokinase Deficiency	disease	C16;C18	Disease or Syndrome	0.62	1	2002	2012	   1	   5	CTD_human;ORPHANET
     5652	PRSS8	0.641	0.5	C0011999	Diastematomyelia	disease	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0013949	Embryopathies	disease	C16;C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0015929	Fetal Diseases	group	C16;C13	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0027794	Neural Tube Defects	group	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0027806	Neurenteric Cyst	disease	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0032045	Placenta Disorders	group	C13	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0037274	Dermatologic disorders	group	C17	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0080218	Tethered Cord Syndrome	disease	C16;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0152234	Iniencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0152426	Craniorachischisis	disease	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0266453	Exencephaly	disease	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0344479	Spinal Cord Myelodysplasia	disease	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2004	2006	   1	   0	CTD_human
     5652	PRSS8	0.641	0.5	C0702169	Acrania	disease	C16;C10	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     5654	HTRA1	0.532	0.692	C0002170	Alopecia	disease	C23;C17	Disease or Syndrome	0.41	1	2011	2015	   1	   0	GENOMICS_ENGLAND
     5654	HTRA1	0.532	0.692	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2006	2017	   1	   0	CTD_human
     5654	HTRA1	0.532	0.692	C0026654	Moyamoya Disease	disease	C10;C14	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     5654	HTRA1	0.532	0.692	C0158266	Intervertebral Disc Degeneration	disease	C05	Disease or Syndrome	0.33	1	2010	2017	   1	   0	GENOMICS_ENGLAND
     5654	HTRA1	0.532	0.692	C0206729	Neurofibrosarcoma	disease	C04;C10	Neoplastic Process	0.30	1	2016	2016	   1	   0	ORPHANET
     5654	HTRA1	0.532	0.692	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
     5654	HTRA1	0.532	0.692	C0242383	Age related macular degeneration	disease	C11	Disease or Syndrome	0.50	0.94	2006	2019	   0	   7	GENOMICS_ENGLAND
     5654	HTRA1	0.532	0.692	C0338656	Impaired cognition	disease	F03	Mental or Behavioral Dysfunction	0.41	1	2014	2015	   1	   1	GENOMICS_ENGLAND
     5654	HTRA1	0.532	0.692	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.40	1	2014	2014	   1	   0	GENOMICS_ENGLAND
     5654	HTRA1	0.532	0.692	C0751587	CADASIL Syndrome	disease	C23;C16;C10;C14	Disease or Syndrome	0.34	1	2015	2019	   0	   0	CTD_human
     5654	HTRA1	0.532	0.692	C0751690	Malignant Peripheral Nerve Sheath Tumor	disease	C04;C10	Neoplastic Process	0.30	1	2016	2016	   1	   0	ORPHANET
     5654	HTRA1	0.532	0.692	C1449626	CADASILM	disease	C23;C16;C10;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     5654	HTRA1	0.532	0.692	C1838577	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy	disease	C23;C17;C05;C10;C14	Disease or Syndrome	0.80	0.962	2002	2019	   7	  10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5654	HTRA1	0.532	0.692	C1857813	Macular Degeneration, Age-Related, 7	disease	C11	Disease or Syndrome	0.40				   0	   1	CTD_human
     5654	HTRA1	0.532	0.692	C2733158	Cerebral Small Vessel Diseases	group	C10;C14	Disease or Syndrome	0.50	1	2011	2019	   1	   1	GENOMICS_ENGLAND
     5654	HTRA1	0.532	0.692	C4225211	CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2	disease		Disease or Syndrome	0.60	1	2014	2015	   3	  12	GENOMICS_ENGLAND;UNIPROT
     5655	KLK10	0.608	0.538	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	2000	2016	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.37	1	2005	2018	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2007	2007	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	2000	2016	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.34	1	2002	2018	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.34	1	2003	2013	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.35	1	2001	2009	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     5655	KLK10	0.608	0.538	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     5657	PRTN3	0.503	0.808	C0023473	Myeloid Leukemia, Chronic	disease	C04;C15	Neoplastic Process	0.40	1	1997	2011	   1	   0	CTD_human
     5657	PRTN3	0.503	0.808	C3495801	Granulomatosis with polyangiitis	disease	C08;C20;C14	Disease or Syndrome	0.60	0.988	1992	2019	   2	   0	CTD_human;ORPHANET
     5660	PSAP	0.532	0.846	C0268262	Metachromatic Leukodystrophy due to Saposin B Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.71	1	1990	2019	   8	   7	CTD_human;GENOMICS_ENGLAND;UNIPROT
     5660	PSAP	0.532	0.846	C0751273	Infantile Globoid Cell Leukodystrophy	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2005	2020	   1	   0	ORPHANET
     5660	PSAP	0.532	0.846	C0751276	Metachromatic leukodystrophy, juvenile type	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
     5660	PSAP	0.532	0.846	C0751278	Metachromatic Leukodystrophy, Infant	disease	C16;C18;C10	Disease or Syndrome	0.31	1	2014	2019	   1	   0	ORPHANET
     5660	PSAP	0.532	0.846	C0751279	Metachromatic Leukodystrophy, Adult-Type (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
     5660	PSAP	0.532	0.846	C1864651	GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.70	1	1991	2016	   4	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     5660	PSAP	0.532	0.846	C2673266	KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY	disease	C16;C18;C10	Disease or Syndrome	0.62	1	2000	2020	   5	   1	CTD_human;GENOMICS_ENGLAND
     5660	PSAP	0.532	0.846	C2673635	Combined Saposin Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.71	1	1978	2016	   6	   3	CTD_human;GENOMICS_ENGLAND;ORPHANET
     5662	PSD	0.626	0.654	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.40	1	2005	2019	   1	   0	PSYGENET
     5663	PSEN1	0.469	0.846	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.7	0.971	1990	2020	13	6	CTD_human
17852	5663	PSEN1	0.469	0.846	C0236642	Pick Disease of the Brain	disease	C10;F03	Disease or Syndrome	0.8	1	1995	2018	6	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
17855	5663	PSEN1	0.469	0.846	C0338451	Frontotemporal dementia	disease	C18;C10;F03	Disease or Syndrome	0.8	1	1995	2018	5	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
17856	5663	PSEN1	0.469	0.846	C0338462	Semantic Dementia	disease	C18;C10;F03	Mental or Behavioral Dysfunction	0.6	1	2000	2000	1	0	CTD_human;ORPHANET
17921	5961	PRPH2	0.551	0.5	C0311338	Fundus Albipunctatus	disease	C11	Congenital Abnormality	0.7	1	1993	1993	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
17923	5961	PRPH2	0.551	0.5	C1405854	Retinitis punctata albescens (disorder)	disease	C11	Disease or Syndrome	0.54	1	1993	1997	1	0	CTD_human;ORPHANET
17926	5961	PRPH2	0.551	0.5	C1842475	Retinitis Pigmentosa 7	disease	C16;C11	Disease or Syndrome	0.91	1	1985	2016	11	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
17927	5961	PRPH2	0.551	0.5	C1842914	Adult-Onset Vitelliform Macular Dystrophy	disease	C16;C11	Disease or Syndrome	0.75	1	1997	2016	6	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17931	5961	PRPH2	0.551	0.5	C2751290	CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2	disease	C11	Disease or Syndrome	0.7	1	2006	2016	4	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
17935	5961	PRPH2	0.551	0.5	C4551999	MACULAR DYSTROPHY, PATTERNED, 1	disease	C11	Disease or Syndrome	0.6	1	1993	2016	4	16	GENOMICS_ENGLAND;UNIPROT
17939	5962	RDX	0.593	0.615	C1970239	DEAFNESS, AUTOSOMAL RECESSIVE, 24	disease	C23;C10;C09	Disease or Syndrome	0.7	1	1993	2007	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
17949	5966	REL	0.579	0.692	C0019829	Hodgkin Disease	disease	C04;C20;C15	Neoplastic Process	0.55	1	2001	2010	1	0	CGI;CTD_human
17976	5970	RELA	0.406	0.885	C0009319	Colitis	disease	C06	Disease or Syndrome	0.55	0.857	1996	2019	1	0	CTD_human
17988	5970	RELA	0.406	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.51	1	2006	2018	2	0	CTD_human
17989	5970	RELA	0.406	0.885	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.51	1	2008	2011	1	0	CTD_human
18046	5972	REN	0.37	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.969	1975	2020	17	0	CTD_human
18068	5972	REN	0.37	0.923	C0149721	Left Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.6	0.941	1993	2018	2	0	CTD_human
18073	5972	REN	0.37	0.923	C0266313	Allanson Pantzar McLeod syndrome	disease	C16;C13;C12	Disease or Syndrome	0.79	0.9	2005	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18080	5972	REN	0.37	0.923	C2751310	Hyperuricemic Nephropathy, Familial Juvenile 2	disease	C23;C13;C12;C15	Disease or Syndrome	0.71	1	2009	2009	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
18085	5977	DPF2	0.604	0.731	C4747954	COFFIN-SIRIS SYNDROME 7	disease		Disease or Syndrome	0.61	1	2018	2020	1	5	GENOMICS_ENGLAND;UNIPROT
18088	5978	REST	0.535	0.808	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.61	1	2015	2015	1	0	CTD_human;ORPHANET
18114	5978	REST	0.535	0.808	C3891301	WILMS TUMOR, SUSCEPTIBILITY TO	phenotype	C04	Finding	0.7	1	2015	2015	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18124	5979	RET	0.392	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.6	1	2008	2019	2	0	CTD_human;UNIPROT
18126	5979	RET	0.392	0.885	C0019569	Hirschsprung Disease	disease	C16;C06	Disease or Syndrome	0.7	0.98	1993	2019	2	28	CTD_human
18129	5979	RET	0.392	0.885	C0025268	Multiple Endocrine Neoplasia Type 2a	disease	C16;C04;C19	Neoplastic Process	0.8	0.989	1990	2019	15	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18130	5979	RET	0.392	0.885	C0025269	Multiple Endocrine Neoplasia Type 2b	disease	C16;C04;C19	Neoplastic Process	1	1	1992	2019	10	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18131	5979	RET	0.392	0.885	C0027662	Multiple Endocrine Neoplasia	disease	C16;C04;C19	Neoplastic Process	0.7	0.976	1994	2018	2	1	CTD_human;GENOMICS_ENGLAND
18132	5979	RET	0.392	0.885	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	1	0.96	1990	2019	1	8	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
18134	5979	RET	0.392	0.885	C0040136	Thyroid Neoplasm	disease	C04;C19	Neoplastic Process	0.7	0.994	1992	2019	1	2	CGI;CTD_human
18140	5979	RET	0.392	0.885	C0238462	Medullary carcinoma of thyroid	disease	C04;C19	Neoplastic Process	0.7	0.953	1992	2020	1	18	CGI;CTD_human
18141	5979	RET	0.392	0.885	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.6	0.972	1989	2020	3	0	CTD_human;ORPHANET
18179	6314	ATXN7	0.581	0.654	C0752125	Spinocerebellar Ataxia Type 7	disease	C16;C10	Disease or Syndrome	0.8	0.985	1997	2019	3	0	CTD_human;GENOMICS_ENGLAND
18183	6315	ATXN8OS	0.65	0.423	C1837454	SPINOCEREBELLAR ATAXIA 8	disease	C16;C10	Disease or Syndrome	0.6	1	2000	2019	0	0	CTD_human;ORPHANET
18233	6323	SCN1A	0.477	0.808	C0009952	Febrile Convulsions	disease	C23;C10	Disease or Syndrome	0.7	0.939	2002	2020	3	0	CTD_human
18261	6323	SCN1A	0.477	0.808	C0751122	Infantile Severe Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.9	0.974	2001	2020	17	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
18264	6323	SCN1A	0.477	0.808	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.53	1	2011	2018	1	0	CTD_human
18266	6323	SCN1A	0.477	0.808	C1858673	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2	disease	C23;C10	Disease or Syndrome	0.73	1	2000	2012	32	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18267	6323	SCN1A	0.477	0.808	C1864987	Migraine, Familial Hemiplegic, 3	disease	C10	Disease or Syndrome	0.7	1	2000	2018	17	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
18271	6323	SCN1A	0.477	0.808	C3502809	Generalized Epilepsy with Febrile Seizures Plus	disease	C23;C10	Disease or Syndrome	0.6	0.983	2000	2017	15	0	CLINGEN
18273	6323	SCN1A	0.477	0.808	C4551549	Early Infantile Epileptic Encephalopathy 6	disease	C10	Disease or Syndrome	0.8	1	2000	2018	46	0	GENOMICS_ENGLAND;UNIPROT
18283	6324	SCN1B	0.575	0.538	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.55	1	2008	2019	7	0	CLINGEN;CTD_human
18287	6324	SCN1B	0.575	0.538	C1858672	GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1	disease	C23;C10	Disease or Syndrome	0.71	1	1998	2019	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
18289	6324	SCN1B	0.575	0.538	C2748541	Brugada Syndrome 5	disease	C16;C14	Disease or Syndrome	0.6	1	1970	2019	4	3	CTD_human;GENOMICS_ENGLAND
18290	6324	SCN1B	0.575	0.538	C2748542	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	disease	C16;C14	Disease or Syndrome	0.6	1	2008	2017	7	2	CLINGEN;GENOMICS_ENGLAND
18291	6324	SCN1B	0.575	0.538	C3502809	Generalized Epilepsy with Febrile Seizures Plus	disease	C23;C10	Disease or Syndrome	0.7	1	2000	2011	0	1	ORPHANET
18292	6324	SCN1B	0.575	0.538	C3809311	ATRIAL FIBRILLATION, FAMILIAL, 13	disease		Disease or Syndrome	0.7	1	2005	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18293	6324	SCN1B	0.575	0.538	C4479236	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52	disease		Disease or Syndrome	0.7	1	1998	2016	5	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
18303	6326	SCN2A	0.518	0.731	C0220669	Familial benign neonatal epilepsy	disease	C16;C10	Disease or Syndrome	0.6	1	2002	2019	3	0	GENOMICS_ENGLAND;ORPHANET
18312	6326	SCN2A	0.518	0.731	C1843140	SEIZURES, BENIGN FAMILIAL INFANTILE, 3	disease	C16;C10	Disease or Syndrome	0.66	0.97	2001	2018	17	46	GENOMICS_ENGLAND;UNIPROT
18313	6326	SCN2A	0.518	0.731	C3150987	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11	disease		Disease or Syndrome	0.7	1	2004	2019	28	65	CTD_human;GENOMICS_ENGLAND;UNIPROT
18318	6327	SCN2B	0.678	0.192	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.51	1	2009	2016	5	0	CLINGEN;ORPHANET
18322	6327	SCN2B	0.678	0.192	C3809312	ATRIAL FIBRILLATION, FAMILIAL, 14	disease		Disease or Syndrome	0.6	1	2009	2009	1	2	CTD_human;UNIPROT
18329	6328	SCN3A	0.617	0.538	C4693694	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4	disease		Disease or Syndrome	0.6	1	2014	2017	2	4	GENOMICS_ENGLAND;UNIPROT
18330	6328	SCN3A	0.617	0.538	C4693699	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62	disease		Disease or Syndrome	0.6	1	2017	2018	2	5	GENOMICS_ENGLAND;UNIPROT
18331	6329	SCN4A	0.554	0.731	C0027125	Myotonia	phenotype	C23;C10	Finding	0.62	1	1993	2008	2	2	CTD_human;GENOMICS_ENGLAND
18333	6329	SCN4A	0.554	0.731	C0221055	Paramyotonia Congenita (disorder)	disease	C05;C10	Disease or Syndrome	0.8	0.977	1992	2019	18	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18334	6329	SCN4A	0.554	0.731	C0238357	Hyperkalemic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	1	1	1989	2019	10	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18335	6329	SCN4A	0.554	0.731	C0238358	Hypokalemic periodic paralysis	disease	C16;C18;C05;C10	Disease or Syndrome	0.9	1	2001	2019	2	4	CTD_human;GENOMICS_ENGLAND
18342	6329	SCN4A	0.554	0.731	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.64	1	2003	2016	1	3	CTD_human;GENOMICS_ENGLAND
18348	6329	SCN4A	0.554	0.731	C2750061	Hypokalemic Periodic Paralysis, Type 2	disease	C16;C18;C05;C10	Disease or Syndrome	0.73	1	1999	2019	14	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
18350	6329	SCN4A	0.554	0.731	C2931826	Potassium aggravated myotonia	disease	C16;C05;C10	Disease or Syndrome	0.79	1	1993	2019	15	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18352	6329	SCN4A	0.554	0.731	C3280112	MYASTHENIC SYNDROME, CONGENITAL, 16	disease		Disease or Syndrome	0.6	1	2003	2016	4	10	GENOMICS_ENGLAND;UNIPROT
18357	6330	SCN4B	0.705	0.346	C1141890	Congenital long QT syndrome	disease	C23;C16;C14	Disease or Syndrome	0.51	1	2007	2007	1	0	CLINGEN;GENOMICS_ENGLAND
18359	6330	SCN4B	0.705	0.346	C2678484	Long Qt Syndrome 10	disease	C23;C16;C14	Disease or Syndrome	0.7	1	2007	2013	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18362	6331	SCN5A	0.513	0.654	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.7	1	1998	2018	2	3	GENOMICS_ENGLAND
18363	6331	SCN5A	0.513	0.654	C0023976	Long QT Syndrome	disease	C23;C16;C14	Disease or Syndrome	0.7	0.987	1995	2020	10	4	CTD_human;GENOMICS_ENGLAND
18366	6331	SCN5A	0.513	0.654	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.8	0.963	1995	2018	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
18371	6331	SCN5A	0.513	0.654	C0340493	Paroxysmal familial ventricular fibrillation	disease	C23;C14	Disease or Syndrome	0.7	1	2000	2016	0	1	CTD_human;GENOMICS_ENGLAND
18375	6331	SCN5A	0.513	0.654	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	1	0.984	1995	2020	26	102	CLINGEN;CTD_human;GENOMICS_ENGLAND
18377	6331	SCN5A	0.513	0.654	C1832680	CARDIOMYOPATHY, DILATED, 1E	disease	C14	Disease or Syndrome	0.9	1	1995	2017	7	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
18378	6331	SCN5A	0.513	0.654	C1837845	SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE	disease	C23;C14	Disease or Syndrome	0.71	1	1995	2012	5	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
18381	6331	SCN5A	0.513	0.654	C1859062	LONG QT SYNDROME 3	disease	C23;C16;C14	Disease or Syndrome	1	1	1995	2018	30	153	CTD_human;GENOMICS_ENGLAND;UNIPROT
18382	6331	SCN5A	0.513	0.654	C1879286	Hereditary bundle branch system defect	disease	C23;C14	Disease or Syndrome	0.98	1	1995	2013	10	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18384	6331	SCN5A	0.513	0.654	C2751898	Ventricular Fibrillation, Paroxysmal Familial, 1	disease	C23;C14	Disease or Syndrome	0.8	0.833	1995	2018	3	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
18386	6331	SCN5A	0.513	0.654	C3151464	ATRIAL FIBRILLATION, FAMILIAL, 10	disease		Disease or Syndrome	0.7	1	1995	2012	4	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
18389	6331	SCN5A	0.513	0.654	C4551804	Brugada Syndrome 1	disease	C16;C14	Disease or Syndrome	0.91	1	1995	2018	52	234	CTD_human;GENOMICS_ENGLAND;UNIPROT
18395	6334	SCN8A	0.51	0.731	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.9	0.971	2007	2020	3	1	CTD_human;GENOMICS_ENGLAND
18447	6334	SCN8A	0.51	0.731	C3280415	COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA	disease		Disease or Syndrome	0.6	1	2012	2016	2	4	CTD_human;GENOMICS_ENGLAND
18448	6334	SCN8A	0.51	0.731	C3281191	SCN8A-related epilepsy with encephalopathy	disease	C23;C10;F03;F01	Disease or Syndrome	0.72	1	2002	2017	16	52	CTD_human;GENOMICS_ENGLAND;UNIPROT
18450	6334	SCN8A	0.51	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.67	1	2006	2019	1	0	CTD_human;GENOMICS_ENGLAND
18451	6334	SCN8A	0.51	0.731	C4310728	SEIZURES, BENIGN FAMILIAL INFANTILE, 5	disease		Disease or Syndrome	0.7	1	2014	2016	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
18452	6335	SCN9A	0.543	0.615	C0002768	Congenital Pain Insensitivity	disease	C16;C10	Disease or Syndrome	0.6	1	2004	2018	2	0	GENOMICS_ENGLAND;ORPHANET
18456	6335	SCN9A	0.543	0.615	C0014805	Primary Erythermalgia	disease	C14	Disease or Syndrome	0.8	1	2004	2017	15	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18482	6335	SCN9A	0.543	0.615	C0751122	Infantile Severe Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.57	1	2006	2020	4	0	CTD_human;ORPHANET
18487	6335	SCN9A	0.543	0.615	C1833661	PAROXYSMAL EXTREME PAIN DISORDER	disease	C23	Disease or Syndrome	0.8	1	2004	2018	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18488	6335	SCN9A	0.543	0.615	C1855739	Indifference to Pain, Congenital, Autosomal Recessive	disease	C23;C16;C10	Disease or Syndrome	0.8	0.95	2004	2018	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18489	6335	SCN9A	0.543	0.615	C2751778	Generalized Epilepsy With Febrile Seizures Plus, 7	disease	C23;C10	Disease or Syndrome	0.7	1	1979	2014	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18501	6336	SCN10A	0.566	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.62	1	2006	2017	1	0	CTD_human
18524	6336	SCN10A	0.566	0.692	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.8	0.929	1998	2019	9	13	CLINGEN;CTD_human;ORPHANET
18533	6336	SCN10A	0.566	0.692	C3809893	EPISODIC PAIN SYNDROME, FAMILIAL, 2	disease		Disease or Syndrome	0.7	1	2005	2016	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
18538	6337	SCNN1A	0.601	0.577	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.51	1	2004	2017	2	0	CTD_human;GENOMICS_ENGLAND
18547	6337	SCNN1A	0.601	0.577	C0221043	Liddle Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.54	1	2003	2019	2	0	CTD_human;ORPHANET
18556	6337	SCNN1A	0.601	0.577	C1449843	Pseudohypoaldosteronism, Type I, Autosomal Recessive	disease	C16;C13;C12	Disease or Syndrome	0.61	1	1999	2013	7	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18560	6337	SCNN1A	0.601	0.577	C2751666	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2	disease	C08	Disease or Syndrome	0.6	1	1999	2009	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18566	6338	SCNN1B	0.628	0.577	C0010674	Cystic Fibrosis	disease	C16;C06;C08	Disease or Syndrome	0.6	1	2005	2019	2	0	CTD_human
18568	6338	SCNN1B	0.628	0.577	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.53	1	2005	2019	1	0	CTD_human;GENOMICS_ENGLAND
18570	6338	SCNN1B	0.628	0.577	C0221043	Liddle Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.9	1	1995	2018	8	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18571	6338	SCNN1B	0.628	0.577	C0268436	Pseudohypoaldosteronism, Type I	disease	C16;C13;C12	Disease or Syndrome	0.52	1	1999	2019	0	0	CTD_human
18575	6338	SCNN1B	0.628	0.577	C1449843	Pseudohypoaldosteronism, Type I, Autosomal Recessive	disease	C16;C13;C12	Disease or Syndrome	0.6	1	1996	2019	6	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18579	6338	SCNN1B	0.628	0.577	C2749757	BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1	disease	C08	Disease or Syndrome	0.6	1	2005	2014	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18588	6340	SCNN1G	0.633	0.577	C0221043	Liddle Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.6	1	1996	2019	1	0	GENOMICS_ENGLAND;ORPHANET
18589	6340	SCNN1G	0.633	0.577	C0268436	Pseudohypoaldosteronism, Type I	disease	C16;C13;C12	Disease or Syndrome	0.56	1	1996	2013	1	0	CTD_human
18593	6340	SCNN1G	0.633	0.577	C1449843	Pseudohypoaldosteronism, Type I, Autosomal Recessive	disease	C16;C13;C12	Disease or Syndrome	0.7	1	1996	2015	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
18605	6341	SCO1	0.638	0.769	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.94	1	2000	2013	6	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18606	6341	SCO1	0.638	0.769	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.52	1	2007	2019	2	0	CTD_human;GENOMICS_ENGLAND
18623	6342	SCP2	0.644	0.5	C3150990	LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	disease		Disease or Syndrome	0.7	1	2006	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
18643	6347	CCL2	0.321	0.962	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.6	0.875	2001	2019	1	0	CTD_human
18649	6347	CCL2	0.321	0.962	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.51	1	2005	2017	2	0	CTD_human
18650	6347	CCL2	0.321	0.962	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.6	0.955	2001	2020	2	0	CTD_human
18652	6347	CCL2	0.321	0.962	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.6	0.969	2000	2020	1	0	CTD_human
18659	6347	CCL2	0.321	0.962	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.56	0.875	2003	2019	1	0	CTD_human
18660	6347	CCL2	0.321	0.962	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.59	0.909	1998	2019	1	0	CTD_human
18664	6347	CCL2	0.321	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.57	1	2007	2019	1	0	CTD_human
18666	6347	CCL2	0.321	0.962	C0020459	Hyperinsulinism	disease	C18	Disease or Syndrome	0.56	1	2004	2018	1	0	CTD_human
18669	6347	CCL2	0.321	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	1	2006	2019	2	0	CTD_human
18671	6347	CCL2	0.321	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.54	1	2003	2011	3	0	CTD_human
18674	6347	CCL2	0.321	0.962	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.6	0.824	1995	2019	2	0	CTD_human
18688	6347	CCL2	0.321	0.962	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.6	1	2005	2020	1	0	CTD_human
18690	6347	CCL2	0.321	0.962	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.56	1	2009	2019	1	0	CTD_human
18691	6347	CCL2	0.321	0.962	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.51	1	2011	2018	1	0	CTD_human
18692	6347	CCL2	0.321	0.962	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.57	0.909	1994	2019	3	0	CTD_human
18700	6347	CCL2	0.321	0.962	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.51	1	2007	2019	2	0	CTD_human
18714	6347	CCL2	0.321	0.962	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.55	0.875	1999	2019	1	0	CTD_human
18778	6347	CCL2	0.321	0.962	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.55	1	2009	2019	1	0	CTD_human
18836	6352	CCL5	0.403	0.885	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.6	0.886	1996	2019	1	0	CTD_human
18886	6356	CCL11	0.473	0.885	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.7	0.953	1995	2019	0	0	CTD_human
18894	6356	CCL11	0.473	0.885	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.55	1	1999	2020	1	0	CTD_human
18929	6364	CCL20	0.474	0.846	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.64	1	2004	2017	1	1	CTD_human
19029	6389	SDHA	0.517	0.731	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.73	0.917	1992	2017	11	3	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
19034	6389	SDHA	0.517	0.731	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.7	1	2004	2019	4	0	GENOMICS_ENGLAND;ORPHANET
19045	6389	SDHA	0.517	0.731	C1855008	Mitochondrial Complex II Deficiency	disease	C16;C18	Disease or Syndrome	0.7	1	2000	2017	4	39	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19047	6389	SDHA	0.517	0.731	C3150898	CARDIOMYOPATHY, DILATED, 1GG	disease		Disease or Syndrome	0.6	1	2010	2016	2	2	GENOMICS_ENGLAND;UNIPROT
19049	6389	SDHA	0.517	0.731	C3279992	PARAGANGLIOMAS 5	disease		Disease or Syndrome	0.7	1	2000	2017	2	39	CTD_human;GENOMICS_ENGLAND;UNIPROT
19051	6390	SDHB	0.474	0.846	C0030421	Paraganglioma	disease	C04	Neoplastic Process	0.7	0.983	2001	2020	2	2	CGI;CTD_human
19052	6390	SDHB	0.474	0.846	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.8	0.989	1982	2020	9	65	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
19054	6390	SDHB	0.474	0.846	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.8	0.971	1982	2019	4	57	CTD_human;GENOMICS_ENGLAND;ORPHANET
19062	6390	SDHB	0.474	0.846	C1847319	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	disease	C06;C04	Disease or Syndrome	0.76	0.889	2008	2016	4	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
19064	6390	SDHB	0.474	0.846	C1861848	PARAGANGLIOMAS 4	disease	C16;C04	Neoplastic Process	0.71	1	1982	2017	8	67	CTD_human;GENOMICS_ENGLAND;UNIPROT
19070	6391	SDHC	0.517	0.846	C0238198	Gastrointestinal Stromal Tumors	group	C06;C04	Neoplastic Process	0.8	0.973	2000	2019	1	9	CTD_human;GENOMICS_ENGLAND;ORPHANET
19074	6391	SDHC	0.517	0.846	C1708353	Hereditary Paraganglioma-Pheochromocytoma Syndrome	disease	C16;C04	Disease or Syndrome	0.61	1	2000	2018	8	7	CLINGEN;GENOMICS_ENGLAND
19075	6391	SDHC	0.517	0.846	C1847319	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	disease	C06;C04	Disease or Syndrome	0.62	1	2008	2013	1	1	CTD_human;ORPHANET
19083	6392	SDHD	0.472	0.885	C0030421	Paraganglioma	disease	C04	Neoplastic Process	0.8	0.994	1996	2020	6	6	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
19084	6392	SDHD	0.472	0.885	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.8	0.993	2000	2020	3	31	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
19090	6392	SDHD	0.472	0.885	C1708353	Hereditary Paraganglioma-Pheochromocytoma Syndrome	disease	C16;C04	Disease or Syndrome	0.6	1	1997	2015	9	16	CLINGEN;GENOMICS_ENGLAND
19091	6392	SDHD	0.472	0.885	C1847319	PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	disease	C06;C04	Disease or Syndrome	0.76	1	2000	2019	1	26	CTD_human;GENOMICS_ENGLAND;ORPHANET
19092	6392	SDHD	0.472	0.885	C1855008	Mitochondrial Complex II Deficiency	disease	C16;C18	Disease or Syndrome	0.72	1	2012	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19098	6399	TRAPPC2	0.722	0.308	C0038015	Spondyloepiphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.7	1	2000	2014	0	0	CTD_human;GENOMICS_ENGLAND
19102	6399	TRAPPC2	0.722	0.308	C3541456	Spondyloepiphyseal Dysplasia Tarda, X-Linked	disease	C16;C05	Congenital Abnormality	0.8	1	1999	2019	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
19198	6418	SET	0.507	0.808	C4748195	MENTAL RETARDATION, AUTOSOMAL DOMINANT 58	disease		Disease or Syndrome	0.6	1	2014	2018	3	5	GENOMICS_ENGLAND;UNIPROT
19246	6424	SFRP4	0.524	0.654	C0265294	Pyle metaphyseal dysplasia	disease	C16;C05	Disease or Syndrome	0.73	1	2012	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
19287	6439	SFTPB	0.575	0.654	C0020192	Hyaline Membrane Disease	disease	C16;C08	Disease or Syndrome	0.51	1	2000	2001	1	0	ORPHANET
19288	6439	SFTPB	0.575	0.654	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.6	1	1995	2018	1	0	CTD_human
19293	6439	SFTPB	0.575	0.654	C1968602	Surfactant Metabolism Dysfunction, Pulmonary, 1	disease	C08	Disease or Syndrome	0.7	1	1994	2015	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19304	6440	SFTPC	0.556	0.692	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.6	0.875	2003	2019	1	0	CTD_human;ORPHANET
19305	6440	SFTPC	0.556	0.692	C1970470	SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2 (disorder)	disease	C08	Disease or Syndrome	0.7	1	2001	2009	7	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
19309	6441	SFTPD	0.5	0.846	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.7	0.917	2001	2019	1	3	CTD_human
19319	6442	SGCA	0.592	0.654	C2936332	Alpha-Sarcoglycanopathies	disease	C16;C05;C08;C10;C14	Disease or Syndrome	1	1	1994	2019	10	56	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19327	6443	SGCB	0.656	0.346	C1858593	Limb-girdle muscular dystrophy, type 2E	disease	C16;C05;C08;C10;C14	Disease or Syndrome	0.96	1	1995	2018	5	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
19332	6444	SGCD	0.641	0.615	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.58	0.9	1997	2015	2	0	CTD_human;GENOMICS_ENGLAND
19333	6444	SGCD	0.641	0.615	C1832525	Limb-girdle muscular dystrophy type 2F	disease	C16;C05;C08;C10;C14	Disease or Syndrome	0.94	1	1996	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
19334	6444	SGCD	0.641	0.615	C1847667	CARDIOMYOPATHY, DILATED, 1L	disease	C14	Disease or Syndrome	0.9	1	1997	2017	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
19338	6445	SGCG	0.621	0.615	C0410173	Severe autosomal recessive muscular dystrophy of childhood - North African type (disorder)	disease	C16;C05;C08;C10;C14	Disease or Syndrome	1	1	1995	2018	3	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
19339	6445	SGCG	0.621	0.615	C0686353	Muscular Dystrophies, Limb-Girdle	group	C16;C05;C10	Disease or Syndrome	0.6	1	1995	2020	0	0	GENOMICS_ENGLAND
19372	6448	SGSH	0.638	0.692	C0026706	Mucopolysaccharidosis III	disease	C16;C18;C17	Disease or Syndrome	0.89	1	1997	2019	1	6	CTD_human;GENOMICS_ENGLAND
19374	6448	SGSH	0.638	0.692	C0086647	Mucopolysaccharidosis Type IIIA	disease	C16;C18;C17	Disease or Syndrome	0.8	1	1991	2019	19	63	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19378	6452	SH3BP2	0.623	0.654	C0008029	Cherubism	disease	C16;C05;C07	Disease or Syndrome	1	0.971	2001	2019	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19386	6462	SHBG	0.438	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	1994	2019	2	0	CTD_human;PSYGENET
19412	6469	SHH	0.461	0.846	C0079541	Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.7	1	1994	2018	6	22	CTD_human;GENOMICS_ENGLAND
19423	6469	SHH	0.461	0.846	C1840235	SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR	disease	C16;C07	Congenital Abnormality	0.72	1	2001	2007	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
19424	6469	SHH	0.461	0.846	C1840529	HOLOPROSENCEPHALY 3	disease	C16;C05;C10	Disease or Syndrome	0.9	1	1995	2013	15	35	CTD_human;GENOMICS_ENGLAND;UNIPROT
19427	6469	SHH	0.461	0.846	C1868114	POLYDACTYLY, PREAXIAL II (disorder)	disease	C16;C11;C05	Disease or Syndrome	0.51	1	2003	2017	4	0	GENOMICS_ENGLAND;ORPHANET
19454	6473	SHOX	0.561	0.654	C0265309	Leri-Weill dyschondrosteosis	disease	C23;C16;C05	Disease or Syndrome	0.8	0.962	1999	2019	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
19455	6473	SHOX	0.561	0.654	C0432230	Langer Mesomelic Dysplasia Syndrome	disease	C23;C16;C05	Disease or Syndrome	0.8	0.958	2000	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19457	6473	SHOX	0.561	0.654	C1845118	SHORT STATURE, IDIOPATHIC, X-LINKED	disease	C23;C16	Congenital Abnormality	0.71	1	2017	2017	0	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
19460	6476	SI	0.569	0.692	C1283620	Sucrase-isomaltase deficiency, congenital	disease	C16;C18	Disease or Syndrome	0.79	1	1996	2018	6	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
19476	6487	ST3GAL3	0.606	0.654	C1970200	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12	disease	C23;C10;F03;F01	Disease or Syndrome	0.7	1	2007	2011	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
19487	6491	STIL	0.584	0.731	C2675187	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 7 (disorder)	disease	C16;C05;C10	Disease or Syndrome	0.71	1	2009	2015	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
19491	6492	SIM1	0.626	0.654	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.7	0.955	1998	2019	1	0	GENOMICS_ENGLAND
19505	6495	SIX1	0.496	0.692	C0265234	Branchio-Oto-Renal Syndrome	disease	C16	Disease or Syndrome	0.9	1	1998	2018	11	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
19510	6495	SIX1	0.496	0.692	C1842124	BRANCHIOOTIC SYNDROME 3 (disorder)	disease	C16	Disease or Syndrome	0.72	1	1998	2019	8	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
19511	6495	SIX1	0.496	0.692	C1854594	DEAFNESS, AUTOSOMAL DOMINANT 23	disease	C23;C10;C09	Disease or Syndrome	0.6	1	1998	2009	2	4	CTD_human;GENOMICS_ENGLAND
19521	6496	SIX3	0.56	0.692	C0079541	Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.7	1	1996	2018	1	0	CTD_human;GENOMICS_ENGLAND
19522	6496	SIX3	0.56	0.692	C0266484	Schizencephaly	disease	C16;C10	Congenital Abnormality	0.61	1	2008	2010	2	2	GENOMICS_ENGLAND;UNIPROT
19528	6496	SIX3	0.56	0.692	C1834877	HOLOPROSENCEPHALY 2 (disorder)	disease	C16;C05;C10	Disease or Syndrome	0.92	1	1999	2011	7	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
19544	6497	SKI	0.503	0.808	C1321551	Shprintzen-Goldberg syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.74	1	2002	2015	4	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19559	6499	SKIV2L	0.615	0.654	C1857276	Trichohepatoenteric Syndrome	disease	C23;C16;C13;C17	Disease or Syndrome	0.67	0.889	2012	2018	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
19560	6499	SKIV2L	0.615	0.654	C3281289	TRICHOHEPATOENTERIC SYNDROME 2	disease		Disease or Syndrome	0.6	1	2012	2017	3	0	GENOMICS_ENGLAND;UNIPROT
19574	6502	SKP2	0.492	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.6	1	1998	2019	1	0	CTD_human
19595	6505	SLC1A1	0.561	0.654	C0152136	Low Tension Glaucoma	disease	C11	Disease or Syndrome	0.53	1	2007	2018	1	0	CTD_human
19622	6505	SLC1A1	0.561	0.654	C1857253	Dicarboxylicaminoaciduria	disease	C23;C16;C13;C12;C10;F03;F01	Disease or Syndrome	0.91	1	1992	2011	3	0	CLINGEN;CTD_human;ORPHANET;UNIPROT
19654	6506	SLC1A2	0.511	0.731	C4310717	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41	disease		Disease or Syndrome	0.7	1	2012	2018	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
19666	6507	SLC1A3	0.573	0.577	C2675211	EPISODIC ATAXIA, TYPE 6 (disorder)	disease	C23;C10	Disease or Syndrome	0.72	1	2005	2017	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19672	6509	SLC1A4	0.7	0.385	C4225254	SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY	disease		Disease or Syndrome	0.7	1	2015	2018	4	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
19699	6513	SLC2A1	0.388	0.808	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.7	1	1998	2018	4	4	CTD_human;GENOMICS_ENGLAND
19751	6513	SLC2A1	0.388	0.808	C1832855	CHOREOATHETOSIS/SPASTICITY, EPISODIC	disease	C23;C05;C10	Disease or Syndrome	0.71	1	2008	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19752	6513	SLC2A1	0.388	0.808	C1837206	Cryohydrocytosis, Stomatin-Deficient, with Mental Retardation, Seizures, Cataracts, and Massive Hepatosplenomegaly	disease	C23;C06;C18;C11;C10;F03;F01	Disease or Syndrome	0.7	1	2011	2014	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19754	6513	SLC2A1	0.388	0.808	C1842534	DYSTONIA 18 (disorder)	disease	C10	Disease or Syndrome	0.75	1	2000	2019	15	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19755	6513	SLC2A1	0.388	0.808	C1847501	Glut1 Deficiency Syndrome	disease	C16;C18	Disease or Syndrome	0.8	0.983	1989	2019	12	4	CLINGEN;CTD_human;ORPHANET
19762	6513	SLC2A1	0.388	0.808	C3553859	EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	disease		Finding	0.6	1	2000	2015	6	11	GENOMICS_ENGLAND;UNIPROT
19763	6513	SLC2A1	0.388	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.65	1	2010	2017	2	0	CTD_human;GENOMICS_ENGLAND
19770	6513	SLC2A1	0.388	0.808	C4551966	GLUT1 DEFICIENCY SYNDROME 1	disease	C16;C18	Disease or Syndrome	0.7	1	1989	2018	25	35	CLINGEN;GENOMICS_ENGLAND;UNIPROT
19775	6514	SLC2A2	0.572	0.692	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.7	0.839	1990	2019	1	3	CTD_human
19790	6514	SLC2A2	0.572	0.692	C3495427	Fanconi-Bickel Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.8	0.974	1997	2019	10	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19817	6519	SLC3A1	0.593	0.731	C0010691	Cystinuria	disease	C16;C13;C12	Disease or Syndrome	1	0.987	1993	2019	20	34	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
19821	6519	SLC3A1	0.593	0.731	C1848030	Hypotonia-Cystinuria Syndrome	disease	C23;C16;C18;C13;C05;C12;C10;F03;F01	Disease or Syndrome	0.57	0.889	2006	2019	2	0	CTD_human;ORPHANET
19826	6521	SLC4A1	0.522	0.731	C0001126	Renal tubular acidosis	phenotype	C16;C18;C13;C12	Disease or Syndrome	0.69	1	1996	2013	2	0	CTD_human
19830	6521	SLC4A1	0.522	0.731	C0013902	Elliptocytosis, Hereditary	disease	C16;C15	Disease or Syndrome	0.62	1	1992	2005	2	0	CTD_human;GENOMICS_ENGLAND
19834	6521	SLC4A1	0.522	0.731	C0037889	Hereditary spherocytosis	disease	C16;C15	Disease or Syndrome	0.6	1	1992	2019	2	0	CTD_human;ORPHANET
19841	6521	SLC4A1	0.522	0.731	C1704380	Distal Renal Tubular Acidosis	disease	C16;C18;C13;C12	Disease or Syndrome	0.8	0.964	1997	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
19843	6521	SLC4A1	0.522	0.731	C1861453	Pseudohyperkalemia Cardiff	disease	C18	Disease or Syndrome	0.75	1	1991	2019	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19846	6521	SLC4A1	0.522	0.731	C1862322	Ovalocytosis, Malaysian-Melanesian-Filipino Type	disease	C16;C15	Disease or Syndrome	0.8	0.955	1991	2019	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
19848	6521	SLC4A1	0.522	0.731	C1969038	RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA (disorder)	disease	C16;C18;C13;C12;C15	Disease or Syndrome	0.7	1	1998	2004	4	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19850	6521	SLC4A1	0.522	0.731	C2675212	Spherocytosis, Type 4	disease	C16;C15	Disease or Syndrome	0.9	1	1991	2005	17	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
19864	6523	SLC5A1	0.584	0.654	C0268186	Congenital glucose-galactose malabsorption	disease	C16;C06;C18	Disease or Syndrome; Congenital Abnormality	0.8	1	1991	2019	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19865	6524	SLC5A2	0.499	0.769	C0017980	Glycosuria, Renal	disease	C16;C18;C13;C12	Disease or Syndrome	0.8	1	2002	2020	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19901	6528	SLC5A5	0.499	0.769	C1848805	Thyroid Dyshormonogenesis 1	disease	C16;C05;C19	Disease or Syndrome	0.7	1	1997	2016	8	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19909	6529	SLC6A1	0.592	0.538	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.56	1	2002	2020	1	0	CTD_human
19911	6529	SLC6A1	0.592	0.538	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.54	1	2001	2015	1	0	CTD_human
19943	6529	SLC6A1	0.592	0.538	C4085238	MYOCLONIC-ATONIC EPILEPSY	disease		Disease or Syndrome	0.74	1	2012	2019	1	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
19951	6530	SLC6A2	0.49	0.846	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	0.8	2008	2020	5	0	PSYGENET
19981	6530	SLC6A2	0.49	0.846	C1535893	Orthostatic intolerance	phenotype	C23;C10	Finding	0.61	1	2000	2003	2	1	CTD_human;ORPHANET;UNIPROT
19995	6531	SLC6A3	0.453	0.885	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.52	1	1999	2013	6	0	CTD_human;PSYGENET
20005	6531	SLC6A3	0.453	0.885	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.6	0.964	1993	2020	1	0	CTD_human
20008	6531	SLC6A3	0.453	0.885	C0041671	Attention Deficit Disorder	disease	F03	Mental or Behavioral Dysfunction	0.54	1	1995	2017	4	0	CTD_human
20022	6531	SLC6A3	0.453	0.885	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.6	0.8	2001	2019	9	0	CTD_human;PSYGENET
20043	6531	SLC6A3	0.453	0.885	C2751067	Parkinsonism-Dystonia, Infantile	disease	C10	Disease or Syndrome	0.8	1	2009	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
20047	6531	SLC6A3	0.453	0.885	C4747621	PARKINSONISM-DYSTONIA, INFANTILE, 1	disease		Disease or Syndrome	0.6	1	2009	2014	3	6	GENOMICS_ENGLAND;UNIPROT
20051	6532	SLC6A4	0.429	0.808	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.6	0.8	1998	2020	7	0	CTD_human;PSYGENET
20053	6532	SLC6A4	0.429	0.808	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.6	0.945	1997	2019	1	0	CTD_human
20057	6532	SLC6A4	0.429	0.808	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	1995	2019	7	0	CTD_human;PSYGENET
20058	6532	SLC6A4	0.429	0.808	C0005587	Depression, Bipolar	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2000	2006	4	0	CTD_human;PSYGENET
20061	6532	SLC6A4	0.429	0.808	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	1	1997	2020	5	0	PSYGENET
20064	6532	SLC6A4	0.429	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.7	1	1997	2020	9	0	CTD_human;PSYGENET
20069	6532	SLC6A4	0.429	0.808	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.53	1	2001	2009	1	0	CTD_human
20074	6532	SLC6A4	0.429	0.808	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.54	1	1998	2012	9	0	CTD_human;PSYGENET
20076	6532	SLC6A4	0.429	0.808	C0028768	Obsessive-Compulsive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	0.886	1997	2019	2	0	CTD_human;GENOMICS_ENGLAND
20083	6532	SLC6A4	0.429	0.808	C0038644	Sudden infant death syndrome	disease	C23	Disease or Syndrome	0.8	0.933	2001	2014	2	0	CTD_human;GENOMICS_ENGLAND
20084	6532	SLC6A4	0.429	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.6	0.8	1995	2020	9	0	CTD_human;PSYGENET
20086	6532	SLC6A4	0.429	0.808	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2001	2006	4	0	CTD_human;PSYGENET
20106	6532	SLC6A4	0.429	0.808	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.6	0.8	1996	2019	6	0	CTD_human;PSYGENET
20109	6532	SLC6A4	0.429	0.808	C0600427	Cocaine Dependence	disease	C25;F03	Mental or Behavioral Dysfunction	0.55	0.75	2001	2020	5	0	CTD_human;PSYGENET
20115	6532	SLC6A4	0.429	0.808	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	0.8	1998	2020	6	0	CTD_human;PSYGENET
20129	6535	SLC6A8	0.476	0.846	C1845862	Creatine deficiency, X-linked	disease	C16;C18;C10	Disease or Syndrome	1	1	2001	2019	11	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
20137	6536	SLC6A9	0.641	0.5	C4310943	GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	disease		Disease or Syndrome	0.7	1	2016	2016	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
20227	6548	SLC9A1	0.55	0.731	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.51	1	2007	2010	1	0	CTD_human
20244	6548	SLC9A1	0.55	0.731	C4225383	LICHTENSTEIN-KNORR SYNDROME	disease		Disease or Syndrome	0.72	0.667	2015	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20257	6550	SLC9A3	0.612	0.615	C0267663	Congenital secretory diarrhea, sodium type (disorder)	disease	C23;C16;C18	Congenital Abnormality	0.72	1	2015	2019	1	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20273	6555	SLC10A2	0.621	0.538	C2750087	Bile Acid Malabsorption, Primary	disease	C23;C06;C18	Disease or Syndrome	0.71	1	1997	1997	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
20289	6556	SLC11A1	0.525	0.846	C0041296	Tuberculosis	disease	C01	Disease or Syndrome	0.6	0.971	1994	2019	1	0	CTD_human;ORPHANET
20314	6557	SLC12A1	0.631	0.538	C1866495	Bartter syndrome, antenatal type 1	disease	C13;C12;C19	Disease or Syndrome	0.92	1	1996	2017	4	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20320	6558	SLC12A2	0.552	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2004	2019	1	0	CTD_human
20346	6559	SLC12A3	0.493	0.808	C0268450	Gitelman Syndrome	disease	C16;C13;C12	Disease or Syndrome	0.9	1	1996	2020	20	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20358	6566	SLC16A1	0.499	0.846	C1855577	Erythrocyte Lactate Transporter Defect	disease	C05;C10	Disease or Syndrome	0.7	1	2000	2003	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20359	6566	SLC16A1	0.499	0.846	C1864902	Hyperinsulinemic hypoglycemia, familial, 7	disease	C18	Disease or Syndrome	0.7	1	2007	2007	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
20360	6566	SLC16A1	0.499	0.846	C4015186	MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY	disease		Disease or Syndrome	0.6	1	2014	2014	1	1	CTD_human;ORPHANET;UNIPROT
20362	6567	SLC16A2	0.592	0.577	C0795889	Allan-Herndon-Dudley syndrome (AHDS)	disease	C23;C16;C10	Disease or Syndrome	1	1	2004	2020	16	29	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20370	6569	SLC34A1	0.619	0.423	C0085682	Hypophosphatemia	phenotype	C18	Disease or Syndrome	0.68	1	1996	2019	1	0	CTD_human
20372	6569	SLC34A1	0.619	0.423	C0341703	Adult Fanconi syndrome	disease	C16;C13;C12	Disease or Syndrome	0.51	1	2010	2019	1	0	CTD_human;ORPHANET
20375	6569	SLC34A1	0.619	0.423	C2676786	Nephrolithiasis-Osteoporosis, Hypophosphatemic, 1	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.7	1	2002	2014	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
20379	6569	SLC34A1	0.619	0.423	C4310473	Hypercalcemia, infantile, 2	disease	C18	Disease or Syndrome	0.7	1	2010	2016	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
20391	6571	SLC18A2	0.554	0.769	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.6	0.966	1996	2020	1	0	CTD_human
20407	6572	SLC18A3	0.608	0.654	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.55	1	2016	2019	1	0	CTD_human;GENOMICS_ENGLAND
20412	6572	SLC18A3	0.608	0.654	C4310654	MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	disease		Disease or Syndrome	0.6	1	2016	2019	2	0	GENOMICS_ENGLAND;UNIPROT
20453	6591	SNAI2	0.505	0.692	C0080024	Piebaldism	disease	C16;C18;C17	Congenital Abnormality	0.73	1	1998	2014	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
20461	6591	SNAI2	0.505	0.692	C1837203	WAARDENBURG SYNDROME, TYPE IID	disease	C16	Disease or Syndrome	0.7	1	1998	2002	1	0	CTD_human;GENOMICS_ENGLAND
20469	6594	SMARCA1	0.504	0.808	C0265338	Coffin-Siris syndrome	disease	C23;C16;C05;C10;F03;C07;F01	Disease or Syndrome	0.57	1	2012	2019	2	0	CLINGEN;GENOMICS_ENGLAND
20473	6595	SMARCA2	0.527	0.769	C0265338	Coffin-Siris syndrome	disease	C23;C16;C05;C10;F03;C07;F01	Disease or Syndrome	0.53	1	2012	2019	1	0	CTD_human;GENOMICS_ENGLAND
20475	6595	SMARCA2	0.527	0.769	C1303073	Nicolaides Baraitser syndrome	disease	C23;C16;C17;C05;C10;F03;F01	Disease or Syndrome	0.8	0.929	2012	2020	4	36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20491	6597	SMARCA4	0.45	0.885	C0265338	Coffin-Siris syndrome	disease	C23;C16;C05;C10;F03;C07;F01	Disease or Syndrome	0.57	0.875	2012	2018	1	0	CTD_human;GENOMICS_ENGLAND
20515	6648	SOD2	0.379	0.923	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.51	1	2005	2020	2	0	CTD_human
20539	6648	SOD2	0.379	0.923	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.55	1	2005	2020	5	0	CTD_human
20540	6648	SOD2	0.379	0.923	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.57	0.917	2005	2020	5	0	CTD_human
20542	6648	SOD2	0.379	0.923	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.55	1	2002	2019	3	0	CTD_human
20565	6648	SOD2	0.379	0.923	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.52	1	1997	2019	1	0	CTD_human
20619	6648	SOD2	0.379	0.923	C0162871	Aortic Aneurysm, Abdominal	disease	C14	Disease or Syndrome	0.51	1	2007	2018	1	0	CTD_human
20704	6654	SOS1	0.485	0.808	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	1	0.969	1991	2019	13	23	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
20714	6654	SOS1	0.485	0.808	C1853120	Noonan Syndrome 4	disease	C16;C17;C05;C14	Disease or Syndrome	0.9	1	2007	2013	11	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
20719	6655	SOS2	0.608	0.692	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.62	1	2000	2015	4	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
20725	6655	SOS2	0.608	0.692	C4225282	NOONAN SYNDROME 9	disease		Disease or Syndrome	0.7	1	2015	2015	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
20764	6657	SOX2	0.405	0.808	C1859773	Microphthalmia, Syndromic 3	disease	C16;C06;C11;C10	Disease or Syndrome	0.75	1	1996	2018	7	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20769	6658	SOX3	0.535	0.731	C0342376	Panhypopituitarism - X-linked	disease	C16;C10;C19	Disease or Syndrome	0.51	1	1981	2018	2	0	CTD_human;GENOMICS_ENGLAND
20773	6658	SOX3	0.535	0.731	C2678223	Mental Retardation, X-Linked, With Panhypopituitarism	disease	C23;C16;C10;C19;F03;F01	Disease or Syndrome	0.6	1	1981	2005	3	1	CTD_human;GENOMICS_ENGLAND
20816	6662	SOX9	0.419	0.846	C0031900	Pierre Robin Syndrome	disease	C16;C05;C07	Congenital Abnormality	0.7	0.867	1996	2019	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
20831	6662	SOX9	0.419	0.846	C1861922	CAMPOMELIC DYSPLASIA	disease	C16;C05	Disease or Syndrome	1	0.972	1994	2019	16	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20832	6662	SOX9	0.419	0.846	C1861923	Acampomelic Campomelic Dysplasia	disease	C16;C05	Disease or Syndrome	0.69	1	2000	2018	0	0	CTD_human
20840	6663	SOX10	0.461	0.808	C0162809	Kallmann Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.55	1	2013	2019	1	0	ORPHANET
20843	6663	SOX10	0.461	0.808	C1836727	Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, and Hirschsprung Disease	disease	C16;C06;C10	Disease or Syndrome	0.93	1	1998	2018	9	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20846	6663	SOX10	0.461	0.808	C2700265	Waardenburg Syndrome Type 2	disease	C16	Disease or Syndrome	0.57	1	2007	2017	2	0	CTD_human;ORPHANET
20847	6663	SOX10	0.461	0.808	C2700405	WAARDENBURG SYNDROME, TYPE IIE	disease	C16	Disease or Syndrome	0.7	1	1998	2011	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
20848	6663	SOX10	0.461	0.808	C2750452	Waardenburg Syndrome, Type 4c	disease	C16;C06	Disease or Syndrome	0.9	1	1990	2017	16	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
20849	6663	SOX10	0.461	0.808	C3266898	Waardenburg Syndrome	disease	C16	Disease or Syndrome	0.6	0.974	1998	2019	4	0	GENOMICS_ENGLAND;ORPHANET
20854	6664	SOX11	0.494	0.808	C0265338	Coffin-Siris syndrome	disease	C23;C16;C05;C10;F03;C07;F01	Disease or Syndrome	0.66	0.833	2014	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
20855	6664	SOX11	0.494	0.808	C4014528	MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	disease		Disease or Syndrome	0.6	1	2014	2016	2	5	GENOMICS_ENGLAND;UNIPROT
20873	6671	SP4	0.711	0.423	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.63	1	2009	2019	2	1	CTD_human;PSYGENET
20876	6671	SP4	0.711	0.423	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.66	1	2005	2019	1	2	CTD_human
20879	6674	SPAG1	0.663	0.577	C3809706	CILIARY DYSKINESIA, PRIMARY, 28	disease		Disease or Syndrome	0.6	1	2013	2016	1	10	CTD_human;GENOMICS_ENGLAND
20899	6678	SPARC	0.445	0.846	C0029434	Osteogenesis Imperfecta	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.52	1	1991	2018	2	0	CTD_human;GENOMICS_ENGLAND
20922	6678	SPARC	0.445	0.846	C4225301	OSTEOGENESIS IMPERFECTA, TYPE XVII	disease		Disease or Syndrome	0.7	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
20927	6683	SPAST	0.579	0.577	C1866855	Spastic paraplegia 4, autosomal dominant	disease	C16;C10	Disease or Syndrome	1	1	1991	2019	46	100	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20937	6687	SPG7	0.436	0.885	C1846564	SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE	disease	C16;C10	Disease or Syndrome	0.93	1	1998	2018	9	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20939	6687	SPG7	0.436	0.885	C3711370	Spastic Paraplegia Type 7	disease	C23;C16;C10	Disease or Syndrome	0.55	1	2004	2017	1	0	ORPHANET
20941	6688	SPI1	0.631	0.654	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.6	1	1999	2019	1	0	CTD_human
20946	6689	SPIB	0.628	0.538	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.62	1	2010	2015	1	2	CTD_human;ORPHANET
20954	6690	SPINK1	0.492	0.808	C0238339	Hereditary pancreatitis	disease	C06	Disease or Syndrome	0.8	1	2000	2018	7	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20958	6690	SPINK1	0.492	0.808	C1842402	TROPICAL CALCIFIC PANCREATITIS	disease	C06;C18	Disease or Syndrome	0.8	0.938	2002	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20973	6696	SPP1	0.353	0.885	C0017638	Glioma	disease	C04	Neoplastic Process	0.6	1	1995	2019	1	0	CTD_human
20981	6696	SPP1	0.353	0.885	C0022650	Kidney Calculi	disease	C23;C13;C12	Disease or Syndrome	0.6	1	1993	2019	2	0	CTD_human
21018	6696	SPP1	0.353	0.885	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.56	1	1998	2018	1	0	CTD_human
21048	6697	SPR	0.631	0.654	C0268468	Dystonia, Dopa-Responsive, due to Sepiapterin Reductase Deficiency	disease	C23;C16;C18;C10;F01	Disease or Syndrome	0.71	0.889	2001	2017	7	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21063	6708	SPTA1	0.638	0.538	C0520739	Hereditary pyropoikilocytosis	disease	C16;C15	Disease or Syndrome	0.73	1	1989	2019	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
21064	6708	SPTA1	0.638	0.538	C1851741	ELLIPTOCYTOSIS 2 (disorder)	disease	C16;C15	Disease or Syndrome	0.7	1	1989	1996	13	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
21065	6708	SPTA1	0.638	0.538	C2678338	SPHEROCYTOSIS, TYPE 3 (disorder)	disease	C16;C15	Disease or Syndrome	0.8	1	1962	2016	2	4	CTD_human;GENOMICS_ENGLAND
21072	6709	SPTAN1	0.601	0.615	C3150731	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	disease		Disease or Syndrome	0.61	1	2010	2018	1	6	CTD_human;GENOMICS_ENGLAND
21077	6710	SPTB	0.65	0.462	C0013902	Elliptocytosis, Hereditary	disease	C16;C15	Disease or Syndrome	0.75	1	1990	2016	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
21078	6710	SPTB	0.65	0.462	C0037889	Hereditary spherocytosis	disease	C16;C15	Disease or Syndrome	0.68	1	1990	2020	3	3	CTD_human;ORPHANET
21082	6710	SPTB	0.65	0.462	C1866810	ELLIPTOCYTOSIS 3	disease	C16;C15	Disease or Syndrome	0.6	1	1990	1995	4	9	GENOMICS_ENGLAND;UNIPROT
21083	6710	SPTB	0.65	0.462	C2674219	SPHEROCYTOSIS, HEREDITARY, 2	disease		Disease or Syndrome	0.7	1	1993	2016	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
21094	6712	SPTBN2	0.619	0.731	C0752123	Spinocerebellar Ataxia Type 5	disease	C16;C10	Disease or Syndrome	1	0.938	2006	2019	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
21098	6712	SPTBN2	0.619	0.731	C3809327	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	disease		Disease or Syndrome	0.63	1	2012	2019	2	3	GENOMICS_ENGLAND;ORPHANET
21127	6714	SRC	0.467	0.885	C4310789	THROMBOCYTOPENIA 6	disease		Disease or Syndrome	0.7	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21135	6715	SRD5A1	0.631	0.538	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.54	1	2003	2010	2	0	CTD_human
21137	6715	SRD5A1	0.631	0.538	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.55	1	2006	2017	2	0	CTD_human
21149	6716	SRD5A2	0.564	0.615	C0268297	Pseudovaginal Perineoscrotal Hypospadias	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.8	1	1977	2019	18	39	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21158	6716	SRD5A2	0.564	0.615	C3669122	5-Alpha Reductase Deficiency	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.6	1	1992	2019	3	0	CTD_human;ORPHANET
21165	6718	AKR1D1	0.711	0.385	C1856127	Bile acid synthesis defect, congenital, 2	disease	C16;C06;C18	Disease or Syndrome	0.7	1	2003	2015	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21180	6721	SREBF2	0.566	0.577	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.53	1	2003	2019	1	0	CTD_human;UNIPROT
21206	6729	SRP54	0.612	0.769	C0272170	Shwachman syndrome	disease		Disease or Syndrome	0.51	1	2017	2019	1	0	CTD_human;ORPHANET
21221	6731	SRP72	0.711	0.269	C3808553	Bone marrow failure syndrome 1	disease		Disease or Syndrome	0.7	1	2012	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21233	6736	SRY	0.456	0.808	C2748895	Ovotesticular Disorders of Sex Development	disease	C16;C13;C12;C19	Congenital Abnormality	0.8	1	1992	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
21234	6736	SRY	0.456	0.808	C2748896	46,Xy Gonadal Dysgenesis, Complete, Sry-Related	disease	C16;C13;C12;C19	Disease or Syndrome	0.7	1	1990	2017	25	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
21245	6748	SSR4	0.705	0.423	C4012395	Congenital disorder of glycosylation type 1y	disease	C16;C18	Disease or Syndrome	0.7	1	2014	2015	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
21377	6756	SSX1	0.674	0.308	C0039101	synovial sarcoma	disease	C04	Neoplastic Process	0.7	0.918	1998	2018	2	0	CTD_human;ORPHANET
21380	6757	SSX2	0.581	0.615	C0039101	synovial sarcoma	disease	C04	Neoplastic Process	0.7	0.973	1994	2020	1	0	CTD_human;ORPHANET
21382	6760	SS18	0.641	0.462	C0039101	synovial sarcoma	disease	C04	Neoplastic Process	0.6	0.959	1994	2020	2	0	CTD_human;ORPHANET
21387	6768	ST14	0.514	0.769	C1835851	Ichthyosis with hypotrichosis, autosomal recessive	disease	C16;C17	Disease or Syndrome	0.75	1	2007	2018	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21390	6770	STAR	0.513	0.808	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.56	1	1999	2019	1	0	CTD_human
21391	6770	STAR	0.513	0.808	C0342474	Lipoid congenital adrenal hyperplasia	disease	C16;C18;C13;C12;C19	Disease or Syndrome	0.8	1	1995	2018	7	33	CTD_human;GENOMICS_ENGLAND;UNIPROT
21398	6772	STAT1	0.399	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	1	2000	2019	0	0	UNIPROT
21413	6772	STAT1	0.399	0.885	C3151088	IMMUNODEFICIENCY 31B	disease		Disease or Syndrome	0.7	1	2003	2019	8	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21414	6772	STAT1	0.399	0.885	C3279990	CANDIDIASIS, FAMILIAL, 7	disease		Disease or Syndrome	0.7	1	2011	2019	8	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21415	6772	STAT1	0.399	0.885	C4013950	IMMUNODEFICIENCY 31A	disease		Disease or Syndrome	0.7	1	2001	2019	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21417	6773	STAT2	0.569	0.615	C4225260	IMMUNODEFICIENCY 44	disease		Disease or Syndrome	0.7	1	2012	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
21465	6774	STAT3	0.32	0.923	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.7	0.968	2005	2020	1	1	CTD_human
21536	6774	STAT3	0.32	0.923	C1955861	T-Cell Large Granular Lymphocyte Leukemia	disease	C04;C20;C15	Neoplastic Process	0.6	1	2012	2020	2	0	CGI;ORPHANET
21537	6774	STAT3	0.32	0.923	C1968689	Hyper-Immunoglobulin E Syndrome, Autosomal Recessive	disease	C16;C20;C15	Disease or Syndrome	0.55	1	2011	2019	1	0	CTD_human
21539	6774	STAT3	0.32	0.923	C2936739	Hyper-Immunoglobulin E Syndrome, Autosomal Dominant	disease	C16;C20;C15	Disease or Syndrome	0.8	0.981	2007	2020	3	0	CTD_human;ORPHANET
21544	6774	STAT3	0.32	0.923	C3887645	Job Syndrome	disease	C16;C20;C15	Disease or Syndrome	0.8	1	2007	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
21545	6774	STAT3	0.32	0.923	C4014795	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1	disease		Disease or Syndrome	0.7	1	2014	2017	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21554	6774	STAT3	0.32	0.923	C4721531	HYPER-IgE RECURRENT INFECTION SYNDROME 1, AUTOSOMAL DOMINANT	disease	C16;C20;C15	Disease or Syndrome	0.63	1	2007	2018	7	14	GENOMICS_ENGLAND;UNIPROT
21557	6775	STAT4	0.471	0.769	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.67	1	2010	2019	3	2	CTD_human;ORPHANET
21561	6775	STAT4	0.471	0.769	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	0.961	2002	2020	5	15	CTD_human;ORPHANET
21568	6775	STAT4	0.471	0.769	C1527336	Sjogrens Syndrome	disease	C11;C17;C05;C20;C07	Disease or Syndrome	0.45	1	2008	2017	   2	   4	CTD_human
     6775	STAT4	0.471	0.769	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.50	1	2013	2019	   1	   5	CTD_human
     6775	STAT4	0.471	0.769	C2677096	SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11	disease		Finding	0.40				   0	   1	GENOMICS_ENGLAND
     6775	STAT4	0.471	0.769	C2931171	Juvenile pauciarticular chronic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.40	1	2013	2013	   1	   1	ORPHANET
     6775	STAT4	0.471	0.769	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.33	1	2004	2012	   2	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.897	1998	2018	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0007097	Carcinoma	group	C04	Neoplastic Process	0.31	1	2002	2013	   3	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0007124	Noninfiltrating Intraductal Carcinoma	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2008	2011	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	2002	2010	   5	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.50	1	2002	2007	   3	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0032927	Precancerous Conditions	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2010	2011	   2	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2007	   3	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.30	1	2002	2007	   3	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2007	   3	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.30	1	2002	2007	   3	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0206692	Carcinoma, Lobular	disease	C04;C17	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.34	1	2011	2019	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0282313	Condition, Preneoplastic	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2006	2006	   1	   0	GENOMICS_ENGLAND
     6776	STAT5A	0.445	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.897	1998	2018	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C1176475	Ductal Carcinoma	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	2002	2010	   5	   0	CTD_human
     6776	STAT5A	0.445	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C1332347	Atypical Ductal Breast Hyperplasia	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.38	1	2004	2011	   1	   0	CTD_human
     6776	STAT5A	0.445	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0007117	Basal cell carcinoma	disease	C04	Neoplastic Process	0.30				   0	   0	CGI
     6777	STAT5B	0.442	0.808	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.57	0.857	2000	2019	   1	   0	CGI;ORPHANET
     6777	STAT5B	0.442	0.808	C0023494	Leukemia, T-Cell, Chronic	disease	C04;C20;C15	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2018	2018	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.32	1	2015	2016	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0079773	Lymphoma, T-Cell, Cutaneous	disease	C04;C20;C15	Neoplastic Process	0.35	0.833	2002	2016	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0376407	Granulomatous Slack Skin	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0392788	Nasal Type Extranodal NK/T-Cell Lymphoma	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0456889	Enteropathy-Associated T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
     6777	STAT5B	0.442	0.808	C1522378	Leukemia, Large Granular Lymphocytic	disease	C04;C20;C15	Neoplastic Process	0.33	1	2013	2018	   2	   0	CTD_human
     6777	STAT5B	0.442	0.808	C1855548	Laron syndrome type 2	disease	C16;C05;C19	Disease or Syndrome	0.70	1	2003	2016	   5	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     6777	STAT5B	0.442	0.808	C1955860	Leukemia, Natural Killer Cell Large Granular Lymphocytic	disease	C04;C20;C15	Neoplastic Process	0.30	1	2015	2018	   2	   0	CTD_human
     6777	STAT5B	0.442	0.808	C1955861	T-Cell Large Granular Lymphocyte Leukemia	disease	C04;C20;C15	Neoplastic Process	0.53	1	2013	2018	   2	   0	CGI;CTD_human
     6777	STAT5B	0.442	0.808	C1955906	Lymphoma, Extranodal NK-T-Cell	disease	C04	Neoplastic Process	0.30	1	2018	2018	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.33	1	2011	2020	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C2363142	T-Cell Prolymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.33	1	2014	2019	   1	   0	CTD_human
     6777	STAT5B	0.442	0.808	C2931322	T-Lymphocytopenia	disease	C20;C15	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0011615	Dermatitis, Atopic	disease	C16;C17;C20	Disease or Syndrome	0.40	1	2002	2018	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0013604	Edema	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0018922	hemangiopericytoma	disease	C04	Neoplastic Process	0.39	1	2013	2019	   2	   0	ORPHANET
     6778	STAT6	0.475	0.808	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.32	1	2016	2018	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0079744	Diffuse Large B-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.33	1	2004	2007	   0	   0	CGI
     6778	STAT6	0.475	0.808	C0086196	Eczema, Infantile	disease	C16;C17;C20	Disease or Syndrome	0.30	1	2004	2004	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0151603	Anasarca	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     6778	STAT6	0.475	0.808	C1266119	Solitary fibrous tumor	disease	C04	Neoplastic Process	0.60	0.961	2013	2020	   2	   0	CTD_human;ORPHANET
     6778	STAT6	0.475	0.808	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     6779	STATH	0.608	0.769	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0019187	Hepatitis, Alcoholic	disease	C06;C25	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0019193	Hepatitis, Toxic	disease	C06;C25	Injury or Poisoning	0.30	1	2014	2014	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2006	2006	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0023895	Liver diseases	group	C06	Disease or Syndrome	0.30	1	2015	2015	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.31	1	2000	2007	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0035126	Reperfusion Injury	disease	C23;C14	Injury or Poisoning	0.50	1	2006	2015	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0086565	Liver Dysfunction	phenotype	C06	Finding	0.30	1	2015	2015	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.35	1	2006	2016	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0524610	Chronic Alcoholic Hepatitis	disease	C06;C25	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C0860207	Drug-Induced Liver Disease	phenotype	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C1262760	Hepatitis, Drug-Induced	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C3658290	Drug-Induced Acute Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C4277682	Chemical and Drug Induced Liver Injury	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     6783	SULT1E1	0.508	0.808	C4279912	Chemically-Induced Liver Toxicity	disease	C06;C25	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     6785	ELOVL4	0.601	0.577	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     6785	ELOVL4	0.601	0.577	C0271093	Stargardts disease	phenotype		Disease or Syndrome	0.54	1	2005	2012	1	0	ORPHANET
21569	6785	ELOVL4	0.601	0.577	C1838644	Stargardt disease 3	disease	C11	Disease or Syndrome	0.9	0.929	1998	2019	0	3	CTD_human;GENOMICS_ENGLAND
21570	6785	ELOVL4	0.601	0.577	C1851481	Erythrokeratodermia with ataxia	disease	C23;C16;C17;C10	Disease or Syndrome	0.73	1	2014	2019	2	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
21571	6785	ELOVL4	0.601	0.577	C1855465	STARGARDT DISEASE 1 (disorder)	disease		Disease or Syndrome	0.54	1	1999	2018	1	0	ORPHANET
21572	6785	ELOVL4	0.601	0.577	C3280856	ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION	disease		Disease or Syndrome	0.6	1	2011	2011	1	5	GENOMICS_ENGLAND;ORPHANET
21580	6786	STIM1	0.501	0.808	C0410207	Tubular Aggregate Myopathy	disease	C05;C10	Disease or Syndrome	0.7	1	2013	2020	1	4	CTD_human;ORPHANET
21585	6786	STIM1	0.501	0.808	C1861451	Stormorken Syndrome	disease	C23;C16;C11;C17;C10;F03;C15	Disease or Syndrome	0.8	1	2013	2020	5	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
21586	6786	STIM1	0.501	0.808	C2748557	Immune dysfunction with T-cell inactivation due to calcium entry defect 2	disease	C16;C18;C20	Disease or Syndrome	0.72	1	2009	2017	3	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21592	6786	STIM1	0.501	0.808	C4011726	MYOPATHY, TUBULAR AGGREGATE, 1	disease	C05;C10	Disease or Syndrome	0.6	1	2013	2015	4	6	GENOMICS_ENGLAND;UNIPROT
21604	6789	STK4	0.638	0.462	C3553943	T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH OR WITHOUT CARDIAC MALFORMATIONS	disease		Disease or Syndrome	0.73	1	2012	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
21636	6792	CDKL5	0.522	0.692	C0162635	Angelman Syndrome	disease	C16;C10	Disease or Syndrome	0.52	1	2004	2014	1	0	CTD_human;GENOMICS_ENGLAND
21660	6792	CDKL5	0.522	0.692	C1839333	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2	disease	C10	Disease or Syndrome	0.7	0.972	2003	2019	23	16	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21674	6794	STK11	0.435	0.808	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.6	1	1998	2019	0	5	GENOMICS_ENGLAND;UNIPROT
21677	6794	STK11	0.435	0.808	C0025202	melanoma	disease	C04	Neoplastic Process	0.7	1	1999	2018	0	4	CGI;UNIPROT
21679	6794	STK11	0.435	0.808	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.61	1	2004	2015	1	1	CGI;CTD_human
21680	6794	STK11	0.435	0.808	C0031269	Peutz-Jeghers Syndrome	disease	C16;C06;C04;C17	Disease or Syndrome	1	0.992	1997	2019	19	75	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21684	6794	STK11	0.435	0.808	C0152013	Adenocarcinoma of lung (disorder)	disease	C04	Neoplastic Process	0.7	1	2002	2019	1	2	CGI;CTD_human
21693	6794	STK11	0.435	0.808	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.6	1	2003	2020	1	1	CTD_human;UNIPROT
21697	6794	STK11	0.435	0.808	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.6	1	1999	2019	1	0	CGI;CTD_human
21704	6794	STK11	0.435	0.808	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.55	1	1999	2015	0	1	CGI;UNIPROT
21712	6795	AURKC	0.736	0.308	C0403812	Male Infertility with Large-Headed, Multiflagellar, Polyploid Spermatozoa	disease	C12	Disease or Syndrome	0.6	1	2007	2011	2	3	CTD_human;ORPHANET
21720	6809	STX3	0.769	0.423	C0341306	Microvillus inclusion disease	disease	C16;C06;C18;C05;C10	Disease or Syndrome	0.53	1	2014	2020	2	0	GENOMICS_ENGLAND;ORPHANET
21737	6812	STXBP1	0.532	0.692	C0751122	Infantile Severe Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.53	1	2008	2018	2	0	CTD_human;ORPHANET
21740	6812	STXBP1	0.532	0.692	C2677326	Epileptic Encephalopathy, Early Infantile, 4	disease	C10	Disease or Syndrome	0.71	1	2008	2018	13	37	CTD_human;GENOMICS_ENGLAND;UNIPROT
21743	6813	STXBP2	0.686	0.5	C2751293	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5	disease	C15	Disease or Syndrome	0.71	1	2009	2017	4	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
21775	6820	SULT2B1	0.641	0.538	C4539754	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 14	disease		Congenital Abnormality	0.6	1	2017	2017	1	6	GENOMICS_ENGLAND;UNIPROT
21778	6821	SUOX	0.638	0.615	C0268624	Sulfite oxidase deficiency	disease	C16;C18	Disease or Syndrome	0.72	1	1996	2019	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
21781	6821	SUOX	0.638	0.615	C2931746	Sulfocysteinuria	disease	C16;C18	Disease or Syndrome	0.75	1	1997	2020	5	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21800	6833	ABCC8	0.474	0.846	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.7	0.9	1995	2018	2	8	CTD_human;GENOMICS_ENGLAND
21801	6833	ABCC8	0.474	0.846	C0158981	Neonatal diabetes mellitus	disease	C16;C18;C19	Disease or Syndrome	0.7	1	2000	2019	0	10	GENOMICS_ENGLAND
21803	6833	ABCC8	0.474	0.846	C0271714	Hypoglycemia, leucine-induced	disease	C18	Disease or Syndrome	0.7	1	2004	2004	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
21806	6833	ABCC8	0.474	0.846	C1832386	Diabetes Mellitus, Transient Neonatal, 1	disease	C16;C18;C19	Disease or Syndrome	0.55	1	2000	2015	3	0	ORPHANET
21807	6833	ABCC8	0.474	0.846	C1833104	DIABETES MELLITUS, PERMANENT NEONATAL	disease	C18;C19	Disease or Syndrome	0.8	1	2006	2018	7	26	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21808	6833	ABCC8	0.474	0.846	C1835887	DIABETES MELLITUS, TRANSIENT NEONATAL, 2 (disorder)	disease	C16;C18;C19	Disease or Syndrome	0.9	1	2000	2006	1	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
21810	6833	ABCC8	0.474	0.846	C2931832	Hyperinsulinemic hypoglycemia, familial, 1	disease	C16;C06;C18	Disease or Syndrome	0.7	1	1995	2018	21	146	CTD_human;GENOMICS_ENGLAND;UNIPROT
21819	6834	SURF1	0.578	0.654	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	1	0.987	1998	2018	17	23	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
21835	6834	SURF1	0.578	0.654	C4225246	SURF1-related Charcot-Marie-Tooth disease type 4	disease		Disease or Syndrome	0.7	1	2013	2013	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21846	6843	VAMP1	0.628	0.538	C1970107	ATAXIA, SPASTIC, 1, AUTOSOMAL DOMINANT	disease	C23;C16;C10	Disease or Syndrome	0.7	1	2012	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
21880	6853	SYN1	0.597	0.462	C1845343	Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders	disease	C23;C16;C10;F03	Disease or Syndrome	0.7	1	2004	2011	2	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
21932	6855	SYP	0.481	0.808	C3275408	MENTAL RETARDATION, X-LINKED 96	disease		Disease or Syndrome	0.7	1	2009	2009	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
21935	6857	SYT1	0.412	0.846	C4748715	BAKER-GORDON SYNDROME	disease		Disease or Syndrome	0.6	1	2015	2018	3	5	ORPHANET;UNIPROT
21937	6862	TBXT	0.674	0.462	C0008487	Chordoma	disease	C04	Neoplastic Process	0.62	1	2008	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
21950	6862	TBXT	0.674	0.462	C3810343	SACRAL AGENESIS WITH VERTEBRAL ANOMALIES	disease		Disease or Syndrome	0.7	1	2014	2014	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
21974	6863	TAC1	0.424	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.51	1	1996	2018	4	0	CTD_human
21978	6863	TAC1	0.424	0.923	C0030193	Pain	phenotype	C23	Sign or Symptom	0.6	0.96	1993	2020	3	0	CTD_human
22032	6866	TAC3	0.604	0.731	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.64	1	2009	2017	1	0	CTD_human;GENOMICS_ENGLAND
22036	6866	TAC3	0.604	0.731	C3553843	HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.7	1	2009	2013	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
22044	6868	ADAM17	0.453	0.808	C3280501	INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 1	disease		Disease or Syndrome	0.6	1	2010	2012	2	1	CTD_human;GENOMICS_ENGLAND
22048	6869	TACR1	0.502	0.885	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.55	1	2008	2014	5	0	CTD_human;PSYGENET
22049	6869	TACR1	0.502	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2009	2014	3	0	CTD_human;PSYGENET
22076	6870	TACR3	0.553	0.769	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	2008	2008	1	0	CTD_human;PSYGENET
22083	6870	TACR3	0.553	0.769	C0271623	Hypogonadotropic hypogonadism	disease	C19	Disease or Syndrome	0.83	1	2007	2016	1	0	CTD_human;GENOMICS_ENGLAND
22088	6870	TACR3	0.553	0.769	C3553844	HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.9	1	2007	2014	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22092	6872	TAF1	0.581	0.808	C1839130	Dystonia 3, Torsion, X-Linked	disease	C16;C10	Disease or Syndrome	0.8	0.962	1992	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
22094	6872	TAF1	0.581	0.808	C4225418	MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	disease		Disease or Syndrome	0.7	1	2015	2015	2	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22099	6873	TAF2	0.743	0.308	C3810080	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40	disease		Disease or Syndrome	0.7	1	2011	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22100	6875	TAF4B	0.792	0.192	C4014449	SPERMATOGENIC FAILURE 13	disease		Disease or Syndrome	0.6	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND
22109	6878	TAF6	0.769	0.308	C4310702	ALAZAMI-YUAN SYNDROME	disease		Disease or Syndrome	0.7	1	2015	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
22113	6884	TAF13	0.716	0.385	C4479476	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	disease		Mental or Behavioral Dysfunction	0.7	1	2017	2017	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
22116	6885	MAP3K7	0.477	0.808	C0265293	Frontometaphyseal dysplasia	disease	C16;C05	Congenital Abnormality	0.61	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22118	6885	MAP3K7	0.477	0.808	C2931461	Forney Robinson Pascoe syndrome	phenotype	C23;C16;C05;C10;C09;C14	Disease or Syndrome	0.71	1	2016	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22120	6885	MAP3K7	0.477	0.808	C4310697	FRONTOMETAPHYSEAL DYSPLASIA 2	disease		Disease or Syndrome	0.61	1	2015	2019	3	4	GENOMICS_ENGLAND;UNIPROT
22123	6886	TAL1	0.505	0.731	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.6	0.982	1990	2019	2	0	CTD_human;ORPHANET
22133	6888	TALDO1	0.608	0.654	C1291329	Transaldolase Deficiency	disease	C16;C18	Disease or Syndrome	0.74	1	2001	2015	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
22142	6890	TAP1	0.5	0.808	C1858266	Bare Lymphocyte Syndrome, Type I	disease	C16;C18;C20	Disease or Syndrome	0.6	1	1999	1999	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22145	6891	TAP2	0.517	0.808	C1858266	Bare Lymphocyte Syndrome, Type I	disease	C16;C18;C20	Disease or Syndrome	0.71	1	1994	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
22148	6892	TAPBP	0.576	0.769	C1858266	Bare Lymphocyte Syndrome, Type I	disease	C16;C18;C20	Disease or Syndrome	0.61	1	2002	2002	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22158	6898	TAT	0.492	0.846	C0268487	Tyrosine Transaminase Deficiency Disease	disease	C16;C18;C10	Disease or Syndrome	0.8	1	1969	2019	7	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22164	6899	TBX1	0.433	0.808	C0012236	DiGeorge Syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	1	0.988	1995	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22169	6899	TBX1	0.433	0.808	C0039685	Tetralogy of Fallot	disease	C16;C14	Congenital Abnormality	0.79	0.8	1995	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
22171	6899	TBX1	0.433	0.808	C0220704	Shprintzen syndrome	disease	C16;C05;C19;C15;C14	Disease or Syndrome	1	0.96	1996	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22176	6899	TBX1	0.433	0.808	C0795907	CONOTRUNCAL ANOMALY FACE SYNDROME	disease	C16;C05;C19;C15;C14	Disease or Syndrome	0.51	1	2003	2006	4	0	CTD_human;ORPHANET
22178	6899	TBX1	0.433	0.808	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	disease	C16;C14	Disease or Syndrome	0.61	1	1995	1995	0	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
22183	6900	CNTN2	0.581	0.692	C3809374	EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5	disease		Disease or Syndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
22185	6901	TAZ	0.477	0.808	C0574083	3-Methylglutaconic aciduria type 2	disease	C16;C18;C14	Disease or Syndrome	0.8	0.979	1991	2020	10	22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22200	6904	TBCD	0.599	0.615	C0036572	Seizures	phenotype	C23;C10	Sign or Symptom	0.61	1	2016	2019	2	0	CTD_human;GENOMICS_ENGLAND
22240	6904	TBCD	0.599	0.615	C4310671	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM	disease		Disease or Syndrome	0.7	1	2016	2017	4	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22251	6905	TBCE	0.575	0.692	C1855648	KENNY-CAFFEY SYNDROME, TYPE 1	disease	C16;C05	Disease or Syndrome	0.72	1	2002	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
22252	6905	TBCE	0.575	0.692	C1855840	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	disease	C23;C16;C05;C10;C19;F03;F01	Disease or Syndrome	0.75	1	2002	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
22253	6905	TBCE	0.575	0.692	C4310667	ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY	disease		Disease or Syndrome	0.7	1	2016	2016	1	3	CTD_human;ORPHANET;UNIPROT
22260	6908	TBP	0.552	0.846	C1846707	SPINOCEREBELLAR ATAXIA 17	disease	C16;C10	Disease or Syndrome	0.9	1	2003	2019	0	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22285	6934	TCF7L2	0.485	0.846	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.7	0.925	1999	2019	2	2	CTD_human;UNIPROT
22288	6934	TCF7L2	0.485	0.846	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.7	0.965	2006	2020	3	14	CTD_human
22312	6935	ZEB1	0.442	0.808	C0016781	Fuchs Endothelial Dystrophy	disease	C16;C11	Disease or Syndrome	0.6	0.818	2008	2019	1	0	GENOMICS_ENGLAND;ORPHANET
22329	6935	ZEB1	0.442	0.808	C2750448	CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6	disease	C16;C11	Disease or Syndrome	0.7	1	2005	2014	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22335	6938	TCF12	0.565	0.654	C0221356	Brachycephaly	disease	C16;C05	Congenital Abnormality	0.6	1	2013	2013	1	0	CTD_human;ORPHANET
22344	6938	TCF12	0.565	0.654	C3715051	CRANIOSYNOSTOSIS 3	disease		Disease or Syndrome	0.6	1	2013	2015	3	14	GENOMICS_ENGLAND;UNIPROT
22386	6948	TCN2	0.578	0.615	C0342701	Transcobalamin II deficiency	disease		Disease or Syndrome	0.72	1	1984	2014	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
22394	6949	TCOF1	0.55	0.808	C0242387	Mandibulofacial Dysostosis	disease	C16;C11;C05	Disease or Syndrome	1	0.966	1996	2019	5	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
22426	6999	TDO2	0.599	0.654	C2931837	Familial hypertryptophanemia	disease	C16;C18	Disease or Syndrome	0.51	1	2017	2017	1	1	ORPHANET;UNIPROT
22452	7003	TEAD1	0.555	0.731	C1862382	SVEINSSON CHORIORETINAL ATROPHY	disease	C16;C11	Disease or Syndrome	0.73	1	2004	2019	3	1	CTD_human;ORPHANET;UNIPROT
22455	7007	TECTA	0.7	0.385	C1832187	Deafness, Autosomal Dominant 12	disease	C23;C10;C09	Disease or Syndrome	0.9	1	1999	2014	2	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
22456	7007	TECTA	0.7	0.385	C1863655	Deafness, Autosomal Recessive 21	disease	C23;C10;C09	Disease or Syndrome	0.6	1	1999	1999	1	6	CTD_human;GENOMICS_ENGLAND
22477	7010	TEK	0.462	0.692	C1838437	VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	disease	C16;C14	Congenital Abnormality	0.73	1	1996	2017	5	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
22479	7010	TEK	0.462	0.692	C4310639	GLAUCOMA 3, PRIMARY CONGENITAL, E	disease		Disease or Syndrome	0.6	1	2016	2016	1	4	CTD_human;UNIPROT
22487	7012	TERC	0.471	0.846	C0265965	Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.7	1	2001	2019	5	27	CTD_human;GENOMICS_ENGLAND
22491	7012	TERC	0.471	0.846	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.58	1	2007	2019	4	0	CTD_human;ORPHANET
22495	7012	TERC	0.471	0.846	C3553622	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2	disease		Disease or Syndrome	0.6	1	2002	2018	3	9	CTD_human;GENOMICS_ENGLAND
22501	7015	TERT	0.374	0.846	C0002874	Aplastic Anemia	disease	C15	Disease or Syndrome	0.79	1	2005	2013	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
22513	7015	TERT	0.374	0.846	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.7	1	2003	2018	3	0	CTD_human;GENOMICS_ENGLAND
22515	7015	TERT	0.374	0.846	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.55	1	2006	2016	1	0	CTD_human
22519	7015	TERT	0.374	0.846	C0025202	melanoma	disease	C04	Neoplastic Process	0.7	1	2001	2019	2	0	CTD_human;GENOMICS_ENGLAND
22538	7015	TERT	0.374	0.846	C0265965	Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.6	1	2005	2019	5	0	CTD_human;GENOMICS_ENGLAND
22540	7015	TERT	0.374	0.846	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.56	1	2007	2018	1	0	CTD_human
22556	7015	TERT	0.374	0.846	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.6	1	2007	2019	5	0	CTD_human;ORPHANET
22557	7015	TERT	0.374	0.846	C1846142	HOYERAAL-HREIDARSSON SYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	Disease or Syndrome	0.62	1	2007	2013	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22560	7015	TERT	0.374	0.846	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.52	1	2005	2019	3	0	CTD_human;GENOMICS_ENGLAND
22561	7015	TERT	0.374	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.977	1998	2019	4	0	CTD_human
22563	7015	TERT	0.374	0.846	C3151443	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2	disease		Disease or Syndrome	0.6	1	2005	2016	11	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
22565	7015	TERT	0.374	0.846	C3553617	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1	disease		Disease or Syndrome	0.6	1	2005	2016	8	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
22601	7036	TFR2	0.585	0.615	C1858664	HEMOCHROMATOSIS, TYPE 3	disease	C16;C18	Disease or Syndrome	1	1	2001	2019	6	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22604	7037	TFRC	0.437	0.885	C0002875	Cooleys anemia	disease	C16;C15	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0003756	Arenaviridae Infections	group	C01	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0005283	beta Thalassemia	disease	C16;C15	Disease or Syndrome	0.35	1	1990	2018	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.31	1	2006	2019	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.31	1	2006	2019	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.34	1	2000	2019	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0012715	Iron Metabolism Disorders	group	C18	Disease or Syndrome	0.30	1	2006	2007	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C0017638	Glioma	disease	C04	Neoplastic Process	0.35	1	1993	2018	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0019025	Hemoglobin F Disease	disease	C16;C15	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.33	1	2006	2008	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.31	1	2005	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0024302	Reticulosarcoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0024304	Lymphoma, Mixed-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.31	1	1994	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0024306	Lymphoma, Undifferentiated	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0027055	Myocardial Reperfusion Injury	phenotype	C23;C14	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.31	1	2006	2019	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.31	1	2011	2012	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0079487	Helicobacter Infections	group	C01	Disease or Syndrome	0.30	1	2006	2006	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C0079740	High Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0079741	Lymphoma, Intermediate-Grade	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0079747	Low Grade Lymphoma (neoplasm)	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0079757	Diffuse Mixed-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0079770	Lymphoma, Small Noncleaved-Cell	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0085578	Thalassemia Minor	disease	C16;C15	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0151744	Myocardial Ischemia	disease	C14	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0162316	Iron deficiency anemia	disease	C18;C15	Disease or Syndrome	0.40	0.923	1990	2019	   3	   0	CTD_human
     7037	TFRC	0.437	0.885	C0205671	Infections, Arenavirus	group	C01	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.34	1	2005	2019	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0242583	Bare Lymphocyte Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0271979	Thalassemia Intermedia	disease	C16;C15	Disease or Syndrome	0.33	1	1997	2007	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.40	1	2016	2016	   1	   1	GENOMICS_ENGLAND
     7037	TFRC	0.437	0.885	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	1	1999	2019	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2010	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2006	2015	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C2700553	Omenn Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C3714542	Lymphoma, Diffuse	disease	C04;C20;C15	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C4225219	IMMUNODEFICIENCY 46	disease		Disease or Syndrome	0.70	1	2016	2016	   1	   2	CTD_human;ORPHANET;UNIPROT
     7037	TFRC	0.437	0.885	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     7037	TFRC	0.437	0.885	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2006	2010	   2	   0	CTD_human
     7037	TFRC	0.437	0.885	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.31	1	1994	2006	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0003469	Anxiety Disorders	group	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.50	1	1994	2019	   1	   1	CTD_human
     7038	TG	0.48	0.808	C0010308	Congenital Hypothyroidism	disease	C16;C05;C19	Disease or Syndrome	0.60	1	1986	2019	   1	   0	GENOMICS_ENGLAND
     7038	TG	0.48	0.808	C0011573	Endogenous depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0013336	Dwarfism	disease	C16;C05;C19	Congenital Abnormality	0.41	1	2004	2014	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0018021	Goiter	phenotype	C19	Disease or Syndrome	0.50	0.944	1987	2019	   2	   0	CTD_human
     7038	TG	0.48	0.808	C0025193	Melancholia	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0086133	Depressive Syndrome	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0282126	Depression, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0342194	Thyroid Dyshormonogenesis 3	disease	C19	Disease or Syndrome	0.70	1	1999	2017	   8	  16	CTD_human;GENOMICS_ENGLAND;UNIPROT
     7038	TG	0.48	0.808	C0376280	Anxiety States, Neurotic	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0677607	Hashimoto Disease	disease	C19	Disease or Syndrome	0.60	0.962	1979	2019	   1	   0	CTD_human
     7038	TG	0.48	0.808	C0920350	Autoimmune thyroiditis	disease	C20;C19	Disease or Syndrome	0.40	0.895	1994	2019	   1	   0	CTD_human
     7038	TG	0.48	0.808	C1279420	Anxiety neurosis (finding)	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2018	2018	   1	   0	CTD_human
     7038	TG	0.48	0.808	C1848805	Thyroid Dyshormonogenesis 1	disease	C16;C05;C19	Disease or Syndrome	0.30	1	2010	2011	   2	   0	ORPHANET
     7039	TGFA	0.432	0.885	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.40	0.917	1993	2017	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0018671	Head and Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0018675	Head Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1997	1997	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1997	1997	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0020542	Pulmonary Hypertension	phenotype	C08	Pathologic Function	0.31	1	2003	2008	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0020608	Hypodontia	disease	C16;C07	Congenital Abnormality	0.40				   0	   0	ORPHANET
     7039	TGFA	0.432	0.885	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.53	1	1995	2001	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.50	1	1997	2006	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0024623	Malignant neoplasm of stomach	disease	C06;C04	Neoplastic Process	0.35	1	1991	2014	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0024667	Animal Mammary Neoplasms	phenotype	C04;C22	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0024668	Mammary Neoplasms, Experimental	phenotype	C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1995	1995	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0027533	Neck Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0027746	Nerve Degeneration	phenotype	C23	Cell or Molecular Dysfunction	0.30	1	1997	1997	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0030246	Pustulosis of Palms and Soles	disease	C17	Disease or Syndrome	0.30	1	1994	1994	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0030354	Papilloma	disease	C04	Neoplastic Process	0.32	1	1991	1999	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.32	1	2006	2011	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.37	1	1990	1997	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0034063	Pulmonary Edema	phenotype	C08	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.38	1	1996	2019	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0038356	Stomach Neoplasms	group	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	1997	1997	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0162770	Right Ventricular Hypertrophy	disease	C23;C14	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0205874	Papilloma, Squamous Cell	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0205875	Papillomatosis	disease	C04	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0206624	Hepatoblastoma	disease	C04	Neoplastic Process	0.51	1	1992	2002	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0273115	Lung Injury	disease	C08;C26	Injury or Poisoning	0.30	1	2002	2002	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0278996	Malignant Head and Neck Neoplasm	disease	C04	Neoplastic Process	0.33	1	1992	2009	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0333355	Inflammatory disease of mucous membrane	group	C06;C07	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.55	1	1996	2014	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.38	1	1996	2014	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0746787	Cancer of Neck	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0751177	Cancer of Head	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C0887900	Upper Aerodigestive Tract Neoplasms	group	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C1257925	Mammary Carcinoma, Animal	disease	C04;C22	Neoplastic Process	0.30	1	1995	1995	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.60	1	1992	2016	   2	   0	CTD_human
     7039	TGFA	0.432	0.885	C2350344	Chronic Lung Injury	disease	C08;C26	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C3711374	Nonsyndromic Deafness	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     7039	TGFA	0.432	0.885	C4082304	Oligodontia	disease		Congenital Abnormality	0.40				   0	   0	ORPHANET
     7039	TGFA	0.432	0.885	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.40	1	1993	2017	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0001787	Osteoporosis, Age-Related	disease	C18;C05	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0002152	Alloxan Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2013	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0003504	Aortic Valve Insufficiency	disease	C14	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.70	0.979	1996	2020	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0005138	Berylliosis	disease	C08;C24	Injury or Poisoning	0.31	1	2005	2007	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0005398	Cholestasis, Extrahepatic	disease	C06	Disease or Syndrome	0.30	1	2017	2018	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2001	2001	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0006111	Brain Diseases	group	C10	Disease or Syndrome	0.31	1	1993	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0006663	Calcinosis	phenotype	C18	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0007097	Carcinoma	group	C04	Neoplastic Process	0.40	1	1990	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.31	1	1994	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.40	1	1994	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0007140	Carcinosarcoma	disease	C04	Neoplastic Process	0.30	1	2004	2004	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0008312	Primary biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.32	0.667	2007	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.31	1	2014	2016	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.50	0.971	1995	2020	   1	   1	CTD_human
     7040	TGFB1	0.287	0.962	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.40	1	1999	2014	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0010474	Curling Ulcer	disease	C06	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0010674	Cystic Fibrosis	disease	C16;C06;C08	Disease or Syndrome	0.70	0.952	2000	2019	   1	   0	CTD_human;GENOMICS_ENGLAND;ORPHANET
     7040	TGFB1	0.287	0.962	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2012	2018	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0011853	Diabetes Mellitus, Experimental	disease	C18;C19	Experimental Model of Disease	0.50	1	2005	2013	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.70	1	2002	2020	   1	   1	CTD_human
     7040	TGFB1	0.287	0.962	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.60	0.99	1996	2019	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0011882	Diabetic Neuropathies	group	C10;C19	Disease or Syndrome	0.50	1	2005	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0011989	Camurati-Engelmann Syndrome	disease	C16;C05	Disease or Syndrome	0.80	1	2000	2019	   5	   9	CTD_human;GENOMICS_ENGLAND;UNIPROT
     7040	TGFB1	0.287	0.962	C0013238	Dry Eye Syndromes	disease	C11	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0013264	Muscular Dystrophy, Duchenne	disease	C16;C05;C10	Disease or Syndrome	0.40	0.917	1995	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0013295	Duodenal Ulcer	disease	C06	Disease or Syndrome	0.32	1	2003	2007	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.33	1	2017	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0016059	Fibrosis	phenotype	C23	Pathologic Function	0.60	1	1999	2019	   8	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.40	0.833	1993	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2009	2010	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.36	1	1997	2011	   3	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0019189	Hepatitis, Chronic	disease	C06	Disease or Syndrome	0.34	1	1991	2012	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0019207	Hepatoma, Morris	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0019208	Hepatoma, Novikoff	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.40	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.50	1	2000	2009	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0020507	Hyperplasia	phenotype	C23	Pathologic Function	0.32	1	2003	2010	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0020517	Hypersensitivity	group	C20	Pathologic Function	0.30	1	2008	2011	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.60	1	1996	2020	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0021290	Neonatal disorder	group	C16	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.38	1	2002	2010	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.40	1	2001	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.40	0.974	2001	2019	   3	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0022660	Kidney Failure, Acute	disease	C13;C12	Disease or Syndrome	0.33	1	1999	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.60	1	1998	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0023890	Liver Cirrhosis	disease	C23;C06	Disease or Syndrome	0.40	0.97	1991	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0023891	Liver Cirrhosis, Alcoholic	disease	C23;C06;C25	Disease or Syndrome	0.30	1	2013	2013	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0023892	Biliary cirrhosis	disease	C23;C06	Disease or Syndrome	0.40	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.50	1	2003	2018	   5	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0023904	Liver Neoplasms, Experimental	phenotype	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.60	1	2001	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0024117	Chronic Obstructive Airway Disease	disease	C08	Disease or Syndrome	0.60	0.911	1994	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.38	1	2000	2019	   3	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0026848	Myopathy	group	C05;C10	Disease or Syndrome	0.31	1	2010	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.60	1	1996	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0027626	Neoplasm Invasiveness	phenotype	C23;C04	Pathologic Function	0.30	1	2013	2016	   5	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.40	0.982	1994	2020	   4	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0027719	Nephrosclerosis	disease	C13;C12	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.35	1	1992	2019	   3	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0028797	Occupational Diseases	group	C24	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0029172	Oral Submucous Fibrosis	disease	C07	Disease or Syndrome	0.36	1	2002	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0029408	Degenerative polyarthritis	disease	C05	Disease or Syndrome	0.50	1	2000	2020	   1	   1	CTD_human
     7040	TGFB1	0.287	0.962	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.60	0.962	1997	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0029458	Osteoporosis, Postmenopausal	disease	C18;C05	Disease or Syndrome	0.39	1	2000	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0029459	Osteoporosis, Senile	disease	C18;C05	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.37	1	2002	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0030354	Papilloma	disease	C04	Neoplastic Process	0.32	1	2000	2010	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0030848	Peyronie Disease	disease	C17;C12	Disease or Syndrome	0.40	1	2003	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0032226	Pleural Diseases	group	C08	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0032285	Pneumonia	disease	C01;C08	Disease or Syndrome	0.38	0.889	2002	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0032300	Lobar Pneumonia	disease	C01;C08	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.40	1	1998	2015	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.50	1	2003	2013	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0034067	Pulmonary Emphysema	disease	C08	Disease or Syndrome	0.36	1	2003	2017	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.70	0.983	1991	2020	   7	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0036202	Sarcoidosis	disease	C15	Disease or Syndrome	0.35	1	2001	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.34	1	2013	2019	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.33	1	2005	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	1994	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0038433	Streptozotocin Diabetes	disease	C18;C19	Experimental Model of Disease	0.30	1	2006	2013	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.35	1	2002	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0040028	Thrombocythemia, Essential	disease	C15	Disease or Syndrome	0.32	1	2004	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0041948	Uremia	disease	C13;C12	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0041956	Ureteral obstruction	phenotype	C13;C12	Disease or Syndrome	0.40	1	1999	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0042109	Urticaria	disease	C17;C20	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0085584	Encephalopathies	group	C10	Disease or Syndrome	0.41	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0086132	Depressive Symptoms	phenotype	F01	Sign or Symptom	0.32	1	2012	2017	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0086237	Epilepsy, Cryptogenic	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0086404	Experimental Hepatoma	disease	C06;C04	Neoplastic Process; Experimental Model of Disease	0.30	1	2017	2017	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0086432	Hyalinosis, Segmental Glomerular	disease	C13;C12	Disease or Syndrome	0.30	1	2005	2010	   3	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0086743	Osteoarthrosis Deformans	disease	C05	Disease or Syndrome	0.30	1	2019	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0149519	Chronic Persistent Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0158266	Intervertebral Disc Degeneration	disease	C05	Disease or Syndrome	0.36	1	2005	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205642	Adenocarcinoma, Oxyphilic	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205643	Carcinoma, Cribriform	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205644	Carcinoma, Granular Cell	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205696	Anaplastic carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205697	Carcinoma, Spindle-Cell	disease	C04	Neoplastic Process	0.31	0.5	2002	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205698	Undifferentiated carcinoma	disease	C04	Neoplastic Process	0.30	1	2002	2002	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205699	Carcinomatosis	phenotype	C04	Neoplastic Process	0.31	1	2002	2012	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205874	Papilloma, Squamous Cell	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0205875	Papillomatosis	disease	C04	Neoplastic Process	0.30	1	2010	2010	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0221227	Centriacinar Emphysema	disease	C08	Disease or Syndrome	0.31	1	2003	2013	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0236018	Aura	phenotype	C10	Finding	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0238065	Secondary Biliary Cholangitis	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0239946	Fibrosis, Liver	disease	C23;C06	Disease or Syndrome	0.40	0.992	1992	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0241910	Autoimmune Chronic Hepatitis	disease	C06;C20	Disease or Syndrome	0.31	1	2010	2011	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.40	0.973	2000	2019	   3	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0242488	Acute Lung Injury	disease	C08	Injury or Poisoning	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.33	1	2005	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0263628	Tumoral calcinosis	disease	C18	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0264393	Panacinar Emphysema	disease	C08	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0264423	Asthma, Occupational	disease	C08;C20;C24	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0265287	Acromicric Dysplasia	disease	C16;C05	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0271673	Symmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0271674	Asymmetric Diabetic Proximal Motor Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0271678	Diabetic Mononeuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0271680	Diabetic Polyneuropathies	group	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0271685	Diabetic Amyotrophy	disease	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0271686	Diabetic Autonomic Neuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.40	1	1998	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2007	2007	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.40	0.929	1994	2020	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0392164	Pulmonary Cystic Fibrosis	disease	C16;C06;C08	Disease or Syndrome	0.31	1	2006	2006	   0	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0393835	Diabetic Asymmetric Polyneuropathy	disease	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.34	1	2003	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0455503	H/O: depression	phenotype		Finding	0.30	1	2012	2012	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0520463	Chronic active hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0521174	Microcalcification	phenotype	C18	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0521607	Peritoneal Fibrosis	disease	C23;C06	Disease or Syndrome	0.60	1	1998	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0524611	Cryptogenic Chronic Hepatitis	disease	C06	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0525045	Mood Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2001	2001	   1	   0	PSYGENET
     7040	TGFB1	0.287	0.962	C0553980	Endomyocardial Fibrosis	phenotype	C14	Pathologic Function	0.30	1	2015	2015	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0600519	Ventricular Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2006	2006	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0600520	Left Ventricle Remodeling	phenotype	C23	Organ or Tissue Function	0.30	1	2006	2006	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0751074	Diabetic Neuralgia	disease	C10;C19	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0751111	Awakening Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0751406	Post-Traumatic Osteoporosis	disease	C18;C05	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0751956	Acute Cerebrovascular Accidents	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0878576	Posterior Leukoencephalopathy Syndrome	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0887898	Experimental Lung Inflammation	disease	C01;C08	Experimental Model of Disease	0.30	1	2011	2011	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C0917713	Becker Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.31	1	2010	2011	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1306571	Hepatic Insufficiency	phenotype	C06	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1527303	Chronic Airflow Obstruction	disease	C08	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1527304	Allergic Reaction	phenotype	C20	Pathologic Function	0.30	1	2008	2011	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1527396	Fibrocystic Disease of Pancreas	disease	C16;C06;C08	Disease or Syndrome	0.30				   0	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1565662	Acute Kidney Insufficiency	disease	C13;C12	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1623038	Cirrhosis	disease	C23	Disease or Syndrome	0.40	1	1991	2019	   8	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1719672	Severe Sepsis	disease	C23;C01	Disease or Syndrome	0.31	1	2005	2010	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.31	1	2014	2016	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C1876165	Copper-Overload Cirrhosis	disease	C16;C06;C18;C10	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.40	0.986	1990	2020	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C2350873	Beryllium Disease	disease	C08;C24	Disease or Syndrome	0.30	1	2005	2007	   2	   0	CTD_human
     7040	TGFB1	0.287	0.962	C2350878	Focal Emphysema	disease	C08	Disease or Syndrome	0.30	1	2003	2003	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C2609414	Acute kidney injury	disease	C13;C12	Injury or Poisoning	0.30	1	1999	1999	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C2717759	Degenerative Intervertebral Discs	disease	C05	Anatomical Abnormality	0.31	1	2011	2013	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C2717859	Peritoneal Sclerosis	phenotype	C23;C06	Finding	0.30	1	2006	2006	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C2717860	Encapsulating Peritoneal Sclerosis	disease	C23;C06	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C3160858	Posterior reversible encephalopathy syndrome	disease	C10	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C3241937	Nonalcoholic Steatohepatitis	disease	C06	Disease or Syndrome	0.34	1	2006	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C3489628	Thrombocytosis, Autosomal Dominant	disease	C15	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C3489726	Geleophysic dysplasia	disease	C16;C05	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C3542021	Duchenne and Becker Muscular Dystrophy	disease	C16;C05;C10	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C3714636	Pneumonitis	disease	C01;C08	Disease or Syndrome	0.40	0.929	2001	2019	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C3830362	Early Pregnancy Loss	phenotype	C13	Finding	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C4551595	Biliary Cirrhosis, Primary, 1	disease	C23;C06	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C4552766	Miscarriage	disease	C13	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
     7040	TGFB1	0.287	0.962	C4721507	Alveolitis, Fibrosing	disease	C08	Disease or Syndrome	0.30	1	2004	2016	   7	   0	CTD_human
     7040	TGFB1	0.287	0.962	C4748708	INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY	disease		Disease or Syndrome	0.40	1	2018	2018	   1	   3	UNIPROT
     7042	TGFB2	0.433	0.885	C0003504	Aortic Valve Insufficiency	disease	C14	Disease or Syndrome	0.40	1	2011	2011	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0004364	Autoimmune Diseases	group	C20	Disease or Syndrome	0.31	1	2014	2017	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0008311	Cholangitis	disease	C06	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.30	1	2014	2014	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0010520	Cyanosis	phenotype	C23	Sign or Symptom	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.33	0.75	2011	2018	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0015393	Eye Abnormalities	group	C16;C11	Congenital Abnormality	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0017601	Glaucoma	disease	C11	Disease or Syndrome	0.40	1	2007	2019	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.31	1	1997	2013	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0034067	Pulmonary Emphysema	disease	C08	Disease or Syndrome	0.30	1	2013	2013	   1	   0	GENOMICS_ENGLAND
     7042	TGFB2	0.433	0.885	C0035238	Congenital abnormality of respiratory system	group	C16;C08	Congenital Abnormality	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0041956	Ureteral obstruction	phenotype	C13;C12	Disease or Syndrome	0.31	1	2007	2016	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0042063	Urogenital Abnormalities	group	C16;C13;C12	Congenital Abnormality	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0151491	Congenital musculoskeletal anomalies	group	C16;C05	Congenital Abnormality	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0162872	Aortic Aneurysm, Thoracic	disease	C14	Disease or Syndrome	0.31	1	2012	2014	   2	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0206762	Limb Deformities, Congenital	group	C16;C05	Congenital Abnormality	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0340630	Aortic Aneurysm, Thoracoabdominal	disease	C14	Disease or Syndrome	0.30	1	2012	2012	   2	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0345967	Malignant mesothelioma	disease	C04;C08	Neoplastic Process	0.30	1	2015	2015	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	1997	1997	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.50	1	2012	2012	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.31	1	1999	2014	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C2697932	Loeys-Dietz Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.89	1	2012	2018	   2	   3	CTD_human;GENOMICS_ENGLAND
     7042	TGFB2	0.433	0.885	C3553762	LOEYS-DIETZ SYNDROME 4	disease		Disease or Syndrome	0.60	1	2012	2018	   4	  11	GENOMICS_ENGLAND;UNIPROT
     7042	TGFB2	0.433	0.885	C4551955	Loeys-Dietz Syndrome, Type 1a	disease	C16;C05;C14	Disease or Syndrome	0.30	1	2012	2012	   1	   0	CTD_human
     7042	TGFB2	0.433	0.885	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.60	1	2012	2014	   3	   0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
     7043	TGFB3	0.498	0.808	C0008925	Cleft Palate	disease	C16;C05;C07	Congenital Abnormality	0.39	1	1995	2020	   2	   0	CTD_human
     7043	TGFB3	0.498	0.808	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     7043	TGFB3	0.498	0.808	C0034067	Pulmonary Emphysema	disease	C08	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
     7043	TGFB3	0.498	0.808	C0035238	Congenital abnormality of respiratory system	group	C16;C08	Congenital Abnormality	0.30	1	1995	1995	   1	   0	CTD_human
     7043	TGFB3	0.498	0.808	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     7043	TGFB3	0.498	0.808	C1837218	Cleft palate, isolated	disease	C16;C05;C07	Congenital Abnormality	0.39	1	1995	2020	   2	   0	CTD_human
     7043	TGFB3	0.498	0.808	C1862511	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1 (disorder)	disease	C16;C14	Disease or Syndrome	0.60	1	2015	2015	   1	   0	CTD_human;GENOMICS_ENGLAND
     7043	TGFB3	0.498	0.808	C2697932	Loeys-Dietz Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.53	1	2015	2018	   1	   0	CTD_human;GENOMICS_ENGLAND
     7043	TGFB3	0.498	0.808	C3711374	Nonsyndromic Deafness	disease	C23;C10;C09	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     7043	TGFB3	0.498	0.808	C3810012	RIENHOFF SYNDROME	disease		Disease or Syndrome	0.61	1	2013	2015	   3	   0	GENOMICS_ENGLAND;UNIPROT
     7043	TGFB3	0.498	0.808	C4016411	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA 1	phenotype		Finding	0.30				   0	   0	GENOMICS_ENGLAND
     7043	TGFB3	0.498	0.808	C4551955	Loeys-Dietz Syndrome, Type 1a	disease	C16;C05;C14	Disease or Syndrome	0.30				   0	   0	CTD_human
     7043	TGFB3	0.498	0.808	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.70	1	2006	2015	   3	   0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
     7044	LEFTY2	0.736	0.231	C0000772	Multiple congenital anomalies	group	C16	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     7044	LEFTY2	0.736	0.231	C0175707	Asplenia Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.30	1	1999	1999	   1	   0	CTD_human
     7044	LEFTY2	0.736	0.231	C0265357	Polysplenia Syndrome	disease	C16;C15;C14	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     7044	LEFTY2	0.736	0.231	C0266642	Situs ambiguus	disease	C16;C15;C14	Congenital Abnormality	0.50	1	1999	1999	   1	   0	CTD_human;ORPHANET
     7044	LEFTY2	0.736	0.231	C1167664	Situs ambiguous	disease		Congenital Abnormality	0.30				   0	   0	ORPHANET
     7044	LEFTY2	0.736	0.231	C3178805	Heterotaxy Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.50	1	1999	1999	   1	   0	CTD_human;GENOMICS_ENGLAND
     7044	LEFTY2	0.736	0.231	C3178806	Right Atrial Isomerism	disease	C16;C15;C14	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     7044	LEFTY2	0.736	0.231	C3178807	Left Atrial Isomerism	disease	C16;C15;C14	Congenital Abnormality	0.30	1	1999	1999	   1	   0	CTD_human
     7044	LEFTY2	0.736	0.231	C4277690	Ciliopathies	disease	C16	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     7045	TGFBI	0.484	0.769	C0000786	Spontaneous abortion	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     7045	TGFBI	0.484	0.769	C0000822	Abortion, Tubal	phenotype	C13	Pathologic Function	0.30	1	2008	2008	   1	   0	CTD_human
     7045	TGFBI	0.484	0.769	C0011881	Diabetic Nephropathy	disease	C13;C12;C19	Disease or Syndrome	0.53	1	2003	2012	   1	   0	CTD_human
     7045	TGFBI	0.484	0.769	C0017667	Nodular glomerulosclerosis	disease	C13;C12;C19	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
     7045	TGFBI	0.484	0.769	C0034189	Pyemia	phenotype	C23;C01	Pathologic Function	0.30	1	2017	2017	   1	   0	CTD_human
     7045	TGFBI	0.484	0.769	C0036690	Septicemia	disease	C23;C01	Disease or Syndrome	0.33	1	2017	2020	   1	   0	CTD_human
     7045	TGFBI	0.484	0.769	C0243026	Sepsis	disease	C23;C01	Disease or Syndrome	0.33	1	2017	2020	   1	   0	CTD_human
     7045	TGFBI	0.484	0.769	C0339278	Reis-Bucklers corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.8	0.95	1998	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22605	7045	TGFBI	0.484	0.769	C0521723	Corneal dystrophy, epithelial basement membrane	disease	C11;C10;C14	Disease or Syndrome	0.71	1	1998	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22606	7045	TGFBI	0.484	0.769	C1275685	Avellino corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.8	1	1998	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22607	7045	TGFBI	0.484	0.769	C1562894	Thiel-Behnke corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.75	1	1998	2015	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22608	7045	TGFBI	0.484	0.769	C1641846	Groenouw corneal dystrophy type I (disorder)	disease	C16;C11	Disease or Syndrome	0.73	1	1998	2011	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22609	7045	TGFBI	0.484	0.769	C1690006	Lattice corneal dystrophy Type I	disease	C16;C11	Disease or Syndrome	0.8	0.96	1998	2019	12	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22611	7045	TGFBI	0.484	0.769	C1837974	Corneal Dystrophy, Lattice Type IIIA	disease	C16;C11	Disease or Syndrome	0.73	0.857	1998	2011	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
22628	7046	TGFBR1	0.451	0.885	C0546476	Multiple self-healing squamous epithelioma	disease	C04;C17	Neoplastic Process	0.56	1	1997	2018	1	0	CTD_human;ORPHANET
22631	7046	TGFBR1	0.451	0.885	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.73	1	2005	2012	4	0	CTD_human;ORPHANET
22632	7046	TGFBR1	0.451	0.885	C2697932	Loeys-Dietz Syndrome	disease	C16;C05;C14	Disease or Syndrome	1	1	1993	2019	10	8	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
22639	7046	TGFBR1	0.451	0.885	C4551955	Loeys-Dietz Syndrome, Type 1a	disease	C16;C05;C14	Disease or Syndrome	0.7	1	2005	2016	12	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
22641	7046	TGFBR1	0.451	0.885	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.6	1	2005	2019	8	12	CLINGEN;GENOMICS_ENGLAND
22666	7048	TGFBR2	0.413	0.846	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.54	1	2004	2018	1	0	CTD_human
22669	7048	TGFBR2	0.413	0.846	C0152018	Esophageal carcinoma	disease	C06;C04	Neoplastic Process	0.61	1	2000	2000	1	1	CGI;UNIPROT
22687	7048	TGFBR2	0.413	0.846	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.6	1	2006	2018	1	0	CTD_human
22691	7048	TGFBR2	0.413	0.846	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.6	1	2000	2000	1	1	CGI;CTD_human
22698	7048	TGFBR2	0.413	0.846	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.6	1	1995	2018	1	0	CTD_human;ORPHANET
22702	7048	TGFBR2	0.413	0.846	C1836635	Loeys-Dietz Aortic Aneurysm Syndrome	disease	C16;C05;C14	Disease or Syndrome	0.73	1	2004	2012	7	0	CTD_human;ORPHANET
22703	7048	TGFBR2	0.413	0.846	C1860896	COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6	disease	C16;C06;C04;C18	Neoplastic Process	0.6	1	1998	1998	1	4	CTD_human;UNIPROT
22704	7048	TGFBR2	0.413	0.846	C2674574	Aortic aneurysm, familial thoracic 3	disease	C16;C05;C14	Disease or Syndrome	0.7	1	2003	2017	15	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
22705	7048	TGFBR2	0.413	0.846	C2697932	Loeys-Dietz Syndrome	disease	C16;C05;C14	Disease or Syndrome	1	1	2003	2019	10	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
22711	7048	TGFBR2	0.413	0.846	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.6	1	2003	2019	14	20	CLINGEN;GENOMICS_ENGLAND
22717	7050	TGIF1	0.588	0.769	C0079541	Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.7	1	1995	2018	1	0	CTD_human;GENOMICS_ENGLAND
22720	7050	TGIF1	0.588	0.769	C0751617	Semilobar Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.6	1	2006	2006	1	0	CTD_human;ORPHANET
22721	7050	TGIF1	0.588	0.769	C1840528	HOLOPROSENCEPHALY 4 (disorder)	disease	C16;C05;C10	Disease or Syndrome	0.7	1	2000	2013	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22724	7051	TGM1	0.565	0.769	C0020758	Congenital ichthyosis	disease	C16;C17	Disease or Syndrome	0.6	0.958	1997	2020	0	0	CTD_human
22727	7051	TGM1	0.565	0.769	C0079154	Congenital Nonbullous Ichthyosiform Erythroderma	disease	C16;C17	Disease or Syndrome	1	1	1994	2019	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
22734	7051	TGM1	0.565	0.769	C1855789	Self-Healing Collodion Baby	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.51	1	1998	2017	2	0	ORPHANET
22735	7051	TGM1	0.565	0.769	C3536797	Ichthyosis Congenita II	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.51	1	1998	2010	0	0	CTD_human
22738	7051	TGM1	0.565	0.769	C4511230	Bathing suit ichthyosis	disease		Disease or Syndrome	0.55	1	1998	2017	1	0	ORPHANET
22739	7051	TGM1	0.565	0.769	C4551630	Ichthyosis Congenita I	disease	C16;C17	Disease or Syndrome	0.9	1	1995	2017	7	79	CTD_human;GENOMICS_ENGLAND;UNIPROT
22772	7053	TGM3	0.653	0.385	C0432347	Uncombable hair syndrome	disease	C17	Disease or Syndrome	0.52	1	2016	2018	1	0	CTD_human;ORPHANET
22784	7054	TH	0.462	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.58	0.9	1998	2017	1	0	CTD_human
22790	7054	TH	0.462	0.885	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.6	0.979	1989	2020	1	0	CTD_human
22796	7054	TH	0.462	0.885	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.7	1	1992	2019	2	0	CTD_human
22821	7054	TH	0.462	0.885	C2673535	DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE (disorder)	disease	C10	Disease or Syndrome	0.72	1	1964	2018	35	52	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22854	7056	THBD	0.457	0.769	C0035222	Respiratory Distress Syndrome, Adult	disease	C08	Disease or Syndrome	0.55	1	2003	2017	1	0	CTD_human
22860	7056	THBD	0.457	0.769	C0398623	Thrombophilia	disease	C15	Disease or Syndrome	0.7	0.909	1991	2019	1	0	CTD_human
22871	7056	THBD	0.457	0.769	C2752036	HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6	disease		Finding	0.6	1	2009	2013	3	7	GENOMICS_ENGLAND;UNIPROT
22872	7056	THBD	0.457	0.769	C2931788	Atypical Hemolytic Uremic Syndrome	disease	C13;C12;C15	Disease or Syndrome	0.57	1	2009	2018	1	0	CTD_human;GENOMICS_ENGLAND
22874	7056	THBD	0.457	0.769	C3280976	Thrombophilia due to Thrombomodulin Defect	disease	C15	Disease or Syndrome	0.7	1	1995	2015	6	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22921	7067	THRA	0.566	0.769	C3280817	HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6	disease		Disease or Syndrome	0.7	1	2012	2016	6	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22926	7068	THRB	0.554	0.769	C0206682	Follicular thyroid carcinoma	disease	C04	Neoplastic Process	0.53	1	2004	2017	1	0	CTD_human
22929	7068	THRB	0.554	0.769	C1840364	THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY	disease	C19	Disease or Syndrome	0.7	1	1993	2014	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
22931	7068	THRB	0.554	0.769	C2937288	THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	disease	C19	Disease or Syndrome	0.72	1	1989	2014	20	40	CTD_human;GENOMICS_ENGLAND;UNIPROT
22932	7068	THRB	0.554	0.769	C2940786	Thyroid Hormone Resistance Syndrome	disease	C19	Disease or Syndrome	0.9	0.973	1990	2019	3	1	CTD_human;GENOMICS_ENGLAND
22934	7068	THRB	0.554	0.769	C3489796	Thyroid Hormone Resistance, Generalized, Autosomal Recessive	disease	C19	Disease or Syndrome	0.62	1	1992	2014	1	3	CTD_human;GENOMICS_ENGLAND
22936	7068	THRB	0.554	0.769	C4722330	Generalized Thyroid Hormone Resistance	disease	C19	Disease or Syndrome	0.7	0.99	1988	2019	3	7	CTD_human;GENOMICS_ENGLAND
22948	7071	KLF10	0.631	0.615	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.51	1	1995	2017	6	0	CLINGEN;GENOMICS_ENGLAND
22949	7072	TIA1	0.595	0.577	C0221054	Welander Distal Myopathy	disease	C16;C05;C10	Disease or Syndrome	0.74	1	1999	2019	3	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
22968	7076	TIMP1	0.38	0.885	C0018799	Heart Diseases	group	C14	Disease or Syndrome	0.51	1	2008	2018	1	0	CTD_human
22971	7076	TIMP1	0.38	0.885	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.54	1	2004	2019	1	0	CTD_human
22977	7076	TIMP1	0.38	0.885	C0034069	Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.56	1	2011	2019	1	0	CTD_human
23021	7078	TIMP3	0.445	0.923	C1850938	FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY	disease	C11	Disease or Syndrome	1	1	1994	2019	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23035	7080	NKX2-1	0.457	0.808	C0238463	Papillary thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.7	0.947	2001	2019	1	0	CTD_human;ORPHANET
23036	7080	NKX2-1	0.457	0.808	C0393584	Benign Hereditary Chorea	disease	C23;C10	Disease or Syndrome	0.8	0.96	2002	2018	9	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23042	7080	NKX2-1	0.457	0.808	C1970269	Choreoathetosis, Hypothyroidism, And Neonatal Respiratory Distress	disease	C23;C16;C05;C08;C10;C19	Disease or Syndrome	0.77	1	2002	2018	8	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23058	7084	TK2	0.585	0.615	C3149750	MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	disease		Disease or Syndrome	0.7	1	2001	2016	8	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
23060	7084	TK2	0.585	0.615	C4310734	PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	disease		Disease or Syndrome	0.7	1	2012	2012	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
23076	7086	TKT	0.595	0.769	C4310751	SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	disease		Disease or Syndrome	0.71	1	2016	2019	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
23077	7087	ICAM5	0.716	0.346	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.53	1	2005	2013	1	0	CTD_human;UNIPROT
23106	7092	TLL1	0.716	0.5	C2751315	Atrial Septal Defect 6	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.71	1	2009	2019	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
23128	7097	TLR2	0.361	0.923	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.56	1	2005	2012	1	0	CTD_human
23129	7097	TLR2	0.361	0.923	C0022568	Keratitis	disease	C11	Disease or Syndrome	0.55	1	2006	2019	1	0	CTD_human
23155	7098	TLR3	0.427	0.885	C0276226	Herpes encephalitis	disease	C01;C10	Disease or Syndrome	0.7	0.947	2007	2019	1	0	CTD_human;ORPHANET
23156	7098	TLR3	0.427	0.885	C2751803	HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2	disease		Finding	0.6	1	2007	2017	2	4	GENOMICS_ENGLAND;UNIPROT
23168	7099	TLR4	0.321	0.962	C0011882	Diabetic Neuropathies	group	C10;C19	Disease or Syndrome	0.51	1	2004	2012	1	0	CTD_human
23186	7099	TLR4	0.321	0.962	C0035078	Kidney Failure	disease	C13;C12	Disease or Syndrome	0.51	1	2005	2017	1	0	CTD_human
23204	7099	TLR4	0.321	0.962	C0520459	Necrotizing Enterocolitis	disease	C06	Disease or Syndrome	0.6	0.929	2006	2018	1	0	CTD_human
23239	7124	TNF	0.231	0.962	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.7	0.975	1989	2020	4	1	CTD_human
23252	7124	TNF	0.231	0.962	C0006625	Cachexia	phenotype	C23	Sign or Symptom	0.6	1	1990	2020	1	0	CTD_human
23259	7124	TNF	0.231	0.962	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.6	0.971	1996	2020	3	0	CTD_human
23273	7124	TNF	0.231	0.962	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	0.95	1995	2020	1	0	CTD_human
23282	7124	TNF	0.231	0.962	C0018790	Cardiac Arrest	disease	C14	Disease or Syndrome	0.6	1	1998	2019	1	0	CTD_human
23284	7124	TNF	0.231	0.962	C0018801	Heart failure	disease	C14	Disease or Syndrome	0.6	0.965	1996	2019	5	0	CTD_human
23285	7124	TNF	0.231	0.962	C0018802	Congestive heart failure	disease	C14	Disease or Syndrome	0.6	0.972	1996	2020	5	0	CTD_human
23296	7124	TNF	0.231	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.6	1	1995	2020	11	0	CTD_human
23301	7124	TNF	0.231	0.962	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	1	1998	2020	4	0	CTD_human
23306	7124	TNF	0.231	0.962	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.6	1	2001	2016	15	0	CTD_human
23307	7124	TNF	0.231	0.962	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.6	0.964	1992	2020	2	0	CTD_human
23321	7124	TNF	0.231	0.962	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.6	1	1999	2019	1	0	CTD_human
23330	7124	TNF	0.231	0.962	C0027051	Myocardial Infarction	disease	C23;C14	Disease or Syndrome	0.6	0.961	2000	2019	2	0	CTD_human
23353	7124	TNF	0.231	0.962	C0033141	Cardiomyopathies, Primary	group	C14	Disease or Syndrome	0.51	1	2000	2014	1	0	CTD_human
23373	7124	TNF	0.231	0.962	C0038220	Status Epilepticus	disease	C23;C10	Disease or Syndrome	0.59	1	2008	2019	1	0	CTD_human
23377	7124	TNF	0.231	0.962	C0038454	Cerebrovascular accident	group	C10;C14	Disease or Syndrome	0.6	0.956	1999	2020	1	0	CTD_human
23441	7124	TNF	0.231	0.962	C0600327	Toxic Shock Syndrome	disease	C23;C01	Disease or Syndrome	0.54	1	1990	2018	1	0	CTD_human
23452	7128	TNFAIP3	0.481	0.808	C4225218	AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	disease		Disease or Syndrome	0.71	1	2016	2019	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23479	7132	TNFRSF1A	0.409	0.923	C0006625	Cachexia	phenotype	C23	Sign or Symptom	0.52	1	2001	2009	1	0	CTD_human
23486	7132	TNFRSF1A	0.409	0.923	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.59	1	2002	2019	1	0	CTD_human
23508	7132	TNFRSF1A	0.409	0.923	C1275126	TNF receptor-associated periodic fever syndrome (TRAPS)	disease	C23;C16;C17	Disease or Syndrome	1	1	1998	2019	7	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23524	7133	TNFRSF1B	0.425	0.885	C0026948	Mycosis Fungoides	group	C04;C20;C15	Neoplastic Process	0.51	1	2015	2016	1	0	CTD_human;ORPHANET
23530	7133	TNFRSF1B	0.425	0.885	C0036920	Sezary Syndrome	disease	C04;C20;C15	Neoplastic Process	0.51	1	2015	2019	1	0	CTD_human;ORPHANET
23542	7134	TNNC1	0.647	0.462	C2678475	Cardiomyopathy, Dilated, 1z	disease	C14	Disease or Syndrome	0.7	1	2004	2019	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
23543	7134	TNNC1	0.647	0.462	C2750472	Cardiomyopathy, Familial Hypertrophic, 13	disease	C16;C14	Disease or Syndrome	0.9	1	2001	2019	7	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
23546	7136	TNNI2	0.631	0.423	C0220662	ARTHROGRYPOSIS, DISTAL, TYPE 1	disease	C16;C05	Disease or Syndrome; Congenital Abnormality	0.54	1	1997	2016	1	0	ORPHANET
23547	7136	TNNI2	0.631	0.423	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	disease	C16;C05	Disease or Syndrome	0.96	1	2003	2018	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23550	7137	TNNI3	0.52	0.769	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.7	0.991	1988	2019	14	19	CLINGEN;GENOMICS_ENGLAND
23551	7137	TNNI3	0.52	0.769	C0007196	Restrictive cardiomyopathy	disease	C14	Disease or Syndrome	0.7	1	2003	2017	1	5	CTD_human
23560	7137	TNNI3	0.52	0.769	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.69	1	2006	2018	1	5	CTD_human;GENOMICS_ENGLAND
23564	7137	TNNI3	0.52	0.769	C1860752	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7	disease		Disease or Syndrome	0.9	1	1997	2019	8	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
23565	7137	TNNI3	0.52	0.769	C1861861	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1 (disorder)	disease	C14	Disease or Syndrome	0.8	1	2003	2019	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
23566	7137	TNNI3	0.52	0.769	C2678474	CARDIOMYOPATHY, DILATED, 2A (disorder)	disease	C14	Disease or Syndrome	0.7	1	2003	2019	5	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
23567	7137	TNNI3	0.52	0.769	C2750091	Cardiomyopathy, Dilated, 1FF	disease	C14	Disease or Syndrome	0.7	1	2003	2019	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
23569	7138	TNNT1	0.633	0.577	C1854380	NEMALINE MYOPATHY 5	disease	C05;C10	Disease or Syndrome	0.95	1	2000	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
23570	7139	TNNT2	0.601	0.423	C0007193	Cardiomyopathy, Dilated	group	C14	Disease or Syndrome	0.63	1	2000	2019	2	13	CTD_human
23571	7139	TNNT2	0.601	0.423	C0007194	Hypertrophic Cardiomyopathy	disease	C14	Disease or Syndrome	0.8	0.982	1991	2018	12	19	CLINGEN;CTD_human;GENOMICS_ENGLAND
23597	7139	TNNT2	0.601	0.423	C0878544	Cardiomyopathies	group	C14	Disease or Syndrome	0.7	1	2004	2019	2	3	CTD_human;GENOMICS_ENGLAND
23604	7139	TNNT2	0.601	0.423	C1832243	CARDIOMYOPATHY, DILATED, 1D (disorder)	disease	C14	Disease or Syndrome	0.9	1	1991	2019	8	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
23605	7139	TNNT2	0.601	0.423	C1861864	Cardiomyopathy, Familial Hypertrophic, 2	disease	C16;C14	Disease or Syndrome	0.9	1	1991	2019	16	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
23609	7139	TNNT2	0.601	0.423	C2676271	CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3 (disorder)	disease	C14	Disease or Syndrome	0.6	1	1991	2019	3	21	CTD_human;GENOMICS_ENGLAND
23612	7140	TNNT3	0.653	0.308	C0220662	ARTHROGRYPOSIS, DISTAL, TYPE 1	disease	C16;C05	Disease or Syndrome; Congenital Abnormality	0.52	1	2009	2013	2	0	GENOMICS_ENGLAND;ORPHANET
23613	7140	TNNT3	0.653	0.308	C1834523	ARTHROGRYPOSIS, DISTAL, TYPE 2B	disease	C16;C05	Disease or Syndrome	0.52	1	2003	2013	4	0	GENOMICS_ENGLAND;ORPHANET
23625	7148	TNXB	0.572	0.731	C1848029	Ehlers-Danlos syndrome caused by tenascin-X deficiency	disease	C16;C17;C15;C14	Disease or Syndrome	0.61	1	1997	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23626	7148	TNXB	0.572	0.731	C4014831	VESICOURETERAL REFLUX 8	disease		Disease or Syndrome	0.6	1	2013	2013	1	3	GENOMICS_ENGLAND;UNIPROT
23665	7156	TOP3A	0.656	0.615	C4748176	MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2	disease		Disease or Syndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
23667	7157	TP53	0.236	0.962	C0001418	Adenocarcinoma	group	C04	Neoplastic Process	0.7	0.975	1986	2020	3	1	CTD_human
23676	7157	TP53	0.236	0.962	C0005684	Malignant neoplasm of urinary bladder	disease	C04;C13;C12	Neoplastic Process	0.6	0.97	1991	2020	5	0	CTD_human
23677	7157	TP53	0.236	0.962	C0005695	Bladder Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.6	0.984	1991	2020	5	0	CTD_human
23678	7157	TP53	0.236	0.962	C0006118	Brain Neoplasms	group	C04;C10	Neoplastic Process	0.7	0.947	1991	2019	0	72	UNIPROT
23679	7157	TP53	0.236	0.962	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	1	0.973	1982	2020	6	9	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
23685	7157	TP53	0.236	0.962	C0007114	Malignant neoplasm of skin	disease	C04;C17	Neoplastic Process	0.6	0.97	1991	2019	1	0	CTD_human
23688	7157	TP53	0.236	0.962	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.6	0.95	1990	2019	2	0	CTD_human
23697	7157	TP53	0.236	0.962	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.7	0.947	1989	2020	8	7	CTD_human;GENOMICS_ENGLAND
23698	7157	TP53	0.236	0.962	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.7	0.989	1991	2018	8	67	CTD_human
23704	7157	TP53	0.236	0.962	C0014859	Esophageal Neoplasms	group	C06;C04	Neoplastic Process	0.6	0.969	1990	2020	2	0	CTD_human
23706	7157	TP53	0.236	0.962	C0017638	Glioma	disease	C04	Neoplastic Process	0.9	0.946	1991	2020	3	2	CGI;CTD_human
23708	7157	TP53	0.236	0.962	C0018923	Hemangiosarcoma	disease	C04	Neoplastic Process	0.6	0.947	1994	2019	1	0	CTD_human
23719	7157	TP53	0.236	0.962	C0023434	Chronic Lymphocytic Leukemia	disease	C04;C20;C15	Neoplastic Process	0.8	0.977	1991	2020	6	22	CGI;CTD_human;ORPHANET
23722	7157	TP53	0.236	0.962	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.7	0.961	1986	2020	0	27	CGI
23724	7157	TP53	0.236	0.962	C0023903	Liver neoplasms	group	C06;C04	Neoplastic Process	0.7	0.945	1991	2019	2	0	CTD_human
23727	7157	TP53	0.236	0.962	C0024121	Lung Neoplasms	group	C04;C08	Neoplastic Process	0.8	0.974	1990	2019	5	0	CGI;CTD_human
23730	7157	TP53	0.236	0.962	C0025202	melanoma	disease	C04	Neoplastic Process	0.7	0.943	1991	2020	4	0	CGI;CTD_human
23731	7157	TP53	0.236	0.962	C0026640	Mouth Neoplasms	group	C04;C07	Neoplastic Process	0.55	0.875	1995	2013	1	0	CTD_human
23734	7157	TP53	0.236	0.962	C0027627	Neoplasm Metastasis	phenotype	C23;C04	Neoplastic Process	0.6	0.936	1991	2020	1	0	CTD_human
23736	7157	TP53	0.236	0.962	C0029463	Osteosarcoma	disease	C04	Neoplastic Process	1	0.953	1987	2020	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23739	7157	TP53	0.236	0.962	C0030297	Pancreatic Neoplasm	disease	C06;C04;C19	Neoplastic Process	0.9	1	1993	2019	0	0	CGI;CTD_human
23748	7157	TP53	0.236	0.962	C0037286	Skin Neoplasms	group	C04;C17	Neoplastic Process	0.7	0.977	1993	2017	1	0	CTD_human
23758	7157	TP53	0.236	0.962	C0079772	T-Cell Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.6	0.964	1994	2018	1	0	CTD_human
23761	7157	TP53	0.236	0.962	C0085390	Li-Fraumeni Syndrome	disease	C16;C04;C18	Disease or Syndrome	1	0.977	1988	2020	22	180	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
23764	7157	TP53	0.236	0.962	C0149925	Small cell carcinoma of lung	disease	C04;C08	Neoplastic Process	0.7	0.96	1990	2019	3	32	CTD_human;ORPHANET
23767	7157	TP53	0.236	0.962	C0153381	Malignant neoplasm of mouth	group	C04;C07	Neoplastic Process	0.6	0.886	1992	2019	1	0	CTD_human
23770	7157	TP53	0.236	0.962	C0205641	Adenocarcinoma, Basal Cell	disease	C04	Neoplastic Process	0.51	1	1994	2012	3	0	CTD_human
23774	7157	TP53	0.236	0.962	C0205645	Adenocarcinoma, Tubular	disease	C04	Neoplastic Process	0.54	1	1994	2015	3	0	CTD_human
23785	7157	TP53	0.236	0.962	C0205770	Choroid Plexus Papilloma	disease	C04;C10	Neoplastic Process	0.74	0.75	2002	2016	1	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
23786	7157	TP53	0.236	0.962	C0205944	Sarcoma, Epithelioid	disease	C04	Neoplastic Process	0.52	1	2009	2013	1	0	CTD_human
23787	7157	TP53	0.236	0.962	C0205945	Sarcoma, Spindle Cell	disease	C04	Neoplastic Process	0.51	1	2009	2018	1	0	CTD_human
23788	7157	TP53	0.236	0.962	C0205969	Thymic Carcinoma	disease	C04;C15	Neoplastic Process	0.56	1	1995	2019	1	0	CGI;CTD_human
23790	7157	TP53	0.236	0.962	C0206686	Adrenocortical carcinoma	disease	C04;C19	Neoplastic Process	0.8	0.96	1992	2017	5	18	CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23791	7157	TP53	0.236	0.962	C0206698	Cholangiocarcinoma	disease	C04	Neoplastic Process	0.6	0.885	1993	2019	1	0	CTD_human
23794	7157	TP53	0.236	0.962	C0235974	Pancreatic carcinoma	disease	C06;C04;C19	Neoplastic Process	0.7	0.965	1991	2019	0	7	CGI;GENOMICS_ENGLAND
23795	7157	TP53	0.236	0.962	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.8	0.944	1989	2020	5	0	CGI;CTD_human
23796	7157	TP53	0.236	0.962	C0259783	mixed gliomas	disease	C04	Neoplastic Process	0.51	1	2006	2014	3	0	CTD_human
23804	7157	TP53	0.236	0.962	C0279626	Squamous cell carcinoma of esophagus	disease	C06;C04	Neoplastic Process	0.6	0.98	1991	2020	1	0	CTD_human
23811	7157	TP53	0.236	0.962	C0345904	Malignant neoplasm of liver	disease	C06;C04	Neoplastic Process	0.6	0.957	1993	2020	2	0	CTD_human
23812	7157	TP53	0.236	0.962	C0345905	Intrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.6	1	1995	2019	1	0	CTD_human
23815	7157	TP53	0.236	0.962	C0346647	Malignant neoplasm of pancreas	disease	C06;C04;C19	Neoplastic Process	0.8	0.978	1991	2019	0	0	CGI;CTD_human
23827	7157	TP53	0.236	0.962	C0546837	Malignant neoplasm of esophagus	disease	C06;C04	Neoplastic Process	0.7	0.963	1990	2020	2	1	CTD_human
23828	7157	TP53	0.236	0.962	C0549473	Thyroid carcinoma	disease	C04;C19	Neoplastic Process	0.6	0.955	1991	2019	1	0	CGI;CTD_human
23829	7157	TP53	0.236	0.962	C0555198	Malignant Glioma	disease	C04	Neoplastic Process	0.6	1	1992	2019	3	0	CTD_human
23833	7157	TP53	0.236	0.962	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.9	0.971	1982	2020	6	0	CGI;CTD_human
23852	7157	TP53	0.236	0.962	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.7	0.963	1991	2020	1	170	CGI;CTD_human
23853	7157	TP53	0.236	0.962	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.7	0.958	1991	2020	1	0	CGI;CTD_human
23857	7157	TP53	0.236	0.962	C1261473	Sarcoma	group	C04	Neoplastic Process	1	0.955	1987	2020	2	1	CGI;CTD_human;GENOMICS_ENGLAND
23865	7157	TP53	0.236	0.962	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.7	0.984	1982	2020	6	84	CTD_human
23871	7157	TP53	0.236	0.962	C1859972	ADRENOCORTICAL CARCINOMA, HEREDITARY	disease	C04;C19	Neoplastic Process	0.62	1	1994	2001	0	6	CTD_human;GENOMICS_ENGLAND
23875	7157	TP53	0.236	0.962	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	1	0.959	1990	2020	6	67	CGI;CTD_human;GENOMICS_ENGLAND
23887	7157	TP53	0.236	0.962	C2931822	Nasopharyngeal carcinoma	disease	C04;C07;C09	Neoplastic Process	0.7	0.924	1992	2019	1	6	CTD_human;GENOMICS_ENGLAND
23891	7157	TP53	0.236	0.962	C3714644	Thymus Neoplasms	group	C04;C15	Neoplastic Process	0.51	1	1998	2000	0	0	CGI
23892	7157	TP53	0.236	0.962	C3805278	Extrahepatic Cholangiocarcinoma	disease	C04	Neoplastic Process	0.56	1	2000	2019	1	0	CTD_human
23895	7157	TP53	0.236	0.962	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.51	1	1999	2018	6	0	CTD_human
23941	7166	TPH1	0.553	0.731	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.6	1	2004	2019	5	0	PSYGENET
24012	7274	TTPA	0.612	0.577	C1848533	Ataxia with vitamin E deficiency	disease	C23;C18;C10	Disease or Syndrome	1	1	1985	2015	10	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24017	7275	TUB	0.659	0.385	C4015424	RETINAL DYSTROPHY AND OBESITY	disease		Disease or Syndrome	0.61	1	1996	2014	1	1	CTD_human;GENOMICS_ENGLAND
24019	7276	TTR	0.423	0.885	C0007286	Carpal Tunnel Syndrome	disease	C10;C26	Disease or Syndrome	0.8	0.95	1991	2019	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
24030	7276	TTR	0.423	0.885	C0206245	Amyloid Neuropathies, Familial	group	C16;C18;C10	Disease or Syndrome	0.7	1	1983	2019	6	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
24039	7276	TTR	0.423	0.885	C0740340	Amyloidosis, Familial	disease	C16;C18	Disease or Syndrome	0.6	1	1981	2019	3	0	CTD_human;GENOMICS_ENGLAND
24047	7276	TTR	0.423	0.885	C2750824	Dystransthyretinemic Euthyroidal Hyperthyroxinemia	disease	C19	Disease or Syndrome	0.7	1	1990	2018	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
24048	7276	TTR	0.423	0.885	C2751492	AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	disease	C16;C18;C10	Disease or Syndrome	1	0.992	1983	2020	74	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
24054	7277	TUBA4A	0.751	0.269	C4015512	AMYOTROPHIC LATERAL SCLEROSIS 22 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	disease		Disease or Syndrome	0.7	1	2014	2015	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
24065	7280	TUBB2A	0.678	0.538	C3810407	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5	disease		Disease or Syndrome	0.7	1	2014	2014	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
24072	7283	TUBG1	0.729	0.231	C3809420	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4	disease		Disease or Syndrome	0.7	1	2013	2018	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
24076	7284	TUFM	0.678	0.615	C1857682	Combined Oxidative Phosphorylation Deficiency 4	disease	C16;C18	Disease or Syndrome	0.71	1	2007	2019	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24080	7287	TULP1	0.623	0.462	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.66	1	1999	2016	2	1	GENOMICS_ENGLAND;ORPHANET
24081	7287	TULP1	0.623	0.462	C1838603	Retinitis Pigmentosa 14	disease	C16;C11	Disease or Syndrome	0.91	1	1997	2010	5	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
24082	7287	TULP1	0.623	0.462	C3151206	LEBER CONGENITAL AMAUROSIS 15	disease		Disease or Syndrome	0.7	1	2004	2007	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
24100	7291	TWIST1	0.397	0.846	C0175699	Saethre-Chotzen Syndrome	disease	C16;C05	Disease or Syndrome	1	0.986	1995	2019	7	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24103	7291	TWIST1	0.397	0.846	C0221356	Brachycephaly	disease	C16;C05	Congenital Abnormality	0.6	1	2002	2007	2	0	CTD_human;ORPHANET
24105	7291	TWIST1	0.397	0.846	C0265534	Scaphycephaly	disease	C16;C05	Congenital Abnormality	0.62	1	2002	2010	2	0	CTD_human;ORPHANET
24113	7291	TWIST1	0.397	0.846	C1867146	Robinow Sorauf syndrome	disease	C16;C05	Disease or Syndrome	0.6	1	1997	1998	2	1	CTD_human;GENOMICS_ENGLAND
24116	7291	TWIST1	0.397	0.846	C4551902	Craniosynostosis, Type 1	disease	C16;C05	Disease or Syndrome	0.7	1	1997	2015	3	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
24117	7292	TNFSF4	0.54	0.808	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.6	0.967	2008	2019	8	0	CTD_human;ORPHANET
24124	7293	TNFRSF4	0.547	0.692	C3810053	IMMUNODEFICIENCY 16	disease		Disease or Syndrome	0.61	0	2013	2013	1	1	CTD_human;ORPHANET;UNIPROT
24163	7297	TYK2	0.505	0.769	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.62	0.8	2010	2016	1	2	CTD_human;GENOMICS_ENGLAND
24182	7297	TYK2	0.505	0.769	C1969086	Tyrosine Kinase 2 Deficiency	disease	C16;C20;C15	Disease or Syndrome	0.72	1	2006	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
24196	7298	TYMS	0.425	0.846	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.6	1	1998	2015	11	0	CTD_human
24259	7299	TYR	0.473	0.808	C0078918	Albinism, Oculocutaneous	disease	C16;C18;C11;C17	Congenital Abnormality	0.9	0.982	1981	2019	3	10	CTD_human;GENOMICS_ENGLAND
24263	7299	TYR	0.473	0.808	C0268494	Oculocutaneous albinism type 1	disease	C16;C18;C11;C17	Disease or Syndrome	0.7	1	1991	2018	1	1	CTD_human;GENOMICS_ENGLAND
24267	7299	TYR	0.473	0.808	C1847024	ALBINISM, OCULOCUTANEOUS, TYPE IB (disorder)	disease	C16;C18;C11;C17	Disease or Syndrome	0.72	1	1990	2017	6	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
24268	7299	TYR	0.473	0.808	C1863198	ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS (disorder)	disease		Disease or Syndrome	0.6	1	1997	2017	2	12	GENOMICS_ENGLAND;ORPHANET
24270	7299	TYR	0.473	0.808	C4551504	Oculocutaneous albinism type 1A	disease	C16;C18;C11;C17	Disease or Syndrome	0.8	1	1989	2017	23	100	CTD_human;GENOMICS_ENGLAND;UNIPROT
24278	7305	TYROBP	0.573	0.769	C1857316	POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY	disease	C16;C18;C01;C17;C05;C10	Disease or Syndrome	0.7	1	1990	2019	0	5	CTD_human
24291	7306	TYRP1	0.507	0.846	C0342683	ALBINISM, OCULOCUTANEOUS, TYPE III	disease	C16;C18;C11;C17	Disease or Syndrome	0.74	1	1997	2013	4	9	GENOMICS_ENGLAND;ORPHANET;UNIPROT
24293	7306	TYRP1	0.507	0.846	C2931599	Oculocutaneous albinism type 3	disease	C16;C18;C11;C17	Disease or Syndrome	0.64	1	2004	2011	0	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
24304	7307	U2AF1	0.604	0.577	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.8	0.963	2011	2020	2	2	CGI;CTD_human;UNIPROT
24313	7317	UBA1	0.666	0.615	C1844934	Arthrogryposis multiplex congenita, distal, X-linked	disease	C16;C05	Disease or Syndrome	0.72	1	2008	2015	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24315	7319	UBE2A	0.623	0.692	C3275464	MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE	disease		Disease or Syndrome	0.7	1	2006	2018	7	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24351	7337	UBE3A	0.561	0.692	C0162635	Angelman Syndrome	disease	C16;C10	Disease or Syndrome	1	0.967	1997	2020	12	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
24368	7343	UBTF	0.705	0.462	C4540086	NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY	disease		Disease or Syndrome	0.7	1	2017	2017	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
24376	7345	UCHL1	0.482	0.885	C3150899	PARKINSON DISEASE 5, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.7	1	1998	2003	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
24377	7345	UCHL1	0.482	0.885	C3809665	SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.71	1	1998	2018	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24407	7351	UCP2	0.493	0.808	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	0.857	1998	2019	2	0	CTD_human
24408	7351	UCP2	0.493	0.808	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.54	1	2000	2019	1	0	CTD_human
24411	7351	UCP2	0.493	0.808	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.59	1	2004	2019	1	0	CTD_human
24430	7352	UCP3	0.619	0.577	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.7	0.907	1998	2018	1	1	CTD_human;UNIPROT
24446	7355	SLC35A2	0.525	0.808	C3806688	Solute carrier family 35 member A2 congenital disorder of glycosylation	disease	C16;C18;C05;C10	Disease or Syndrome	0.73	1	2013	2019	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24479	7369	UMOD	0.52	0.846	C0022658	Kidney Diseases	group	C13;C12	Disease or Syndrome	0.7	1	1993	2019	2	0	CTD_human
24485	7369	UMOD	0.52	0.846	C1835934	Glomerulocystic Kidney Disease with Hyperuricemia and Isosthenuria	disease	C23;C13;C12	Disease or Syndrome	0.7	1	2003	2006	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
24486	7369	UMOD	0.52	0.846	C1859040	Medullary Cystic Kidney Disease Type 2	disease	C16;C13;C12	Disease or Syndrome	0.79	1	2002	2019	8	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
24489	7369	UMOD	0.52	0.846	C4551496	Hyperuricemic Nephropathy, Familial Juvenile 1	disease	C23;C16;C18;C13;C05;C12	Disease or Syndrome	1	1	2001	2018	14	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
24501	7422	VEGFA	0.266	0.923	C0007102	Malignant tumor of colon	disease	C06;C04	Neoplastic Process	0.6	0.964	1995	2019	1	0	CTD_human
24530	7422	VEGFA	0.266	0.923	C0020541	Portal Hypertension	disease	C06	Disease or Syndrome	0.54	1	2008	2016	1	0	CTD_human
24557	7422	VEGFA	0.266	0.923	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.6	0.951	1994	2020	1	0	CTD_human
24560	7422	VEGFA	0.266	0.923	C0035328	Retinal Vein Occlusion	disease	C11;C14	Disease or Syndrome	0.6	1	2006	2019	1	0	CTD_human
24625	7504	XK	0.575	0.654	C0398568	Blood group deletion syndrome	disease	C16;C10	Disease or Syndrome	0.72	1	1998	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24637	7507	XPA	0.52	0.846	C0043346	Xeroderma Pigmentosum	disease	C16;C04;C18;C17	Congenital Abnormality	0.7	1	1991	2020	1	4	CTD_human
24639	7507	XPA	0.52	0.846	C0268135	Xeroderma pigmentosum, group A	disease	C16;C04;C18;C17	Disease or Syndrome	1	0.968	1978	2019	17	46	CLINGEN;GENOMICS_ENGLAND;UNIPROT
24652	7508	XPC	0.504	0.808	C0007137	Squamous cell carcinoma	disease	C04	Neoplastic Process	0.56	0.714	2005	2017	1	0	CGI;CTD_human
24659	7508	XPC	0.504	0.808	C0043346	Xeroderma Pigmentosum	disease	C16;C04;C18;C17	Congenital Abnormality	0.7	0.974	1994	2019	1	5	CTD_human
24668	7508	XPC	0.504	0.808	C2752147	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	disease	C16;C04;C18;C17	Disease or Syndrome; Congenital Abnormality	1	0.987	1989	2019	15	59	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
24708	7516	XRCC2	0.512	0.731	C0015625	Fanconi Anemia	disease	C16;C18;C15	Disease or Syndrome	0.54	1	2012	2019	3	0	GENOMICS_ENGLAND;ORPHANET
24712	7516	XRCC2	0.512	0.731	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.53	1	1999	2019	4	0	CLINGEN;ORPHANET
24743	7517	XRCC3	0.505	0.769	C3151417	MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6	phenotype		Finding	0.6	1	2000	2000	1	0	CTD_human;UNIPROT
24760	7518	XRCC4	0.528	0.769	C4225288	SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION	disease		Disease or Syndrome	0.6	1	2014	2018	5	9	GENOMICS_ENGLAND;UNIPROT
24780	7528	YY1	0.481	0.808	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.6	1	2010	2010	1	0	CTD_human;GENOMICS_ENGLAND
24782	7528	YY1	0.481	0.808	C4479652	GABRIELE-DE VRIES SYNDROME	disease		Disease or Syndrome	0.7	1	2010	2017	2	6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
24788	7531	YWHAE	0.53	0.692	C0265219	Miller Dieker syndrome	disease	C16;C10	Disease or Syndrome	0.6	1	2000	2017	1	0	ORPHANET
24794	7532	YWHAG	0.621	0.5	C4540034	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56	disease		Disease or Syndrome	0.6	1	2014	2017	3	4	GENOMICS_ENGLAND;UNIPROT
24816	7535	ZAP70	0.497	0.769	C0085110	Severe Combined Immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.6	0.846	1994	2017	2	0	CTD_human;GENOMICS_ENGLAND
24821	7535	ZAP70	0.497	0.769	C2931299	ZAP70 deficiency	disease	C16;C18;C20	Disease or Syndrome	0.73	1	1994	2019	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
24823	7535	ZAP70	0.497	0.769	C4310768	AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2	disease		Disease or Syndrome	0.7	1	2016	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
24841	7545	ZIC1	0.545	0.731	C0030044	Acrocephaly	disease	C16;C05	Congenital Abnormality	0.6	1	2015	2015	1	0	CTD_human;ORPHANET
24842	7545	ZIC1	0.545	0.731	C0221356	Brachycephaly	disease	C16;C05	Congenital Abnormality	0.6	1	2015	2015	1	0	CTD_human;ORPHANET
24855	7546	ZIC2	0.556	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.52	1	2011	2018	1	0	PSYGENET
24867	7546	ZIC2	0.556	0.769	C1864827	HOLOPROSENCEPHALY 5	disease	C16;C05;C10	Disease or Syndrome	0.9	1	1998	2016	8	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
24871	7547	ZIC3	0.587	0.423	C0266642	Situs ambiguus	disease	C16;C15;C14	Congenital Abnormality	0.6	1	1997	2018	1	0	GENOMICS_ENGLAND;ORPHANET
24877	7547	ZIC3	0.587	0.423	C1844020	HETEROTAXY, VISCERAL, 1, X-LINKED	disease	C16;C15;C14	Disease or Syndrome	0.91	1	1952	2014	7	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
24880	7547	ZIC3	0.587	0.423	C3178805	Heterotaxy Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.52	0.889	1952	2018	0	0	GENOMICS_ENGLAND
24886	7552	ZNF711	0.691	0.423	C1136249	Mental Retardation, X-Linked	disease	C16;C10	Disease or Syndrome	0.52	1	1999	2010	1	0	CTD_human;GENOMICS_ENGLAND
24887	7552	ZNF711	0.691	0.423	C2749020	Mental Retardation, X-Linked, Znf711-Related	disease	C23;C16;C10;F03;F01	Disease or Syndrome	0.6	1	2009	2017	2	8	GENOMICS_ENGLAND;UNIPROT
24893	7555	CNBP	0.556	0.692	C2931689	Dystrophia myotonica 2	disease	C16;C05;C10	Disease or Syndrome	0.6	0.978	2002	2018	1	0	CTD_human;GENOMICS_ENGLAND
24897	7592	ZNF41	0.711	0.385	C1136249	Mental Retardation, X-Linked	disease	C16;C10	Disease or Syndrome	0.52	1	2003	2013	2	0	CTD_human;GENOMICS_ENGLAND
24913	7700	ZNF141	0.792	0.154	C3808889	POLYDACTYLY, POSTAXIAL, TYPE A6	disease		Disease or Syndrome	0.6	1	2013	2013	1	1	GENOMICS_ENGLAND;UNIPROT
24926	7704	ZBTB16	0.545	0.808	C0023487	Acute Promyelocytic Leukemia	disease	C04	Neoplastic Process	0.6	0.975	1993	2019	3	0	CTD_human;ORPHANET
24933	7704	ZBTB16	0.545	0.808	C2676231	Skeletal Defects, Genital Hypoplasia, And Mental Retardation	disease	C23;C16;C05;C12;C10;C19;F03;F01	Disease or Syndrome	0.7	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
24934	7707	ZNF148	0.615	0.654	C4310644	GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES	disease		Disease or Syndrome	0.6	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND
24941	7737	RNF113A	0.597	0.769	C4225420	TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	disease		Disease or Syndrome	0.6	1	2013	2017	2	1	CTD_human;GENOMICS_ENGLAND
24981	7780	SLC30A2	0.821	0.192	C1842486	Zinc Deficiency, Neonatal, due to Low Breast Milk Zinc	disease	C23	Disease or Syndrome	0.65	0.833	2006	2019	2	2	CTD_human;UNIPROT
24988	7784	ZP3	0.805	0.115	C4540205	OOCYTE MATURATION DEFECT 3	disease		Disease or Syndrome	0.6	1	2017	2017	2	1	ORPHANET;UNIPROT
25009	7809	BSND	0.603	0.692	C1865270	BARTTER SYNDROME, TYPE 4A	disease	C23;C13;C12;C10;C19;C09	Disease or Syndrome	0.91	1	1998	2017	11	6	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
25021	7827	NPHS2	0.576	0.538	C0027726	Nephrotic Syndrome	group	C13;C12	Disease or Syndrome	0.7	1	1995	2019	1	0	CTD_human
25029	7827	NPHS2	0.576	0.538	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	disease	C13;C12	Disease or Syndrome	0.61	1	2000	2018	3	34	CTD_human;ORPHANET
25030	7827	NPHS2	0.576	0.538	C3496337	Idiopathic Nephrotic Syndrome	disease	C13;C12	Disease or Syndrome	0.68	1	1995	2018	15	42	GENOMICS_ENGLAND;UNIPROT
25039	7837	PXDN	0.647	0.5	C3151617	ANTERIOR SEGMENT DYSGENESIS 7	disease		Disease or Syndrome	0.7	1	2011	2015	2	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
25043	7840	ALMS1	0.559	0.808	C0268425	Alstrom Syndrome	disease	C16;C11;C10	Disease or Syndrome	1	1	1998	2020	11	179	CLINGEN;CTD_human;GENOMICS_ENGLAND
25048	7841	MOGS	0.626	0.731	C1853736	Congenital Disorder Of Glycosylation, Type IIB	disease	C16;C18	Disease or Syndrome	0.73	1	1973	2019	5	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
25059	7846	TUBA1A	0.597	0.769	C1969029	Lissencephaly 3	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.7	1	2007	2018	6	40	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25066	7849	PAX8	0.477	0.731	C0010308	Congenital Hypothyroidism	disease	C16;C05;C19	Disease or Syndrome	0.7	1	1998	2019	1	0	GENOMICS_ENGLAND
25067	7849	PAX8	0.477	0.731	C0151516	Thyroid Hypoplasia	disease	C16;C19	Disease or Syndrome	0.7	0.917	1998	2014	4	0	GENOMICS_ENGLAND;ORPHANET
25071	7849	PAX8	0.477	0.731	C1869118	HYPOTHYROIDISM, CONGENITAL, DUE TO THYROID DYSGENESIS	disease	C16;C05;C19	Congenital Abnormality	0.71	1	1998	2019	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
25106	7852	CXCR4	0.362	0.923	C0472817	WHIM syndrome	disease	C16;C01;C17;C20	Disease or Syndrome	1	1	2000	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
25127	7862	BRPF1	0.686	0.385	C4310617	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS	disease		Disease or Syndrome	0.71	1	2017	2019	2	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
25131	7867	MAPKAPK3	0.743	0.308	C4310713	MACULAR DYSTROPHY, PATTERNED, 3	disease		Disease or Syndrome	0.51	1	2016	2016	1	1	ORPHANET;UNIPROT
25135	7871	SLMAP	0.686	0.462	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.51	1	1997	2012	4	0	CLINGEN;ORPHANET
25142	7879	RAB7A	0.597	0.692	C1833219	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)	disease	C16;C10	Disease or Syndrome	0.8	1	2003	2019	6	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25170	7915	ALDH5A1	0.619	0.462	C0268631	succinic semialdehyde dehydrogenase deficiency	disease	C16;C18;F03	Disease or Syndrome	0.8	1	2000	2019	9	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
25225	8291	DYSF	0.582	0.692	C1847532	MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET	disease	C16;C05;C10	Disease or Syndrome	0.71	1	2009	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
25227	8291	DYSF	0.582	0.692	C1850889	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B	disease	C16;C05;C10	Disease or Syndrome	1	0.992	1989	2019	17	150	CTD_human;GENOMICS_ENGLAND;UNIPROT
25230	8291	DYSF	0.582	0.692	C4551973	Miyoshi Muscular Dystrophy 1	disease	C23;C16;C05;C10	Disease or Syndrome	0.7	0.974	1996	2019	19	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
25234	8292	COLQ	0.628	0.654	C1864233	ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY (disorder)	disease	C16;C10	Disease or Syndrome	0.74	1	1998	2018	7	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
25257	8302	KLRC4	0.666	0.654	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.63	1	2013	2017	2	0	CTD_human;ORPHANET
25260	8309	ACOX2	0.769	0.423	C4310624	BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	disease		Disease or Syndrome	0.6	1	2016	2017	2	2	CTD_human;UNIPROT
25276	8312	AXIN1	0.559	0.577	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.8	0.944	2000	2019	2	4	CGI;CTD_human;UNIPROT
25294	8313	AXIN2	0.507	0.692	C1837750	Oligodontia-Colorectal Cancer Syndrome	disease	C16;C06;C04;C07	Neoplastic Process	0.71	1	2004	2017	7	14	CLINGEN;CTD_human;ORPHANET
25300	8314	BAP1	0.454	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	1	1998	2019	2	0	CGI;CTD_human
25308	8314	BAP1	0.454	0.731	C0022665	Kidney Neoplasm	disease	C04;C13;C12	Neoplastic Process	0.62	1	2016	2019	1	1	CGI;CTD_human
25314	8314	BAP1	0.454	0.731	C0025202	melanoma	disease	C04	Neoplastic Process	0.7	0.95	2010	2019	0	1	CGI;GENOMICS_ENGLAND
25315	8314	BAP1	0.454	0.731	C0025286	Meningioma	disease	C04;C10	Neoplastic Process	0.69	0.9	2011	2019	1	0	CTD_human;GENOMICS_ENGLAND
25316	8314	BAP1	0.454	0.731	C0025500	Mesothelioma	disease	C04	Neoplastic Process	0.6	0.985	2011	2020	4	0	CGI;CTD_human
25326	8314	BAP1	0.454	0.731	C0151779	Cutaneous Melanoma	disease	C04;C17	Neoplastic Process	0.8	0.955	2012	2019	2	0	CGI;CTD_human;GENOMICS_ENGLAND
25340	8314	BAP1	0.454	0.731	C0220633	Uveal melanoma	disease	C04;C11	Neoplastic Process	0.8	0.973	2010	2020	5	2	CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET
25341	8314	BAP1	0.454	0.731	C0242379	Malignant neoplasm of lung	disease	C04;C08	Neoplastic Process	0.55	1	2015	2019	1	0	CTD_human;UNIPROT
25345	8314	BAP1	0.454	0.731	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.6	0.982	2011	2019	4	0	CGI;CTD_human
25366	8314	BAP1	0.454	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.6	1	1998	2019	2	0	CGI;CTD_human
25367	8314	BAP1	0.454	0.731	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.56	0.857	2013	2019	1	0	CGI;CTD_human
25399	8314	BAP1	0.454	0.731	C3280492	TUMOR PREDISPOSITION SYNDROME	disease		Disease or Syndrome	0.79	1	2008	2019	7	56	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
25407	8318	CDC45	0.588	0.692	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	disease	C23;C16;C05;C07;C09	Disease or Syndrome	0.52	1	2016	2020	1	0	CTD_human;ORPHANET
25410	8318	CDC45	0.588	0.692	C4310738	MEIER-GORLIN SYNDROME 7	disease		Disease or Syndrome	0.6	1	2015	2016	2	12	GENOMICS_ENGLAND;UNIPROT
25435	8322	FZD4	0.49	0.923	C1851402	Exudative vitreoretinopathy 1	disease	C16;C11	Disease or Syndrome	0.74	1	2002	2017	14	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25437	8323	FZD6	0.623	0.615	C3279974	NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10	disease		Disease or Syndrome	0.7	1	2011	2011	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25442	8328	GFI1B	0.623	0.5	C1861194	Thrombasthenia-Thrombocytopenia, Hereditary	disease	C16;C15	Disease or Syndrome	0.71	1	2002	2019	12	4	CLINGEN;CTD_human;GENOMICS_ENGLAND
25505	8398	PLA2G6	0.476	0.846	C0270724	Infantile Neuroaxonal Dystrophy	disease	C10	Disease or Syndrome	1	1	2004	2020	7	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25507	8398	PLA2G6	0.476	0.846	C1857747	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2 (disorder)	disease	C18;C10	Disease or Syndrome	0.74	1	2006	2019	5	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
25508	8398	PLA2G6	0.476	0.846	C2751842	PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE	disease	C10	Disease or Syndrome	0.76	0.917	2006	2019	4	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25521	8405	SPOP	0.597	0.5	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.7	0.957	2012	2020	3	1	CTD_human;GENOMICS_ENGLAND
25522	8405	SPOP	0.597	0.5	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.57	1	2012	2019	1	0	CGI;CTD_human
25565	8419	BFSP2	0.686	0.385	C3808115	CATARACT 12, MULTIPLE TYPES	disease		Disease or Syndrome	0.6	1	2000	2004	3	0	GENOMICS_ENGLAND;UNIPROT
25567	8425	LTBP4	0.604	0.654	C0010495	Cutis Laxa	disease	C16;C17	Disease or Syndrome	0.6	1	2013	2013	1	0	GENOMICS_ENGLAND
25574	8425	LTBP4	0.604	0.654	C2750804	Cutis Laxa With Severe Pulmonary, Gastrointestinal, And Urinary Abnormalities	disease	C16;C06;C13;C17;C05;C12;C08	Disease or Syndrome	0.7	1	2009	2015	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25580	8431	NR0B2	0.474	0.808	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.69	1	2001	2020	0	0	CTD_human;GENOMICS_ENGLAND
25605	8438	RAD54L	0.633	0.423	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.62	0.5	2017	2017	0	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
25608	8438	RAD54L	0.633	0.423	C0024305	Lymphoma, Non-Hodgkin	disease	C04;C20;C15	Neoplastic Process	0.6	NA	NA	NA	0	0	CGI;CTD_human;UNIPROT
25615	8438	RAD54L	0.633	0.423	C0338106	Adenocarcinoma of colon	disease	C06;C04	Neoplastic Process	0.6	NA	NA	NA	0	1	CGI;UNIPROT
25624	8438	RAD54L	0.633	0.423	C4721532	Lymphoma, Non-Hodgkin, Familial	disease	C04;C20;C15	Neoplastic Process	0.6	NA	NA	NA	0	0	CTD_human;GENOMICS_ENGLAND
25630	8443	GNPAT	0.663	0.462	C1857242	Rhizomelic chondrodysplasia punctata, type 2	disease	C16;C18;C05	Disease or Syndrome	0.92	1	1992	2017	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25636	8450	CUL4B	0.556	0.769	C1845861	MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND ABNORMAL GAIT	disease	C16;C10	Disease or Syndrome	0.72	1	1991	2020	9	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25650	8452	CUL3	0.592	0.654	C3469606	PSEUDOHYPOALDOSTERONISM, TYPE IIE	disease	C16;C13;C12	Disease or Syndrome	0.71	1	2012	2015	1	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
25659	8456	FOXN1	0.615	0.654	C1866426	T-cell immunodeficiency, congenital alopecia and nail dystrophy	disease	C23;C16;C18;C17;C20	Disease or Syndrome	0.91	1	1966	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
25662	8462	KLF11	0.626	0.654	C0342276	Maturity onset diabetes mellitus in young	disease	C18;C19	Disease or Syndrome	0.62	1	2011	2019	1	0	GENOMICS_ENGLAND;ORPHANET
25663	8462	KLF11	0.626	0.654	C1864839	MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7 (disorder)	disease	C18;C19	Disease or Syndrome	0.7	1	2005	2005	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
25675	8600	TNFSF11	0.453	0.846	C0029456	Osteoporosis	disease	C18;C05	Disease or Syndrome	0.6	0.987	1999	2020	1	0	CTD_human
25680	8600	TNFSF11	0.453	0.846	C1850126	Osteopetrosis, mild autosomal recessive form	disease	C05	Disease or Syndrome	0.8	1	2000	2016	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
25687	8604	SLC25A12	0.711	0.462	C2751855	Hypomyelination, Global Cerebral	disease	C23;C16;C18;C10;F01	Disease or Syndrome	0.94	1	2005	2019	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25718	8621	CDK13	0.606	0.692	C4479246	CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	disease		Disease or Syndrome	0.71	1	2015	2019	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
25739	8622	PDE8B	0.638	0.5	C1836694	Striatal Degeneration, Autosomal Dominant	disease	C23	Disease or Syndrome	0.54	1	2010	2019	1	0	CTD_human;ORPHANET
25740	8622	PDE8B	0.638	0.5	C3280094	PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3	disease		Disease or Syndrome	0.7	1	2008	2008	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
25746	8625	RFXANK	0.644	0.577	C2931418	Bare lymphocyte syndrome 2	disease	C16;C18;C20	Disease or Syndrome	0.73	0.833	1998	2012	4	3	CTD_human;ORPHANET;UNIPROT
25749	8626	TP63	0.362	0.769	C0005689	Bladder Exstrophy	disease	C16;C13;C12	Disease or Syndrome	0.61	1	1999	2012	1	0	ORPHANET
25755	8626	TP63	0.362	0.769	C0008924	Cleft upper lip	disease	C16;C07	Congenital Abnormality	0.72	1	2006	2017	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
25783	8626	TP63	0.362	0.769	C0406704	Rudiger syndrome 1	disease	C16;C17;C05;C07	Disease or Syndrome	0.8	0.944	1999	2019	3	0	CTD_human;ORPHANET
25784	8626	TP63	0.362	0.769	C0406709	Hay-Wells syndrome	disease	C16;C11;C17;C05;C07	Disease or Syndrome	0.8	0.95	2001	2019	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
25789	8626	TP63	0.362	0.769	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.53	0.75	2001	2012	1	0	CTD_human;UNIPROT
25793	8626	TP63	0.362	0.769	C1785148	RAPP-HODGKIN SYNDROME	disease	C16;C17;C05;C07	Disease or Syndrome	1	1	2001	2019	7	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25797	8626	TP63	0.362	0.769	C1854442	SPLIT-HAND/FOOT MALFORMATION 4	disease	C16;C05	Disease or Syndrome	0.75	1	2000	2019	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25798	8626	TP63	0.362	0.769	C1858562	ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3	disease	C16;C17;C05;C07	Disease or Syndrome	0.71	1	1999	2019	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
25800	8626	TP63	0.362	0.769	C1863204	ADULT SYNDROME	disease	C23;C16;C11;C17;C05;C07	Disease or Syndrome	0.8	1	2001	2019	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25801	8626	TP63	0.362	0.769	C1863753	LIMB-MAMMARY SYNDROME	disease	C16;C05	Disease or Syndrome	0.66	1	2001	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
25809	8629	JRK	0.612	0.5	C0270853	Juvenile Myoclonic Epilepsy	disease	C10	Disease or Syndrome	0.51	1	2001	2001	1	0	CTD_human;ORPHANET
25846	8912	CACNA1H	0.628	0.423	C2749872	EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	phenotype		Finding	0.6	1	2003	2018	5	13	GENOMICS_ENGLAND;UNIPROT
25849	8912	CACNA1H	0.628	0.423	C4310756	HYPERALDOSTERONISM, FAMILIAL, TYPE IV	disease		Disease or Syndrome	0.7	1	2015	2016	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
25865	8913	CACNA1G	0.59	0.577	C4225205	SPINOCEREBELLAR ATAXIA 42	disease		Disease or Syndrome	0.73	1	2015	2020	4	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
25866	8913	CACNA1G	0.59	0.577	C4748120	SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS	disease		Disease or Syndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
25883	8915	BCL10	0.491	0.769	C0242647	Mucosa-Associated Lymphoid Tissue Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.8	0.968	1999	2018	2	3	CGI;CTD_human;ORPHANET
25889	8915	BCL10	0.491	0.769	C4015195	IMMUNODEFICIENCY 37	disease		Disease or Syndrome	0.6	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND
25901	8924	HERC2	0.568	0.692	C3809753	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38	disease		Disease or Syndrome	0.7	1	2012	2013	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25906	8925	HERC1	0.674	0.5	C4310766	MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION	disease		Disease or Syndrome	0.7	1	2015	2016	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25917	8929	PHOX2B	0.565	0.731	C0027819	Neuroblastoma	disease	C04	Neoplastic Process	0.8	0.897	2004	2020	3	0	CGI;CTD_human;ORPHANET
25923	8929	PHOX2B	0.565	0.731	C1275808	Congenital central hypoventilation	disease	C23;C08;C10	Disease or Syndrome	1	0.958	2002	2020	6	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
25924	8929	PHOX2B	0.565	0.731	C1859049	CCHS WITH HIRSCHSPRUNG DISEASE	disease	C23;C08;C10	Disease or Syndrome; Congenital Abnormality	0.64	1	2003	2014	2	1	CTD_human;ORPHANET
25926	8929	PHOX2B	0.565	0.731	C2751683	Hirschsprung disease ganglioneuroblastoma	disease	C16;C06;C04	Disease or Syndrome	0.6	1	2017	2017	1	1	GENOMICS_ENGLAND;ORPHANET
25940	8942	KYNU	0.617	0.692	C0268474	Hydroxykynureninuria	phenotype	C16;C18	Disease or Syndrome	0.71	1	2007	2017	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25946	8942	KYNU	0.617	0.692	C4540014	VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2	disease		Disease or Syndrome	0.6	1	2017	2017	1	3	GENOMICS_ENGLAND;ORPHANET
25952	8943	AP3D1	0.678	0.385	C0079504	Hermanski-Pudlak Syndrome	disease	C16;C18;C11;C17;C15	Disease or Syndrome	0.53	1	2009	2019	1	0	CTD_human;GENOMICS_ENGLAND
25963	8974	P4HA2	0.653	0.577	C4310655	MYOPIA 25, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.6	1	2015	2015	1	4	CTD_human;UNIPROT
25976	8985	PLOD3	0.659	0.385	C2676285	Bone Fragility with Contractures, Arterial Rupture, and Deafness	disease	C23;C17;C05	Disease or Syndrome	0.7	1	2008	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25981	8988	HSPB3	0.448	0.769	C3150619	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC	disease		Disease or Syndrome	0.6	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
25985	8989	TRPA1	0.546	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	Sign or Symptom	0.57	1	2008	2019	3	0	CTD_human
26005	8989	TRPA1	0.546	0.846	C3808667	EPISODIC PAIN SYNDROME, FAMILIAL, 1	disease		Disease or Syndrome	0.6	1	2010	2018	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26039	8996	NOL3	0.575	0.808	C3539916	MYOCLONUS, FAMILIAL CORTICAL	disease		Disease or Syndrome	0.61	1	2012	2014	2	2	CTD_human;ORPHANET;UNIPROT
26091	9031	BAZ1B	0.53	0.731	C0175702	Williams Syndrome	disease	C16;C10;C14	Disease or Syndrome	0.6	1	1998	2017	1	0	CTD_human
26123	9049	AIP	0.517	0.769	C0033375	Prolactinoma	disease	C04;C10;C19	Neoplastic Process	0.7	1	2009	2018	2	0	GENOMICS_ENGLAND;ORPHANET
26130	9049	AIP	0.517	0.769	C0221406	Pituitary-dependent Cushings disease	disease	C10;C19	Disease or Syndrome	0.32	1	2010	2012	   0	   0	GENOMICS_ENGLAND
     9049	AIP	0.517	0.769	C0338078	Non-Functioning Pituitary Gland Neoplasm	disease	C04;C10;C19	Neoplastic Process	0.31	1	2013	2018	   1	   0	ORPHANET
     9049	AIP	0.517	0.769	C0346302	Growth Hormone-Secreting Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.39	1	2007	2018	   0	   0	CTD_human
     9049	AIP	0.517	0.769	C1306214	ACTH-Secreting Pituitary Adenoma	disease	C04;C10;C19	Neoplastic Process	0.32	1	2007	2014	   0	   0	CTD_human
     9049	AIP	0.517	0.769	C1704374	Carcinoma of Endocrine Gland	disease	C04;C19	Neoplastic Process	0.30				   0	   0	GENOMICS_ENGLAND
     9049	AIP	0.517	0.769	C3489630	Somatotrophinoma, Familial	disease	C04;C10;C19	Neoplastic Process	0.34	1	2007	2010	   0	   0	CTD_human
     9049	AIP	0.517	0.769	C4538355	PITUITARY ADENOMA 1, MULTIPLE TYPES	disease		Neoplastic Process	0.60	1	2006	2018	   6	   8	GENOMICS_ENGLAND;UNIPROT
     9050	PSTPIP2	0.76	0.385	C0263859	Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome	disease	C05	Disease or Syndrome	0.31	1	2010	2016	   1	   0	CTD_human
     9051	PSTPIP1	0.65	0.577	C0001144	Acne Vulgaris	disease	C17	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     9051	PSTPIP1	0.65	0.577	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
     9051	PSTPIP1	0.65	0.577	C0079541	Holoprosencephaly	disease	C16;C05;C10	Congenital Abnormality	0.30				   0	   0	GENOMICS_ENGLAND
     9051	PSTPIP1	0.65	0.577	C0085652	Pyoderma Gangrenosum	disease	C17	Disease or Syndrome	0.44	0.8	2005	2016	   1	   0	CTD_human
     9051	PSTPIP1	0.65	0.577	C0162836	Hidradenitis Suppurativa	disease	C01;C17	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
     9051	PSTPIP1	0.65	0.577	C0702166	Acne	disease	C17	Disease or Syndrome	0.40	1	2016	2016	   1	   0	CTD_human
     9051	PSTPIP1	0.65	0.577	C1858361	Pyogenic Arthritis, Pyoderma Gangrenosum and Acne	disease	C01;C17;C05	Disease or Syndrome	0.80	1	2002	2019	   6	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     9051	PSTPIP1	0.65	0.577	C1860229	Hyperzincemia and Hypercalprotectinemia	disease	C16;C18	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     9051	PSTPIP1	0.65	0.577	C3860213	Autoinflammatory disorder	disease		Disease or Syndrome	0.34	1	2002	2015	   1	   0	GENOMICS_ENGLAND
     9052	GPRC5A	0.579	0.692	C0003873	Rheumatoid Arthritis	disease	C17;C05;C20	Disease or Syndrome	0.31	1	2007	2007	   1	   0	CTD_human
     9054	NFS1	0.861	0.308	C4750855	Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency	disease	C23;C18;C11;C05;C10;C14	Disease or Syndrome	0.30	1	2014	2014	   1	   0	ORPHANET
     9055	PRC1	0.599	0.692	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.36	1	2007	2018	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.47	1	2007	2018	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C0919267	ovarian neoplasm	disease	C04;C13;C19	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C1140680	Malignant neoplasm of ovary	disease	C04;C13;C19	Neoplastic Process	0.30	1	2019	2019	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.31	1	2007	2014	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.35	1	2016	2019	   1	   0	CTD_human
     9055	PRC1	0.599	0.692	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2014	2014	   1	   0	CTD_human
     9056	SLC7A7	0.603	0.654	C0002514	Amino Acid Metabolism, Inborn Errors	group	C16;C18	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     9056	SLC7A7	0.603	0.654	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     9056	SLC7A7	0.603	0.654	C0268647	Lysinuric Protein Intolerance	disease	C16;C18	Disease or Syndrome	0.80	1	1980	2020	  10	  47	CTD_human;GENOMICS_ENGLAND;UNIPROT
     9056	SLC7A7	0.603	0.654	C0750905	Amino Acid Metabolism, Inherited Disorders	disease	C16;C18	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
     9060	PAPSS2	0.682	0.462	C0878659	Disproportionate short stature	phenotype	C16;C05;C19	Finding	0.30				   0	   0	GENOMICS_ENGLAND
     9060	PAPSS2	0.682	0.462	C2748515	Spondyloepimetaphyseal Dysplasia, Pakistani Type	disease	C23;C16;C05	Congenital Abnormality	0.92	1	1969	2015	   6	  11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     9064	MAP3K6	0.861	0.192	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.30				   0	   0	UNIPROT
     9064	MAP3K6	0.861	0.192	C0346163	Endometrioid carcinoma ovary	disease	C04;C13;C19	Neoplastic Process	0.30				   0	   0	UNIPROT
     9064	MAP3K6	0.861	0.192	C1708349	Hereditary Diffuse Gastric Cancer	disease	C06;C04	Neoplastic Process	0.31	1	2014	2014	   1	   0	ORPHANET
     9071	CLDN10	0.626	0.577	C4522164	HELIX SYNDROME	disease		Disease or Syndrome	0.61	1	2009	2018	   3	   3	GENOMICS_ENGLAND;UNIPROT
     9075	CLDN2	0.575	0.692	C0030305	Pancreatitis	disease	C06	Disease or Syndrome	0.42	1	2012	2020	   1	   0	CTD_human
     9076	CLDN1	0.481	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.40	0.9	1999	2019	   2	   0	CTD_human
     9076	CLDN1	0.481	0.808	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
     9076	CLDN1	0.481	0.808	C0011616	Contact Dermatitis	disease	C17	Disease or Syndrome	0.31	1	2013	2013	   1	   0	CTD_human
     9076	CLDN1	0.481	0.808	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
     9076	CLDN1	0.481	0.808	C0086873	Pseudopelade	disease	C23;C17	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     9076	CLDN1	0.481	0.808	C0162351	Contact hypersensitivity	phenotype	C17	Pathologic Function	0.30	1	2013	2013	   1	   0	CTD_human
     9076	CLDN1	0.481	0.808	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     9076	CLDN1	0.481	0.808	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.40	0.9	1999	2019	   2	   0	CTD_human
     9076	CLDN1	0.481	0.808	C1257931	Mammary Neoplasms, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2013	   2	   0	CTD_human
     9076	CLDN1	0.481	0.808	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.37	1	2000	2016	   2	   0	CTD_human
     9076	CLDN1	0.481	0.808	C1843355	ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS	disease	C23;C16;C06;C17;C15	Disease or Syndrome	0.75	1	2004	2018	   2	   2	CTD_human;GENOMICS_ENGLAND;ORPHANET
     9076	CLDN1	0.481	0.808	C2936846	Scarring alopecia	disease	C23;C17;C19	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     9076	CLDN1	0.481	0.808	C4704874	Mammary Carcinoma, Human	disease	C04;C17	Neoplastic Process	0.30	1	2009	2013	   2	   0	CTD_human
     9077	DIRAS3	0.631	0.385	C0206682	Follicular thyroid carcinoma	disease	C04	Neoplastic Process	0.30	1	2005	2005	   1	   0	GENOMICS_ENGLAND
     9077	DIRAS3	0.631	0.385	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2009	2017	   1	   0	CTD_human
     9080	CLDN9	0.861	0.231	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     9080	CLDN9	0.861	0.231	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.30	1	2007	2007	   1	   0	CTD_human
     9081	PRY	0.861	0.115	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	disease	C16;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     9082	XKRY	0.931	0.077	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	disease	C16;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     9083	BPY2	0.76	0.231	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	disease	C16;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     9084	VCY	0.89	0.231	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	disease	C16;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     9085	CDY1	0.805	0.231	C1839071	Spermatogenic Failure, Nonobstructive, Y-Linked	disease	C16;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     9088	PKMYT1	0.7	0.385	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
     9088	PKMYT1	0.7	0.385	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2017	2019	   1	   0	CTD_human
     9091	PIGQ	0.61	0.577	C0014544	Epilepsy	disease	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     9091	PIGQ	0.61	0.577	C0029124	Optic Atrophy	disease	C11;C10	Disease or Syndrome	0.40	1	2019	2019	   1	   1	GENOMICS_ENGLAND
     9091	PIGQ	0.61	0.577	C0393706	Early infantile epileptic encephalopathy with suppression bursts	disease	C10	Disease or Syndrome	0.31	1	2014	2014	   1	   0	ORPHANET
     9091	PIGQ	0.61	0.577	C0424605	Developmental delay (disorder)	phenotype	F03	Mental or Behavioral Dysfunction	0.40	1	2019	2019	   1	   1	GENOMICS_ENGLAND
     9091	PIGQ	0.61	0.577	C0557874	Global developmental delay	disease		Mental or Behavioral Dysfunction	0.40	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     9091	PIGQ	0.61	0.577	C2674422	Seizures, intractable	phenotype		Finding	0.40	1	2019	2019	   1	   1	GENOMICS_ENGLAND
     9091	PIGQ	0.61	0.577	C4552072	X-linked infantile spasms	disease	C10	Disease or Syndrome	0.30	1	2019	2019	   1	   0	GENOMICS_ENGLAND
     9094	UNC119	0.691	0.462	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.30				   0	   0	GENOMICS_ENGLAND
     9094	UNC119	0.691	0.462	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.31	1	2000	2019	   1	   0	CTD_human
     9094	UNC119	0.691	0.462	C0206744	T-Lymphocytopenia, Idiopathic CD4-Positive	disease	C20;C15	Disease or Syndrome	0.30				   0	   0	CTD_human
     9094	UNC119	0.691	0.462	C0494261	Combined immunodeficiency	disease	C16;C18;C20	Disease or Syndrome	0.30	1	2012	2012	   1	   0	GENOMICS_ENGLAND
     9094	UNC119	0.691	0.462	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.31	1	2000	2016	   2	   0	ORPHANET
     9094	UNC119	0.691	0.462	C3809768	IMMUNODEFICIENCY 13	disease		Disease or Syndrome	0.62	1	2012	2012	   1	   1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
     9094	UNC119	0.691	0.462	C4085590	Cone-Rod Dystrophies	disease	C16;C11	Disease or Syndrome	0.31	1	2007	2007	   0	   0	GENOMICS_ENGLAND
     9095	TBX19	0.695	0.462	C0001956	Alcohol Use Disorder	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     9095	TBX19	0.695	0.462	C0001973	Alcoholic Intoxication, Chronic	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     9095	TBX19	0.695	0.462	C0011570	Mental Depression	disease	F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	PSYGENET
     9095	TBX19	0.695	0.462	C0011581	Depressive disorder	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	PSYGENET
     9095	TBX19	0.695	0.462	C0085762	Alcohol abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.30	1	2008	2008	   1	   0	CTD_human
     9095	TBX19	0.695	0.462	C0271583	ACTH Deficiency, Isolated	disease	C16;C18;C19	Disease or Syndrome	0.76	1	2001	2019	   6	   9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
     9095	TBX19	0.695	0.462	C0342388	Adrenocorticotropic hormone (ACTH) deficiency (disorder)	disease	C19	Disease or Syndrome	0.62	1	2003	2018	   2	   0	ORPHANET
     9096	TBX18	0.695	0.231	C0521619	Obstruction of pelviureteric junction	phenotype	C16;C13;C12	Pathologic Function	0.70	1	2015	2015	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
     9096	TBX18	0.695	0.231	C1840451	MULTICYSTIC RENAL DYSPLASIA, BILATERAL	disease	C16;C13;C12	Disease or Syndrome	0.40				   0	   3	CTD_human
     9096	TBX18	0.695	0.231	C4048262	Hydronephrosis Due To Pujo	disease	C16;C13;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
     9098	USP6	0.633	0.692	C0410005	Nodular fasciitis	disease	C04;C05;C10	Disease or Syndrome	0.40	1	2011	2019	   1	   0	ORPHANET
     9099	USP2	0.682	0.462	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
     9101	USP8	0.587	0.654	C0010481	Cushing Syndrome	disease	C19	Disease or Syndrome	0.30	1	2015	2015	   1	   0	ORPHANET
     9101	USP8	0.587	0.654	C0221406	Pituitary-dependent Cushings disease	disease	C10;C19	Disease or Syndrome	0.8	1	2015	2020	2	4	CTD_human;ORPHANET;UNIPROT
26134	9103	FCGR2C	0.61	0.654	C0398650	Immune thrombocytopenic purpura	disease	C23;C20;C15	Disease or Syndrome	0.54	0.75	2008	2019	1	0	CTD_human;ORPHANET
26200	9126	SMC3	0.535	0.846	C1853099	Cornelia de Lange Syndrome 3	disease	C16;C10	Disease or Syndrome	0.6	1	2014	2019	3	20	CTD_human;GENOMICS_ENGLAND
26212	9128	PRPF4	0.67	0.462	C4014681	RETINITIS PIGMENTOSA 70	disease		Disease or Syndrome	0.7	1	2014	2014	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
26216	9129	PRPF3	0.695	0.385	C1832378	Retinitis Pigmentosa 18	disease	C16;C11	Disease or Syndrome	0.93	1	2002	2011	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
26231	9131	AIFM1	0.527	0.769	C0795910	COWCHOCK SYNDROME	disease	C23;C16;C10;C09	Disease or Syndrome	0.75	1	1985	2019	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26234	9131	AIFM1	0.527	0.769	C1845095	DEAFNESS, X-LINKED 5 (disorder)	disease	C23;C16;C10;C09	Disease or Syndrome	0.7	1	2010	2017	6	17	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26236	9131	AIFM1	0.527	0.769	C3151753	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6	disease		Disease or Syndrome	0.7	1	1985	2016	8	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26244	9132	KCNQ4	0.674	0.462	C2677637	Deafness, Autosomal Dominant 2A	disease	C23;C10;C09	Disease or Syndrome	0.7	1	1997	2015	6	25	CTD_human;GENOMICS_ENGLAND;UNIPROT
26277	9149	DYRK1B	0.647	0.462	C4014361	ABDOMINAL OBESITY-METABOLIC SYNDROME 3	disease		Disease or Syndrome	0.7	1	2014	2014	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
26278	9150	CTDP1	0.641	0.577	C1858726	Congenital Cataracts, Facial Dysmorphism, And Neuropathy	disease	C16;C11;C05;C10	Disease or Syndrome; Congenital Abnormality	0.6	1	2003	2003	1	1	CTD_human;GENOMICS_ENGLAND
26285	9152	SLC6A5	0.67	0.5	C3553288	HYPEREKPLEXIA 3	disease		Disease or Syndrome	0.8	1	2003	2019	3	11	GENOMICS_ENGLAND;UNIPROT
26305	9158	FIBP	0.674	0.538	C4310715	THAUVIN-ROBINET-FAIVRE SYNDROME	disease		Disease or Syndrome	0.7	1	2016	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
26339	9179	AP4M1	0.638	0.5	C2752008	Spastic Paraplegia-50, Autosomal Recessive	disease	C16;C10	Disease or Syndrome	0.61	1	2009	2019	2	6	CTD_human;GENOMICS_ENGLAND
26344	9180	OSMR	0.599	0.577	C0268398	Familial lichen amyloidosis	disease	C16;C18;C17	Disease or Syndrome	0.51	1	2010	2010	1	0	CTD_human;ORPHANET
26346	9180	OSMR	0.599	0.577	C4551501	AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1	disease	C16;C18;C17	Disease or Syndrome	0.7	1	2008	2010	3	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
26357	9187	SLC24A1	0.716	0.154	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.72	1	2010	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
26361	9187	SLC24A1	0.716	0.154	C3151193	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D	disease		Disease or Syndrome	0.6	1	2010	2015	1	5	GENOMICS_ENGLAND
26377	9197	SLC33A1	0.529	0.769	C2675528	Spastic Paraplegia 42, Autosomal Dominant	disease	C16;C10	Disease or Syndrome	0.71	1	2008	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26378	9197	SLC33A1	0.529	0.769	C3280965	CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION	disease		Disease or Syndrome	0.7	1	2012	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26403	9210	BMP15	0.659	0.385	C1845294	Ovarian Dysgenesis 2	disease	C16;C13;C12;C19	Disease or Syndrome	0.7	1	2004	2015	8	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
26407	9211	LGI1	0.568	0.731	C1838062	Autosomal Dominant Lateral Temporal Lobe Epilepsy	disease	C23;C10;F03	Disease or Syndrome	0.8	0.927	2002	2020	1	0	GENOMICS_ENGLAND;ORPHANET
26408	9211	LGI1	0.568	0.731	C4551957	Epilepsy, Familial Temporal Lobe 1	disease	C23;C10;F03	Disease or Syndrome	1	1	2002	2020	11	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
26431	9241	NOG	0.518	0.731	C0175700	Multiple synostosis syndrome	disease	C05	Disease or Syndrome	0.6	1	1999	2015	2	0	GENOMICS_ENGLAND;ORPHANET
26432	9241	NOG	0.518	0.731	C0342282	Multiple synostoses syndrome 1	disease	C16;C05	Disease or Syndrome	0.73	1	1999	2014	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26433	9241	NOG	0.518	0.731	C1861305	TARSAL-CARPAL COALITION SYNDROME	disease	C16;C05	Disease or Syndrome	0.77	1	2002	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26434	9241	NOG	0.518	0.731	C1861385	SYMPHALANGISM, PROXIMAL	disease	C05	Disease or Syndrome	0.8	1	1995	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
26435	9241	NOG	0.518	0.731	C1866656	STAPES ANKYLOSIS WITH BROAD THUMB AND TOES (disorder)	disease	C16;C05	Disease or Syndrome	0.75	1	2002	2015	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
26436	9241	NOG	0.518	0.731	C1969652	BRACHYDACTYLY, TYPE B2 (disorder)	disease	C16;C05	Disease or Syndrome	0.73	1	2007	2017	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26437	9241	NOG	0.518	0.731	C3714899	SYMPHALANGISM, PROXIMAL, 1A	disease	C05	Disease or Syndrome	0.7	1	1999	2019	5	10	GENOMICS_ENGLAND;UNIPROT
26441	9244	CRLF1	0.597	0.654	C1832409	Crisponi syndrome	disease	C23;C16;C17;C05;C10	Disease or Syndrome	0.7	1	2003	2019	3	9	CTD_human;ORPHANET
26442	9244	CRLF1	0.597	0.654	C1848947	COLD-INDUCED SWEATING SYNDROME 1	disease	C23;C16;C17;C05;C10	Disease or Syndrome	0.72	1	2003	2014	7	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26447	9247	GCM2	0.647	0.538	C1832648	Hypoparathyroidism familial isolated	disease	C19	Disease or Syndrome	0.72	0.857	2005	2017	6	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
26448	9247	GCM2	0.647	0.538	C4479229	HYPERPARATHYROIDISM 4	disease		Disease or Syndrome	0.6	1	2016	2017	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
26461	9254	CACNA2D2	0.626	0.615	C0004134	Ataxia	phenotype	C23;C10	Sign or Symptom	0.51	1	2004	2019	2	0	CTD_human;GENOMICS_ENGLAND
26464	9254	CACNA2D2	0.626	0.615	C0014553	Absence Epilepsy	disease	C10	Disease or Syndrome	0.51	1	2002	2010	2	0	CTD_human;GENOMICS_ENGLAND
26490	9255	AIMP1	0.566	0.769	C1850053	Pelizaeus-Merzbacher-like disease, autosomal recessive, 2	disease	C20;C10	Disease or Syndrome	0.7	1	2010	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
26525	9289	ADGRG1	0.59	0.654	C1847352	POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	disease	C16;C10	Disease or Syndrome	0.8	0.958	2004	2019	6	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26539	9294	S1PR2	0.585	0.731	C1835854	DEAFNESS, AUTOSOMAL RECESSIVE 68	disease	C23;C10;C09	Disease or Syndrome	0.9	1	2006	2018	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
26557	9313	MMP20	0.663	0.538	C2675858	Amelogenesis Imperfecta, Hypomaturation Type, Iia2	disease	C16;C07	Disease or Syndrome	0.8	1	2002	2017	1	4	CTD_human;GENOMICS_ENGLAND
26587	9319	TRIP13	0.559	0.654	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	Neoplastic Process	0.62	1	2017	2020	1	0	CTD_human;ORPHANET
26603	9320	TRIP12	0.678	0.462	C4540324	MENTAL RETARDATION, AUTOSOMAL DOMINANT 49	disease		Mental or Behavioral Dysfunction	0.6	1	2017	2017	2	11	GENOMICS_ENGLAND;UNIPROT
26605	9321	TRIP11	0.595	0.654	C0265273	Achondrogenesis type 1A	disease	C16;C05	Congenital Abnormality	0.91	1	2010	2018	1	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
26607	9321	TRIP11	0.595	0.654	C2745953	Spondylometaphyseal dysplasia with dentinogenesis imperfecta	disease	C16;C05;C07	Disease or Syndrome	0.61	1	2019	2019	1	7	ORPHANET;UNIPROT
26608	9325	TRIP4	0.641	0.654	C4225177	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1	disease		Disease or Syndrome; Congenital Abnormality	0.6	1	2016	2016	2	3	CTD_human;GENOMICS_ENGLAND
26611	9326	ZNHIT3	0.666	0.462	C1850055	PEHO syndrome	disease	C11;C10	Disease or Syndrome	0.73	1	2017	2020	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26638	9333	TGM5	0.656	0.615	C1853354	Peeling skin syndrome, acral type	disease	C17	Disease or Syndrome	0.75	1	1998	2018	4	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26647	9342	SNAP29	0.633	0.654	C1836033	Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	disease	C16;C17;C10	Disease or Syndrome	0.95	1	2005	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26649	9343	EFTUD2	0.647	0.462	C1864652	Growth and mental retardation, mandibulofacial dysostosis, microcephaly, and cleft palate	disease	C23;C16;C11;C05;C10;F03;F01	Disease or Syndrome	0.8	0.938	1997	2019	5	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26666	9361	LONP1	0.517	0.808	C1838180	CODAS syndrome	disease	C23;C16;C11;C05;C07	Disease or Syndrome	0.78	0.8	1991	2019	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26669	9364	RAB28	0.792	0.077	C3809299	CONE-ROD DYSTROPHY 18	disease		Disease or Syndrome	0.9	1	2013	2018	4	5	CLINGEN;CTD_human;GENOMICS_ENGLAND
26675	9365	KL	0.448	0.769	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.57	1	2006	2019	1	0	CTD_human
26702	9365	KL	0.448	0.769	C1876187	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL	disease	C16;C18;C05	Disease or Syndrome	0.54	1	2007	2019	2	0	ORPHANET
26706	9365	KL	0.448	0.769	C4692564	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 1	disease		Disease or Syndrome	0.6	1	2007	2015	2	1	ORPHANET
26707	9365	KL	0.448	0.769	C4693864	TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3	disease		Disease or Syndrome	0.6	1	2007	2007	1	1	GENOMICS_ENGLAND;UNIPROT
26710	9368	SLC9A3R1	0.547	0.577	C2676782	Nephrolithiasis-Osteoporosis, Hypophosphatemic, 2	disease	C16;C18;C13;C05;C12	Disease or Syndrome	0.7	1	2008	2012	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
26732	9370	ADIPOQ	0.376	0.885	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.6	0.95	1999	2020	3	0	CTD_human
26744	9370	ADIPOQ	0.376	0.885	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.6	0.944	2004	2019	1	0	CTD_human
26748	9370	ADIPOQ	0.376	0.885	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.6	0.933	1998	2020	2	0	CTD_human
26753	9370	ADIPOQ	0.376	0.885	C0085207	Gestational Diabetes	phenotype	C18;C13;C19	Disease or Syndrome	0.6	0.947	2004	2020	1	0	CTD_human
26792	9373	PLAA	0.597	0.692	C4479631	NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES	disease		Disease or Syndrome	0.7	1	2017	2017	2	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
26807	9378	NRXN1	0.581	0.692	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.7	0.962	2007	2019	4	0	CTD_human;GENOMICS_ENGLAND
26815	9378	NRXN1	0.581	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.7	0.932	2008	2019	3	1	CTD_human
26821	9378	NRXN1	0.581	0.692	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2008	2019	1	0	CTD_human
26823	9378	NRXN1	0.581	0.692	C3280479	PITT-HOPKINS-LIKE SYNDROME 2	disease		Disease or Syndrome	0.6	1	2009	2014	1	3	CTD_human;GENOMICS_ENGLAND
26828	9379	NRXN2	0.769	0.308	C1510586	Autism Spectrum Disorders	disease	F03	Mental or Behavioral Dysfunction	0.74	1	2011	2018	2	0	CTD_human;GENOMICS_ENGLAND
26830	9380	GRHPR	0.722	0.308	C0020500	Hyperoxaluria	disease	C13;C12	Disease or Syndrome	0.61	1	2004	2012	0	0	GENOMICS_ENGLAND
26831	9380	GRHPR	0.722	0.308	C0020501	Primary Hyperoxaluria	disease	C16;C18;C13;C12	Disease or Syndrome	0.64	1	2007	2019	0	3	GENOMICS_ENGLAND
26833	9380	GRHPR	0.722	0.308	C0268165	Primary hyperoxaluria type 2	disease	C16;C18;C13;C12	Disease or Syndrome	0.8	1	1999	2019	1	54	CTD_human;GENOMICS_ENGLAND;ORPHANET
26843	9381	OTOF	0.691	0.385	C1832828	Deafness, Autosomal Recessive 9	disease	C23;C10;C09	Disease or Syndrome	0.96	1	1998	2019	12	87	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
26848	9382	COG1	0.628	0.692	C2931011	Congenital disorder of glycosylation, type 2G	disease	C16;C18	Disease or Syndrome	0.6	1	2009	2016	2	1	CTD_human;GENOMICS_ENGLAND
26850	9394	HS6ST1	0.617	0.731	C3553977	HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.6	1	2011	2014	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
26854	9401	RECQL4	0.496	0.808	C0032339	Rothmund-Thomson syndrome	disease	C16;C18;C17	Disease or Syndrome	1	0.986	1999	2019	13	12	CLINGEN;CTD_human;GENOMICS_ENGLAND
26855	9401	RECQL4	0.496	0.808	C0265308	Baller-Gerold syndrome	disease	C16;C05	Disease or Syndrome	0.77	1	1999	2018	4	54	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26857	9401	RECQL4	0.496	0.808	C1849453	Rapadilino syndrome	disease	C16;C18;C17;C05;C19;C14	Disease or Syndrome	0.75	1	1999	2012	3	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
26859	9409	PEX16	0.597	0.615	C0043459	Zellweger Syndrome	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.54	1	1998	2016	3	0	CTD_human;GENOMICS_ENGLAND
26863	9409	PEX16	0.597	0.615	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.53	1	1998	2019	3	0	CTD_human;GENOMICS_ENGLAND
26864	9409	PEX16	0.597	0.615	C3553959	PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER)	disease	C16;C18	Disease or Syndrome	0.6	1	2002	2016	4	1	CTD_human;GENOMICS_ENGLAND
26865	9409	PEX16	0.597	0.615	C3553960	PEROXISOME BIOGENESIS DISORDER 8B	disease	C16;C18	Disease or Syndrome	0.7	1	2010	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
26875	9414	TJP2	0.663	0.5	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.51	1	2011	2014	2	0	CTD_human;GENOMICS_ENGLAND
26876	9414	TJP2	0.663	0.5	C1843139	Hypercholanemia, Familial	disease	C16;C18	Disease or Syndrome	0.71	1	2003	2014	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26877	9414	TJP2	0.663	0.5	C2931067	Cholestasis, progressive familial intrahepatic 4	disease	C16;C06;C18	Disease or Syndrome	0.7	1	2014	2014	2	13	CTD_human;GENOMICS_ENGLAND;ORPHANET
26879	9415	FADS2	0.575	0.692	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.61	1	2011	2019	2	1	CTD_human;PSYGENET
26893	9419	CRIPT	0.716	0.308	C4014339	SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES	disease		Disease or Syndrome	0.6	1	2014	2016	2	3	GENOMICS_ENGLAND;UNIPROT
26912	9420	CYP7B1	0.563	0.692	C1849115	SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE (disorder)	disease	C16;C10	Disease or Syndrome	0.7	1	2008	2020	8	15	GENOMICS_ENGLAND;ORPHANET;UNIPROT
26914	9420	CYP7B1	0.563	0.692	C2931356	Spastic paraplegia type 5A, recessive	disease	C16;C10	Disease or Syndrome	0.51	1	2010	2018	1	0	CTD_human;ORPHANET
26915	9420	CYP7B1	0.563	0.692	C3151147	Bile Acid Synthesis Defect, Congenital, 3	disease	C16;C06;C18	Disease or Syndrome	0.7	1	1998	2020	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26933	9427	ECEL1	0.638	0.308	C3554415	Distal arthrogryposis type 5D	disease		Disease or Syndrome	0.95	1	2013	2018	5	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26959	9429	ABCG2	0.419	0.885	C1841837	URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1	disease		Finding	0.6	1	2016	2016	1	2	CTD_human;GENOMICS_ENGLAND
26964	9439	MED23	0.612	0.654	C3280265	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18	disease		Disease or Syndrome	0.7	1	2011	2015	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
26968	9440	MED17	0.769	0.269	C3150921	MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	disease		Disease or Syndrome	0.7	1	2010	2010	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26984	9445	ITM2B	0.617	0.654	C1861735	Dementia, familial Danish	disease	C23;C11;C10;F03;C09	Disease or Syndrome	0.8	0.944	2000	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26985	9445	ITM2B	0.617	0.654	C1867773	CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1	disease		Disease or Syndrome	0.8	1	1999	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26986	9445	ITM2B	0.617	0.654	C4015146	RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES	disease		Disease or Syndrome	0.7	1	2014	2014	1	1	CTD_human;ORPHANET;UNIPROT
27021	9451	EIF2AK3	0.501	0.808	C0432217	Wolcott-Rallison syndrome	disease	C16;C18;C05;C20;C19	Disease or Syndrome	1	0.964	1995	2019	4	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27036	9455	HOMER2	0.691	0.5	C4225240	DEAFNESS, AUTOSOMAL DOMINANT 68	disease		Disease or Syndrome	0.7	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
27133	9469	CHST3	0.517	0.846	C0038015	Spondyloepiphyseal Dysplasia	disease	C16;C05	Disease or Syndrome	0.62	1	2016	2018	1	0	CTD_human;GENOMICS_ENGLAND
27136	9469	CHST3	0.517	0.846	C1837657	Spondyloepiphyseal dysplasia, Omani type	disease	C16;C05	Disease or Syndrome	0.75	1	2004	2017	4	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
27180	9479	MAPK8IP1	0.716	0.462	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.62	1	2000	2018	1	1	CTD_human;UNIPROT
27184	9487	PIGL	0.581	0.731	C1848392	Zunich neuroectodermal syndrome	disease	C23;C16;C11;C17;C10;F03;C09;F01;C14	Disease or Syndrome	0.73	1	2012	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27216	9496	TBX4	0.576	0.731	C1840061	SMALL PATELLA SYNDROME	disease	C05	Disease or Syndrome	0.75	1	2004	2019	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27229	9499	MYOT	0.695	0.385	C0686353	Muscular Dystrophies, Limb-Girdle	group	C16;C05;C10	Disease or Syndrome	0.6	1	1995	2019	1	0	CTD_human;GENOMICS_ENGLAND
27231	9499	MYOT	0.695	0.385	C1866785	Spheroid body myopathy	disease	C05;C10	Disease or Syndrome	0.72	1	2004	2006	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27234	9499	MYOT	0.695	0.385	C3714934	MYOPATHY, MYOFIBRILLAR, 3	disease	C05;C10	Disease or Syndrome	0.75	1	1988	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27240	9508	ADAMTS3	0.581	0.808	C4748408	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3	disease		Disease or Syndrome	0.61	1	2017	2018	2	3	GENOMICS_ENGLAND;UNIPROT
27242	9509	ADAMTS2	0.579	0.808	C2700425	EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE	disease	C16;C17;C15;C14	Disease or Syndrome	0.76	0.923	1992	2019	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
27249	9512	PMPCB	0.769	0.192	C4693741	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6	disease		Disease or Syndrome	0.6	1	2018	2018	1	5	GENOMICS_ENGLAND;UNIPROT
27251	9516	LITAF	0.65	0.462	C0270913	Charcot-Marie-Tooth disease, Type 1C	disease	C16;C10	Disease or Syndrome	0.79	1	2003	2017	8	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
27255	9517	SPTLC2	0.736	0.346	C0020071	Hereditary Sensory Autonomic Neuropathy, Type 1	disease	C16;C10	Disease or Syndrome	0.58	1	2010	2019	3	0	GENOMICS_ENGLAND;ORPHANET
27256	9517	SPTLC2	0.736	0.346	C3150896	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC	disease		Disease or Syndrome	0.7	1	2010	2017	5	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
27278	9524	TECR	0.674	0.423	C3151462	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	disease		Disease or Syndrome	0.6	1	2011	2013	2	1	CTD_human;UNIPROT
27282	9526	MPDU1	0.682	0.5	C1836669	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If	disease	C16;C18	Disease or Syndrome	0.73	1	2001	2016	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27289	9531	BAG3	0.498	0.846	C2678065	Myofibrillar Myopathy	disease	C05;C10	Disease or Syndrome	0.8	1	2006	2018	9	1	CLINGEN;CTD_human;GENOMICS_ENGLAND
27290	9531	BAG3	0.498	0.846	C2751831	Myopathy, Myofibrillar, Bag3-Related	disease	C05;C10	Disease or Syndrome	0.7	1	1990	2018	8	11	GENOMICS_ENGLAND;ORPHANET;UNIPROT
27291	9531	BAG3	0.498	0.846	C3151293	CARDIOMYOPATHY, DILATED, 1HH	disease		Disease or Syndrome	0.9	1	1990	2018	6	21	CTD_human;GENOMICS_ENGLAND;UNIPROT
27295	9533	POLR1C	0.595	0.615	C1855433	Mandibulofacial dysostosis, Treacher Collins type, autosomal recessive	disease	C16;C11;C05	Disease or Syndrome	0.72	1	1998	2018	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27297	9533	POLR1C	0.595	0.615	C4225305	LEUKODYSTROPHY, HYPOMYELINATING, 11	disease		Disease or Syndrome	0.7	1	1978	2015	2	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
27301	9536	PTGES	0.54	0.769	C0021368	Inflammation	phenotype	C23	Pathologic Function	0.51	1	2003	2015	1	0	CTD_human
27341	9557	CHD1L	0.631	0.577	C1968949	Cakut	disease	C16;C13;C12	Disease or Syndrome	0.51	1	2012	2014	2	0	CLINGEN;GENOMICS_ENGLAND
27351	9562	MINPP1	0.705	0.462	C4225426	THYROID CANCER, NONMEDULLARY, 2	disease		Neoplastic Process	0.6	1	2001	2001	1	2	GENOMICS_ENGLAND;UNIPROT
27355	9563	H6PD	0.619	0.654	C1291245	Cortisone reductase deficiency	disease	C23;C16;C18;C13;C17;C12;C19	Disease or Syndrome	0.55	1	2005	2011	1	0	CTD_human;ORPHANET
27375	9568	GABBR2	0.65	0.538	C4693546	NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS	disease		Disease or Syndrome	0.6	1	2016	2018	4	2	GENOMICS_ENGLAND;UNIPROT
27376	9568	GABBR2	0.65	0.538	C4693550	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59	disease		Disease or Syndrome	0.6	1	2017	2018	3	3	GENOMICS_ENGLAND;UNIPROT
27377	9569	GTF2IRD1	0.522	0.769	C0175702	Williams Syndrome	disease	C16;C10;C14	Disease or Syndrome	0.6	0.963	1999	2019	1	0	CTD_human
27389	9570	GOSR2	0.653	0.423	C3279627	EPILEPSY, PROGRESSIVE MYOCLONIC, 6	disease		Disease or Syndrome	0.7	1	2011	2014	3	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
27396	9573	GDF3	0.595	0.5	C0022738	Klippel-Feil Syndrome	disease	C16;C05	Disease or Syndrome	0.63	1	2010	2015	1	0	GENOMICS_ENGLAND;ORPHANET
27406	9573	GDF3	0.595	0.5	C3150967	KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.6	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
27407	9573	GDF3	0.595	0.5	C3150968	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	disease		Disease or Syndrome	0.7	1	2010	2010	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
27408	9573	GDF3	0.595	0.5	C3150969	MICROPHTHALMIA, ISOLATED 7	disease		Disease or Syndrome	0.7	1	2010	2010	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
27412	9575	CLOCK	0.463	0.885	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.6	1	2000	2019	5	0	PSYGENET
27434	9581	PREPL	0.644	0.538	C1848030	Hypotonia-Cystinuria Syndrome	disease	C23;C16;C18;C13;C05;C12;C10;F03;F01	Disease or Syndrome	0.68	0.917	2006	2019	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
27488	9607	CARTPT	0.576	0.692	C0009171	Cocaine Abuse	disease	C25;F03	Mental or Behavioral Dysfunction	0.51	1	1999	2010	3	0	CTD_human;PSYGENET
27509	9611	NCOR1	0.597	0.731	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.55	1	2006	2016	1	0	CGI;CTD_human
27520	9611	NCOR1	0.597	0.731	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.55	1	2006	2016	1	0	CGI;CTD_human
27566	9630	GNA14	0.674	0.5	C0346073	Tufted angioma of skin	disease	C04;C17	Neoplastic Process	0.51	1	2016	2019	1	0	GENOMICS_ENGLAND;ORPHANET
27569	9631	NUP155	0.78	0.231	C4014269	ATRIAL FIBRILLATION, FAMILIAL, 15	disease		Disease or Syndrome	0.6	1	2008	2008	1	1	CTD_human;UNIPROT
27588	9636	ISG15	0.531	0.808	C4015293	IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION	disease		Disease or Syndrome	0.7	1	2012	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
27596	9639	ARHGEF10	0.729	0.577	C1842357	Slowed Nerve Conduction Velocity, Autosomal Dominant	disease	C16;C10	Disease or Syndrome	0.7	1	2003	2003	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27601	9640	ZNF592	0.7	0.462	C1847114	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5	disease	C16;C10	Disease or Syndrome	0.61	1	2010	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
27622	9652	TTC37	0.626	0.654	C1857276	Trichohepatoenteric Syndrome	disease	C23;C16;C13;C17	Disease or Syndrome	0.7	0.917	2010	2018	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
27623	9652	TTC37	0.626	0.654	C4551982	TRICHOHEPATOENTERIC SYNDROME 1	disease	C23;C16;C13;C17	Disease or Syndrome	0.6	1	2010	2017	3	10	GENOMICS_ENGLAND;UNIPROT
27625	9657	IQCB1	0.641	0.654	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.68	1	2005	2019	2	4	GENOMICS_ENGLAND;ORPHANET
27626	9657	IQCB1	0.641	0.654	C0403553	Renal dysplasia and retinal aplasia (disorder)	disease	C16;C13;C11;C12;C10	Disease or Syndrome	0.69	1	2005	2018	1	1	GENOMICS_ENGLAND;ORPHANET
27627	9657	IQCB1	0.641	0.654	C1836517	Senior-Loken Syndrome 5	disease	C16;C13;C11;C12;C10	Disease or Syndrome	0.6	1	2005	2013	0	11	CTD_human;GENOMICS_ENGLAND
27631	9662	CEP135	0.695	0.615	C3553414	MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.6	1	2012	2012	1	4	CTD_human;GENOMICS_ENGLAND
27637	9663	LPIN2	0.628	0.615	C1864997	Majeed syndrome	disease	C16;C01;C05;C20;C15	Disease or Syndrome	0.77	1	2005	2019	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27650	9681	DEPDC5	0.631	0.538	C1858477	Epilepsy, Partial, with Variable Foci	disease	C10	Disease or Syndrome	0.77	1	2013	2019	8	23	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
27653	9681	DEPDC5	0.631	0.538	C4551983	EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 1	disease	C10	Disease or Syndrome	0.6	1	1999	2016	8	67	GENOMICS_ENGLAND;UNIPROT
27660	9688	NUP93	0.729	0.385	C4225166	NEPHROTIC SYNDROME, TYPE 12	disease		Disease or Syndrome	0.7	1	2016	2016	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27698	9698	PUM1	0.653	0.654	C4693672	SPINOCEREBELLAR ATAXIA 47	disease		Disease or Syndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
27707	9702	CEP57	0.615	0.615	C1850343	Mosaic variegated aneuploidy syndrome 1	disease	C16	Disease or Syndrome	0.64	1	2011	2019	3	2	CTD_human;ORPHANET
27710	9702	CEP57	0.615	0.615	C3279843	MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2	disease		Disease or Syndrome	0.6	1	2002	2019	11	3	CLINGEN;GENOMICS_ENGLAND
27726	9711	RUBCN	0.716	0.423	C3810326	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15	disease		Disease or Syndrome	0.6	1	2010	2013	2	1	GENOMICS_ENGLAND;ORPHANET
27743	9719	ADAMTSL2	0.666	0.346	C3278147	GELEOPHYSIC DYSPLASIA 1	disease		Disease or Syndrome	0.6	1	2008	2011	2	12	GENOMICS_ENGLAND;UNIPROT
27749	9723	SEMA3E	0.515	0.769	C0265354	CHARGE Syndrome	disease	C16;C11	Disease or Syndrome	0.73	1	2002	2020	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
27759	9731	CEP104	0.67	0.423	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.53	1	2015	2019	1	0	GENOMICS_ENGLAND;ORPHANET
27780	9739	SETD1A	0.619	0.615	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.65	1	2014	2019	2	5	GENOMICS_ENGLAND;PSYGENET
27787	9742	IFT140	0.572	0.692	C0265275	Jeune thoracic dystrophy	disease	C16;C17;C05	Disease or Syndrome	0.82	1	2012	2013	3	5	GENOMICS_ENGLAND;ORPHANET
27790	9742	IFT140	0.572	0.692	C1849437	Mainzer-Saldino Disease	disease	C23;C16;C11;C10	Disease or Syndrome	0.93	1	2012	2017	5	20	GENOMICS_ENGLAND;ORPHANET;UNIPROT
27816	9750	RIPOR2	0.792	0.269	C4225298	DEAFNESS, AUTOSOMAL RECESSIVE 104	disease		Disease or Syndrome	0.6	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND
27819	9754	STARD8	0.743	0.346	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.51	1	2007	2008	1	1	CTD_human;UNIPROT
27846	9757	KMT2B	0.529	0.808	C4310633	DYSTONIA 28, CHILDHOOD-ONSET	disease		Disease or Syndrome	0.61	1	2016	2019	3	17	GENOMICS_ENGLAND;UNIPROT
27865	10300	KATNB1	0.674	0.346	C4015525	LISSENCEPHALY 6 WITH MICROCEPHALY	disease		Congenital Abnormality	0.7	1	2014	2016	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27874	10309	CCNO	0.621	0.538	C4014534	CILIARY DYSKINESIA, PRIMARY, 29	disease		Disease or Syndrome	0.7	1	2014	2019	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
27880	10312	TCIRG1	0.565	0.692	C1850127	Osteopetrosis, Autosomal Recessive 1	disease	C05	Disease or Syndrome	0.9	1	1985	2015	3	44	CTD_human;GENOMICS_ENGLAND;UNIPROT
27886	10318	TNIP1	0.564	0.769	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.7	0.926	2009	2019	7	5	CTD_human;ORPHANET
27906	10452	TOMM40	0.59	0.538	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.51	1	2013	2018	5	0	CTD_human;ORPHANET
27920	10681	GNB5	0.736	0.308	C4310678	LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA	disease		Disease or Syndrome	0.7	1	2016	2018	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
27921	10681	GNB5	0.736	0.308	C4310682	INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	disease		Disease or Syndrome	0.71	1	2016	2018	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
27922	10682	EBP	0.494	0.846	C0008445	Chondrodysplasia Punctata	disease	C05	Congenital Abnormality	0.6	1	1990	2017	1	0	CTD_human
27924	10682	EBP	0.494	0.846	C0282102	Chondrodysplasia punctata, X-linked dominant type	disease	C05	Disease or Syndrome	1	1	1983	2019	10	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
27926	10682	EBP	0.494	0.846	C4085243	MEND SYNDROME	disease		Disease or Syndrome	0.73	1	2003	2019	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27937	10683	DLL3	0.552	0.654	C0265343	Jarcho-Levin syndrome	disease	C23;C16	Disease or Syndrome	0.87	1	2000	2019	2	8	GENOMICS_ENGLAND;UNIPROT
27952	10683	DLL3	0.552	0.654	C1837549	SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 2	disease	C05	Disease or Syndrome	0.52	1	2002	2004	0	0	CTD_human
27956	10686	CLDN16	0.647	0.538	C0268448	Primary hypomagnesemia (disorder)	disease	C23;C16;C18;C13;C12	Disease or Syndrome	0.9	1	1999	2016	6	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27957	10686	CLDN16	0.647	0.538	C3151482	HYPERCALCIURIA, CHILDHOOD, SELF-LIMITING	disease		Disease or Syndrome	0.6	1	2000	2010	3	1	ORPHANET
27962	10845	CLPX	0.931	0.154	C4693947	PROTOPORPHYRIA, ERYTHROPOIETIC, 2	disease		Disease or Syndrome	0.6	1	2015	2017	2	1	GENOMICS_ENGLAND;UNIPROT
27967	10846	PDE10A	0.619	0.615	C4310791	STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	disease		Disease or Syndrome	0.7	1	2016	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27968	10846	PDE10A	0.619	0.615	C4310792	DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET	disease		Disease or Syndrome	0.7	1	2016	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27970	10847	SRCAP	0.61	0.731	C0729582	Floating-harbor syndrome	disease	C23;C16;C05;C14	Disease or Syndrome	0.8	1	2012	2020	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
28003	10861	SLC26A1	0.686	0.577	C1833683	NEPHROLITHIASIS, CALCIUM OXALATE	disease	C13;C12	Disease or Syndrome	0.7	1	2010	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
28061	23607	CD2AP	0.558	0.731	C0750900	Alzheimers Disease, Focal Onset	disease	C10;F03	Mental or Behavioral Dysfunction	0.30	1	2011	2018	   3	   0	CTD_human
    23607	CD2AP	0.558	0.731	C0750901	Alzheimer Disease, Early Onset	disease	C10;F03	Disease or Syndrome	0.30	1	2011	2018	   3	   0	CTD_human
    23607	CD2AP	0.558	0.731	C1842982	FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO	phenotype		Finding	0.40	1	2007	2019	   2	   1	GENOMICS_ENGLAND
    23607	CD2AP	0.558	0.731	C1868672	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	disease	C13;C12	Disease or Syndrome	0.30	1	2007	2007	   1	   0	ORPHANET
    23619	ZIM2	0.89	0.077	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
    23619	ZIM2	0.89	0.077	C0036095	Salivary Gland Neoplasms	group	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
    23619	ZIM2	0.89	0.077	C0220636	Malignant neoplasm of salivary gland	disease	C04;C07	Neoplastic Process	0.30	1	2006	2006	   1	   0	CTD_human
    23621	BACE1	0.559	0.769	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.6	0.985	1999	2020	1	0	CTD_human
28063	23621	BACE1	0.559	0.769	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.58	0.5	2005	2019	2	0	PSYGENET
28092	27125	AFF4	0.644	0.769	C4085597	CHOPS SYNDROME	disease	C23;C10;F03;F01	Disease or Syndrome	0.71	1	2015	2015	1	3	CTD_human;ORPHANET;UNIPROT
28098	27130	INVS	0.619	0.538	C1865872	NEPHRONOPHTHISIS 2	disease	C13;C12	Disease or Syndrome	0.96	1	1993	2020	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28107	27136	MORC1	0.805	0.192	C0041696	Unipolar Depression	disease	F03	Mental or Behavioral Dysfunction	0.51	1	2014	2018	1	0	PSYGENET
28137	27151	CPAMD8	0.722	0.231	C4310622	ANTERIOR SEGMENT DYSGENESIS 8	disease		Disease or Syndrome	0.7	1	2016	2019	2	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28139	27152	INTU	0.555	0.769	C4693616	SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY	disease		Disease or Syndrome	0.6	1	2016	2018	2	3	GENOMICS_ENGLAND;UNIPROT
28163	29072	SETD2	0.424	0.846	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.7	0.957	2003	2019	6	0	CGI;CTD_human;UNIPROT
28179	29072	SETD2	0.424	0.846	C4085873	LUSCAN-LUMISH SYNDROME	disease		Disease or Syndrome	0.71	1	2012	2018	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28183	29078	NDUFAF4	0.686	0.385	C4748778	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15	disease		Disease or Syndrome	0.6	1	2008	2017	2	2	GENOMICS_ENGLAND;UNIPROT
28195	29089	UBE2T	0.55	0.731	C0015625	Fanconi Anemia	disease	C16;C18;C15	Disease or Syndrome	0.59	1	2006	2019	2	0	GENOMICS_ENGLAND;ORPHANET
28203	29089	UBE2T	0.55	0.731	C4084840	FANCONI ANEMIA, COMPLEMENTATION GROUP T	disease		Disease or Syndrome	0.71	1	2015	2019	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28207	29098	RANGRF	0.751	0.231	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.55	0.889	2008	2019	6	0	CLINGEN;ORPHANET
28248	29110	TBK1	0.513	0.846	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.7	1	2015	2019	3	1	GENOMICS_ENGLAND;ORPHANET
28254	29110	TBK1	0.513	0.846	C4225325	FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4	disease		Disease or Syndrome	0.7	1	2015	2015	2	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
28255	29110	TBK1	0.513	0.846	C4693542	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8	phenotype		Finding	0.6	1	2012	2015	2	3	GENOMICS_ENGLAND;UNIPROT
28272	29119	CTNNA3	0.612	0.692	C3810138	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13	disease		Disease or Syndrome	0.7	1	2013	2013	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28278	29123	ANKRD11	0.556	0.808	C0220687	KBG syndrome	disease	C23;C16;C05;C10;F03;C07;F01	Disease or Syndrome	0.8	1	2008	2019	13	45	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28315	29760	BLNK	0.603	0.731	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.61	1	2015	2015	1	0	CTD_human;GENOMICS_ENGLAND
28326	29801	ZDHHC8	0.769	0.346	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.6	0.2	2004	2017	5	0	PSYGENET
28327	29851	ICOS	0.502	0.731	C0009447	Common Variable Immunodeficiency	disease	C20	Disease or Syndrome	0.8	1	2001	2017	0	0	CTD_human;ORPHANET
28338	29887	SNX10	0.633	0.577	C3554478	OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8	disease		Disease or Syndrome	0.7	1	2012	2013	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
28355	29899	GPSM2	0.682	0.538	C1858695	Chudley-Mccullough syndrome	disease	C23;C16;C04;C10;C09	Disease or Syndrome	0.76	1	1996	2018	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
28360	29914	UBIAD1	0.7	0.462	C0271287	Schnyder crystalline corneal dystrophy	disease	C16;C11	Disease or Syndrome	1	0.957	2007	2019	10	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28365	29920	PYCR2	0.682	0.462	C4225332	LEUKODYSTROPHY, HYPOMYELINATING, 10	disease		Disease or Syndrome	0.7	1	2015	2017	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28387	29925	GMPPB	0.578	0.538	C3714932	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14	disease		Disease or Syndrome	0.7	1	2013	2017	5	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28388	29925	GMPPB	0.578	0.538	C3809216	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14	disease		Disease or Syndrome	0.6	1	2013	2017	2	13	GENOMICS_ENGLAND;UNIPROT
28389	29925	GMPPB	0.578	0.538	C3809221	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14	disease		Disease or Syndrome	0.7	1	2013	2017	2	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
28392	29926	GMPPA	0.711	0.385	C3809738	ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	disease		Disease or Syndrome	0.7	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
28397	29927	SEC61A1	0.722	0.5	C4310741	HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4	disease		Disease or Syndrome	0.7	1	2016	2019	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28398	29929	ALG6	0.805	0.231	C2930997	Congenital disorder of glycosylation type 1C	disease	C16;C18	Disease or Syndrome	0.77	1	1999	2016	8	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
28400	29940	DSE	0.7	0.462	C3809845	EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2	disease		Disease or Syndrome	0.7	1	2013	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28421	29954	POMT2	0.544	0.615	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.6	1	2005	2018	1	0	CTD_human;ORPHANET
28424	29954	POMT2	0.544	0.615	C0457133	Muscle eye brain disease	disease	C16;C11;C10	Disease or Syndrome	0.53	1	2007	2018	2	0	CTD_human;ORPHANET
28428	29954	POMT2	0.544	0.615	C3150411	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 2	disease	C16;C05;C10	Disease or Syndrome	0.6	1	2005	2017	10	18	GENOMICS_ENGLAND;UNIPROT
28429	29954	POMT2	0.544	0.615	C3150416	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	disease	C16;C05;C10	Disease or Syndrome	0.7	1	2005	2017	6	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
28430	29954	POMT2	0.544	0.615	C3150418	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2	disease		Disease or Syndrome	0.71	1	2005	2018	6	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
28434	29957	SLC25A24	0.575	0.731	C2676780	Progeroid Syndrome, Congenital, Petty Type	phenotype	C23;C16;C18	Disease or Syndrome	0.62	1	2017	2019	2	2	GENOMICS_ENGLAND;UNIPROT
28436	29958	DMGDH	0.89	0.154	C1853892	Dimethylglycine Dehydrogenase Deficiency	disease	C16;C18	Disease or Syndrome	0.7	1	1997	2016	5	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28442	29968	PSAT1	0.478	0.846	C0265218	Neu-Laxova syndrome	disease	C23;C16;C13;C17;C05;C10	Disease or Syndrome	0.61	1	2014	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28443	29968	PSAT1	0.478	0.846	C1970253	Phosphoserine Aminotransferase Deficiency	disease	C23;C16;C05;C10;F01	Disease or Syndrome	0.71	1	2007	2020	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28444	29968	PSAT1	0.478	0.846	C4015019	NEU-LAXOVA SYNDROME 2	disease		Disease or Syndrome	0.61	1	2007	2017	3	4	GENOMICS_ENGLAND;UNIPROT
28447	29978	UBQLN2	0.656	0.462	C3275459	AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA	disease		Disease or Syndrome	0.7	1	2011	2015	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
28456	29980	DONSON	0.636	0.538	C4539873	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	disease		Disease or Syndrome	0.62	1	2017	2019	2	10	GENOMICS_ENGLAND;UNIPROT
28466	30008	EFEMP2	0.559	0.692	C0003486	Aortic Aneurysm	disease	C14	Disease or Syndrome	0.62	1	2006	2018	2	0	GENOMICS_ENGLAND
28467	30008	EFEMP2	0.559	0.692	C0010495	Cutis Laxa	disease	C16;C17	Disease or Syndrome	0.65	1	2010	2016	1	0	GENOMICS_ENGLAND
28473	30008	EFEMP2	0.559	0.692	C3280798	CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	disease		Disease or Syndrome	0.7	1	1991	2016	4	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
28475	30009	TBX21	0.541	0.808	C0004096	Asthma	disease	C08;C20	Disease or Syndrome	0.7	0.944	2002	2019	1	1	CTD_human
28499	30061	SLC40A1	0.57	0.731	C1853733	HEMOCHROMATOSIS, TYPE 4	disease	C16;C18	Disease or Syndrome	1	1	1999	2019	15	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28505	30062	RAX	0.729	0.346	C1970237	Microphthalmia, Isolated 3	disease	C16;C11	Disease or Syndrome	0.7	1	2004	2014	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28515	50619	DEF6	0.751	0.346	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.52	1	2006	2018	1	0	CTD_human
28518	50628	GEMIN4	0.565	0.808	C4693567	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES	disease		Disease or Syndrome	0.6	1	2015	2019	3	1	GENOMICS_ENGLAND;UNIPROT
28530	50640	PNPLA8	0.792	0.308	C1855033	Mitochondrial myopathy with lactic acidosis	disease	C23;C18;C05;C10;C09	Disease or Syndrome	0.6	1	2014	2018	2	1	CTD_human;GENOMICS_ENGLAND
28532	50651	SLC45A1	0.674	0.269	C4479636	INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES	disease		Disease or Syndrome	0.6	1	2017	2017	2	3	GENOMICS_ENGLAND;UNIPROT
28534	50674	NEUROG3	0.647	0.5	C1835888	Diarrhea 4, Malabsorptive, Congenital	disease	C23;C06;C18	Disease or Syndrome	0.7	1	2006	2006	1	3	CTD_human;ORPHANET;UNIPROT
28536	50717	DCAF8	0.821	0.115	C4013360	GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.7	1	2014	2014	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28559	50814	NSDHL	0.621	0.538	C0265267	Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects	disease	C16;C17;C05	Disease or Syndrome	0.78	0.909	2000	2019	4	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28561	50814	NSDHL	0.621	0.538	C3151781	CK syndrome	disease	C23;C16;C18;C10;F03;F01	Disease or Syndrome	0.72	1	2000	2016	6	7	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
28567	50846	DHH	0.65	0.423	C1856273	46,XY Gonadal Dysgenesis, Complete or Partial, DHH-Related	disease	C16;C13;C12;C19	Congenital Abnormality	0.7	1	2004	2018	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
28568	50846	DHH	0.65	0.423	C2751325	46,Xy Gonadal Dysgenesis, Partial, With Minifascicular Neuropathy	disease	C16;C13;C12;C10;C19	Disease or Syndrome	0.7	1	2000	2012	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
28580	50937	CDON	0.601	0.731	C3280215	HOLOPROSENCEPHALY 11	disease		Disease or Syndrome	0.9	1	2003	2011	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28587	50939	IMPG2	0.659	0.308	C3150819	RETINITIS PIGMENTOSA 56	disease		Disease or Syndrome	0.6	NA	NA	NA	0	5	CTD_human;GENOMICS_ENGLAND
28588	50939	IMPG2	0.659	0.308	C4015343	MACULAR DYSTROPHY, VITELLIFORM, 5	disease		Disease or Syndrome	0.6	1	2010	2017	3	4	GENOMICS_ENGLAND;UNIPROT
28591	50940	PDE11A	0.612	0.654	C1864851	Pigmented Nodular Adrenocortical Disease, Primary, 2	disease	C19	Disease or Syndrome	0.6	1	2006	2006	1	4	CTD_human;GENOMICS_ENGLAND
28603	50943	FOXP3	0.368	0.846	C0342288	Insulin-dependent diabetes mellitus secretory diarrhea syndrome	disease	C23;C16;C18;C20;C19	Disease or Syndrome	1	0.971	1991	2019	13	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28610	50944	SHANK1	0.678	0.385	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.53	1	2008	2018	1	0	CTD_human;GENOMICS_ENGLAND
28631	50945	TBX22	0.603	0.577	C1844830	CLEFT PALATE, X-LINKED	disease	C16;C05;C07	Disease or Syndrome	0.9	0.929	2001	2018	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
28632	50945	TBX22	0.603	0.577	C1844862	Abruzzo Erickson syndrome	disease	C23;C16;C05;C10;C07;C09	Disease or Syndrome	0.71	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
28636	50945	TBX22	0.603	0.577	C4707825	X-linked cleft palate and ankyloglossia	disease	C16;C05;C07	Congenital Abnormality	0.54	1	2001	2011	3	0	ORPHANET
28644	50964	SOST	0.474	0.808	C0265301	Sclerosteosis	disease	C16;C05	Disease or Syndrome	0.6	1	1999	2019	0	0	CTD_human
28646	50964	SOST	0.474	0.808	C0432272	Van Buchem disease	disease	C16;C05	Disease or Syndrome	0.9	1	1986	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28647	50964	SOST	0.474	0.808	C2675746	CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT (disorder)	disease	C16;C05	Disease or Syndrome	0.73	1	2011	2017	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
28650	50964	SOST	0.474	0.808	C4551483	SCLEROSTEOSIS 1	disease	C16;C05	Disease or Syndrome	0.8	1	2001	2013	3	3	GENOMICS_ENGLAND;UNIPROT
28651	51002	TPRKB	0.691	0.385	C0795949	Galloway Mowat syndrome	disease	C23;C16;C13;C05;C12;C10	Disease or Syndrome	0.52	1	2017	2019	1	0	CTD_human;ORPHANET
28652	51002	TPRKB	0.691	0.385	C4540274	GALLOWAY-MOWAT SYNDROME 5	disease		Disease or Syndrome	0.6	1	2017	2018	2	2	GENOMICS_ENGLAND;UNIPROT
28658	51004	COQ6	0.76	0.385	C3553349	COENZYME Q10 DEFICIENCY, PRIMARY, 6	disease		Disease or Syndrome	0.7	1	2011	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28667	51008	ASCC1	0.495	0.846	C4225176	SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	disease		Disease or Syndrome	0.6	1	2018	2018	1	1	CTD_human;GENOMICS_ENGLAND
28669	51010	EXOSC3	0.61	0.692	C1843504	Pontocerebellar Hypoplasia Type 1	disease	C16;C10	Disease or Syndrome; Congenital Abnormality	0.68	1	2012	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28670	51010	EXOSC3	0.61	0.692	C3553449	PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	disease		Disease or Syndrome	0.75	1	2012	2020	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
28678	51021	MRPS16	0.821	0.231	C1864843	Combined Oxidative Phosphorylation Deficiency 2	disease	C23;C16;C18;C05;C10	Disease or Syndrome	0.7	1	2004	2015	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28683	51025	PAM16	0.729	0.462	C2750075	Chondrodysplasia, Megarbane-Dagher-Melki Type	disease	C23;C16;C05;C19;F03	Disease or Syndrome	0.7	1	2014	2016	2	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28700	51053	GMNN	0.554	0.808	C1868684	EAR, PATELLA, SHORT STATURE SYNDROME	disease	C23;C16;C05;C07;C09	Disease or Syndrome	0.61	1	2015	2015	1	3	CTD_human;ORPHANET
28702	51053	GMNN	0.554	0.808	C4225188	MEIER-GORLIN SYNDROME 6	disease		Disease or Syndrome	0.6	1	2015	2019	2	3	GENOMICS_ENGLAND;UNIPROT
28711	51057	WDPCP	0.576	0.769	C1857587	Orstavik Lindemann Solberg syndrome	disease	C16;C04;C05;C07;C14	Disease or Syndrome	0.7	1	2010	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28714	51057	WDPCP	0.576	0.769	C3150127	BARDET-BIEDL SYNDROME 15	disease		Disease or Syndrome	0.6	1	2010	2016	2	1	CTD_human;GENOMICS_ENGLAND
28721	51062	ATL1	0.593	0.654	C2931355	Spastic paraplegia 3, autosomal dominant	disease	C16;C10	Disease or Syndrome	0.75	1	2001	2018	17	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28722	51062	ATL1	0.593	0.654	C3150972	NEUROPATHY, HEREDITARY SENSORY, TYPE ID	disease		Disease or Syndrome	0.7	1	2001	2015	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28725	51067	YARS2	0.663	0.462	C1838103	MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.56	1	2010	2017	4	0	CTD_human;ORPHANET
28726	51067	YARS2	0.663	0.462	C3150802	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2	disease		Disease or Syndrome	0.62	1	2010	2018	5	7	GENOMICS_ENGLAND;UNIPROT
28734	51079	NDUFA13	0.556	0.692	C0749424	Thyroid Hurthle Cell Carcinoma	disease	C04;C19	Neoplastic Process	0.6	1	2005	2015	2	1	CTD_human;GENOMICS_ENGLAND
28741	51081	MRPS7	0.722	0.5	C4693450	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34	disease		Disease or Syndrome	0.7	1	2015	2015	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28755	51082	POLR1D	0.603	0.692	C3150983	TREACHER COLLINS SYNDROME 2	disease		Disease or Syndrome	0.7	1	1996	2011	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28767	51083	GAL	0.493	0.846	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.51	1	2000	2017	1	0	CTD_human
28794	51083	GAL	0.493	0.846	C4225318	EPILEPSY, FAMILIAL TEMPORAL LOBE, 8	disease		Disease or Syndrome	0.6	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
28805	51086	TNNI3K	0.691	0.346	C4015285	CARDIAC CONDUCTION DISEASE WITH OR WITHOUT DILATED CARDIOMYOPATHY	disease		Disease or Syndrome	0.7	1	2014	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28814	51091	SEPSECS	0.656	0.423	C3151140	PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	disease		Disease or Syndrome	0.75	1	2003	2018	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28818	51094	ADIPOR1	0.529	0.808	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.53	1	2007	2014	1	0	CTD_human
28823	51095	TRNT1	0.7	0.192	C4015172	SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY	disease		Disease or Syndrome	0.73	1	2014	2016	1	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28824	51095	TRNT1	0.7	0.192	C4310776	RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS	disease		Disease or Syndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
28833	51099	ABHD5	0.641	0.538	C0268238	Triglyceride storage disease with ichthyosis	disease	C16;C18;C17;C05;C10	Disease or Syndrome	1	1	1982	2019	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28835	51102	MECR	0.736	0.385	C4310634	DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES	disease		Disease or Syndrome	0.7	1	2016	2016	1	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28838	51103	NDUFAF1	0.7	0.308	C4748769	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11	disease		Disease or Syndrome	0.6	1	2007	2011	2	4	GENOMICS_ENGLAND;UNIPROT
28840	51109	RDH11	0.769	0.346	C4015242	RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME	disease		Disease or Syndrome	0.6	1	2014	2014	1	2	CTD_human;ORPHANET
28842	51111	KMT5B	0.736	0.423	C4540474	MENTAL RETARDATION, AUTOSOMAL DOMINANT 51	disease		Mental or Behavioral Dysfunction	0.6	1	2014	2018	3	8	GENOMICS_ENGLAND;UNIPROT
28846	51112	TRAPPC12	0.751	0.385	C4540059	ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY	disease		Disease or Syndrome	0.7	1	2017	2017	1	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28849	51114	ZDHHC9	0.67	0.577	C3275406	MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE	disease		Disease or Syndrome	0.9	1	2007	2018	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28851	51116	MRPS2	0.839	0.154	C4693722	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36	disease		Disease or Syndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
28852	51117	COQ4	0.78	0.269	C4225392	COENZYME Q10 DEFICIENCY, PRIMARY, 7	disease		Disease or Syndrome	0.7	1	2015	2016	4	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28855	51119	SBDS	0.601	0.692	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.62	1	2005	2017	1	0	CGI;GENOMICS_ENGLAND
28858	51119	SBDS	0.601	0.692	C0272170	Shwachman syndrome	disease		Disease or Syndrome	1	0.972	2003	2019	9	7	CLINGEN;CTD_human;GENOMICS_ENGLAND
28860	51119	SBDS	0.601	0.692	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.62	1	2009	2017	1	0	CGI;GENOMICS_ENGLAND
28861	51119	SBDS	0.601	0.692	C4692625	SHWACHMAN-DIAMOND SYNDROME 1	disease		Disease or Syndrome	0.6	1	2003	2015	4	9	GENOMICS_ENGLAND;UNIPROT
28863	51124	IER3IP1	0.711	0.423	C3280240	MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	disease		Disease or Syndrome	0.71	1	2011	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28867	51128	SAR1B	0.686	0.462	C0795956	Chylomicron retention disease	disease	C16;C06;C18	Disease or Syndrome	0.8	1	2003	2019	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28892	51132	RLIM	0.686	0.5	C4283894	MENTAL RETARDATION, X-LINKED 61	disease		Disease or Syndrome	0.7	1	2009	2016	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
28895	51134	CEP83	0.839	0.077	C3890591	NEPHRONOPHTHISIS 18	disease		Disease or Syndrome	0.7	1	2014	2014	1	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
28907	51135	IRAK4	0.578	0.769	C1843256	IRAK4 Deficiency	disease	C16;C20	Disease or Syndrome	0.61	1	2003	2014	6	0	CTD_human;ORPHANET;UNIPROT
28910	51142	CHCHD2	0.638	0.538	C4225238	PARKINSON DISEASE 22, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.7	1	2015	2015	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28925	51151	SLC45A2	0.626	0.538	C0078918	Albinism, Oculocutaneous	disease	C16;C18;C11;C17	Congenital Abnormality	0.6	0.923	2001	2019	1	0	GENOMICS_ENGLAND
28930	51151	SLC45A2	0.626	0.538	C1847836	Oculocutaneous Albinism, Type IV	disease	C16;C18;C11;C17	Disease or Syndrome	0.78	1	2001	2017	7	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28936	51156	SERPINA10	0.805	0.192	C0398623	Thrombophilia	disease	C15	Disease or Syndrome	0.51	1	2000	2004	2	0	CTD_human;GENOMICS_ENGLAND
28940	51164	DCTN4	0.472	0.846	C0010674	Cystic Fibrosis	disease	C16;C06;C08	Disease or Syndrome	0.54	1	2012	2019	1	0	CTD_human;ORPHANET
28949	51168	MYO15A	0.722	0.346	C1838263	Deafness, Autosomal Recessive 3	disease	C23;C10;C09	Disease or Syndrome	0.92	1	1998	2019	3	69	CTD_human;GENOMICS_ENGLAND;UNIPROT
28979	51181	DCXR	0.751	0.308	C0268162	Pentosuria	disease	C16;C18	Disease or Syndrome	0.7	1	2011	2017	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
28984	51185	CRBN	0.551	0.654	C0026764	Multiple Myeloma	disease	C04;C20;C15;C14	Neoplastic Process	0.6	0.943	2013	2020	1	0	CGI;CTD_human
28987	51185	CRBN	0.551	0.654	C1843942	Mental Retardation, Autosomal Recessive 2	disease	C23;C10;F03;F01	Disease or Syndrome	0.91	0.857	2004	2019	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
29008	51196	PLCE1	0.572	0.654	C1853124	NEPHROTIC SYNDROME, TYPE 3	disease	C13;C12	Disease or Syndrome	0.71	1	2006	2010	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
29011	51199	NIN	0.659	0.731	C3553870	SECKEL SYNDROME 7	disease		Disease or Syndrome	0.7	1	2012	2014	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29021	51204	TACO1	0.647	0.577	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.61	1	2009	2016	3	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
29022	51204	TACO1	0.647	0.577	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.6	1	2009	2016	3	1	CTD_human;GENOMICS_ENGLAND
29032	51206	GP6	0.597	0.615	C3280120	Glycoprotein VI deficiency	disease		Disease or Syndrome	0.6	1	2000	2013	6	2	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29035	51218	GLRX5	0.659	0.538	C4225155	ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY	disease		Disease or Syndrome	0.6	1	2007	2016	4	3	GENOMICS_ENGLAND;UNIPROT
29036	51218	GLRX5	0.659	0.538	C4225178	Childhood-onset spasticity with hyperglycinemia	disease	C23;C16;C18;C05;C10	Disease or Syndrome	0.6	1	2014	2014	2	2	GENOMICS_ENGLAND;ORPHANET
29051	51227	PIGP	0.633	0.462	C4539843	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55	disease		Disease or Syndrome	0.6	1	2017	2019	2	2	GENOMICS_ENGLAND;UNIPROT
29052	51232	CRIM1	0.76	0.308	C1865286	MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA	disease	C16;C11	Disease or Syndrome	0.51	1	2015	2016	2	0	GENOMICS_ENGLAND;ORPHANET
29053	51244	CCDC174	0.769	0.269	C4225196	HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION	disease		Disease or Syndrome	0.6	1	2015	2015	1	1	CTD_human;ORPHANET
29058	51251	NT5C3A	0.593	0.692	C1849507	Uridine 5-Prime Monophosphate Hydrolase Deficiency, Hemolytic Anemia due to	disease	C16;C15	Disease or Syndrome	0.7	1	2001	2016	10	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29059	51256	TBC1D7	0.729	0.385	C0221355	Macrocephaly	disease	C16;C05;C10	Congenital Abnormality	0.62	1	2013	2014	2	0	GENOMICS_ENGLAND;ORPHANET
29066	51259	TMEM216	0.544	0.615	C1842577	JOUBERT SYNDROME 2	disease	C16;C13;C11;C12;C10	Disease or Syndrome	0.72	1	2010	2017	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
29068	51259	TMEM216	0.544	0.615	C1864148	MECKEL SYNDROME, TYPE 2	disease	C23;C16;C13;C12;C08;C10;C09	Disease or Syndrome	0.71	1	2010	2014	1	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
29096	51293	CD320	0.729	0.462	C3150900	METHYLMALONIC ACIDURIA, TRANSIENT, DUE TO TRANSCOBALAMIN RECEPTOR DEFECT	disease		Disease or Syndrome	0.9	1	2010	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
29102	51294	PCDH12	0.722	0.346	C4538630	MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS	disease		Disease or Syndrome	0.6	1	2008	2017	3	4	GENOMICS_ENGLAND;UNIPROT
29119	51305	KCNK9	0.615	0.577	C2676770	Birk-Barel Mental Retardation Dysmorphism Syndrome	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.73	1	2008	2020	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29124	51308	REEP2	0.792	0.269	C3810160	SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2014	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29138	51317	PHF21A	0.682	0.5	C1832588	Chromosome 11p11.2 Deletion Syndrome	disease	C23;C16;C04;C05	Disease or Syndrome	0.55	1	2012	2019	2	0	GENOMICS_ENGLAND;ORPHANET
29156	51322	WAC	0.686	0.615	C4225239	DESANTO-SHINAWI SYNDROME	disease		Disease or Syndrome	0.6	1	2015	2016	1	12	CTD_human;ORPHANET
29160	51324	SPG21	0.695	0.5	C1855346	MAST SYNDROME	disease	C16;C10;F03	Disease or Syndrome	0.74	1	2003	2017	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
29172	51339	DACT1	0.547	0.692	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.51	1	2008	2019	1	0	CTD_human;UNIPROT
29176	51339	DACT1	0.547	0.692	C0265246	Townes syndrome	disease	C23;C16;C06;C10;C09	Disease or Syndrome	0.51	1	2017	2017	1	0	CTD_human;ORPHANET
29194	51360	MBTPS2	0.513	0.769	C1839988	Ichthyosis follicularis atrichia photophobia syndrome	disease	C23;C16;C11;C17;C10	Disease or Syndrome	0.74	1	1997	2015	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29199	51360	MBTPS2	0.513	0.769	C3806745	PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC PLAQUES, X-LINKED	disease		Disease or Syndrome	0.7	1	2013	2014	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
29200	51360	MBTPS2	0.513	0.769	C3887525	Keratosis Follicularis Spinulosa Decalvans, X-Linked	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	0.74	1	2010	2016	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
29207	51364	ZMYND10	0.553	0.731	C3809543	CILIARY DYSKINESIA, PRIMARY, 22	disease		Disease or Syndrome	0.9	1	2013	2018	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
29220	51371	POMP	0.674	0.346	C1866029	Keratosis Linearis with Ichthyosis Congenita and Sclerosing Keratoderma	disease	C16;C17	Disease or Syndrome	0.62	1	2010	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29250	51422	PRKAG2	0.582	0.654	C0043202	Wolff-Parkinson-White Syndrome	disease	C16;C14	Disease or Syndrome	0.8	1	1977	2016	6	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
29252	51422	PRKAG2	0.582	0.654	C1833236	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6 (disorder)	disease	C16;C14	Disease or Syndrome	0.7	1	1977	2018	5	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
29253	51422	PRKAG2	0.582	0.654	C1849813	Glycogen Storage Disease of Heart, Lethal Congenital	disease	C16;C18;C14	Disease or Syndrome	0.7	1	1977	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29267	51428	DDX41	0.636	0.538	C4225174	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO	disease		Finding	0.7	1	2015	2016	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29285	51466	EVL	0.729	0.308	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.52	1	2008	2015	2	1	CTD_human;UNIPROT
29292	51473	DCDC2	0.546	0.769	C1857750	DEAFNESS, AUTOSOMAL RECESSIVE 66	disease	C23;C10;C09	Disease or Syndrome	0.7	1	2015	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
29294	51473	DCDC2	0.546	0.769	C4015542	NEPHRONOPHTHISIS 19	disease		Disease or Syndrome	0.61	1	2012	2020	3	3	CTD_human;GENOMICS_ENGLAND
29295	51473	DCDC2	0.546	0.769	C4479344	SCLEROSING CHOLANGITIS, NEONATAL	disease		Disease or Syndrome	0.74	1	2015	2018	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
29297	51475	CABP2	0.861	0.115	C3888355	DEAFNESS, AUTOSOMAL RECESSIVE 93	disease		Disease or Syndrome	0.8	1	2012	2017	1	1	CTD_human;GENOMICS_ENGLAND
29316	51501	HIKESHI	0.751	0.385	C4225170	LEUKODYSTROPHY, HYPOMYELINATING, 13	disease		Disease or Syndrome	0.7	1	2016	2017	2	1	CTD_human;ORPHANET;UNIPROT
29318	51506	UFC1	0.716	0.462	C4748081	NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH	disease		Disease or Syndrome	0.6	1	2017	2019	3	2	GENOMICS_ENGLAND;UNIPROT
29327	51520	LARS1	0.678	0.577	C3809522	INFANTILE LIVER FAILURE SYNDROME 1	disease		Disease or Syndrome	0.7	1	2012	2012	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29331	51524	TMEM138	0.656	0.385	C3280906	JOUBERT SYNDROME 16	disease		Disease or Syndrome	0.6	1	2012	2015	1	4	GENOMICS_ENGLAND;UNIPROT
29370	51567	TDP2	0.628	0.462	C4310780	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23	disease		Disease or Syndrome	0.61	1	2014	2019	2	2	GENOMICS_ENGLAND;ORPHANET
29372	51569	UFM1	0.722	0.385	C4693535	LEUKODYSTROPHY, HYPOMYELINATING, 14	disease		Disease or Syndrome	0.6	1	2017	2019	3	1	GENOMICS_ENGLAND;UNIPROT
29382	51574	LARP7	0.674	0.615	C3554439	Microcephalic primordial dwarfism Alazami type	disease	C23;C16;C05;C10;C19;F03;F01	Disease or Syndrome	0.75	1	2012	2020	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
29403	51594	NBAS	0.566	0.692	C3541319	SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY	disease		Disease or Syndrome	0.76	1	2010	2019	2	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29404	51594	NBAS	0.566	0.692	C3809651	INFANTILE LIVER FAILURE SYNDROME 2	disease		Disease or Syndrome	0.73	1	2015	2019	1	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29413	51601	LIPT1	0.674	0.462	C4225379	LIPOYLTRANSFERASE 1 DEFICIENCY	disease		Disease or Syndrome	0.7	1	2013	2018	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29419	51604	PIGT	0.633	0.615	C3809356	MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3	disease		Disease or Syndrome	0.71	1	2013	2017	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29438	51626	DYNC2LI1	0.601	0.5	C4310724	SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY	disease		Disease or Syndrome	0.6	1	2015	2015	2	11	GENOMICS_ENGLAND;UNIPROT
29439	51633	OTUD6B	0.659	0.538	C4479520	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	disease		Disease or Syndrome	0.7	1	2017	2017	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29463	51651	PTRH2	0.641	0.577	C4015728	NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET	disease		Disease or Syndrome	0.71	1	2014	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29478	51660	MPC1	0.653	0.577	C3553607	MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	disease		Disease or Syndrome	0.7	1	2012	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29480	51684	SUFU	0.493	0.769	C0004779	Basal Cell Nevus Syndrome	disease	C16;C04;C05;C07	Neoplastic Process	1	0.938	2006	2018	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET
29481	51684	SUFU	0.493	0.769	C0025149	Medulloblastoma	disease	C04	Neoplastic Process	0.8	0.95	1996	2019	10	14	CGI;CLINGEN;CTD_human;GENOMICS_ENGLAND
29487	51684	SUFU	0.493	0.769	C0751291	Desmoplastic Medulloblastoma	disease	C04	Neoplastic Process	0.74	1	2002	2014	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
29497	51684	SUFU	0.493	0.769	C4540342	JOUBERT SYNDROME 32	disease		Disease or Syndrome	0.6	1	2017	2019	2	2	GENOMICS_ENGLAND;UNIPROT
29502	51702	PADI3	0.78	0.192	C0432347	Uncombable hair syndrome	disease	C17	Disease or Syndrome	0.51	1	2016	2016	1	0	CTD_human;ORPHANET
29510	51715	RAB23	0.541	0.654	C1275078	Acrocephalopolysyndactyly type 2	disease	C16;C05	Disease or Syndrome	0.75	0.833	2007	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
29512	51715	RAB23	0.541	0.654	C4551510	CARPENTER SYNDROME 1	disease	C16;C05	Disease or Syndrome	0.6	1	2007	2013	3	2	GENOMICS_ENGLAND;UNIPROT
29518	51726	DNAJB11	0.751	0.346	C4748044	POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE	disease		Disease or Syndrome	0.6	1	2018	2018	2	5	GENOMICS_ENGLAND;UNIPROT
29532	51733	UPB1	0.722	0.346	C1291512	Beta-Ureidopropionase Deficiency	disease	C16;C18;C10	Disease or Syndrome	0.72	1	2004	2016	6	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29617	51741	WWOX	0.453	0.808	C3280452	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12	disease		Disease or Syndrome	0.73	1	2014	2019	2	9	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29620	51741	WWOX	0.453	0.808	C4015519	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28	disease		Disease or Syndrome	0.7	1	2014	2015	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
29632	51750	RTEL1	0.459	0.808	C0265965	Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.69	1	2013	2018	2	0	GENOMICS_ENGLAND;ORPHANET
29634	51750	RTEL1	0.459	0.808	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.63	1	2015	2018	1	0	CTD_human;ORPHANET
29635	51750	RTEL1	0.459	0.808	C1846142	HOYERAAL-HREIDARSSON SYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	Disease or Syndrome	0.59	1	2013	2018	2	0	GENOMICS_ENGLAND;ORPHANET
29636	51750	RTEL1	0.459	0.808	C3554656	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5	disease		Disease or Syndrome	0.7	1	2009	2018	8	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
29638	51750	RTEL1	0.459	0.808	C4225346	PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3	disease		Disease or Syndrome	0.7	1	2009	2018	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
29642	51752	ERAP1	0.556	0.692	C0004943	Behcet Syndrome	disease	C16;C11;C17;C07;C14	Disease or Syndrome	0.7	1	2013	2020	2	1	CTD_human;ORPHANET
29657	51761	ATP8A2	0.659	0.577	C3808977	CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 4	disease		Disease or Syndrome	0.8	1	1969	2018	2	3	GENOMICS_ENGLAND;UNIPROT
29662	51763	INPP5K	0.587	0.654	C4479410	MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	disease		Disease or Syndrome	0.7	1	2017	2017	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
29664	51776	MAP3K20	0.564	0.769	C0546264	Congenital Fiber Type Disproportion	disease	C05;C10	Congenital Abnormality	0.51	1	2017	2017	1	0	GENOMICS_ENGLAND;ORPHANET
29665	51776	MAP3K20	0.564	0.769	C4225167	SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY	disease		Disease or Syndrome	0.7	1	2016	2016	1	0	CTD_human;ORPHANET;UNIPROT
29669	51778	MYOZ2	0.716	0.308	C3151204	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16	disease		Disease or Syndrome	0.6	1	2007	2007	1	2	CTD_human;UNIPROT
29684	51807	TUBA8	0.691	0.385	C2750798	Polymicrogyria With Optic Nerve Hypoplasia	disease	C16;C10	Disease or Syndrome	0.71	1	2009	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29688	51816	ADA2	0.545	0.846	C0282492	Sneddon Syndrome	disease	C17;C10;C14	Disease or Syndrome	0.71	1	1986	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29690	51816	ADA2	0.545	0.846	C1260899	Anemia, Diamond-Blackfan	disease	C16;C15	Disease or Syndrome	0.61	0.667	2014	2020	2	2	GENOMICS_ENGLAND;ORPHANET
29694	51816	ADA2	0.545	0.846	C3887654	POLYARTERITIS NODOSA, CHILDHOOD-ONSET	disease	C17;C14	Disease or Syndrome	0.76	1	2014	2019	3	12	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29719	53335	BCL11A	0.541	0.769	C4310833	INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	disease		Disease or Syndrome	0.6	1	2016	2018	2	9	CTD_human;UNIPROT
29724	53345	TM6SF2	0.638	0.462	C0400966	Non-alcoholic Fatty Liver Disease	disease	C06	Disease or Syndrome	0.6	0.955	2014	2020	2	0	CTD_human;GENOMICS_ENGLAND
29740	53405	CLIC5	0.792	0.308	C4015050	DEAFNESS, AUTOSOMAL RECESSIVE 103	disease		Disease or Syndrome	0.6	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND
29742	53616	ADAM22	0.678	0.615	C4693688	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61	disease		Disease or Syndrome	0.6	1	2016	2019	2	2	GENOMICS_ENGLAND;UNIPROT
29743	53630	BCO1	0.705	0.462	C2676023	Hypercarotenemia And Vitamin A Deficiency, Autosomal Dominant	disease	C18	Disease or Syndrome	0.6	1	2007	2007	1	1	CTD_human;ORPHANET;UNIPROT
29769	53834	FGFRL1	0.588	0.615	C1956097	Wolf-Hirschhorn Syndrome	disease	C16	Disease or Syndrome	0.51	1	2009	2017	0	0	CTD_human
29775	53904	MYO3A	0.78	0.269	C1846784	Deafness, Autosomal Recessive 30	disease	C23;C10;C09	Disease or Syndrome	0.81	1	2011	2018	1	7	CTD_human;GENOMICS_ENGLAND
29784	54106	TLR9	0.411	0.885	C0267380	Crohns disease of the ileum	disease	C06	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
    54106	TLR9	0.411	0.885	C0678202	Regional enteritis	disease	C06	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
    54106	TLR9	0.411	0.885	C0949272	IIeocolitis	disease	C06	Disease or Syndrome	0.30	1	2004	2007	   2	   0	CTD_human
    54112	GPR88	0.805	0.115	C4310787	CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	disease		Disease or Syndrome	0.40				   0	   1	CTD_human
    54187	NANS	0.545	0.692	C0005941	Bone Diseases, Developmental	group	C05	Disease or Syndrome	0.30	1	2016	2016	   1	   0	CTD_human
    54187	NANS	0.545	0.692	C0008073	Developmental Disabilities	group	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
    54187	NANS	0.545	0.692	C0085996	Child Development Deviations	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
    54187	NANS	0.545	0.692	C0085997	Child Development Disorders, Specific	disease	F03	Mental or Behavioral Dysfunction	0.30	1	2016	2016	   1	   0	CTD_human
    54187	NANS	0.545	0.692	C1864872	Spondyloepimetaphyseal dysplasia, Genevieve type	disease	C23;C16;C17;C05;C10;F03;F01	Disease or Syndrome	0.70	1	2016	2016	   1	   1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
    54205	CYCS	0.599	0.769	C0007786	Brain Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2002	2002	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0007787	Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0015695	Fatty Liver	disease	C06	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0022116	Ischemia	phenotype	C23	Pathologic Function	0.30	1	2004	2004	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0028754	Obesity	disease	C23;C18	Disease or Syndrome	0.30	1	2005	2005	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0040034	Thrombocytopenia	phenotype	C15	Disease or Syndrome	0.65	1	2008	2019	   1	   1	CTD_human;GENOMICS_ENGLAND
    54205	CYCS	0.599	0.769	C0263454	Chloracne	disease	C17	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0268583	Methylmalonic acidemia	phenotype	C16;C18	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0472381	Posterior Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0751019	Carotid Circulation Transient Ischemic Attack	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0751020	Transient Ischemic Attack, Vertebrobasilar Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0751021	Crescendo Transient Ischemic Attacks	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0751022	Brain Stem Ischemia, Transient	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0917798	Cerebral Ischemia	disease	C10;C14	Pathologic Function	0.30	1	2002	2002	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C0917805	Transient Cerebral Ischemia	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C1527335	Transient Ischemic Attack, Anterior Circulation	disease	C10;C14	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C1855119	Methylmalonic aciduria	disease	C16;C18	Disease or Syndrome	0.30	1	2006	2006	   1	   0	CTD_human
    54205	CYCS	0.599	0.769	C2677608	Thrombocytopenia 4	disease	C15	Disease or Syndrome	0.71	1	2008	2018	   3	   3	CTD_human;GENOMICS_ENGLAND;UNIPROT
    54205	CYCS	0.599	0.769	C2711227	Steatohepatitis	disease	C06	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
    54206	ERRFI1	0.612	0.538	C0007621	Neoplastic Cell Transformation	phenotype	C23;C04	Neoplastic Process	0.30	1	2017	2017	   1	   0	CTD_human
    54206	ERRFI1	0.612	0.538	C0014175	Endometriosis	disease	C13	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
    54206	ERRFI1	0.612	0.538	C0032460	Polycystic Ovary Syndrome	disease	C04;C13;C19	Disease or Syndrome	0.31	1	2011	2011	   1	   0	CTD_human
    54206	ERRFI1	0.612	0.538	C0269102	Endometrioma	disease	C13	Neoplastic Process	0.30	1	2011	2011	   1	   0	CTD_human
    54206	ERRFI1	0.612	0.538	C1136382	Sclerocystic Ovaries	disease	C04;C13;C19	Disease or Syndrome	0.30	1	2011	2011	   1	   0	CTD_human
    54209	TREM2	0.519	0.769	C0002395	Alzheimers Disease	disease	C10;F03	Disease or Syndrome	0.7	0.977	2007	2020	3	2	CTD_human;GENOMICS_ENGLAND
29788	54209	TREM2	0.519	0.769	C0276496	Familial Alzheimer Disease (FAD)	disease	C10;F03	Disease or Syndrome	0.51	1	2013	2017	3	0	CTD_human;ORPHANET
29793	54209	TREM2	0.519	0.769	C0497327	Dementia	disease	C10;F03	Mental or Behavioral Dysfunction	0.7	1	2005	2020	2	0	CTD_human;GENOMICS_ENGLAND
29798	54714	CNGB3	0.633	0.192	C1849792	Achromatopsia 3	disease	C23;C11;C10	Disease or Syndrome	0.93	1	2000	2018	6	106	CTD_human;GENOMICS_ENGLAND;UNIPROT
29799	54714	CNGB3	0.633	0.192	C1855465	STARGARDT DISEASE 1 (disorder)	disease		Disease or Syndrome	0.7	1	2005	2005	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29800	54714	CNGB3	0.633	0.192	C4282180	Juvenile macular degeneration	disease		Disease or Syndrome	0.51	0	2005	2005	0	0	CTD_human;GENOMICS_ENGLAND
29829	54716	SLC6A20	0.805	0.269	C0268654	Iminoglycinuria	disease	C16;C18;C13;C12	Disease or Syndrome	0.6	1	2008	2011	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29830	54716	SLC6A20	0.805	0.269	C0543541	HYPERGLYCINURIA (disorder)	disease	C16;C18;C13;C12	Disease or Syndrome	0.6	1	2008	2008	1	0	CTD_human;GENOMICS_ENGLAND
29856	54756	IL17RD	0.617	0.654	C3808975	HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.6	1	2013	2013	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
29858	54757	FAM20A	0.7	0.346	C2931783	Amelogenesis imperfecta nephrocalcinosis	disease	C16;C18;C13;C12;C07	Disease or Syndrome	0.78	1	2011	2019	12	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29863	54765	TRIM44	0.612	0.423	C0003076	Aniridia	disease	C16;C11	Congenital Abnormality	0.61	1	2015	2015	1	0	CTD_human;ORPHANET
29866	54768	HYDIN	0.641	0.538	C0020255	Hydrocephalus	disease	C10	Disease or Syndrome	0.63	1	1973	2013	2	0	CTD_human
29873	54768	HYDIN	0.641	0.538	C1837615	Ciliary Dyskinesia, Primary, 5	disease	C16;C08;C09	Disease or Syndrome	0.6	1	2012	2019	2	3	CTD_human;GENOMICS_ENGLAND
29907	54790	TET2	0.458	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.8	0.973	2009	2020	2	0	CGI;CTD_human;GENOMICS_ENGLAND
29911	54795	TRPM4	0.633	0.577	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.53	1	2012	2018	7	0	CLINGEN;ORPHANET
29913	54795	TRPM4	0.633	0.577	C1970298	Progressive Familial Heart Block, Type Ib	disease	C23;C14	Disease or Syndrome	0.7	1	2005	2018	6	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
29915	54796	BNC2	0.612	0.615	C0238506	Congenital posterior urethral valves	disease	C16;C13;C12	Congenital Abnormality	0.6	1	2019	2019	1	0	GENOMICS_ENGLAND;ORPHANET
29920	54800	KLHL24	0.821	0.115	C4310631	EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED, WITH SCARRING AND HAIR LOSS	disease		Disease or Syndrome	0.7	1	2016	2018	4	3	CLINGEN;CTD_human;ORPHANET
29929	54802	TRIT1	0.621	0.692	C4693466	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35	disease		Disease or Syndrome	0.6	1	2014	2017	2	5	GENOMICS_ENGLAND;UNIPROT
29957	54805	CNNM2	0.641	0.346	C3151295	HYPOMAGNESEMIA 6, RENAL	disease		Disease or Syndrome	0.7	1	2011	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
29960	54805	CNNM2	0.641	0.346	C4225333	HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION	disease		Disease or Syndrome	0.7	1	2014	2016	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
29976	54806	AHI1	0.513	0.846	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.7	0.969	2004	2019	1	9	GENOMICS_ENGLAND;ORPHANET
29978	54806	AHI1	0.513	0.846	C1837713	JOUBERT SYNDROME 3	disease	C23;C11;C10	Disease or Syndrome	0.9	1	1992	2017	7	45	CTD_human;GENOMICS_ENGLAND;UNIPROT
29985	54808	DYM	0.563	0.769	C0265286	Dyggve-Melchior-Clausen syndrome	disease	C23;C16;C05;C10;C19;F03;F01	Disease or Syndrome	0.78	1	2003	2017	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29988	54808	DYM	0.563	0.769	C1846431	SMITH-MCCORT DYSPLASIA	disease	C16;C05	Disease or Syndrome	0.82	1	2003	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29990	54808	DYM	0.563	0.769	C3888088	SMITH-MCCORT DYSPLASIA 1	disease	C16;C05	Disease or Syndrome	0.65	1	2003	2018	4	3	GENOMICS_ENGLAND;UNIPROT
29997	54809	SAMD9	0.606	0.808	C1864861	Tumoral Calcinosis, Normophosphatemic, Familial	disease	C16;C18;C05	Disease or Syndrome	0.7	1	2006	2017	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30001	54809	SAMD9	0.606	0.808	C4284088	MIRAGE SYNDROME	phenotype	C23	Disease or Syndrome	0.79	1	2006	2020	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30009	54820	NDE1	0.608	0.462	C1857977	MICROHYDRANENCEPHALY	disease	C16;C05;C10	Disease or Syndrome	0.62	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
30044	54832	VPS13C	0.653	0.346	C4225186	PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	disease		Disease or Syndrome	0.7	1	2016	2018	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
30048	54840	APTX	0.59	0.5	C1859598	ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	disease	C23;C10;C15;F01	Disease or Syndrome	0.8	1	2000	2017	11	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
30049	54845	ESRP1	0.628	0.5	C4693935	DEAFNESS, AUTOSOMAL RECESSIVE 109	disease		Disease or Syndrome	0.6	1	2017	2017	1	1	GENOMICS_ENGLAND;UNIPROT
30059	54862	CC2D1A	0.628	0.462	C1838023	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3	disease	C23;C10;F03;F01	Disease or Syndrome	0.6	1	2006	2006	1	1	CTD_human;GENOMICS_ENGLAND
30063	54872	PIGG	0.792	0.231	C4310794	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53	disease		Disease or Syndrome	0.7	1	2017	2019	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30082	54880	BCOR	0.471	0.808	C0796016	Microphthalmia, syndromic 1	disease	C16;C11	Congenital Abnormality	0.65	1	2004	2018	1	1	CTD_human;ORPHANET
30083	54880	BCOR	0.471	0.808	C1846265	Microphthalmia, syndromic 2	disease	C16;C11;C14	Disease or Syndrome	0.8	1	2004	2020	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30121	54888	NSUN2	0.559	0.846	C1970199	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	disease	C23;C10;F03;F01	Disease or Syndrome	0.7	1	2011	2012	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
30162	54899	PXK	0.821	0.231	C0024141	Lupus Erythematosus, Systemic	disease	C17;C20	Disease or Syndrome	0.67	0.875	2008	2015	2	2	CTD_human;ORPHANET
30166	54901	CDKAL1	0.617	0.615	C0011860	Diabetes Mellitus, Non-Insulin-Dependent	disease	C18;C19	Disease or Syndrome	0.7	0.984	2007	2019	3	88	CTD_human
30202	54902	TTC19	0.663	0.385	C1852372	MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)	disease	C18	Disease or Syndrome	0.53	1	2011	2018	0	0	CTD_human;GENOMICS_ENGLAND
30213	54903	MKS1	0.505	0.769	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.66	1	2006	2017	2	20	GENOMICS_ENGLAND;ORPHANET
30214	54903	MKS1	0.505	0.769	C0752166	Bardet-Biedl Syndrome	disease	C16;C11;C10	Disease or Syndrome	0.74	1	2004	2012	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
30216	54903	MKS1	0.505	0.769	C2673873	BARDET-BIEDL SYNDROME 13	disease	C16;C11;C10	Disease or Syndrome	0.7	1	1969	2016	4	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
30218	54903	MKS1	0.505	0.769	C3714506	Meckel syndrome type 1	disease	C23;C16;C13;C11;C12;C08;C10;C09	Disease or Syndrome	0.8	0.929	1969	2019	7	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
30224	54919	DNAAF5	0.67	0.5	C3543825	CILIARY DYSKINESIA, PRIMARY, 18	disease		Disease or Syndrome	0.7	1	2012	2018	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
30238	54928	IMPAD1	0.7	0.385	C3279757	CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	disease		Disease or Syndrome	0.71	1	2011	2012	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30240	54931	TRMT10C	0.839	0.154	C4310773	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	disease		Disease or Syndrome	0.7	1	2016	2016	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30245	54936	ADPRS	0.743	0.308	C4748527	NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES	disease		Disease or Syndrome	0.6	1	2018	2018	2	8	GENOMICS_ENGLAND;UNIPROT
30247	54938	SARS2	0.57	0.692	C3151209	Hyperuricemia, pulmonary hypertension, renal failure, alkalosis syndrome	disease	C23;C18;C13;C11;C05;C12;C08;C10;C14	Disease or Syndrome	0.72	1	2011	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30255	54941	RNF125	0.647	0.654	C4015710	TENORIO SYNDROME	disease		Disease or Syndrome	0.7	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
30266	54949	SDHAF2	0.604	0.692	C1708353	Hereditary Paraganglioma-Pheochromocytoma Syndrome	disease	C16;C04	Disease or Syndrome	0.6	1	1981	2017	6	5	CLINGEN;GENOMICS_ENGLAND
30267	54949	SDHAF2	0.604	0.692	C1866552	PARAGANGLIOMAS 2 (disorder)	disease	C16;C04	Disease or Syndrome	0.71	1	2009	2012	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
30277	54968	TMEM70	0.636	0.654	C3279699	Encephalocardiomyopathy, Mitochondrial, Neonatal, Due To Atp Synthase Deficiency	disease	C18;C05;C10	Disease or Syndrome	0.7	1	2008	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30284	54977	SLC25A38	0.716	0.462	C4225425	ANEMIA, SIDEROBLASTIC, 2, PYRIDOXINE-REFRACTORY	disease		Disease or Syndrome	0.6	1	2009	2015	2	8	GENOMICS_ENGLAND;UNIPROT
30290	54982	CLN6	0.67	0.231	C0022340	Late-Infantile Neuronal Ceroid Lipfuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.59	1	1998	2019	1	0	CTD_human
30291	54982	CLN6	0.67	0.231	C0022797	Adult Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.83	1	1998	2019	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30293	54982	CLN6	0.67	0.231	C0027877	Neuronal Ceroid-Lipofuscinoses	disease	C16;C18;C10	Disease or Syndrome	0.7	0.952	1998	2019	1	6	CTD_human
30300	54982	CLN6	0.67	0.231	C0751383	Juvenile Neuronal Ceroid Lipofuscinosis	disease	C16;C18;C10	Disease or Syndrome	0.58	1	1998	2019	1	0	CTD_human
30310	54982	CLN6	0.67	0.231	C1866282	CEROID LIPOFUSCINOSIS, NEURONAL, 6	disease	C16;C18;C10	Disease or Syndrome	0.92	1	1998	2019	9	41	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30324	55005	RMND1	0.674	0.462	C3554067	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11	disease		Disease or Syndrome	0.7	1	2012	2016	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30342	55149	MTPAP	0.581	0.769	C3150925	SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2010	2017	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30348	55151	TMEM38B	0.78	0.231	C3554428	OSTEOGENESIS IMPERFECTA, TYPE XIV	disease		Disease or Syndrome	0.51	1	2012	2017	1	0	CTD_human;GENOMICS_ENGLAND
30352	55154	MSTO1	0.582	0.692	C4540096	MYOPATHY, MITOCHONDRIAL, AND ATAXIA	disease		Disease or Syndrome	0.7	1	2017	2018	3	6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
30353	55157	DARS2	0.638	0.577	C1970180	Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation	disease	C18;C10	Disease or Syndrome	0.78	1	2007	2019	6	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30367	55163	PNPO	0.659	0.5	C1864723	Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency	disease	C23;C18;C10;C14	Disease or Syndrome	0.71	1	2005	2019	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30371	55165	CEP55	0.534	0.731	C1856053	Hydranencephaly with Renal Aplasia-Dysplasia	disease	C16;C13;C12;C10	Disease or Syndrome	0.62	1	2017	2019	2	3	GENOMICS_ENGLAND;ORPHANET
30379	55172	DNAAF2	0.678	0.538	C2675867	CILIARY DYSKINESIA, PRIMARY, 10	disease	C16;C08;C09	Disease or Syndrome	0.7	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
30385	55180	LINS1	0.691	0.231	C3280538	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	disease		Disease or Syndrome	0.7	1	2011	2018	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30389	55187	VPS13D	0.769	0.346	C1846492	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4	disease	C16;C10	Disease or Syndrome	0.7	1	2018	2018	2	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
30400	55193	PBRM1	0.566	0.615	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.7	1	2011	2020	2	0	CGI;CTD_human
30431	55209	SETD5	0.56	0.731	C3810406	MENTAL RETARDATION, AUTOSOMAL DOMINANT 23	disease		Disease or Syndrome	0.7	1	2014	2018	5	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30440	55210	ATAD3A	0.628	0.692	C4310677	HAREL-YOON SYNDROME	disease		Disease or Syndrome	0.7	1	2015	2018	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
30447	55212	BBS7	0.682	0.462	C1859565	BARDET-BIEDL SYNDROME 7	disease	C16;C11;C10	Disease or Syndrome	0.7	1	2003	2015	4	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
30455	55213	RCBTB1	0.572	0.692	C4310680	RETINAL DYSTROPHY WITH OR WITHOUT EXTRAOCULAR ANOMALIES	disease		Disease or Syndrome	0.7	1	2016	2016	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
30458	55214	P3H2	0.743	0.308	C3280346	MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION	disease		Disease or Syndrome	0.7	1	2011	2011	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
30465	55215	FANCI	0.543	0.731	C1836861	FANCONI ANEMIA, COMPLEMENTATION GROUP I	disease	C16;C18;C15	Disease or Syndrome	0.71	1	2001	2018	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
30471	55217	TMLHE	0.821	0.231	C3550875	AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	disease		Disease or Syndrome	0.6	1	2011	2015	2	0	GENOMICS_ENGLAND;UNIPROT
30481	55240	STEAP3	0.666	0.385	C3808920	ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2	disease		Disease or Syndrome	0.6	1	2011	2011	1	1	GENOMICS_ENGLAND;ORPHANET
30486	55249	YY1AP1	0.711	0.462	C1865267	Arterial Occlusive Disease, Progressive, with Hypertension, Heart Defects, Bone Fragility, and Brachysyndactyly	disease	C16;C05;C14	Disease or Syndrome	0.74	1	2017	2019	1	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
30491	55250	ELP2	0.716	0.538	C4310641	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58	disease		Disease or Syndrome	0.7	1	2015	2015	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30509	55275	VPS53	0.659	0.654	C4014488	PONTOCEREBELLAR HYPOPLASIA, TYPE 2E	disease	C16;C10	Disease or Syndrome	0.7	1	1989	2018	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30520	55280	CWF19L1	0.691	0.346	C4015301	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17	disease		Disease or Syndrome	0.6	1	2014	2018	3	4	GENOMICS_ENGLAND;ORPHANET
30524	55294	FBXW7	0.465	0.808	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.6	1	2001	2019	1	1	CTD_human;UNIPROT
30535	55294	FBXW7	0.465	0.808	C0476089	Endometrial Carcinoma	disease	C04;C13	Neoplastic Process	0.57	1	2002	2019	1	0	CGI;CTD_human
30544	55294	FBXW7	0.465	0.808	C1961099	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	disease	C04;C20;C15	Neoplastic Process	0.6	0.935	2007	2019	2	0	CGI;CTD_human
30576	55315	SLC29A3	0.578	0.769	C1864445	Histiocytosis with joint contractures and sensorineural deafness	disease	C23;C05;C10;C09;C15	Disease or Syndrome	0.8	1	1998	2019	12	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30581	55325	UFSP2	0.736	0.192	C1840572	HIP DYSPLASIA, BEUKES TYPE	disease	C16;C05	Disease or Syndrome	0.71	1	2015	2018	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30586	55331	ACER3	0.743	0.423	C4540358	LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET	disease		Disease or Syndrome	0.6	1	2016	2018	2	2	ORPHANET;UNIPROT
30590	55343	SLC35C1	0.705	0.577	C0398739	Congenital disorder of glycosylation, type 2C	disease	C16;C18	Disease or Syndrome	0.9	1	2001	2016	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30637	55503	TRPV6	0.603	0.615	C1300287	Transient neonatal hyperparathyroidism	phenotype	C23;C19	Disease or Syndrome	0.61	1	2018	2019	2	6	GENOMICS_ENGLAND;UNIPROT
30644	55505	NOP10	0.631	0.654	C1857144	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1	disease		Disease or Syndrome	0.6	1	2007	2007	1	1	GENOMICS_ENGLAND;UNIPROT
30652	55521	TRIM36	0.78	0.231	C0002902	Anencephaly	disease	C16;C10	Congenital Abnormality	0.61	1	2017	2017	1	0	CTD_human;UNIPROT
30656	55526	DHTKD1	0.711	0.385	C1859817	2-AMINOADIPIC 2-OXOADIPIC ACIDURIA	disease		Finding	0.7	1	2012	2016	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30657	55526	DHTKD1	0.711	0.385	C3554366	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q	disease		Disease or Syndrome	0.9	1	2012	2018	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
30680	55532	SLC30A10	0.578	0.654	C2750442	Hypermanganesemia with Dystonia Polycythemia and Cirrhosis	disease	C18	Disease or Syndrome	0.74	1	2012	2018	7	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30698	55572	FOXRED1	0.633	0.462	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.51	1	2010	2016	2	0	CTD_human;GENOMICS_ENGLAND
30703	55572	FOXRED1	0.633	0.462	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C18	Disease or Syndrome	0.6	1	1998	2016	4	3	GENOMICS_ENGLAND;ORPHANET
30709	55572	FOXRED1	0.633	0.462	C4748791	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19	disease		Disease or Syndrome	0.6	1	2010	2015	3	3	GENOMICS_ENGLAND;UNIPROT
30731	55603	TENT5A	0.695	0.577	C4693736	OSTEOGENESIS IMPERFECTA, TYPE XVIII	disease		Disease or Syndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
30734	55605	KIF21A	0.653	0.423	C1851102	Fibrosis Of Extraocular Muscles, Congenital, 1	disease	C23;C16;C11;C10	Disease or Syndrome	0.97	0.923	2001	2016	5	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
30735	55605	KIF21A	0.653	0.423	C2751105	FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B (disorder)	disease	C23;C16;C11;C10	Disease or Syndrome	0.6	1	2014	2014	0	3	CTD_human
30736	55612	FERMT1	0.599	0.577	C0406557	Poikiloderma of Kindler	disease	C23;C16;C17;C07	Disease or Syndrome	1	0.957	2003	2019	6	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30745	55621	TRMT1	0.821	0.269	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.52	1	2011	2017	2	0	CTD_human;GENOMICS_ENGLAND
30748	55624	POMGNT1	0.537	0.538	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.72	1	2003	2009	1	0	CTD_human;ORPHANET
30750	55624	POMGNT1	0.537	0.538	C0457133	Muscle eye brain disease	disease	C16;C11;C10	Disease or Syndrome	0.7	1	2001	2017	1	74	CTD_human;ORPHANET
30754	55624	POMGNT1	0.537	0.538	C3150412	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 3	disease		Disease or Syndrome	0.9	1	2001	2017	5	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
30755	55624	POMGNT1	0.537	0.538	C3150417	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3	disease		Disease or Syndrome	0.7	1	2001	2017	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30756	55624	POMGNT1	0.537	0.538	C3151519	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3	disease	C16;C05;C10	Disease or Syndrome	0.6	1	2001	2016	13	18	GENOMICS_ENGLAND;UNIPROT
30758	55624	POMGNT1	0.537	0.538	C4310704	RETINITIS PIGMENTOSA 76	disease		Disease or Syndrome	0.7	1	2001	2017	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
30764	55630	SLC39A4	0.628	0.692	C0221036	Acrodermatitis enteropathica	disease	C16;C17	Disease or Syndrome	1	0.957	2002	2019	10	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30770	55636	CHD7	0.441	0.846	C0162809	Kallmann Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.6	1	2006	2018	1	0	CTD_human;ORPHANET
30771	55636	CHD7	0.441	0.846	C0265354	CHARGE Syndrome	disease	C16;C11	Disease or Syndrome	1	0.981	2004	2020	24	204	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
30780	55636	CHD7	0.441	0.846	C2936502	Familial CHARGE Syndrome	disease	C16;C11	Disease or Syndrome	0.51	1	2005	2015	2	0	CTD_human
30781	55636	CHD7	0.441	0.846	C3552553	HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.6	1	2004	2016	5	25	GENOMICS_ENGLAND;UNIPROT
30782	55640	FLVCR2	0.736	0.346	C1856972	Encephaloclastic Proliferative Vasculopathy	disease	C16;C10	Disease or Syndrome	0.72	1	2010	2016	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30784	55644	OSGEP	0.626	0.615	C0795949	Galloway Mowat syndrome	disease	C23;C16;C13;C05;C12;C10	Disease or Syndrome	0.53	1	2017	2019	1	0	CTD_human;ORPHANET
30786	55644	OSGEP	0.626	0.615	C4540266	GALLOWAY-MOWAT SYNDROME 3	disease		Disease or Syndrome	0.6	1	2017	2017	2	12	GENOMICS_ENGLAND;UNIPROT
30787	55650	PIGV	0.636	0.615	C1855923	Hyperphosphatasia with Mental Retardation	disease	C23;C16;C18;C10;F03;F01	Disease or Syndrome	0.74	1	2010	2017	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
30788	55650	PIGV	0.636	0.615	C4551502	HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1	disease	C23;C16;C18;C10;F03;F01	Disease or Syndrome	0.6	1	2010	2016	3	6	GENOMICS_ENGLAND;UNIPROT
30791	55651	NHP2	0.623	0.654	C3151441	DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2	disease		Disease or Syndrome	0.7	1	2001	2014	4	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
30794	55654	TMEM127	0.638	0.615	C0031511	Pheochromocytoma	disease	C04	Neoplastic Process	0.8	1	2010	2020	2	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
30806	55670	PEX26	0.584	0.615	C0043459	Zellweger Syndrome	disease	C16;C06;C18;C13;C12;C10	Disease or Syndrome	0.51	1	2003	2015	2	0	CTD_human;GENOMICS_ENGLAND
30809	55670	PEX26	0.584	0.615	C0282527	Infantile Refsum Disease (disorder)	disease	C16;C18;C10	Disease or Syndrome	0.61	1	2003	2006	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
30812	55670	PEX26	0.584	0.615	C1832200	Peroxisome biogenesis disorders	group	C16;C18	Disease or Syndrome	0.64	1	2003	2016	2	3	CTD_human;GENOMICS_ENGLAND
30816	55670	PEX26	0.584	0.615	C3553951	PEROXISOME BIOGENESIS DISORDER 7B	disease	C16;C18	Disease or Syndrome	0.7	1	2003	2017	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
30818	55670	PEX26	0.584	0.615	C3888385	PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER)	disease	C16;C18	Disease or Syndrome	0.7	1	2003	2017	7	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
30825	55679	LIMS2	0.751	0.308	C4225192	MUSCULAR DYSTROPHY, AUTOSOMAL RECESSIVE, WITH CARDIOMYOPATHY AND TRIANGULAR TONGUE	disease		Disease or Syndrome	0.7	1	2015	2015	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30834	55687	TRMU	0.716	0.385	C3278664	LIVER FAILURE, INFANTILE, TRANSIENT	disease		Disease or Syndrome	0.7	1	2009	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30849	55690	PACS1	0.603	0.615	C3554343	MENTAL RETARDATION, AUTOSOMAL DOMINANT 17	disease	C23	Disease or Syndrome	0.73	1	2012	2019	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
30861	55691	FRMD4A	0.65	0.538	C4225193	CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA	disease		Disease or Syndrome	0.7	1	2015	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
30864	55697	VAC14	0.588	0.731	C4310743	STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	disease		Disease or Syndrome	0.7	1	2008	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30874	55699	IARS2	0.59	0.654	C4014942	CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA	disease		Disease or Syndrome	0.73	1	2014	2018	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30880	55703	POLR3B	0.628	0.654	C2676243	Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism	disease	C23;C16;C10;C19;C07	Disease or Syndrome	0.73	1	2011	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
30881	55703	POLR3B	0.628	0.654	C3280644	LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	disease		Disease or Syndrome	0.6	1	2011	2015	5	14	GENOMICS_ENGLAND;UNIPROT
30885	55704	CCDC88A	0.61	0.615	C1850056	Progressive encephalopathy with edema, hypsarrhythmia, and optic atrophy-like syndrome	disease	C11;C10	Disease or Syndrome	0.54	0.75	2003	2020	2	0	GENOMICS_ENGLAND;ORPHANET
30892	55714	TENM3	0.599	0.692	C3554592	MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9	disease		Disease or Syndrome	0.6	1	2012	2012	1	2	CTD_human;GENOMICS_ENGLAND
30900	55717	WDR11	0.524	0.808	C0162809	Kallmann Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.74	1	2010	2018	2	0	GENOMICS_ENGLAND;ORPHANET
30905	55717	WDR11	0.524	0.808	C3540450	HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.7	1	2010	2018	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
30934	55737	VPS35	0.656	0.5	C3280133	PARKINSON DISEASE 17	disease		Disease or Syndrome	0.9	1	2011	2015	8	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
30957	55743	CHFR	0.633	0.5	C0007131	Non-Small Cell Lung Carcinoma	disease	C04;C08	Neoplastic Process	0.55	0.8	2008	2015	1	1	CTD_human;UNIPROT
30972	55746	NUP133	0.678	0.577	C4748549	NEPHROTIC SYNDROME, TYPE 18	disease		Disease or Syndrome	0.6	1	2018	2018	2	3	GENOMICS_ENGLAND;UNIPROT
30981	55750	AGK	0.65	0.654	C1859317	Cataract and cardiomyopathy	disease	C11;C14	Disease or Syndrome	0.78	1	1986	2017	4	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
30982	55750	AGK	0.65	0.654	C3553494	CATARACT 38	disease		Disease or Syndrome	0.6	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND
30988	55755	CDK5RAP2	0.682	0.577	C1858108	Microcephaly, Primary Autosomal Recessive, 3	disease	C16;C05;C10	Disease or Syndrome	0.6	1	2005	2017	0	15	CTD_human;GENOMICS_ENGLAND
30989	55755	CDK5RAP2	0.682	0.577	C3711387	Autosomal Recessive Primary Microcephaly	disease	C16;C05;C10	Disease or Syndrome	0.69	0.889	2007	2017	0	2	GENOMICS_ENGLAND;ORPHANET
31012	55764	IFT122	0.56	0.846	C0432235	CRANIOECTODERMAL DYSPLASIA 1	disease	C16;C17;C05	Disease or Syndrome	0.73	1	2009	2018	8	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31026	55768	NGLY1	0.601	0.654	C3808991	NGLY1 deficiency	disease	C16;C18	Disease or Syndrome	0.77	1	2012	2020	7	19	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
31028	55773	TBC1D23	0.729	0.308	C4540164	PONTOCEREBELLAR HYPOPLASIA, TYPE 11	disease		Congenital Abnormality	0.6	1	2017	2018	3	4	GENOMICS_ENGLAND;UNIPROT
31030	55775	TDP1	0.612	0.538	C1846574	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY	disease	C16;C10	Disease or Syndrome	0.9	0.923	2002	2020	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
31034	55777	MBD5	0.581	0.808	C1969562	Mental Retardation, Autosomal Dominant 1	disease	C23;C10;F03;F01	Disease or Syndrome	0.61	1	2007	2017	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
31038	55779	CFAP44	0.792	0.077	C4539824	SPERMATOGENIC FAILURE 20	disease		Disease or Syndrome	0.6	1	2017	2017	1	6	GENOMICS_ENGLAND
31040	55780	ERMARD	0.647	0.538	C1868720	Periventricular Nodular Heterotopia	disease	C16;C10	Disease or Syndrome	0.72	1	2013	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31041	55780	ERMARD	0.647	0.538	C3809872	PERIVENTRICULAR NODULAR HETEROTOPIA 6	disease		Disease or Syndrome	0.6	1	2013	2013	1	1	GENOMICS_ENGLAND;UNIPROT
31055	55788	LMBRD1	0.716	0.385	C1848578	METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE (disorder)	disease	C16;C18	Disease or Syndrome	0.63	1	2009	2016	2	3	CTD_human;GENOMICS_ENGLAND
31063	55800	SCN3B	0.686	0.269	C1142166	Brugada Syndrome (disorder)	disease	C16;C14	Disease or Syndrome	0.53	0.917	2001	2016	11	0	CLINGEN
31067	55800	SCN3B	0.686	0.269	C2751088	Brugada Syndrome 7	disease	C16;C14	Disease or Syndrome	0.9	1	2009	2016	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31074	55806	HR	0.722	0.192	C0263505	Alopecia universalis	disease	C23;C17	Disease or Syndrome	0.71	1	1998	1998	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31075	55806	HR	0.722	0.192	C1859592	ATRICHIA WITH PAPULAR LESIONS	disease	C23;C17	Disease or Syndrome	0.9	1	1998	2008	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
31076	55806	HR	0.722	0.192	C1859877	Alopecia universalis congenita	disease	C23;C17	Congenital Abnormality	0.9	1	1998	2014	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31077	55806	HR	0.722	0.192	C2750815	Marie Unna Hereditary Hypotrichosis 1	disease	C17	Disease or Syndrome	0.61	1	1999	2012	1	4	GENOMICS_ENGLAND
31078	55806	HR	0.722	0.192	C2931059	Marie Unna congenital hypotrichosis	disease	C17	Disease or Syndrome	0.51	1	2009	2009	1	0	CTD_human;ORPHANET
31091	55812	SPATA7	0.656	0.385	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.65	1	2009	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31092	55812	SPATA7	0.656	0.385	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.67	1	2005	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31094	55812	SPATA7	0.656	0.385	C1858677	LEBER CONGENITAL AMAUROSIS 3 (disorder)	disease	C16;C11	Disease or Syndrome	0.7	1	2015	2015	0	0	CTD_human;GENOMICS_ENGLAND
31103	55823	VPS11	0.633	0.654	C4225247	LEUKODYSTROPHY, HYPOMYELINATING, 12	disease		Disease or Syndrome	0.7	1	2015	2016	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31124	55835	CENPJ	0.546	0.846	C0265202	Seckel syndrome	disease	C23;C16;C05;C10;C19	Disease or Syndrome	0.71	1	2010	2010	1	0	GENOMICS_ENGLAND;ORPHANET
31126	55835	CENPJ	0.546	0.846	C1842109	Microcephaly, Primary Autosomal Recessive, 6	disease	C16;C05;C10	Disease or Syndrome	0.71	1	2005	2011	4	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
31128	55835	CENPJ	0.546	0.846	C3888212	SECKEL SYNDROME 4	disease		Disease or Syndrome	0.6	1	2006	2010	2	13	CTD_human;GENOMICS_ENGLAND
31140	55851	PSENEN	0.695	0.423	C3714534	dowling-degos disease	disease	C16;C17	Disease or Syndrome	0.52	1	2010	2018	2	0	GENOMICS_ENGLAND;ORPHANET
31142	55857	KIZ	0.722	0.308	C4014312	RETINITIS PIGMENTOSA 69	disease		Disease or Syndrome	0.6	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND
31145	55858	TMEM165	0.711	0.385	C3553571	Carbohydrate deficient glycoprotein syndrome type 2k	disease	C16;C18;C05	Disease or Syndrome	0.7	1	2012	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31155	55863	TMEM126B	0.716	0.385	C4748830	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29	disease		Disease or Syndrome	0.6	1	2016	2016	2	4	GENOMICS_ENGLAND;UNIPROT
31156	55869	HDAC8	0.511	0.885	C0270972	Cornelia De Lange Syndrome	disease	C16;C10	Disease or Syndrome	0.6	0.963	2009	2019	5	0	CLINGEN;ORPHANET
31158	55869	HDAC8	0.511	0.885	C3550903	CORNELIA DE LANGE SYNDROME 5	disease		Disease or Syndrome	0.6	1	2012	2019	2	26	GENOMICS_ENGLAND;UNIPROT
31165	55870	ASH1L	0.623	0.577	C4540478	MENTAL RETARDATION, AUTOSOMAL DOMINANT 52	disease		Mental or Behavioral Dysfunction	0.6	1	2012	2017	4	13	GENOMICS_ENGLAND;UNIPROT
31192	55906	ZC4H2	0.561	0.731	C0796200	Wieacker-Wolff syndrome	disease	C23;C16;C11;C05;C10;F01	Disease or Syndrome	0.71	1	2013	2017	2	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31214	55967	NDUFA12	0.659	0.462	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.51	1	2011	2016	3	0	CLINGEN;GENOMICS_ENGLAND
31226	55975	KLHL7	0.581	0.731	C1832409	Crisponi syndrome	disease	C23;C16;C17;C05;C10	Disease or Syndrome	0.53	0.667	2016	2019	1	0	CTD_human;ORPHANET
31227	55975	KLHL7	0.581	0.731	C1848947	COLD-INDUCED SWEATING SYNDROME 1	disease	C23;C16;C17;C05;C10	Disease or Syndrome	0.6	1	2016	2016	1	4	CTD_human;ORPHANET
31229	55975	KLHL7	0.581	0.731	C2751986	RETINITIS PIGMENTOSA 42	disease	C16;C11	Disease or Syndrome	0.7	1	2009	2011	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31230	55975	KLHL7	0.581	0.731	C4310742	CRISPONI/COLD-INDUCED SWEATING SYNDROME 3	disease		Disease or Syndrome	0.6	1	2016	2016	1	6	GENOMICS_ENGLAND;UNIPROT
31231	55997	CFC1	0.588	0.577	C0013069	Double Outlet Right Ventricle	disease	C16;C14	Congenital Abnormality	0.62	1	1999	2008	1	0	CTD_human
31232	55997	CFC1	0.588	0.577	C0040761	Transposition of Great Vessels	disease	C16;C14	Congenital Abnormality	0.61	1	1999	2002	1	0	CTD_human
31235	55997	CFC1	0.588	0.577	C1415817	HETEROTAXY, VISCERAL, 2, AUTOSOMAL	disease		Disease or Syndrome	0.9	1	2000	2015	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31246	56006	SMG9	0.729	0.346	C4310793	HEART AND BRAIN MALFORMATION SYNDROME	disease		Disease or Syndrome	0.6	1	2016	2019	2	2	CTD_human;GENOMICS_ENGLAND
31250	56052	ALG1	0.61	0.808	C2931005	Congenital disorder of glycosylation type 1K	disease	C16;C18	Disease or Syndrome	0.74	1	2004	2017	6	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
31265	56160	NSMCE3	0.751	0.346	C4310653	LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME	disease		Disease or Syndrome	0.7	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
31274	56172	ANKH	0.606	0.692	C0856830	Calcium pyrophosphate arthropathy	disease	C05	Disease or Syndrome	0.75	1	1999	2012	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31276	56172	ANKH	0.606	0.692	C1852502	CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	disease	C05;C07	Disease or Syndrome	0.99	1	1999	2018	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
31278	56203	LMOD3	0.7	0.423	C4015360	NEMALINE MYOPATHY 10	disease		Disease or Syndrome	0.9	1	2014	2018	6	8	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
31280	56244	BTNL2	0.546	0.808	C0036202	Sarcoidosis	disease	C15	Disease or Syndrome	0.7	1	2005	2019	1	0	CTD_human;ORPHANET
31284	56246	MRAP	0.674	0.5	C4049714	Familial Glucocorticoid Deficiency Type 2	disease	C19	Disease or Syndrome	0.61	1	2005	2010	0	2	CTD_human;GENOMICS_ENGLAND
31286	56262	LRRC8A	0.644	0.692	C0001768	Agammaglobulinemia	disease	C20;C15	Disease or Syndrome	0.62	0.5	2003	2017	0	0	CTD_human;GENOMICS_ENGLAND
31328	56479	KCNQ5	0.686	0.5	C4539851	MENTAL RETARDATION, AUTOSOMAL DOMINANT 46	disease		Mental or Behavioral Dysfunction	0.6	1	2017	2019	2	4	GENOMICS_ENGLAND;UNIPROT
31336	56521	DNAJC12	0.705	0.423	C4479270	HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT	disease		Disease or Syndrome	0.7	1	2017	2017	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31345	56603	CYP26B1	0.666	0.5	C3280729	RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES	disease		Disease or Syndrome	0.7	1	2011	2016	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31347	56606	SLC2A9	0.619	0.731	C0473219	Renal hypouricemia	disease	C23;C16;C18;C13;C12	Disease or Syndrome	0.6	1	2008	2019	4	0	CTD_human;ORPHANET
31349	56606	SLC2A9	0.619	0.731	C2677549	Hypouricemia, Renal, 2	disease	C16;C18;C13;C12	Disease or Syndrome	0.72	1	2008	2019	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
31361	56616	DIABLO	0.555	0.692	C3279948	DEAFNESS, AUTOSOMAL DOMINANT 64	disease		Disease or Syndrome	0.7	1	2011	2016	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
31370	56623	INPP5E	0.561	0.615	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.78	1	2003	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
31373	56623	INPP5E	0.561	0.615	C1857802	MORM syndrome	disease	C23;C16;C18;C11;C12;C10;F03;F01	Disease or Syndrome	0.72	1	2009	2019	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
31376	56623	INPP5E	0.561	0.615	C4551568	Joubert syndrome 1	disease	C16;C13;C11;C12	Disease or Syndrome	0.7	1	2009	2019	7	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31385	56652	TWNK	0.516	0.692	C1836439	Progressive External Ophthalmoplegia with Mitochondrial DNA Deletions, Autosomal Dominant, 3	disease	C23;C18;C11;C05;C10	Disease or Syndrome	0.7	1	2001	2019	15	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
31386	56652	TWNK	0.516	0.692	C1843851	Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	disease	C23;C16;C11;C10	Disease or Syndrome	0.51	1	2005	2014	1	0	CTD_human;ORPHANET
31387	56652	TWNK	0.516	0.692	C1849096	Infantile onset spinocerebellar ataxia	disease	C16;C10	Disease or Syndrome	0.77	1	1997	2019	8	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
31388	56652	TWNK	0.516	0.692	C4015307	PERRAULT SYNDROME 5	disease		Disease or Syndrome	0.6	1	2010	2014	2	6	GENOMICS_ENGLAND;UNIPROT
31393	56683	CFAP298	0.678	0.5	C3809684	CILIARY DYSKINESIA, PRIMARY, 26	disease		Disease or Syndrome	0.7	1	2013	2013	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31395	56683	CFAP298	0.678	0.5	C4551720	Primary Ciliary Dyskinesia	disease	C16;C08;C09	Disease or Syndrome	0.51	1	2013	2013	1	0	GENOMICS_ENGLAND;ORPHANET
31464	56916	SMARCAD1	0.656	0.423	C0406707	Basan syndrome	disease	C23;C16;C17	Disease or Syndrome	0.73	1	2014	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
31465	56916	SMARCAD1	0.656	0.423	C0406767	Keratoderma with scleroatrophy of the extremities	disease	C04;C17	Congenital Abnormality	0.6	1	2018	2018	1	3	CTD_human;ORPHANET
31466	56916	SMARCAD1	0.656	0.423	C1852150	Fingerprints, Absence of	phenotype	C16;C17	Finding	0.6	1	2011	2011	1	3	CTD_human;ORPHANET
31469	56922	MCCC1	0.7	0.308	C0268600	3-methylcrotonyl CoA carboxylase 1 deficiency	disease	C16;C18;C10	Disease or Syndrome	0.73	1	2001	2016	12	50	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31498	56945	MRPS22	0.638	0.5	C2673642	Combined Oxidative Phosphorylation Deficiency 5	disease	C16;C18	Disease or Syndrome	0.7	1	2007	2017	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31515	56947	MFF	0.705	0.462	C4310726	ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	disease		Disease or Syndrome	0.7	1	2012	2016	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
31527	56975	FAM20C	0.578	0.731	C1850106	RAINE SYNDROME	disease	C16;C11;C05;C10;C07	Disease or Syndrome	0.8	1	2000	2019	9	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31535	56978	PRDM8	0.678	0.462	C4225258	EPILEPSY, PROGRESSIVE MYOCLONIC, 10	disease		Disease or Syndrome	0.7	1	2012	2012	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31539	56983	POGLUT1	0.691	0.385	C3714534	dowling-degos disease	disease	C16;C17	Disease or Syndrome	0.62	1	2014	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31540	56983	POGLUT1	0.691	0.385	C3810313	DOWLING-DEGOS DISEASE 4	disease		Disease or Syndrome	0.6	1	2014	2017	2	6	GENOMICS_ENGLAND;UNIPROT
31541	56983	POGLUT1	0.691	0.385	C4310660	MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 21	disease	C16;C05;C10	Disease or Syndrome	0.6	1	2016	2017	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31549	56997	COQ8A	0.674	0.385	C2677589	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 9	disease	C16;C10	Disease or Syndrome	0.9	1	2008	2019	13	32	CTD_human;GENOMICS_ENGLAND;UNIPROT
31550	56997	COQ8A	0.674	0.385	C3551954	COENZYME Q10 DEFICIENCY, PRIMARY, 1	disease		Disease or Syndrome	0.6	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND
31571	57010	CABP4	0.711	0.154	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.62	1	2006	2010	1	0	GENOMICS_ENGLAND;ORPHANET
31573	57010	CABP4	0.711	0.154	C4041558	Cone-rod synaptic disorder, congenital nonprogressive	disease	C16;C11	Disease or Syndrome	0.7	1	2006	2006	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31592	57017	COQ9	0.7	0.423	C3553374	COENZYME Q10 DEFICIENCY, PRIMARY, 5	disease		Disease or Syndrome	0.7	1	2001	2017	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
31640	57038	RARS2	0.663	0.462	C1969084	Pontocerebellar Hypoplasia Type 6	disease	C16;C10	Disease or Syndrome; Congenital Abnormality	0.79	0.933	2010	2020	4	13	CTD_human;GENOMICS_ENGLAND;ORPHANET
31666	57057	TBX20	0.663	0.346	C1969657	Atrial Septal Defect 4	disease	C16;C14	Disease or Syndrome; Congenital Abnormality	0.7	1	2007	2010	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31667	57061	HYMAI	0.67	0.538	C1832386	Diabetes Mellitus, Transient Neonatal, 1	disease	C16;C18;C19	Disease or Syndrome	0.52	1	2000	2011	2	0	CTD_human;ORPHANET
31670	57082	KNL1	0.644	0.615	C1858516	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE	disease	C16;C05;C10	Disease or Syndrome	0.7	1	2012	2016	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
31694	57094	CPA6	0.716	0.346	C3280730	EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	disease		Disease or Syndrome	0.7	1	2012	2012	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31695	57094	CPA6	0.716	0.346	C3280734	FEBRILE SEIZURES, FAMILIAL, 11	disease		Disease or Syndrome	0.7	1	2012	2012	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
31699	57096	RPGRIP1	0.553	0.654	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.68	1	2004	2017	1	1	CTD_human;GENOMICS_ENGLAND
31711	57096	RPGRIP1	0.553	0.654	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.8	1	2001	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
31723	57096	RPGRIP1	0.553	0.654	C1854260	LEBER CONGENITAL AMAUROSIS 6 (disorder)	disease	C11	Disease or Syndrome; Congenital Abnormality	0.9	1	2001	2018	6	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
31724	57096	RPGRIP1	0.553	0.654	C2750720	Cone-Rod Dystrophy 13	disease	C16;C11	Disease or Syndrome	0.7	1	2000	2015	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
31735	57104	PNPLA2	0.511	0.846	C1853136	Neutral Lipid Storage Disease with Myopathy	disease	C16;C18;C05;C10	Disease or Syndrome	0.8	1	2007	2019	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31738	57105	CYSLTR2	0.633	0.538	C0220633	Uveal melanoma	disease	C04;C11	Neoplastic Process	0.53	1	2016	2019	1	0	CTD_human;ORPHANET
31744	57107	PDSS2	0.626	0.577	C3553358	COENZYME Q10 DEFICIENCY, PRIMARY, 3	disease		Disease or Syndrome	0.7	1	2006	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31757	57122	NUP107	0.595	0.5	C4225228	NEPHROTIC SYNDROME, TYPE 11	disease		Disease or Syndrome	0.7	1	2015	2018	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
31762	57128	LYRM4	0.736	0.385	C3810055	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19	disease		Disease or Syndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
31778	57152	SLURP1	0.56	0.654	C0025221	Meleda Disease	disease	C16;C17	Disease or Syndrome; Congenital Abnormality	1	0.973	2001	2019	12	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31780	57152	SLURP1	0.56	0.654	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.58	1	2003	2019	3	0	CTD_human;GENOMICS_ENGLAND
31789	57158	JPH2	0.736	0.154	C3151264	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17	disease		Disease or Syndrome	0.7	1	2004	2019	11	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
31797	57165	GJC2	0.593	0.692	C1837355	Leukodystrophy, Hypomyelinating, 2	disease	C16;C18;C10	Disease or Syndrome	0.93	1	2004	2019	8	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31798	57165	GJC2	0.593	0.692	C2750784	SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE (disorder)	disease	C16;C10	Disease or Syndrome	0.71	1	2008	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31799	57165	GJC2	0.593	0.692	C4747646	LYMPHATIC MALFORMATION 3	disease		Disease or Syndrome	0.7	1	2008	2015	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
31814	57465	TBC1D24	0.53	0.808	C0795934	Digitorenocerebral Syndrome	disease	C23;C16;C05;C10;F03;C09;F01	Disease or Syndrome	0.7	0.941	2010	2019	3	11	GENOMICS_ENGLAND;UNIPROT
31815	57465	TBC1D24	0.53	0.808	C0917800	Epilepsy, Myoclonic, Infantile	disease	C10	Disease or Syndrome	0.76	1	2010	2017	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31822	57817	HAMP	0.433	0.846	C0022661	Kidney Failure, Chronic	disease	C13;C12	Disease or Syndrome	0.57	0.875	2006	2020	1	0	CTD_human
31826	57817	HAMP	0.433	0.846	C0282193	Iron Overload	disease	C18	Disease or Syndrome	0.6	0.973	2002	2020	2	0	CTD_human
31832	57817	HAMP	0.433	0.846	C1865616	HEMOCHROMATOSIS, TYPE 2B	disease	C16;C18	Disease or Syndrome	0.7	1	2003	2016	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
31833	57817	HAMP	0.433	0.846	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.95	2005	2019	1	0	CTD_human
31844	57822	GRHL3	0.572	0.692	C0175697	Van der Woude syndrome	disease	C23;C16;C04;C05;C07	Disease or Syndrome	0.79	0.889	2014	2017	1	0	GENOMICS_ENGLAND;ORPHANET
31852	57822	GRHL3	0.572	0.692	C1847604	Van der Woude syndrome 2	disease	C16;C05;C07	Disease or Syndrome	0.7	1	2014	2014	1	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
31864	58484	NLRC4	0.556	0.769	C0343068	Familial cold urticaria	disease	C16;C17	Disease or Syndrome	0.72	1	2014	2019	1	0	CTD_human;ORPHANET
31865	58484	NLRC4	0.556	0.769	C0409818	Chronic Infantile Neurological, Cutaneous, and Articular Syndrome	disease	C16;C17	Disease or Syndrome	0.51	1	2017	2017	1	0	CTD_human;ORPHANET
31870	58484	NLRC4	0.556	0.769	C4015067	AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS	disease		Disease or Syndrome	0.7	1	2014	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31871	58484	NLRC4	0.556	0.769	C4015276	FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4	disease		Disease or Syndrome	0.8	1	2014	2017	2	1	GENOMICS_ENGLAND;UNIPROT
31877	58495	OVOL2	0.633	0.462	C1852555	CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT	disease	C16;C11	Disease or Syndrome	0.67	0.875	2003	2020	1	4	CTD_human;GENOMICS_ENGLAND
31878	58497	PRUNE1	0.678	0.308	C4479566	NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES	disease		Disease or Syndrome	0.71	1	2015	2019	4	7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31939	59067	IL21	0.441	0.769	C4014258	IMMUNODEFICIENCY, COMMON VARIABLE, 11	disease		Disease or Syndrome	0.7	1	2009	2014	2	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31950	59272	ACE2	0.477	0.769	C0020538	Hypertensive disease	group	C14	Disease or Syndrome	0.6	0.982	2003	2019	4	0	CTD_human
31961	59335	PRDM12	0.839	0.231	C4225308	NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII	disease		Disease or Syndrome	0.7	1	2015	2017	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31996	59341	TRPV4	0.457	0.808	C0265280	Spondylometaphyseal dysplasia, Kozlowski type	disease	C16;C05	Congenital Abnormality	0.76	0.857	2009	2017	3	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
31997	59341	TRPV4	0.457	0.808	C0265281	Metatropic dwarfism	disease	C16;C05;C19	Congenital Abnormality	0.8	1	2009	2020	6	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32006	59341	TRPV4	0.457	0.808	C0432227	Brachyolmia Type 3	disease	C16;C05	Congenital Abnormality	0.76	1	2008	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32018	59341	TRPV4	0.457	0.808	C0751335	Scapuloperoneal Form of Spinal Muscular Atrophy	disease	C10	Disease or Syndrome	0.74	1	2003	2017	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32022	59341	TRPV4	0.457	0.808	C1838492	SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE (disorder)	disease	C10	Disease or Syndrome	0.7	1	2010	2012	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32023	59341	TRPV4	0.457	0.808	C1847406	Digital Arthropathy-Brachydactyly, Familial	disease	C16;C05	Disease or Syndrome	0.71	1	2011	2019	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32024	59341	TRPV4	0.457	0.808	C1853710	HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC (disorder)	disease	C16;C10	Disease or Syndrome	0.74	1	2005	2020	8	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
32025	59341	TRPV4	0.457	0.808	C1868616	Parastremmatic dwarfism	disease	C23;C16;C05;C10;C19;F03;F01	Congenital Abnormality	0.73	1	2010	2012	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32028	59341	TRPV4	0.457	0.808	C3150755	SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1	phenotype		Finding	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
32029	59341	TRPV4	0.457	0.808	C3159322	SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE	disease	C16;C05	Disease or Syndrome	0.71	1	2010	2010	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
32046	59344	ALOXE3	0.644	0.538	C0079154	Congenital Nonbullous Ichthyosiform Erythroderma	disease	C16;C17	Disease or Syndrome	0.65	1	2003	2016	5	0	CTD_human;ORPHANET
32053	59344	ALOXE3	0.644	0.538	C3539888	ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3	disease		Disease or Syndrome	0.6	1	2002	2016	5	9	GENOMICS_ENGLAND;UNIPROT
32062	59345	GNB4	0.751	0.346	C3554654	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F	disease		Disease or Syndrome	0.7	1	2013	2017	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32067	59352	LGR6	0.502	0.923	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.52	1	2008	2018	2	0	CTD_human;UNIPROT
32076	60386	SLC25A19	0.653	0.577	C1846648	MICROCEPHALY, AMISH TYPE (disorder)	disease	C16;C05;C10	Disease or Syndrome	0.72	0.8	2002	2019	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32077	60386	SLC25A19	0.653	0.577	C3150973	Progressive polyneuropathy with bilateral striatal necrosis	disease	C18;C10	Disease or Syndrome	0.71	1	2006	2019	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32102	60481	ELOVL5	0.638	0.462	C4518337	Spinocerebellar ataxia type 38	disease	C16;C10	Disease or Syndrome	0.74	1	2014	2019	1	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32108	60482	SLC5A7	0.597	0.654	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.53	1	2016	2019	1	0	CTD_human;GENOMICS_ENGLAND
32113	60482	SLC5A7	0.597	0.654	C1834703	Neuropathy, Distal Hereditary Motor, Type VIIA	disease	C23;C16;C08;C10;C09	Disease or Syndrome	0.61	1	2012	2018	2	1	CTD_human;GENOMICS_ENGLAND
32114	60482	SLC5A7	0.597	0.654	C4310694	MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC	disease		Disease or Syndrome	0.6	1	2016	2016	2	7	GENOMICS_ENGLAND;UNIPROT
32135	60495	HPSE2	0.588	0.692	C0403555	Ochoa syndrome	disease	C23;C13;C12	Congenital Abnormality	0.89	1	2009	2019	2	7	CTD_human;GENOMICS_ENGLAND
32137	60506	NYX	0.678	0.192	C0339535	Night blindness, congenital stationary	disease	C16;C11	Congenital Abnormality	0.7	0.923	2000	2015	0	1	CTD_human;GENOMICS_ENGLAND
32141	60506	NYX	0.678	0.192	C3495587	Night Blindness, Congenital Stationary, Type 1A	disease	C16;C11	Disease or Syndrome	0.92	1	1998	2019	2	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
32146	60509	AGBL5	0.711	0.269	C4310759	RETINITIS PIGMENTOSA 75	disease		Disease or Syndrome	0.7	1	2015	2016	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
32152	60528	ELAC2	0.67	0.346	C2931456	Prostate cancer, familial	disease	C04;C12	Neoplastic Process	0.6	1	2001	2016	2	0	GENOMICS_ENGLAND;ORPHANET
32154	60528	ELAC2	0.67	0.346	C3809526	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	disease		Disease or Syndrome	0.7	1	2012	2016	3	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32167	60529	ALX4	0.56	0.692	C1865044	PARIETAL FORAMINA 2	disease	C23;C16;C10	Disease or Syndrome	0.7	1	2000	2018	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
32168	60529	ALX4	0.56	0.692	C1868598	PARIETAL FORAMINA	disease	C23;C16;C10	Congenital Abnormality	0.89	1	2000	2019	2	2	GENOMICS_ENGLAND;ORPHANET
32171	60529	ALX4	0.56	0.692	C3150703	FRONTONASAL DYSPLASIA 2	disease		Disease or Syndrome	0.6	1	2013	2018	2	4	GENOMICS_ENGLAND;ORPHANET
32175	60558	GUF1	0.805	0.154	C4310737	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	disease		Disease or Syndrome	0.6	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
32187	60675	PROK2	0.555	0.769	C0162809	Kallmann Syndrome	disease	C16;C13;C12;C19	Disease or Syndrome	0.6	1	2007	2019	1	0	CTD_human;ORPHANET
32199	60675	PROK2	0.555	0.769	C3552343	HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA	disease		Disease or Syndrome	0.6	1	2006	2019	5	7	GENOMICS_ENGLAND;UNIPROT
32206	60681	FKBP10	0.606	0.538	C1850168	Bruck syndrome 1	disease	C16;C17;C05	Disease or Syndrome	0.7	1	2010	2013	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32208	60681	FKBP10	0.606	0.538	C3151218	OSTEOGENESIS IMPERFECTA, TYPE XI	disease		Disease or Syndrome	0.63	1	2012	2018	0	3	CTD_human;GENOMICS_ENGLAND
32210	60684	TRAPPC11	0.65	0.5	C4517996	Autosomal recessive limb girdle muscular dystrophy type 2S	disease		Disease or Syndrome	0.6	1	2013	2018	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32228	63826	SRR	0.617	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.7	0.75	2005	2019	4	1	PSYGENET
32238	63894	VIPAS39	0.705	0.5	C1859722	Arthrogryposis, renal dysfunction, and cholestasis 1	disease	C16;C06;C13;C05;C12	Disease or Syndrome	0.9	1	2010	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32241	63895	PIEZO2	0.529	0.769	C0220666	ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, TYPE IIA	disease	C16;C05;C07	Disease or Syndrome	0.74	1	2014	2019	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32242	63895	PIEZO2	0.529	0.769	C0796033	MARDEN-WALKER SYNDROME	disease	C16;C11;C17;C05	Disease or Syndrome	0.74	1	2014	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32244	63895	PIEZO2	0.529	0.769	C1862472	Oculomelic amyoplasia	disease	C23;C16;C11;C05;C10	Disease or Syndrome	0.75	1	2013	2019	2	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32245	63895	PIEZO2	0.529	0.769	C4310692	ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH	disease		Disease or Syndrome	0.6	1	2016	2017	2	11	CTD_human;UNIPROT
32246	63901	FAM111A	0.663	0.462	C0265291	Kenny-Caffey syndrome	disease	C16;C05	Disease or Syndrome	0.51	1	2013	2019	1	0	GENOMICS_ENGLAND;ORPHANET
32247	63901	FAM111A	0.663	0.462	C1865639	Gracile bone dysplasia	disease	C16;C05	Disease or Syndrome	0.72	1	2013	2019	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32248	63901	FAM111A	0.663	0.462	C4316787	Kenny-Caffey syndrome, type 2	disease	C16;C18;C05;C19	Disease or Syndrome	0.71	1	2013	2014	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32250	63910	SLC17A9	0.78	0.346	C0265970	Porokeratosis, Disseminated Superficial Actinic	disease	C16;C17	Disease or Syndrome	0.51	1	2014	2015	2	0	GENOMICS_ENGLAND;ORPHANET
32251	63910	SLC17A9	0.78	0.346	C4015128	POROKERATOSIS 8, DISSEMINATED SUPERFICIAL ACTINIC TYPE	disease		Disease or Syndrome	0.7	1	2014	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32253	63916	ELMO2	0.729	0.538	C1847197	Vascular Malformation, Primary Intraosseous	disease	C16;C14	Disease or Syndrome	0.63	1	2016	2019	1	3	CTD_human;ORPHANET
32259	63924	CIDEC	0.666	0.462	C3808940	LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5	disease		Disease or Syndrome	0.6	1	2009	2009	1	1	GENOMICS_ENGLAND;ORPHANET
32262	63925	ZNF335	0.711	0.462	C3554499	MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2012	2017	1	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32266	63929	XPNPEP3	0.769	0.269	C3150419	NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	disease		Disease or Syndrome	0.7	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32289	63976	PRDM16	0.522	0.808	C3809288	LEFT VENTRICULAR NONCOMPACTION 8	disease		Disease or Syndrome	0.7	1	2013	2013	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
32304	63982	ANO3	0.716	0.385	C3554374	DYSTONIA 24	disease		Disease or Syndrome	0.71	1	2012	2016	3	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32325	64167	ERAP2	0.615	0.577	C0267380	Crohns disease of the ileum	disease	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
    64167	ERAP2	0.615	0.577	C0678202	Regional enteritis	disease	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
    64167	ERAP2	0.615	0.577	C0949272	IIeocolitis	disease	C06	Disease or Syndrome	0.30	1	2010	2010	   1	   0	CTD_human
    64170	CARD9	0.566	0.654	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.43	1	2008	2017	   1	   5	CTD_human
    64170	CARD9	0.566	0.654	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.41	1	2014	2017	   1	   1	CTD_human
    64170	CARD9	0.566	0.654	C0021390	Inflammatory Bowel Diseases	group	C06	Disease or Syndrome	0.50	0.938	2009	2020	   1	   2	CTD_human
    64170	CARD9	0.566	0.654	C0038013	Ankylosing spondylitis	disease	C05	Disease or Syndrome	0.44	1	2010	2016	   1	   3	CTD_human
    64170	CARD9	0.566	0.654	C1395264	Deep seated dermatophytosis	disease	C01;C17	Disease or Syndrome	0.40	1	2013	2013	   1	   0	GENOMICS_ENGLAND
    64170	CARD9	0.566	0.654	C1859353	Candidiasis, Familial, 2	disease	C01;C17	Disease or Syndrome	0.70	1	2009	2013	   3	   7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
    64175	P3H1	0.736	0.231	C0023931	Lobstein Disease	disease	C16;C17;C05	Disease or Syndrome	0.30	1	2008	2008	   1	   0	CTD_human
    64175	P3H1	0.736	0.231	C0029434	Osteogenesis Imperfecta	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.60	1	2007	2019	   1	   0	CTD_human
    64175	P3H1	0.736	0.231	C0268358	Osteogenesis imperfecta, dominant perinatal lethal	disease	C16;C17;C05	Disease or Syndrome; Congenital Abnormality	0.31	1	2009	2011	   1	   0	ORPHANET
    64175	P3H1	0.736	0.231	C0268362	Osteogenesis imperfecta type III (disorder)	disease	C16;C17;C05	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
    64175	P3H1	0.736	0.231	C1970458	Osteogenesis imperfecta, type VIII	disease	C16;C17;C05	Disease or Syndrome	0.83	1	2007	2018	   1	  12	CTD_human;GENOMICS_ENGLAND
    64207	IRF2BPL	0.631	0.462	C0004238	Atrial Fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
    64207	IRF2BPL	0.631	0.462	C0235480	Paroxysmal atrial fibrillation	disease	C23;C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
    64207	IRF2BPL	0.631	0.462	C2585653	Persistent atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
    64207	IRF2BPL	0.631	0.462	C3468561	familial atrial fibrillation	phenotype	C23;C14	Pathologic Function	0.30	1	2018	2018	   1	   0	CTD_human
    64207	IRF2BPL	0.631	0.462	C4748127	NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES	disease		Disease or Syndrome	0.60	1	2014	2019	   3	   7	GENOMICS_ENGLAND;UNIPROT
    64211	LHX5	1	0.038	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2003	2003	   1	   0	PSYGENET
    64215	DNAJC1	0.821	0.154	C0025202	melanoma	disease	C04	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    64216	TFB2M	0.861	0.231	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30				   0	   0	GENOMICS_ENGLAND
    64218	SEMA4A	0.569	0.692	C0009405	Hereditary Nonpolyposis Colorectal Neoplasms	group	C16;C06;C04;C18	Neoplastic Process	0.30	1	2014	2016	   2	   0	CLINGEN
    64218	SEMA4A	0.569	0.692	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.31	1	2006	2006	   1	   0	GENOMICS_ENGLAND
    64218	SEMA4A	0.569	0.692	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.31	1	2006	2006	   1	   0	GENOMICS_ENGLAND
    64218	SEMA4A	0.569	0.692	C1112155	Hereditary non-polyposis colorectal cancer syndrome	disease		Congenital Abnormality	0.30	1	2014	2016	   2	   0	CLINGEN
    64218	SEMA4A	0.569	0.692	C1333990	Hereditary Nonpolyposis Colorectal Cancer	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2014	2016	   2	   0	CLINGEN
    64218	SEMA4A	0.569	0.692	C1333991	Hereditary Non-Polyposis Colon Cancer Type 2	disease	C16;C04	Neoplastic Process	0.30	1	2014	2016	   2	   0	CLINGEN
    64218	SEMA4A	0.569	0.692	C1846529	CONE-ROD DYSTROPHY 10	disease	C16;C11	Disease or Syndrome	0.70	1	2006	2006	   1	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
    64218	SEMA4A	0.569	0.692	C1853214	RETINITIS PIGMENTOSA 35	disease	C16;C11	Disease or Syndrome	0.70	1	2006	2012	   2	   2	CTD_human;GENOMICS_ENGLAND;UNIPROT
    64218	SEMA4A	0.569	0.692	C2936783	Colorectal cancer, hereditary nonpolyposis, type 1	disease	C16;C06;C04;C18	Neoplastic Process	0.30	1	2014	2016	   2	   0	CLINGEN
    64218	SEMA4A	0.569	0.692	C3489532	Cone-Rod Dystrophy 2	disease	C16;C11	Disease or Syndrome	0.31	1	2006	2006	   1	   0	ORPHANET
    64218	SEMA4A	0.569	0.692	C3896578	Familial Colorectal Cancer Type X	disease	C16;C06;C04;C18	Neoplastic Process	0.31	1	2014	2014	   1	   0	ORPHANET
    64219	PJA1	0.821	0.269	C0220767	Craniofrontonasal dysplasia	disease	C16;C05	Disease or Syndrome	0.30	1	2001	2001	   1	   0	GENOMICS_ENGLAND
    64219	PJA1	0.821	0.269	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2001	2001	   1	   0	GENOMICS_ENGLAND
    64220	STRA6	0.597	0.731	C0003119	Anophthalmos	disease	C16;C11	Congenital Abnormality	0.48	1	2007	2013	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0015397	Disorder of eye	group	C11	Disease or Syndrome	0.31	1	2013	2013	   0	   0	GENOMICS_ENGLAND
    64220	STRA6	0.597	0.731	C0018798	Congenital Heart Defects	group	C16;C14	Congenital Abnormality	0.31	1	2007	2007	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0019284	Diaphragmatic Hernia	phenotype	C23	Disease or Syndrome	0.31	1	2007	2007	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0024115	Lung diseases	group	C08	Disease or Syndrome	0.30	1	2007	2007	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0026010	Microphthalmos	disease	C16;C11	Congenital Abnormality	0.44	1	2007	2013	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0243050	Cardiovascular Abnormalities	group	C16;C14	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0376634	Craniofacial Abnormalities	group	C16;C05	Congenital Abnormality	0.30	1	2008	2008	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C0917816	Mental deficiency	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2007	2007	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C1832661	ANOPHTHALMIA AND PULMONARY HYPOPLASIA	disease	C16;C11;C08	Disease or Syndrome	0.80	1	2007	2017	   5	  18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
    64220	STRA6	0.597	0.731	C2677362	Alveolar capillary dysplasia	disease	C16;C08	Congenital Abnormality	0.30	1	2007	2007	   1	   0	CTD_human
    64220	STRA6	0.597	0.731	C2931501	Microphthalmia associated with colobomatous cyst	phenotype	C23;C16;C04;C11	Disease or Syndrome	0.30	1	2011	2011	   1	   0	ORPHANET
    64220	STRA6	0.597	0.731	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.42	1	2007	2009	   1	   0	CTD_human
    64221	ROBO3	0.52	0.808	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2008	2008	   1	   0	CTD_human
    64221	ROBO3	0.52	0.808	C1846496	Gaze Palsy, Familial Horizontal, with Progressive Scoliosis	disease	C05	Disease or Syndrome	0.40	1	2006	2015	   0	   0	ORPHANET
    64221	ROBO3	0.52	0.808	C4551964	GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1	disease	C23;C18;C11;C05;C10	Disease or Syndrome	0.80	1	2004	2015	   2	  11	CTD_human;GENOMICS_ENGLAND;UNIPROT
    64224	HERPUD2	0.839	0.115	C0087031	Juvenile-Onset Still Disease	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    64224	HERPUD2	0.839	0.115	C3495559	Juvenile arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    64224	HERPUD2	0.839	0.115	C3714758	Juvenile psoriatic arthritis	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    64224	HERPUD2	0.839	0.115	C4552091	Polyarthritis, Juvenile, Rheumatoid Factor Negative	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    64224	HERPUD2	0.839	0.115	C4704862	Polyarthritis, Juvenile, Rheumatoid Factor Positive	disease	C17;C05;C20	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    64231	MS4A6A	0.821	0.231	C0017661	IGA Glomerulonephritis	disease	C13;C12;C20	Disease or Syndrome	0.30	1	2014	2014	   1	   0	CTD_human
    64231	MS4A6A	0.821	0.231	C1135196	Heart Failure, Diastolic	disease	C14	Disease or Syndrome	0.30	1	2018	2018	   1	   0	CTD_human
    64232	MS4A5	0.931	0.115	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.30				   0	   0	UNIPROT
    64240	ABCG5	0.592	0.577	C0004153	Atherosclerosis	disease	C14	Disease or Syndrome	0.35	1	2000	2014	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0005818	Blood Platelet Disorders	group	C15	Disease or Syndrome	0.30	1	2016	2016	   1	   0	GENOMICS_ENGLAND
    64240	ABCG5	0.592	0.577	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.41	1	2000	2014	   2	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0010068	Coronary heart disease	disease	C14	Disease or Syndrome	0.42	1	2009	2018	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.46	1	2004	2019	   0	   0	GENOMICS_ENGLAND
    64240	ABCG5	0.592	0.577	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.33	1	2010	2018	   1	   0	GENOMICS_ENGLAND
    64240	ABCG5	0.592	0.577	C0023772	Lipid Metabolism, Inborn Errors	group	C16;C18	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0033578	Prostatic Neoplasms	group	C04;C12	Neoplastic Process	0.30	1	2012	2012	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0043325	Xanthomatosis	disease	C18	Disease or Syndrome	0.30	1	2001	2001	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0242339	Dyslipidemias	group	C18	Disease or Syndrome	0.30	1	2009	2009	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0302314	Xanthoma	disease	C18	Disease or Syndrome	0.33	1	2001	2019	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0342881	Familial hypercholesterolemia - homozygous	disease	C16;C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
    64240	ABCG5	0.592	0.577	C0342907	Sitosterolemia	disease	C16;C06;C18	Congenital Abnormality	0.80	0.976	2000	2020	   7	   6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
    64240	ABCG5	0.592	0.577	C0376358	Malignant neoplasm of prostate	disease	C04;C12	Neoplastic Process	0.31	1	2012	2015	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C0598784	Dyslipoproteinemias	phenotype	C18	Pathologic Function	0.30	1	2009	2009	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C1563937	Atherogenesis	phenotype	C14	Pathologic Function	0.30	1	2001	2001	   1	   0	CTD_human
    64240	ABCG5	0.592	0.577	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.32	1	2000	2014	   2	   0	CTD_human
    64240	ABCG5	0.592	0.577	C2749759	Macrothrombocytopenia-Stomatocytosis, Mediterranean	disease	C16;C06;C18	Disease or Syndrome	0.30	1	2000	2001	   2	   0	CTD_human
    64241	ABCG8	0.573	0.538	C0005818	Blood Platelet Disorders	group	C15	Disease or Syndrome	0.30	1	2017	2017	   1	   0	GENOMICS_ENGLAND
    64241	ABCG8	0.573	0.538	C0009438	Common Bile Duct Calculi	phenotype	C23;C06	Body Substance	0.30	1	2007	2007	   1	   0	CTD_human
    64241	ABCG8	0.573	0.538	C0010054	Coronary Arteriosclerosis	disease	C14	Disease or Syndrome	0.42	1	2000	2010	   1	   0	CTD_human
    64241	ABCG8	0.573	0.538	C0020443	Hypercholesterolemia	disease	C18	Disease or Syndrome	0.47	1	2004	2018	   1	   0	GENOMICS_ENGLAND
    64241	ABCG8	0.573	0.538	C0020445	Hypercholesterolemia, Familial	disease	C16;C18	Disease or Syndrome	0.32	1	2009	2019	   1	   0	GENOMICS_ENGLAND
    64241	ABCG8	0.573	0.538	C0023893	Liver Cirrhosis, Experimental	disease	C23;C06	Experimental Model of Disease	0.30	1	2014	2014	   1	   0	CTD_human
    64241	ABCG8	0.573	0.538	C0242216	Biliary calculi	phenotype	C23;C06	Body Substance	0.42	1	2007	2019	   1	   2	CTD_human
    64241	ABCG8	0.573	0.538	C0268318	Cholestasis of pregnancy	disease	C06;C13	Disease or Syndrome	0.30	1	2015	2015	   1	   0	GENOMICS_ENGLAND
    64241	ABCG8	0.573	0.538	C0342881	Familial hypercholesterolemia - homozygous	disease	C16;C18	Disease or Syndrome	0.30	1	2010	2010	   1	   0	ORPHANET
    64241	ABCG8	0.573	0.538	C0342907	Sitosterolemia	disease	C16;C06;C18	Congenital Abnormality	1.00	1	2000	2019	   5	  12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
    64241	ABCG8	0.573	0.538	C1956346	Coronary Artery Disease	disease	C14	Disease or Syndrome	0.45	1	2000	2018	   1	   2	CTD_human
    64241	ABCG8	0.573	0.538	C1969115	GALLBLADDER DISEASE 4	disease	C06	Disease or Syndrome	0.40				   0	   1	CTD_human
    64241	ABCG8	0.573	0.538	C2749759	Macrothrombocytopenia-Stomatocytosis, Mediterranean	disease	C16;C06;C18	Disease or Syndrome	0.30	1	2000	2000	   1	   0	CTD_human
    64283	ARHGEF28	0.615	0.423	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.37	1	2013	2020	   1	   0	GENOMICS_ENGLAND
    64288	ZSCAN31	0.76	0.346	C0033975	Psychotic Disorders	group	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
    64288	ZSCAN31	0.76	0.346	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.41	1	2014	2015	   1	   1	PSYGENET
    64288	ZSCAN31	0.76	0.346	C0349204	Nonorganic psychosis	disease	F03	Mental or Behavioral Dysfunction	0.31	1	2014	2014	   1	   0	PSYGENET
    64321	SOX17	0.555	0.615	C0009402	Colorectal Carcinoma	disease	C06;C04	Neoplastic Process	0.32	1	2008	2011	   1	   0	CTD_human
    64321	SOX17	0.555	0.615	C0009404	Colorectal Neoplasms	group	C06;C04	Neoplastic Process	0.31	1	2008	2008	   1	   0	CTD_human
    64321	SOX17	0.555	0.615	C0042580	Vesico-Ureteral Reflux	disease	C13;C12	Disease or Syndrome	0.41	1	2010	2010	   0	   0	CTD_human
    64321	SOX17	0.555	0.615	C0232910	Teratogenesis	phenotype	C23	Pathologic Function	0.30	1	2014	2014	   1	   0	CTD_human
    64321	SOX17	0.555	0.615	C0340543	Familial primary pulmonary hypertension	disease	C08	Disease or Syndrome	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
    64321	SOX17	0.555	0.615	C1150929	2-oxo-hept-3-ene-1,7-dioate hydratase activity	phenotype		Molecular Function	0.30	1	2018	2018	   1	   0	GENOMICS_ENGLAND
    64321	SOX17	0.555	0.615	C3150927	VESICOURETERAL REFLUX 3	disease		Disease or Syndrome	0.60	1	2010	2010	   1	   2	GENOMICS_ENGLAND;UNIPROT
    64321	SOX17	0.555	0.615	C4551858	Vesicoureteral Reflux 1	disease	C13;C12	Disease or Syndrome	0.30				   0	   0	CTD_human
    64321	SOX17	0.555	0.615	C4706552	Familial vesicoureteral reflux	disease		Congenital Abnormality	0.30	1	2010	2010	   1	   0	ORPHANET
    64324	NSD1	0.505	0.769	C0004352	Autistic Disorder	disease	F03	Mental or Behavioral Dysfunction	0.41	1	2007	2007	   1	   1	CTD_human
    64324	NSD1	0.505	0.769	C0004903	Beckwith-Wiedemann Syndrome	disease	C16	Disease or Syndrome	0.43	1	2003	2017	   2	  52	GENOMICS_ENGLAND
    64324	NSD1	0.505	0.769	C0010606	Adenoid Cystic Carcinoma	disease	C04	Neoplastic Process	0.30	1	2013	2013	   1	   0	CTD_human
    64324	NSD1	0.505	0.769	C0020796	Profound Mental Retardation	disease	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
    64324	NSD1	0.505	0.769	C0023467	Leukemia, Myelocytic, Acute	disease	C04	Neoplastic Process	0.70	1	2002	2019	   1	   4	CTD_human;GENOMICS_ENGLAND
    64324	NSD1	0.505	0.769	C0025363	Mental Retardation, Psychosocial	phenotype	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.30	1	2003	2003	   1	   0	CTD_human
    64324	NSD1	0.505	0.769	C0026998	Acute Myeloid Leukemia, M1	disease	C04	Neoplastic Process	0.30				   0	   0	CTD_human
    64324	NSD1	0.505	0.769	C0175695	Sotos syndrome	disease	C16	Disease or Syndrome	0.7	0.987	2002	2019	20	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
32326	64324	NSD1	0.505	0.769	C0265210	Weaver syndrome	disease	C16;C05;C19	Disease or Syndrome	0.65	1	2003	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32332	64324	NSD1	0.505	0.769	C4551477	SOTOS SYNDROME 1	disease	C16	Disease or Syndrome	0.61	1	2002	2019	8	201	GENOMICS_ENGLAND;UNIPROT
32335	64327	LMBR1	0.619	0.308	C0265559	Acheiropodia	disease	C16;C05	Congenital Abnormality	0.82	1	2001	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32337	64327	LMBR1	0.619	0.308	C1851100	LAURIN-SANDROW SYNDROME	disease	C16;C05	Disease or Syndrome	0.7	1	2001	2014	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32341	64327	LMBR1	0.619	0.308	C1861355	Syndactyly, Type IV	disease	C16;C05	Disease or Syndrome	0.61	1	2000	2014	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32342	64327	LMBR1	0.619	0.308	C1868114	POLYDACTYLY, PREAXIAL II (disorder)	disease	C16;C11;C05	Disease or Syndrome	0.73	1	2000	2017	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
32355	64374	SIL1	0.584	0.731	C0024814	Marinesco-Sjogren syndrome	disease	C16;C10	Disease or Syndrome	0.8	1	2001	2019	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
32371	64377	CHST8	0.769	0.346	C4015729	PEELING SKIN SYNDROME 3	disease		Disease or Syndrome	0.6	1	2012	2012	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32373	64388	GREM2	0.722	0.5	C4310638	TOOTH AGENESIS, SELECTIVE, 9	disease		Congenital Abnormality	0.6	1	2015	2015	1	3	CTD_human;UNIPROT
32391	64412	GZF1	0.76	0.231	C4540020	JOINT LAXITY, SHORT STATURE, AND MYOPIA	disease		Disease or Syndrome	0.6	1	2017	2017	1	2	GENOMICS_ENGLAND;ORPHANET
32392	64419	MTMR14	0.674	0.615	C0175709	Centronuclear myopathy	disease	C05;C10	Disease or Syndrome	0.53	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
32397	64419	MTMR14	0.674	0.615	C1834558	Myopathy, Centronuclear, Autosomal Dominant	disease	C05;C10	Disease or Syndrome	0.6	1	2006	2006	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32400	64419	MTMR14	0.674	0.615	C4551952	Myopathy, Centronuclear, 1	disease	C05;C10	Disease or Syndrome	0.6	1	2006	2009	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32404	64421	DCLRE1C	0.544	0.808	C1865370	Severe combined immunodeficiency with sensitivity to ionizing radiation	disease	C16;C18;C20	Disease or Syndrome	0.91	1	2001	2015	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
32406	64421	DCLRE1C	0.544	0.808	C2700553	Omenn Syndrome	disease	C16;C18;C20	Disease or Syndrome	0.75	1	1997	2015	1	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32408	64423	INF2	0.644	0.423	C0017668	Focal glomerulosclerosis	disease	C13;C12	Disease or Syndrome	0.7	1	2010	2019	2	1	CTD_human;GENOMICS_ENGLAND
32415	64423	INF2	0.644	0.423	C2750475	Focal Segmental Glomerulosclerosis 5	disease	C13;C12	Disease or Syndrome	0.7	1	2010	2017	7	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
32416	64423	INF2	0.644	0.423	C3280845	CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E	disease		Disease or Syndrome	0.7	1	2011	2017	6	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32422	64446	DNAI2	0.666	0.5	C2676235	CILIARY DYSKINESIA, PRIMARY, 9	disease	C16;C08;C09;C14	Disease or Syndrome	0.6	1	2008	2015	1	2	CTD_human;GENOMICS_ENGLAND
32431	64478	CSMD1	0.61	0.5	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.7	1	2011	2020	5	8	PSYGENET
32459	64699	TMPRSS3	0.65	0.538	C1832827	DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	disease	C23;C10;C09	Disease or Syndrome	0.7	1	2001	2017	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
32496	64788	LMF1	0.769	0.231	C1855498	Lipase deficiency combined	disease	C16;C18	Disease or Syndrome	0.72	1	2007	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
32498	64801	ARV1	0.691	0.423	C4310762	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38	disease		Disease or Syndrome	0.7	1	2015	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32503	64802	NMNAT1	0.656	0.269	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.8	1	2003	2018	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
32505	64802	NMNAT1	0.656	0.269	C1837873	LEBER CONGENITAL AMAUROSIS 9 (disorder)	disease	C11	Disease or Syndrome	0.94	1	2003	2018	6	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
32515	64805	P2RY12	0.533	0.731	C1853278	Bleeding Disorder Due To P2RY12 Defect	disease	C16;C15	Disease or Syndrome	0.8	1	2001	2015	3	0	CTD_human;ORPHANET;UNIPROT
32518	64837	KLC2	0.736	0.346	C1836010	Spastic Paraplegia, Optic Atrophy, and Neuropathy	disease	C23;C16;C11;C10	Disease or Syndrome	0.71	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
32520	64840	PORCN	0.545	0.692	C0016395	Focal Dermal Hypoplasia	disease	C16;C17;C05	Disease or Syndrome	1	0.968	1962	2019	9	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32530	64857	PLEKHG2	0.705	0.423	C4225213	LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA	disease		Disease or Syndrome	0.7	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32551	64919	BCL11B	0.568	0.731	C4310656	IMMUNODEFICIENCY 49	disease		Disease or Syndrome	0.7	1	2016	2018	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32571	65018	PINK1	0.516	0.769	C0030567	Parkinson Disease	disease	C10	Disease or Syndrome	0.6	0.987	2002	2020	5	0	CTD_human
32574	65018	PINK1	0.516	0.769	C0242422	Parkinsonian Disorders	group	C10	Disease or Syndrome	0.7	1	2001	2019	6	1	CTD_human
32584	65018	PINK1	0.516	0.769	C1853833	Parkinson Disease 6, Autosomal Recessive Early-Onset	disease	C10	Disease or Syndrome	0.93	1	2004	2017	27	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
32589	65055	REEP1	0.653	0.423	C1833308	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V	disease	C10	Disease or Syndrome	0.51	1	2012	2012	1	0	CTD_human;ORPHANET
32590	65055	REEP1	0.653	0.423	C1853247	SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT	disease	C16;C10	Disease or Syndrome	0.92	1	2006	2018	7	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32595	65057	ACD	0.603	0.731	C1846142	HOYERAAL-HREIDARSSON SYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	Disease or Syndrome	0.51	1	2014	2014	1	0	GENOMICS_ENGLAND;ORPHANET
32597	65057	ACD	0.603	0.731	C4225284	DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6	disease		Disease or Syndrome	0.7	1	2014	2014	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32605	65062	TMEM237	0.612	0.538	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.51	1	2011	2012	2	0	GENOMICS_ENGLAND;ORPHANET
32611	65078	RTN4R	0.595	0.692	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.67	0.857	2004	2017	3	7	CTD_human;UNIPROT
32612	65080	MRPL44	0.805	0.308	C3809339	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16	disease		Disease or Syndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32613	65082	VPS33A	0.695	0.538	C4310627	MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME	disease		Disease or Syndrome	0.7	1	2017	2017	2	1	CTD_human;ORPHANET;UNIPROT
32623	65109	UPF3B	0.619	0.615	C1136249	Mental Retardation, X-Linked	disease	C16;C10	Disease or Syndrome	0.52	1	2007	2010	1	0	CTD_human;GENOMICS_ENGLAND
32624	65109	UPF3B	0.619	0.615	C1970822	Mental Retardation, X-Linked, Syndromic 14	disease	C16;C10	Disease or Syndrome	0.7	1	2007	2012	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
32638	65125	WNK1	0.416	0.846	C1840391	Pseudohypoaldosteronism, Type IIc	disease	C16;C13;C12	Disease or Syndrome	0.6	1	2001	2005	2	2	CTD_human;GENOMICS_ENGLAND
32640	65125	WNK1	0.416	0.846	C2752089	Neuropathy, Hereditary Sensory And Autonomic, Type IIA	disease	C16;C10	Disease or Syndrome	0.6	1	2001	2006	4	6	CTD_human;GENOMICS_ENGLAND
32658	65217	PCDH15	0.601	0.577	C1384666	hearing impairment	phenotype	C23;C10;C09	Disease or Syndrome	0.63	1	2003	2019	2	4	CTD_human;GENOMICS_ENGLAND
32663	65217	PCDH15	0.601	0.577	C1832845	USHER SYNDROME, TYPE ID	disease	C23;C16;C11;C10;C09	Disease or Syndrome	0.6	1	2003	2016	3	4	GENOMICS_ENGLAND;UNIPROT
32664	65217	PCDH15	0.601	0.577	C1836027	Deafness, Autosomal Recessive 23	disease	C23;C10;C09	Disease or Syndrome	0.92	1	2003	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
32668	65217	PCDH15	0.601	0.577	C1865885	Usher Syndrome, Type IF	disease	C23;C16;C11;C10;C09	Disease or Syndrome	0.87	1	2001	2017	3	90	GENOMICS_ENGLAND;UNIPROT
32679	65250	CPLANE1	0.575	0.692	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.69	1	2012	2019	4	1	GENOMICS_ENGLAND;ORPHANET
32681	65250	CPLANE1	0.575	0.692	C2745997	OROFACIODIGITAL SYNDROME VI	disease	C16;C05	Disease or Syndrome	0.75	1	2012	2019	3	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32682	65250	CPLANE1	0.575	0.692	C3553264	JOUBERT SYNDROME 17	disease		Disease or Syndrome	0.8	1	2012	2018	5	65	GENOMICS_ENGLAND;UNIPROT
32694	65266	WNK4	0.644	0.538	C1840390	Pseudohypoaldosteronism, Type IIb	disease	C16;C13;C12	Disease or Syndrome	0.7	1	2001	2013	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
32704	65993	MRPS34	0.722	0.346	C4540029	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32	disease		Disease or Syndrome	0.6	1	2017	2017	1	2	GENOMICS_ENGLAND;UNIPROT
32711	78987	CRELD1	0.67	0.269	C1853508	ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2	disease		Finding	0.6	1	2003	2005	2	5	GENOMICS_ENGLAND;UNIPROT
32712	78987	CRELD1	0.67	0.269	C1853509	Atrioventricular Septal Defect, Partial, with Heterotaxy Syndrome	disease	C16;C15;C14	Disease or Syndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
32721	78989	COLEC11	0.641	0.654	C0796279	Carnevale syndrome	disease	C16;C11;C05;C12;C10;C19	Disease or Syndrome	0.7	1	1989	2017	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32737	79001	VKORC1	0.603	0.731	C0750384	Coumarin Resistance	phenotype	C16;C18	Disease or Syndrome	0.8	0.933	2004	2018	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
32739	79001	VKORC1	0.603	0.731	C1843832	VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2	disease	C16;C15	Disease or Syndrome	0.7	1	2004	2011	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32778	79042	TSEN34	0.722	0.346	C2676465	Pontocerebellar Hypoplasia Type 2C	disease	C10	Disease or Syndrome	0.7	1	2008	2011	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32788	79048	SECISBP2	0.792	0.269	C1864761	Thyroid Hormone Metabolism, Abnormal	disease	C19	Disease or Syndrome	0.73	1	2005	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32792	79053	ALG8	0.659	0.577	C2931002	Congenital disorder of glycosylation type 1H	disease	C16;C18	Disease or Syndrome	0.74	1	2004	2020	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
32803	79058	ASPSCR1	0.653	0.538	C0206657	Alveolar Soft Part Sarcoma	disease	C04	Neoplastic Process	0.7	1	2001	2020	1	0	CTD_human;ORPHANET
32820	79068	FTO	0.486	0.885	C2752001	Growth Retardation, Developmental Delay, Coarse Facies, And Early Death	disease	C23;C16;C05;C19;F03	Congenital Abnormality	0.7	1	2009	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32836	79083	MLPH	0.743	0.423	C1836573	GRISCELLI SYNDROME, TYPE 3	disease	C23;C16;C18;C17	Disease or Syndrome	0.7	1	2003	2003	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32839	79087	ALG12	0.705	0.5	C2931001	Congenital disorder of glycosylation type 1G	disease	C16;C18	Disease or Syndrome	0.71	1	2002	2016	6	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
32843	79092	CARD14	0.546	0.846	C0032027	Pityriasis Rubra Pilaris	disease	C17	Disease or Syndrome	0.8	1	2012	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32844	79092	CARD14	0.546	0.846	C0033860	Psoriasis	disease	C17	Disease or Syndrome	0.7	0.947	2003	2019	3	1	CTD_human;GENOMICS_ENGLAND
32846	79092	CARD14	0.546	0.846	C1864497	PSORIASIS 2	disease		Disease or Syndrome	0.81	1	2012	2018	7	13	GENOMICS_ENGLAND;UNIPROT
32856	79133	NDUFAF5	0.674	0.462	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C18	Disease or Syndrome	0.6	1	2008	2019	4	1	GENOMICS_ENGLAND;ORPHANET
32857	79133	NDUFAF5	0.674	0.462	C4748785	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16	disease		Disease or Syndrome	0.6	1	2008	2012	4	3	GENOMICS_ENGLAND;UNIPROT
32867	79143	MBOAT7	0.612	0.5	C4310673	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57	disease		Disease or Syndrome	0.6	1	2012	2012	1	5	CTD_human;GENOMICS_ENGLAND
32869	79147	FKRP	0.513	0.731	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.8	1	2001	2018	1	18	CTD_human;GENOMICS_ENGLAND;ORPHANET
32871	79147	FKRP	0.513	0.731	C0457133	Muscle eye brain disease	disease	C16;C11;C10	Disease or Syndrome	0.53	1	2004	2017	2	0	CTD_human;ORPHANET
32874	79147	FKRP	0.513	0.731	C1846672	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2I	disease	C16;C05;C10	Disease or Syndrome	0.95	1	2000	2018	9	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
32875	79147	FKRP	0.513	0.731	C1847759	MUSCULAR DYSTROPHY, CONGENITAL, 1C	disease	C16;C05;C10	Disease or Syndrome	0.96	1	2000	2016	9	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
32877	79147	FKRP	0.513	0.731	C3150413	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5	disease		Disease or Syndrome	0.6	1	2000	2016	6	7	GENOMICS_ENGLAND;UNIPROT
32882	79152	FA2H	0.573	0.654	C0037773	Spastic Paraplegia, Hereditary	disease	C16;C10	Disease or Syndrome	0.57	1	2010	2019	1	0	GENOMICS_ENGLAND
32884	79152	FA2H	0.573	0.654	C3496228	Leukodystrophy, Dysmyelinating, And Spastic Paraparesis With Or Without Dystonia	disease	C16;C10	Disease or Syndrome	0.95	1	2008	2020	6	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32885	79152	FA2H	0.573	0.654	C3668943	Fatty Acid Hydroxylase-Associated Neurodegeneration	disease	C16;C10	Disease or Syndrome	0.53	1	2008	2020	2	0	GENOMICS_ENGLAND;ORPHANET
32889	79158	GNPTAB	0.592	0.731	C0020725	Type II Mucolipidosis	disease	C16;C18;C05;C10	Disease or Syndrome	0.9	1	2004	2020	4	0	GENOMICS_ENGLAND;ORPHANET
32890	79158	GNPTAB	0.592	0.731	C0033788	Pseudo-Hurler Polydystrophy	disease	C16;C18;C05;C10	Disease or Syndrome	0.73	1	2004	2019	18	101	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32892	79158	GNPTAB	0.592	0.731	C2673377	MUCOLIPIDOSIS II ALPHA/BETA (disorder)	disease	C16;C18;C05;C10	Disease or Syndrome	0.93	1	2004	2019	19	136	CTD_human;GENOMICS_ENGLAND;UNIPROT
32908	79188	TMEM43	0.653	0.462	C1858379	ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5 (disorder)	disease	C16;C14	Disease or Syndrome	0.7	1	2008	2017	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32909	79188	TMEM43	0.653	0.462	C3553060	EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.6	1	2011	2017	3	2	GENOMICS_ENGLAND;UNIPROT
32912	79228	THOC6	0.705	0.577	C3150939	THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.73	1	2013	2020	2	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32940	79443	FYCO1	0.769	0.269	C1864908	Cataract, autosomal recessive congenital 2	disease	C11	Disease or Syndrome	0.7	1	2001	2011	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
32970	79577	CDC73	0.543	0.615	C0262587	Parathyroid Adenoma	disease	C04;C19	Neoplastic Process	0.7	0.882	2002	2019	0	0	CGI;CTD_human
32972	79577	CDC73	0.543	0.615	C0687150	Parathyroid Gland Adenocarcinoma	disease	C04;C19	Neoplastic Process	0.8	0.947	2002	2019	2	18	CTD_human;GENOMICS_ENGLAND;ORPHANET
32974	79577	CDC73	0.543	0.615	C1704981	Hyperparathyroidism-Jaw Tumor Syndrome	disease	C04;C05;C19;C07	Neoplastic Process	0.8	1	1990	2020	9	5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32975	79577	CDC73	0.543	0.615	C1840402	HYPERPARATHYROIDISM 1	disease	C19	Disease or Syndrome	0.7	1	2002	2019	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
32978	79577	CDC73	0.543	0.615	C4551961	Familial Isolated Hyperparathyroidism	disease	C19	Disease or Syndrome	0.6	0.967	1993	2020	1	0	CTD_human;ORPHANET
32979	79581	SLC52A2	0.483	0.808	C0796274	Brown-Vialetto-Van Laere Syndrome 1	disease	C23;C10;C09	Disease or Syndrome	0.57	1	2012	2019	0	0	CTD_human;ORPHANET
32981	79581	SLC52A2	0.483	0.808	C3553538	BROWN-VIALETTO-VAN LAERE SYNDROME 2	disease		Disease or Syndrome	0.7	1	2010	2017	9	20	CLINGEN;GENOMICS_ENGLAND;UNIPROT
32989	79583	TMEM231	0.554	0.692	C3554235	JOUBERT SYNDROME 20	disease		Disease or Syndrome	0.6	1	2012	2016	4	4	GENOMICS_ENGLAND;UNIPROT
32991	79583	TMEM231	0.554	0.692	C3809352	MECKEL SYNDROME, TYPE 11	disease		Disease or Syndrome	0.6	1	2012	2016	2	6	GENOMICS_ENGLAND;UNIPROT
32993	79587	CARS2	0.7	0.423	C4225251	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27	disease		Disease or Syndrome	0.7	1	2014	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33001	79600	TCTN1	0.597	0.615	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.61	1	2011	2017	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33020	79621	RNASEH2B	0.595	0.615	C0393591	AICARDI-GOUTIERES SYNDROME	disease	C16;C20;C10	Disease or Syndrome	0.68	1	2006	2019	1	1	CTD_human;GENOMICS_ENGLAND
33022	79621	RNASEH2B	0.595	0.615	C3489724	Aicardi-Goutieres Syndrome 2	disease	C16;C20;C10	Disease or Syndrome	0.7	1	2006	2018	8	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
33028	79628	SH3TC2	0.666	0.385	C1866636	CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C	disease	C16;C10	Disease or Syndrome	1	1	2003	2019	2	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
33029	79628	SH3TC2	0.666	0.385	C3150596	MONONEUROPATHY OF THE MEDIAN NERVE, MILD	disease		Disease or Syndrome	0.7	1	2009	2010	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
33031	79631	EFL1	0.638	0.577	C4693704	SHWACHMAN-DIAMOND SYNDROME 2	disease		Disease or Syndrome	0.6	1	2017	2018	2	2	GENOMICS_ENGLAND;UNIPROT
33053	79633	FAT4	0.539	0.808	C0340834	Hennekam lymphangiectasia-lymphedema syndrome	disease	C16;C05;C15	Disease or Syndrome	0.51	1	2014	2017	1	0	CTD_human;ORPHANET
33056	79633	FAT4	0.539	0.808	C1832390	Van Maldergem Wetzburger Verloes syndrome	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.54	1	2013	2018	1	0	CTD_human;ORPHANET
33059	79633	FAT4	0.539	0.808	C3809875	VAN MALDERGEM SYNDROME 2	disease		Disease or Syndrome	0.6	1	2013	2014	2	7	GENOMICS_ENGLAND;UNIPROT
33061	79633	FAT4	0.539	0.808	C4014939	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2	disease		Disease or Syndrome	0.6	1	2013	2018	3	5	GENOMICS_ENGLAND;UNIPROT
33062	79641	ROGDI	0.663	0.462	C0406740	Kohlschutter Tonz syndrome	disease	C16;C10;F03;C07	Disease or Syndrome	0.74	1	1995	2017	3	11	CTD_human;GENOMICS_ENGLAND;ORPHANET
33072	79644	SRD5A3	0.604	0.692	C2675185	Kahrizi Syndrome	disease	C23;C16;C11;C05;C10;F03;F01	Disease or Syndrome	0.61	1	2011	2016	2	1	CTD_human;GENOMICS_ENGLAND
33074	79644	SRD5A3	0.604	0.692	C4317224	Congenital disorder of glycosylation type 1q	disease	C16;C18	Disease or Syndrome	0.7	1	2008	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
33077	79648	MCPH1	0.54	0.846	C1855081	MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	disease	C16;C05;C10	Disease or Syndrome	0.76	1	2002	2014	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
33080	79650	USB1	0.636	0.577	C0265965	Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.55	1	2010	2016	3	0	GENOMICS_ENGLAND;ORPHANET
33081	79650	USB1	0.636	0.577	C1858723	Poikiloderma with Neutropenia	disease	C16;C17;C15	Disease or Syndrome	0.8	1	2010	2018	3	24	CTD_human;GENOMICS_ENGLAND;ORPHANET
33084	79651	RHBDF2	0.595	0.538	C1835664	TYLOSIS WITH ESOPHAGEAL CANCER	disease	C16;C06;C04;C17	Neoplastic Process	0.74	1	2012	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33091	79659	DYNC2H1	0.555	0.731	C0024507	Majewski Syndrome	disease	C16;C05	Disease or Syndrome	0.6	1	2011	2012	3	2	CTD_human;ORPHANET
33092	79659	DYNC2H1	0.555	0.731	C0036069	Saldino-Noonan Syndrome	disease	C16;C05	Disease or Syndrome	0.91	1	2009	2018	7	101	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33095	79659	DYNC2H1	0.555	0.731	C0265275	Jeune thoracic dystrophy	disease	C16;C17;C05	Disease or Syndrome	0.67	1	2009	2018	2	68	GENOMICS_ENGLAND;ORPHANET
33096	79659	DYNC2H1	0.555	0.731	C0432197	Short rib-polydactyly syndrome, Verma-Naumoff type	disease	C16;C05	Disease or Syndrome	0.75	1	2009	2018	2	0	CTD_human;ORPHANET
33142	79695	GALNT12	0.78	0.269	C1837315	COLORECTAL CANCER, SUSCEPTIBILITY TO, 1	disease		Finding	0.7	1	2004	2016	5	6	CLINGEN;GENOMICS_ENGLAND;UNIPROT
33147	79717	PPCS	0.792	0.308	C4748647	CARDIOMYOPATHY, DILATED, 2C	disease		Disease or Syndrome	0.6	1	2018	2018	1	1	GENOMICS_ENGLAND;UNIPROT
33163	79718	TBL1XR1	0.534	0.808	C1865644	Plantar Lipomatosis, Unusual Facies, and Developmental Delay	disease	C23;C18;C17;F03	Disease or Syndrome	0.75	1	1998	2018	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33164	79718	TBL1XR1	0.534	0.808	C4310784	MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	disease		Disease or Syndrome	0.7	1	1998	2016	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
33167	79719	AAGAB	0.695	0.538	C1835662	Keratosis palmoplantaris papulosa	disease	C16;C17	Disease or Syndrome	0.72	1	2012	2017	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
33168	79719	AAGAB	0.695	0.538	C4551675	Keratoderma, Palmoplantar	disease	C16;C17	Disease or Syndrome	0.62	1	2012	2013	1	1	CTD_human;GENOMICS_ENGLAND
33179	79728	PALB2	0.485	0.769	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.8	0.97	2006	2020	6	221	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
33191	79728	PALB2	0.485	0.769	C0346153	Breast Cancer, Familial	disease	C04;C17	Neoplastic Process	0.7	0.944	2006	2019	10	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
33196	79728	PALB2	0.485	0.769	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.7	0.961	2007	2020	1	4	CGI;CTD_human
33203	79728	PALB2	0.485	0.769	C1835817	FANCONI ANEMIA, COMPLEMENTATION GROUP N	disease	C16;C18;C15	Disease or Syndrome	0.71	1	2007	2018	5	13	CLINGEN;CTD_human;GENOMICS_ENGLAND
33223	79731	NARS2	0.65	0.577	C4015643	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24	disease		Disease or Syndrome	0.7	1	2015	2015	3	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33228	79734	KCTD17	0.743	0.308	C1834570	Myoclonic dystonia	disease	C10	Disease or Syndrome	0.51	1	2015	2015	1	0	CTD_human;ORPHANET
33229	79734	KCTD17	0.743	0.308	C4225341	DYSTONIA 26, MYOCLONIC	disease		Disease or Syndrome	0.6	1	2015	2015	1	1	GENOMICS_ENGLAND;UNIPROT
33233	79738	BBS10	0.644	0.538	C0752166	Bardet-Biedl Syndrome	disease	C16;C11;C10	Disease or Syndrome	0.7	0.974	1966	2020	2	25	ORPHANET
33234	79738	BBS10	0.644	0.538	C1859568	BARDET-BIEDL SYNDROME 10	disease	C16;C11;C10	Disease or Syndrome	0.9	1	2006	2017	7	94	CTD_human;GENOMICS_ENGLAND;UNIPROT
33254	79751	SLC25A22	0.595	0.577	C0270855	Early myoclonic encephalopathy	disease	C10	Disease or Syndrome	0.7	1	2005	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33256	79753	SNIP1	0.682	0.462	C3281055	PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	disease		Disease or Syndrome	0.6	1	2012	2012	1	1	GENOMICS_ENGLAND;UNIPROT
33257	79755	ZNF750	0.743	0.385	C1853258	Seborrhea-Like Dermatitis with Psoriasiform Elements	disease	C17	Disease or Syndrome	0.6	1	2006	2011	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33278	79783	SUGCT	0.686	0.385	C0342873	Glutaric Aciduria III	disease	C16;C18	Disease or Syndrome	0.7	1	2008	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33287	79784	MYH14	0.663	0.577	C1833503	Deafness, Autosomal Dominant 4	disease	C23;C10;C09	Disease or Syndrome	0.71	1	2004	2019	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
33288	79784	MYH14	0.663	0.577	C3280556	PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS	disease		Disease or Syndrome	0.71	1	2011	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33294	79796	ALG9	0.644	0.654	C1849762	Polycystic Kidney Disease, Potter Type I, with Microbrachycephaly, Hypertelorism, and Brachymelia	disease	C16;C13;C05;C12	Disease or Syndrome	0.6	1	2004	2016	2	1	CTD_human;GENOMICS_ENGLAND
33295	79796	ALG9	0.644	0.654	C2931006	Congenital disorder of glycosylation type 1L	disease	C16;C18	Disease or Syndrome	0.73	1	2004	2020	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
33300	79797	ZNF408	0.678	0.269	C4225315	RETINITIS PIGMENTOSA 72	disease		Disease or Syndrome	0.6	1	2015	2015	1	2	CTD_human;UNIPROT
33301	79797	ZNF408	0.678	0.269	C4225316	EXUDATIVE VITREORETINOPATHY 6	disease		Disease or Syndrome	0.6	1	2013	2013	1	2	CTD_human;UNIPROT
33302	79798	ARMC5	0.67	0.5	C1857451	Acth-Independent Macronodular Adrenal Hyperplasia	disease	C19	Disease or Syndrome	0.52	1	2013	2018	1	0	CTD_human;ORPHANET
33303	79798	ARMC5	0.67	0.5	C4014803	ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2	disease		Disease or Syndrome	0.68	1	2013	2018	10	13	GENOMICS_ENGLAND;UNIPROT
33306	79803	HPS6	0.769	0.308	C0079504	Hermanski-Pudlak Syndrome	disease	C16;C18;C11;C17;C15	Disease or Syndrome	0.61	1	2017	2019	0	3	CTD_human;GENOMICS_ENGLAND
33307	79803	HPS6	0.769	0.308	C3888007	HERMANSKY-PUDLAK SYNDROME 6	disease	C16;C18;C11;C17;C15	Disease or Syndrome	0.6	1	2003	2009	1	12	GENOMICS_ENGLAND
33323	79809	TTC21B	0.619	0.654	C0265275	Jeune thoracic dystrophy	disease	C16;C17;C05	Disease or Syndrome	0.7	1	2011	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
33328	79809	TTC21B	0.619	0.654	C3151185	SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY	disease		Disease or Syndrome	0.6	1	2011	2014	2	2	GENOMICS_ENGLAND;UNIPROT
33329	79809	TTC21B	0.619	0.654	C3151186	NEPHRONOPHTHISIS 12	disease		Disease or Syndrome	0.7	1	2011	2017	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
33340	79813	EHMT1	0.46	0.808	C0795833	KLEEFSTRA SYNDROME 1	disease	C23;C16;C05;C10;F03;F01;C14	Disease or Syndrome	1	1	2006	2019	11	24	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
33343	79816	TLE6	0.931	0.038	C4225197	PREIMPLANTATION EMBRYONIC LETHALITY 1	disease		Disease or Syndrome	0.6	1	2015	2015	1	2	CTD_human;UNIPROT
33361	79823	CAMKMT	0.51	0.808	C1848030	Hypotonia-Cystinuria Syndrome	disease	C23;C16;C18;C13;C05;C12;C10;F03;F01	Disease or Syndrome	0.52	1	2008	2018	1	0	CTD_human
33364	79827	CLMP	0.705	0.462	C0021847	Intestinal Pseudo-Obstruction	disease	C06	Disease or Syndrome	0.74	1	2012	2016	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33374	79840	NHEJ1	0.705	0.385	C1969799	Severe Combined Immunodeficiency with Microcephaly, Growth Retardation, and Sensitivity to Ionizing Radiation	disease	C23;C16;C18;C05;C20;C10	Disease or Syndrome	0.71	1	2006	2012	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33378	79848	CSPP1	0.544	0.769	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.55	1	2014	2019	3	0	GENOMICS_ENGLAND;ORPHANET
33393	79867	TCTN2	0.578	0.654	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.6	1	2011	2015	2	10	GENOMICS_ENGLAND;ORPHANET
33406	79868	ALG13	0.631	0.577	C3550904	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36	disease	C10	Disease or Syndrome	0.7	1	2012	2016	6	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
33437	79876	UBA5	0.582	0.731	C4310699	SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24	disease		Disease or Syndrome	0.6	1	2016	2016	1	0	GENOMICS_ENGLAND;UNIPROT
33438	79876	UBA5	0.582	0.731	C4310700	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	disease		Disease or Syndrome	0.7	1	2016	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
33444	79882	ZC3H14	0.691	0.308	C4310703	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	disease		Disease or Syndrome	0.6	1	2011	2011	1	1	CTD_human;GENOMICS_ENGLAND
33450	79902	NUP85	0.792	0.154	C4748545	NEPHROTIC SYNDROME, TYPE 17	disease		Disease or Syndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
33455	79912	PYROXD1	0.769	0.269	C4310645	MYOPATHY, MYOFIBRILLAR, 8	disease		Disease or Syndrome	0.7	1	2016	2019	4	5	CLINGEN;GENOMICS_ENGLAND;UNIPROT
33481	79934	COQ8B	0.722	0.423	C3809965	NEPHROTIC SYNDROME, TYPE 9	disease		Disease or Syndrome	0.7	1	2013	2016	2	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
33492	79944	L2HGDH	0.653	0.462	C1855995	L-2-HYDROXYGLUTARIC ACIDURIA	disease	C16;C18;C10	Disease or Syndrome	1	1	2004	2018	8	15	GENOMICS_ENGLAND;ORPHANET;UNIPROT
33493	79944	L2HGDH	0.653	0.462	C2746066	Combined D-2- and L-2-hydroxyglutaric aciduria	disease	C16;C18;C10	Disease or Syndrome	0.7	1	2004	2018	3	0	CTD_human;GENOMICS_ENGLAND
33498	79947	DHDDS	0.468	0.885	C3151227	RETINITIS PIGMENTOSA 59	disease		Disease or Syndrome	0.7	1	2011	2017	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
33499	79947	DHDDS	0.468	0.885	C4693376	DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES	disease		Disease or Syndrome	0.6	1	2016	2017	2	3	GENOMICS_ENGLAND;UNIPROT
33508	79955	PDZD7	0.659	0.385	C1848634	USHER SYNDROME, TYPE IIA	disease	C23;C16;C11;C10;C09	Disease or Syndrome	0.6	NA	NA	NA	0	2	CTD_human;GENOMICS_ENGLAND
33521	79977	GRHL2	0.59	0.731	C1837640	Deafness, Autosomal Dominant 28	disease	C23;C10;C09	Disease or Syndrome	0.61	1	2011	2014	1	2	CTD_human;GENOMICS_ENGLAND
33523	79977	GRHL2	0.59	0.731	C4014987	Nail and tooth abnormalities, marginal palmoplantar keratoderma, oral hyperpigmentation syndrome	disease	C16;C05;C19	Disease or Syndrome	0.7	1	2014	2014	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33526	79983	POF1B	0.751	0.308	C1845105	Premature Ovarian Failure 2b	disease	C13;C19	Disease or Syndrome	0.7	1	2004	2016	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
33532	79991	STN1	0.604	0.769	C2677299	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS (disorder)	disease	C23;C16;C04;C18;C11;C05;C10	Disease or Syndrome	0.51	1	2015	2016	1	0	CTD_human;ORPHANET
33533	79991	STN1	0.604	0.769	C4479220	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	disease		Disease or Syndrome	0.6	1	2016	2016	1	2	GENOMICS_ENGLAND;UNIPROT
33540	80000	GREB1L	0.686	0.423	C4540497	RENAL HYPODYSPLASIA/APLASIA 3	disease		Congenital Abnormality	0.6	1	2017	2017	3	20	GENOMICS_ENGLAND;UNIPROT
33545	80025	PANK2	0.559	0.808	C0018523	Hallervorden-Spatz Syndrome	disease	C16;C10	Disease or Syndrome	0.8	0.989	2001	2019	9	41	CTD_human;GENOMICS_ENGLAND;UNIPROT
33551	80025	PANK2	0.559	0.808	C1846582	Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis Pigmentosa, And Pallidal Degeneration	disease	C16;C10	Disease or Syndrome	0.62	1	2002	2006	1	5	CTD_human;GENOMICS_ENGLAND
33590	80055	PGAP1	0.65	0.423	C4014343	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42	disease		Disease or Syndrome	0.6	1	2007	2015	1	13	CTD_human;GENOMICS_ENGLAND
33593	80067	DCAF17	0.653	0.577	C0342286	Woodhouse Sakati syndrome	disease	C23;C18;C17;C10;C19;F03;F01;C14	Disease or Syndrome	0.8	1	2008	2020	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET
33608	80114	BICC1	0.636	0.577	C3275898	RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO	disease		Finding	0.6	1	2012	2012	1	2	GENOMICS_ENGLAND;UNIPROT
33618	80144	FRAS1	0.56	0.577	C0265233	Cryptophthalmos syndrome	disease	C16;C13;C11;C05;C12	Disease or Syndrome	1	0.867	2006	2017	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
33629	80155	NAA15	0.7	0.423	C3714756	Intellectual Disability	group	C23;C10;F03;F01	Mental or Behavioral Dysfunction	0.63	1	2015	2018	1	0	CTD_human;GENOMICS_ENGLAND
33630	80155	NAA15	0.7	0.423	C4540470	MENTAL RETARDATION, AUTOSOMAL DOMINANT 50	disease		Mental or Behavioral Dysfunction	0.6	1	2017	2017	1	12	GENOMICS_ENGLAND;UNIPROT
33644	80169	CTC1	0.601	0.538	C0265965	Dyskeratosis Congenita	disease	C16;C17;C15	Disease or Syndrome	0.64	1	2012	2019	5	10	GENOMICS_ENGLAND;ORPHANET
33647	80169	CTC1	0.601	0.538	C2677299	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS (disorder)	disease	C23;C16;C04;C18;C11;C05;C10	Disease or Syndrome	0.76	1	2012	2018	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
33649	80169	CTC1	0.601	0.538	C4552029	CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 1	disease	C23;C16;C04;C18;C11;C05;C10	Disease or Syndrome	0.6	1	2012	2018	4	18	GENOMICS_ENGLAND;UNIPROT
33655	80184	CEP290	0.517	0.769	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.7	1	2006	2019	2	8	GENOMICS_ENGLAND;ORPHANET
33656	80184	CEP290	0.517	0.769	C0403553	Renal dysplasia and retinal aplasia (disorder)	disease	C16;C13;C11;C12;C10	Disease or Syndrome	0.54	1	2007	2013	3	0	GENOMICS_ENGLAND;ORPHANET
33659	80184	CEP290	0.517	0.769	C1857779	SENIOR-LOKEN SYNDROME 6	disease	C16;C13;C11;C12;C10	Disease or Syndrome	0.7	1	2006	2018	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
33660	80184	CEP290	0.517	0.769	C1857780	JOUBERT SYNDROME 5	disease	C23;C13;C11;C12;C10	Disease or Syndrome	0.91	1	2006	2019	11	45	CTD_human;GENOMICS_ENGLAND;UNIPROT
33661	80184	CEP290	0.517	0.769	C1857821	LEBER CONGENITAL AMAUROSIS 10 (disorder)	disease	C11	Disease or Syndrome	0.8	1	2006	2018	7	17	CTD_human;GENOMICS_ENGLAND
33662	80184	CEP290	0.517	0.769	C1970161	MECKEL SYNDROME, TYPE 4	disease	C23;C16;C13;C05;C12;C10	Disease or Syndrome	0.61	1	2006	2018	6	26	CTD_human;GENOMICS_ENGLAND
33663	80184	CEP290	0.517	0.769	C2673874	BARDET-BIEDL SYNDROME 14 (disorder)	disease	C16;C11;C10	Disease or Syndrome	0.6	1	2006	2018	3	13	CTD_human;GENOMICS_ENGLAND
33671	80185	TTI2	0.736	0.346	C3809853	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39	disease		Disease or Syndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33676	80199	FUZ	0.597	0.731	C0027794	Neural Tube Defects	group	C16;C10	Congenital Abnormality	0.59	0.889	1997	2017	0	0	CTD_human;GENOMICS_ENGLAND
33684	80199	FUZ	0.597	0.731	C0344490	Sacral agenesis	disease	C23;C16;C10	Congenital Abnormality	0.6	1	2011	2011	1	0	GENOMICS_ENGLAND;ORPHANET
33693	80204	FBXO11	0.604	0.692	C4748135	INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES	disease		Disease or Syndrome	0.6	1	2006	2018	5	3	GENOMICS_ENGLAND;UNIPROT
33707	80207	OPA3	0.653	0.385	C0574084	3-Methylglutaconic aciduria type 3	disease	C23;C16;C18;C11;C10	Disease or Syndrome	0.9	1	2001	2016	2	11	CTD_human;GENOMICS_ENGLAND
33708	80207	OPA3	0.653	0.385	C1833809	OPTIC ATROPHY AND CATARACT, AUTOSOMAL DOMINANT	disease	C16;C11;C10	Disease or Syndrome	0.71	1	2001	2016	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33710	80208	SPG11	0.576	0.538	C1858479	Spastic paraplegia 11, autosomal recessive	disease	C16;C10	Disease or Syndrome	0.96	1	2004	2019	8	134	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33711	80208	SPG11	0.576	0.538	C1865864	AMYOTROPHIC LATERAL SCLEROSIS 5	disease	C18;C10	Disease or Syndrome	0.6	1	2009	2010	2	8	CTD_human;GENOMICS_ENGLAND
33714	80208	SPG11	0.576	0.538	C4225253	CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X	disease		Disease or Syndrome	0.7	1	2007	2016	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET
33715	80210	ARMC9	0.612	0.731	C0431399	Familial aplasia of the vermis	disease	C16;C13;C11;C12	Disease or Syndrome	0.52	1	2017	2018	1	0	GENOMICS_ENGLAND;ORPHANET
33717	80210	ARMC9	0.612	0.731	C4539937	JOUBERT SYNDROME 30	disease		Disease or Syndrome	0.6	1	2017	2017	1	9	GENOMICS_ENGLAND;UNIPROT
33729	80217	CFAP43	0.931	0.038	C4539818	SPERMATOGENIC FAILURE 19	disease		Disease or Syndrome	0.8	1	2017	2018	2	10	GENOMICS_ENGLAND;UNIPROT
33730	80222	TARS2	0.729	0.423	C4014668	COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	disease		Disease or Syndrome	0.7	1	2014	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33731	80224	NUBPL	0.67	0.423	C0751651	Mitochondrial Diseases	group	C18	Disease or Syndrome	0.51	1	2010	2016	2	0	CTD_human;GENOMICS_ENGLAND
33735	80224	NUBPL	0.67	0.423	C1838979	MITOCHONDRIAL COMPLEX I DEFICIENCY	disease	C18	Disease or Syndrome	0.61	1	2010	2016	4	2	GENOMICS_ENGLAND;ORPHANET
33736	80224	NUBPL	0.67	0.423	C4748792	MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21	disease		Disease or Syndrome	0.6	1	2010	2013	2	5	GENOMICS_ENGLAND;UNIPROT
33739	80232	WDR26	0.606	0.769	C4539927	SKRABAN-DEARDORFF SYNDROME	disease		Disease or Syndrome	0.7	1	2017	2017	2	8	GENOMICS_ENGLAND;ORPHANET;UNIPROT
33741	80254	CEP63	0.666	0.5	C0025958	Microcephaly	disease	C16;C05;C10	Congenital Abnormality	0.6	1	2011	2015	2	0	CTD_human;GENOMICS_ENGLAND
33751	80270	HSD3B7	0.7	0.385	C1843116	Bile acid synthesis defect, congenital, 1	disease	C16;C06;C18	Disease or Syndrome	0.7	1	2000	2016	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33768	80308	FLAD1	0.638	0.692	C4310822	LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	disease		Disease or Syndrome	0.7	1	2006	2016	4	6	CLINGEN;GENOMICS_ENGLAND;UNIPROT
33790	80324	PUS1	0.695	0.462	C1838103	MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.64	1	2007	2014	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33792	80324	PUS1	0.695	0.462	C4551958	MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1	disease	C16;C18;C05;C10;C14	Disease or Syndrome	0.61	1	2004	2019	7	5	GENOMICS_ENGLAND;UNIPROT
33797	80326	WNT10A	0.547	0.731	C0796093	Odontoonychodermal dysplasia	disease	C16;C17;C07	Disease or Syndrome	0.73	1	2007	2019	5	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33799	80326	WNT10A	0.547	0.731	C1835492	TOOTH AGENESIS, SELECTIVE, 4 (disorder)	disease	C16;C07	Disease or Syndrome	0.61	1	2009	2018	8	24	CTD_human;UNIPROT
33801	80326	WNT10A	0.547	0.731	C1857069	SCHOPF-SCHULZ-PASSARGE SYNDROME (disorder)	disease	C16;C04;C11;C17;C07	Disease or Syndrome	0.77	1	2009	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33806	80331	DNAJC5	0.653	0.5	C1834207	Ceroid Lipofuscinosis, Neuronal, Parry Type	disease	C16;C18;C10	Disease or Syndrome	0.7	1	2011	2013	5	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
33825	80347	COASY	0.551	0.654	C3810230	NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6	disease		Disease or Syndrome	0.7	1	2014	2018	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33839	80704	SLC19A3	0.61	0.692	C1843807	Basal ganglia disease, biotin-responsive	disease	C10	Disease or Syndrome	1	1	2005	2019	4	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33874	80746	TSEN2	0.705	0.423	C2676466	Pontocerebellar Hypoplasia Type 2B	disease	C10	Disease or Syndrome	0.7	1	2008	2011	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
33904	80781	COL18A1	0.449	0.808	C1849409	Knobloch syndrome	disease	C23;C16;C11;C10	Disease or Syndrome	0.7	1	2000	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33906	80781	COL18A1	0.449	0.808	C4551775	Knobloch Syndrome, Type I	disease	C23;C16;C11;C10	Disease or Syndrome	0.6	1	2000	2017	3	3	CTD_human;GENOMICS_ENGLAND
33915	80816	ASXL3	0.59	0.577	C3809650	BAINBRIDGE-ROPERS SYNDROME	disease		Disease or Syndrome	0.76	1	2013	2019	2	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
33919	80821	DDHD1	0.716	0.423	C1836295	SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE (disorder)	disease	C23;C10	Disease or Syndrome	0.62	1	2012	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33934	81027	TUBB1	0.78	0.385	C2751259	Macrothrombocytopenia, Autosomal Dominant, Tubb1-Related	disease	C15	Disease or Syndrome	0.7	1	2009	2014	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
33946	81031	SLC2A10	0.55	0.615	C1859726	ARTERIAL TORTUOSITY SYNDROME	disease	C16;C17;C05;C14	Disease or Syndrome	0.8	0.913	2003	2020	4	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33948	81031	SLC2A10	0.55	0.615	C4707243	Familial thoracic aortic aneurysm and aortic dissection	disease		Disease or Syndrome	0.6	1	2003	2010	2	1	CLINGEN;GENOMICS_ENGLAND
33952	81034	SLC25A32	0.821	0.115	C4225187	EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE	disease		Disease or Syndrome	0.6	1	2016	2017	2	2	GENOMICS_ENGLAND;UNIPROT
33986	81494	CFHR5	0.659	0.385	C3553720	CFHR5 DEFICIENCY	disease		Disease or Syndrome	0.7	1	2010	2017	7	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
33998	81545	FBXO38	0.792	0.115	C3888271	NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID	disease	C10	Disease or Syndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34004	81562	LMAN2L	0.641	0.385	C0005586	Bipolar Disorder	disease	F03	Mental or Behavioral Dysfunction	0.61	1	2013	2019	2	2	CTD_human;PSYGENET
34017	81562	LMAN2L	0.641	0.385	C4225168	MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	disease		Disease or Syndrome	0.6	1	2016	2016	1	1	CTD_human;UNIPROT
34036	81570	CLPB	0.631	0.654	C4225393	3-methylglutaconic aciduria type 7	disease	C16;C18	Disease or Syndrome	0.7	1	2015	2017	3	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34054	81607	NECTIN4	0.599	0.538	C3150807	ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	disease		Disease or Syndrome	0.73	1	2010	2018	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34071	134864	TAAR1	0.682	0.423	C0036341	Schizophrenia	disease	F03	Mental or Behavioral Dysfunction	0.57	1	2007	2020	1	0	PSYGENET
34085	135656	MUCL3	0.691	0.731	C0878555	Diffuse panbronchiolitis	disease	C01;C08	Disease or Syndrome	0.51	1	2002	2012	1	0	CTD_human;ORPHANET
34088	135935	NOBOX	0.805	0.154	C1969060	Premature Ovarian Failure 5	disease	C13;C19	Disease or Syndrome	0.7	1	2007	2016	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
34100	136371	ASB10	0.805	0.077	C1863926	GLAUCOMA 1, OPEN ANGLE, F (disorder)	disease	C11	Disease or Syndrome	0.7	1	2012	2012	1	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
34105	136647	MPLKIP	0.604	0.654	C1955934	Trichothiodystrophy Syndromes	disease	C16;C17	Disease or Syndrome	0.55	1	2005	2016	0	0	CTD_human;ORPHANET
34115	137392	FAM92A	0.729	0.308	C0220697	POLYDACTYLY, POSTAXIAL	disease	C16;C05	Disease or Syndrome	0.51	1	2019	2019	1	0	CTD_human
34118	137392	FAM92A	0.729	0.308	C3887487	Postaxial polydactyly type A	disease	C16;C05	Disease or Syndrome	0.51	1	2019	2019	1	0	CTD_human;ORPHANET
34122	137492	VPS37A	0.656	0.577	C3539494	SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2012	2012	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34129	137814	NKX2-6	0.695	0.385	C0041207	Truncus Arteriosus, Persistent	disease	C16;C14	Congenital Abnormality	0.6	1	2005	2014	2	1	GENOMICS_ENGLAND;ORPHANET
34131	137814	NKX2-6	0.695	0.385	C1857586	CONOTRUNCAL HEART MALFORMATIONS (disorder)	disease	C16;C14	Disease or Syndrome	0.7	1	2005	2015	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
34144	138050	HGSNAT	0.628	0.577	C0026706	Mucopolysaccharidosis III	disease	C16;C18;C17	Disease or Syndrome	0.8	1	2006	2016	2	5	CTD_human;GENOMICS_ENGLAND
34148	138050	HGSNAT	0.628	0.577	C0086649	MPS III C	disease	C16;C18;C17	Disease or Syndrome	0.8	1	2006	2019	11	36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34150	138050	HGSNAT	0.628	0.577	C4225287	RETINITIS PIGMENTOSA 73	disease		Disease or Syndrome	0.7	1	2006	2016	3	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
34166	139212	PIH1D3	0.674	0.538	C4478372	CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED	disease		Disease or Syndrome	0.6	1	2017	2017	1	2	CTD_human;GENOMICS_ENGLAND
34171	139285	AMER1	0.57	0.654	C0432268	Osteopathia striata cranial sclerosis	disease	C05	Disease or Syndrome	0.99	1	2009	2019	2	8	CTD_human;GENOMICS_ENGLAND;ORPHANET
34203	140628	GATA5	0.578	0.615	C4693563	CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5	disease		Disease or Syndrome	0.6	1	2012	2015	10	6	GENOMICS_ENGLAND;UNIPROT
34216	140732	SUN5	0.805	0.154	C4310674	SPERMATOGENIC FAILURE 16	disease		Disease or Syndrome	0.75	1	2016	2018	4	7	CTD_human;ORPHANET;UNIPROT
34246	140803	TRPM6	0.656	0.538	C1865974	Hypomagnesemia 1, Intestinal	disease	C18	Disease or Syndrome	0.8	1	2002	2019	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34256	142680	SLC34A3	0.695	0.308	C1853271	HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	disease	C23;C16;C18;C13;C05;C12	Disease or Syndrome	0.8	1	2006	2019	4	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34329	144165	PRICKLE1	0.647	0.615	C2676254	Prickle1-Related Progressive Myoclonus Epilepsy with Ataxia	disease	C10	Disease or Syndrome	0.7	1	2008	2011	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
34342	144568	A2ML1	0.59	0.692	C0028326	Noonan Syndrome	disease	C16;C17;C05;C14	Disease or Syndrome	0.6	1	2015	2016	3	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
34359	145173	B3GLCT	0.554	0.731	C0796012	Krause-Kivlin syndrome	disease	C23;C16;C05;C07	Disease or Syndrome	0.7	0.933	2006	2019	6	5	CTD_human;GENOMICS_ENGLAND
34362	145226	RDH12	0.65	0.308	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.66	1	2007	2019	2	5	CTD_human;GENOMICS_ENGLAND
34365	145226	RDH12	0.65	0.308	C2675186	LEBER CONGENITAL AMAUROSIS 13	disease	C11	Disease or Syndrome	0.71	1	2004	2019	8	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
34369	145258	GSC	0.631	0.615	C1865361	SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, SKELETAL ABNORMALITIES	disease	C05	Disease or Syndrome	0.63	1	1997	2013	2	3	GENOMICS_ENGLAND;ORPHANET
34384	145873	MESP2	0.653	0.462	C1837549	SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 2	disease	C05	Disease or Syndrome	0.6	1	2004	2008	2	16	CTD_human;GENOMICS_ENGLAND
34395	146057	TTBK2	0.682	0.423	C1858351	SPINOCEREBELLAR ATAXIA 11	disease	C16;C10	Disease or Syndrome	0.66	1	2007	2019	0	2	CTD_human;GENOMICS_ENGLAND
34397	146059	CDAN1	0.61	0.731	C0271933	Congenital dyserythropoietic anemia, type I	disease	C16;C15	Disease or Syndrome	0.78	1	2002	2018	2	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34401	146167	SLC38A8	0.743	0.269	C3807873	FOVEAL HYPOPLASIA 2	disease		Disease or Syndrome	0.7	1	2013	2014	2	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
34405	146183	OTOA	0.76	0.423	C1846896	Deafness, Autosomal Recessive 22	disease	C23;C10;C09	Disease or Syndrome	0.8	1	2012	2019	1	7	CTD_human;GENOMICS_ENGLAND
34408	146206	CARMIL2	0.695	0.462	C4748304	IMMUNODEFICIENCY 58	disease		Disease or Syndrome	0.6	1	2016	2018	5	8	ORPHANET;UNIPROT
34414	146227	BEAN1	0.705	0.385	C1861736	SPINOCEREBELLAR ATAXIA 31 (disorder)	disease	C16;C10	Disease or Syndrome	0.63	1	2007	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34428	146862	UNC45B	0.805	0.192	C4225389	CATARACT 43	disease		Disease or Syndrome	0.6	1	2014	2014	1	1	CTD_human;UNIPROT
34430	147007	TMEM199	0.792	0.231	C4225190	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIp	disease		Disease or Syndrome; Congenital Abnormality	0.7	1	2016	2016	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34431	147138	TMC8	0.705	0.231	C0014522	Epidermodysplasia Verruciformis	disease	C01;C17	Neoplastic Process	0.6	1	2002	2018	1	0	GENOMICS_ENGLAND;ORPHANET
34437	147183	KRT25	0.736	0.269	C4225214	WOOLLY HAIR, AUTOSOMAL RECESSIVE 3	disease		Disease or Syndrome	0.6	1	2015	2018	3	2	GENOMICS_ENGLAND;UNIPROT
34438	147372	CCBE1	0.585	0.769	C0020305	Hydrops Fetalis	disease	C23;C16;C13;C20;C15	Disease or Syndrome	0.6	1	2003	2010	2	0	CTD_human;GENOMICS_ENGLAND
34442	147372	CCBE1	0.585	0.769	C0340834	Hennekam lymphangiectasia-lymphedema syndrome	disease	C16;C05;C15	Disease or Syndrome	0.61	1	2009	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34448	147372	CCBE1	0.585	0.769	C4012050	HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1	disease	C16;C05;C15	Disease or Syndrome	0.7	1	2003	2014	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
34451	147409	DSG4	0.686	0.423	C1842839	HYPOTRICHOSIS 6	disease	C17	Disease or Syndrome	0.8	1	1996	2004	1	0	CTD_human;GENOMICS_ENGLAND
34455	147495	APCDD1	0.644	0.538	C1854310	Hypotrichosis simplex	disease	C17	Disease or Syndrome	0.53	1	2010	2018	1	0	CTD_human;ORPHANET
34456	147495	APCDD1	0.644	0.538	C4551976	HYPOTRICHOSIS 1	disease		Disease or Syndrome	0.6	1	2010	2012	2	1	GENOMICS_ENGLAND;UNIPROT
34473	147912	SIX5	0.666	0.5	C0265234	Branchio-Oto-Renal Syndrome	disease	C16	Disease or Syndrome	0.53	1	2000	2014	6	0	CLINGEN;CTD_human
34475	147912	SIX5	0.666	0.5	C1970479	Branchiootorenal Syndrome 2	disease	C16	Disease or Syndrome	0.7	1	1999	2007	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
34486	148022	TICAM1	0.593	0.846	C0276226	Herpes encephalitis	disease	C01;C10	Disease or Syndrome	0.63	0.333	2011	2015	1	0	CTD_human;ORPHANET
34487	148022	TICAM1	0.593	0.846	C3553869	ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 6	disease		Finding	0.6	1	2011	2015	2	3	GENOMICS_ENGLAND;UNIPROT
34501	148738	HJV	0.621	0.654	C0268060	Juvenile hemochromatosis	disease	C16;C18	Disease or Syndrome	0.7	1	2000	2020	0	1	CTD_human
34503	148738	HJV	0.621	0.654	C1865614	HEMOCHROMATOSIS, TYPE 2A	disease	C16;C18	Disease or Syndrome	0.9	1	2004	2016	5	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
34508	148789	B3GALNT2	0.578	0.577	C0457133	Muscle eye brain disease	disease	C16;C11;C10	Disease or Syndrome	0.51	1	2013	2018	1	0	CTD_human;ORPHANET
34511	148789	B3GALNT2	0.578	0.577	C3554638	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11	disease		Disease or Syndrome	0.6	1	2013	2017	1	13	GENOMICS_ENGLAND;UNIPROT
34520	149233	IL23R	0.466	0.769	C0009324	Ulcerative Colitis	disease	C06	Disease or Syndrome	0.7	0.982	2006	2020	3	6	CTD_human;GENOMICS_ENGLAND
34521	149233	IL23R	0.466	0.769	C0010346	Crohn Disease	disease	C06	Disease or Syndrome	0.7	0.95	2006	2020	2	9	CTD_human;GENOMICS_ENGLAND
34532	149461	CLDN19	0.659	0.423	C1855466	Hypomagnesemia 5, Renal, with Ocular Involvement	disease	C16;C18;C13;C11;C12	Disease or Syndrome	0.6	1	2006	2006	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34534	149461	CLDN19	0.659	0.423	C4721891	HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT	disease		Disease or Syndrome	0.6	1	1979	2017	3	4	GENOMICS_ENGLAND;UNIPROT
34563	150094	SIK1	0.544	0.731	C4225360	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30	disease		Disease or Syndrome	0.7	1	2015	2015	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
34574	150468	CKAP2L	0.666	0.577	C0795940	Filippi syndrome	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.72	1	2002	2016	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
34620	151648	SGO1	0.674	0.346	C4015474	Chronic atrial and intestinal dysrhythmia	disease	C23;C14	Disease or Syndrome	0.72	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34638	152137	CCDC50	0.751	0.423	C1843895	Deafness, Autosomal Dominant 44	disease	C23;C10;C09	Disease or Syndrome	0.51	1	2007	2016	1	0	CTD_human;GENOMICS_ENGLAND
34665	152816	ODAPH	0.839	0.077	C3553830	AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4	disease		Disease or Syndrome	0.6	1	2012	2012	1	5	CTD_human;GENOMICS_ENGLAND
34670	152926	PPM1K	0.656	0.5	C0024776	Maple Syrup Urine Disease	disease	C16;C18;C10	Disease or Syndrome	0.52	1	2009	2013	0	0	CTD_human
34692	153201	SLC36A2	0.861	0.154	C0268654	Iminoglycinuria	disease	C16;C18;C13;C12	Disease or Syndrome	0.61	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34693	153201	SLC36A2	0.861	0.154	C0543541	HYPERGLYCINURIA (disorder)	disease	C16;C18;C13;C12	Disease or Syndrome	0.7	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34698	153241	CEP120	0.564	0.731	C0265275	Jeune thoracic dystrophy	disease	C16;C17;C05	Disease or Syndrome	0.52	1	2015	2018	2	0	GENOMICS_ENGLAND;ORPHANET
34700	153241	CEP120	0.564	0.731	C4225378	SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY	disease		Disease or Syndrome	0.6	1	2015	2018	3	2	GENOMICS_ENGLAND;UNIPROT
34702	153241	CEP120	0.564	0.731	C4540355	JOUBERT SYNDROME 31	disease		Disease or Syndrome	0.6	1	2016	2016	1	5	GENOMICS_ENGLAND;UNIPROT
34705	153562	MARVELD2	0.705	0.462	C1857811	DEAFNESS, AUTOSOMAL RECESSIVE 49	disease	C23;C10;C09	Disease or Syndrome	0.81	1	2006	2015	1	3	CTD_human;GENOMICS_ENGLAND
34714	154288	KHDC3L	0.76	0.115	C0678213	Complete hydatidiform mole	disease	C04;C13	Neoplastic Process	0.52	1	2011	2014	2	0	CTD_human;ORPHANET
34735	154881	KCTD7	0.65	0.423	C2673257	EPILEPSY, PROGRESSIVE MYOCLONIC 3	disease	C10	Disease or Syndrome	0.71	1	1990	2018	5	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34742	157570	ESCO2	0.581	0.615	C0392475	Roberts-SC phocomelia syndrome	disease	C16;C05	Disease or Syndrome	0.8	1	1979	2019	7	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
34746	157657	C8orf37	0.628	0.538	C0035334	Retinitis Pigmentosa	disease	C16;C11	Disease or Syndrome	0.95	1	2012	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34748	157657	C8orf37	0.628	0.538	C3281045	CONE-ROD DYSTROPHY 16	disease		Disease or Syndrome	0.9	1	2012	2018	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
34750	157657	C8orf37	0.628	0.538	C4319932	BARDET-BIEDL SYNDROME 21	disease		Disease or Syndrome	0.71	1	2016	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
34753	157680	VPS13B	0.579	0.769	C0265223	Cohen syndrome	disease	C23;C16;C18;C11;C05;C10;F03;F01	Congenital Abnormality	0.8	1	1994	2020	10	284	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34776	158326	FREM1	0.633	0.423	C0221363	Bifid nose	disease	C08;C09	Congenital Abnormality	0.62	1	2011	2013	1	0	CTD_human;GENOMICS_ENGLAND
34779	158326	FREM1	0.633	0.423	C0265535	Trigonocephaly	disease	C16;C05	Congenital Abnormality	0.7	1	2011	2011	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34785	158326	FREM1	0.633	0.423	C1855425	Marles Greenberg Persaud syndrome	disease	C16;C11;C05	Disease or Syndrome	0.75	0.875	2001	2017	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
34787	158326	FREM1	0.633	0.423	C2750433	Bifid Nose With Or Without Anorectal And Renal Anomalies	disease	C06;C13;C12	Disease or Syndrome	0.72	0.8	2001	2014	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34790	158326	FREM1	0.633	0.423	C3280974	TRIGONOCEPHALY 2	disease		Congenital Abnormality	0.6	1	2001	2011	2	2	GENOMICS_ENGLAND;UNIPROT
34825	160418	TMTC3	0.636	0.538	C4310646	LISSENCEPHALY 8	disease		Disease or Syndrome	0.6	1	2016	2016	1	5	GENOMICS_ENGLAND;UNIPROT
34858	161497	STRC	0.7	0.192	C1863561	Deafness, Autosomal Recessive 16	disease	C23;C10;C09	Disease or Syndrome	0.83	1	2001	2018	1	3	CTD_human;GENOMICS_ENGLAND
34859	161497	STRC	0.7	0.192	C1970187	Deafness, Sensorineural, And Male Infertility	disease	C23;C12;C10;C09	Disease or Syndrome	0.6	1	2007	2007	1	0	CTD_human;ORPHANET
34870	161582	DNAAF4	0.623	0.731	C3809641	CILIARY DYSKINESIA, PRIMARY, 25	disease		Disease or Syndrome	0.8	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND
34879	161742	SPRED1	0.644	0.577	C1969623	NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME	disease	C23;C17	Disease or Syndrome	0.8	0.963	2005	2019	10	32	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
34881	162417	NAGS	0.716	0.423	C0268543	Hyperammonemia, type III	disease	C16;C18;C10	Disease or Syndrome	0.76	1	1971	2018	10	18	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
34884	162514	TRPV3	0.61	0.577	C2609071	Olmsted syndrome	disease		Disease or Syndrome	0.8	1	2012	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34885	162514	TRPV3	0.61	0.577	C4225339	PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL 2	disease		Disease or Syndrome	0.7	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34889	163175	LGI4	0.678	0.308	C4479539	ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	disease		Disease or Syndrome	0.7	1	2006	2017	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
34890	163183	SYNE4	0.861	0.115	C3147083	DEAFNESS, AUTOSOMAL RECESSIVE 76	disease		Disease or Syndrome	0.6	1	2018	2018	1	1	CTD_human;GENOMICS_ENGLAND
34904	163786	SASS6	0.691	0.423	C4225338	MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34907	164045	HFM1	0.659	0.615	C3810376	PREMATURE OVARIAN FAILURE 9	disease		Disease or Syndrome	0.7	1	2014	2016	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
34916	164656	TMPRSS6	0.584	0.654	C0085576	Iron-Refractory Iron Deficiency Anemia	disease	C18;C15	Disease or Syndrome	0.8	1	2008	2019	13	27	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34922	165918	RNF168	0.653	0.731	C2677792	Riddle Syndrome	disease	C23;C16;C05;C20;C10;F03	Disease or Syndrome	0.97	1	2007	2017	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
34928	166378	SPATA5	0.67	0.654	C4225276	EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME	disease		Disease or Syndrome	0.71	1	2015	2017	3	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34932	166379	BBS12	0.674	0.462	C1859570	BARDET-BIEDL SYNDROME 12	disease	C16;C11;C10	Disease or Syndrome	0.7	1	2007	2014	4	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
34937	166752	FREM3	0.805	0.269	C1269683	Major Depressive Disorder	disease	F03	Mental or Behavioral Dysfunction	0.51	1	2012	2015	2	0	CTD_human;PSYGENET
34940	166785	MMAA	0.743	0.346	C1855109	Methylmalonic aciduria cblA type	disease	C16;C18	Disease or Syndrome	0.7	1	2002	2017	8	56	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34944	167465	ZNF366	0.729	0.423	C0006142	Malignant neoplasm of breast	disease	C04;C17	Neoplastic Process	0.55	1	2010	2019	1	0	CTD_human
34952	167465	ZNF366	0.729	0.423	C0678222	Breast Carcinoma	disease	C04;C17	Neoplastic Process	0.55	1	2010	2019	1	0	CTD_human
34955	167465	ZNF366	0.729	0.423	C1458155	Mammary Neoplasms	group	C04;C17	Neoplastic Process	0.51	1	2010	2015	1	0	CTD_human
34964	167691	LCA5	0.674	0.269	C0339527	Leber Congenital Amaurosis	disease	C11	Disease or Syndrome	0.68	1	2003	2018	2	5	GENOMICS_ENGLAND;ORPHANET
34970	167691	LCA5	0.674	0.269	C1858301	LEBER CONGENITAL AMAUROSIS 5	disease	C11	Disease or Syndrome	0.91	1	2007	2017	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
34980	168507	PKD1L1	0.729	0.231	C4310668	HETEROTAXY, VISCERAL, 8, AUTOSOMAL	disease		Disease or Syndrome	0.7	1	2016	2016	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
34986	168667	BMPER	0.641	0.577	C1842691	Diaphanospondylodysostosis	disease	C16;C05	Disease or Syndrome	0.73	1	2010	2019	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34994	169522	KCNV2	0.736	0.115	C1835897	Retinal Cone Dystrophy 3B	disease	C16;C11	Disease or Syndrome	0.74	1	2006	2013	3	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35009	169792	GLIS3	0.59	0.654	C1857775	Diabetes Mellitus, Neonatal, with Congenital Hypothyroidism	disease	C16;C18;C05;C19	Disease or Syndrome	0.9	1	2003	2009	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
35016	170302	ARX	0.516	0.654	C0393706	Early infantile epileptic encephalopathy with suppression bursts	disease	C10	Disease or Syndrome	0.78	0.944	2007	2018	10	0	CLINGEN;ORPHANET
35017	170302	ARX	0.516	0.654	C0796124	Proud Syndrome	disease	C23;C16;C13;C12;C10;F03;F01	Disease or Syndrome	0.7	1	2002	2004	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35018	170302	ARX	0.516	0.654	C0796244	MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED (disorder)	disease	C16;C10	Disease or Syndrome	0.7	1	2002	2015	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
35019	170302	ARX	0.516	0.654	C0796250	PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME	disease	C23;C16;C10	Disease or Syndrome	0.74	1	1996	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35020	170302	ARX	0.516	0.654	C1846171	Lissencephaly, X-Linked, 2	disease	C16;C13;C12;C10	Disease or Syndrome	0.74	1	2002	2016	3	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35021	170302	ARX	0.516	0.654	C1846172	Hydranencephaly and Abnormal Genitalia	disease	C16;C13;C12;C10	Disease or Syndrome	0.6	1	2004	2004	1	2	CTD_human;GENOMICS_ENGLAND
35023	170302	ARX	0.516	0.654	C3463992	EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1	disease	C10	Disease or Syndrome	0.7	1	2002	2018	12	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
35024	170302	ARX	0.516	0.654	C4552072	X-linked infantile spasms	disease	C10	Disease or Syndrome	0.7	0.96	2002	2018	9	0	CLINGEN;CTD_human;ORPHANET
35038	170691	ADAMTS17	0.678	0.385	C2750787	Weill-Marchesani-Like Syndrome	disease	C16;C11;C05;C19	Disease or Syndrome	0.75	0.857	2009	2019	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
35040	170692	ADAMTS18	0.636	0.654	C3809567	MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS	disease		Disease or Syndrome	0.71	1	2013	2013	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35052	171023	ASXL1	0.482	0.808	C0349639	Juvenile Myelomonocytic Leukemia	disease	C04;C15	Neoplastic Process	0.6	1	2010	2018	2	0	CTD_human;GENOMICS_ENGLAND
35053	171023	ASXL1	0.482	0.808	C0796232	Bohring syndrome	disease	C23;C16;C05;C10;F03;F01	Disease or Syndrome	0.8	0.933	2011	2019	3	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
35057	171023	ASXL1	0.482	0.808	C3463824	MYELODYSPLASTIC SYNDROME	group	C15	Neoplastic Process	0.8	0.96	2009	2019	2	0	CGI;CTD_human;GENOMICS_ENGLAND
35095	196527	ANO6	0.736	0.423	C0796149	Scott Syndrome	disease	C15	Disease or Syndrome	0.66	0.889	2010	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35099	196528	ARID2	0.543	0.808	C2239176	Liver carcinoma	disease	C06;C04	Neoplastic Process	0.6	0.923	2011	2018	2	0	CGI;CTD_human
35103	197131	UBR1	0.612	0.731	C0175692	Johanson-Blizzard syndrome	disease	C23;C16;C06;C17;C10;C19;F03;C09;F01	Disease or Syndrome	1	1	2002	2018	7	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35117	197322	ACSF3	0.743	0.308	C3280314	Combined Malonic and Methylmalonic Aciduria	disease	C16;C18	Disease or Syndrome	0.73	1	2011	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35119	199221	DZIP1L	0.769	0.308	C0085548	Autosomal Recessive Polycystic Kidney Disease	disease	C16;C13;C12	Disease or Syndrome	0.81	0	2017	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35120	199221	DZIP1L	0.769	0.308	C4539903	POLYCYSTIC KIDNEY DISEASE 5	disease		Disease or Syndrome	0.6	1	2017	2017	1	4	GENOMICS_ENGLAND;UNIPROT
35123	199713	NLRP7	0.7	0.269	C0678213	Complete hydatidiform mole	disease	C04;C13	Neoplastic Process	0.56	0.875	2009	2014	2	0	CTD_human;ORPHANET
35125	199857	ALG14	0.722	0.308	C0751882	Myasthenic Syndromes, Congenital	disease	C16;C10	Disease or Syndrome	0.51	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND
35130	199857	ALG14	0.722	0.308	C4015596	MYASTHENIC SYNDROME, CONGENITAL, 15	disease		Disease or Syndrome	0.6	1	2013	2017	3	1	GENOMICS_ENGLAND;UNIPROT
35139	200205	IBA57	0.666	0.423	C3809165	MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3	disease		Disease or Syndrome	0.71	1	2013	2018	4	12	GENOMICS_ENGLAND;ORPHANET;UNIPROT
35140	200205	IBA57	0.666	0.423	C4225322	SPASTIC PARAPLEGIA 74, AUTOSOMAL RECESSIVE	disease		Disease or Syndrome	0.7	1	2015	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35178	200576	PIKFYVE	0.722	0.577	C1562113	Fleck corneal dystrophy	disease	C16;C11	Disease or Syndrome	0.75	1	2005	2015	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35185	200879	LIPH	0.691	0.346	C1836672	Total Hypotrichosis, Mari type	disease	C23;C17	Disease or Syndrome	0.7	1	2006	2016	3	3	GENOMICS_ENGLAND;UNIPROT
35189	200894	ARL13B	0.631	0.538	C2676771	JOUBERT SYNDROME 8 (disorder)	disease	C16;C11;C10	Disease or Syndrome	0.7	1	2006	2017	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
35209	201163	FLCN	0.537	0.885	C0007134	Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.9	0.92	2002	2020	2	0	CTD_human;GENOMICS_ENGLAND
35220	201163	FLCN	0.537	0.885	C0149781	Spontaneous pneumothorax	disease	C08	Disease or Syndrome	0.7	0.882	2002	2019	2	0	CTD_human;GENOMICS_ENGLAND
35223	201163	FLCN	0.537	0.885	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	disease	C04;C13;C12	Neoplastic Process	0.9	0.938	2002	2020	2	2	CTD_human;UNIPROT
35225	201163	FLCN	0.537	0.885	C0346010	Multiple fibrofolliculomas	disease	C16;C04	Disease or Syndrome	1	0.968	2002	2020	11	53	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
35226	201163	FLCN	0.537	0.885	C0346255	Oncocytoma, renal	disease	C04;C13;C12	Neoplastic Process	0.51	1	2002	2004	1	0	CTD_human;GENOMICS_ENGLAND
35227	201163	FLCN	0.537	0.885	C0740457	Malignant neoplasm of kidney	disease	C04;C13;C12	Neoplastic Process	0.6	1	2002	2018	0	0	CGI;GENOMICS_ENGLAND
35234	201163	FLCN	0.537	0.885	C1378703	Renal carcinoma	disease	C04;C13;C12	Neoplastic Process	0.6	1	2002	2018	1	0	CGI;GENOMICS_ENGLAND
35235	201163	FLCN	0.537	0.885	C1868193	PNEUMOTHORAX, PRIMARY SPONTANEOUS	disease		Disease or Syndrome	0.8	0.895	2002	2019	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35245	201294	UNC13D	0.659	0.5	C1837174	HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3	disease	C15	Disease or Syndrome	0.86	1	2003	2019	1	20	CTD_human;GENOMICS_ENGLAND
35251	201595	STT3B	0.76	0.385	C2931007	Congenital disorder of glycosylation type 1X	disease	C16;C18;C15	Disease or Syndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35255	201973	PRIMPOL	0.839	0.269	C3809464	MYOPIA 22, AUTOSOMAL DOMINANT	disease		Disease or Syndrome	0.6	1	2013	2014	2	1	CTD_human;UNIPROT
35257	202018	TAPT1	0.674	0.538	C4225162	OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	disease		Disease or Syndrome	0.7	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35265	203068	TUBB	0.603	0.692	C4014283	CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6	disease		Disease or Syndrome	0.7	1	2012	2018	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
35266	203068	TUBB	0.603	0.692	C4551592	SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1	disease	C16;C04;C17	Disease or Syndrome	0.6	1	2015	2015	1	2	GENOMICS_ENGLAND;UNIPROT
35267	203228	C9orf72	0.496	0.769	C0002736	Amyotrophic Lateral Sclerosis	disease	C18;C10	Disease or Syndrome	0.8	0.985	2009	2020	4	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
35281	203228	C9orf72	0.496	0.769	C3888102	Frontotemporal Dementia With Motor Neuron Disease	disease	C18;C10;F03	Disease or Syndrome	0.8	1	2012	2020	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35297	203286	ANKS6	0.682	0.346	C3809320	NEPHRONOPHTHISIS 16	disease		Disease or Syndrome	0.7	1	1990	2013	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
35357	653361	NCF1	0.521	0.808	C1856251	Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome B-Positive, Type I	disease	C16;C20;C15	Disease or Syndrome	0.7	1	2000	2013	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
35359	653509	SFTPA1	0.546	0.808	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.57	1	2003	2019	2	0	GENOMICS_ENGLAND;ORPHANET
35529	724066	ATXN8	0.743	0.269	C1837454	SPINOCEREBELLAR ATAXIA 8	disease	C16;C10	Disease or Syndrome	0.67	1	1999	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35532	727676	SNORD118	0.686	0.462	C3281200	LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	disease	C16;C04;C18;C10	Disease or Syndrome	0.71	1	2016	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35534	727857	BHLHA9	0.644	0.269	C1836206	Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction	disease	C16;C05	Disease or Syndrome	0.71	1	2012	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35535	727857	BHLHA9	0.644	0.269	C1843758	Camptosynpolydactyly, Complex	disease	C16;C05	Disease or Syndrome	0.6	1	2016	2016	1	1	CTD_human;UNIPROT
35541	727897	MUC5B	0.532	0.808	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.7	0.952	2011	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35556	728294	D2HGDH	0.691	0.5	C2746066	Combined D-2- and L-2-hydroxyglutaric aciduria	disease	C16;C18;C10	Disease or Syndrome	0.66	1	2005	2019	1	0	CTD_human;GENOMICS_ENGLAND
35557	728294	D2HGDH	0.691	0.5	C3152055	D-2-HYDROXYGLUTARIC ACIDURIA 1	disease		Disease or Syndrome	0.74	1	2005	2019	5	10	GENOMICS_ENGLAND;ORPHANET;UNIPROT
35592	729238	SFTPA2	0.563	0.731	C1800706	Idiopathic Pulmonary Fibrosis	disease	C08	Disease or Syndrome	0.74	1	2009	2017	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35606	729920	CRPPA	0.566	0.654	C0265221	Walker-Warburg congenital muscular dystrophy	disease	C16;C11;C10	Disease or Syndrome	0.65	1	2012	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35619	729920	CRPPA	0.566	0.654	C3553330	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7	disease		Disease or Syndrome	0.6	1	1989	2015	7	19	GENOMICS_ENGLAND;UNIPROT
35620	729920	CRPPA	0.566	0.654	C4015095	MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 7	disease		Disease or Syndrome	0.7	1	1989	2017	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35626	768206	PRCD	0.7	0.269	C1864621	RETINITIS PIGMENTOSA 36	disease	C16;C11	Disease or Syndrome	0.7	1	2006	2016	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
35657	790955	UQCC3	0.839	0.038	C4015253	MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	disease		Disease or Syndrome	0.6	1	2014	2017	2	0	GENOMICS_ENGLAND;UNIPROT
35781	100128927	ZBTB42	0.931	0.115	C4015686	LETHAL CONGENITAL CONTRACTURE SYNDROME 6	disease		Disease or Syndrome	0.61	1	2014	2014	1	1	CTD_human;UNIPROT
35784	100131801	PET100	0.65	0.577	C0023264	Leigh Disease	disease	C16;C18;C10	Disease or Syndrome	0.52	1	1996	2015	4	0	CLINGEN;GENOMICS_ENGLAND
35786	100131801	PET100	0.65	0.577	C0268237	Cytochrome-c Oxidase Deficiency	disease	C16;C18	Disease or Syndrome; Congenital Abnormality	0.62	1	2013	2015	3	2	CTD_human;GENOMICS_ENGLAND
35799	100134444	KCNJ18	0.722	0.346	C2750473	THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2	disease		Finding	0.7	1	2010	2016	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
35807	100151683	RNU4ATAC	0.556	0.808	C1846059	Roifman syndrome	disease	C16;C11;C05;C20;C10;C14	Disease or Syndrome	0.74	1	2015	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35808	100151683	RNU4ATAC	0.556	0.808	C1859452	MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	disease	C23;C16;C13;C05;C10;C19	Congenital Abnormality	0.7	1	2011	2019	3	0	CTD_human;GENOMICS_ENGLAND
35817	100288687	DUX4	0.604	0.5	C0238288	Muscular Dystrophy, Facioscapulohumeral	disease	C16;C05;C10	Disease or Syndrome	0.6	0.989	2006	2019	1	0	CTD_human;ORPHANET
36015	100506658	OCLN	0.507	0.846	C3489725	Pseudo-TORCH syndrome	disease	C16;C20;C10	Disease or Syndrome	0.62	1	2010	2016	2	3	GENOMICS_ENGLAND;ORPHANET
36016	100506658	OCLN	0.507	0.846	C4552078	PSEUDO-TORCH SYNDROME 1	disease	C16;C20;C10	Disease or Syndrome	0.7	1	2010	2013	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
36130	100996717	NOTCH2NLC	0.78	0.192	C1863843	Neuronal intranuclear inclusion disease	disease	C10	Disease or Syndrome	0.53	1	2019	2019	3	0	CTD_human;ORPHANET
NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
